Citrus Sinensis ID: 047140
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.920 | 0.285 | 0.401 | 6e-57 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.849 | 0.259 | 0.404 | 2e-51 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.865 | 0.262 | 0.399 | 2e-47 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.907 | 0.289 | 0.335 | 7e-44 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.884 | 0.236 | 0.328 | 4e-37 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.760 | 0.190 | 0.342 | 2e-36 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.869 | 0.423 | 0.319 | 2e-34 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.747 | 0.187 | 0.353 | 2e-34 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.869 | 0.326 | 0.303 | 4e-34 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.776 | 0.355 | 0.351 | 2e-33 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 221 bits (562), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 124/309 (40%), Positives = 177/309 (57%), Gaps = 21/309 (6%)
Query: 21 RSQTSDFQILNFFICGVIIPVAQ-FLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR 79
R+ T+ F N G V + L++ VAVKV N+Q A KSF ECE +K IR
Sbjct: 696 RNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIR 755
Query: 80 HRNLIKVISTCS-----NEEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLN 126
HRNL+K+++ CS EF+AL+ E+MP+GSL+ +L+ L + +RLN
Sbjct: 756 HRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLN 815
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL-----TGEYQS 181
I IDVAS L+YLH + HCDLKP NVLLDD++ AH+SDF +A+LL +
Sbjct: 816 IAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ 875
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
++ TIG APEY G+ S NGDVYSFGI+L+E FT K+PT+E+F TL +
Sbjct: 876 LSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYT 935
Query: 242 NNWLPISTMEVVDANLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ LP +++VD ++L + F E C++ VF + + C ESP R+ +V +L
Sbjct: 936 KSALPERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKEL 994
Query: 301 FKIRDSLLR 309
IR+ +
Sbjct: 995 ISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 116/287 (40%), Positives = 165/287 (57%), Gaps = 21/287 (7%)
Query: 44 FLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF-----KAL 98
FL S VA+KV NL A KSF ECE + IRHRNL+K+++ CS+ +F +AL
Sbjct: 737 FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRAL 796
Query: 99 VLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
V E+MP+G+L+ +L+ L +F RLNI IDVASAL YLH + HCD
Sbjct: 797 VYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCD 856
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLL------TGEYQSMTQTQTLATIGCIAPEYRRKGRE 204
+KP N+LLD ++ AH+SDF +A+LL T Q + TIG APEY G
Sbjct: 857 IKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQ-FSSAGVRGTIGYAAPEYGMGGHP 915
Query: 205 STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTMEVVDANLLSQEDI 263
S GDVYSFGI+L+E FT K+PT+++F +TL + + L +++ D +L
Sbjct: 916 SIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYA 975
Query: 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
+C++ VF + + C+ ESP RI+ E ++KL IR+S R+
Sbjct: 976 QHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 121/303 (39%), Positives = 160/303 (52%), Gaps = 32/303 (10%)
Query: 22 SQTSDFQILNFFICGVIIPVAQFLISSAME-VAVKVFNLQCGRAFKSFNIECEMMKSIRH 80
S TS F N G V + L+ + VAVKV NL A KSF ECE K IRH
Sbjct: 707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766
Query: 81 RNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNI 127
RNL+K+I+ CS+ +F+ALV E+MP GSL+ +L + L ++LNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY------QS 181
IDVASALEYLH V HCD+KP N+LLDD++ AH+SDF +A+LL +Y
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLY-KYDRESFLNQ 885
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
+ TIG APEY G+ S GDVYSFGI+L+E F+ KKPTDE F + L +
Sbjct: 886 FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT 945
Query: 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301
+ L T A ++ + V + I+C+ E P R+ E V +L
Sbjct: 946 KSILSGCTSSGGSN-----------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELI 994
Query: 302 KIR 304
IR
Sbjct: 995 SIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 103/307 (33%), Positives = 170/307 (55%), Gaps = 23/307 (7%)
Query: 22 SQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFK-SFNIECEMMKSIRH 80
+ T F + G V + ++ + +VAVKV + + F SF EC+++K RH
Sbjct: 656 AATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRH 715
Query: 81 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEY 137
RNLI++I+TCS F ALVL MP+GSLE++LY S+ LD+ Q +NI DVA + Y
Sbjct: 716 RNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAY 775
Query: 138 LHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-------- 189
LH +V+HCDLKP N+LLDD M A ++DF I++L+ G ++++ +++
Sbjct: 776 LHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLL 835
Query: 190 --TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247
++G IAPEY R ST+GDVYSFG++L+E + ++PTD + N +L + + P
Sbjct: 836 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPD 895
Query: 248 STMEVVDANLLSQEDIHFVAKEQCVSF-------VFNLAIECTVESPEQRINAREIVAKL 300
S +++ L + E+C + L + CT +P R + ++ ++
Sbjct: 896 SLEGIIEQALSRWKPQG--KPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEM 953
Query: 301 FKIRDSL 307
++++ L
Sbjct: 954 GRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 97/295 (32%), Positives = 160/295 (54%), Gaps = 18/295 (6%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHR 81
T F N + V + + +AVKV NL+ + K F E + + ++HR
Sbjct: 867 TDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHR 926
Query: 82 NLIKVIS-TCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLH 139
NL+K++ + + KALVL +M +G+LE ++ S I + +++++ + +AS ++YLH
Sbjct: 927 NLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLH 986
Query: 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA---TIGCIAP 196
GY ++HCDLKP N+LLD + VAH+SDF A++L T T A TIG +AP
Sbjct: 987 SGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046
Query: 197 EYRRKGRESTNGDVYSFGIMLMETFTRKKPT--DEIFNREMTL-----KHWGNNWLPIST 249
E+ + +T DV+SFGI++ME T+++PT ++ +++MTL K GN
Sbjct: 1047 EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGR--KGM 1104
Query: 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
+ V+D L + I + +E+ + L + CT PE R + EI+ L K+R
Sbjct: 1105 VRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 85/248 (34%), Positives = 138/248 (55%), Gaps = 10/248 (4%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYLYSSNC-----I 118
KSFN E + + +IRHR+L+K++ CS+ + L+ EYM +GS+ +L+++ +
Sbjct: 988 KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047
Query: 119 LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
L RL I + +A +EYLH+ ++H D+K NVLLD N+ AHL DF +AK+LTG
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107
Query: 179 YQSMTQTQTL--ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT 236
Y + T++ T+ + G IAPEY + + DVYS GI+LME T K PT+ +F+ E
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167
Query: 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF-VFNLAIECTVESPEQRINARE 295
+ W L L+ E + E+ ++ V +A++CT P++R ++R+
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQ 1227
Query: 296 IVAKLFKI 303
L +
Sbjct: 1228 ASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 146 bits (369), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 91/285 (31%), Positives = 146/285 (51%), Gaps = 13/285 (4%)
Query: 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH 80
R T DF + N G V + + +E+AVK ++ G+ F E +M ++H
Sbjct: 327 RVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQH 386
Query: 81 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYL 138
+NL+K+ E + LV E++P+ SL+++L+ LD +R NI++ V+ L YL
Sbjct: 387 KNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYL 446
Query: 139 HFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEY 198
H G +IH DLK NVLLD+ M+ +SDF +A+ + + + T G +APEY
Sbjct: 447 HEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEY 506
Query: 199 RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG-NNWLPISTMEVVDANL 257
GR S DVYSFG++++E T K+ + L + NW+ ++ME++D L
Sbjct: 507 AMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGTDLPTFAWQNWIEGTSMELIDPVL 566
Query: 258 LSQEDIHFVAKE--QCVSFVFNLAIECTVESPEQRINAREIVAKL 300
L D KE QC+ +A+ C E+P +R +V+ L
Sbjct: 567 LQTHD----KKESMQCL----EIALSCVQENPTKRPTMDSVVSML 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (369), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 89/252 (35%), Positives = 135/252 (53%), Gaps = 18/252 (7%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYLYSSNCIL---- 119
KSF+ E + + IRHR+L+K++ CS+ E L+ EYM +GS+ +L+ +L
Sbjct: 991 KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050
Query: 120 ---DIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176
D RL I + +A +EYLH ++H D+K NVLLD NM AHL DF +AK+LT
Sbjct: 1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110
Query: 177 GEYQSMTQTQTL--ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234
+ T + T + G IAPEY + + DVYS GI+LME T K PTD +F E
Sbjct: 1111 ENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE 1170
Query: 235 MTLKHWGNNWLPISTM---EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI 291
M + W L ++ +++D L + + F C V +A++CT SP++R
Sbjct: 1171 MDMVRWVETHLEVAGSARDKLIDPKL--KPLLPFEEDAACQ--VLEIALQCTKTSPQERP 1226
Query: 292 NAREIVAKLFKI 303
++R+ L +
Sbjct: 1227 SSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 145 bits (366), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 86/283 (30%), Positives = 150/283 (53%), Gaps = 11/283 (3%)
Query: 22 SQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR 81
+ T++F N G PV + ++ + ME+AVK + G+ + F E +++ ++HR
Sbjct: 510 AATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHR 569
Query: 82 NLIKVISTCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLH 139
NL++++ C E K LV EY+P+ SL+ +++ LD +R+ I+ +A + YLH
Sbjct: 570 NLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLH 629
Query: 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYR 199
++IH DLK N+LLD M+ +SDF +A++ G ++ + T G +APEY
Sbjct: 630 QDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYA 689
Query: 200 RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT--LKHWGNNWLPISTMEVVDANL 257
+G+ S DVYSFG++++E T KK + F+ E + + H + W E++D NL
Sbjct: 690 MEGQFSIKSDVYSFGVLMLEIITGKK--NSAFHEESSNLVGHIWDLWENGEATEIID-NL 746
Query: 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ QE E+ V + + C E+ R++ +V L
Sbjct: 747 MDQE----TYDEREVMKCIQIGLLCVQENASDRVDMSSVVIML 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (359), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 90/256 (35%), Positives = 135/256 (52%), Gaps = 13/256 (5%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
VAVK + + + + F E + +RHRNL++++ C + LV ++MP+GSL+ Y
Sbjct: 372 VAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMY 431
Query: 112 LYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L+ N IL QR I+ VAS L YLH G+ VIH D+K NVLLD M + DF
Sbjct: 432 LFDENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDF 491
Query: 170 SIAKLLTGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
+AKL E+ S T+ + T G +APE + G+ +T+ DVY+FG +L+E ++P +
Sbjct: 492 GLAKLY--EHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIE 549
Query: 229 -EIFNREMTLKHW-GNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
E+ + W + W +VVD L + D E+ V V L + C+ S
Sbjct: 550 TSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFD------EEEVVMVIKLGLLCSNNS 603
Query: 287 PEQRINAREIVAKLFK 302
PE R R++V L K
Sbjct: 604 PEVRPTMRQVVMYLEK 619
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.913 | 0.280 | 0.574 | 8e-88 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.821 | 0.213 | 0.606 | 1e-87 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.936 | 0.269 | 0.543 | 7e-87 | |
| 302143440 | 929 | unnamed protein product [Vitis vinifera] | 0.865 | 0.291 | 0.593 | 2e-86 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.865 | 0.186 | 0.593 | 6e-86 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.891 | 0.196 | 0.574 | 1e-85 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.881 | 0.237 | 0.594 | 2e-85 | |
| 147855067 | 646 | hypothetical protein VITISV_024048 [Viti | 0.888 | 0.430 | 0.576 | 2e-84 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.932 | 0.275 | 0.530 | 2e-83 | |
| 359492792 | 1067 | PREDICTED: probable LRR receptor-like se | 0.900 | 0.264 | 0.538 | 2e-83 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 329 bits (844), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 165/287 (57%), Positives = 210/287 (73%), Gaps = 1/287 (0%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL 83
T++F N G V Q + + VAVK+FNLQ RAF+SF+ ECE+M++IRHRNL
Sbjct: 728 TNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNL 787
Query: 84 IKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 143
+K+I +CSN +FKALVLEYMP GSLEK+LYS N LDI QR+NIMIDVASALEYLH GY
Sbjct: 788 VKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYP 847
Query: 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR 203
+ V+HCDLKP NVLLD++MVAH+ DF IAKLL GE +S QT+TLATIG +APEY G
Sbjct: 848 SPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGL 906
Query: 204 ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263
ST DVYSFGIMLME TRK+PTDE+F EM+LK LP S +++VD+N+L++ D
Sbjct: 907 VSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDG 966
Query: 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
+ V KE CV+ + LA++C ESP +R+ EI+A+L I+ LR+
Sbjct: 967 YSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (842), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 162/267 (60%), Positives = 202/267 (75%), Gaps = 10/267 (3%)
Query: 41 VAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
V + ++S + VAVKVFNL+ AFKSF +ECE+M++IRHRNL K+IS+CSN +FKALVL
Sbjct: 932 VYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVL 991
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
EYMP+GSLEK+LYS N LD QRL IMIDVAS LEYLH YS V+HCDLKP NVLLDD
Sbjct: 992 EYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDD 1051
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+MVAH+SDF IAKLL G + M +T+TL T+G +APEY +G ST GD+YS+GI+LMET
Sbjct: 1052 DMVAHISDFGIAKLLMGS-EFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMET 1110
Query: 221 FTRKKPTDEIFNREMTLKHW----GNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 276
F RKKPTDE+F E+TLK W NN MEV+DANLL++ED F K C S +
Sbjct: 1111 FVRKKPTDEMFVEELTLKSWVESSTNN-----IMEVIDANLLTEEDESFALKRACFSSIM 1165
Query: 277 NLAIECTVESPEQRINAREIVAKLFKI 303
LA++CTVE PE+RIN +++V +L K+
Sbjct: 1166 TLALDCTVEPPEKRINTKDVVVRLKKL 1192
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 326 bits (836), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 162/298 (54%), Positives = 217/298 (72%), Gaps = 5/298 (1%)
Query: 9 AFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSF 68
++ I +++F+ T+ F N G + V + +S A+KVFNLQ AFKSF
Sbjct: 788 TWRRISYQEIFQ--ATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSF 845
Query: 69 NIECEMMKSIRHRNLIKVISTCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 126
+ ECE+M IRHRNLIK++S+CSN +FKALVLEY+P+GSLE++LYS N LDI QRLN
Sbjct: 846 DAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLN 905
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
IMIDVA A+EYLH G S V+HCDLKP N+LLD++ H+ DF IAKLL E +S+ +TQ
Sbjct: 906 IMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EEESIRETQ 964
Query: 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246
TLATIG +AP+Y G +T+GDVYS+GI+LMETFTR++PTDEIF+ EM++K+W +WL
Sbjct: 965 TLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLC 1024
Query: 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
S EVVDANLL ED F+AK+QC+S + LA++C +SPE+RI +++V L KI+
Sbjct: 1025 GSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143440|emb|CBI22001.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 324 bits (831), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 162/273 (59%), Positives = 207/273 (75%), Gaps = 2/273 (0%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95
G + V + ++S+ + VAVKVFNL+ AF+SF+ ECE+M+SIRHRNL+K+I+ CSN +F
Sbjct: 658 GSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDF 717
Query: 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
KALVLEYMP GSL+K+LYS N LD+ QRLNIMIDVASALEYLH + V+HCDLKP N
Sbjct: 718 KALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNN 777
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
+LLDD+MVAH+ DF IA+LLT E +SM QT+TL TIG +APEY G ST GDV+S+GI
Sbjct: 778 ILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGI 836
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
MLME F RKKP DE+FN ++TLK W + L S +EVVDANLL +ED F K C+S +
Sbjct: 837 MLMEVFARKKPMDEMFNGDLTLKSWVES-LADSMIEVVDANLLRREDEDFATKLSCLSSI 895
Query: 276 FNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
LA+ CT +SPE+RI+ +++V L KI+ LL
Sbjct: 896 MALALACTTDSPEERIDMKDVVVGLKKIKIELL 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 323 bits (828), Expect = 6e-86, Method: Composition-based stats.
Identities = 162/273 (59%), Positives = 207/273 (75%), Gaps = 2/273 (0%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95
G + V + ++S+ + VAVKVFNL+ AF+SF+ ECE+M+SIRHRNL+K+I+ CSN +F
Sbjct: 1183 GSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDF 1242
Query: 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
KALVLEYMP GSL+K+LYS N LD+ QRLNIMIDVASALEYLH + V+HCDLKP N
Sbjct: 1243 KALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNN 1302
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
+LLDD+MVAH+ DF IA+LLT E +SM QT+TL TIG +APEY G ST GDV+S+GI
Sbjct: 1303 ILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGI 1361
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
MLME F RKKP DE+FN ++TLK W + L S +EVVDANLL +ED F K C+S +
Sbjct: 1362 MLMEVFARKKPMDEMFNGDLTLKSWVES-LADSMIEVVDANLLRREDEDFATKLSCLSSI 1420
Query: 276 FNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
LA+ CT +SPE+RI+ +++V L KI+ LL
Sbjct: 1421 MALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 322 bits (825), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 166/289 (57%), Positives = 209/289 (72%), Gaps = 10/289 (3%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL 83
TS F N G + V + ++S + VAVKVFNL+ AFKSF +ECE+M++IRHRNL
Sbjct: 916 TSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNL 975
Query: 84 IKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 143
K+IS+CSN +FKALVLEYMP+ SLEK+LYS N LD QRL IMIDVAS LEYLH YS
Sbjct: 976 AKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYS 1035
Query: 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR 203
V+HCDLKP NVLLDD+MVAH+SDF IAKLL G + M +T+TL TIG +APEY +G
Sbjct: 1036 NPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKRTKTLGTIGYMAPEYGSEGI 1094
Query: 204 ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW----GNNWLPISTMEVVDANLLS 259
ST D YS+GI+LME F RKKPTDE+F E+TLK W NN MEV+DANLL+
Sbjct: 1095 VSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVESSANN-----IMEVIDANLLT 1149
Query: 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
+ED F K+ C S + LA++CT+E PE+RIN +++VA+L KI + ++
Sbjct: 1150 EEDESFALKQACFSSIMTLALDCTIEPPEKRINMKDVVARLKKILNQIV 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 322 bits (825), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 166/279 (59%), Positives = 206/279 (73%), Gaps = 3/279 (1%)
Query: 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTC 90
N G + V + ++S VAVKVFNL+ AFKSF+ ECE+M++I+HRNL+K+IS+C
Sbjct: 882 NMIGTGSLGMVHRGVLSDGSIVAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSC 941
Query: 91 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ-VIHC 149
S FKALVLEYMP+GSLEK+LYS N L++ QRLNIMIDVASALEYLH +S V+HC
Sbjct: 942 SILNFKALVLEYMPNGSLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHC 1001
Query: 150 DLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
DLKP NVLLD+ MVA L DF I+KLLT E +SM QT+TL TIG +APEY +G ST GD
Sbjct: 1002 DLKPNNVLLDEEMVARLGDFGISKLLT-ETESMEQTRTLGTIGYMAPEYGSEGIVSTRGD 1060
Query: 210 VYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKE 269
VYS+GIM+METF RKKPTDE+F E+TL+ W + L MEVVD NL+ +ED HF KE
Sbjct: 1061 VYSYGIMMMETFARKKPTDEMFGGEVTLRSWVES-LAGRVMEVVDGNLVRREDQHFGIKE 1119
Query: 270 QCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
C+ + LA+ECT ESP RI+ +E+V +L KIR LL
Sbjct: 1120 SCLRSIMALALECTTESPRDRIDMKEVVVRLKKIRIKLL 1158
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147855067|emb|CAN82376.1| hypothetical protein VITISV_024048 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 318 bits (814), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 166/288 (57%), Positives = 206/288 (71%), Gaps = 10/288 (3%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL 83
TS F N G + V + ++S + VAVKVFNL+ AFKSF +ECE+M++I HRNL
Sbjct: 340 TSYFCEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNICHRNL 399
Query: 84 IKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 143
K+I++CSN +FKALVLEYMP+GSLEK+LYS N LD FQRL IMIDVAS LEYLH YS
Sbjct: 400 AKIINSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFFQRLKIMIDVASGLEYLHHDYS 459
Query: 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR 203
V+HCDLKP NVLLDDNMVAH+SDF IAKLL G M +T+TL TIG +APEY +G
Sbjct: 460 NPVVHCDLKPSNVLLDDNMVAHISDFGIAKLLMGSV-FMKRTKTLGTIGYMAPEYGSEGI 518
Query: 204 ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW----GNNWLPISTMEVVDANLLS 259
ST GD+YS+GIMLMETF RKKPTDE+F E+TLK W NN MEV+D +LL
Sbjct: 519 VSTKGDIYSYGIMLMETFVRKKPTDEMFMEELTLKSWVESSANN-----IMEVIDVDLLI 573
Query: 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+ED + C S + LA++CTVE PE+RIN +++V +L KI + +
Sbjct: 574 EEDEKISLRPACFSSIITLALDCTVEPPEKRINMKDVVVRLKKILNQI 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 315 bits (807), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 157/296 (53%), Positives = 214/296 (72%), Gaps = 4/296 (1%)
Query: 9 AFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSF 68
++ I +++R T F N G V + +S + +AVKVF+LQ F
Sbjct: 755 TWRKISYHELYR--ATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRF 812
Query: 69 NIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
+ ECE+++ +RHRNL+K+IS+C N +FKAL+LE++PHGSLEK+LYS N LDI QRLNIM
Sbjct: 813 DSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIM 872
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188
IDVASALEYLH G + V+HCDLKP NVL++++MVAH+SDF I++LL GE ++TQT TL
Sbjct: 873 IDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTL 931
Query: 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248
ATIG +APEY +G S GDVYS+GI LMETFTRKKPTD++F EM+LK+W LP +
Sbjct: 932 ATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKA 991
Query: 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
EV+DANLL +E+ HFVAK+ C++ + NLA+EC+ + P +RI R+++ L KI+
Sbjct: 992 ITEVIDANLLIEEE-HFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492792|ref|XP_002278117.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 315 bits (806), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 153/284 (53%), Positives = 209/284 (73%), Gaps = 2/284 (0%)
Query: 22 SQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR 81
S T++F N G V + +S AVK+ +LQ A KSF+ ECE+++++RHR
Sbjct: 778 SATNNFCEANLLGVGSFGSVYKGTLSDNTIAAVKILDLQVEGALKSFDAECEVLRNVRHR 837
Query: 82 NLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 141
NL+K+IS+CSN +F+ALVL+YMP+GSLE+ LYS N LD+ QRLNIMIDVA+A+EYLH G
Sbjct: 838 NLVKIISSCSNLDFRALVLQYMPNGSLERMLYSYNYFLDLTQRLNIMIDVATAVEYLHHG 897
Query: 142 YSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK 201
YS V+HCDLKP NVLLD+ MVAH++DF IAK+ +Y+SMTQT T+ T+G IAPEY +
Sbjct: 898 YSETVVHCDLKPSNVLLDEEMVAHVNDFGIAKIFA-KYKSMTQTATVGTMGYIAPEYGSE 956
Query: 202 GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261
GR ST GDVYS+GIMLMETFTRKKPT E+F ++L+ W ++ P MEVVDANLL+++
Sbjct: 957 GRVSTKGDVYSYGIMLMETFTRKKPTHEMFVGGLSLRQWVDSSFPDLIMEVVDANLLARD 1016
Query: 262 DIHFVAKEQ-CVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
+ Q C+ + L ++C+++SPEQR++ +E+V +L KIR
Sbjct: 1017 QNNTNGNLQTCLLSIMGLGLQCSLDSPEQRLDMKEVVVRLSKIR 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.920 | 0.285 | 0.404 | 1.7e-51 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.920 | 0.285 | 0.381 | 1.5e-49 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.920 | 0.284 | 0.385 | 1.8e-48 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.968 | 0.295 | 0.387 | 6.2e-47 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.862 | 0.537 | 0.406 | 1.4e-41 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.817 | 0.249 | 0.365 | 2.4e-41 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.869 | 0.263 | 0.403 | 4e-41 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.817 | 0.261 | 0.357 | 5e-39 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.884 | 0.236 | 0.328 | 7.3e-36 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.760 | 0.190 | 0.346 | 1.8e-33 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 1.7e-51, P = 1.7e-51
Identities = 125/309 (40%), Positives = 179/309 (57%)
Query: 21 RSQTSDFQILNFFICGVIIPVAQ-FLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR 79
R+ T+ F N G V + L++ VAVKV N+Q A KSF ECE +K IR
Sbjct: 696 RNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIR 755
Query: 80 HRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLN 126
HRNL+K+++ CS+ EF+AL+ E+MP+GSL+ +L+ L + +RLN
Sbjct: 756 HRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLN 815
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT--GE---YQS 181
I IDVAS L+YLH + HCDLKP NVLLDD++ AH+SDF +A+LL E +
Sbjct: 816 IAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ 875
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
++ TIG APEY G+ S NGDVYSFGI+L+E FT K+PT+E+F TL +
Sbjct: 876 LSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYT 935
Query: 242 NNWLPISTMEVVDANLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ LP +++VD ++L + F E C++ VF + + C ESP R+ +V +L
Sbjct: 936 KSALPERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLATSIVVKEL 994
Query: 301 FKIRDSLLR 309
IR+ +
Sbjct: 995 ISIRERFFK 1003
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 118/309 (38%), Positives = 176/309 (56%)
Query: 21 RSQTSDFQILNFFICGVIIPVAQFLISSAME-VAVKVFNLQCGRAFKSFNIECEMMKSIR 79
R+ T F N G V + L+ + + VAVKV N+Q A KSF ECE +K IR
Sbjct: 695 RNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIR 754
Query: 80 HRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLN 126
HRNL+K+++ C++ EF+AL+ E+MP+GSL+K+L+ L + +RLN
Sbjct: 755 HRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLN 814
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT-----GEYQS 181
I IDVAS L+YLH + HCDLKP N+LLDD++ AH+SDF +A+LL +
Sbjct: 815 IAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQ 874
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
++ TIG APEY G+ S +GDVYSFG++++E FT K+PT+E+F TL +
Sbjct: 875 LSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYT 934
Query: 242 NNWLPISTMEVVDANLL-SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
LP +++ D ++L S + F E C+ + ++ + C ESP R+ E +L
Sbjct: 935 KAALPERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCEESPLNRLATSEAAKEL 993
Query: 301 FKIRDSLLR 309
IR+ +
Sbjct: 994 ISIRERFFK 1002
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 1.8e-48, P = 1.8e-48
Identities = 119/309 (38%), Positives = 176/309 (56%)
Query: 21 RSQTSDFQILNFFICGVIIPVAQFLISSAME-VAVKVFNLQCGRAFKSFNIECEMMKSIR 79
R+ T+ F N G V + L+ + + VAVKV N+Q A KSF ECE +K R
Sbjct: 697 RNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTR 756
Query: 80 HRNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLN 126
HRNL+K+++ C++ EF+AL+ EY+P+GS++ +L+ L + +RLN
Sbjct: 757 HRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLN 816
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG-EYQSMTQT 185
I+IDVAS L+YLH + HCDLKP NVLL+D++ AH+SDF +A+LL + +S
Sbjct: 817 IVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQ 876
Query: 186 QTLA----TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
+ A TIG APEY G+ S +GDVYSFG++L+E FT K+PTDE+F +TL +
Sbjct: 877 LSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYT 936
Query: 242 NNWLPISTMEVVDANLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
LP E+ D +L + F E C++ V + + C E P R+ E+ +L
Sbjct: 937 KLALPEKVFEIADKAILHIGLRVGFRTAE-CLTLVLEVGLRCCEEYPTNRLATSEVAKEL 995
Query: 301 FKIRDSLLR 309
IR+ +
Sbjct: 996 ISIRERFFK 1004
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.2e-47, P = 6.2e-47
Identities = 127/328 (38%), Positives = 182/328 (55%)
Query: 5 SNILAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQ-FLISSAMEVAVKVFNLQCGR 63
S + +F +S D ++ T F N G V + FL S VA+KV NL C R
Sbjct: 698 SPVKSFYEKISYDELYKT-TGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKR 755
Query: 64 -AFKSFNIECEMMKSIRHRNLIKVISTCSNEEF-----KALVLEYMPHGSLEKYLYSSNC 117
A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E+MP+G+L+ +L+
Sbjct: 756 GAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI 815
Query: 118 --------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L +F RLNI IDVASAL YLH + HCD+KP N+LLD ++ AH+SDF
Sbjct: 816 EETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDF 875
Query: 170 SIAKLL------TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
+A+LL T Q + TIG APEY G S GDVYSFGI+L+E FT
Sbjct: 876 GLAQLLLKFDRDTFHIQ-FSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTG 934
Query: 224 KKPTDEIFNREMTLKHWGNNWLPI-STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
K+PT+++F +TL + + L +++ D +L +C++ VF + + C
Sbjct: 935 KRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSC 994
Query: 283 TVESPEQRINAREIVAKLFKIRDSLLRN 310
+ ESP RI+ E ++KL IR+S R+
Sbjct: 995 SEESPVNRISMAEAISKLVSIRESFFRD 1022
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.4e-41, P = 1.4e-41
Identities = 122/300 (40%), Positives = 161/300 (53%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAME-VAVKVFNLQCGRAFKSFNIECEMMKSIRHRN 82
TS F N G V + L+ + VAVKV NL A KSF ECE K IRHRN
Sbjct: 206 TSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRN 265
Query: 83 LIKVISTCSN-----EEFKALVLEYMPHGSLEKYLY-----SSNC---ILDIFQRLNIMI 129
L K+I+ CS+ +F+ALV E+MP GSL+ +L S+N L +++NI I
Sbjct: 266 LAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAI 325
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG--EYQSMTQTQT 187
DVASALEYLH V HCD+KP NVLLDD++ AH+SDF +A+LL E + Q +
Sbjct: 326 DVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSS 385
Query: 188 LA---TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244
TIG APEY + S GDVYSFG++L+E FT KKPTD F L + +
Sbjct: 386 AGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHGYTKSV 445
Query: 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
L ST S+ V ++ + V + I+C+ E P R+ E V +L I+
Sbjct: 446 LSCST---------SRGGRTMV--DEWLRLVLEVGIKCSEEYPRDRMGMAEAVRELVSIK 494
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 2.4e-41, P = 2.4e-41
Identities = 102/279 (36%), Positives = 165/279 (59%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-----EEFKALVLEYMPHG 106
VAVKV L+ +A KSF ECE ++++RHRNL+K+++ CS+ +FKA+V ++MP+G
Sbjct: 733 VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNG 792
Query: 107 SLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
SLE +++ + L++ +R+ I++DVA AL+YLH V+HCD+K NVLLD
Sbjct: 793 SLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDS 852
Query: 161 NMVAHLSDFSIAKLL---TGEYQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIM 216
+MVAH+ DF +A++L T Q T + + TIG APEY ST+GD+YS+GI+
Sbjct: 853 DMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGIL 912
Query: 217 LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL--SQEDIHFVAKE----- 269
++E T K+PTD F ++ L+ + L +VVD L+ S+ ++
Sbjct: 913 VLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRI 972
Query: 270 -QCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+C+ ++ L + C+ E P R +I+ +L I+ +L
Sbjct: 973 TECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 4.0e-41, P = 4.0e-41
Identities = 122/302 (40%), Positives = 164/302 (54%)
Query: 22 SQTSDFQILNFFICGVIIPVAQFLISSAME-VAVKVFNLQCGRAFKSFNIECEMMKSIRH 80
S TS F N G V + L+ + VAVKV NL A KSF ECE K IRH
Sbjct: 707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766
Query: 81 RNLIKVISTCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNI 127
RNL+K+I+ CS+ +F+ALV E+MP GSL+ +L + L ++LNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG-EYQSMTQTQ 186
IDVASALEYLH V HCD+KP N+LLDD++ AH+SDF +A+LL + +S
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQF 886
Query: 187 TLA----TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242
+ A TIG APEY G+ S GDVYSFGI+L+E F+ KKPTDE F + L +
Sbjct: 887 SSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK 946
Query: 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302
+ L T +N + ++ + V + I+C+ E P R+ E V +L
Sbjct: 947 SILSGCTSSG-GSNAI----------DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELIS 995
Query: 303 IR 304
IR
Sbjct: 996 IR 997
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 5.0e-39, P = 5.0e-39
Identities = 99/277 (35%), Positives = 161/277 (58%)
Query: 51 EVAVKVFNLQCGRAFK-SFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVKV + + F SF EC+++K RHRNLI++I+TCS F ALVL MP+GSLE
Sbjct: 685 KVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLE 744
Query: 110 KYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
++LY S+ LD+ Q +NI DVA + YLH +V+HCDLKP N+LLDD M A +
Sbjct: 745 RHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALV 804
Query: 167 SDFSIAKLLTGEYQSMTQTQTLA----------TIGCIAPEYRRKGRESTNGDVYSFGIM 216
+DF I++L+ G ++++ +++ ++G IAPEY R ST+GDVYSFG++
Sbjct: 805 TDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 864
Query: 217 LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL------SQEDIHFVAKEQ 270
L+E + ++PTD + N +L + + P S +++ L E + +E
Sbjct: 865 LLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREV 924
Query: 271 CVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+ + L + CT +P R + ++ ++ ++++ L
Sbjct: 925 ILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 7.3e-36, P = 7.3e-36
Identities = 97/295 (32%), Positives = 161/295 (54%)
Query: 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHR 81
T F N + V + + +AVKV NL+ + K F E + + ++HR
Sbjct: 867 TDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHR 926
Query: 82 NLIKVISTC-SNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLH 139
NL+K++ + + KALVL +M +G+LE ++ S I + +++++ + +AS ++YLH
Sbjct: 927 NLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLH 986
Query: 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA---TIGCIAP 196
GY ++HCDLKP N+LLD + VAH+SDF A++L T T A TIG +AP
Sbjct: 987 SGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAP 1046
Query: 197 EYRRKGRESTNGDVYSFGIMLMETFTRKKPT--DEIFNREMTL-----KHWGNNWLPIST 249
E+ + +T DV+SFGI++ME T+++PT ++ +++MTL K GN +
Sbjct: 1047 EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGM-- 1104
Query: 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
+ V+D L + I + +E+ + L + CT PE R + EI+ L K+R
Sbjct: 1105 VRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 377 (137.8 bits), Expect = 1.8e-33, P = 1.8e-33
Identities = 86/248 (34%), Positives = 139/248 (56%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEE--FKALVLEYMPHGSLEKYLYSS-NC----I 118
KSFN E + + +IRHR+L+K++ CS++ L+ EYM +GS+ +L+++ N +
Sbjct: 988 KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047
Query: 119 LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
L RL I + +A +EYLH+ ++H D+K NVLLD N+ AHL DF +AK+LTG
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107
Query: 179 YQSMTQTQTL--ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT 236
Y + T++ T+ + G IAPEY + + DVYS GI+LME T K PT+ +F+ E
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167
Query: 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF-VFNLAIECTVESPEQRINARE 295
+ W L L+ E + E+ ++ V +A++CT P++R ++R+
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQ 1227
Query: 296 IVAKLFKI 303
L +
Sbjct: 1228 ASEYLLNV 1235
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 313 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.004 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.004 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-38
Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 28/254 (11%)
Query: 50 MEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+EVAVK + F E +M+ + H N++K++ C+ EE +V+EYM G L
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL 88
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL + L + L+ + +A +EYL S IH DL N L+ +N+V +SD
Sbjct: 89 LSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISD 145
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +++ L + + I +APE ++G+ ++ DV+SFG++L E FT ++P
Sbjct: 146 FGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
+ N E+ +E + L Q C +++L ++C E
Sbjct: 205 PGMSNEEV--------------LEYLKNGYRLPQP-------PNCPPELYDLMLQCWAED 243
Query: 287 PEQRINAREIVAKL 300
PE R E+V L
Sbjct: 244 PEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 51 EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VA+K+ + + E E++K + H N++K+ +E LV+EY GSL+
Sbjct: 20 KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSD 168
L + L + L I++ + LEYLH S +IH DLKP N+LLD DN L+D
Sbjct: 80 DLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNGDVYSFGIMLME 219
F ++KLLT + + T +APE KG S D++S G++L E
Sbjct: 137 FGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 71/255 (27%), Positives = 119/255 (46%), Gaps = 29/255 (11%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+EVAVK + + F E +M+ + H N++K++ C+ EE +V+EYMP G L
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL 88
Query: 109 EKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
YL + L + L+ + +A +EYL S IH DL N L+ +N+V +S
Sbjct: 89 LDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
DF +++ L + I +APE ++G+ ++ DV+SFG++L E FT ++P
Sbjct: 146 DFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
+ N E+ +E + L + C ++ L ++C E
Sbjct: 205 YPGMSNAEV--------------LEYLKKGYRLPKP-------PNCPPELYKLMLQCWAE 243
Query: 286 SPEQRINAREIVAKL 300
PE R E+V L
Sbjct: 244 DPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 70/265 (26%), Positives = 109/265 (41%), Gaps = 43/265 (16%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNI----ECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101
+ VAVK+ + + E +++ + H N++++I +++ LV+E
Sbjct: 21 KGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVME 78
Query: 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
Y G L YL S L + I + + LEYLH S +IH DLKP N+LLD+N
Sbjct: 79 YCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDEN 134
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMET 220
V ++DF +AK L S+T T T +APE G DV+S G++L E
Sbjct: 135 GVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192
Query: 221 FTRKKP--------TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
T K P ++ R + + S S+E + K
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS---------GSEEAKDLIKK---- 239
Query: 273 SFVFNLAIECTVESPEQRINAREIV 297
C + P +R A EI+
Sbjct: 240 ---------CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 7e-35
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 25/253 (9%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+VAVK + F E +MK + H N+++++ C+ E +V EYMP G L
Sbjct: 29 TKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL 88
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L L + L + + +A +EYL S +H DL N L+ +N+V +SD
Sbjct: 89 LDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISD 145
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +++ + + + I +APE + G+ ++ DV+SFG++L E FT ++P
Sbjct: 146 FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY 205
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ N E+ LP E C ++ L ++C P
Sbjct: 206 PGMSNEEVLELLEDGYRLPRP--------------------ENCPDELYELMLQCWAYDP 245
Query: 288 EQRINAREIVAKL 300
E R E+V L
Sbjct: 246 EDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 31/252 (12%)
Query: 51 EVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+KV + + + E +++K ++H N++++ +E+ LV+EY G L
Sbjct: 26 LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L L + + + SALEYLH S ++H DLKP N+LLD++ L+DF
Sbjct: 86 DLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPE---YRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+A+ L + T T +APE + G+ D++S G++L E T K P
Sbjct: 142 GLARQLDPGEKLTTFVGTPEY---MAPEVLLGKGYGKAV---DIWSLGVILYELLTGKPP 195
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
K G +S E + + V +
Sbjct: 196 FPGDDQLLELFKKIGKP--KPPFPP--PEWDISPEAKDLI--RKL--LVKD--------- 238
Query: 287 PEQRINAREIVA 298
PE+R+ A E +
Sbjct: 239 PEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 39/268 (14%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNI----ECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101
EVAVK A + E +MK + H N+++++ C+ EE LVLE
Sbjct: 20 DGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76
Query: 102 YMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153
YM G L YL S L + L+ I +A +EYL S + +H DL
Sbjct: 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAA 133
Query: 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N L+ +++V +SDF +++ + + +T I +APE + G ++ DV+SF
Sbjct: 134 RNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF 193
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
G++L E FT P + N E+ L++ + L + E C
Sbjct: 194 GVLLWEIFTLGATPYPGLSNEEV-LEY------------LRKGYRLPK-------PEYCP 233
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKL 300
++ L + C PE R E+V +L
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 73/257 (28%), Positives = 117/257 (45%), Gaps = 37/257 (14%)
Query: 52 VAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK L+ A ++F E +M ++RH NL++++ +V EYM GSL
Sbjct: 32 VAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89
Query: 111 YLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
YL S ++ + Q+L +DV +EYL +H DL NVL+ +++VA +SDF
Sbjct: 90 YLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF 146
Query: 170 SIAKLLTGEYQSMTQTQTLAT--IGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
+AK +Q Q + APE R+ + ST DV+SFGI+L E ++
Sbjct: 147 GLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----- 194
Query: 228 DEIFNREMTLKHWGNNWLP-ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
+G P I +VV ++ A E C V+ + +C
Sbjct: 195 ------------FGRVPYPRIPLKDVVPH---VEKGYRMEAPEGCPPEVYKVMKDCWELD 239
Query: 287 PEQRINAREIVAKLFKI 303
P +R +++ +L I
Sbjct: 240 PAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 65/259 (25%), Positives = 100/259 (38%), Gaps = 46/259 (17%)
Query: 51 EVAVKVFNLQCGRA--FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHG 106
+AVK L ++ E ++ S++H N+++ + +EE L LEY+ G
Sbjct: 27 LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 107 SLEKYLYSSNCILDIFQRLNI------MIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
SL L F +L + L YLH S ++H D+K N+L+D
Sbjct: 87 SLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDS 136
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+ V L+DF AK L T +APE R D++S G ++E
Sbjct: 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196
Query: 221 FTRKKPTDEIFNREMTLKHWGNN----WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 276
T K P E+ N L G++ +P LS+E F+ K
Sbjct: 197 ATGKPPWSELGNPMAALYKIGSSGEPPEIPEH---------LSEEAKDFLRK-------- 239
Query: 277 NLAIECTVESPEQRINARE 295
C P++R A E
Sbjct: 240 -----CLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 20/262 (7%)
Query: 51 EVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGS 107
+VAVK N +S F E E+++++ H N++K C ++ L++EY+P GS
Sbjct: 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L YL +++ + L + ++YL S + IH DL N+L++ + +S
Sbjct: 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKIS 151
Query: 168 DFSIAKLLTG--EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
DF +AK+L +Y + + I APE R + S+ DV+SFG+ L E FT
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESP-IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210
Query: 226 PTDE---IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
P+ F R + + M V L +E C V++L C
Sbjct: 211 PSQSPPAEFLRMIGIAQ--------GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLC 262
Query: 283 TVESPEQRINAREIVAKLFKIR 304
P+ R + +++ + ++R
Sbjct: 263 WEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 46/272 (16%)
Query: 48 SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
VAVK A K F E E++ + +H N++K C+ + +V EYM HG
Sbjct: 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 107 SLEKYLYS------------SNCI-LDIFQRLNIMIDVASALEYL---HFGYSAQVIHCD 150
L K+L S S L + Q L I + +AS + YL HF +H D
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF------VHRD 147
Query: 151 LKPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
L N L+ ++V + DF +++ + T +Y + T+ I + PE + +T D
Sbjct: 148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH-TMLPIRWMPPESIMYRKFTTESD 206
Query: 210 VYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268
V+SFG++L E FT K+P + N E+ +E + L Q
Sbjct: 207 VWSFGVVLWEIFTYGKQPWYGLSNEEV--------------IECITQGRLLQR------P 246
Query: 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
C S V+++ + C P+QRIN ++I +L
Sbjct: 247 RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 51 EVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVK L+ G + ++F E ++MK +RH L+++ + CS EE +V EYM GSL
Sbjct: 32 KVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 110 KYLYSSNCILDIFQRLNIMID----VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
+L S RL ++D +A + YL S IH DL N+L+ +N+V
Sbjct: 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCK 143
Query: 166 LSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
++DF +A+L+ EY + I APE GR + DV+SFGI+L E T
Sbjct: 144 IADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201
Query: 225 K-PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT 283
+ P + NRE +E V+ C +++L ++C
Sbjct: 202 RVPYPGMTNRE--------------VLEQVERGY------RMPRPPNCPEELYDLMLQCW 241
Query: 284 VESPEQR 290
+ PE+R
Sbjct: 242 DKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 65/277 (23%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI 84
+F + G V + L + + VA+K+ + F E + +K +RH++LI
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 85 KVISTCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYS 143
+ + CS E ++ E M GSL +L S +L + +++ VA + YL
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---E 122
Query: 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR 203
IH DL N+L+ +++V ++DF +A+L+ + + + APE G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180
Query: 204 ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263
ST DV+SFGI+L E FT + +P M +
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQ-------------------VPYPGMNNHEVYDQITAGY 221
Query: 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+C ++ + +EC PE R + + + +L
Sbjct: 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.5 bits (241), Expect = 6e-23
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 31/284 (10%)
Query: 44 FLISSAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEFKALV 99
+L VA+KV + + + F E +++ S+ H N++K+ +E LV
Sbjct: 17 YLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76
Query: 100 LEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
+EY+ GSLE L L + L I+ + SALEYLH S +IH D+KP N+L
Sbjct: 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENIL 133
Query: 158 LD-DNMVAHLSDFSIAKLLTGEYQSMTQTQTLA----TIGCIAPEYRRKGRE---STNGD 209
LD D V L DF +AKLL + + + T G +APE S++ D
Sbjct: 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSD 193
Query: 210 VYSFGIMLMETFTRKKP---TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266
++S GI L E T P TLK P + +N
Sbjct: 194 IWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN---------- 243
Query: 267 AKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
E +L + + P+ R+++ ++ L +
Sbjct: 244 -PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-22
Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 39/270 (14%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
M VAVK A K F E E++ +++H +++K C + + +V EYM HG L
Sbjct: 36 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 110 KYLYS---------------SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
K+L + + L + Q L+I +AS + YL S +H DL
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATR 152
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFG 214
N L+ N++ + DF +++ + T+ I + PE + +T DV+SFG
Sbjct: 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212
Query: 215 IMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273
++L E FT K+P W +S EV++ ++Q + C
Sbjct: 213 VILWEIFTYGKQP-----------------WFQLSNTEVIEC--ITQGRV-LERPRVCPK 252
Query: 274 FVFNLAIECTVESPEQRINAREIVAKLFKI 303
V+++ + C P+QR+N +EI L +
Sbjct: 253 EVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 72/256 (28%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 48 SAMEVAVKVFNLQCGRAFK-SFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
EVAVK K F E E++K H N++K+I C ++ +V+E +P G
Sbjct: 18 GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
SL +L L + + L + +D A+ +EYL S IH DL N L+ +N V +
Sbjct: 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKI 134
Query: 167 SDFSIAKL-LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-K 224
SDF +++ G Y + + I APE GR ++ DV+S+GI+L ETF+
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIP-IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGD 193
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTV 284
P + N++ T E +++ A + C ++ L ++C
Sbjct: 194 TPYPGMSNQQ--------------TRERIESGY------RMPAPQLCPEEIYRLMLQCWA 233
Query: 285 ESPEQRINAREIVAKL 300
PE R + EI +L
Sbjct: 234 YDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 64/253 (25%), Positives = 120/253 (47%), Gaps = 31/253 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VAVK N++C ++F E +M + H+NL++++ + +V+E M G+L
Sbjct: 31 KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVN 87
Query: 111 YLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+L + ++ + Q L +DVA +EYL S +++H DL N+L+ ++ VA +SDF
Sbjct: 88 FLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF 144
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
+A++ SM + + APE + + S+ DV+S+G++L E F+
Sbjct: 145 GLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS------- 192
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
+ R P M + + ++ E C + V+ L C P++
Sbjct: 193 -YGRA-----------PYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 290 RINAREIVAKLFK 302
R + ++ KL K
Sbjct: 241 RPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-20
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 51 EVAVKVFNLQCGRA-FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK L+ G K F E ++MK +RH LI++ + C+ EE +V E M +GSL
Sbjct: 32 PVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 110 KYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+YL L + Q +++ VAS + YL + IH DL NVL+ +N + ++D
Sbjct: 90 EYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVAD 146
Query: 169 FSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
F +A+++ Y++ + I APE R S DV+SFGI+L E T
Sbjct: 147 FGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++M + H NL+++ C+ + +V EYM +G L YL L L++ D
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLA 189
V A+EYL S IH DL N L+ ++ V +SDF +A+ +L +Y S T+
Sbjct: 109 VCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-- 163
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249
+ PE R S+ DV+SFG+++ E F+ K M + + N+
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK---------MPYERFSNS------ 208
Query: 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
EVV++ + + V+ + C E PE R
Sbjct: 209 -EVVES---VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 6/176 (3%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
EVA+KV L+ + E +++K +H N++K + ++ +V+E+ GSL+
Sbjct: 27 EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
L S+N L Q + ++ LEYLH S +IH D+K N+LL + L DF
Sbjct: 87 LLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
++ L+ T + T +APE D++S GI +E K P
Sbjct: 144 LSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 63/250 (25%), Positives = 120/250 (48%), Gaps = 41/250 (16%)
Query: 68 FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSN----------- 116
F E E+M ++H N++ ++ C+ E+ ++ EY+ HG L ++L ++
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 117 ----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172
LD L+I I +A+ +EYL S +H DL N L+ + + +SDF ++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 173 KLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK-KPTDEI 230
+ + + +Y + Q+++L + + PE G+ +T D++SFG++L E F+ +P
Sbjct: 172 RDIYSADYYRV-QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP---- 226
Query: 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
++G S EV++ + + E C + V+ L IEC E P +R
Sbjct: 227 --------YYG-----FSNQEVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270
Query: 291 INAREIVAKL 300
++I +L
Sbjct: 271 PRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
VAVK + + F E +MK I+H NL++++ C+ E ++ E+M +G+L Y
Sbjct: 34 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 112 LYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
L N ++ L + ++SA+EYL IH DL N L+ +N + ++DF
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 149
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+++L+TG+ + I APE + S DV++FG++L E T
Sbjct: 150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 57/159 (35%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQ 123
++F E +M +RH NL++++ E+ +V EYM GSL YL S +L
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
L +DV A+EYL + +H DL NVL+ ++ VA +SDF LT E S
Sbjct: 104 LLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQ 156
Query: 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
T L + APE R+ + ST DV+SFGI+L E ++
Sbjct: 157 DTGKLP-VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-19
Identities = 56/179 (31%), Positives = 87/179 (48%), Gaps = 9/179 (5%)
Query: 52 VAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSL 108
VAVK +CG+ S + E ++K++ H N++K CS + K L++EY+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL L++ Q L + + YLH S IH DL NVLLD++ + + D
Sbjct: 96 RDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGD 150
Query: 169 FSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
F +AK + G + + + A E ++ + S DV+SFG+ L E T
Sbjct: 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-18
Identities = 54/172 (31%), Positives = 91/172 (52%), Gaps = 7/172 (4%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 124
++F E ++MK +RH L+++ + S EE +V EYM GSL +L L + Q
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+++ +AS + Y+ +H DL+ N+L+ +N+V ++DF +A+L+ + Q
Sbjct: 105 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161
Query: 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK-PTDEIFNREM 235
I APE GR + DV+SFGI+L E T+ + P + NRE+
Sbjct: 162 GAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 24/252 (9%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
EVA+K L+ N E +MK +H N++ + + +V+EYM GSL
Sbjct: 45 KEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+ + ++ Q + +V LEYLH S VIH D+K N+LL + L+DF
Sbjct: 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADF 160
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
A LT E +S + + T +APE ++ D++S GIM +E + P
Sbjct: 161 GFAAQLTKE-KSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
L +P + + S E F+ K C V+ PE+
Sbjct: 219 -EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK-------------CLVKDPEK 260
Query: 290 RINAREIVAKLF 301
R +A E++ F
Sbjct: 261 RPSAEELLQHPF 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 7/170 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++M + H L+++ C+ + +V EYM +G L YL Q L + D
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLA 189
V + YL S Q IH DL N L+DD +SDF +++ +L EY S ++
Sbjct: 109 VCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-- 163
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLK 238
+ PE + S+ DV++FG+++ E ++ K P + N E K
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-18
Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
++ I H ++K+ EE LVLEY P G L +L + R ++
Sbjct: 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVL 104
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIG 192
ALEYLH S +I+ DLKP N+LLD + L+DF +AK L ++T T T
Sbjct: 105 ALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL---SSEGSRTNTFCGTPE 158
Query: 193 CIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
+APE D +S G++L E T K P EI+ +
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-18
Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 44/272 (16%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
M VAVK A + F E E++ ++H+++++ C+ +V EYM HG
Sbjct: 33 QDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG 92
Query: 107 SLEKYLYSSNC---ILD-----------IFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
L ++L S IL + Q L I +AS + YL S +H DL
Sbjct: 93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLA 149
Query: 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE---YRRKGRESTNGD 209
N L+ +V + DF +++ + +T+ I + PE YR+ ES D
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES---D 206
Query: 210 VYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268
++SFG++L E FT K+P W +S E ++ +E
Sbjct: 207 IWSFGVVLWEIFTYGKQP-----------------WYQLSNTEAIECITQGRE---LERP 246
Query: 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
C V+ + C P+QR+ ++I ++L
Sbjct: 247 RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 8/187 (4%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VA+K + + + F E ++M + H L+++ C+ LV E+M HG L
Sbjct: 30 KVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
YL + L + +DV + YL S+ VIH DL N L+ +N V +SDF
Sbjct: 89 YLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFG 145
Query: 171 IAKL-LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTD 228
+ + L +Y S T T+ + +PE + S+ DV+SFG+++ E F+ K P +
Sbjct: 146 MTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
Query: 229 EIFNREM 235
N E+
Sbjct: 204 NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 56/173 (32%), Positives = 83/173 (47%), Gaps = 7/173 (4%)
Query: 52 VAVKVFNLQCGRAFK-SFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK + K F E ++K H N++K+I C+ + +V+E +P G
Sbjct: 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+L L Q + +D A+ + YL S IH DL N L+ +N V +SDF
Sbjct: 82 FLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFG 138
Query: 171 IAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+++ G Y S Q I APE GR S+ DV+S+GI+L ETF+
Sbjct: 139 MSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 37/219 (16%)
Query: 45 LISSAMEVAVKVFN---LQCGRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVL 100
+ E A+K+ + L + K IE E + + H +IK+ T +EE VL
Sbjct: 22 EKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81
Query: 101 EYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
EY P+G L +Y+ Y S LD ++ ALEYLH S +IH DLKP N+LL
Sbjct: 82 EYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILL 135
Query: 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRES------------- 205
D +M ++DF AK+L S + AT E R+ S
Sbjct: 136 DKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194
Query: 206 ------TNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
+ D+++ G ++ + T K P F +
Sbjct: 195 NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 24/226 (10%)
Query: 68 FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 127
F E ++K H N++++I C+ ++ +V+E + G +L + L + + + +
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM 99
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
+ + A+ +EYL S IH DL N L+ + V +SDF +++ + T
Sbjct: 100 VENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLP 246
+ APE GR S+ DV+SFGI+L E F+ P + N++
Sbjct: 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------------ 204
Query: 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN 292
T E + ++ + E C V+ L C P QR +
Sbjct: 205 --TREAI------EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 127
E +++K + H N+IK + + +V+EY G L + + F Q L+
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
+ + AL+YLH S +++H D+KP N+ L N + L DF I+K+L+ + +T
Sbjct: 109 FVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTV- 163
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+ T ++PE + + D++S G +L E T K P
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 28/187 (14%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVIS----TCSNEEFK----ALVLE 101
A+K + + + E K + + L S C +K ++VLE
Sbjct: 29 YALKKIH---------VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79
Query: 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
YM GSL L I + I + L+YLH +IH D+KP N+L++
Sbjct: 80 YMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TKRHIIHRDIKPSNLLINSK 136
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRKGRE-STNGDVYSFGIMLME 219
++DF I+K+L ++ Q T + T+ ++PE R +G S D++S G+ L+E
Sbjct: 137 GEVKIADFGISKVLE---NTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLE 192
Query: 220 TFTRKKP 226
K P
Sbjct: 193 CALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 54/172 (31%), Positives = 88/172 (51%), Gaps = 7/172 (4%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 124
+SF E ++MK +RH L+++ + S E +V EYM GSL +L L +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+++ VA+ + Y+ IH DL+ N+L+ D +V ++DF +A+L+ + Q
Sbjct: 105 VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK-PTDEIFNREM 235
I APE GR + DV+SFGI+L E T+ + P + NRE+
Sbjct: 162 GAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 54/172 (31%), Positives = 90/172 (52%), Gaps = 7/172 (4%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 124
++F E ++MK +RH L+ + + S EE +V E+M GSL +L + L + Q
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL 104
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+++ +A + Y+ IH DL+ N+L+ DN+V ++DF +A+L+ + Q
Sbjct: 105 VDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161
Query: 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK-PTDEIFNREM 235
I APE GR + DV+SFGI+L E T+ + P + NRE+
Sbjct: 162 GAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-17
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 6/187 (3%)
Query: 50 MEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+KV + A K E +M S+ H ++++++ C + + L+ + MP G L
Sbjct: 37 IPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL 95
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
Y+ + + LN + +A + YL +++H DL NVL+ ++D
Sbjct: 96 LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITD 152
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPT 227
F +AKLL + + I +A E + DV+S+G+ + E T KP
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
Query: 228 DEIFNRE 234
+ I E
Sbjct: 213 EGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 39/271 (14%)
Query: 48 SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKA--LV 99
S ++VAVK L + F E MK H N++K+I C S ++ ++
Sbjct: 26 SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI 85
Query: 100 LEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
L +M HG L +L S L + L M+D+A +EYL + IH DL
Sbjct: 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAAR 142
Query: 155 NVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N +L ++M ++DF ++ K+ +G+Y + + + IA E ++ DV++F
Sbjct: 143 NCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-VKWIAIESLADRVYTSKSDVWAF 201
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
G+ + E TR + P + N E+ ++L N L Q E C+
Sbjct: 202 GVTMWEIATRGQTPYPGVENHEIY------DYL-------RHGNRLKQ-------PEDCL 241
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+++L C P+ R ++ L I
Sbjct: 242 DELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 75 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 134
M ++H N++K+I C +E+ L+ EY+ +L + L + L +R I I +A A
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKA 792
Query: 135 LEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI 194
L +LH S V+ +L P +++D HL S+ LL T T+ + +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYV 845
Query: 195 APEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG---------NNWL 245
APE R + D+Y FG++L+E T K P D F ++ W + W
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW- 904
Query: 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
I D ++ E + V NLA+ CT P R A +++ L
Sbjct: 905 -IDPSIRGDVSVNQNEIVE----------VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 66/258 (25%), Positives = 112/258 (43%), Gaps = 36/258 (13%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
VAVK A K F+ E E++ +++H +++K C + +V EYM HG L K+
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 112 LYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
L + L Q L+I +A+ + YL S +H DL N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVG 154
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
+N++ + DF +++ + T+ I + PE + +T DV+S G++L E
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214
Query: 220 TFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 278
FT K+P W +S EV++ ++Q + C V++L
Sbjct: 215 IFTYGKQP-----------------WYQLSNNEVIEC--ITQGRV-LQRPRTCPKEVYDL 254
Query: 279 AIECTVESPEQRINAREI 296
+ C P R+N +EI
Sbjct: 255 MLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 62/258 (24%), Positives = 121/258 (46%), Gaps = 28/258 (10%)
Query: 51 EVAVKVFNLQCGRAFKS---FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
EVAV + L+ G K F E +M H N+I++ + + ++ EYM +G+
Sbjct: 33 EVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGA 92
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L+KYL + +Q + ++ +A+ ++YL +H DL N+L++ N+ +S
Sbjct: 93 LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVS 149
Query: 168 DFSIAKLLTGEYQ-SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KK 225
DF ++++L + + + T + I APE + ++ DV+SFGI++ E + ++
Sbjct: 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
P ++ N E+ M+ ++ + A C S V+ L ++C +
Sbjct: 210 PYWDMSNHEV--------------MKAIN------DGFRLPAPMDCPSAVYQLMLQCWQQ 249
Query: 286 SPEQRINAREIVAKLFKI 303
+R +IV L K+
Sbjct: 250 DRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 10/179 (5%)
Query: 49 AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
AM+ K ++ G N E +++ + H L+ + + +EE LV++ + G L
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLN-ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL 87
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+Y S Q + ++ ALEYLH S +IH D+KP N+LLD+ H++D
Sbjct: 88 -RYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITD 143
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNGDVYSFGIMLMETFTRKKP 226
F+IA +T + + T T T G +APE R+G S D +S G+ E K+P
Sbjct: 144 FNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 73/260 (28%), Positives = 116/260 (44%), Gaps = 18/260 (6%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLE 109
VAVK + F E E++KS++H N++K C + + LV+EY+P+GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
YL LD + L + +EYL S + +H DL N+L++ + DF
Sbjct: 96 DYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDF 152
Query: 170 SIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT---RK 224
+ K+L EY + + + I APE + + S DV+SFG++L E FT +
Sbjct: 153 GLTKVLPQDKEYYKVREPGE-SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTV 284
F R M GN+ M V L + + A C + ++ + EC
Sbjct: 212 CSPPAEFMRMM-----GND--KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWN 264
Query: 285 ESPEQRINAREIVAKLFKIR 304
P QR + E+ ++ IR
Sbjct: 265 NDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 48 SAMEVAVKVFNLQ-CGRA-FKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKA--LV 99
S ++VAVK + C R+ + F E MK H N++++I C +E + + ++
Sbjct: 25 SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84
Query: 100 LEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
L +M HG L +L S L + M D+AS +EYL S IH DL
Sbjct: 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAAR 141
Query: 155 NVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N +L++NM ++DF ++ K+ G+Y + + + IA E +T DV+SF
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSF 200
Query: 214 GIMLMETFTR-KKPTDEIFNREM 235
G+ + E TR + P + N E+
Sbjct: 201 GVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 43/274 (15%)
Query: 49 AMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHG 106
VAVK+ + E EMMK I +H+N+I ++ C+ E +V+EY HG
Sbjct: 42 TSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG 101
Query: 107 SLEKYL---------YSSNCILDIFQRL------NIMIDVASALEYLHFGYSAQVIHCDL 151
+L +L S + + L + VA +E+L S + IH DL
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDL 158
Query: 152 KPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDV 210
NVL+ ++ V ++DF +A+ + +Y T L + +APE + DV
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP-VKWMAPEALFDRVYTHQSDV 217
Query: 211 YSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQ 270
+SFG++L E FT G+ + I E+ LL + + + K Q
Sbjct: 218 WSFGVLLWEIFTLG----------------GSPYPGIPVEELFK--LLKEG--YRMEKPQ 257
Query: 271 -CVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
C +++L +C E P QR +++V L ++
Sbjct: 258 NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 11/188 (5%)
Query: 46 ISSAMEVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ + +VA+K +L +C + E + M H N++K ++ + LV+ Y+
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 105 HGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
GSL K Y LD ++ +V LEYLH S IH D+K N+LL ++
Sbjct: 83 GGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGED 138
Query: 162 MVAHLSDFSI-AKLLTGEYQSMTQTQTLATIGC-IAPEYRRKGRESTNG-DVYSFGIMLM 218
++DF + A L G ++ +T C +APE + D++SFGI +
Sbjct: 139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198
Query: 219 ETFTRKKP 226
E T P
Sbjct: 199 ELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 39/272 (14%)
Query: 48 SAMEVAVKVF--NLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA------LV 99
S +VAVK+ ++ + F E MK H N+IK+I K ++
Sbjct: 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 100 LEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
L +M HG L +L S L + + MID+AS +EYL S IH DL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAAR 142
Query: 155 NVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N +L++NM ++DF ++ K+ +G+Y L + +A E +T+ DV++F
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP-VKWLALESLADNVYTTHSDVWAF 201
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
G+ + E TR + P + N E+ N+L + N L Q C+
Sbjct: 202 GVTMWEIMTRGQTPYAGVENSEIY------NYL-------IKGNRLKQ-------PPDCL 241
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
V+ L +C P+ R + + + +L I
Sbjct: 242 EDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 45/272 (16%)
Query: 49 AMEVAVKVF-NLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
A VA+K ++ + + F E +M + H N++ ++ + E+ ++ EY+ G
Sbjct: 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93
Query: 108 LEKYLY----------------SSNCILDIFQRLNIMIDVASALEYL--HFGYSAQVIHC 149
L ++L + LD L+I I +A+ +EYL HF +H
Sbjct: 94 LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHK 148
Query: 150 DLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
DL N+L+ + + +SD +++ + Q ++L I + PE G+ S++ D
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD 208
Query: 210 VYSFGIMLMETFTRK-KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268
++SFG++L E F+ +P N+E+ +E+V L
Sbjct: 209 IWSFGVVLWEIFSFGLQPYYGFSNQEV--------------IEMVRKRQL------LPCS 248
Query: 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
E C +++L EC E P +R ++I +L
Sbjct: 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94
G+ +P + + + VA+K+ N G +A F E +M S+ H +L++++ C +
Sbjct: 26 GIWVPEGE---TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT 82
Query: 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
+ LV + MPHG L Y++ + LN + +A + YL +++H DL
Sbjct: 83 IQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAAR 138
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE---YRRKGRESTNGDVY 211
NVL+ ++DF +A+LL G+ + I +A E YR+ +S DV+
Sbjct: 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQS---DVW 195
Query: 212 SFGIMLMETFT-RKKPTDEIFNREM 235
S+G+ + E T KP D I RE+
Sbjct: 196 SYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 62/243 (25%), Positives = 111/243 (45%), Gaps = 30/243 (12%)
Query: 51 EVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VA+K +L+ G + ++F E +MK ++H L+++ + + E ++ EYM +GSL
Sbjct: 32 KVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLV 88
Query: 110 KYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L + I L I + +++ +A + ++ IH DL+ N+L+ + + ++D
Sbjct: 89 DFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIAD 145
Query: 169 FSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
F +A+L+ EY + + I APE G + DV+SFGI+L E T
Sbjct: 146 FGLARLIEDNEYTA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT----- 198
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+G P T V NL + + C ++ L C E P
Sbjct: 199 ------------YGRIPYPGMTNPEVIQNL--ERGYRMPRPDNCPEELYELMRLCWKEKP 244
Query: 288 EQR 290
E+R
Sbjct: 245 EER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 50/191 (26%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 51 EVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
E+ V + L+ G + + F E +M H N+I + + + +V EYM +GS
Sbjct: 32 EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS 91
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAQVIHCDLKPINVLLDDNMVAHL 166
L+ +L + + Q + ++ +AS ++YL GY +H DL N+L++ N+V +
Sbjct: 92 LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKV 147
Query: 167 SDFSIAKLLTGEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-K 224
SDF ++++L + ++ T I APE + ++ DV+S+GI++ E + +
Sbjct: 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207
Query: 225 KPTDEIFNREM 235
+P E+ N+++
Sbjct: 208 RPYWEMSNQDV 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 66 KSFNIECEMM-KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 118
+ F E E++ K H N+I ++ C N + + +EY P+G+L +L S +
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 119 ---------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L Q L DVA+ ++YL Q IH DL NVL+ +N+ + ++DF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADF 163
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
+++ GE + +T + +A E +T DV+SFG++L E
Sbjct: 164 GLSR---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 20/195 (10%)
Query: 51 EVAVKVF---NLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
EVAVK ++ G+ K F E +M + H ++++I C E LV+E P G
Sbjct: 25 EVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGP 81
Query: 108 LEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
L KYL + D+ + VA + YL S +H DL NVLL + A
Sbjct: 82 LLKYLKKRREIPVSDL---KELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAK 135
Query: 166 LSDFSIAKLL---TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+SDF +++ L + Y++ T + APE G+ S+ DV+S+G+ L E F+
Sbjct: 136 ISDFGMSRALGAGSDYYRA--TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
Query: 223 R-KKPTDEIFNREMT 236
KP E+ E+
Sbjct: 194 YGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 29/247 (11%)
Query: 47 SSAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+++ +VAVK L+ G + ++F E +MK+++H L+++ + + EE ++ EYM
Sbjct: 28 NNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85
Query: 106 GSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
GSL +L S + +L + +A + Y+ IH DL+ NVL+ ++++
Sbjct: 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMC 142
Query: 165 HLSDFSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
++DF +A+++ EY + + I APE G + DV+SFGI+L E T
Sbjct: 143 KIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT 283
K +P M D Q E C ++++ C
Sbjct: 201 GK-------------------IPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCW 241
Query: 284 VESPEQR 290
E E+R
Sbjct: 242 KEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 52 VAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K +L+ A KS E +++K+++H N++K I + + ++LEY +GSL
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87
Query: 110 KYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
+ + + ++Q V L YLH VIH D+K N+L + V
Sbjct: 88 QIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH---EQGVIHRDIKAANILTTKDGV 137
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
L+DF +A L S + T +APE ST D++S G ++E T
Sbjct: 138 VKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
Query: 224 KKP 226
P
Sbjct: 196 NPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-14
Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 7/179 (3%)
Query: 48 SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+ ++VA+K N + + + F E ++M + H L+++ C+ ++ +V E+M +G
Sbjct: 27 AQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L YL L L++ DV +EYL IH DL N L+ V +S
Sbjct: 86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVS 142
Query: 168 DFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
DF + + +L EY S + + + PE + S+ DV+SFG+++ E FT K
Sbjct: 143 DFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 71/258 (27%), Positives = 113/258 (43%), Gaps = 42/258 (16%)
Query: 53 AVKVFNLQCGR--AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
AVK +Q K E ++++ ++H NL+K + E + +EY G+LE+
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 111 YLYSSNCILD--IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
L ILD + + + + L YLH S ++H D+KP N+ LD N V L D
Sbjct: 89 LLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD 142
Query: 169 FSIAKLLT------GEY-QSMTQTQTLATIGCIAPEYRRKGRESTNG---DVYSFGIMLM 218
F A L GE QS+ T +APE G+ +G D++S G +++
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAY-----MAPEVITGGKGKGHGRAADIWSLGCVVL 197
Query: 219 ETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 278
E T K+P E+ N + H G P + D+ LS E F+ ++C +
Sbjct: 198 EMATGKRPWSELDNEFQIMFHVGAGHKPP----IPDSLQLSPEGKDFL--DRC--LESD- 248
Query: 279 AIECTVESPEQRINAREI 296
P++R A E+
Sbjct: 249 --------PKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 62/270 (22%), Positives = 117/270 (43%), Gaps = 53/270 (19%)
Query: 52 VAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VAVKV L+ A + F E +++ + N+ +++ C+ + +++EYM +G L
Sbjct: 49 VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 109 EKYLY----------------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
++L S + + L + +AS + YL S +H DL
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTL------LYMATQIASGMRYLE---SLNFVHRDLA 157
Query: 153 PINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
N L+ N ++DF +++ L + +Y Q + I +A E G+ +T DV+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 212 SFGIMLMETFT--RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED---IHFV 266
+FG+ L E T R++P + + ++++ +E +A ++D I+
Sbjct: 217 AFGVTLWEILTLCREQPYEHLTDQQV--------------IE--NAGHFFRDDGRQIYLP 260
Query: 267 AKEQCVSFVFNLAIECTVESPEQRINAREI 296
C ++ L +EC E R REI
Sbjct: 261 RPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 55/231 (23%), Positives = 105/231 (45%), Gaps = 11/231 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
E E+++++ H N++K C+ + L++E++P GSL++YL + +++ Q+L
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188
+ + ++YL S Q +H DL NVL++ + DF + K + + + T L
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 189 -ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247
+ + APE + + DV+SFG+ L E T E + LK G +
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY--CDSESSPMTLFLKMIGPTHGQM 230
Query: 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVA 298
+ +V +L +E C V+ L +C P +R + ++
Sbjct: 231 TVTRLV--RVL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +++ ++ N ++ +EYM GSL+K L + I +
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
V L YLH + ++IH D+KP N+L++ L DF ++ L S+ +T
Sbjct: 109 VLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKT----F 159
Query: 191 IGC---IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+G +APE + S D++S G+ L+E T + P
Sbjct: 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 80 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 124
H N+I ++ C + + L +EY PHG+L +L S + L Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
L+ DVA ++YL Q IH DL N+L+ +N VA ++DF +++ G+ + +
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
T + +A E +TN DV+S+G++L E
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N+++ + + + + + LEY+P GS+ L + + R N +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQ 114
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM-TQTQTLA 189
+ L YLH + +IH D+K N+L+D+ +SDF I+K L S T +
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 190 TIGCI---APEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
G + APE ++ + D++S G +++E T K P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 47 SSAMEVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
S + VAVK L+ G + K F E +M + H N++K++ C E + +++E M
Sbjct: 24 SGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81
Query: 104 PHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPI 154
G L YL + +L + + L+I +DVA YL HF IH DL
Sbjct: 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHF------IHRDLAAR 135
Query: 155 NVLL-----DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
N L+ D + V + DF +A+ + + + L + +APE G+ +T D
Sbjct: 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSD 195
Query: 210 VYSFGIMLMETFT 222
V+SFG+++ E T
Sbjct: 196 VWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 61/271 (22%), Positives = 110/271 (40%), Gaps = 52/271 (19%)
Query: 52 VAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK+ + ++ F E +M H N++K++ C+ + L+ EYM +G L +
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 111 YLYSSN---------------------CILDIFQRLNIMIDVASALEYL---HFGYSAQV 146
+L + L ++L I VA+ + YL F
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF------ 151
Query: 147 IHCDLKPINVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRES 205
+H DL N L+ +NMV ++DF ++ + + +Y ++ + I + PE R +
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIP-IRWMPPESIFYNRYT 210
Query: 206 TNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265
T DV+++G++L E F+ E + + V D N+LS
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY------------VRDGNVLS------ 252
Query: 266 VAKEQCVSFVFNLAIECTVESPEQRINAREI 296
+ C ++NL C + P R + I
Sbjct: 253 -CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR- 124
E ++ S+ H N+I E F +V+EY P G L K + +
Sbjct: 49 EIRILASVNHPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ 103
Query: 125 --LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
I I + L+ LH +++H DLK N+LL N + + D I+K+L ++M
Sbjct: 104 EIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNM 157
Query: 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+TQ T +APE + S D++S G +L E T P
Sbjct: 158 AKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 9/182 (4%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNI-ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+++ EVA+K NLQ + K I E +M+ +H N++ + + + +V+EY+
Sbjct: 41 VATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
GSL + + +D Q + + ALE+LH S QVIH D+K N+LL +
Sbjct: 100 GGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSV 154
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
L+DF +T E QS ++ + T +APE + D++S GIM +E +
Sbjct: 155 KLTDFGFCAQITPE-QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
Query: 225 KP 226
P
Sbjct: 213 PP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
E ++++ +RH N++++ +++ + +V EYM H L L S Q M
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
+ L+YLH S ++H D+K N+L++++ V L+DF +A+ T
Sbjct: 107 KQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 53 AVKVFNL----QCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
AVK +L Q G+ A K E ++ ++H N+++ + T E+ + LE +P GS
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L K L + LEYLH +H D+K N+L+D N V L+
Sbjct: 89 LAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLA 144
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGC---IAPEY-RRKGRESTNGDVYSFGIMLMETFTR 223
DF +AK Q + + + G +APE ++G D++S G ++E T
Sbjct: 145 DFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
Query: 224 KKP 226
K P
Sbjct: 199 KPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94
G+ IP S + VA+K + GR F+ M S+ H +++++ C
Sbjct: 26 GIWIPEGD---SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS 82
Query: 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
+ LV + P GSL ++ LD + LN + +A + YL +++H +L
Sbjct: 83 LQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAAR 138
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFG 214
N+LL + + ++DF +A LL + + ++ I +A E GR + DV+S+G
Sbjct: 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 215 IMLMETFT 222
+ + E +
Sbjct: 199 VTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-13
Identities = 57/260 (21%), Positives = 119/260 (45%), Gaps = 30/260 (11%)
Query: 51 EVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
E+ V + L+ G + + F E +M H N+I + + ++ E+M +G+
Sbjct: 32 EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGA 91
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L+ +L ++ + Q + ++ +A+ ++YL +H DL N+L++ N+V +S
Sbjct: 92 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVS 148
Query: 168 DFSIAKLLTGEYQSMTQTQTLA---TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR- 223
DF +++ L + T T +L I APE + ++ DV+S+GI++ E +
Sbjct: 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 208
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT 283
++P +W +S +V++A ++D C + + L ++C
Sbjct: 209 ERP------------YWD-----MSNQDVINA---IEQDYRLPPPMDCPTALHQLMLDCW 248
Query: 284 VESPEQRINAREIVAKLFKI 303
+ R +IV+ L K+
Sbjct: 249 QKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 62/259 (23%), Positives = 116/259 (44%), Gaps = 33/259 (12%)
Query: 52 VAVKVFN-LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
V VK + F E +M + + H+N+++++ C E ++LEY G L++
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 111 YLYSSNCI--------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+L ++ L Q++ + +A +++L +A+ +H DL N L+
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQR 154
Query: 163 VAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221
+S S++K + EY + L + +APE ++ ST DV+SFG+++ E F
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKL--RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIE 281
T+ + L +G +S EV+ N L + E C S ++ L
Sbjct: 213 TQGE-----------LPFYG-----LSDEEVL--NRLQAGKLELPVPEGCPSRLYKLMTR 254
Query: 282 CTVESPEQRINAREIVAKL 300
C +P+ R + E+V+ L
Sbjct: 255 CWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 61/268 (22%), Positives = 108/268 (40%), Gaps = 29/268 (10%)
Query: 41 VAQFLISSAMEVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99
V + + VAVK + + F E +M+ H +++K+I + E +V
Sbjct: 26 VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIV 84
Query: 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
+E P G L YL + LD+ + +++AL YL S + +H D+ NVL+
Sbjct: 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVS 141
Query: 160 DNMVAHLSDFSIAKLLTGEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLM 218
L DF +++ L E +S ++ I +APE R ++ DV+ FG+ +
Sbjct: 142 SPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199
Query: 219 ETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 277
E KP + N ++ + LP+ C +++
Sbjct: 200 EILMLGVKPFQGVKNNDVIGRIENGERLPMP--------------------PNCPPTLYS 239
Query: 278 LAIECTVESPEQRINAREIVAKLFKIRD 305
L +C P +R E+ A+L I
Sbjct: 240 LMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-13
Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 8/180 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 129
EC+++K + H N+I+ ++ +V+EY P G+L +Y+ N +LD L+ +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLLTGEYQSMTQTQTL 188
+ AL ++H + ++H DLK N+LLD + MV + DF I+K+L+ + ++ T +
Sbjct: 109 QILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VV 162
Query: 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248
T I+PE + D+++ G +L E + K+ + + LK + PIS
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 132
+MK H N++ ++ C E LV L YM HG L ++ S + + + VA
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA 108
Query: 133 SALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQ-TQTLAT 190
+EYL S + +H DL N +LD++ ++DF +A+ + EY S+ T
Sbjct: 109 KGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 191 IGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250
+ +A E + + +T DV+SFG++L E TR P P +
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDV 206
Query: 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ D + + + E C ++ + + C PE R E+V+++ +I
Sbjct: 207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 27/184 (14%)
Query: 71 ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 118
E EMMK I +H+N+I ++ C+ + +++EY G+L +YL Y+ +
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 119 ----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174
L ++ VA +EYL S + IH DL NVL+ ++ V ++DF +A+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 175 LTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK------PT 227
+ +Y T L + +APE + DV+SFG++L E FT P
Sbjct: 190 IHHIDYYKKTTNGRLP-VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248
Query: 228 DEIF 231
+E+F
Sbjct: 249 EELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (164), Expect = 1e-12
Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 5/115 (4%)
Query: 75 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 134
+K ++H N++K++ E LV EY L+KYL L +IM +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 135 LEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT-QTL 188
L Y H S +++H DLKP N+L++ + V L+DF +A+ ++ T TL
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 34/184 (18%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
VA+KV L+ G F+ E M+K RH N++ + + +V+EY GSL+
Sbjct: 31 VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-- 88
Query: 112 LYSSNCILDIFQRLN----------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
DI+Q + + L YLH IH D+K N+LL ++
Sbjct: 89 --------DIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTED 137
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEY---RRKGRESTNGDVYSFGI 215
L+DF ++ LT ++ + ++ IG +APE RKG D+++ GI
Sbjct: 138 GDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
Query: 216 MLME 219
+E
Sbjct: 193 TAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 27/184 (14%)
Query: 71 ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 118
E EMMK I +H+N+I ++ C+ + +++EY G+L +YL Y +
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 119 LD---IFQRL-NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174
D F+ L + VA +EYL S + IH DL NVL+ +N V ++DF +A+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 175 LTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK------PT 227
+ +Y T L + +APE + DV+SFG+++ E FT P
Sbjct: 187 VNNIDYYKKTTNGRLP-VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245
Query: 228 DEIF 231
+E+F
Sbjct: 246 EELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 66 KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDI 121
K+ E E +K + H N+++ + + EE+ ++ LEY+P GS L Y ++
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 122 FQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181
F V L YLH S ++H DLK N+L+D + + +SDF I+K Y +
Sbjct: 113 FTE-----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNG--DVYSFGIMLMETFTRKKP--TDEIF 231
++ +APE + + D++S G +++E F ++P +E
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 51 EVAVKVFNL-----QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
E+AVK + + + E +++K+++H +++ ++E ++ +EYMP
Sbjct: 29 ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
GS++ L + + + R + +EYLH S ++H D+K N+L D
Sbjct: 89 GSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144
Query: 166 LSDFSIAKLLTGEYQSMTQTQTL-ATIGCIAPE------YRRKGRESTNGDVYSFGIMLM 218
L DF +K L S T +++ T ++PE Y RK DV+S G ++
Sbjct: 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK------ADVWSVGCTVV 198
Query: 219 ETFTRKKP 226
E T K P
Sbjct: 199 EMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 22/170 (12%)
Query: 66 KSFNIECEMM-KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 118
+ F E E++ K H N+I ++ C + + L +EY PHG+L +L S +
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 119 ---------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L Q L+ DVA ++YL Q IH DL N+L+ +N VA ++DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
+++ G+ + +T + +A E +TN DV+S+G++L E
Sbjct: 157 GLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 52 VAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K + F E +M H N+I++ + ++ EYM +GSL+K
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+L ++ + Q + ++ +AS ++YL Y +H DL N+L++ N+V +SDF
Sbjct: 95 FLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDF 150
Query: 170 SIAKLL---TGEYQSMTQTQTLATIGCI-----APEYRRKGRESTNGDVYSFGIMLMETF 221
+++ L Y + G I APE + ++ DV+SFGI++ E
Sbjct: 151 GLSRRLEDSEATYTTKG--------GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
Query: 222 T 222
+
Sbjct: 203 S 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 45/261 (17%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
V +KV R +F +M + H++L+K+ C +E +V EY+ G L+
Sbjct: 32 SVVLKVLG-SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDV 89
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNM----V 163
+L+ + + +L++ +ASAL YL +++H ++ N+L+ N
Sbjct: 90 FLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF 146
Query: 164 AHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTN--GDVYSFGIMLMET 220
LSD I +L+ E + + I IAPE R G+ S D +SFG L+E
Sbjct: 147 IKLSDPGIPITVLSREER-------VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 221 FTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 279
+ ++P + + E + + LP+ ++ NL
Sbjct: 200 CSNGEEPLSTLSSSEKERFYQDQHRLPM----------PDCAEL------------ANLI 237
Query: 280 IECTVESPEQRINAREIVAKL 300
+C P +R + R I+ L
Sbjct: 238 NQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 27/176 (15%)
Query: 71 ECEMMKSIRHRNLIKVI-STCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRL 125
E +M + H ++I+++ +TC + F L +E+M GS L KY ++ +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI-----I 106
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLLT------GE 178
N + L YLH Q+IH D+K N+L+D ++DF A L GE
Sbjct: 107 NYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP--TDEIFN 232
+Q Q L TI +APE R + + DV+S G +++E T K P ++ N
Sbjct: 164 FQG----QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 15/167 (8%)
Query: 70 IECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL-- 125
E +++ ++H N+++ + + L V+EY G L + + C + + +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEE 104
Query: 126 ----NIMIDVASALEYLHFGYSA--QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179
I+ + AL H V+H DLKP N+ LD N L DF +AK+L +
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD- 163
Query: 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
S +T + T ++PE D++S G ++ E P
Sbjct: 164 SSFAKT-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 27/184 (14%)
Query: 71 ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL---------YS-SNCIL 119
E EMMK I +H+N+I ++ C+ + +++EY G+L +YL YS C L
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 120 D----IFQRL-NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174
F+ L + VA +EYL S + IH DL NVL+ ++ V ++DF +A+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 175 LTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK------PT 227
+ +Y T L + +APE + DV+SFG++L E FT P
Sbjct: 184 VHNIDYYKKTTNGRLP-VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242
Query: 228 DEIF 231
+E+F
Sbjct: 243 EELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 24/202 (11%)
Query: 41 VAQFLISSAME-------VAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSN 92
+A+FL A E VAVK+ + A F E ++M +++ N+I+++ C +
Sbjct: 29 LAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88
Query: 93 EEFKALVLEYMPHGSLEKYL-----YS----SNCI--LDIFQRLNIMIDVASALEYLHFG 141
++ ++ EYM +G L ++L S +N I + I L + + +AS ++YL
Sbjct: 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-- 146
Query: 142 YSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRR 200
S +H DL N L+ ++ ++DF +++ L +G+Y + Q + + I +A E
Sbjct: 147 -SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI-QGRAVLPIRWMAWESIL 204
Query: 201 KGRESTNGDVYSFGIMLMETFT 222
G+ +T DV++FG+ L E FT
Sbjct: 205 LGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/267 (20%), Positives = 118/267 (44%), Gaps = 42/267 (15%)
Query: 52 VAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K + + F E M ++H N++ ++ + E+ +++ Y H L +
Sbjct: 38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97
Query: 111 YLY---------------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
+L + L+ ++I+ +A+ +E+L S V+H DL N
Sbjct: 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRN 154
Query: 156 VLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFG 214
VL+ D + +SD + + + +Y + +L I ++PE G+ S + D++S+G
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKL-MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213
Query: 215 IMLMETFTRKKPTDEIFNREMTLKHWG-NNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273
++L E F+ +G + S +V++ ++ + + C +
Sbjct: 214 VVLWEVFS-----------------YGLQPYCGYSNQDVIE--MIRNRQV-LPCPDDCPA 253
Query: 274 FVFNLAIECTVESPEQRINAREIVAKL 300
+V+ L +EC E P +R ++I ++L
Sbjct: 254 WVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 14/192 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+S+ + +A+K + R + + E + ++HRN+++ + + S F + +E +P
Sbjct: 30 LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89
Query: 106 GSLEKYLYSSNCILDIFQRLNIMI----DVASALEYLHFGYSAQVIHCDLKPINVLLDD- 160
GSL L S L + +I + L+YLH Q++H D+K NVL++
Sbjct: 90 GSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTY 144
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTN--GDVYSFGIMLM 218
+ V +SDF +K L G T+T T T+ +APE KG D++S G ++
Sbjct: 145 SGVVKISDFGTSKRLAG-INPCTETFT-GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202
Query: 219 ETFTRKKPTDEI 230
E T K P E+
Sbjct: 203 EMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +++SIRH L+ + + ++ LV+EY+P G L +L S
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQ 109
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
V ALEYLH S +++ DLKP N+LLD + ++DF AK + G +T TL
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL-- 158
Query: 191 IGCIAPEY------RRKGRESTNGDVYSFGIMLME 219
C PEY KG D ++ GI++ E
Sbjct: 159 --CGTPEYLAPEIILSKGYGKA-VDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95
G +I V Q + ++ +A + + ++ E +++KS++H N+++ + TC ++
Sbjct: 24 GQLIAVKQVELDTSNVLAAE-------KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT 76
Query: 96 KALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
++ +E++P GS+ L + + F + I + YLH + V+H D+K
Sbjct: 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH---NNCVVHRDIKGN 131
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIG----CIAPEYRRKGRESTNGDV 210
NV+L N + L DF A+ L T + L ++ +APE + D+
Sbjct: 132 NVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDI 191
Query: 211 YSFGIMLMETFTRKKP 226
+S G + E T K P
Sbjct: 192 WSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K + H +I++ T ++ F +++EY+P G L YL +S + +
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASE 109
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ ALEYLH S ++++ DLKP N+LLD L+DF AK L +T TL
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTL-- 158
Query: 191 IGCIAPEY------RRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
C PEY + KG + D ++ GI++ E P I+ +
Sbjct: 159 --CGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 71 ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDI--- 121
E E+MK I +H+N+I ++ C+ E +++EY G+L ++L + + DI
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 122 ------FQRL-NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174
F+ L + VA +EYL S + IH DL NVL+ ++ V ++DF +A+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 175 LTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK------PT 227
+ +Y T L + +APE + DV+SFGI++ E FT P
Sbjct: 184 VHDIDYYKKTSNGRLP-VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+E+F L +E C ++ L EC P
Sbjct: 243 EELFK-------------------------LLREGHRMDKPSNCTHELYMLMRECWHAVP 277
Query: 288 EQRINAREIVAKLFKI 303
QR +++V L K+
Sbjct: 278 TQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 49/175 (28%), Positives = 73/175 (41%), Gaps = 9/175 (5%)
Query: 52 VAVKVF-NLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK + + F E +M S+ H NLI++ +V E P GSL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLD 84
Query: 111 YLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L I + + +A+ + YL S + IH DL N+LL + + DF
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDF 141
Query: 170 SIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ + L ++ M + + C APE R S DV+ FG+ L E FT
Sbjct: 142 GLMRALPQNEDHYVMEEHLKVPFAWC-APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 42/256 (16%)
Query: 53 AVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL 112
A K+ ++ + F +E +++ +H N++ + E +++E+ G+L+ +
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93
Query: 113 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172
L Q + + AL +LH S +VIH DLK N+LL + L+DF ++
Sbjct: 94 LELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
Query: 173 KLLTGEYQSMTQTQTLATIGCIAPE-----------YRRKGRESTNGDVYSFGIMLMETF 221
Q + + T +APE Y K D++S GI L+E
Sbjct: 151 AKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYK------ADIWSLGITLIELA 202
Query: 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAI 280
+ P E+ + LK + S +D + S F+
Sbjct: 203 QMEPPHHELNPMRVLLK------ILKSEPPTLDQPSKWSSSFNDFLKS------------ 244
Query: 281 ECTVESPEQRINAREI 296
C V+ P+ R A E+
Sbjct: 245 -CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 17/192 (8%)
Query: 52 VAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
A+KV + E +++ + ++K+ + ++ LV+EY+P G L
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
L + LD + ++ ALEYLH S +IH DLKP N+L+D N L+D
Sbjct: 81 ASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTD 136
Query: 169 FSIAKL-LTGEYQSMTQT-----QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
F ++K+ L ++ + + T IAPE S D +S G +L E
Sbjct: 137 FGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
Query: 223 RKKPTDEIFNRE 234
P F+ E
Sbjct: 197 GIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 10/214 (4%)
Query: 17 DVFRRSQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMM 75
D+ RR+ DF+++ G V + +++ A+KV L+ G F E MM
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60
Query: 76 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 135
K +H N++ + + + +E+ GSL+ +Y L Q + + L
Sbjct: 61 KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGL 119
Query: 136 EYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIA 195
YLH S +H D+K N+LL DN L+DF ++ +T + + T +A
Sbjct: 120 YYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMA 174
Query: 196 PE---YRRKGRESTNGDVYSFGIMLMETFTRKKP 226
PE RKG + D+++ GI +E + P
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 29/230 (12%)
Query: 64 AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 123
+ ++F E +MK+++H L+K+ + + E ++ E+M GSL +L S Q
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQ 99
Query: 124 RLNIMIDVASAL-EYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT-GEYQS 181
L +ID ++ + E + F IH DL+ N+L+ ++V ++DF +A+++ EY +
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
+ I APE G + DV+SFGI+LME T +G
Sbjct: 160 REGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT-----------------YG 200
Query: 242 NNWLP-ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
P +S EV+ A + E C ++N+ + C PE+R
Sbjct: 201 RIPYPGMSNPEVIRA---LERGYRMPRPENCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 50 MEVAVK-VFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K V R F E +MK ++++++ S + +V+E M G L
Sbjct: 37 TRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 109 EKYLYS------SNCILDIFQRLNIM---IDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
+ YL S +N L + ++A + YL + + +H DL N ++
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVA 153
Query: 160 DNMVAHLSDFSIAKLLTGEYQS---MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
+++ + DF + + + Y++ + L + +APE + G +T DV+SFG++
Sbjct: 154 EDLTVKIGDFGMTRDI---YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210
Query: 217 LMETFT 222
L E T
Sbjct: 211 LWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 47 SSAMEVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ ++VAVK C +S F +E +M H+N++++I + ++LE M
Sbjct: 34 AVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAG 93
Query: 106 GSLEKYLY---------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
G L+ +L SS + D+ L DVA +YL IH D+ N
Sbjct: 94 GDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKGCKYLE---ENHFIHRDIAARNC 147
Query: 157 LLDD---NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
LL VA ++DF +A+ + + + I + PE G ++ DV+SF
Sbjct: 148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207
Query: 214 GIMLMETFT 222
G++L E F+
Sbjct: 208 GVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +++K + H N+IK++ ++ LV E+M L K + L + +
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ L + H S ++H DLKP N+L++ V L+DF +A+ T + T
Sbjct: 107 LLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVT 161
Query: 191 IGCIAPE--YRRKGRESTNGDVYSFGIMLMETFTRK 224
APE KG ST D++S G + E +R+
Sbjct: 162 RWYRAPELLLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 9e-11
Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 34/192 (17%)
Query: 52 VAVKVFN------LQCGRAFKSFNIECEMMKSIRHRNLIKVISTC---SNEEFKAL--VL 100
VA+K + + R + E ++++ +RH N+I ++ S E+F + V
Sbjct: 28 VAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
E M L K + S + D + + + L+YLH SA VIH DLKP N+L++
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLH---SANVIHRDLKPSNILVNS 138
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQ-TQTLATIGCIAPE-------YRRKGRESTNGDVYS 212
N + DF +A+ + + T+ + T APE Y + D++S
Sbjct: 139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY------TKAIDIWS 192
Query: 213 FGIMLMETFTRK 224
G + E TRK
Sbjct: 193 VGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 31/103 (30%), Positives = 56/103 (54%), Gaps = 4/103 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++++ ++H N+I ++ ++ LV E+M LEK + + +L + M+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
LEYLH S ++H DLKP N+L+ + V L+DF +A+
Sbjct: 111 TLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 39/253 (15%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI----LDIFQRLN 126
E ++K + H ++IK+ CS + L++EY +GSL +L S + L N
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 127 IMIDVASALEYLHFG--------------YSAQ--VIHCDLKPINVLLDDNMVAHLSDFS 170
L G Y A+ ++H DL NVL+ + +SDF
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230
+++ + E + +++ + +A E +T DV+SFG++L E T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG------ 226
Query: 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
GN + I+ + NLL + E C ++NL + C + P++R
Sbjct: 227 ----------GNPYPGIAPERLF--NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273
Query: 291 INAREIVAKLFKI 303
+I +L K+
Sbjct: 274 PTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 6/178 (3%)
Query: 48 SAMEVAVKVFNLQCGRAFK-SFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105
+ M+VAVK+ + + + E ++M + H N++ ++ C+ ++ EY +
Sbjct: 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 106 GSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
G L +L L + L+ VA + +L S IH DL NVLL +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIV 180
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF +A+ + + + + + +APE + DV+S+GI+L E F+
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 14/155 (9%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHGSLE---KYLYSSNCILDIFQRL 125
E E+ KS + ++K +E + +EY GSL+ K + +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY-QSMTQ 184
I V L YLH S ++IH D+KP N+LL L DF + +GE S+
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAG 161
Query: 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
T T T +APE + S DV+S G+ L+E
Sbjct: 162 TFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 56/183 (30%), Positives = 91/183 (49%), Gaps = 11/183 (6%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVIST--CSNEEFKALVLEYM 103
+++ EVA+K NLQ + E +MK +++ N++ + + +E F +V+EY+
Sbjct: 41 VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF--VVMEYL 98
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
GSL + + C +D Q + + ALE+LH + QVIH D+K NVLL +
Sbjct: 99 AGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGS 153
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
L+DF +T E QS T + T +APE + D++S GIM +E
Sbjct: 154 VKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 224 KKP 226
+ P
Sbjct: 212 EPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 70 IECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNI 127
IE +++++ H ++I++ T + +VL PH S + Y Y + L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
+ L YLH + ++IH D+K N+ ++D + D A+ + T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+ T APE + + ++ D++S GI+L E
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 48 SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
+ VAVK+ + A F E ++M ++ N+I++++ C + ++ EYM +G
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 107 SLEKYL---------YSSNCILDIFQRLNIM-IDVASALEYLHFGYSAQVIHCDLKPINV 156
L ++L ++ + + L M +AS ++YL S +H DL N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161
Query: 157 LLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
L+ N ++DF +++ L +G+Y + Q + + I ++ E G+ +T DV++FG+
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRI-QGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 216 MLMETFT--RKKP----TDE 229
L E T +++P +DE
Sbjct: 221 TLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNI 127
E M+K +RH NL+ +I ++ LV E++ H LEKY LD +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKY 105
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
+ + +E+ H S +IH D+KP N+L+ + V L DF A+ L + T
Sbjct: 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDY 160
Query: 188 LATIGCIAPEY----RRKGRESTNGDVYSFGIMLMETFT 222
+AT APE + GR D+++ G ++ E T
Sbjct: 161 VATRWYRAPELLVGDTKYGRAV---DIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 4e-10
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 7/181 (3%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+++ EVA++ NLQ + E +M+ ++ N++ + + + +V+EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
GSL + + C +D Q + + ALE+LH S QVIH D+K N+LL +
Sbjct: 102 GSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
L+DF +T E QS ++ + T +APE + D++S GIM +E +
Sbjct: 157 LTDFGFCAQITPE-QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 226 P 226
P
Sbjct: 215 P 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 8/179 (4%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNI-ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
++VA+KV + ++ + + E E+M + + ++++I C E LV+E
Sbjct: 20 KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASG 78
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
G L K+L + + + +M V+ ++YL +H DL NVLL + A
Sbjct: 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAK 135
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLAT--IGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+SDF ++K L G S + ++ + APE + S+ DV+S+GI + E F+
Sbjct: 136 ISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 16/184 (8%)
Query: 51 EVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVI-STCSNEEFKALVLEYMPHG 106
EVA+K+ F E + + H N++ ++ S + V EY+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMV 163
+L + L +++ L + +M+ V AL H + ++H DLKP N+++
Sbjct: 65 TLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLAT--IGC---IAPEYRRKGRESTNGDVYSFGIMLM 218
A + DF I LL G + T T T +G APE R + N D+Y++G++ +
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 219 ETFT 222
E T
Sbjct: 181 ECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 6e-10
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 7/181 (3%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
I++ EVA+K NLQ + E +M+ ++ N++ + + + +V+EY+
Sbjct: 41 IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
GSL + + C +D Q + + AL++LH S QVIH D+K N+LL +
Sbjct: 101 GSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVK 155
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
L+DF +T E QS T + T +APE + D++S GIM +E +
Sbjct: 156 LTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 226 P 226
P
Sbjct: 214 P 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 43/256 (16%)
Query: 52 VAVKVFNLQCGRAFKSFNI-----ECEMMKSIRH---RNLIKVISTCSNEEFKALVLEYM 103
VA+K+ NL ++ E ++ +R N+ K + +++EY
Sbjct: 29 VALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
GS+ + L + I + + + I+ +V AL+Y+H VIH D+K N+L+ +
Sbjct: 85 EGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGN 139
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRE-STNGDVYSFGIMLMETF 221
L DF +A LL Q+ ++ T T +APE +G+ T D++S GI + E
Sbjct: 140 VKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
Query: 222 TRKKP-TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
T P +D R M L +P S ++ N S+ FVA
Sbjct: 197 TGNPPYSDVDAFRAMML-------IPKSKPPRLEDNGYSKLLREFVAA------------ 237
Query: 281 ECTVESPEQRINAREI 296
C E P++R++A E+
Sbjct: 238 -CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 51 EVAVKV--FNLQCGRAFKSFN-IECE--MMKSIRHRNLIKVISTCSNEEFKALVL--EYM 103
E+AVK F+ K N +ECE ++K++RH +++ + E K L + EYM
Sbjct: 29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
P GS++ L + + + R + + YLH S ++H D+K N+L D
Sbjct: 89 PGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGN 144
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTL-ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
L DF +K + S T +++ T ++PE DV+S ++E T
Sbjct: 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
Query: 223 RKKPTDE 229
K P E
Sbjct: 205 EKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 46 ISSAMEVAVKVFNL--QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
S+ +VAVK +L Q R FN E +M+ +H N++++ S+ + +V+E++
Sbjct: 41 KSTGRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
G+L + + ++ Q + + V AL +LH + VIH D+K ++LL +
Sbjct: 99 EGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGR 153
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTL-ATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
LSDF ++ E + + ++L T +APE + T D++S GIM++E
Sbjct: 154 VKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 6/155 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K + H N++K++ E LV E++ H L+K++ +S + I L I
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSY 105
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ L+ L F +S +V+H DLKP N+L++ L+DF +A+ + T T + T
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 163
Query: 191 IGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRK 224
+ APE + ST D++S G + E TR+
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 60/257 (23%), Positives = 106/257 (41%), Gaps = 27/257 (10%)
Query: 52 VAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 97
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
Y+ + LN + +A + YL +++H DL NVL+ ++DF
Sbjct: 98 YVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFG 154
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDE 229
+AKLL + + I +A E + DV+S+G+ + E T KP D
Sbjct: 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
I E++ S +E L Q I C V+ + ++C + +
Sbjct: 215 IPASEIS-----------SILE--KGERLPQPPI-------CTIDVYMIMVKCWMIDADS 254
Query: 290 RINAREIVAKLFKI-RD 305
R RE++ + K+ RD
Sbjct: 255 RPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 48/197 (24%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMI 129
E ++ ++H N+I + ++ + +EY G+L +K + + + L +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+ SA+ Y+H A ++H D+K +N+ L + L DF I+K+L EY SM +T +
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMAET-VVG 163
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI-- 247
T ++PE + + + D+++ G +L E T K+ D + +K N+ P+
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS 223
Query: 248 ---STMEVVDANLLSQE 261
S + + +LL Q+
Sbjct: 224 VYSSELISLVHSLLQQD 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E E+++ H ++K+ T ++++ +++EY G L L + D + +
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIAC 101
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL-A 189
V A EYLH + +I+ DLKP N+LLD N L DF AK L +S +T T
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCG 154
Query: 190 TIGCIAPEY-RRKGRESTNGDVYSFGIMLMETFTRKKP 226
T +APE KG + D +S GI+L E T + P
Sbjct: 155 TPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQR 124
E + +S++H NL++ + C+ LV+E+ P G L+ YL S QR
Sbjct: 45 EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR 104
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ ++A L +LH IH DL N LL ++ + D+ ++ E +T
Sbjct: 105 M--ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159
Query: 185 TQTLATIGCIAPEYRRK-------GRESTNGDVYSFGIMLMETF 221
Q + IAPE + ++ +V+S G+ + E F
Sbjct: 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 41/110 (37%), Positives = 54/110 (49%), Gaps = 17/110 (15%)
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I + + ALEYLH S VIH D+KP NVL++ N L DF I+ L S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 187 TLATIGC--------IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
GC I PE +KG DV+S GI ++E T + P D
Sbjct: 163 ---DAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 12/215 (5%)
Query: 17 DVFRRSQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMM 75
D+ RR+ D++++ G V + + + AVK+ L+ G F E M+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 76 KSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 135
K +H N++ + + E + +EY GSL+ +Y L Q + + L
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGL 119
Query: 136 EYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT-LATIGCI 194
YLH S +H D+K N+LL DN L+DF +A +T ++ + ++ + T +
Sbjct: 120 AYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWM 173
Query: 195 APE---YRRKGRESTNGDVYSFGIMLMETFTRKKP 226
APE + G + D+++ GI +E + P
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 13/173 (7%)
Query: 52 VAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+ C + + F E + H N++++ + +V EYM +G+L+
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+L L Q + ++ +AS ++YL GY +H L VL++ ++V +S F
Sbjct: 96 FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGF 151
Query: 170 SIAKLLTGE--YQSMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
+ E Y +M+ ++ L APE + S+ DV+SFGI++ E
Sbjct: 152 RRLQEDKSEAIYTTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 46/146 (31%), Positives = 69/146 (47%), Gaps = 6/146 (4%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
++K+++H L+ + + E VL+Y+ G L +L C L+ R +VAS
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVAS 107
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC 193
A+ YLH S +I+ DLKP N+LLD L+DF + K G T + T
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEY 162
Query: 194 IAPEYRRKGRESTNGDVYSFGIMLME 219
+APE RK D + G +L E
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 9/165 (5%)
Query: 70 IECE--MMKSIRHRNLIKVISTCSNEEFKALV--LEYMPHGSLEKYLYSSNCILDIFQRL 125
+ECE ++K+++H +++ + K L +EYMP GS++ L + + + R
Sbjct: 51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR- 109
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185
+ + YLH S ++H D+K N+L D L DF +K L S T
Sbjct: 110 KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 186 QTL-ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
+++ T ++PE DV+S G ++E T K P E
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 53/204 (25%), Positives = 102/204 (50%), Gaps = 30/204 (14%)
Query: 52 VAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK+ + A F E +++ ++ N+I+++ C +E+ ++ EYM +G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 111 YLYS----------------SNCILDIFQR--LNIMIDVASALEYLHFGYSAQVIHCDLK 152
+L S ++C+ I L++ + +AS ++YL S +H DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 153 PINVLLDDNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
N L+ +N+ ++DF +++ L G+Y + Q + + I +A E G+ +T DV+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRI-QGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 212 SFGIMLMETFT--RKKP----TDE 229
+FG+ L E +++P TDE
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 33/192 (17%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
VA+KV + + E ++K ++K + +V+EY GS
Sbjct: 31 VAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS---- 84
Query: 112 LYSSNCILDIFQRLN----------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
+ DI + N I+ LEYLH S + IH D+K N+LL++
Sbjct: 85 ------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEE 135
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLM 218
A L+DF ++ LT +M + T+ IG +APE ++ + D++S GI +
Sbjct: 136 GQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAPEVIQEIGYNNKADIWSLGITAI 190
Query: 219 ETFTRKKPTDEI 230
E K P +I
Sbjct: 191 EMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLE-YMPHGSLEKYLYSSNCI-------LDIF 122
E ++ + H+N++ ++ C + VL YM G+L+ +L L
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK-LLTGEYQS 181
Q +++ I +A + YLH VIH D+ N ++D+ + ++D ++++ L +Y
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMT 236
+ + + +A E S+ DV+SFG++L E T + P EI EM
Sbjct: 175 LGDNEN-RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 37/172 (21%)
Query: 71 ECEMMKSIRHRNLIKVISTC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 125
E E+++ + H N++K C N E + L LE+M GSLE I D
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLA 171
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ- 184
++ + S + YLH ++H D+KP N+L++ ++DF ++++L Q+M
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPC 225
Query: 185 TQTLATIGCIAPEYRRKGRESTN----------GDVYSFGIMLMETFTRKKP 226
++ TI ++PE R +T+ GD++S G+ ++E + + P
Sbjct: 226 NSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 4/107 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++++ +RH N++ + + LV EY+ LE L +S L + +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQ 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177
+ A+ Y H S +IH D+KP N+L+ ++ V L DF A+ L
Sbjct: 109 LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 53/259 (20%), Positives = 108/259 (41%), Gaps = 32/259 (12%)
Query: 52 VAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K N R F E +MK ++++++ S + +++E M G L+
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 111 YLYS---------SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
YL S + + + + ++A + YL+ + + +H DL N ++ ++
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221
+ DF + + + + L + ++PE + G +T DV+SFG++L E
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
Query: 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIE 281
T + + + E L+ V++ LL + D C +F L
Sbjct: 216 TLAEQPYQGMSNEQVLRF------------VMEGGLLDKPD-------NCPDMLFELMRM 256
Query: 282 CTVESPEQRINAREIVAKL 300
C +P+ R + EI++ +
Sbjct: 257 CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 11/173 (6%)
Query: 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVASALEYLHFGYSAQVIHCDLKP 153
ALVL+Y G L + + S F+ + I V A+ ++H S +IH D+K
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKS 171
Query: 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N+LL N + L DF +K+ T +APE R+ S D++S
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNW--LPIST---MEVVDANLLSQE 261
G++L E T K+P D E+ K + LP S M+ + LLS +
Sbjct: 232 GVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSD 284
|
Length = 496 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 29/114 (25%), Positives = 55/114 (48%), Gaps = 6/114 (5%)
Query: 60 QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 119
CG F + E ++M I+H N++ ++ +F LV++ M L+K + L
Sbjct: 60 MCGIHFTTLR-ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRL 116
Query: 120 DIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
Q I++ + + L LH Y +H DL P N+ ++ + ++DF +A+
Sbjct: 117 TESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 15/175 (8%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
++K+++H L+ + + + VL+Y+ G L +L + R ++AS
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIAS 107
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC 193
AL YLH S +I+ DLKP N+LLD L+DF + K G S T + T
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEY 162
Query: 194 IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP---------TDEIFNREMTLKH 239
+APE RK D + G +L E P D I N+ + LK
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +M+ + + ++++I C E + LV+E G L K+L + + + ++
Sbjct: 46 EANVMQQLDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQ 103
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE---YQSMTQTQT 187
V+ ++YL +H DL NVLL A +SDF ++K L + Y++ +T
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA--KTHG 158
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
+ APE + S+ DV+SFG+++ E F+ +KP
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 24/178 (13%)
Query: 52 VAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+KV LQ G F + E ++K ++H N++ + +E LV EY+ H L
Sbjct: 33 VALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLC 90
Query: 110 KY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+Y L+ N L +FQ L L Y+H Y ++H DLKP N+L+ D
Sbjct: 91 QYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY---ILHRDLKPQNLLISDTG 140
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLME 219
L+DF +A+ S T + + T+ P+ E ST D++ G + +E
Sbjct: 141 ELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 27/255 (10%)
Query: 48 SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+ +VAVK +L+ + + E +M+ H N++ + ++ + +V+E++ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L + + ++ Q + + V AL YLH + VIH D+K ++LL + LS
Sbjct: 106 LTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLS 160
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF ++ E + + T +APE + T D++S GIM++E + P
Sbjct: 161 DFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP- 217
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAIECTVES 286
FN P+ M + NL + +D H V+ + +L + V
Sbjct: 218 --YFNEP-----------PLQAMRRIRDNLPPRVKDSHKVS--SVLRGFLDLML---VRE 259
Query: 287 PEQRINAREIVAKLF 301
P QR A+E++ F
Sbjct: 260 PSQRATAQELLQHPF 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
+++EY+ GS L + D FQ ++ ++ L+YLH S + IH D+K NVL
Sbjct: 79 IIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFG 214
L + L+DF +A LT TQ + +G +APE ++ + D++S G
Sbjct: 134 LSEQGDVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 188
Query: 215 IMLMETFTRKKPTDEI 230
I +E + P ++
Sbjct: 189 ITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
+++EY+ GS L LD Q I+ ++ L+YLH S + IH D+K NVL
Sbjct: 79 IIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIML 217
L ++ L+DF +A LT + + + T +APE ++ + D++S GI
Sbjct: 134 LSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
Query: 218 METFTRKKPTDEIF----------NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267
+E + P E+ N TL+ GN P+ E V+A L + A
Sbjct: 192 IELAKGEPPHSELHPMKVLFLIPKNNPPTLE--GNYSKPLK--EFVEACLNKEPSFRPTA 247
Query: 268 KE 269
KE
Sbjct: 248 KE 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQ 123
E ++ + +I+ + ++ +V+EY +G L K L + + F
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF- 107
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
I + L +LH S +++H D+K +N+ LD + D +AKLL+ +
Sbjct: 108 -----IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157
Query: 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
+ T ++PE + DV++ G++L E T K P D
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 18/181 (9%)
Query: 54 VKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE---K 110
V++F+L +A E +++K + H N+IK ++ + +VLE G L K
Sbjct: 35 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 94
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ ++ + + SALE++H S +V+H D+KP NV + V L D
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 151
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFGIMLMETFTRKK 225
+ G + S T + +G P Y R NG D++S G +L E +
Sbjct: 152 L-----GRFFSSKTTAAHSLVG--TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
Query: 226 P 226
P
Sbjct: 205 P 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 7/130 (5%)
Query: 98 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
LV+ M G L+ ++Y+ + + + LE+LH ++++ DLKP NV
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENV 126
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
LLDD+ +SD +A L G T G +APE + + D ++ G
Sbjct: 127 LLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCT 183
Query: 217 LMETFTRKKP 226
L E + P
Sbjct: 184 LYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 10/175 (5%)
Query: 52 VAVKVFNLQCGRAFKSFNI-ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K +L S I E +MK ++H N++++ E LV EYM L+K
Sbjct: 28 VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKK 86
Query: 111 YL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
Y+ + LD + + + + H +V+H DLKP N+L++ L+D
Sbjct: 87 YMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLAD 143
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFT 222
F +A+ T + + T+ AP+ R ST+ D++S G ++ E T
Sbjct: 144 FGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
++K+++H L+ + + + VL+Y+ G L +L C L+ R ++AS
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC 193
AL YLH S +++ DLKP N+LLD L+DF + K E+ T T T
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTST-FCGTPEY 162
Query: 194 IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP---------TDEIFNREMTLK 238
+APE K D + G +L E P D I N+ + LK
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DIFQR 124
E + + + H N+++ + C LVLE+ P G L+ YL S+ ++ D+ QR
Sbjct: 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR 104
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ +VAS L +LH A IH DL N L ++ + D+ +A E +T+
Sbjct: 105 M--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
Query: 185 TQTLATIGCIAPEY------RRKGRESTN-GDVYSFGIMLMETFT 222
+ +APE ++ T +++S G+ + E FT
Sbjct: 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 71 ECEMMKSIRHRNLIK---VISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 120
E ++++ +H N+I +I S E F +V E M L K + + + D
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYF 111
Query: 121 IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY- 179
++Q L L+Y+H SA V+H DLKP N+LL+ N + DF +A++ E+
Sbjct: 112 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 180 QSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
+ T+ +AT APE + T D++S G +L E + +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 32/259 (12%)
Query: 52 VAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VAVK N R F E +MK ++++++ S + +V+E M HG L+
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98
Query: 111 YLYS-----SNCILDIFQRLNIMI----DVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
YL S N L MI ++A + YL+ + + +H DL N ++ +
Sbjct: 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221
+ DF + + + + L + +APE + G +T+ D++SFG++L E
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215
Query: 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIE 281
+ + + + E LK V+D L Q + C V +L
Sbjct: 216 SLAEQPYQGLSNEQVLKF------------VMDGGYLDQ-------PDNCPERVTDLMRM 256
Query: 282 CTVESPEQRINAREIVAKL 300
C +P+ R EIV L
Sbjct: 257 CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 75 MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 122
+++ H N+++++ C ++ E K LV E++ L YL + I D+
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
++ L++LH + ++H DLKP N+L+ L+DF +A++ + Q M
Sbjct: 115 RQF------LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQ-M 162
Query: 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
T + T+ APE + +T D++S G + E F RK
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N++ + E L+ E++ L+KYL S +D
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMD 99
Query: 131 VASALEYLH-------FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
YL+ F +S +V+H DLKP N+L+D+ V L+DF +A+ +
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--V 157
Query: 184 QTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRK 224
T + T+ APE R ST D++S G + E T+K
Sbjct: 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 7/179 (3%)
Query: 48 SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
S +VAVK+ +L+ + + E +M+ +H+N++++ + E +++E++ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L + S L+ Q + V AL YLH S VIH D+K ++LL + LS
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLS 159
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF ++ + + + T +APE + T D++S GIM++E + P
Sbjct: 160 DFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 75 MKSIRHRNLIKVISTCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 122
+++ H N++++ C+ + E K LV E++ L YL + I D+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM- 115
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
M + L++LH S +V+H DLKP N+L+ + L+DF +A++ + +Q
Sbjct: 116 -----MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMA 165
Query: 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
T + T+ APE + +T D++S G + E F RK
Sbjct: 166 L-TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 46/245 (18%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLN 126
E ++ +RH N I+ E LV+EY L S++ IL++ Q +
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVE 116
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I AL+ L + +S + IH D+K N+LL + L+DF A L ++
Sbjct: 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPAN 169
Query: 187 T-LATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN-REMT-LKHW 240
+ + T +APE +G+ DV+S GI +E RK P +FN M+ L H
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHI 226
Query: 241 GNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
N P + +N S +FV C + P+ R ++ E++
Sbjct: 227 AQNDSP-----TLSSNDWSDYFRNFVDS-------------CLQKIPQDRPSSEELLKHR 268
Query: 301 FKIRD 305
F +R+
Sbjct: 269 FVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 36/110 (32%), Positives = 51/110 (46%), Gaps = 21/110 (19%)
Query: 127 IMIDVASALEYL---HFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
+ + + AL YL H VIH D+KP N+LLD + L DF I+ L S
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKA 170
Query: 184 QTQTLATIGC---IAPEY----RRKGRESTNGDVYSFGIMLMETFTRKKP 226
+T+ + GC +APE + DV+S GI L+E T + P
Sbjct: 171 KTR---SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQ 123
E ++ ++H N++ ++ +V+EY G L K L+S + IL F
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF- 107
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLLTGEYQSM 182
+ ++ L+++H +++H D+K N+ L N MVA L DF IA+ L SM
Sbjct: 108 -----VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN---DSM 156
Query: 183 TQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241
T T ++PE + + D++S G +L E T K P + ++ LK
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216
Query: 242 NNWLPIS 248
+ PIS
Sbjct: 217 GYFAPIS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 25/166 (15%)
Query: 71 ECEMMKSIRHRNLIK---VISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 120
E ++++ + H N+I ++ E F +V E M L + + SS + D
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQY 112
Query: 121 -IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179
++Q L L+Y+H SA V+H DLKP N+LL+ N + DF +A+ + +
Sbjct: 113 FLYQLLR-------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162
Query: 180 QSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
M T+ + T APE E T DV+S G + E RK
Sbjct: 163 DFM--TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 15/174 (8%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
++K+++H L+ + + E VL+++ G L +L + R ++AS
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIAS 107
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC 193
AL YLH S +++ DLKP N+LLD L+DF + K G QS T T T
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEY 162
Query: 194 IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP---------TDEIFNREMTLK 238
+APE RK D + G +L E P D I ++ + L+
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 80 HRNLIKVISTCSNEEFKA-------LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMI 129
H N++K+++ KA LV EYM H + N + D+ +R IM
Sbjct: 66 HPNIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMY 114
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ---TQ 186
+ AL+Y+H S VIH DLKP N+LL+ + L+DF +A+ L+ ++ T
Sbjct: 115 QLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 187 TLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
+AT APE T G D++S G +L E K
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 40/135 (29%), Positives = 56/135 (41%), Gaps = 22/135 (16%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKA-----LVLEYMPH---GSLEKYLYSSNCILDIF 122
E M+K ++H NL+ +I E F+ LV EY H LEK +
Sbjct: 50 EIRMLKQLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEH 100
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
I+ A+ + H IH D+KP N+L+ L DF A++LTG
Sbjct: 101 LIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGD 155
Query: 183 TQTQTLATIGCIAPE 197
T +AT APE
Sbjct: 156 DYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 18/181 (9%)
Query: 54 VKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE---K 110
V++F + +A + E +++K + H N+IK +++ +VLE G L K
Sbjct: 35 VQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK 94
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ ++ + + SALE++H S +++H D+KP NV + V L D
Sbjct: 95 HFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLG 151
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFGIMLMETFTRKK 225
+ G + S T + +G P Y R NG D++S G +L E +
Sbjct: 152 L-----GRFFSSKTTAAHSLVG--TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
Query: 226 P 226
P
Sbjct: 205 P 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 28/195 (14%)
Query: 51 EVAVKV--FNLQCGRAFKSFN-IECE--MMKSIRHRNLIKVISTCSN--EEFKALVLEYM 103
E+AVK F+ + K N +ECE ++K++ H +++ + E ++ +E+M
Sbjct: 29 ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88
Query: 104 PHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
P GS++ L S + + + ++ I LE + + +S ++H D+K N+L D
Sbjct: 89 PGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLHSNMIVHRDIKGANILRDSVG 143
Query: 163 VAHLSDFSIAKLL-------TGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNGDVYSFG 214
L DF +K L TG +S+T T + I+ E Y RK D++S G
Sbjct: 144 NVKLGDFGASKRLQTICLSGTG-MKSVTGTPYWMSPEVISGEGYGRK------ADIWSVG 196
Query: 215 IMLMETFTRKKPTDE 229
++E T K P E
Sbjct: 197 CTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 46 ISSAME------VAVKVFNLQCGRAFKSFNI------ECEMMKSIRHRNL--IKVISTCS 91
+ SA++ VA+K + AF + E ++++ +H N+ I+ I
Sbjct: 21 VCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP 76
Query: 92 NEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHC 149
+FK +V++ M L ++S + + R + + L+Y+H SA VIH
Sbjct: 77 GADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIH---SANVIHR 131
Query: 150 DLKPINVLLDDNMVAHLSDFSIAKLLTG--EYQSMTQTQTLATIGCIAPEYRRK-GREST 206
DLKP N+L++++ + DF +A+ L+ T+ +AT APE +T
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTT 191
Query: 207 NGDVYSFGIMLMETFTRK 224
D++S G + E R+
Sbjct: 192 AIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 24/180 (13%)
Query: 52 VAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+KV +++ G F + E ++K ++H N++ + +E V EYM H L
Sbjct: 33 VALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLA 90
Query: 110 KY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+Y L+ N L +FQ L L Y+H ++H DLKP N+L+
Sbjct: 91 QYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH---GQHILHRDLKPQNLLISYLG 140
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETF 221
L+DF +A+ S T + + T+ P+ + S+ D++ G + +E
Sbjct: 141 ELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 71 ECEMMKSIRHRNLIK----VISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 126
E ++ ++RH N+++ V+ + F LV+EY L L + Q
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKC 112
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
+M+ + L+YLH + +IH DLK N+LL D ++DF +A+ + M T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TP 167
Query: 187 TLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
+ T+ APE T D+++ G +L E K
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 18/181 (9%)
Query: 54 VKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE---K 110
V++F + +A + E +++K + H N+IK + + + +VLE G L K
Sbjct: 35 VQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK 94
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
Y ++ + + SA+E++H S +V+H D+KP NV + V L D
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 151
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFGIMLMETFTRKK 225
+ G + S T + +G P Y R NG D++S G +L E +
Sbjct: 152 L-----GRFFSSKTTAAHSLVG--TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
Query: 226 P 226
P
Sbjct: 205 P 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 39/111 (35%), Positives = 53/111 (47%), Gaps = 18/111 (16%)
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I + AL YL ++IH D+KP N+LLD N L DF I+ L S+ +T+
Sbjct: 112 IAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTR 166
Query: 187 TLATIGC---IAPEYRRKGRESTNG-----DVYSFGIMLMETFTRKKPTDE 229
GC +APE R + +G DV+S GI L E T K P +
Sbjct: 167 ---DAGCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 7/130 (5%)
Query: 98 LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
LV+ M G L+ ++Y+ L++ + ++ + + +LH S +++ D+KP NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
LLDD LSD +A L T TQ T G +APE ++ S D ++ G
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183
Query: 217 LMETFTRKKP 226
+ E + P
Sbjct: 184 IYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 59/256 (23%), Positives = 112/256 (43%), Gaps = 27/256 (10%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
SS VAVK +L+ + + E +M+ +H N++++ ++ + +V+E++ G
Sbjct: 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
+L + + ++ Q + + V AL LH + VIH D+K ++LL + L
Sbjct: 103 ALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKL 157
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
SDF ++ E + + T +APE + D++S GIM++E + P
Sbjct: 158 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAIECTVE 285
FN P+ M+++ NL + +++H V+ + V
Sbjct: 216 ---YFNEP-----------PLKAMKMIRDNLPPKLKNLHKVS-----PSLKGFLDRLLVR 256
Query: 286 SPEQRINAREIVAKLF 301
P QR A E++ F
Sbjct: 257 DPAQRATAAELLKHPF 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 49 AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGS 107
AM+V K +Q + + E +++ +R + + E K L+L+Y+ G
Sbjct: 32 AMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGE 91
Query: 108 LEKYLYSSNCILDIFQRLNIMI---DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
+ +LY D F + ++ ALE+LH +++ D+K N+LLD
Sbjct: 92 MFTHLYQR----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHV 144
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNGDVYSFGIMLMETFTR 223
L+DF ++K E + T + TI +APE R KG D +S GI++ E T
Sbjct: 145 VLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
Query: 224 KKP 226
P
Sbjct: 204 ASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 11/140 (7%)
Query: 92 NEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
NE + +E+M GSL++ I ++I + I + V L YL+ +++H D
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHRD 129
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLLTGEY-QSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
+KP N+L++ L DF + +GE S+ T + T ++PE + G+ + D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGV----SGELINSIADT-FVGTSTYMSPERIQGGKYTVKSD 184
Query: 210 VYSFGIMLMETFTRKKPTDE 229
V+S GI ++E K P
Sbjct: 185 VWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 40/195 (20%)
Query: 87 ISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQV 146
IS C+ E+M GSL+ Y +L I + V L YL +S ++
Sbjct: 74 ISICT---------EFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKI 116
Query: 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-S 205
+H D+KP N+L++ L DF ++ L S+ +T + T +APE R G +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPE-RISGEQYG 171
Query: 206 TNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME--------VVDANL 257
+ DV+S GI ME + P +I + +L +P+ ++ V+
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQ 224
Query: 258 LSQEDIHFVAKEQCV 272
S++ +HF+ QC+
Sbjct: 225 FSEKFVHFIT--QCM 237
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 61/258 (23%), Positives = 107/258 (41%), Gaps = 29/258 (11%)
Query: 52 VAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+KV +A K E +M + + +++ C + LV + MP+G L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLD 97
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
Y+ + + LN + +A + YL +++H DL NVL+ ++DF
Sbjct: 98 YVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDE 229
+A+LL + I +A E R + DV+S+G+ + E T KP D
Sbjct: 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
I RE+ ++++ L Q I C V+ + ++C + E
Sbjct: 215 IPAREIP--------------DLLEKGERLPQPPI-------CTIDVYMIMVKCWMIDSE 253
Query: 289 QRINAREIVAKLFKI-RD 305
R RE+V + ++ RD
Sbjct: 254 CRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
++EY GS L LD I+ +V LEYLH IH D+K N+LL
Sbjct: 77 IMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILL 131
Query: 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIML 217
+ L+DF ++ LT +M++ T T +APE ++ D++S GI
Sbjct: 132 SEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188
Query: 218 METFTRKKP 226
+E + P
Sbjct: 189 IELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
L+L+Y+ G L +LY + R+ I ++ AL++LH +I+ D+K N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG--DVYSFGI 215
LD L+DF ++K E + + TI +APE R G + D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 216 MLMETFTRKKP 226
+ E T P
Sbjct: 197 LTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 29/108 (26%), Positives = 56/108 (51%), Gaps = 4/108 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E + +++ +H ++K++ + LV+EYMP L + L L Q + M
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM 107
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
+ + Y+H + ++H DLKP N+L+ + V ++DF +A+L + E
Sbjct: 108 LLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 26/111 (23%), Positives = 56/111 (50%), Gaps = 12/111 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIF 122
E ++++ ++H N++ +I C + +K LV E+ H L L + N +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
+ +M + + L Y+H +++H D+K N+L+ + + L+DF +A+
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H+N++++ +++ LV EY L+KY S N +D + M
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
+ L + H S V+H DLKP N+L++ N L+DF +A+
Sbjct: 108 LLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 48/158 (30%), Positives = 69/158 (43%), Gaps = 33/158 (20%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNI-MIDVAS--------ALEYLHFGYSAQVIH 148
L+LEY+ G L +L +R I M D A ALE+LH +I+
Sbjct: 77 LILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLALEHLH---QQGIIY 123
Query: 149 CDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG 208
DLKP N+LLD L+DF + K E ++T T TI +APE +
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHT-FCGTIEYMAPEILMRSGHGKAV 181
Query: 209 DVYSFGIMLMETFT---------RKKPTDEIFNREMTL 237
D +S G ++ + T RKK D+I ++ L
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 71 ECEMMKSIRHRNLIK----VISTCSNEEFKA------LVLEYMPH---GSLEKYL--YSS 115
E ++++ + HRN++ V +FK LV EYM H G LE L +S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 116 NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175
+ I ++L LE L++ + +H D+K N+LL++ L+DF +A+L
Sbjct: 116 DHIKSFMKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 176 TGEYQSMTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRK 224
E +S T + T+ PE + R DV+S G +L E FT+K
Sbjct: 167 NSE-ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 12/192 (6%)
Query: 53 AVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL 112
A KV + + + +E E++ + H ++K++ + +++E+ P G+++ +
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 113 YSSNCILDI-FQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171
LD I + LE L + +S ++IH DLK NVLL + L+DF +
Sbjct: 101 LE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV 156
Query: 172 AKLLTGEYQSMTQTQTLATIGCIAPEY-----RRKGRESTNGDVYSFGIMLMETFTRKKP 226
+ Q + + T +APE + D++S GI L+E + P
Sbjct: 157 SAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
Query: 227 TDEIFNREMTLK 238
E+ + LK
Sbjct: 215 HHELNPMRVLLK 226
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 48/260 (18%), Positives = 92/260 (35%), Gaps = 49/260 (18%)
Query: 55 KVFNLQCGRAFKSFNIECEMMKSIRHRNLIKV----ISTCSNEEFKALVLEYMPHGSLEK 110
K F+ E + ++ I N++K+ I + +L+LEY G L +
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
L L +L++ ID L L+ + + +L ++ L+ +N
Sbjct: 112 VLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN--------Y 160
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKK 225
K++ + + + + + + + D+YS G++L E FT K
Sbjct: 161 KLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220
Query: 226 P-----TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
P T EI++ + + NN L + C + +
Sbjct: 221 PFENLTTKEIYD--LIINK--NNSLKLPL--------------------DCPLEIKCIVE 256
Query: 281 ECTVESPEQRINAREIVAKL 300
CT +R N +EI+ L
Sbjct: 257 ACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 98 LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
LV+ M G L ++Y+ N + + S LE+LH ++I+ DLKP
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPE 126
Query: 155 NVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYS 212
NVLLD++ +SD +A +L G+ ++T+ A T G +APE + + D ++
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEEYDFSVDYFA 182
Query: 213 FGIMLMETFTRKKP----TDEIFNREMT 236
G+ L E + P +++ N+E+
Sbjct: 183 LGVTLYEMIAARGPFRARGEKVENKELK 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 119 LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
L L+ VA +E+L S +H DL NVLL + + DF +A+ + +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+++ T + +APE +T DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 36/123 (29%), Positives = 62/123 (50%), Gaps = 25/123 (20%)
Query: 120 DIFQRLN--IMI----------DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
D+F RL+ +M ++A AL++LH S +I+ DLKP N+LLD+ L+
Sbjct: 84 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140
Query: 168 DFSIAKLLTGEYQSMTQTQT----LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
DF ++K +S+ + T+ +APE + + + D +SFG+++ E T
Sbjct: 141 DFGLSK------ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
Query: 224 KKP 226
P
Sbjct: 195 SLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 129
E ++++ + R ++ + ++ LVL M G L+ ++Y + + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ LE LH ++++ DLKP N+LLDD+ +SD +A + + T +
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVG 163
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T+G +APE + R + + D ++ G +L E + P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI--- 127
E ++K ++H N++++ +E+ LV EY+ L+K++ SS D + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKT 106
Query: 128 -MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA-HLSDFSIAKLLTGEYQSMTQT 185
+ + + Y H S +V+H DLKP N+L+D A L+DF +A+ + T T
Sbjct: 107 YLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFT 161
Query: 186 QTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRK 224
+ T+ APE R ST D++S G + E +K
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 28/175 (16%)
Query: 71 ECEMMKSIRHRNLIK----VISTCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF 122
E +++K ++H N++ + + K +V YM H L L + + L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
Q M+ + + YLH ++H D+K N+L+D+ + ++DF +A+ G +
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 183 TQTQTLAT---IGCI------APEY----RRKGRESTNGDVYSFGIMLMETFTRK 224
T + PE RR T D++ G + E FTR+
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYT---TAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---- 126
E + + H ++K +++ L++EY G L K I QRL
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLP 165
Query: 127 --------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
+ + AL+ +H S +++H DLK N+ L + L DF +K +
Sbjct: 166 FQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK 238
+ T +APE + R S D++S G++L E T +P RE+ +
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282
Query: 239 HWGNNWLPI-----STMEVVDANLLSQE 261
+ P S M+ + LLS+
Sbjct: 283 VLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 129
E ++K + H N+++++ +E LV E++ L+KY+ S LD + +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+ + Y H S +V+H DLKP N+L+D L+DF +A+ + T T +
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV 161
Query: 190 TIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRK------KPTDEIF 231
T+ APE R+ ST D++S G + E R+ D++F
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 49 AMEVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRN---LIKVISTCSNEEFKAL-VLEY 102
A++ VF + C R F+ E +M+ +H N + ++ + F+ + V+
Sbjct: 29 ALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+ L K + S + ++ + + L+YLH SA ++H D+KP N+L++ N
Sbjct: 85 LMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNC 140
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETF 221
V + DF +A++ + +S TQ + T APE R T+ D++S G + E
Sbjct: 141 VLKICDFGLARVEEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
Query: 222 TRK 224
R+
Sbjct: 200 GRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 3/119 (2%)
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
P + L + + L + VA+ +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF +A+ + + +++ T + +APE +T DV+SFGI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 10/124 (8%)
Query: 52 VAVKVFNL--QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK NL K E + ++H N++ +++ + +V M +GS E
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 110 KYLYSSNCILDIFQRL---NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L + + L I+ DV +AL+Y+H S IH +K ++LL + L
Sbjct: 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVL 142
Query: 167 SDFS 170
S
Sbjct: 143 SGLR 146
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 7/153 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K+++H N++ + E LV EY+ L++YL NC ++ N+ I
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYL--DNC-GNLMSMHNVKIF 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ L L + + +++H DLKP N+L+++ L+DF +A+ + T + + T
Sbjct: 109 MFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVT 166
Query: 191 IGCIAPEYRRKGRE-STNGDVYSFGIMLMETFT 222
+ P+ E ST D++ G +L E T
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 31/194 (15%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVI------STCSNEEFKAL------- 98
VAVK L ++ K E ++++ + H N++KV + E+ +L
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 99 -VLEYMP---HGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153
V EYM LE+ S L ++Q L L+Y+H SA V+H DLKP
Sbjct: 93 IVQEYMETDLANVLEQGPLSEEHARLFMYQLLR-------GLKYIH---SANVLHRDLKP 142
Query: 154 INVLLD-DNMVAHLSDFSIAKLLTGEYQ-SMTQTQTLATIGCIAPEYRRKGRESTNG-DV 210
NV ++ +++V + DF +A+++ Y ++ L T +P T D+
Sbjct: 143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202
Query: 211 YSFGIMLMETFTRK 224
++ G + E T K
Sbjct: 203 WAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 44/244 (18%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E + ++ I+H N I+ E LV+EY L S++ +L++ ++ ++
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 126
Query: 131 VAS----ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
+A+ AL+ L + +S +IH D+K N+LL + L+DF A + +
Sbjct: 127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANS 180
Query: 187 TLATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM--TLKHWG 241
+ T +APE +G+ DV+S GI +E RK P +FN L H
Sbjct: 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIA 237
Query: 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301
N P L S E + N C + P+ R + E++ +F
Sbjct: 238 QNESP---------TLQSNE---------WSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
Query: 302 KIRD 305
+R+
Sbjct: 280 VLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 75 MKSIRHRNLIKVISTC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLN 126
++S H N+++++ C ++ E K LV E++ L YL S C L +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKD 111
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
+M + +++LH S +++H DLKP N+L+ + ++DF +A++ + E M T
Sbjct: 112 LMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTS 165
Query: 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+ T+ APE + +T D++S G + E F R+
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 27/103 (26%), Positives = 56/103 (54%), Gaps = 4/103 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N++ + E+ LV EY+ L++YL +++ N+ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLF 109
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
+ L L++ + +V+H DLKP N+L+++ L+DF +A+
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 129
E ++++ + + ++ + ++ LVL M G L+ ++Y+ N + + L
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTL 188
++ LE LH ++ DLKP N+LLDD +SD +A K+ GE + +
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRV 162
Query: 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248
T+G +APE R + + D + G ++ E + P R+ +K
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP---FRGRKEKVKR--------- 210
Query: 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
E VD +L E+++ + + + + + P+QR+ +E A K R
Sbjct: 211 --EEVDRRVLETEEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVK-RHPFF 264
Query: 309 RNV 311
RN+
Sbjct: 265 RNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 23/191 (12%)
Query: 48 SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
S M +V N++ RA MM + K+ + ++++ LV+EY+ G
Sbjct: 32 SDMIAKNQVTNVKAERAI--------MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD 83
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
+ + + + + + + +V +E LH +IH D+KP N+L+D L+
Sbjct: 84 CASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLT 139
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP- 226
DF +++ + + + T +APE + D +S G ++ E P
Sbjct: 140 DFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193
Query: 227 ----TDEIFNR 233
D +F+
Sbjct: 194 HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 50/186 (26%), Positives = 78/186 (41%), Gaps = 26/186 (13%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLN 126
E ++ +RH N I+ E LV+EY L S++ +L++ Q +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 116
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I AL+ L + +S +IH D+K N+LL + + L DF A ++
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANX 170
Query: 187 TLATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM--TLKHWG 241
+ T +APE +G+ DV+S GI +E RK P +FN L H
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIA 227
Query: 242 NNWLPI 247
N P
Sbjct: 228 QNESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
VA +E+L S + IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 191 IGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ +APE +T DV+SFG++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 21/131 (16%)
Query: 52 VAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K L+ G F + E ++K ++H N++ + ++ LV EY+ L+
Sbjct: 33 VALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLK 90
Query: 110 KYLYSSNCILD-------IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+Y+ L +FQ L L Y H +V+H DLKP N+L+ +
Sbjct: 91 QYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH---QRRVLHRDLKPQNLLISERG 140
Query: 163 VAHLSDFSIAK 173
L+DF +A+
Sbjct: 141 ELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
VA +E+L S + IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 191 IGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ +APE + DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 36/150 (24%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N++ + ++ LV EY+ L++Y+ I+ + N+ I
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIF 109
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ L L + + +V+H DLKP N+L+++ L+DF +A+ + T + + T
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVT 167
Query: 191 IGCIAPEYRRKGRE-STNGDVYSFGIMLME 219
+ P+ E ST D++ G + E
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
VA +E+L S + IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 191 IGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ +APE +T DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I+ ++ L+YLH S + IH D+K NVLL + L+DF +A LT TQ +
Sbjct: 106 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-----TQIK 157
Query: 187 TLATIGC---IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230
+G +APE ++ D++S GI +E + P ++
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 10/191 (5%)
Query: 53 AVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL 112
A KV + + + + +E +++ S H N++K++ E +++E+ G+++ +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 113 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172
L Q + AL YLH ++IH DLK N+L + L+DF ++
Sbjct: 94 LELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150
Query: 173 KLLTGEYQSMTQTQTLATIGCIAPEY----RRKGRE-STNGDVYSFGIMLMETFTRKKPT 227
T Q + + T +APE K R DV+S GI L+E + P
Sbjct: 151 AKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208
Query: 228 DEIFNREMTLK 238
E+ + LK
Sbjct: 209 HELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 69 NIECEMMK------SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 122
++EC M++ + H L + T +E V+EY+ G L ++ SS D
Sbjct: 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEA 96
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL-LTGEYQS 181
+ ++ L++LH +I+ DLK NVLLD + ++DF + K + GE ++
Sbjct: 97 RARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIF 231
T T IAPE + + + + D +SFG++L E + P DE+F
Sbjct: 154 ST---FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 22/132 (16%)
Query: 100 LEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
+EYM GSL+K LY + + I V L++L + +IH D+KP NV
Sbjct: 78 MEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNV 134
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG----- 208
L++ N L DF ++ L S+ +T IGC +APE + G + N
Sbjct: 135 LVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 209 -DVYSFGIMLME 219
DV+S G+ ++E
Sbjct: 188 SDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ--TQTLATI 191
L+Y+H SA V+H DLKP N+L++ + + DF +A+ + T+ +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 192 GCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
APE + T DV+S G +L E RK
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 19/163 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLY-------SSNCILDIFQ 123
E +++K+I HR +I +I K+ V MP + + Y + I +
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
RL AL YLH +IH D+K N+ LD+ A L DF A L +
Sbjct: 193 RL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
Query: 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T+ +PE D++S G++L E +
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 11/128 (8%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K+ RH L + + ++ V+EY+ G L +L + R +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAE 103
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ SAL+YLH S ++++ DLK N++LD + ++DF + K + +T T+ T
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKT 154
Query: 191 IGCIAPEY 198
C PEY
Sbjct: 155 F-CGTPEY 161
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 9/130 (6%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
+L+ M G L +L + R ++ LE++H + V++ DLKP N+L
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF---VVYRDLKPANIL 129
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIM 216
LD++ +SD +A ++ ++ T G +APE +KG ++ D +S G M
Sbjct: 130 LDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCM 185
Query: 217 LMETFTRKKP 226
L + P
Sbjct: 186 LFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 34/131 (25%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 97 ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
++ +E+M GSL++ L + I +I +++I V L YL + Q++H D+KP N
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKH--QIMHRDVKPSN 134
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
+L++ L DF + +G+ + T ++PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 216 MLMETFTRKKP 226
L+E + P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 68 FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 127
E +++ ++K+ + +EE LV+EYMP G L L + + R I
Sbjct: 48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYI 107
Query: 128 MIDVASALEYLH-FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173
++ AL+ +H G+ IH D+KP N+L+D + L+DF + K
Sbjct: 108 A-ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 71 ECEMMKSIRHRNLIKV--ISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
E ++ ++H N++ V + SN + +V+EY+ H L+ + + + +M
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ--TQ 186
+ + S + +LH ++H DLK N+LL++ + + DF +A+ EY S + TQ
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQ 165
Query: 187 TLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKP 226
+ T+ APE +E ST D++S G + E KKP
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE-LLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ LE++H + V++ DLKP N+LLD++ +SD +A ++ ++
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVG 157
Query: 190 TIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKP 226
T G +APE +KG ++ D +S G ML + P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 9/131 (6%)
Query: 98 LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
LVL M G L+ ++Y+ N D + + ++ LE LH ++++ DLKP N+
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133
Query: 157 LLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
LLDD +SD +A ++ GE T + T+G +APE + R + + D + G
Sbjct: 134 LLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGC 189
Query: 216 MLMETFTRKKP 226
++ E K P
Sbjct: 190 LIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 25/179 (13%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +++ + + L+K++ ++E+ L +EY+P G L + + + R M +
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAE 109
Query: 131 VASALEYLH-FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+ A++ LH GY IH DLKP N L+D + L+DF ++K + S+
Sbjct: 110 MFEAVDALHELGY----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV------- 158
Query: 190 TIGC---IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNREMTLKHW 240
+G +APE R D +S G ML E P +E + LK+W
Sbjct: 159 -VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 19/175 (10%)
Query: 69 NIECEMMK----SIRHRN--LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 122
++EC M++ ++ N L + T +E V+E++ G L ++ D++
Sbjct: 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLY 96
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL-LTGEYQS 181
+ ++ L++LH S +I+ DLK NV+LD + ++DF + K + G+ ++
Sbjct: 97 RATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIF 231
T T IAPE + + + + D +SFG++L E + P DE+F
Sbjct: 154 ST---FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 22/184 (11%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
EV +KV + +SF MM + H++L+ C + +V EY+ GSL+
Sbjct: 28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD 87
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAH- 165
YL + +++I +L + +A AL +L + H ++ NVLL +D +
Sbjct: 88 TYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNP 144
Query: 166 ----LSD--FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLM 218
LSD SI L + L I + PE + S D +SFG L
Sbjct: 145 PFIKLSDPGISITVL--------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196
Query: 219 ETFT 222
E F+
Sbjct: 197 EIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185
NI + + AL YLH +++H DL P N++L ++ ++DF +AK E + T
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LT 171
Query: 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+ TI PE + DV++FG +L + T + P
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 10/182 (5%)
Query: 49 AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGS 107
AM+V K +Q + + E ++++ IR + + + K L+L+Y+ G
Sbjct: 32 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGE 91
Query: 108 LEKYLYSSNCILDIFQRLNIMI-DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L +L + Q + I ++ ALE+LH +I+ D+K N+LLD N L
Sbjct: 92 LFTHLSQRERFKE--QEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVL 146
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG--DVYSFGIMLMETFTRK 224
+DF ++K E + TI +AP+ R G + D +S G+++ E T
Sbjct: 147 TDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205
Query: 225 KP 226
P
Sbjct: 206 SP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 14/165 (8%)
Query: 69 NIECEMMK------SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 122
++EC M++ + H L + T +E V+EY+ G L ++ S + D+
Sbjct: 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLP 96
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL-LTGEYQS 181
+ ++ L++LH S +++ DLK N+LLD + ++DF + K + G+ ++
Sbjct: 97 RATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153
Query: 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T T IAPE + +T+ D +SFG++L E + P
Sbjct: 154 CT---FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 119 LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
LD+ L VA +++L S IH D+ NVLL D VA + DF +A+ + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ + + +APE + DV+S+GI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 40/134 (29%), Positives = 56/134 (41%), Gaps = 16/134 (11%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
LVL ++ G L +L D+ + ++ ALE LH VI+ DLKP N+L
Sbjct: 70 LVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENIL 125
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYS 212
LD L DF + KL +M T C PEY +G D ++
Sbjct: 126 LDYQGHIALCDFGLCKL------NMKDDDKTNTF-CGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 213 FGIMLMETFTRKKP 226
G++L E T P
Sbjct: 179 LGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 20/96 (20%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ A EYLH S +I+ DLKP N+LLD+ ++DF AK + +T TL
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------DRTFTL- 175
Query: 190 TIGCIAPEY------RRKGRESTNGDVYSFGIMLME 219
C PEY + KG D ++ G++L E
Sbjct: 176 ---CGTPEYLAPEVIQSKGHGKAV-DWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 71 ECEMMKSIRHRNLIKVIST-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 129
E +++K +RH N+I + S E V E + G+ L +S + F + +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLY 115
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+ L+Y+H SA V+H DLKP N+L+++N + DF +A++ Q T ++
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167
Query: 190 TIGCIAPE----YRRKGRESTNGDVYSFGIMLMETFTRK 224
T APE +++ E D++S G + E K
Sbjct: 168 TRYYRAPEIMLTWQKYDVEV---DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 129
E +++ + R ++ + ++ LVL M G L+ ++Y+ N D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTL 188
++ LE L ++++ DLKP N+LLDD +SD +A ++ GE T +
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRV 162
Query: 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T+G +APE + + + D + G ++ E + P
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 42/157 (26%)
Query: 71 ECEMMKSIRHRNLIKVIS----TCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 124
E ++K + H N+I ++ S E+F+ LV M L + Q+
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QK 114
Query: 125 LN------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA----KL 174
L+ ++ + L+Y+H SA +IH DLKP N+ ++++ + DF +A
Sbjct: 115 LSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
Query: 175 LTGEYQSM--------------TQTQTLATIGCIAPE 197
+TG + QT + ++GCI E
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 34/131 (25%), Positives = 56/131 (42%), Gaps = 19/131 (14%)
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE------ 178
L+I + + +EY+H S V+H DLKP N+LL + D+ A E
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 179 ---------YQSMTQT-QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
Y SMT + + T +APE S + D+Y+ G++L + T P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 229 EIFNREMTLKH 239
R+++ +
Sbjct: 233 RKKGRKISYRD 243
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 3/104 (2%)
Query: 119 LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178
LD L+ VA + +L S IH DL N+LL + + DF +A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ + + +APE + DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 9/175 (5%)
Query: 54 VKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-FKALVLEYMPHGSLEK 110
+K NL+ R K+ E +++ ++H N++ + E+ +V+ + G L
Sbjct: 30 IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89
Query: 111 YLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L +L Q + + +A AL+YLH ++H DLK NV L + + D
Sbjct: 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDL 146
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
IA++L + M T + T ++PE + DV++ G + E T K
Sbjct: 147 GIARVLENQC-DMAST-LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 24/169 (14%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLN 126
E + ++ ++H N I+ E LV+EY L S++ +L++ Q +
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 122
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
I AL+ L + +S +IH D+K N+LL + L+DF A S
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANS 176
Query: 187 TLATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN 232
+ T +APE +G+ DV+S GI +E RK P +FN
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 25/134 (18%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMM---KSIR----HRNLIK---VISTCSNEEFKALVLE 101
VA+K + F S+ EC + KS+R H N++K V N+E V E
Sbjct: 27 VAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELY-FVFE 78
Query: 102 YMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH-FGYSAQVIHCDLKPINVLLD 159
YM G+L + + +I+ + L ++H G+ H DLKP N+L+
Sbjct: 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF----FHRDLKPENLLVS 133
Query: 160 DNMVAHLSDFSIAK 173
V ++DF +A+
Sbjct: 134 GPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 83 LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 142
++++ ++ + +V+EYMP G L L S+ + + + R +V AL+ +H
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 159
Query: 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRK 201
S IH D+KP N+LLD + L+DF + E M + T + T I+PE +
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYISPEVLKS 217
Query: 202 -------GRESTNGDVYSFGIMLMETFTRKKP 226
GRE D +S G+ L E P
Sbjct: 218 QGGDGYYGREC---DWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 97 ALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
++ +E+M GSL++ L + I + I +++I V L YL + +++H D+KP N
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH--KIMHRDVKPSN 134
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215
+L++ L DF ++ L SM + + T ++PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 216 MLMETFTRKKP 226
L+E + P
Sbjct: 191 SLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 27/136 (19%), Positives = 62/136 (45%), Gaps = 17/136 (12%)
Query: 44 FLISSAME-VAVKVFNLQCGRAFKSFNIECE--MMKSIRHRNLI--KVISTCSNEEFKAL 98
+L+ + E +K+ K + E E +++ + + L KV+++ ++ + L
Sbjct: 15 YLLGTKDEDYVLKINP----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
++E++ +L++ + ++ +I +A L LH + H DL P N+L+
Sbjct: 71 LMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV 122
Query: 159 DDNMVAHLSDFSIAKL 174
DD + + D+ A
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
E ++ +++H N+ V S EE L V++Y G L K + + +L F I+
Sbjct: 49 EVAVLSNMKHPNI--VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQIL 104
Query: 129 ---IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185
+ + AL+++H +++H D+K N+ L + L DF IA++L ++
Sbjct: 105 DWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---STVELA 158
Query: 186 QT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244
+T + T ++PE + D+++ G +L E T K + + + LK ++
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY 218
Query: 245 LPISTMEVVD-ANLLSQ 260
P+S+ D NL+SQ
Sbjct: 219 PPVSSHYSYDLRNLVSQ 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 6/149 (4%)
Query: 80 HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 139
H L+ + S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 113
Query: 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYR 199
+I+ DLK NVLLD L+D+ + K G T + T IAPE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 200 RKGRESTNGDVYSFGIMLMETFTRKKPTD 228
R + D ++ G+++ E + P D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 17/160 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNI 127
E +++ I H + + + +E + LVLE++ G +L + + F I
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
++ EYL S +++ DLKP N+LLD + ++DF AK++ T+T T
Sbjct: 141 VL----IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYT 187
Query: 188 L-ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
L T IAPE D ++ GI + E P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 35/179 (19%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 128
E E++ ++ H L + ++ E + LV++Y P G L + L C+ + R
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 129 IDVASALEYLH-FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK------------LL 175
+V ALEYLH G ++ DLKP N+LL ++ LSDF ++K L
Sbjct: 111 -EVLLALEYLHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 176 TGEYQSMTQTQTLATIGC---------------IAPEYRRKGRESTNGDVYSFGIMLME 219
G +S + T IAPE + D ++ GI+L E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 15/74 (20%)
Query: 108 LEKYLYSSNCILDIFQRL---------NIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
LEK + ++ +IF+R+ NIM D+ + LEY+H + H D+KP N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159
Query: 159 DDNMVAHLSDFSIA 172
D N ++ D+ IA
Sbjct: 160 DGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
+M + H +L V C +V E++ HG L+ L + + ++ + +AS
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH-------LSDFSIAKLLTGEYQSMTQTQ 186
AL YL ++H ++ N+LL +A LSD ++ + ++++ +
Sbjct: 129 ALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS------FTALSREE 179
Query: 187 TLATIGCIAPEYRRKGRE-STNGDVYSFGIMLME 219
+ I IAPE G ST D +SFG L+E
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 16/127 (12%)
Query: 69 NIECEMMKSIRHRNLIKVISTCSNEEFKA--------LVLEYMPHGSLEKYL--YS-SNC 117
N E +MK++ H N+I + E FK +V+E++P ++ KY+ Y+ +N
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNH 165
Query: 118 ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLT 176
L +F + AL Y+H S + H DLKP N+L+D N L DF AK L
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222
Query: 177 GEYQSMT 183
+S++
Sbjct: 223 AGQRSVS 229
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 17/168 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMI 129
E ++++I H ++I++ T + +F L+L P + Y Y ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
V A++YLH ++IH D+K N+ ++ L DF A + +
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV----DINANKYYG 242
Query: 190 TIGCIA---PEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234
G IA PE + D++S GI+L E T D +F ++
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 63 RAFKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMPHGSLEKYLYSSN 116
RA++ E ++K + H+N+I +++ S EEF+ LV+E M +L + ++
Sbjct: 66 RAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME- 119
Query: 117 CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176
LD + ++ + +++LH SA +IH DLKP N+++ + + DF +A+
Sbjct: 120 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
+ T + T APE N D++S G ++ E
Sbjct: 175 TNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 83 LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 142
++++ ++++ +V+EYMP G L L S+ + + + + +V AL+ +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH--- 159
Query: 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRK 201
S +IH D+KP N+LLD + L+DF + + M + T + T I+PE +
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 202 -------GRESTNGDVYSFGIMLMETFTRKKP 226
GRE D +S G+ L E P
Sbjct: 218 QGGDGYYGREC---DWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 42/139 (30%)
Query: 63 RAFKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKA--LVLEYMP------------ 104
RA++ +MK + H+N+I +++ S EEF+ LV+E M
Sbjct: 61 RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD 116
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
H + LY C +++LH SA +IH DLKP N+++ +
Sbjct: 117 HERMSYLLYQMLC----------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTL 157
Query: 165 HLSDFSIAKLLTGEYQSMT 183
+ DF +A+ G MT
Sbjct: 158 KILDFGLAR-TAGTSFMMT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
+E+M GSL++ L + I + I I V L YL + +++H D+KP N+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKH--KIMHRDVKPSNILVN 134
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
L DF ++ L SM + + T ++PE + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQL---IDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 11/173 (6%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +M+++++ N++++ LV EY+ LE N + R I
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY-- 107
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
++ +H+ + ++H D+KP N+L+ N V L DF A+ L+ E + T+ +AT
Sbjct: 108 --QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164
Query: 191 IGCIAPEYRRKGRESTNGDVYSFGIMLME------TFTRKKPTDEIFNREMTL 237
+PE D++S G +L E F + D++F + L
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 14/120 (11%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ SAL +LH +I+ DLK NVLLD L+DF + K G + T +
Sbjct: 104 EITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCG 158
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIF----NREMTLKHW 240
T IAPE ++ + D ++ G++L E P D++F N E+ W
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 6/133 (4%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
LV+EY+ G L ++ + + R ++ AL +LH +I+ DLK NVL
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGIIYRDLKLDNVL 128
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIML 217
LD + L+D+ + K G T + T IAPE R + D ++ G+++
Sbjct: 129 LDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186
Query: 218 METFTRKKPTDEI 230
E + P D I
Sbjct: 187 FEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 18/130 (13%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAQVIHCDLKPINV 156
+V+EYMP G L L S+ I + + R +V AL+ +H G+ IH D+KP N+
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIHSMGF----IHRDVKPDNM 173
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-------GRESTNGD 209
LLD + L+DF + T + T I+PE + GRE D
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGREC---D 229
Query: 210 VYSFGIMLME 219
+S G+ L E
Sbjct: 230 WWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 11/128 (8%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++++ RH L + + V+EY G L +L + R +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAE 103
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ SALEYLH S V++ D+K N++LD + ++DF + K + ++ T+ T
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKT 154
Query: 191 IGCIAPEY 198
C PEY
Sbjct: 155 F-CGTPEY 161
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 63 RAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEFKA--LVLEYMPHGSLEKYLYSSN 116
RA++ E +MK + H+N+I +++ + EEF+ LV+E M +L + +
Sbjct: 62 RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME- 115
Query: 117 CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176
LD + ++ + +++LH SA +IH DLKP N+++ + + DF +A+
Sbjct: 116 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
Query: 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
S T + T APE N D++S G ++ E K
Sbjct: 171 ---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 7e-04
Identities = 39/164 (23%), Positives = 69/164 (42%), Gaps = 20/164 (12%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQ 123
E ++ ++H N++ + + +V+EY G L + L+ + IL F
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
+ + ++++H +V+H D+K N+ L N L DF A+LLT
Sbjct: 107 -----VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGA 155
Query: 184 QTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T + T + PE + D++S G +L E T K P
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 10/107 (9%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+V AL +LH VI+ DLK N+LLD L+DF + K G +T T
Sbjct: 104 EVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCG 158
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIF 231
T IAPE ++ + D ++ G+++ E + P D++F
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 26/193 (13%)
Query: 42 AQFLISSAMEVAVKVFNLQCGRAFKSF------NIECEMMKSIRHRNLIKVIS----TCS 91
A F + + VAVK + R F+S E ++K ++H N+I ++ S
Sbjct: 35 AAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90
Query: 92 NEEFKALVL-EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
EEF + L ++ L + D Q L + + L+Y+H SA +IH D
Sbjct: 91 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRD 145
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGD 209
LKP N+ ++++ + DF +A+ E T +AT APE + D
Sbjct: 146 LKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVD 200
Query: 210 VYSFGIMLMETFT 222
++S G ++ E T
Sbjct: 201 IWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 30/113 (26%), Positives = 48/113 (42%), Gaps = 20/113 (17%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ L++LH +I+ DLK NVLLD ++DF + K + + T +
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK------EGILGGVTTS 154
Query: 190 TIGC-----IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFN 232
T C IAPE D ++ G++L E + P DE+F
Sbjct: 155 TF-CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 10/80 (12%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
LV+EY+ G ++ L+ I F + + +VA AL+YLH +IH DLKP
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPD 133
Query: 155 NVLLDDNMVAHLSDFSIAKL 174
N+L+ + L+DF ++K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
MM+ + H++++ + C + +V E++ G L+ +++ + +L + + +AS
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLL-------DDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
AL YL ++H ++ N+LL + LSD I + +++ +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQE 167
Query: 187 TLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK 238
+ I IAPE + S D +SFG L E +N E+ LK
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 47/192 (24%), Positives = 78/192 (40%), Gaps = 45/192 (23%)
Query: 66 KSFN-IEC---EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL------EKYLYSS 115
K+FN IE ++MK + N IK+ + + + L+++Y+ G L E L +
Sbjct: 52 KNFNAIEPMVHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA 109
Query: 116 NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV-AHLSDFSIAKL 174
I Q + AL LH +IH D+K NVL D +L D+ + K+
Sbjct: 110 EVKKIIRQ-------LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159
Query: 175 L--------TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+ T +Y S PE + + D ++ G++ E T K P
Sbjct: 160 IGTPSCYDGTLDYFS--------------PEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
Query: 227 TDEIFNREMTLK 238
E + E+ L+
Sbjct: 206 FKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 40/138 (28%), Positives = 56/138 (40%), Gaps = 10/138 (7%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
LV+EY P G L L N D F +A + +H + +H D+KP NVL
Sbjct: 78 LVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEY------RRKGRESTNGDVY 211
+D L+DF A LT + + + T IAPE KG D +
Sbjct: 135 IDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 212 SFGIMLMETFTRKKPTDE 229
S G++ E + P E
Sbjct: 194 SLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 15/101 (14%)
Query: 134 ALEYLH-FGYSAQVIHCDLKPINVLLDDNMVAHLSDF-SIAKLLT-GEYQSMTQTQTLAT 190
A++ +H GY +H D+KP NVLLD N L+DF S +LL G QS + T
Sbjct: 114 AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV---AVGT 166
Query: 191 IGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKP 226
I+PE + KGR D +S G+ + E + P
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 63 RAFKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKAL--VLEYMPHGSLEKYLYSSN 116
RA++ E +MK + H+N+I +++ S EEF+ + V+E M +L + +
Sbjct: 69 RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME- 122
Query: 117 CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176
LD + ++ + +++LH SA +IH DLKP N+++ + + DF +A+
Sbjct: 123 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
Query: 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
S T + T APE N D++S G ++ E
Sbjct: 178 ---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 20/75 (26%), Positives = 27/75 (36%), Gaps = 6/75 (8%)
Query: 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL--HF-GYSAQVIHCDLKPIN 155
LE+ + R ++ + L L H Q+IH DL P N
Sbjct: 151 RLEWDILEPRALLRLDL--VEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN 208
Query: 156 VLLD-DNMVAHLSDF 169
VL D D V+ DF
Sbjct: 209 VLFDDDTDVSGFIDF 223
|
Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 10/111 (9%)
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++A L +LH S +I+ DLK NV+LD ++DF + K + +T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCG 163
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNREM 235
T IAPE + D ++FG++L E + P DE+F M
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 39/169 (23%)
Query: 71 ECEMMKSIRHRNLIKVIS----TCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 126
E ++K ++H N+I ++ S E F + L G+ N I+ Q+L+
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLS 116
Query: 127 ------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL----LT 176
++ + L+Y+H SA +IH DLKP NV ++++ + DF +A+ +T
Sbjct: 117 DEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT 173
Query: 177 G--------------EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
G + QT + ++GCI E KG+ G+ Y
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL-LKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 34/129 (26%), Positives = 59/129 (45%), Gaps = 13/129 (10%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-I 129
E ++++ RH L + + + V+EY G L + + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
++ SAL YLH S V++ DLK N++LD + ++DF + K + ++ T+
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 153
Query: 190 TIGCIAPEY 198
T C PEY
Sbjct: 154 TF-CGTPEY 161
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 53/168 (31%)
Query: 63 RAFKSFNIECEMMKSIRHRNLIKVI----STCSNEEFKA--LVLEYM---------PHGS 107
RA++ E ++K ++H N+I ++ S S +EF+ LV+ YM S
Sbjct: 60 RAYR----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS 115
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
+K Y ++Q L L+Y+H SA +IH DLKP N+ ++++ +
Sbjct: 116 EDKVQYL------VYQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKIL 159
Query: 168 DFSIAKL----LTG--------------EYQSMTQTQTLATIGCIAPE 197
DF +A+ +TG + QT + ++GCI E
Sbjct: 160 DFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAE 207
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.49 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.14 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.69 | |
| PLN02236 | 344 | choline kinase | 97.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.63 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.4 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.33 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.12 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.02 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.65 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.63 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.59 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.35 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.15 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.1 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 96.03 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.03 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.74 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.62 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=365.79 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=218.3
Q ss_pred hhcccccccccccccceeeeEEEEEe-ecceEEEEEEeeccc-------chhHHHHHHHHHHHhcCCCCcceeeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC-------GRAFKSFNIECEMMKSIRHRNLIKVISTCSN 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (313)
.++.+.|-+.+.||+|+||.|-+|.. ++++.||||++.+.. ......+.+|+++|++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 45678899999999999999999994 469999999997641 1123446799999999999999999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCC
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDF 169 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~df 169 (313)
....|||+||++||+|.+++-.++ .+.+.....+++|++.|+.||| ++||+||||||+|||++.+ ..+||+||
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999999998776 6888888999999999999999 9999999999999999866 78999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCC---CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE---STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|+++..+.. ..-...+||+.|.|||++.+... ..+.|+||+||++|-+++|.+||++..........
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ------- 393 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ------- 393 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-------
Confidence 999977522 23455789999999999987654 34779999999999999999999887554422211
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...............++++..+||..||.+||+.|||++|+++|+|--
T Consensus 394 ---------I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 394 ---------ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ---------HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 112222233344667899999999999999999999999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-53 Score=374.18 Aligned_cols=251 Identities=23% Similarity=0.249 Sum_probs=224.4
Q ss_pred cccccccccccceeeeEEEEEe-ecceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+|..++.||+|||+.||.+.. .+|+.||+|++++. .....+.+.+|+++.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 67999999999874 4667889999999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+|..++|..+++. ...+++.+++.+++||+.||.||| +++|+|||||..|++++++-+|||+|||+|..+.....
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999984 448999999999999999999999 99999999999999999999999999999998864422
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....+||+.|.|||++.....+..+||||+||++|.||.|++||+...-.+.+.......+
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------------- 235 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------------- 235 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc----------------
Confidence 34456899999999999999999999999999999999999999988766655554433322
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..|..++.++.+||.++|+.||.+|||+++|+.|.+-
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1244678889999999999999999999999999876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=355.33 Aligned_cols=258 Identities=21% Similarity=0.232 Sum_probs=217.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc-ceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF-KALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 101 (313)
.+.+.++.||+|.-|+||++.++ +++.+|+|++... .+.....+.+|+++++..+||+||++++.|.+++. .+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 37788899999999999999977 5999999999544 46678899999999999999999999999999995 999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
||++|+|.+++...+ .+++..+.+++.+|++||.|||. ..+|+||||||+|+|++..|.|||||||.+..+.+.
T Consensus 159 YMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999998765 69999999999999999999993 399999999999999999999999999999987643
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh-hhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR-EMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......||..|||||-+.+..|+.++||||||++++|+.+|+.||...... ...+ ..+..+++.
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~---------~Ll~~Iv~~----- 297 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF---------ELLCAIVDE----- 297 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH---------HHHHHHhcC-----
Confidence 334567999999999999999999999999999999999999999765110 0000 001111111
Q ss_pred hhhhhhhhh-hhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKE-QCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 261 ~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
++ ...|. .+++++.+|+..||++||.+|||+.|+++|+|-...
T Consensus 298 pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 298 PP--PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CC--CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 01 01133 489999999999999999999999999999997753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=348.07 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=213.4
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
....+|.+.+.||+|+|+.||+|+++ ++..||||.+... .+...+.+..|+++|+.++|||||.+++++.+++++|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 34578999999999999999999976 5899999999776 56678888999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC------CceeEcCCcch
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN------MVAHLSDFSIA 172 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~------~~~~l~dfg~~ 172 (313)
|||||+||||.+++...+ .+++.+++.++.||+.||++|| .++|+||||||+|||++.. -.+||+|||++
T Consensus 87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999999887 7999999999999999999999 9999999999999999764 46899999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
+.+.+. .......|++.|||||++....|+.++|+||+|+++|+|++|..||......+...............
T Consensus 163 R~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~--- 236 (429)
T KOG0595|consen 163 RFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL--- 236 (429)
T ss_pred hhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch---
Confidence 988633 24456789999999999999999999999999999999999999999877666554333222211111
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
+...+..+.+|+...++.+|.+|.+..+-..|.
T Consensus 237 ---------------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 237 ---------------PAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred ---------------hhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 222344455777777777777777776655553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=338.20 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=212.3
Q ss_pred hcccccccccccccceeeeEEEEE-eecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeee-eeeeCc-cc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVIS-TCSNEE-FK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~-~~ 96 (313)
....+|+|.++||+|+||.||++. ..+|..||.|.++.. +....+....|+.+|++|+|||||++++ .|.+++ -+
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 344689999999999999999999 557999999999865 4456788999999999999999999998 454444 48
Q ss_pred eEEEEeecCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 97 ALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
+||||+|.+|+|.+.++ +..+.+++..+|+++.|++.||..+|..+. .-+.||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999999996 346689999999999999999999993221 23999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
+.+... ........||+.||+||.+...+|+.+|||||+||++|||+.-.+||.+..-.+....+....+.+
T Consensus 176 r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~------ 247 (375)
T KOG0591|consen 176 RFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP------ 247 (375)
T ss_pred hHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC------
Confidence 987532 223456789999999999999999999999999999999999999998874333333322222111
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....-++..+..|+..|+.+||..||+...++..+.
T Consensus 248 -------------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 -------------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 012457889999999999999999999655544433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=343.43 Aligned_cols=255 Identities=26% Similarity=0.263 Sum_probs=220.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
..-.++|++.+.||+|+||.||+++.+ +++.+|+|++++. .........+|..+|+.++||.||++.-.|+++..+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 344789999999999999999999965 4999999999875 234567889999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+|+||+.||.|...|++.+ .+++..+.-++..|+.||.||| +.||+|||+||+|||++.+|.++|+|||+++...
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999998877 7999999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... .....+||..|||||++.+.+++.++|+||||+++|+|++|.+||.................
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------ 242 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------ 242 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence 3221 23346899999999999999999999999999999999999999988876655544332220
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC----CHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI----NAREIVAKLF 301 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~il~~l~ 301 (313)
...+.-.+.+..++++++|+.||++|. ++.+|.+|++
T Consensus 243 --------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 243 --------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred --------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 111233678899999999999999995 7888888864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=334.94 Aligned_cols=270 Identities=20% Similarity=0.216 Sum_probs=221.5
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+.|+.+.++|+|++|.|++++++ +|+.||||+|..+ ++...+-..+|+++|+++.|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46899999999999999999977 5999999999654 34556678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
||+. ++.+.+.......+...+..++.|++.|+.|+| +++++||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-- 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-- 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence 9987 777878777668999999999999999999999 9999999999999999999999999999999887432
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-ccccccccccccc---
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-WLPISTMEVVDAN--- 256 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--- 256 (313)
...+.+..|.+|+|||++.+ .+|+...||||+||++.||++|.+.|++.++.+..+.+.... .......+++...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 24456789999999998887 789999999999999999999999999988766655443321 1111122222211
Q ss_pred ---ccCh----hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 257 ---LLSQ----EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 257 ---~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..+. ++.+. .-...+..+.+|+++||+.||.+|++-++++.|..
T Consensus 236 ~Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y 286 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY 286 (396)
T ss_pred eeeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence 0110 11111 12346678999999999999999999999999853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-51 Score=356.06 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=223.3
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+.++.++.||+|.||.||.|.++...+||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+..+||||||++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 356788999999999999999987779999999875 3445778899999999999999999999999889999999999
Q ss_pred CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 105 HGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 105 ~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
.|+|.+++.. .+..+...+.+.++.|||+|++||+ ++++|||||...|||++++..+||+|||+++...... ...
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YTA 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc-eee
Confidence 9999999987 5567899999999999999999999 9999999999999999999999999999999443332 223
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....-+..|.|||.+....++.+|||||||++|||++| |+.||..+...+.......+
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-------------------- 420 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-------------------- 420 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------------------
Confidence 334445678999999999999999999999999999999 99999988877665544322
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+.+.|..||+.++++|..||+.+|++|||++.+...+.++...
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 22334778999999999999999999999999998888877653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=350.09 Aligned_cols=262 Identities=27% Similarity=0.383 Sum_probs=220.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-cceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-FKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 100 (313)
.....+.+.+|.|+||.||++.+.....||+|++.... ......|.+|+.+|.+++|||||+++|+|.+.. .+++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 44566777899999999999998644449999997652 223669999999999999999999999999987 799999
Q ss_pred EeecCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceeCCCCCCceEecCCC-ceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQ-VIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 177 (313)
||+++|+|.+++.. ....++...+..++.+|+.||.||| +++ |+||||||+|+|++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999987 3668999999999999999999999 999 99999999999999997 999999999986543
Q ss_pred ccccccccccccccccCCCcccc--cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRR--KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.. .......||..|||||++. ...++.++||||||+++|||+||..||......+.........
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~------------ 262 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG------------ 262 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------
Confidence 22 2334468999999999999 5699999999999999999999999998887633332221111
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
.....+..++..+..|+..||..||+.||++.+++..+..+...+..
T Consensus 263 -------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 263 -------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11112344888899999999999999999999999999998876553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=348.96 Aligned_cols=277 Identities=18% Similarity=0.176 Sum_probs=224.7
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccch-hHHHHHHHHHHHhcCC-CCcceeeeeeeeeCc-c
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIR-HRNLIKVISTCSNEE-F 95 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~ 95 (313)
...+-++|+++++||.|+||.||+|+.+ +++.||||.++..... ..-.-.+|+..|++|+ ||||+++.+++.++. .
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3455689999999999999999999954 6999999999876322 2233467999999998 999999999998887 9
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
+++|||||+. +|.++++..++.+++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+++..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence 9999999975 999999988889999999999999999999999 999999999999999999999999999999976
Q ss_pred ccccccccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc------
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS------ 248 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 248 (313)
. .....+.+..|.+|+|||++. ..-|+.+.|+||+||+++|+.+-++.|.+....+..+..+.-...+..
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 5 333456778999999999776 556899999999999999999999999998877766655432211111
Q ss_pred --ccccccc--cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 --TMEVVDA--NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 --~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+...++- ......+.....+ +++.++.+++..|+.+||.+||||+++++|+.-..
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 0011110 0111112222223 48999999999999999999999999999987554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=346.75 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=219.0
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++++.||+|+||.||+|+.+ +|+.+|+|+++++ .......++.|..+|...++|+||+++..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4579999999999999999999955 5999999999886 34567889999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc-
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG- 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~- 177 (313)
||||++||++..+|...+ .+++..+..++.+++.|+..+| +.|++||||||+|+|||..|.+||.|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998887 7999999999999999999999 99999999999999999999999999999853211
Q ss_pred --------------c--------ccc---c-------------------cccccccccccCCCcccccCCCCCcchhHHH
Q 047140 178 --------------E--------YQS---M-------------------TQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213 (313)
Q Consensus 178 --------------~--------~~~---~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 213 (313)
. ... . ......||+.|+|||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 000 0 0112348999999999999999999999999
Q ss_pred HHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-
Q 047140 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN- 292 (313)
Q Consensus 214 G~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps- 292 (313)
||++||||.|.+||.+..+.+....+..+.. ....+....+++++++||.+||. ||++|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-----------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRE-----------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999999887766554443321 11111123456889999999999 9999985
Q ss_pred --HHHHHHHHHH
Q 047140 293 --AREIVAKLFK 302 (313)
Q Consensus 293 --~~~il~~l~~ 302 (313)
+.||.+|||-
T Consensus 437 ~G~~EIK~HPfF 448 (550)
T KOG0605|consen 437 KGAEEIKKHPFF 448 (550)
T ss_pred ccHHHHhcCCcc
Confidence 8999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=337.14 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=215.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc--cceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--FKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 100 (313)
..+|..++.||+|+||+||++... +|...|||..........+.+.+|+.+|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 457889999999999999999965 48999999997663333677899999999999999999999854444 689999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhcccc-
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGE- 178 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~- 178 (313)
||+++|+|.+++.+.+..+++..++.+.+|++.||.||| ++|++|+||||+|||++. ++.+||+|||++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999987657999999999999999999999 999999999999999999 799999999999877641
Q ss_pred cccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhh-hhhhhhhhhccCCccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEI-FNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
..........||+.|||||++.+. .....+|||||||++.||+||..||... ......+......
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~------------- 239 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED------------- 239 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-------------
Confidence 111223456799999999999863 3345999999999999999999999873 2222222211111
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.....+..++.++.+++.+|+..||+.||||++++.|++.....
T Consensus 240 ------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 ------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11133566889999999999999999999999999999986644
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=333.40 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=224.4
Q ss_pred cccccccccccccceeeeEEEEE-eecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
-.+.|++...||.|..++||+|+ .+.++.||||++..+ +....+.+++|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 36799999999999999999999 556999999999876 5556789999999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 101 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
.||.+|++.++++.. ...+++..+..+++++++||.||| ++|.+|||||+.|||++++|.|+|+|||.+..+...+
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999864 446999999999999999999999 9999999999999999999999999999987664443
Q ss_pred ccccc--cccccccccCCCcccc--cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 180 QSMTQ--TQTLATIGCIAPEYRR--KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 180 ~~~~~--~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.+... ....++++|||||++. -..|+.++||||||++..||.+|..||..+-+.++......+...... ....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccCCh
Confidence 32222 3457999999999854 347999999999999999999999999998877766655444322111 111111
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......+..+.+++..||..||.+||||+++++|.|--.
T Consensus 260 ----------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 260 ----------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred ----------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 113345668999999999999999999999999977543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=346.18 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=219.3
Q ss_pred hhcccccccccccccceeeeEEEEEe-ecceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
..-.++|.-++.||.|+|++|++|+. .+++.+|||++.+. ......-+..|-++|.+| .||.|++++-.|.|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567999999999999999999994 46999999999764 223345677799999999 89999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
+|+|+||+++|+|.++|++.+ .+++...+.++.+|+.||+||| ++||+||||||+|||+++++.++|+|||.++.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999999987 7999999999999999999999 999999999999999999999999999999987
Q ss_pred cccccc---------ccc--cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc
Q 047140 176 TGEYQS---------MTQ--TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 176 ~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~ 244 (313)
.+.... ... ....||-.|.+||++.....++++|+|+|||++|+|+.|.+||.+...-.....+...
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 654322 111 3366899999999999999999999999999999999999999776543332222221
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+...++.+.+|++++|..||++|+|+.+|.+|+.
T Consensus 303 -------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 303 -------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred -------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 12235567888999999999999999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=313.78 Aligned_cols=272 Identities=21% Similarity=0.247 Sum_probs=220.6
Q ss_pred cccccccccccceeeeEEEEE-eecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|...+++|+|.||.||+|. .++|+.||||+++... ...-....+|+..|+.++|+||+.++++|.+...+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 589999999999999999999 5579999999998652 2233456789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|++. +|+..++.....++..++..++.++++||+|+| .+.|+||||||.|+|++++|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9986 999999988889999999999999999999999 999999999999999999999999999999988754432
Q ss_pred ccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-----ccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-----ISTMEVVDA 255 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 255 (313)
......|.+|+|||++. ...|+...|+||.||++.||+.|.+-|.+.++.+........-..+ ..+.++-|-
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 23347889999999665 5679999999999999999999999998887655544333221111 111121111
Q ss_pred ---cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 ---NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+....+. ....++.++.+|+.+||..||.+|+|+.|+++|.+--
T Consensus 236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 1111111111 3455778889999999999999999999999997654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=340.43 Aligned_cols=277 Identities=35% Similarity=0.511 Sum_probs=223.7
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-cceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-FKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv 99 (313)
..++++|.....||+|+||.||+|...++..||||++.........+|.+|++++.+++|||+++++|||.+.+ ..+||
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 56679999999999999999999999888999999887653321455999999999999999999999999998 59999
Q ss_pred EEeecCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
+||++.|+|.+.+..... .++|..+.+|+.++|.||+|||..+...|+||||||+|||+|++..+||+|||+++.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999987765 7899999999999999999999765567999999999999999999999999999543220
Q ss_pred ccccccccc-ccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh-hhhhhhhccCC-cccccccccccc
Q 047140 179 YQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN-REMTLKHWGNN-WLPISTMEVVDA 255 (313)
Q Consensus 179 ~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~ 255 (313)
. ...... .||.+|+|||+......+.++||||||++++|++||+.+.+...+ .+.....|... +......+++|+
T Consensus 231 ~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 231 D--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred c--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 1 111111 789999999999999999999999999999999999988775432 12223333322 222367788887
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.+...... ....-..+..+...|++.+|++||+|.++++.+..+
T Consensus 309 ~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 309 RLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 76531111 002344488899999999999999999998888443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=340.78 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=219.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc----cc-hhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ----CG-RAFKSFNIECEMMKSIR-HRNLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 94 (313)
...+.|.+++.||+|+||.|+.|.+. +++.||+|++..+ .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44579999999999999999999854 6899999987654 11 24556778999999998 999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~ 173 (313)
.+++||||+.||+|.+++...+ .+++.....+++|+++|++|+| ++||+||||||+|||++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999999844 7889999999999999999999 9999999999999999999 999999999998
Q ss_pred hcccccccccccccccccccCCCcccccCC-C-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGR-E-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
... ..........|++.|+|||++.+.. | ..++||||+|++||.|++|..||................+
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~------- 240 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF------- 240 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-------
Confidence 763 1223455678999999999999877 7 5899999999999999999999988655555443322221
Q ss_pred cccccccChhhhhhhhhhhh-HHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQC-VSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..+..+ +.++.+|+++||..||.+|+|+.+|+.|+|-..
T Consensus 241 --------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 --------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 123334 778999999999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=318.72 Aligned_cols=250 Identities=24% Similarity=0.243 Sum_probs=220.6
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.-++|++.+.||.|+||.|.+++.+ +|..+|+|+++++ .....++..+|..+|+.+.||.++++.+.|.+.+.++|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3468999999999999999999966 5999999999875 34567888999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||.+||-|..++++.+ .+++...+-++.||+.||+||| +.+|++||+||+|||+|++|.+||+|||+++...+
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999998877 7999999999999999999999 99999999999999999999999999999987642
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....+||+.|+|||++...+++.++|.||||+++|||+.|.+||....+...+..+.....
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-------------- 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-------------- 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--------------
Confidence 24567899999999999999999999999999999999999999988777555544433321
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCC-----CCHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQR-----INAREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-----ps~~~il~~l~~ 302 (313)
..|.-.+.++.+|++++|++|-.+| ....+|..|+|-
T Consensus 259 -------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF 300 (355)
T KOG0616|consen 259 -------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWF 300 (355)
T ss_pred -------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccc
Confidence 1255678889999999999999999 466788888774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=335.02 Aligned_cols=276 Identities=21% Similarity=0.210 Sum_probs=221.9
Q ss_pred hcccccccccccccceeeeEEEEE-eecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 96 (313)
+-.+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+. +.......+|+.+|++|+||||+++.+...+. +.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 335689999999999999999999 4579999999998764 45566778899999999999999999999877 689
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|||+|||++ ||..++.+.+-.+++.++..+++||+.||.|+| .+|++|||||.+|||+|.+|.+||+|||+++.+.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999987 999999988778999999999999999999999 9999999999999999999999999999999776
Q ss_pred cccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhh---hhhhhhccCCcccc-cccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNR---EMTLKHWGNNWLPI-STME 251 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~---~~~~~~~~~~~~~~-~~~~ 251 (313)
.... ...+....|.+|+|||++.+. .|+.+.|+||.||++.||++|++.|.+.... +..+..+....... ....
T Consensus 270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 5442 235667789999999988765 7999999999999999999999999876543 33333333321111 0001
Q ss_pred ccc-ccccChhh---hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVD-ANLLSQED---IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~-~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
+-. ....+..+ .-.......+....+|+..+|..||.+|.||.+++.+-+-
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 111 11111111 1111245678889999999999999999999999987543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=335.85 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=220.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|-+.+.||+|+||.||+|+.+ +.+.||+|.+.+. .+.....+.+|+++++.++||||+.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999955 6899999999765 34567789999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+.| +|..++...+ .++++.+..++.++++||.||| +.+|.|+|+||.|||++.+|.+|+||||+++.+..+ +
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence 9976 9999998766 7999999999999999999999 999999999999999999999999999999977643 3
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.......||+-|||||++.+.+|+..+|+|||||++||+.+|.+||...+..+....+......
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~---------------- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK---------------- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----------------
Confidence 3456678999999999999999999999999999999999999999887765554443332211
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.+.+.+..+.+++..+|.+||.+|.|..+++.|++-
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 134678889999999999999999999999999764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=341.20 Aligned_cols=252 Identities=24% Similarity=0.273 Sum_probs=222.7
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
..-|++++.||.|+.|.|-+|.+. +|+.+|||++.+. .......+.+|+-+|+-++|||+++++++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 357899999999999999999955 6999999999765 234466788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
.||.+||-|.+++-..+ ++++.+..++++||+.|+.|+| ..+|+|||+||+|+|++..+++||+|||+|..-.++
T Consensus 91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 99999999999998887 7889999999999999999999 999999999999999999999999999999754322
Q ss_pred ccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......+|+++|.|||++.+.+| +.++||||.|++||.||||..||++...+......+.+.
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--------------- 228 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--------------- 228 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---------------
Confidence 23566789999999999999998 789999999999999999999999766655555544433
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
+..|.+++.++.+|+++||.+||+.|.|++||++|||-.
T Consensus 229 ------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 229 ------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 233567899999999999999999999999999999964
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=336.80 Aligned_cols=254 Identities=22% Similarity=0.260 Sum_probs=219.8
Q ss_pred ccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
...|+.-.+||+|+.|.||.|. ..+++.||||++...+-...+-+.+|+.+|+..+|+|||++++.|..++.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4578888899999999999999 456899999999876555567889999999999999999999999988999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++||+|.|.+.... +++.++..+.++++.||+||| .+||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999999998764 899999999999999999999 99999999999999999999999999999988765443
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
....-.||+.|||||++....|+++.||||||++++||+-|.+||--..+....+... ....
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------------~ng~ 486 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------TNGT 486 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------------hcCC
Confidence 3445679999999999999999999999999999999999999985433322222111 1122
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..+..+..++..+.+|+.+||..||++|++|.++|+|++-
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 2333466789999999999999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=349.44 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=228.1
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.+....+.||+|.||.||+|... ....||||.++..+.. ..++|++|++++..++|||||+++|+|..++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45667789999999999999943 2468999999887555 7889999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 98 LVLEYMPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
||+||++.|||.++|.... .+++..+.+.++.|||.|+.||- ++++|||||-..|.|+.++-.|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999997432 13888999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
||+|||+++.....+.........-++.||+||-+..++++..|||||+||+|||+++ |..||.+.++.+.........
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999997765555555556777899999999999999999999999999999999 999999998877766544332
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
. +.-|.+||.++++||..||+.+|++||+++||-..|+..-..
T Consensus 723 l--------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 723 L--------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred c--------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1 333788999999999999999999999999999999987654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=317.74 Aligned_cols=278 Identities=21% Similarity=0.180 Sum_probs=219.1
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEee--cccchhHHHHHHHHHHHhcCCCCcceeeeeeeee-----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN----- 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 92 (313)
..+...|...+.||.|++|.|+.|..+ +|+.||||++. .++....+...+|+.+|+.++|+||+.+.+++.-
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345677888899999999999999955 69999999997 4566677888999999999999999999999854
Q ss_pred CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
-+.+|+|+|+|+. +|...++.+. .++...+..++.|++.||.|+| +.+++|||+||+|++++.+..+||+|||++
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence 3578999999954 9999998765 6999999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCccc-ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-ccc--
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYR-RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PIS-- 248 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~-- 248 (313)
+..........-+.+..|.+|+|||+. ....|+.+.||||.||++.||++|++.|.+.+..+........... +..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987544223334677899999999965 4568999999999999999999999999886544332222211111 100
Q ss_pred -------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 -------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+...............++.++.+.+|+.+||..||.+|+|++|+++||.-.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 1111111000001111112347888999999999999999999999999998643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=329.77 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=206.2
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC-c
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE-E 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 94 (313)
.++|++.+.||.|+||.||+|... +++.||+|+++... ......+.+|+.++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999731 35689999997542 33456788999999999 899999999998764 4
Q ss_pred cceEEEEeecCCCHHHHHhcCC----------------------------------------------------------
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------- 116 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 116 (313)
.+++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6899999999999999986431
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccccccccccc
Q 047140 117 ---CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC 193 (313)
Q Consensus 117 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y 193 (313)
..++...+..++.||+.||.||| +++++||||||+|||++.++.++|+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677888999999999999999 999999999999999999999999999999765322111112233456789
Q ss_pred CCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhH
Q 047140 194 IAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272 (313)
Q Consensus 194 ~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (313)
+|||++.+..++.++|||||||++|||++ |..||......+......... . ....+..++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------------~-------~~~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG------------T-------RMRAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC------------C-------CCCCCCCCC
Confidence 99999998899999999999999999997 999997643222111110000 0 001133467
Q ss_pred HHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 273 ~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
+.+.+++.+||..||++|||+.++++.|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=326.52 Aligned_cols=249 Identities=23% Similarity=0.267 Sum_probs=209.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999965 58999999997542 234567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.|++.||.||| ++|++||||||+||++++++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999997665 6889999999999999999999 999999999999999999999999999998765321
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~----------------- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK----------------- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence 123457889999999999899999999999999999999999997654332222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~~ 303 (313)
...+...+..+.+|+++||..||.+||+ ++++++|+|-.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 0112335677899999999999999995 99999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=299.91 Aligned_cols=253 Identities=22% Similarity=0.244 Sum_probs=220.4
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++++.||+|.||.||+|+.+ ++..||+|++.++ .....+.+.+|+++-..|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4579999999999999999999955 6889999999764 23345778999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
++||...|.+...+... ...+++...+.++.|++.||.|+| .++++||||||+|+|++.+|.+|++|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999844 336899999999999999999999 9999999999999999999999999999987543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.......+||..|++||+..+...+...|+|++|++.||++.|.+||+.....+.+..+....
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-------------- 238 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-------------- 238 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--------------
Confidence 222345679999999999999999999999999999999999999999887555544433222
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...|..++..+.++|.+|+..+|.+|.+..|++.|+|-.
T Consensus 239 -------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 239 -------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred -------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 222466788899999999999999999999999999964
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=322.37 Aligned_cols=272 Identities=17% Similarity=0.136 Sum_probs=208.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|+||.||++..+ +++.||+|++... .....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999965 5889999999754 23345678889999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|++++.+..+. .....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 99886655444 33346899999999999999999999 99999999999999999999999999999886532211
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccc---------cccc
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLP---------ISTM 250 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~---------~~~~ 250 (313)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||............... .... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 1122345788999999998888999999999999999999999999765433221111100 0000 0000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....................++.++.+|+++||+.||++|||++++++|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 000000000011111122346788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=330.69 Aligned_cols=249 Identities=18% Similarity=0.190 Sum_probs=209.7
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 478999999999999999999965 5899999999754 123456788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+.+++|.+.+...+ .+++..+..++.|++.||.||| +++++|+||||+|||+++++.++|+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 99999999999997765 6889999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.....++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~---------------- 231 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR---------------- 231 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 123468889999999999999999999999999999999999997654332222111110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..++..+.+|+.+||+.||++||+ +++++.|+|-
T Consensus 232 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 232 -----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred -----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 0112335677899999999999999997 7999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=331.35 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=217.1
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++..++..||+|+||+||+|.+- -.||||+++-. .++..+.|++|+.++++-+|.||+-+.|+|..+.. .||+-
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 346678999999999999999963 34999999765 45678899999999999999999999999999887 89999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+|+|.+|..++.-....+...+.+.|++|++.|+.||| .++|+|+|||..||++.+++.|||+|||++.........
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999999887778999999999999999999999 999999999999999999999999999999865544333
Q ss_pred ccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.......+...|||||++. ..+|++++||||||+++|||++|..||. ...++...-.....+ .
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~-------------l 610 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGY-------------L 610 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccc-------------c
Confidence 3344455788999999875 4578999999999999999999999997 332222211111110 0
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.+.......+++.++.+|+..||+.+|++||.+.+|+..+.++...+
T Consensus 611 --~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 611 --MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred --CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 01112234578999999999999999999999999999888887643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=334.44 Aligned_cols=272 Identities=18% Similarity=0.213 Sum_probs=212.2
Q ss_pred cccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCC-C-----CcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-H-----RNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~ 95 (313)
+..+|++.+.||+|+||.|.+|. .++++.||||++++. +.-......|+.+|+.|+ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 44499999999999999999999 456999999999887 344556677999999996 3 499999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC--CCceeEcCCcch
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD--NMVAHLSDFSIA 172 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~ 172 (313)
+|||+|.+.. ||.++++... ..++...++.++.||+.+|.+|| ..+|+|+||||+|||+.+ ...+||+|||.+
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999954 9999998653 36899999999999999999999 999999999999999964 458999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC----------
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN---------- 242 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~---------- 242 (313)
+.... ....+.-+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+....+.......-
T Consensus 339 c~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87542 233667788999999999999999999999999999999999998776544332211110
Q ss_pred ------------Cccc--cccccc----------------ccccccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCC
Q 047140 243 ------------NWLP--ISTMEV----------------VDANLLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290 (313)
Q Consensus 243 ------------~~~~--~~~~~~----------------~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 290 (313)
.+.+ ....+. .+....+ ...............+.+++++||.+||..|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0000 000000 0000000 0111111122456778999999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 047140 291 INAREIVAKLFKIR 304 (313)
Q Consensus 291 ps~~~il~~l~~~~ 304 (313)
+|+.++++|+|--.
T Consensus 494 ~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 494 ITPAQALNHPFLTG 507 (586)
T ss_pred CCHHHHhcCccccc
Confidence 99999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.54 Aligned_cols=274 Identities=20% Similarity=0.230 Sum_probs=207.4
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..++|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.++...++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3478999999999999999999965 58999999997542 223345678999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+. ++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9996 5898888776557899999999999999999999 9999999999999999999999999999986543211
Q ss_pred cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc----cC----Ccccc-ccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW----GN----NWLPI-STM 250 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~----~~----~~~~~-~~~ 250 (313)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+........... .. .|... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233457888999998765 457899999999999999999999997654322111110 00 00000 000
Q ss_pred ccccccc---cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 251 EVVDANL---LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 251 ~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....... ..............+..+.+|+.+||+.||++|||+.++++|+|-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 0000000 000000111112345678999999999999999999999999884
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=316.88 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=219.4
Q ss_pred hcccccccccccccceeeeEEEEE-eecceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...-+|++.+.||.|.+|.|-+|. +++|+.||||.++++ ++...-.+++|++++..|+||||++++++|++.+...
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 345689999999999999999999 578999999999765 4556678999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
|||||..+|.|.|++...+ .+++...+.+++||++|+.|+| +++++|||||.+|||+|+++++||+|||++-.+..
T Consensus 130 ivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999998776 7999999999999999999999 99999999999999999999999999999987652
Q ss_pred ccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.......+|++.|.+||++++.+| .+..|.||||+++|.|..|..||++.+.......+....+.
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr----------- 271 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR----------- 271 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-----------
Confidence 224456789999999999999988 78999999999999999999999987655444433333221
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...-+.++.-||+.||.+||++|.|+.+|..|-|-
T Consensus 272 -----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 272 -----------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 11234556789999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=323.10 Aligned_cols=273 Identities=18% Similarity=0.211 Sum_probs=212.0
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||++... ++..+|+|.+... .+.....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 5889999998765 33455779999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+++.... .+++..+..++.|++.||.||| +. +++|+||||+|||+++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997654 6889999999999999999999 75 6999999999999999999999999998765322
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-------cc-----cc
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-------LP-----IS 248 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-------~~-----~~ 248 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||......+.......... .. ..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 12334688899999999988999999999999999999999999965443222111100000 00 00
Q ss_pred cccccc---ccccCh------------hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 TMEVVD---ANLLSQ------------EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 ~~~~~~---~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...... ...... ..........++.++.+|+.+||..||++|||+.++++|+|-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 000000 000000 00000001236788999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=308.69 Aligned_cols=281 Identities=20% Similarity=0.190 Sum_probs=220.4
Q ss_pred hhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNE- 93 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (313)
..+++..++|+....|++|+||.||+|+.+ +++.||+|+++-+.+ .---...+|+.+|.+++|||||.+-++.+-.
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 556777899999999999999999999955 699999999976521 1223456799999999999999999988643
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
+.+|||||||++ +|..++.+...++...++..++.|+++|++||| .+.|+|||+|++|+|++..|.+||+|||+|
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchh
Confidence 569999999987 999999998889999999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------c
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------W 244 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~ 244 (313)
+.++.... ..+...-|.+|+|||++.+. .|+.+.|+||+||++.|++++.+.|.+.+..+....+.... |
T Consensus 225 R~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 225 REYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 99876533 23456789999999987765 68999999999999999999999998876554433332211 1
Q ss_pred cccccccccc-cccc--Chhhhhhhhhh-hhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 245 LPISTMEVVD-ANLL--SQEDIHFVAKE-QCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 245 ~~~~~~~~~~-~~~~--~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....-..+. .... +........+. ..++.-.+|+..+|..||++|.||.+.|+|-|-..
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 1100000000 0000 00011111111 15688999999999999999999999999976543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.92 Aligned_cols=255 Identities=18% Similarity=0.209 Sum_probs=206.6
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++|++|+++.+++.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788899999999999999964 69999999987542 2233457789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+.+... ...+++..+..++.|++.||.||| +.+++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888643 336889999999999999999999 9999999999999999999999999999987643211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||............ .....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--------------~~~~~-- 218 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--------------DRRVK-- 218 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--------------HHHhh--
Confidence 123346889999999999999999999999999999999999999764322111000 00000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~~ 303 (313)
......+...+.++.+|+++||+.||++||+ ++++++|+|-.
T Consensus 219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 0001113346778999999999999999997 89999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=320.78 Aligned_cols=269 Identities=19% Similarity=0.212 Sum_probs=207.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||.|+||.||+|..+ +++.||+|+++... ......+.+|+++++.++||||+++++++.+++..++|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999965 58999999997542 22345677899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++ +|.+++...+..++...+..++.|++.||.||| ++|++||||||+|||+++++.+||+|||++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 975 999998776656889999999999999999999 9999999999999999999999999999987543211 1
Q ss_pred cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------ccc----cccc
Q 047140 183 TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------WLP----ISTM 250 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~~~----~~~~ 250 (313)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... |.. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233457888999998765 568999999999999999999999997654433222111100 000 0000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..... .........+.++.+|+.+||+.||.+|||++|+++|+|
T Consensus 239 ~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 239 SYLFPQYRAQ--PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred ccccCccCCC--chHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 0000000000 001112345778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=307.62 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=221.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
....++|++...||+|.|+.|+++.+. +|+.+|+|+++.. .....+.+.+|+++-+.|+||||+++.+.+.+.+..|
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345789999999999999999999955 6999999988643 3346788999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhh
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKL 174 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~ 174 (313)
+|+|++.|++|..-|-.. ..+++..+...++||+.+|.|+| .++|||||+||.|+++.+. --+||+|||++..
T Consensus 87 lvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999997666443 25789999999999999999999 9999999999999999543 4589999999998
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
+. .........|++.|+|||++...+++..+|||+.|+++|-|+.|.+||.+.+....+..+....
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~----------- 228 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA----------- 228 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc-----------
Confidence 76 3335667889999999999999999999999999999999999999998865544444333332
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+...++++++++|+++||..||.+|+|+.|+++|+|--.
T Consensus 229 ------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 229 ------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 22222235678899999999999999999999999999999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=326.52 Aligned_cols=245 Identities=20% Similarity=0.197 Sum_probs=203.4
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||++..+ +++.||+|++... .......+.+|+++++.++||||+++++++.+++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999965 6899999999754 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 186 (313)
+|.+.+.... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9999987655 6899999999999999999999 9999999999999999999999999999987532211 12233
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
..|+..|+|||++.+..++.++|||||||++|+|++|..||................ ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------------------~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------------------IR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------------CC
Confidence 468999999999999999999999999999999999999996543322211111100 01
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
.+..++.++.+|+.+||..||++|| ++.++++|+|-
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 1334677899999999999999999 89999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=326.36 Aligned_cols=257 Identities=21% Similarity=0.199 Sum_probs=210.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 58999999997542 234567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999997655 6889999999999999999999 99999999999999999999999999999876532
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||......+.......... .......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------~~~~~~~-- 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-------TLQRPVY-- 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-------cccCCCC--
Confidence 22345688999999999988999999999999999999999999976544332211111000 0000000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......++.++.+++.+||..+|.+||++.++++|+|-.
T Consensus 223 ----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 223 ----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred ----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 000124577899999999999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.91 Aligned_cols=250 Identities=19% Similarity=0.198 Sum_probs=209.4
Q ss_pred cccccccccccccceeeeEEEEEeec--ceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISS--AMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|..+. +..||+|++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 35689999999999999999998553 368999998653 2334567888999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999997665 6889999999999999999999 99999999999999999999999999999876532
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. .....++..|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-------------- 244 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-------------- 244 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 1 223468889999999998889999999999999999999999997654432222211110
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+...+..+.+++++||+.||++|+ +++++++|+|-
T Consensus 245 -------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 245 -------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 001234566789999999999999995 89999999874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=323.92 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=223.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc-ceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF-KALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 100 (313)
++|..++.+|+|+||.++.++++ +++.+++|.+... ..........|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 68999999999999999999976 5889999999765 33445577889999999999999999999988877 99999
Q ss_pred EeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 101 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+||++.+.+...+ ..+++..+..|+.|++.|+.||| .++|+|||||+.||++++++.|+|+|||+++.+++..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998764 67999999999999999999999 9999999999999999999999999999999887543
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......||+.|++||++.+.+|+.++|||||||++|||++-+++|.+.........+.....
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~--------------- 223 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY--------------- 223 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC---------------
Confidence 134567899999999999999999999999999999999999999987765555444332221
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+.+..++.++..+++.||..+|+.||++.+++.+|..+...
T Consensus 224 -----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 224 -----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred -----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 223566889999999999999999999999999998776543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=322.10 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=217.2
Q ss_pred ccccccccccccceeeeEEEEEe-ecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
...|+...+||+|+||.||+|.. .+++.||+|++..+ .....+.+..|+.+|.+++++||.++++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35788889999999999999994 46999999999876 45567889999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
||.||++.+.++..+ .+++..+.-++++++.||.||| .++.+|+|||+.||++..+|.+|++|||.+..+......
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999999998776 4588888889999999999999 999999999999999999999999999999877654433
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
. ....||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+....+.+-.. .
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~------------------~ 227 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS------------------A 227 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC------------------C
Confidence 2 4567999999999999999999999999999999999999999887663222211100 0
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
+.. ....++..+++|+..||+.||+.||+|.++++|-.-
T Consensus 228 PP~--L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI 266 (467)
T KOG0201|consen 228 PPR--LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI 266 (467)
T ss_pred CCc--cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence 111 123578889999999999999999999999999543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=294.48 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=212.0
Q ss_pred ccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----cce
Q 047140 24 TSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-----FKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 97 (313)
.++|+|.+.||.|||+-||++. ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 5799999999999999999999 5569999999998887778889999999999999999999999875443 489
Q ss_pred EEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecCCCceeEcCCcch
Q 047140 98 LVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
++++|+..|+|.+.+... +..+++.+++.++.+|++||.+|| ... ++|+||||.||++++.+.+++.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 999999999999999643 457999999999999999999999 777 999999999999999999999999998
Q ss_pred hhccccccc-------ccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 173 KLLTGEYQS-------MTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 173 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
+...-.... +.......|..|+|||.+. +-..+.++|||||||++|+|+.|..||+............
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-- 254 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-- 254 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--
Confidence 754321111 1122344788899999876 3456899999999999999999999997654322111100
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+ .......+....+++.+.++++.||++||.+||++.+++.++.++.
T Consensus 255 ----------v-----~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 ----------V-----QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------e-----eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 0011111122347899999999999999999999999999998763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=317.41 Aligned_cols=262 Identities=21% Similarity=0.349 Sum_probs=203.9
Q ss_pred ccccccccccccceeeeEEEEEeec-----------------ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCccee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-----------------AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
.++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 3479999987642 334567889999999999999999
Q ss_pred eeeeeeeCccceEEEEeecCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 047140 86 VISTCSNEEFKALVLEYMPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVI 147 (313)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~ 147 (313)
+++++.+.+..++|+||+++++|.+++.... ..++...++.++.||+.||.||| +.+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999986431 23577888999999999999999 99999
Q ss_pred eCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh--CCC
Q 047140 148 HCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT--RKK 225 (313)
Q Consensus 148 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~ 225 (313)
|+||||+||++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876533221112223345678999999988889999999999999999987 567
Q ss_pred CChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 226 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
||......+....... ...... .......+..++..+.+|+.+||..||++|||+.+|.+.|.
T Consensus 241 p~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGE----------FFRDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHH----------Hhhhcc---ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765543222111000 000000 00001113356788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=318.20 Aligned_cols=273 Identities=18% Similarity=0.218 Sum_probs=210.5
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.++||.|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999965 5889999988764 33445678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+++.... .+++..+..++.+++.||.||| .. +++|+||||+|||+++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999997654 5889999999999999999999 74 7999999999999999999999999998755321
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc--cCCccccccc----ccc-
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW--GNNWLPISTM----EVV- 253 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~----~~~- 253 (313)
......++..|+|||++.+..++.++|+|||||++|+|++|..||............. .......... ...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1223457889999999998889999999999999999999999997544322211100 0000000000 000
Q ss_pred ------cccccCh------------hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 ------DANLLSQ------------EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ------~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+. ...........+.++.+|+.+||+.||++|||+.+++.|+|-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 0000000 00000001124678999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=321.83 Aligned_cols=261 Identities=20% Similarity=0.220 Sum_probs=224.4
Q ss_pred hhhhcccccccccccccceeeeEEEEEeec-ceEEEEEEeecccc---hhHHHHHHHHHHHhcCC-CCcceeeeeeeeeC
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCG---RAFKSFNIECEMMKSIR-HRNLIKVISTCSNE 93 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 93 (313)
+...+...|++++.||+|.||.||+++.+. |+.+|+|.+++... .....+.+|+++|+++. ||||+.+.++|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 456778899999999999999999999664 99999999987633 24578999999999998 99999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC----CceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN----MVAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~----~~~~l~df 169 (313)
..+++|||++.||.|.+.+... .+++..+..++.|++.++.||| ..|++|||+||+|+|+... +.++++||
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999999876 3999999999999999999999 9999999999999999643 57999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
|++..... ........||+.|+|||++...+++..+|+||+|+++|.|+.|.+||.+..............+
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~----- 255 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF----- 255 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----
Confidence 99998765 2245567899999999999999999999999999999999999999988765444443322222
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........++..+.+++++||..||..|+|+.++++|||-..
T Consensus 256 ------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 256 ------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS 298 (382)
T ss_pred ------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence 1111124567888999999999999999999999999999543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=320.81 Aligned_cols=245 Identities=19% Similarity=0.197 Sum_probs=202.9
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||++++++|..++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999954 6899999999764 2334556778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 186 (313)
+|..++.... .+++..++.++.||+.||.||| +++++||||||+|||+++++.++|+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence 9998887654 6899999999999999999999 9999999999999999999999999999987532211 11223
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
..++..|+|||++.+..++.++|||||||++|+|++|..||................ ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------------------~~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------------------IR 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------------CC
Confidence 458899999999998999999999999999999999999996654332221111100 01
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
.+..+++++.+++.+||..||++|| ++.++++|+|-
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 1334678899999999999999998 89999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=322.72 Aligned_cols=273 Identities=19% Similarity=0.174 Sum_probs=203.5
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----ccce
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-----EFKA 97 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 97 (313)
+|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999955 6899999998643 223445688999999999999999999988543 2479
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+. ++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+|||+++++.++|+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 59999887654 6899999999999999999999 99999999999999999999999999999875432
Q ss_pred ccc-cccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCcccc-----
Q 047140 178 EYQ-SMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWLPI----- 247 (313)
Q Consensus 178 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~----- 247 (313)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.............. ......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 111233568889999998865 6789999999999999999999999966432211100000 000000
Q ss_pred ---cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 248 ---STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 248 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.......................++..+.+++.+||..||++|||++++++|+|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 00000000000000000011124567789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=328.37 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=208.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||.|+||.||+|... +++.||||++... .......+.+|+++++.++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999965 5899999999754 1234566788999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999997765 6899999999999999999999 99999999999999999999999999999865422110
Q ss_pred cc------------------------------------cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCC
Q 047140 181 SM------------------------------------TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224 (313)
Q Consensus 181 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~ 224 (313)
.. ......||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001235889999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC---HHHHHHHHH
Q 047140 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN---AREIVAKLF 301 (313)
Q Consensus 225 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~il~~l~ 301 (313)
.||......+.......... .........+++++.+|+.+|+. +|.+|++ +.++++|+|
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKE-----------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCC-----------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 99976654333222111100 00000111356778999999996 9999998 999999987
Q ss_pred H
Q 047140 302 K 302 (313)
Q Consensus 302 ~ 302 (313)
-
T Consensus 299 ~ 299 (364)
T cd05599 299 F 299 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=323.69 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=204.6
Q ss_pred ccccccccccccceeeeEEEEEe------ecceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI------SSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
.++|++++.||+|+||.||+|.. .++..||+|+++.. .....+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35899999999999999999963 13668999999754 233456788999999999 89999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------------------------------------------
Q 047140 96 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 116 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 116 (313)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 117 ---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 117 ---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
..+++..++.++.||+.||.||| +.+++|+||||+|||+++++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 13677888999999999999999 999999999999999999999999999998765432211
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.................
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY---------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc----------------
Confidence 11222334567999999999999999999999999999998 8889866432221111111000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...+.++.+|+.+||+.||++|||+.++++.++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 000122346679999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=308.78 Aligned_cols=245 Identities=18% Similarity=0.231 Sum_probs=202.3
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccc---hhHHHHHHHHHHHhcCCCCcceeeeeeeee----CccceEEEEee
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEFKALVLEYM 103 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 103 (313)
..+++|+++.||+|.. +|+.||||.++.... ...+.+.+|+.++++++||||+++++++.+ ....++|+||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6789999999999997 689999999976422 235778899999999999999999999877 34689999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|.+++.... .+++.....++.+++.||.||| . .+++||||||+||++++++.+||+|||++..+...
T Consensus 105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---- 176 (283)
T PHA02988 105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---- 176 (283)
T ss_pred CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence 9999999997654 6888999999999999999999 7 48999999999999999999999999998765321
Q ss_pred cccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 183 TQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||......+..........
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~---------------- 239 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN---------------- 239 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC----------------
Confidence 123457788999999876 6789999999999999999999999986644332221111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..+++.+.+++.+||+.||++|||++++++.|..+.
T Consensus 240 ---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 ---SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01112346788999999999999999999999999998875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=306.90 Aligned_cols=256 Identities=20% Similarity=0.310 Sum_probs=207.8
Q ss_pred ccccccccccccceeeeEEEEEee----cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357999999999999999999854 36699999997653 3345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||++++++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876557899999999999999999999 999999999999999999999999999986543211
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. ........++..|+|||++.+..++.++|||||||++|++++ |..||................
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-------------- 225 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF-------------- 225 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------------
Confidence 1 011112234567999999999999999999999999999775 999997654433221111000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||..+|.+||++.+|++.+..+
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111345778899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=319.27 Aligned_cols=244 Identities=23% Similarity=0.188 Sum_probs=201.9
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 5889999999753 233456778899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
.+++...+ .+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99997655 6899999999999999999999 9999999999999999999999999999987532211 1123346
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
++..|+|||++.+..++.++|||||||++|+|++|..||................ ...+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------------------~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------------------LRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------CCCC
Confidence 8899999999999999999999999999999999999997654332221111100 0113
Q ss_pred hhhHHHHHHHHhHhhccCCCCCC---CHHHHHHHHHHH
Q 047140 269 EQCVSFVFNLAIECTVESPEQRI---NAREIVAKLFKI 303 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rp---s~~~il~~l~~~ 303 (313)
..+++.+.+++.+||..||++|| ++.+++.|+|-.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 34677899999999999999997 589999998743
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=320.38 Aligned_cols=245 Identities=20% Similarity=0.216 Sum_probs=203.0
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++.+++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999965 5899999999754 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 186 (313)
+|.+.+.... .+++..+..++.||+.||.||| +++++||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9998887654 6899999999999999999999 9999999999999999999999999999987532211 11233
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
..++..|+|||++.+..++.++|||||||++|+|++|..||................ ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------------------~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---------------------IK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---------------------cc
Confidence 468899999999998899999999999999999999999996644322221111100 01
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
.+..++.++.+++++||..||++|+ ++.++++|+|-
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 1334677899999999999999997 89999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.49 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=211.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|++... .......+..|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999965 6899999999754 1234567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc-
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY- 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~- 179 (313)
||+++++|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+|||++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999998764 6899999999999999999999 9999999999999999999999999999987654322
Q ss_pred --------------------------ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh
Q 047140 180 --------------------------QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR 233 (313)
Q Consensus 180 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~ 233 (313)
.........++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123345889999999999999999999999999999999999999776543
Q ss_pred hhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-HHHHHHHHHH
Q 047140 234 EMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-AREIVAKLFK 302 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~il~~l~~ 302 (313)
.......... ..........+++++.+|+.+||. ||.+||+ +.++++|+|-
T Consensus 237 ~~~~~i~~~~-----------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 237 ETYNKIINWK-----------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHHHHHhccC-----------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 3222211100 000000112257889999999997 9999999 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=332.28 Aligned_cols=254 Identities=19% Similarity=0.206 Sum_probs=209.4
Q ss_pred ccccccccccceeeeEEEEEee-c-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-S-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.|.+.+.||+|+||.||.|... + +..|++|.+..........+..|+.+++.++||||++++++|..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999854 3 6789999876655555667888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 104 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 104 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
++|+|.+.+... ...+++..+..++.|++.||.||| +.+|+||||||+|||+++++.++|+|||++..+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 336889999999999999999999 99999999999999999999999999999986643322
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
........|+..|+|||++.+..++.++|||||||++|+|++|..||......+..........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY---------------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 2223345588999999999999999999999999999999999999976543322221111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+..++..+.+++.+||..||++||++.+++.+.+.
T Consensus 289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~ 326 (478)
T PTZ00267 289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326 (478)
T ss_pred ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence 00123466789999999999999999999999987554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=305.13 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=210.8
Q ss_pred ccccccccccccceeeeEEEEEeec----ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+. ...|++|.++... ......+.+|+.+++.++|+||+++++.+.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4689999999999999999999642 4589999987543 3345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876557899999999999999999999 999999999999999999999999999999876422
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
..........++..|+|||...+..++.++|+||||+++|++++ |..||............... +
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~------------- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-Y------------- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-C-------------
Confidence 22212222334567999999998899999999999999999998 99998655433222111100 0
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..+++.+.+++..||+.||++||++.++++++.++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001234677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=322.71 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=205.9
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357999999999999999998842 2357999999754 233456788999999999 89999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------------------------------------------
Q 047140 96 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 116 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 116 (313)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccc
Q 047140 117 ----------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186 (313)
Q Consensus 117 ----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 186 (313)
..+++..++.++.|++.||.||| +++++||||||+|||+++++.++|+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 23677889999999999999999 99999999999999999999999999999876533221111222
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
..++..|+|||++.+..++.++|||||||++|+|++ |..||................. ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-------------------~~ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-------------------QM 334 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-------------------Cc
Confidence 334567999999988899999999999999999997 9999976543222111111100 00
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+...+.++.+++.+||+.||++|||+.++++.+.++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01223467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.91 Aligned_cols=256 Identities=20% Similarity=0.204 Sum_probs=204.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|+.++..++|+||+++++.+.++..+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999955 58999999997542 234467888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++...+ .+++..+..++.|++.||.||| ++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999997765 6899999999999999999999 99999999999999999999999999999875432110
Q ss_pred c---------------------------------ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 181 S---------------------------------MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 181 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
. .......||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0011246889999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCC---CCCCHHHHHHHHHH
Q 047140 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE---QRINAREIVAKLFK 302 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps~~~il~~l~~ 302 (313)
......+.......... ....+....+++++.+++.+|+. +|+ .||+++++++|+|-
T Consensus 237 ~~~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f 296 (363)
T cd05628 237 CSETPQETYKKVMNWKE-----------------TLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296 (363)
T ss_pred CCCCHHHHHHHHHcCcC-----------------cccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCC
Confidence 76554333222211100 00000011356678889988664 444 56899999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=327.57 Aligned_cols=256 Identities=20% Similarity=0.199 Sum_probs=204.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||.|+||.||++... +++.||||++... .......+.+|+++++.++||||++++++|.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999954 6899999998653 2334567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999997654 6889999999999999999999 99999999999999999999999999999864321100
Q ss_pred c------------c---------------------------------cccccccccccCCCcccccCCCCCcchhHHHHH
Q 047140 181 S------------M---------------------------------TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215 (313)
Q Consensus 181 ~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 215 (313)
. . ......|+..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001235888999999999899999999999999
Q ss_pred HHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCC---CC
Q 047140 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR---IN 292 (313)
Q Consensus 216 ~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps 292 (313)
++|||++|..||......+.......... ....+....++.++.+|+.+||. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRE-----------------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCC-----------------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999976544332221111000 00000112356779999999997 77765 59
Q ss_pred HHHHHHHHHH
Q 047140 293 AREIVAKLFK 302 (313)
Q Consensus 293 ~~~il~~l~~ 302 (313)
+.+++.|+|-
T Consensus 299 ~~~~l~hp~~ 308 (377)
T cd05629 299 AHEIKSHPFF 308 (377)
T ss_pred HHHHhcCCCc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.83 Aligned_cols=256 Identities=19% Similarity=0.209 Sum_probs=204.4
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.|++++.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999954 5889999999754 22345678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc-
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ- 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 180 (313)
|+++|+|.+++.... .+++..+..++.||+.||.||| ..+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997665 6889999999999999999999 99999999999999999999999999998753310000
Q ss_pred --------------------------------------------cccccccccccccCCCcccccCCCCCcchhHHHHHH
Q 047140 181 --------------------------------------------SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216 (313)
Q Consensus 181 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 216 (313)
........||..|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000112458899999999998899999999999999
Q ss_pred HHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhh--ccCCCCCCCHH
Q 047140 217 LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT--VESPEQRINAR 294 (313)
Q Consensus 217 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rps~~ 294 (313)
+|||++|..||......+.......... .........++.++.+|+.+|+ ..+|..||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWEN-----------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcccc-----------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999976544332222111000 0000111235778899999844 55666699999
Q ss_pred HHHHHHHH
Q 047140 295 EIVAKLFK 302 (313)
Q Consensus 295 ~il~~l~~ 302 (313)
++++|+|-
T Consensus 301 ~~l~hp~f 308 (381)
T cd05626 301 DIKAHPFF 308 (381)
T ss_pred HHhcCccc
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=308.30 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=208.3
Q ss_pred cccccccccccceeeeEEEEEeec-c-----eEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-A-----MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
++|++.+.||+|+||.||+|.... + ..|++|.+... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578999999999999999998542 2 57999998654 2344567889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 98 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
+++||+++++|.+++.... ..++...++.++.|++.||.||| ..+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999997531 35788899999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhcc
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~ 241 (313)
.++|+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||......+.......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875432221122233445778999999988899999999999999999998 9999876544332211110
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.. ....+..++.++.+|+.+||+.||.+||++++|+++|..
T Consensus 242 ~~--------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 RQ--------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CC--------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 00 001134578889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=306.79 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=214.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.|+.++.||+|.-|+||++... ++..+|+|++.+.. .........|.+||+.++||.++.++..|+.+.+.|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 468999999999999999999965 47899999998763 33456677899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc-
Q 047140 100 LEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG- 177 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~- 177 (313)
||||+||+|..+++++ +..+++..++.++..|+.||+||| ..|||+|||||+|||+.++|.+.|.||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999866 557999999999999999999999 99999999999999999999999999999864311
Q ss_pred -----c--------------------------ccc----------------------ccccccccccccCCCcccccCCC
Q 047140 178 -----E--------------------------YQS----------------------MTQTQTLATIGCIAPEYRRKGRE 204 (313)
Q Consensus 178 -----~--------------------------~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~ 204 (313)
. ..+ .......||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 000 00112347888999999999999
Q ss_pred CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhc
Q 047140 205 STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTV 284 (313)
Q Consensus 205 ~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 284 (313)
+.+.|+|+||+++|||+.|..||-+....+......... ..++.....+..++|||+++|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------------l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------------LKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------------CcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999998876655543332211 1111122567889999999999
Q ss_pred cCCCCCCC----HHHHHHHHH
Q 047140 285 ESPEQRIN----AREIVAKLF 301 (313)
Q Consensus 285 ~dP~~Rps----~~~il~~l~ 301 (313)
+||++|.. |+||.+|++
T Consensus 374 KdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred cChhhhhccccchHHhhcCcc
Confidence 99999998 999999974
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=314.76 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=210.7
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------------chhHHHHHHHHHHHhcCCCCccee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------------GRAFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
+..-++|++++.||+|.||.|-+|+.. +++.||||++.+.. ....+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 455689999999999999999999944 69999999997531 112467899999999999999999
Q ss_pred eeeeeeeC--ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc
Q 047140 86 VISTCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163 (313)
Q Consensus 86 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~ 163 (313)
++++..+. +.+|||+|||..|.+...- .....+++.+.+.++++++.||+||| .+||+||||||+|+|++++|.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 99999775 5799999999877765422 12223899999999999999999999 999999999999999999999
Q ss_pred eeEcCCcchhhcccccc---cccccccccccccCCCcccccCC----CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh
Q 047140 164 AHLSDFSIAKLLTGEYQ---SMTQTQTLATIGCIAPEYRRKGR----ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT 236 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~ 236 (313)
+||+|||.+..+..... ........||+.|+|||...+.. .+.+.||||+|++||.|+.|..||-+....+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999986622111 11223478999999999876632 377899999999999999999999776655444
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
-.+... +..++....+.+.+.+||.+||.+||++|.+..+|..|||--.+
T Consensus 329 ~KIvn~-------------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVND-------------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcC-------------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 332221 12222233567889999999999999999999999999997654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=308.00 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=211.8
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+|.+.+.||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57899999999999999999842 245789999877655667789999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 99 VLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
|+||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 24899999999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||.................
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~- 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV- 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99999875533221112223345678999999998899999999999999999998 8999876544332211111100
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...+..++.++.+|+.+||+.||.+|||+.++++.+..+...
T Consensus 241 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 241 -------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 001224567799999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=307.04 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=208.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
...++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++..++..++|+
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 34568999999999999999999954 68999999997654455567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999999887554 6899999999999999999999 99999999999999999999999999999876532211
Q ss_pred cccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
......++..|+|||.+. ...++.++|+|||||++|+|++|..||....+.............+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP---------- 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC----------
Confidence 112345778899999874 44578899999999999999999999865543222211111110000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......++..+.+++++||..||++|||++++++|||
T Consensus 230 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 ------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ------CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00012235678999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=311.30 Aligned_cols=270 Identities=22% Similarity=0.244 Sum_probs=202.0
Q ss_pred cccccccccccceeeeEEEEEee--cceEEEEEEeeccc--chhHHHHHHHHHHHhcC---CCCcceeeeeeee-----e
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSI---RHRNLIKVISTCS-----N 92 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 92 (313)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999853 37889999987542 22234556677777665 6999999999985 2
Q ss_pred CccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
+...++|+||++ ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5999988754 335889999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--ccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--IST 249 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 249 (313)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|.+||......+...........+ ...
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 8765322 12234567889999999988899999999999999999999999998764433322221111000 000
Q ss_pred cccc---cccccChh-hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 250 MEVV---DANLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 250 ~~~~---~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... ........ .........+++.+.+++.+||+.||++|||+.++++|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0000 00000000 0000112346788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=323.54 Aligned_cols=256 Identities=20% Similarity=0.221 Sum_probs=208.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++... +++.||+|+++... ......+..|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999965 58999999997642 234567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877557999999999999999999999 99999999999999999999999999999876543221
Q ss_pred cccccccccccccCCCcccc------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRR------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
. ......++..|+|||++. ...++.++|||||||++|+|++|..||................
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------- 225 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ----------- 225 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 1 122345788999999876 4567899999999999999999999997654332221111100
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..........++..+.+|+..||. ||++|||++++++|+|-
T Consensus 226 ------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 226 ------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred ------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 000011122467789999999998 99999999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=300.89 Aligned_cols=273 Identities=21% Similarity=0.205 Sum_probs=212.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCc-ceeeeeeeeeCc-----
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRN-LIKVISTCSNEE----- 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 94 (313)
...|+..++||+|++|.||+|+.+ +|+.||+|++..+.+ ..-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456888889999999999999955 699999999987633 24456678999999999999 999999998877
Q ss_pred -cceEEEEeecCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
.+++|+||++. +|..++.... ...+...+..++.||+.||+||| +++|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78999999976 9999998665 35788899999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--c
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--I 247 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~ 247 (313)
+++.+.-. .........|..|+|||++.+. .|+...||||+||++.||+++.+.|.+.+..+...........+ .
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99966422 2234566788999999988876 78999999999999999999999998887654433322211111 0
Q ss_pred c---cccccccc--ccChh--hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 248 S---TMEVVDAN--LLSQE--DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 248 ~---~~~~~~~~--~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
. .....+.. ..... .......+....+..+++.+||+.+|.+|.|++.++.|+.-
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 0 00111110 00000 00011112233689999999999999999999999999543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=302.78 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=205.6
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
++|++.+.||+|+||.||++..+++..+|+|.+... ......+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 578999999999999999999877788999988654 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++......+++..+..++.|++.||.||| +++++|+||+|+||++++++.++++|||.+......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence 99999999765446889999999999999999999 999999999999999999999999999988755322111 11
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||++.+..++.++|+||||+++|++++ |..||......+..........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------------- 219 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------------- 219 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------------------
Confidence 22234567999999988889999999999999999999 8999976544333222211100
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
...+...+..+.+++.+||..||.+||+++++++.+
T Consensus 220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 001122456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=316.84 Aligned_cols=248 Identities=19% Similarity=0.219 Sum_probs=202.0
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHH---hcCCCCcceeeeeeeeeCccceEE
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMM---KSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
|++.+.||+|+||.||++... +++.||||+++.. .....+.+..|.+++ +.++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999965 5899999999754 223345666776665 456899999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++++|...+... .+++..++.++.||+.||.||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999999888653 5899999999999999999999 9999999999999999999999999999876432211
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||......+.........
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------------- 217 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------------- 217 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence 11234568889999999999999999999999999999999999997654332221111000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..++..+.+++.+||+.||.+|| ++.++++|+|-
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 011334677899999999999999999 79999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=307.47 Aligned_cols=272 Identities=22% Similarity=0.235 Sum_probs=209.1
Q ss_pred hhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC---
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--- 93 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (313)
.......-.|+..+.+|+|+||.||+|... +++.||||+.-.+.. .--+|+++|+.++|||||++.-+|...
T Consensus 17 ~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 17 NDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred CCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 344456668999999999999999999954 589999999865522 113599999999999999999988543
Q ss_pred --ccceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEc
Q 047140 94 --EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLS 167 (313)
Q Consensus 94 --~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~ 167 (313)
-++.+||||++. +|.++++. .+..++.-.+.-+..||.+||+||| ..||+||||||.|+|+|.+ |.+|||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEec
Confidence 256799999976 99999974 2457888899999999999999999 9999999999999999966 999999
Q ss_pred CCcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||.|+.+..+. ....+..|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+..+.......--..+
T Consensus 169 DFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 169 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 999999886543 2355678899999997765 579999999999999999999999998876544433222111111
Q ss_pred --ccc-------cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 --IST-------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 --~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+.+ .+.-.+. ..............++++.+|+.++|..+|.+|.++.++++|+.
T Consensus 246 t~e~I~~mn~~y~~~~~p~-ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQ-IKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred CHHHHhhcCcccccccCcc-cccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 000 0000000 11111111134567888999999999999999999999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=341.09 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=223.6
Q ss_pred cccccccccccceeeeEEEEEeec--ce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS--AM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
+..+..+.||+|.||.||.|...+ +. .||+|.++.. +......|.+|..+|+.++||||++++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456778899999999999999763 43 4899999765 4556788999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 98 LVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
|++|||+||||..+|++. ...++...++.++.+||.|+.||+ .+++|||||...|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999876 557899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++.+.............-+..|||||.+....++.++|||||||++||++| |..||....+.+........
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-------- 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-------- 920 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--------
Confidence 996544333333333456788999999999999999999999999999999 99999888776654422111
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
-++..|..|++.++++|..||+.+|++||++..|++.+..+....
T Consensus 921 ------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 921 ------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 133447889999999999999999999999999999887776553
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=316.59 Aligned_cols=245 Identities=22% Similarity=0.222 Sum_probs=201.7
Q ss_pred cccccceeeeEEEEEee----cceEEEEEEeecc----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+.||+|+||.||++... +++.||+|+++.. .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999842 4789999999753 123345677899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+.+...+ .+++..+..++.|++.||.||| +.+++|+||||+|||++.++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence 99999999997665 6788888999999999999999 9999999999999999999999999999986432211 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------------------- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------------------- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 1223468899999999998889999999999999999999999997654332221111100
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..+++.+.+++.+||..||++|| ++.+++.|+|-
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 011334577899999999999999999 89999999873
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.79 Aligned_cols=256 Identities=20% Similarity=0.236 Sum_probs=205.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+|++++.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++.|.+++..|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999954 58899999997542 234567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++...+ .+++..+..++.||+.||.||| +.+|+||||||+|||++.+|.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999987654 6889999999999999999999 99999999999999999999999999998753210000
Q ss_pred ---------------------------------------------cccccccccccccCCCcccccCCCCCcchhHHHHH
Q 047140 181 ---------------------------------------------SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGI 215 (313)
Q Consensus 181 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 215 (313)
........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235888999999999999999999999999
Q ss_pred HHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC---
Q 047140 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN--- 292 (313)
Q Consensus 216 ~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 292 (313)
++|||++|..||....+.+.......... ....+....+++++.+++.+|+ .||++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQT-----------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCC-----------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 99999999999976544333222111100 0000112245677889998876 59999997
Q ss_pred HHHHHHHHHH
Q 047140 293 AREIVAKLFK 302 (313)
Q Consensus 293 ~~~il~~l~~ 302 (313)
+.+++.|+|-
T Consensus 299 ~~ei~~hp~f 308 (382)
T cd05625 299 ADEIKAHPFF 308 (382)
T ss_pred HHHHhcCCCc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=320.83 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=210.7
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
.++-||.|+.|.||+|+.. ++.||||+.+.-. ..++.-|++|+|+||+.+.++|...--+|||||||+.|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4667899999999999985 7889999875432 2367778999999999999999999889999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
..+++..+ .+.......|.++|+.++.||| .+.|+|||||.-||||+.+..|||+|||-++..... -..-...
T Consensus 200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 99998776 7888899999999999999999 999999999999999999999999999999876533 1233467
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
||..|||||++.+.+.+.+.|||||||+|||||||..||...+..... |. .....+.++.|
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wG----------------VGsNsL~LpvP 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WG----------------VGSNSLHLPVP 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---Ee----------------ccCCcccccCc
Confidence 999999999999999999999999999999999999999765432221 11 11223345557
Q ss_pred hhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
..|++-++-|++.||+..|..||++.+|+.|+.-...++.+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 88999999999999999999999999999999877766543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.86 Aligned_cols=256 Identities=20% Similarity=0.226 Sum_probs=206.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999955 5899999998653 1234567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999997765 6889999999999999999999 99999999999999999999999999998753210000
Q ss_pred -----------------------------------------cccccccccccccCCCcccccCCCCCcchhHHHHHHHHH
Q 047140 181 -----------------------------------------SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219 (313)
Q Consensus 181 -----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 219 (313)
........|+..|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112358889999999999999999999999999999
Q ss_pred HHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC---CHHHH
Q 047140 220 TFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI---NAREI 296 (313)
Q Consensus 220 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~i 296 (313)
|++|..||......+.......... .........++.++.+++.+|+ .+|++|+ ++.++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~-----------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWET-----------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCc-----------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 9999999977654433222111100 0000112245677889999976 5999999 99999
Q ss_pred HHHHHH
Q 047140 297 VAKLFK 302 (313)
Q Consensus 297 l~~l~~ 302 (313)
++|+|-
T Consensus 299 l~h~~~ 304 (376)
T cd05598 299 KAHPFF 304 (376)
T ss_pred hCCCCc
Confidence 999884
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.00 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=213.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
-++|+.++.||+|+||.|+++..+ +++.+|||+++++ ..+..+....|.+++... +||.+++++..|+...++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 568999999999999999999966 5889999999886 355677888899999888 69999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+.||++..+... ..+++..+.-++..|+.||.||| .+||+|||||.+|||+|.+|.+||+|||+++.-...
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999995443333 36999999999999999999999 999999999999999999999999999999864422
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
+. ......||+.|+|||++.+..|+.+.|+|||||+||||+.|..||.+.+..+.-..+...
T Consensus 522 g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------------- 583 (694)
T KOG0694|consen 522 GD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------------- 583 (694)
T ss_pred CC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Confidence 22 345678999999999999999999999999999999999999999887655443322211
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLF 301 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~ 301 (313)
+...|..++.+..++++++|.+||++|..+ .+|.+||.
T Consensus 584 -----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 584 -----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred -----CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 122356688999999999999999999965 67777753
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=330.13 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=211.0
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc---
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (313)
....++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++..++|+||+++.+.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445689999999999999999999954 6999999999754 2344567888999999999999999988775432
Q ss_pred -----cceEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 95 -----FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 95 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
.+++|+||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998643 346899999999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
+|||+++.+.............|+..|+|||++.+..++.++|||||||++|+|++|..||......+..........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-- 262 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-- 262 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC--
Confidence 999998765433222223345688999999999999999999999999999999999999976543322211111000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+..+++++.+++.+||..||.+||++.++++|++.
T Consensus 263 ------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 263 ------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 01134567889999999999999999999999999763
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.19 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=209.0
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.++||+|+||.||+|...++..|++|.+... ....+.+.+|+.+++.++|+||+++++.+.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4689999999999999999999777888999998654 234578889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...++...+..++.|++.||+||| +.+++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999999754 346788899999999999999999 999999999999999999999999999999765432111
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||+++|+|++ |..||............... +
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~----------------- 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-Y----------------- 221 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-C-----------------
Confidence 1122335667999999988889999999999999999998 99999765433322211110 0
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......++.++.+++.+||..||++||+++++++.|++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001123456779999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=307.24 Aligned_cols=250 Identities=31% Similarity=0.477 Sum_probs=200.1
Q ss_pred ccccccccceeeeEEEEEee-----cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 28 QILNFFICGVIIPVAQFLIS-----SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999976 3679999999654 33457899999999999999999999999998888999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++|+|.+++... ...++...++.++.|++.||.||| +++++|++|+++||++++++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 99999999999887 557899999999999999999999 99999999999999999999999999999876632222
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
............|+|||.+.+..++.++||||||+++||+++ |..||......+.......
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~------------------ 220 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ------------------ 220 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------------
Confidence 223344557778999999998889999999999999999999 7899876644332221110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
......+..++..+.+++..||..||++|||+.++++.|
T Consensus 221 --~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 --GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001112345788899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.43 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=207.9
Q ss_pred ccccccccccccceeeeEEEEEeec------ceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|.+.+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|+++++.++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3579999999999999999998532 478999999765333 567899999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN-------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~ 163 (313)
++||||+++++|.+++...+ ..+++..+..++.|++.+|.||| +++++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999997542 24678899999999999999999 999999999999999999999
Q ss_pred eeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccC
Q 047140 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~ 242 (313)
++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432221112233345678999999999999999999999999999998 99998665433322211110
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. ...+..++..+.+++++||..||.+||++.++++.+.
T Consensus 241 ~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 241 RL--------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred Cc--------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 0012346778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=315.74 Aligned_cols=250 Identities=20% Similarity=0.193 Sum_probs=204.4
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCC-CcceeeeeeeeeCccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 100 (313)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999965 5789999999754 22345677889999999966 56888999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..+..++.||+.||.||| +++++||||||+|||+++++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 9999999999987655 6889999999999999999999 999999999999999999999999999988643211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||......+.........
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------------- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------------- 217 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 112233458899999999999999999999999999999999999997654333222211100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~~ 302 (313)
...+..++..+.+++++||..||.+|++. .++++|+|-
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 01123467779999999999999999986 789998763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=319.98 Aligned_cols=267 Identities=20% Similarity=0.179 Sum_probs=202.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.+|++.+.||+|+||.||+|... +++.||+|.... ..+.+|+++++.++||||++++++|..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 58999999999999999999954 589999997532 34678999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
. ++|..++.... .++...++.++.||+.||.||| +++|+||||||+|||++.++.++|+|||++....... ...
T Consensus 166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~ 239 (391)
T PHA03212 166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANK 239 (391)
T ss_pred C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccc
Confidence 5 58988886654 6889999999999999999999 9999999999999999999999999999986533211 112
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh------hhh-hcc-CCccccc-------
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM------TLK-HWG-NNWLPIS------- 248 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~------~~~-~~~-~~~~~~~------- 248 (313)
.....+|..|+|||++.+..++.++|||||||++|+|++|..||........ ... ... ....+..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 2345689999999999999999999999999999999999988643221100 000 000 0000000
Q ss_pred -ccccc----cc-cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 -TMEVV----DA-NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 -~~~~~----~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..... .. ................+.++.+|+.+||..||++|||+.++++|+|-.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 00000 00 000000000011124577899999999999999999999999999853
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.56 Aligned_cols=257 Identities=20% Similarity=0.212 Sum_probs=207.6
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||++..+ +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999965 5889999999653 12334557789999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++|+|.+++... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.++|+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999998754 4788899999999999999999 999999999999999999999999999998765422
Q ss_pred cccccccccccccccCCCcccccC----CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKG----RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
.. .......|+..|+|||++.+. .++.++|+|||||++|+|++|..||................
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------- 263 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK----------- 263 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-----------
Confidence 11 112234689999999987643 47899999999999999999999997654332222111100
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~ 302 (313)
..........++.++.+|+.+||+.+|.+ |+|+.+++.|+|-
T Consensus 264 ------~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 264 ------NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred ------CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 00001112246788999999999999988 9999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=325.92 Aligned_cols=269 Identities=23% Similarity=0.242 Sum_probs=202.0
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--------
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-------- 93 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 93 (313)
..++|++++.||+|+||.||+|... +++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999965 58899999886442 2345699999999999999998887432
Q ss_pred ccceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~df 169 (313)
..+++||||+++ +|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 88777653 3446899999999999999999999 99999999999999999665 7999999
Q ss_pred cchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-- 246 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-- 246 (313)
|+++.+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+...........+
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998664322 1223467889999998765 468999999999999999999999998765433222211100000
Q ss_pred cccc----cccc--ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ISTM----EVVD--ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ~~~~----~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.... ...+ -............+...+.++.+|+.+||..||++|||+.++++|+|-
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 0000 0000 000111122222344567889999999999999999999999999984
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=319.23 Aligned_cols=255 Identities=21% Similarity=0.222 Sum_probs=203.9
Q ss_pred ccccccccccceeeeEEEEEee----cceEEEEEEeecc----cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ----CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+..|+++++.+ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999998842 4789999999753 223345678899999999 589999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+++||||||+|||+++++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999987654 6889999999999999999999 9999999999999999999999999999987653
Q ss_pred cccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||............. .
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--------------~ 221 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--------------R 221 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--------------H
Confidence 22211 12234688999999988765 47889999999999999999999996432211100000 0
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
... ......+..++..+.+++.+||..||++|| +++++++|+|-
T Consensus 222 ~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 222 RIL---KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred HHh---cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 000 000111334677899999999999999999 88899999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=301.38 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=208.8
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46799999999999999999997777889999987542 33567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... +..++...+..++.|++.||.+|| ..+++|+||+|+||++++++.++|+|||++........ .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 999999999754 346899999999999999999999 99999999999999999999999999999876642211 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.......+..|+|||+..+..++.++|+||||+++++|++ |..||.+............. .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~----------------- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-Y----------------- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C-----------------
Confidence 1112223457999999998899999999999999999999 99999765433222111100 0
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||+.||.+||++.++++.++++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=318.68 Aligned_cols=245 Identities=20% Similarity=0.192 Sum_probs=201.6
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||++... +++.||+|++... .......+..|+++++.++||||+++.+++.+++..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999954 6899999999764 2234566778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
+|.+++.... .+++..+..++.||+.||.||| + .+++||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence 9999887654 6899999999999999999999 8 799999999999999999999999999986432211 1122
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---------------------~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------------------I 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---------------------C
Confidence 3458899999999999999999999999999999999999996544322211111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
..+..++.++.+++.+||..||++|+ ++.++++|+|-
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 11334677899999999999999997 99999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=315.88 Aligned_cols=245 Identities=20% Similarity=0.190 Sum_probs=201.7
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|..+ +++.||+|++... .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 5889999999753 223456677888888876 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+.+.... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.++|+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99999887665 6889999999999999999999 9999999999999999999999999999986532111 1223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~---------------------~ 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------------------V 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------------------C
Confidence 3468899999999998999999999999999999999999997654433322211110 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH------HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA------REIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~il~~l~~ 302 (313)
..+..++.++.+++++||+.||++||++ .++++|+|-
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 1123457789999999999999999998 899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.11 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=213.0
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
...+|++.+.||.|+||.||+|....+..+++|.+..........+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34689999999999999999999877899999999877555677889999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++... +..++...+..++.|++.||.||| +++++|+||+|+||++++++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999764 346889999999999999999999 99999999999999999999999999999876532211
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||...+..++.++|+||||+++|+|++ |..||......+.........
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------- 221 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY----------------- 221 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----------------
Confidence 1123335667999999988899999999999999999998 899997654332222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+..+++.+.+++.+||+.||.+|||++++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001134567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=310.58 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=208.8
Q ss_pred ccccccccccccceeeeEEEEEee-cce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..+|++.+.||+|+||.||+|... +++ .||+|.++.. .....+.+.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 468999999999999999999854 333 4899998654 234567788999999999999999999999875 467
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+++||+++|+|.+++......++...++.++.||+.||+||| +.+++|+||||+||++++++.++|+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999876667889999999999999999999 99999999999999999999999999999987643
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
............+..|+|||++.+..++.++||||||+++|++++ |..||......+.........
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------- 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-------------
Confidence 322211222334567999999999999999999999999999998 999987653322211110000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++.++.+++.+||..||.+||++.+++.++..+...
T Consensus 229 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0011234567789999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=315.45 Aligned_cols=245 Identities=20% Similarity=0.183 Sum_probs=201.8
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|..+ +++.||+|++... .......+..|.+++..+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 4889999999764 223445677888998876 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+.+.... .+++..+..++.||+.||.||| +.+++||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence 99999887655 6889999999999999999999 9999999999999999999999999999987532211 1223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~---------------------~ 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD---------------------V 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence 3458889999999998899999999999999999999999997665433322211111 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCC-------CHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRI-------NAREIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~~il~~l~~ 302 (313)
..+..++.++.+++.+||..||++|| ++.++++|+|-
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 01223567789999999999999999 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=305.04 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=208.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
...++|++.+.||+|+||.||+|... +++.|++|.++.........+.+|+.+++.++||||+++++.+..++..++|+
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 34569999999999999999999954 58999999998765455567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..++.++.|++.+|.||| ..|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999999987655 6899999999999999999999 9999999999999999999999999999987553221
Q ss_pred cccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.......++..|+|||++. ...++.++|+|||||++|+|++|..||....+.............+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------- 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---------- 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC----------
Confidence 1123346788999999874 45688999999999999999999999865443222211111100000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......++..+.+++.+||..||++|||+++++.|+|
T Consensus 230 ------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 230 ------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001235667899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=301.02 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=212.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
++|++.+.||.|+||.||+|... +++.+++|++........+.+.+|+++++.++||||+++++++.+++.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 68999999999999999999965 57899999998765556788999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++......+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999998776457899999999999999999999 99999999999999999999999999999876543211 1
Q ss_pred ccccccccccCCCcccccC---CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 184 QTQTLATIGCIAPEYRRKG---RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...................
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-------------- 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------------
Confidence 2234577789999998776 78999999999999999999999997654433322211110000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.........+.++.+++++||..||.+|||+.+++.|.|
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 --PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 001112345778999999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=319.62 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=201.7
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|+..+.||+|+||.||++... +++.||||++... .......+.+|+++++.++|+||+++++++.+++.+++|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 357889999999999999999965 5899999999654 23445678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++++|.+.. ..++..+..++.||+.||.||| +.+++||||||+|||+++++.+||+|||++........
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99999986532 3567788899999999999999 99999999999999999999999999999876542211
Q ss_pred ccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
......++..|+|||++.. ...+.++|||||||++|+|++|..||......+...... ..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--------------~~ 288 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC--------------AI 288 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------------HH
Confidence 1123468899999998743 234578999999999999999999996322111100000 00
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.. ......+..++.++.+|+.+||..||++|||+.|+++|+|-...
T Consensus 289 ~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 289 CM---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred hc---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00 00001123467789999999999999999999999999986654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=298.19 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=200.1
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
+.||+|+||.||+|..+ +++.||+|.+... .......+.+|+++++.++||||+++++++.+....++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999965 6899999987654 234556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
.+++......+++..++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||.+................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766556899999999999999999999 9999999999999999999999999999987543221111111122
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
.+..|+|||.+.+..++.++|+||||+++|++++ |..||................ ....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~--------------------~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------------------RLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------------------CCCC
Confidence 3456999999988889999999999999999998 888986554322211111000 0011
Q ss_pred hhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 268 ~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+..++..+.+++.+||..||++|||+.++++.+.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=304.50 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=212.0
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 57889999999999999999742 345789999876655566788999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc
Q 047140 99 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~ 163 (313)
||||+++++|.+++.... ..+++..++.++.|++.||+||| .++++|+||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997542 24788999999999999999999 999999999999999999999
Q ss_pred eeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccC
Q 047140 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~ 242 (313)
++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...............
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 99999999875533221122233446778999999998999999999999999999999 99998665443322111111
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+. ..+..++..+.+++.+||..||++|||+.++++.+.++...
T Consensus 242 ~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 242 RVL--------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCC--------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 000 01223567799999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=312.91 Aligned_cols=245 Identities=20% Similarity=0.196 Sum_probs=197.7
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 58899999997541 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999987655 6899999999999999999999 9999999999999999999999999999987542211 1223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------------~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---------------------P 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence 4468899999999999899999999999999999999999997654332222111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHH-HHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAR-EIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~il~~l~~ 302 (313)
..+..++.++.+++.+||..||++||++. +++.|+|-
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence 11234567789999999999999999875 77787653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=304.90 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=204.5
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeecccchh--HHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRA--FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
|++++.||+|+||.||++... +++.+|+|++....... ......|+.+++.++|+||+++++++.+....++|+|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999966 47899999998763322 223455999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++.... .++...+..++.|++.||.+|| +.+++|+||||+||++++++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred ccccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999998433 6899999999999999999999 99999999999999999999999999999875411 1223
Q ss_pred ccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||++. +..++.++|+||||+++++|++|..||............ .........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~--------------~~~~~~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII--------------EKILKRPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH--------------HHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh--------------hhccccccc
Confidence 34566788999999988 888999999999999999999999999765111111000 000000000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.........+..+.+++.+||+.||++|||+.++++|+|
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 001111122478999999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=300.81 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=208.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
++|++.+.||.|++|.||.+... ++++|++|.+.... ......+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999954 58999999986542 1234578889999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+.+.... .+++..+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999987655 5888999999999999999999 999999999999999999999999999998765332
Q ss_pred ccccc-ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
..... .....++..|+|||+..+..++.++|+||||+++|++++|..||................
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--------------
Confidence 11111 123446778999999998889999999999999999999999997653322221111000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..++..+.+++.+||..+|++|||+.++++|+|
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 001113346778999999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.43 Aligned_cols=274 Identities=19% Similarity=0.220 Sum_probs=208.5
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.++|+||+++++++.+++..++|+||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 68999999999999999999965 58899999987542 22334577899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++ +|.+.+...+..++...+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence 975 898888776657899999999999999999999 9999999999999999999999999999987543221 1
Q ss_pred cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------cccc-cccccc
Q 047140 183 TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------WLPI-STMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~ 253 (313)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... |... ......
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223456788999998764 567999999999999999999999997654332211111100 0000 000000
Q ss_pred cccccChh-hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+....... .........++.++.+|+.+||..||.+|||+.|+++|+|-..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00000000 0001112346788999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=300.19 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=205.6
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||.+....+..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35789999999999999999987666679999987542 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
.+++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 999999999775557899999999999999999999 99999999999999999999999999998875432211 11
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||...+..++.++|+||||+++|+|++ |..||.................
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 219 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR------------------ 219 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC------------------
Confidence 122335567999999988889999999999999999998 9999865543222111111100
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
...+...+..+.+++.+||..||.+||++.++++.+
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 001223467799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.53 Aligned_cols=258 Identities=21% Similarity=0.284 Sum_probs=213.0
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++.+.||.|++|.||++... ++..+++|.+........+.+..|+++++.++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 368999999999999999999965 5899999999876666677888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++...+..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999876667999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
......++..|+|||++. ...++.++|+||||+++|+|++|..||................
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 224 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-------------- 224 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--------------
Confidence 122345778899999864 3457889999999999999999999997654333222111100
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......+..++.++.+++.+||+.||.+||++.++++|+|-..
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 225 ----PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred ----CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 0001112346678999999999999999999999999988543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=312.89 Aligned_cols=245 Identities=20% Similarity=0.188 Sum_probs=201.5
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||++..+ +++.||+|+++.. .......+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999965 5889999999764 223455677888999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++...... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCccc
Confidence 99999987665 6899999999999999999999 999999999999999999999999999988643211 11122
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|+|||||++|+|++|..||................ .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~---------------------~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE---------------------V 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence 3457889999999999999999999999999999999999997654332221111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~~ 302 (313)
..+..++..+.+|+++||..||++||++ .++++|+|-
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 1123467789999999999999999999 999999765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=316.60 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=206.7
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (313)
.++|++++.||.|+||.||+|... .+..||||++.... ....+.+.+|+++++.+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568999999999999999999842 13479999997542 334567899999999995 9999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------------------------------------------
Q 047140 96 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 116 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 116 (313)
.|+||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 117 ------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 117 ------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
..+++..+..++.|++.||.||| ..+++|+||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13677788899999999999999 999999999999999999
Q ss_pred CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhh
Q 047140 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKH 239 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~ 239 (313)
++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999876533221112223345678999999988899999999999999999997 99998765332221111
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..... ....+..++..+.+++.+||+.||++|||+.++.+.+..+.
T Consensus 353 ~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 353 IKSGY-------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HhcCC-------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11000 00112346778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=317.92 Aligned_cols=261 Identities=27% Similarity=0.331 Sum_probs=220.1
Q ss_pred cccccccccccceeeeEEEEEeec--c---eEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS--A---MEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~--~---~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
++....++||+|.||.||+|..+. + ..||+|..+.+ ......++.+|++++++++||||++++|++....++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345567899999999999999653 2 23899999853 366788999999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|||+|.||+|.+++.+.+..++..+...++.+.+.||+||| +++++||||-..|+|++.++.+||+|||+++.-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999988767999999999999999999999 9999999999999999999999999999987532
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..........-+..|+|||.+....++.++||||||+++||+++ |..||.+....+.........+
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~----------- 380 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY----------- 380 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc-----------
Confidence 11112223346788999999999999999999999999999999 8899999877655444322211
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....+...+.++..++..||..||++||||.++.+.+..+......
T Consensus 381 --------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 --------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111335678899999999999999999999999999999877553
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=298.60 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=208.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+|++.+.||.|++|.||+|..+ .++.|++|.+... ......+.+|+++++.++|+||+++++++..+...++++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 357889999999999999999965 4889999998754 33456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++... ...++...++.++.|++.+|+||| +++++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999998654 335889999999999999999999 999999999999999999999999999998765432111
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....... ..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~---------------- 222 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GY---------------- 222 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CC----------------
Confidence 1112234567999999998999999999999999999998 9999876433222111100 00
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++.++.+++.+||+.||++|||+.++++.+..+
T Consensus 223 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 ---RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011234678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=307.99 Aligned_cols=256 Identities=20% Similarity=0.225 Sum_probs=206.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999954 58999999997532 2223456789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888654 346899999999999999999999 9999999999999999999999999999987643211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|+||+|+++|++++|..||.............. .+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----------~~~------ 218 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----------RVK------ 218 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----------Hhh------
Confidence 12234678899999999888899999999999999999999999975432211100000 000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~~~ 304 (313)
......+..++..+.+|+.+||..||++|| ++.++++|+|-..
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 219 -EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred -hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 000011234677899999999999999999 9999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=314.96 Aligned_cols=254 Identities=20% Similarity=0.196 Sum_probs=201.1
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||++..+ +++.||+|+++.. .......+..|..+++.+ +||||++++++|.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 5889999999764 233456678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++...+ .+++..+..++.|++.||.||| +++++||||||+||++++++.++|+|||++...... .....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence 99999887654 6899999999999999999999 999999999999999999999999999998642211 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||........... ........... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~---------~~~~~~~~~~~---~~~~ 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ---------NTEDYLFQVIL---EKQI 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccc---------cchHHHHHHHH---cCCC
Confidence 35688999999999999999999999999999999999999964321110000 00000000000 0001
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCC------HHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRIN------AREIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~il~~l~~ 302 (313)
..+..++..+.+++++||+.||.+|++ ++++++|+|-
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 123456778999999999999999997 7899999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=303.61 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=209.7
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.+.|++.+.||.|+||.||++... +++.|++|.+........+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999965 4899999999877666778889999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|..++.+....+++..+..++.|++.+|.||| ..+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 9999999888765557899999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred cccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
......++..|+|||++. ...++.++|+|||||++|+|++|..||................
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 231 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-------------- 231 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--------------
Confidence 122345778899999874 3456889999999999999999999986644322211111000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
......+..++.++.+++.+||..||++||++.++++|+|-
T Consensus 232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 232 ----PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred ----CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00011123456778999999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=306.09 Aligned_cols=268 Identities=22% Similarity=0.233 Sum_probs=200.1
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcC---CCCcceeeeeeeee-----Cc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSI---RHRNLIKVISTCSN-----EE 94 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 94 (313)
+|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999965 58999999987532 11223455677777665 79999999999864 24
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..++|+|++.+ +|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999975 898888654 335899999999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC------cccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN------WLPI 247 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~------~~~~ 247 (313)
...... ......++..|+|||++.+..++.++|||||||++|+|++|.+||................ ..+.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 654221 2233457888999999998899999999999999999999999996654332221111100 0000
Q ss_pred cccccccccccCh-hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 248 STMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
... ......... ..........+++.+.+++.+||..||++|||+.+++.|+|
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 234 DVT-LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred ccc-ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 000 000000000 00001112346778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=319.17 Aligned_cols=259 Identities=20% Similarity=0.212 Sum_probs=206.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34579999999999999999999965 5889999998653 2233456788999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++|+|.+++... .+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999999755 4788999999999999999999 99999999999999999999999999999876532
Q ss_pred ccccccccccccccccCCCcccccCC----CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGR----ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
... .......++..|+|||++.+.. ++.++|+|||||++|+|++|..||................
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK---------- 263 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 211 1123456899999999886543 7889999999999999999999997654322221111100
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFKI 303 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~~ 303 (313)
.....+....++..+.+++..||..+|.. |+++.++++|+|-.
T Consensus 264 -------~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 264 -------NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred -------cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 00001112245777899999999865543 89999999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=302.36 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=204.3
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
.+++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999998753 2568999998643 22345568899999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 96 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
.++|+||+++++|.+++.... ...+...+..++.|++.||.||| +.+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 13567788999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||.................
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99999875532221111122334677999999998889999999999999999999 7888866543322211110000
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++..+.+++.+||+.||++|||+.++++++.
T Consensus 240 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 -------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0012345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=314.59 Aligned_cols=272 Identities=20% Similarity=0.184 Sum_probs=204.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
.+.++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999954 5899999999653 2344567788999999999999999999986543
Q ss_pred --cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 95 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..|+||||+++ +|.+.+.. .++...+..++.|++.||.||| ++|++||||||+||+++.++.++|+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999965 77776643 4788899999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-cc---
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-IS--- 248 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~--- 248 (313)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||..................+ ..
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 7543221 2233467889999999999999999999999999999999999997654322111000000000 00
Q ss_pred -----cccccccc-ccChh-----------hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 -----TMEVVDAN-LLSQE-----------DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 -----~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........ ..... +.........+..+.+|+.+||..||++|||+.|+++|+|-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 00000000 00000 000001123456789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=303.21 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=209.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+-|++.+.||.|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++.+..++..++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999965 48899999997665566778889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|..++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++........ .
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 999999988765557899999999999999999999 99999999999999999999999999999875432211 1
Q ss_pred ccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 184 QTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....++..|+|||++. +..++.++|+|||||++|+|++|..||.................
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 225 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------------- 225 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--------------
Confidence 22345788899999873 44578899999999999999999999976543332222111100
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.....+..++.++.+++.+||..||.+||++.++++|+|-.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 226 ----PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred ----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 00011234567899999999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=310.26 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=205.2
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeee-Cc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSN-EE 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 94 (313)
.++|++.+.||.|+||.||+|... +++.||+|++.... ....+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 358999999999999999999632 24789999987542 23346678899999999 89999999998865 45
Q ss_pred cceEEEEeecCCCHHHHHhcCC----------------------------------------------------------
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------- 116 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 116 (313)
.+++++||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999999985421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccC
Q 047140 117 --CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI 194 (313)
Q Consensus 117 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 194 (313)
..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999 9999999999999999999999999999998754322211222334566799
Q ss_pred CCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHH
Q 047140 195 APEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273 (313)
Q Consensus 195 aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (313)
|||++.+..++.++|||||||++|+|++ |..||......+......... .....+..++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~ 303 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-------------------TRMRAPEYATP 303 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-------------------CCCCCCccCCH
Confidence 9999999999999999999999999998 999986533211111000000 00011234567
Q ss_pred HHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 274 FVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 274 ~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
++.+++.+||+.+|++||++.+++++|..+..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 79999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.23 Aligned_cols=248 Identities=19% Similarity=0.223 Sum_probs=199.6
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||+|+||.||++... +++.||+|.+.... ....+.+..|+++++.++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 68999999987542 12335677899999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 109 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 109 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
.+.+.. ....+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||.+..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 988743 2346899999999999999999999 99999999999999999999999999999876543211 122
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|+||||+++|+|++|..||.............. ..... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---------~~~~~--------~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------RILND--------SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---------hhccc--------CC
Confidence 34678899999999999999999999999999999999999965432111000000 00000 00
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
..+..++..+.+++.+||+.||++|| +++++++|+|-
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 11334678899999999999999999 88999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.22 Aligned_cols=249 Identities=20% Similarity=0.215 Sum_probs=203.3
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999965 57899999997642 22344566788888777 6899999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+.+.... .+++..+..++.|++.||.||| +.+++||||||+|||+++++.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 9999999999987655 6889999999999999999999 999999999999999999999999999998643211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------------- 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------------- 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence 112234568899999999999999999999999999999999999997654433222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~ 301 (313)
...+...+.++.+++.+||+.||.+|++. .+++.|+|
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence 01123467789999999999999999984 78888865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=298.26 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=204.7
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
.+|++.+.||+|+||.||++..+++..+++|++.... .....+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 5789999999999999999997777789999986542 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence 99999999766557899999999999999999999 9999999999999999999999999999887543211 1111
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+........ .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------~ 218 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG--------------------Y 218 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC--------------------C
Confidence 12223457999999998899999999999999999999 89998654433222111100 0
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
....+..++..+.+++.+||..+|++|||+.++++.+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111234677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=309.61 Aligned_cols=244 Identities=21% Similarity=0.232 Sum_probs=197.9
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|+++... .........|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999965 48899999997641 23345566788888764 999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||++++++.++|+|||++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence 99999997654 6889999999999999999999 999999999999999999999999999998643211 11123
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|+|||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------------------~ 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN---------------------P 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------C
Confidence 3458889999999998899999999999999999999999997654332221111000 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHH-HHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAR-EIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~il~~l~ 301 (313)
..+..++.++.+++.+||..||++||++. +++.|+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 01223567789999999999999999997 8888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=301.89 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=205.1
Q ss_pred cccccccccccceeeeEEEEEee-----cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-----SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
++|++.+.||+|+||.||+|... ++..|++|.+... .......+.+|+++++.++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57889999999999999999842 3578999999754 23344678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 99 VLEYMPHGSLEKYLYSS----------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
||||+++++|.+++... ...+++..+..++.|++.||.||| +++++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998532 124678889999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhcc
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~ 241 (313)
.++|+|||++................++..|+|||+..+..++.++|+||||+++|+|++ |..||.+............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986543222222233345667999999988889999999999999999998 9999866433222111111
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
... ...+..++..+.+++.+||+.||++||++.++++++..
T Consensus 242 ~~~--------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQL--------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCc--------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000 01133467789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.65 Aligned_cols=245 Identities=19% Similarity=0.185 Sum_probs=198.5
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|..+ +++.||+|+++... .........|..++... +||||+++++++.+++..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999965 58899999997642 23345667788888765 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.|++.||+||| ++|++||||||+||++++++.++|+|||++...... .....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence 99999987654 6889999999999999999999 999999999999999999999999999988643211 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---------------------~ 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---------------------P 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------------------C
Confidence 4558899999999999999999999999999999999999997654332221111000 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH-HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA-REIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~il~~l~~ 302 (313)
..+..++.++.+++.+||..||++||++ +++++|+|-
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 1123356778999999999999999998 578878764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=318.75 Aligned_cols=272 Identities=21% Similarity=0.166 Sum_probs=206.2
Q ss_pred cccccccccccccceeeeEEEEEee---cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS---SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
...+|++.+.||.|+||.||++... .+..|++|.+... ....+|+++++.++||||+++++++......|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3557999999999999999999743 3678999988653 2345799999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
||++. ++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++.......
T Consensus 165 ~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99996 58998885443 7899999999999999999999 9999999999999999999999999999997665433
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh---hhhc------cCCccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT---LKHW------GNNWLPISTM 250 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~---~~~~------~~~~~~~~~~ 250 (313)
.........++..|+|||++.+..++.++|||||||++|+|++|..||.+....... .... ...+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 222233456899999999999999999999999999999999999999654321100 0000 0000000000
Q ss_pred cc---ccc---cccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 251 EV---VDA---NLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 251 ~~---~~~---~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.+ ... .... ............+.++.+++++||..||++|||+.+++.|+|-..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00 000 0000 000000011234677899999999999999999999999998754
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=319.58 Aligned_cols=255 Identities=21% Similarity=0.248 Sum_probs=205.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++..+ +++.||+|++... .......+..|+.++..++|++|+++++.+.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 5899999999753 2334567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.|++.||.||| +.|++||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999997655 6899999999999999999999 99999999999999999999999999999865422110
Q ss_pred c---------------------------------ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 181 S---------------------------------MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 181 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
. .......|+..|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011245889999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC---CHHHHHHHHH
Q 047140 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI---NAREIVAKLF 301 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~il~~l~ 301 (313)
................ ..........++.++.+|+.+|+. ||++|+ ++.++++|+|
T Consensus 237 ~~~~~~~~~~~i~~~~-----------------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 237 CSETPQETYRKVMNWK-----------------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCHHHHHHHHHcCC-----------------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 7665433322211100 000000011256778999999774 999998 4899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=289.63 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=214.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
..|...+.||+|..+.|-++.++ +|...|+|++.... ....+.-..|+++|+++ -||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46788999999999999999966 58899999986431 12344556799999998 7999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.+++|+|.++.|.|.|++.+.. .+++...+++++|+..++.||| .++|||||+||+|||++++.+++|.|||+++.
T Consensus 97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999999998876 6899999999999999999999 99999999999999999999999999999998
Q ss_pred cccccccccccccccccccCCCcccc------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRR------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
+.+.. .....+||++|+|||.+. ...|+...|+|++|+++|.++.|.+||-.....-+..-++.+.+
T Consensus 173 l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky---- 245 (411)
T KOG0599|consen 173 LEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY---- 245 (411)
T ss_pred cCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc----
Confidence 86443 456678999999999763 45789999999999999999999999965543333222222211
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+...+++..+++|+++||++||.+|.|+.++++|+|-+.
T Consensus 246 -------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 246 -------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 1122234567888999999999999999999999999999754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=297.31 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=208.5
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|++|.||++..+ +++.|++|.+... .......+.+|+++++.++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788999999999999999965 5899999998753 344567788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++... ...++...++.++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999764 457899999999999999999999 99999999999999999999999999999876543221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||+++++|++|..||.................
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 218 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF----------------- 218 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 12233577889999999998999999999999999999999999976543222211110000
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++..+.+++.+||+.+|++||++.++++++|
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 0012245677999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=298.81 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=207.2
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeeccc------chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC------GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
+|++++.||.|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+++..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588999999999999999987778999999986531 22345688899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++.+.. .+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 5789999999999999999999 9999999999999999999999999999987653211
Q ss_pred c----cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 180 Q----SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 180 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
. ........++..|+|||++.+..++.++|+||||+++|++++|..||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR------------ 224 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc------------
Confidence 0 111223457888999999998889999999999999999999999997543322211110000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
......+..++.++.+++++||..+|.+||++.+++.|+|
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 225 ------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0000112346778999999999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=303.50 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=213.1
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.....+|++.+.||+|++|.||++... +++.|++|.+..........+.+|+.+++.++|+|++++++.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 445679999999999999999999954 5889999999876545567788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999999998654 4788999999999999999999 9999999999999999999999999999887653221
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+............
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------- 233 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--------------- 233 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC---------------
Confidence 1 12234577889999999888899999999999999999999999966543222111110000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+..++..+.+++.+||..||++||++.+++.|+|-...
T Consensus 234 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 234 ---PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0000123456778999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.83 Aligned_cols=244 Identities=25% Similarity=0.217 Sum_probs=196.9
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHH-HHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++.+.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999965 58999999997541 222344455554 45778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.||+.||.||| ++|++||||||+|||+++++.++|+|||++...... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence 99999887654 6889999999999999999999 999999999999999999999999999998653221 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------------~ 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP---------------------L 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------------C
Confidence 4458899999999999999999999999999999999999997654333221111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH----HHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA----REIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~il~~l~ 301 (313)
..+...+..+.+++.+||+.||.+||++ .+++.|+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 0123457779999999999999999988 58888876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=303.42 Aligned_cols=270 Identities=19% Similarity=0.257 Sum_probs=209.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||++... ++..+++|.+... .......+.+|++++++++||||++++++|.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999965 5889999998754 233456688999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++.... .+++..+..++.|++.||.||| + .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999997664 6889999999999999999999 7 58999999999999999999999999988654321
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc-----------
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM----------- 250 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 250 (313)
......++..|+|||...+..++.++|+||||+++|+|++|..||........... ...........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM-FGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh-hcCccccccccCCcccccCCCC
Confidence 12234578899999998888899999999999999999999999865432221111 11000000000
Q ss_pred ---------ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 251 ---------EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 251 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...+... ...... .....++.++.+++.+||..||++|||+.++++|+|-...
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 232 DSPRPMAIFELLDYIV-NEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CccchhhHHHHHHHHh-cCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0000000 000000 0011256789999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=314.55 Aligned_cols=245 Identities=21% Similarity=0.227 Sum_probs=200.7
Q ss_pred cccccceeeeEEEEEee----cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 31 NFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+.||+|+||.||++... +++.||+|++.... ......+..|++++++++||||+++++++.+++..|+|+||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998742 47899999997642 2234556789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++.... .+++..++.++.||+.||.||| +.+++|+||||+||++++++.++|+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 999999987654 6899999999999999999999 9999999999999999999999999999987543221 122
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
....++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------------- 214 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------------- 214 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence 33468889999999998889999999999999999999999997654332222111100
Q ss_pred hhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 265 FVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..++..+.+++++||+.||++||+ +.+++.|+|-
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 0112346778999999999999999999 6778888653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=301.26 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=206.9
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
++|...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57888999999999999999632 356899999877666667789999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 99 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
++||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999997543 24788999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|+|||++................++..|+|||+..+..++.++|+|||||++|+|++ |..||................
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999875432221111222334678999999998999999999999999999998 899986654332221110000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||..||.+||++.++++.+.
T Consensus 242 --------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 --------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00112346777999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=296.66 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=211.0
Q ss_pred cccccccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
++|++.+.||.|++|.||++...+ ++.+++|.+.... ..+.+.+|+++++.++|+||+++++.+.++...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 689999999999999999999764 8899999987653 2678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999876667899999999999999999999 99999999999999999999999999999886543221 1
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
.....++..|+|||++.+..++.++||||||+++|+|++|..||............... ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~~ 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK------------------PPP 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC------------------CCC
Confidence 22344678899999998889999999999999999999999999765433222111000 000
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||+.||++|||+.+++.|+|
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 01112345678999999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=307.87 Aligned_cols=265 Identities=19% Similarity=0.232 Sum_probs=228.1
Q ss_pred hhcchhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeee
Q 047140 12 TILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVIS 88 (313)
Q Consensus 12 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (313)
.+..+-+.-..|..=|++.+.||+|.|..|-+|++- +|+.||||++.+. +......+..|++.++-++|||||++++
T Consensus 5 ~~~~g~i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYE 84 (864)
T KOG4717|consen 5 GFKRGHIYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYE 84 (864)
T ss_pred ccccccccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeee
Confidence 333444455678889999999999999999999965 6999999999876 3344567888999999999999999999
Q ss_pred eeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe-cCCCceeEc
Q 047140 89 TCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL-DDNMVAHLS 167 (313)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~-~~~~~~~l~ 167 (313)
+....-.+|+|+|+-++|+|.|+|.++...+++....++++||+.|+.|+| +.++|||||||+|+.+ .+.|.|||.
T Consensus 85 ViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 85 VIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred hhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence 999999999999999999999999999888999999999999999999999 9999999999999765 788999999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||++-.+.+.. .....+|+..|-|||++.+..| -++.||||||+++|.|.-|++||....+.+...-+....+
T Consensus 162 DFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-- 236 (864)
T KOG4717|consen 162 DFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-- 236 (864)
T ss_pred eccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--
Confidence 999998776433 4556789999999999999988 4688999999999999999999988766555443332222
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..|.-++.+..+||..||..||++|.+.++|..+.|-.
T Consensus 237 -------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 237 -------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred -------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 22556788999999999999999999999999998853
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.64 Aligned_cols=273 Identities=21% Similarity=0.171 Sum_probs=205.6
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----cce
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-----FKA 97 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 97 (313)
+|++++.||+|+||.||++... +++.||+|++... .......+.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5789999999999999999964 6899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+. ++|.+.+.... .++...+..++.||+.||.||| +.+++||||||+|||+++++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 58888886554 6899999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--ccc-----
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--IST----- 249 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~----- 249 (313)
.. ........++..|+|||++.+. .++.++|||||||++|+|++|..||..................+ ...
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 21 1112234567889999988764 47899999999999999999999997654332211111000000 000
Q ss_pred --cccccc-cccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 250 --MEVVDA-NLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 250 --~~~~~~-~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+.. .... ............++++.+|+.+||..||++|||+.++++|+|-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000000 0000 000000112345778999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.00 Aligned_cols=254 Identities=20% Similarity=0.193 Sum_probs=199.9
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||++..+ +++.||+|++... .......+..|..++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999965 5889999999754 233456678899988877 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|...+.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence 99998886654 6899999999999999999999 9999999999999999999999999999987532111 1123
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|+|||||++|+|++|..||........... .....+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---------~~~~~~~~~i~---~~~~ 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVIL---EKQI 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc---------ccHHHHHHHHh---cCCC
Confidence 35688999999999999999999999999999999999999953221110000 00000000000 0001
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCC------HHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRIN------AREIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~il~~l~~ 302 (313)
..+..++..+.+++.+||+.||++||+ +.++++|+|-
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 123456778999999999999999998 5799999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=305.45 Aligned_cols=273 Identities=19% Similarity=0.172 Sum_probs=207.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 68999999999999999999965 58899999987542 23345677899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++ ++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence 97 4999988776657899999999999999999999 9999999999999999999999999999987543211 1
Q ss_pred cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC--cccccccccccccc--
Q 047140 183 TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN--WLPISTMEVVDANL-- 257 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-- 257 (313)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+......... ..........+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1223356788999998765 457889999999999999999999997654332211110000 00000000000000
Q ss_pred ---cCh--hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 ---LSQ--EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ---~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
... ..........++..+.+|+.+||+.||.+|||++++++|+|-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000 0000011234677899999999999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=298.21 Aligned_cols=258 Identities=20% Similarity=0.319 Sum_probs=205.6
Q ss_pred cccccccccccceeeeEEEEEee-cce----EEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
++|++.+.||.|+||.||+|... +++ ++++|.+.... ......+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 58899999999999999999964 344 57888875432 2344677788889999999999999998864 45789
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
++||+++++|.+++......+++..+..++.|++.||.||| .++++|+||||+||+++.++.++|+|||++......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999999765433
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
..........++..|+|||...+..++.++||||||+++||+++ |..||.+..............
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------- 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-------------- 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------
Confidence 22222233446678999999988899999999999999999998 999997654332211110000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++.++.+++.+||..||++|||+.++++.+..+...
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0001223566789999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=310.51 Aligned_cols=258 Identities=21% Similarity=0.187 Sum_probs=204.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|..++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999965 5899999999753 2234456888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++......+++..+..++.||+.||.||| +++++||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999875557899999999999999999999 99999999999999999999999999999876532221
Q ss_pred cccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.......++..|+|||++.. ..++.++|||||||++|+|++|..||......+..........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~----------- 225 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----------- 225 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 11222458899999998863 4578899999999999999999999976543332222111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCC--CCCCHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE--QRINAREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~--~Rps~~~il~~l~~ 302 (313)
... .......+++.+.+++++||..+++ .|+++.+++.|+|-
T Consensus 226 -~~~----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 226 -HFQ----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred -ccc----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 000 0000123677899999998865444 38899999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=301.67 Aligned_cols=258 Identities=26% Similarity=0.361 Sum_probs=207.9
Q ss_pred ccccccccccccceeeeEEEEEeec------ceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
.++|++.+.||+|+||.||++.... ...+++|.+... .......+.+|+++++.+ +|+||+++++++.+++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4689999999999999999998542 368999998754 234456788999999999 89999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 96 KALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
.+++|||+++++|.+++... ...+++..++.++.|++.||.||| ..+++|+||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 99999999999999998642 235788999999999999999999 999999999999999999
Q ss_pred CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhh
Q 047140 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKH 239 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~ 239 (313)
++.++|+|||++..+.............++..|+|||++.+..++.++|||||||++|++++ |..||......+.....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999999886543221111222234567999999988899999999999999999998 99998665432222111
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.... ....+..++..+.+|+.+||..||++|||+.++++++.++.
T Consensus 248 ~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 KEGY--------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HcCC--------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1000 00112345677999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.61 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=204.9
Q ss_pred cccccccccccceeeeEEEEEeec------ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.+|++.+.||.|+||.||+|.... +..||+|++.... ....+.+..|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 468899999999999999998532 4789999997653 234567889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 98 LVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
+++||+.+++|.+++... ...++...+..++.|++.||.||| +.+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998532 124778889999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhcc
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~ 241 (313)
.++|+|||++................++..|+|||...+..++.++|||||||++|||++ |..||......+.......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876543222112223345678999999988889999999999999999998 8888866543322111111
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. ....+..++..+.+++..||+.||.+||++++|++.+.
T Consensus 242 ~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 242 RQ--------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CC--------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 00 00113457888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=302.43 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=209.0
Q ss_pred ccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
.++|.+++.||+|+||.||++... +...+|+|.+... .......+..|+++++.+ +|+||+++++++..+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 468999999999999999999853 1346999999754 234456788899999999 899999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
+..++|+||+++++|.+++.... ..++...++.++.|++.||.||| +.|++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 99999999999999999997542 24788899999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
++++.++|+|||.+................++..|+|||...+..++.++|+|||||++|+|++ |..||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999875532111111112234467999999988889999999999999999998 888886543222111
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
... ... ....+..++.++.+++.+||..+|.+|||+.++++++.++.+...
T Consensus 254 ~~~-~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 254 LLK-EGH-------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHH-cCC-------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 110 000 001123467789999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.59 Aligned_cols=256 Identities=23% Similarity=0.255 Sum_probs=212.2
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+|++.+.||.|++|.||++... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 457999999999999999999854 6899999999766445567788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++... .+++..+..++.+++.+|.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 9999999988654 4889999999999999999999 99999999999999999999999999999876543221
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||.+.+..++.++|+|||||++|++++|..||................ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~------------------~ 232 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG------------------T 232 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC------------------C
Confidence 1223457788999999988889999999999999999999999997654322221111000 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+..++..+.+++++||..||++||++.+++.|+|-..
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 001112346677999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.99 Aligned_cols=258 Identities=20% Similarity=0.215 Sum_probs=205.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|++.+.||+|+||.||++..+ +++.||+|++... .......+.+|..+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34579999999999999999999966 5889999998653 1233456778999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++++|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||+++++.++|+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999998764 4788899999999999999999 99999999999999999999999999999876543
Q ss_pred ccccccccccccccccCCCcccccCC----CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGR----ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
... .......|+..|+|||++.+.. ++.++|||||||++|+|++|..||................
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------- 263 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---------- 263 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 211 1123456899999999886543 7899999999999999999999997654322221111100
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~ 302 (313)
..........++..+.+++..||..+|.+ |+++.++++|+|-
T Consensus 264 -------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 264 -------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred -------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 00011112346788999999999844433 7899999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=298.06 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=210.8
Q ss_pred ccccccccccccceeeeEEEEEeec-----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeee-Cccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-EEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 96 (313)
.++|++.+.||+|+||.||+|.... +..|++|++... .......+.+|+.+++.++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4789999999999999999999765 689999998754 34456778899999999999999999998766 5678
Q ss_pred eEEEEeecCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 97 ALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
+++++|+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 35889999999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
|+++.+.............++..|+|||++.+..++.++||||||+++|++++ |..||......+....... ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~---- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GY---- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CC----
Confidence 99976543221111222345677999999988889999999999999999999 9999976543322111100 00
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++++.+++.+||..||++|||+.++++.|.++..+
T Consensus 237 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ---------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0001233567899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=311.79 Aligned_cols=276 Identities=20% Similarity=0.162 Sum_probs=206.1
Q ss_pred hhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE- 93 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (313)
...-.+.++|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++...
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 334466789999999999999999999954 68899999987542 22345677899999999999999999988543
Q ss_pred -----ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 94 -----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
...+++++++ +++|.+++... .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 67999887644 5899999999999999999999 99999999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC--cc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN--WL 245 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~--~~ 245 (313)
||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... ..
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998765321 233467889999998876 568999999999999999999999997643322211111000 00
Q ss_pred cccccccccc-------cccChhh-hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 246 PISTMEVVDA-------NLLSQED-IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 246 ~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+.....+... ....... .........++.+.+|+.+||..||++|||+.+++.|+|-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000000000 0000000 000011234566899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=296.11 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=203.2
Q ss_pred cccccccccceeeeEEEEEeec----ceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc-----
Q 047140 27 FQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF----- 95 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 95 (313)
|++++.||+|+||.||.|.... +..||+|.++.. .......+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998642 368999998754 23345678899999999999999999998866543
Q ss_pred -ceEEEEeecCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 96 -KALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 96 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
.++++||+++++|..++... ...+++..+..++.|++.||.||| ..+++|+||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988542 235789999999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
|+++................+..|+|||+..+..++.++|||||||++|||++ |..||......+.........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 99876543221111222234567999999988889999999999999999999 889987654433222111110
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||+.||++|||+.++++++.++
T Consensus 233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011334677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=298.03 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=203.9
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|.+.+.||+|++|.||+|... .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 468999999999999999999965 35689999886542 33445688899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeEc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHLS 167 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l~ 167 (313)
++|+||+++++|.+++.... ..+++..+..++.||+.+|.||| +++++|+||+|+||++++++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997543 25788999999999999999999 99999999999999998765 58999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--- 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG--- 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9999876532211111112223467999999988899999999999999999997 999997654332221111000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||+.||++|||+.++++++.
T Consensus 239 -----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 -----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00112345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.19 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=205.7
Q ss_pred ccccccccccccceeeeEEEEEee-cce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|++.+.||.|+||.||+|.+. +++ +||+|++... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 468999999999999999999854 444 5899998754 334566788999999999999999999999764 478
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+++|++++|+|.+++......+++..+..++.|++.||.||| +++++|+||||+||++++++.++|+|||++.....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876557899999999999999999999 99999999999999999999999999999886643
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
...........++..|+|||...+..++.++|||||||++||+++ |..||.................
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------ 229 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER------------ 229 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc------------
Confidence 222111222334567999999988899999999999999999998 8999865433221111100000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+..++..+.+++.+||..||++||++.+++..+..+.
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0012345677999999999999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=308.31 Aligned_cols=249 Identities=20% Similarity=0.201 Sum_probs=202.3
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+|+..+.||+|+||.||+|... +++.||+|++... .....+.+..|..++..+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999955 5899999999754 1233456778889998885 577888999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..+..++.|++.||.||| ++|++||||||+|||+++++.++|+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999987655 6899999999999999999999 9999999999999999999999999999987532211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------------- 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------------- 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence 11233458899999999998899999999999999999999999997654332222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~ 301 (313)
...+..++.++.+++.+||..||.+|++ ..++++|+|
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence 0112345677899999999999999997 467888865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=294.56 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=205.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.++||.|+||.||+|...+...|++|.+.... .....+.+|+++++.++|+||+++++.+.. ...++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 36799999999999999999987666679999997542 234578889999999999999999998754 5679999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence 999999999754 335788999999999999999999 99999999999999999999999999999876543221 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||+++|++++ |..||................
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------------ 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------ 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC------------------
Confidence 1223345667999999988889999999999999999999 888987654332221111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||+.||++||+++++++.++..
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0001234677799999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.80 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=195.7
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||+|+||.||++..+ +++.||+|.+.... ......+..|++++++++||||+++.+++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 59999999986431 12234556699999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccccc
Q 047140 109 EKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187 (313)
Q Consensus 109 ~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 187 (313)
.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9888654 335888999999999999999999 9999999999999999999999999999987654321 12234
Q ss_pred ccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhh
Q 047140 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267 (313)
Q Consensus 188 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
.++..|+|||++.+..++.++|+|||||++|+|++|..||............... ...... . ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~----~---~~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR---------TLEDEV----K---FE 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH---------hhcccc----c---cc
Confidence 5788999999998888999999999999999999999998653221110000000 000000 0 00
Q ss_pred hhhhHHHHHHHHhHhhccCCCCCCCH----HHHHHHHHH
Q 047140 268 KEQCVSFVFNLAIECTVESPEQRINA----REIVAKLFK 302 (313)
Q Consensus 268 ~~~~~~~l~~li~~~l~~dP~~Rps~----~~il~~l~~ 302 (313)
...++.++.+|+.+||+.||++||++ .+++.|+|-
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 12467789999999999999999999 566677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=298.67 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=206.1
Q ss_pred ccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788999999999999999853 13578999886543 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 047140 99 VLEYMPHGSLEKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~n 155 (313)
++||+.+++|.+++... ...++...++.++.|++.||.||| +.+++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999998642 124778899999999999999999 9999999999999
Q ss_pred eEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhh
Q 047140 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNRE 234 (313)
Q Consensus 156 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~ 234 (313)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876532221111222345667999999888889999999999999999998 999987654332
Q ss_pred hhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 235 MTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
..... .... ....+..++.++.+++..||+.||++||+++++++.+.++..
T Consensus 238 ~~~~~--------------~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLL--------------KTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH--------------hCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 21111 0000 001123466789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=304.84 Aligned_cols=272 Identities=17% Similarity=0.201 Sum_probs=202.7
Q ss_pred cccccccc--eeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 29 ILNFFICG--VIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 29 ~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+++.||+| +|++||++..+ +|+.||+|++... .......+.+|+++++.++||||++++++|.+++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999954 6999999999764 2334567888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+++.||+............
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 335889999999999999999999 9999999999999999999999999998755432111100
Q ss_pred -----cccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc---------c
Q 047140 183 -----TQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL---------P 246 (313)
Q Consensus 183 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~---------~ 246 (313)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122345677999999875 46899999999999999999999999765433222111111000 0
Q ss_pred ccc---------cc-cccccc----cC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 IST---------ME-VVDANL----LS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ~~~---------~~-~~~~~~----~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
... .. ..+... .. ...........+++.+.+|+.+||+.||++|||++++++|+|-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 000 00 000000 00 00000111234577899999999999999999999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=302.31 Aligned_cols=259 Identities=22% Similarity=0.238 Sum_probs=212.4
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
....++|++.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 344589999999999999999999954 6899999999776545567788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++... .+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred ecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999998654 4788899999999999999999 9999999999999999999999999999987553322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
. ......++..|+|||...+..++.++|+||||+++|++++|..||................
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~---------------- 231 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---------------- 231 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC----------------
Confidence 1 1223457788999999998889999999999999999999999996543222111110000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......+...+..+.+++.+||..||++||++.+++.|+|-..
T Consensus 232 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 232 --TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 0001112345677899999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=294.81 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=208.7
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..++|++.+.||.|+||.||+|..+++..|++|.+.... ...+.+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999997777889999987542 3456788999999999999999999999998999999999
Q ss_pred ecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++.... ..++...+..++.+++.||.||| .++++|+||+|+||++++++.++++|||.+........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999997643 46899999999999999999999 99999999999999999999999999999876542111
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
........+..|+|||.+.+..++.++|+||||++++++++ |..||................
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------------- 221 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----------------- 221 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 11112234567999999998899999999999999999998 999997654332222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...+.++.+++.+||..+|++||+++++.+.++.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001122346779999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=300.90 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=206.4
Q ss_pred ccccccccccccceeeeEEEEEeec-----------------ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCccee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-----------------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
.++|++.+.||+|+||.||++.... +..||+|.+... .....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3689999999999999999988542 246899998765 2345678889999999999999999
Q ss_pred eeeeeeeCccceEEEEeecCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 047140 86 VISTCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155 (313)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~n 155 (313)
+++++..++..++++|++++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 25889999999999999999999 9999999999999
Q ss_pred eEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh--CCCCChhhhhh
Q 047140 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT--RKKPTDEIFNR 233 (313)
Q Consensus 156 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~p~~~~~~~ 233 (313)
|++++++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533222222233445678999999988889999999999999999998 67787654433
Q ss_pred hhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 234 EMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+........ +... ........+..++.++.+++.+||+.||++|||+.++++.|.
T Consensus 241 ~~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHF-FRDD------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhc-cccc------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 221111100 0000 000001112345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=311.44 Aligned_cols=272 Identities=21% Similarity=0.180 Sum_probs=204.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----- 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (313)
...++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999954 5899999999753 234456778899999999999999999998643
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
...++||||+++ +|.+.+.. .++...+..++.|++.||.||| ++|++||||||+||++++++.++|+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 347999999975 77777653 4788899999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc--cc----
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW--LP---- 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~--~~---- 246 (313)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+............... .+
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7653221 22335678899999999998999999999999999999999999976543222111100000 00
Q ss_pred ---ccccccccc----------cccCh--hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ---ISTMEVVDA----------NLLSQ--EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ---~~~~~~~~~----------~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......++. ..... .+.........+..+.+|+.+||+.||++|||+.|+++|+|-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 000000000 00000 0000011223456789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=294.73 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=206.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46899999999999999999998788999999987653 33467889999999999999999999875 45689999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
.+++|.+++... +..++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 999999998653 346889999999999999999999 99999999999999999999999999999876542111 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+.....++.++|+||||+++|++++ |..||......+.........
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------ 220 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY------------------ 220 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC------------------
Confidence 1122335678999999988889999999999999999999 999997654433222110000
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...+.++.+++.+||..||++||++++++..|..
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001123456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=294.07 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=205.1
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|++|.||+|..+++..+++|.+.... ...+.+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 46899999999999999999997777889999987642 234678899999999999999999998854 5689999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+..+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999998754 335889999999999999999999 999999999999999999999999999998765432211
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||+++|++++ |..||......+.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------ 220 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------------ 220 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 1122334567999999988889999999999999999999 899997654332222111000
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...+..+.+++.+||..||.+|||++++.+.|.+
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001123456789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=321.03 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=208.7
Q ss_pred ccccccccccccceeeeEEEEEeecc-eEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeee----eC---c
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSA-MEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCS----NE---E 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~---~ 94 (313)
.-+++|.+.|.+|||+.||+|....+ ..+|+|++-..++.....+.+|+++|+.|. |+|||.+++... .+ -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45889999999999999999997654 999999998777888999999999999995 999999999431 11 2
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.+.|.||||+||+|-|+++.. ...+++.++++|+.++++|+.+||.. +..|+|||||-+|||++.+|..||||||.++
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 467899999999999999854 33599999999999999999999932 3459999999999999999999999999987
Q ss_pred hccccc-cccc------ccccccccccCCCccc---ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 174 LLTGEY-QSMT------QTQTLATIGCIAPEYR---RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 174 ~~~~~~-~~~~------~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
...... .... .-....|+.|+|||++ .+.+.++++|||+|||+||.||....||+....... ....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----lng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LNGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Eecc
Confidence 432211 0000 0123367889999965 577899999999999999999999999976522111 1111
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
..++...+++..+.+||+.||+.||.+||++.+++.++.++...
T Consensus 271 -------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 271 -------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11112356899999999999999999999999999999888643
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=295.33 Aligned_cols=257 Identities=20% Similarity=0.260 Sum_probs=207.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999965 6899999988642 2344567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++.. ....+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 2345789999999999999999999 99999999999999999999999999999876543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............. +....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------------~~~~~ 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK------------IEQCD 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH------------HhcCC
Confidence 211 1123457778999999988889999999999999999999999985432211111000 00000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. ......++..+.+++.+||..+|++||++.++++.+..+
T Consensus 225 ~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YP-----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC-----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00 001224567799999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=296.77 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=210.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||.|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999965 58999999997652 34456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++... .+++..++.++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999999765 6899999999999999999999 9999999999999999999999999999987764321 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||+..+..++.++|+||||+++|+|++|..||............... . .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~-----------------~ 215 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-N-----------------P 215 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-C-----------------C
Confidence 223345777899999999888999999999999999999999999654432221111100 0 0
Q ss_pred hhhhhhh-hhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKE-QCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..... .++.++.+++.+||..||++|||++++++|+|-..
T Consensus 216 --~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 216 --PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred --CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 00011 15677999999999999999999999999988654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=293.61 Aligned_cols=249 Identities=20% Similarity=0.253 Sum_probs=205.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+|++.+.||.|+||.||++... +++.+++|.+... .....+.+.+|+.+++.++|+||+++++.+.+++..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999965 5889999998653 3345677888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988653 346789999999999999999999 99999999999999999999999999999876542211
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||..................
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 122345778899999999888999999999999999999999999765433332222111100
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAK 299 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~ 299 (313)
..+..++..+.+++.+||+.||++|||+.++++.
T Consensus 219 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 ---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0123356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.94 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=208.0
Q ss_pred hcccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
...++|.+.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|+++++++ +|+||+++++++..+
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34568999999999999999999731 2558999998754 234456789999999999 899999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
+..++|+||+++++|.+++.... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.++++|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999997543 34899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
................++..|+|||.+.+..++.++||||||+++|++++ |..||................+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY------- 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC-------
Confidence 76543221111222345677999999998899999999999999999998 9999876543222111111000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+...++.+.+++.+||..+|++|||+.++++.+.++
T Consensus 262 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001223466799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=292.59 Aligned_cols=247 Identities=30% Similarity=0.440 Sum_probs=205.9
Q ss_pred cccccceeeeEEEEEeec----ceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLISS----AMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|.... +..|++|.+...... ....+.+|+++++.++|+||+++++++.++...++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 789999999876333 367889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 106 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 106 ~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
++|.+++... ...+++..++.++.|++.||.||| +++++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 357899999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 322222334556788999999988889999999999999999999 6999977643322211110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
......+..++.++.+++.+||..||++|||+.++++++
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 001111344578899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=294.39 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=209.6
Q ss_pred ccccccccccccceeeeEEEEEeec----ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||.|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3578999999999999999998543 2478999887653 4456788999999999999999999999876 45789
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+++......++...++.++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999876556899999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......++..|+|||.+....++.++|+||||++++++++ |..||......+.........
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------------- 225 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------------- 225 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 11 11112234567999999988889999999999999999996 999997665433222111100
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..+|.+|||+.+++..+.++..+
T Consensus 226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011345677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.24 Aligned_cols=271 Identities=20% Similarity=0.155 Sum_probs=204.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----- 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (313)
.+.++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35689999999999999999999955 5889999999753 234456778899999999999999999987543
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
...|+||||+++ +|.+.+.. .++...+..++.|++.||.||| +++++||||||+||++++++.++|+|||++
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 88877753 4788899999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-ccc--
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-IST-- 249 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~-- 249 (313)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||......+...........+ ...
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7653221 1233467889999999999999999999999999999999999997654332211111100000 000
Q ss_pred ------ccccccc-ccCh-----------hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 ------MEVVDAN-LLSQ-----------EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ------~~~~~~~-~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....... .... .+.........+..+.+|+.+||+.||++|||+.++++|+|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0000000 0000 000000111235678999999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=294.18 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=200.3
Q ss_pred cccccccccceeeeEEEEEeec-ce--EEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC------cc
Q 047140 27 FQILNFFICGVIIPVAQFLISS-AM--EVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE------EF 95 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 95 (313)
|.+++.||+|+||.||+|.... +. .||+|.++.. .....+.+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999654 33 6999988754 234567788999999999999999999987432 24
Q ss_pred ceEEEEeecCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 96 KALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
.++++||+++++|.+++.. ....+++..+..++.|++.||.||| .++++|+||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 2235789999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
++.................+..|++||...+..++.++|+||||+++|+|++ |..||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 9886543221111222345667999999998999999999999999999999 8899876543322211111000
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+++.+||..||++|||+.++++++..+
T Consensus 233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 ---------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001234567799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=299.69 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=209.2
Q ss_pred hcccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeee
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCS 91 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 91 (313)
...++|++++.||+|+||.||++... ++..|++|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33578999999999999999999731 2457999998654 234457788999999999 8999999999999
Q ss_pred eCccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCce
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 156 (313)
..+..++|+||+++++|.+++.... ..++...+..++.|++.||.||| ++|++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 9999999999999999999997532 24677889999999999999999 99999999999999
Q ss_pred EecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhh
Q 047140 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREM 235 (313)
Q Consensus 157 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~ 235 (313)
++++++.++|+|||.+................++..|+|||++.+..++.++||||||+++|++++ |..||......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999886643222222222335567999999988889999999999999999998 7888865433222
Q ss_pred hhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 236 TLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
........ ....+..++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus 249 ~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKLLKEGH--------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHcCC--------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 21111000 001123567889999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.89 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=205.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccc---------hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG---------RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
+|.++..||.|++|.||+|... +++.+++|.+..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999964 588999998865421 123568889999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+++++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997764 6788999999999999999999 999999999999999999999999999998766
Q ss_pred ccccccc----cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 176 TGEYQSM----TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 176 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN--------- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---------
Confidence 4221111 112234678899999998888999999999999999999999999765432222111000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..++..+.+++++||+.||.+||++.++++|+|
T Consensus 228 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 228 -----------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred -----------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 000112346778999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.34 Aligned_cols=256 Identities=20% Similarity=0.248 Sum_probs=205.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+..|+.+++.++|++|+++++.+.+++..++|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778889999999999999965 58999999986531 2223456789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 99999999988643 235889999999999999999999 9999999999999999999999999999986543211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||............ .....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~----------~~~~~------ 218 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----------ERLVK------ 218 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----------Hhhhh------
Confidence 122346888999999999889999999999999999999999999754221100000 00000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~~~ 304 (313)
......+..++.++.+|+.+||+.||++||| +.++++|+|-..
T Consensus 219 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 219 -EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred -hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 0000113346778999999999999999999 999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=293.84 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=207.9
Q ss_pred ccccccccccccceeeeEEEEEee-c---ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-S---AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..+|++.+.||+|+||.||+|... + +..+++|.++... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 368999999999999999999854 2 3479999986542 3445688999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++......++...+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999876657899999999999999999999 999999999999999999999999999998765432
Q ss_pred cccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 YQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... ......++..|+|||++.+..++.++|+||||+++|++++ |..||......+........ +
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~------------ 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-Y------------ 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-C------------
Confidence 2111 1111223457999999998899999999999999999887 99998765443222111110 0
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..+++.+.+++.+||+.+|.+||++.++++.+.++
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=298.04 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred cccccccccccceeeeEEEEEeec-c--eEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-A--MEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++.+.||.|+||.||+|..+. + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 589999999999999999998653 3 35788888743 234456788999999999 799999999999999999999
Q ss_pred EEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 100 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
+||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999996532 24788899999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|+|||++....... .......+..|+|||+..+..++.++|||||||++|+|++ |..||...............
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~- 234 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 234 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-
Confidence 999999886322110 1111223456999999988889999999999999999997 99999665433221111000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.....+..++..+.+|+.+||..||.+|||++++++.+..+....
T Consensus 235 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 -------------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000112346778999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=295.88 Aligned_cols=255 Identities=23% Similarity=0.329 Sum_probs=205.7
Q ss_pred ccccccccccccceeeeEEEEEeec------ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++.+.||.|+||.||++.... +..|++|.+... .......+.+|+++++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4689999999999999999998542 368999998654 234456788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
++|+||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999996432 13677889999999999999999 9999999999999999999999999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||.++...............++..|+|||.+.+..++.++|||||||++|++++ |..||................
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG--- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC---
Confidence 9999876543221112223345678999999988889999999999999999998 999987654333221111000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||+.+|++|||+.++++.+.
T Consensus 239 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 -----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00112345778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.92 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=203.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999954 6889999998754 334456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|..+. .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999986542 4678889999999999999999 999999999999999999999999999998765322
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||............ ........+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~~~~~~------ 216 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------LQLLQCIVDED------ 216 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch------HHHHHHHhccC------
Confidence 223346788999999999889999999999999999999999999653321110000 00000000000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.........+.++.+++.+||..||++||++.+++.|+|-.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 00001123566789999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=294.51 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=207.1
Q ss_pred cccccccccccceeeeEEEEEeec-c---eEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-A---MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+|++.+.||+|+||.||+|..+. + ..|++|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 578999999999999999999653 3 36999998764 344567899999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++......++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876557899999999999999999999 9999999999999999999999999999987554322
Q ss_pred ccccccc---cccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 180 QSMTQTQ---TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 180 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
....... ...+..|+|||.+.+..++.++|||||||++||+++ |..||............... +
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~----------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-Y----------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-C-----------
Confidence 1111111 112346999999998999999999999999999886 99998665433222111100 0
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||..+|.+||++.++++.+..+
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011234677799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=298.18 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=204.8
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++.+.||+|+||.||+|..+ ++..|++|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 468999999999999999999853 36789999987653 33456788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~n 155 (313)
++|+||+++++|.+++.... ..+++..++.++.|++.||.||| .++++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999996421 24678889999999999999999 9999999999999
Q ss_pred eEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhh
Q 047140 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNRE 234 (313)
Q Consensus 156 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~ 234 (313)
|++++++.++|+|||.+.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432221111222334567999999988899999999999999999998 888886544332
Q ss_pred hhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 235 MTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......... ...+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 241 ~~~~~~~~~~--------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 VIYYVRDGNV--------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHhcCCC--------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 2111110000 0012345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=307.91 Aligned_cols=244 Identities=23% Similarity=0.211 Sum_probs=194.8
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHH-HHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIEC-EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999965 57899999997531 12223344444 356788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.||+.||.||| +.|++||||||+|||+++++.++|+|||++...... .....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence 99999997654 5788889999999999999999 999999999999999999999999999998753221 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------------------~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------------------L 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------------------c
Confidence 4568899999999999999999999999999999999999997654433221111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHH----HHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAR----EIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~----~il~~l~ 301 (313)
..+..++..+.+++.+||+.||.+||++. ++++|+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 11234677899999999999999999876 6777664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=299.84 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=208.9
Q ss_pred ccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
.++|.+++.||+|+||.||++... ....+|+|.+... .......+..|+++++.+ +||||+++++++.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 368999999999999999999742 2457999998754 234456788999999999 699999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
+..++++||+++++|.+++.... ..++...+..++.|++.||.||| ++|++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 99999999999999999996532 24788889999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
++++.++|+|||.++...............++..|+|||++.+..++.++|+||||+++|++++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999976542211111112223457999999988889999999999999999999 889986554322221
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
...... ....+..++.++.+++.+||+.||++|||+.++++.++.+.....
T Consensus 248 ~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 248 LLREGH--------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHcCC--------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 111000 001123467789999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=296.66 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=203.9
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999998743 24589999886542 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 96 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
.++||||+++++|.+++.... ...+...+..++.|++.||.||| +++++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996431 23466788999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
+|||+++...............++..|+|||...+..++.++|+|||||++|+|++ |..||......+..........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999875432211111122234567999999988889999999999999999998 7888865443322211110000
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+++.+||+.||++|||+.++++.+...
T Consensus 240 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 -------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 001223567899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=317.38 Aligned_cols=269 Identities=18% Similarity=0.140 Sum_probs=201.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|+|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999966 488999996432 3356799999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+. ++|.+++......+++..++.++.|++.||.||| ++||+||||||+|||++.++.++|+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 5999988766557999999999999999999999 9999999999999999999999999999987654332222
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh--------hhhhhhccC-----Ccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR--------EMTLKHWGN-----NWLPIST 249 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~--------~~~~~~~~~-----~~~~~~~ 249 (313)
......|+..|+|||++.+..++.++|||||||++|||++|..|+...... ......... .+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223356899999999999999999999999999999999987654221100 000000000 0000000
Q ss_pred cccccc---c----ccCh-hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 MEVVDA---N----LLSQ-EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ~~~~~~---~----~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...... . .... ...........+..+.+|+.+||+.||++|||+.|+++|+|-
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 000000 0 0000 000000011345678999999999999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.10 Aligned_cols=270 Identities=20% Similarity=0.206 Sum_probs=197.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCC------CcceeeeeeeeeC-cc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH------RNLIKVISTCSNE-EF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~ 95 (313)
.++|++.+.||+|+||.||+|... .++.||||+++... ........|+++++.++| .++++++++|..+ .+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 578999999999999999999954 58899999996532 233455667777777654 4588899988765 57
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCC------------
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNM------------ 162 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~------------ 162 (313)
.|+|+|++ +++|.+++...+ .+++..+..++.||+.||.||| . .||+||||||+|||++.++
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 89999998 669999887664 6899999999999999999999 8 5999999999999998765
Q ss_pred ----ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh
Q 047140 163 ----VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK 238 (313)
Q Consensus 163 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~ 238 (313)
.+||+|||.+.... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 122345688999999999999999999999999999999999999976543222111
Q ss_pred hccC-Cccc---------ccccccccccc--cCh-hhh--------hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHH
Q 047140 239 HWGN-NWLP---------ISTMEVVDANL--LSQ-EDI--------HFVAKEQCVSFVFNLAIECTVESPEQRINAREIV 297 (313)
Q Consensus 239 ~~~~-~~~~---------~~~~~~~~~~~--~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il 297 (313)
.... ...+ .....+..... ... .+. ...........+.+|+.+||+.||++|||+.|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 1000 0000 00000000000 000 000 0000011245688999999999999999999999
Q ss_pred HHHHHHH
Q 047140 298 AKLFKIR 304 (313)
Q Consensus 298 ~~l~~~~ 304 (313)
+|+|-..
T Consensus 437 ~Hp~~~~ 443 (467)
T PTZ00284 437 THPYVLK 443 (467)
T ss_pred cCccccc
Confidence 9999654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=308.84 Aligned_cols=251 Identities=20% Similarity=0.192 Sum_probs=199.5
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||++... +++.||+|++... .....+.+..|..++.++ +|++|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 5889999999764 233456688899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++...+ .+++..+..++.||+.||.||| +++++||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence 99999887654 6899999999999999999999 9999999999999999999999999999987432111 1223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|+|||||++|+|++|..||.......... ..+.+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-----------~~~~~~~~~~---~~~~ 220 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-----------TEDYLFQVIL---EKPI 220 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-----------cHHHHHHHHH---hCCC
Confidence 3568899999999999999999999999999999999999996432111000 0000000000 0001
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCC------HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRIN------AREIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps------~~~il~~l~ 301 (313)
..+...+..+.+++.+||..||++|++ +.+++.|+|
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 123446777899999999999999998 569999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.16 Aligned_cols=258 Identities=19% Similarity=0.173 Sum_probs=204.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++..+ +++.+|+|++... .......+..|..++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999965 4789999998642 1223455788999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999875557899999999999999999999 9999999999999999999999999999987543221
Q ss_pred cccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
........|+..|+|||++. ...++.++|||||||++|+|++|..||......+............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------- 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---------
Confidence 11122346889999999876 3467899999999999999999999997665433332221110000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~ 302 (313)
........++.++.+|+++||..+|.. |+++.++++|+|-
T Consensus 228 -------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 228 -------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred -------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 000012346778999999998665444 7899999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=291.35 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=198.6
Q ss_pred ccccceeeeEEEEEee---cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 32 FFICGVIIPVAQFLIS---SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
.||+|+||.||+|.++ ++..+|+|+++... ....+.+.+|+.+++.++|+||+++++++.. ...++|+||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999743 47899999987542 3456778899999999999999999998864 4678999999999
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc-ccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM-TQT 185 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~ 185 (313)
+|.+++.... .+++..+..++.|++.||.||| .++++|+||||+||++++++.++|+|||.+.......... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997654 6899999999999999999999 9999999999999999999999999999987654322111 111
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
...++..|+|||.+....++.++|+|||||++|||++ |..||................ .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--------------------~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--------------------R 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------------------C
Confidence 2233568999999888889999999999999999998 999997654332211111100 0
Q ss_pred hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 265 FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++.++.+++++||+.||++||++++|...|...
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011334678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.05 Aligned_cols=266 Identities=19% Similarity=0.189 Sum_probs=198.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++.++...++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999965 4789999975433 224589999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+. ++|.+++......+++..+..++.||+.||.||| ..+|+||||||+|||++.++.++|+|||++...... .
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 96 5999988776667899999999999999999999 999999999999999999999999999998743211 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCC-hhhhhh-hh--------hhhhccC-Ccccccc--
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT-DEIFNR-EM--------TLKHWGN-NWLPIST-- 249 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~-~~~~~~-~~--------~~~~~~~-~~~~~~~-- 249 (313)
......++..|+|||++.+..++.++|||||||++|+|+++..++ ...... .. ....... ...+...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 123345888999999999999999999999999999999865544 321110 00 0000000 0000000
Q ss_pred -------ccccccccc---ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 -------MEVVDANLL---SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 -------~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...++.... ...........+++.++.+||.+||+.||++|||+.|+++|+|-
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 000000000 00000001122456778899999999999999999999999984
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.11 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=200.8
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHH
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (313)
+.||+|+||.||++...+++.+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..++|+||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999997778899999987653 333457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccccccc
Q 047140 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189 (313)
Q Consensus 110 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 189 (313)
+++......+++..+..++.+++.+|.|+| ..+++|+||+|+||++++++.++|+|||++........ ........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 999766556889999999999999999999 99999999999999999999999999999865432211 11112234
Q ss_pred ccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 190 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
+..|+|||+..+..++.++|+||||+++|++++ |..||................ ....+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------------~~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------------------RMSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------------------CCCCC
Confidence 567999999988889999999999999999998 999997654332221111100 00112
Q ss_pred hhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..++..+.+++.+||..+|++||++.++++.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=299.07 Aligned_cols=270 Identities=21% Similarity=0.247 Sum_probs=203.4
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999965 58999999986542 22346778899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 103 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 103 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
++ ++|.+++... +..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 5898888643 246899999999999999999999 9999999999999999999999999999987543221
Q ss_pred cccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-------Cccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-------NWLPISTMEV 252 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 252 (313)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||............... .|........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112233467889999987654 5789999999999999999999999765432221111000 0000000000
Q ss_pred ccccccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 253 VDANLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 253 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....... ...........+++++.+++++||..||.+|||+.+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 0000000 000001112346788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=291.40 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=208.6
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|+..+.||.|+||.||.+... +++.+++|.+... .......+.+|++++++++|+||+++++++.+++..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999944 5889999998754 244566788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++... ...+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 446899999999999999999999 99999999999999999999999999999876533221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||+++|+|++|..||......+.........+.+
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--------------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 2233457889999999988889999999999999999999999997644333222211111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.+..++..+.+++.+||..||.+||++.+++++++
T Consensus 221 -----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 221 -----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 01345677999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=293.79 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=211.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..|+..+.||.|+||.||.|... +++.||+|.+... .......+.+|+.+++.++|+||+++++.+.++...++|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56888999999999999999965 5899999998754 234567888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 9999999998754 5788899999999999999999 99999999999999999999999999999876543221
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||....+...........
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN------------------- 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-------------------
Confidence 1223456778999999988889999999999999999999999997654332221110000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..++..+.+++.+||..+|++||++.++++|+|-.....
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 00112346778999999999999999999999999988765544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=299.28 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=204.9
Q ss_pred cccccccccccceeeeEEEEEee-cce--EEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAM--EVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 58899999999999999999964 344 5677777543 234456788899999999 899999999999999999999
Q ss_pred EEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 100 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
+||+++++|.+++.... ..+++..++.++.|++.||.||| ++|++|+||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999996432 25788999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|+|||++....... .......+..|+|||++.+..++.++|||||||++|+|+| |..||......+........
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~- 239 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 239 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-
Confidence 999999886322110 1111223557999999988889999999999999999998 99998654432221111000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
.....+..++..+.+|+.+||+.+|++||++.++++.+.++.+.-+
T Consensus 240 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 240 -------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0000122356778999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=296.62 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=220.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..-|++..+||.|++|+||+|.++ +|+.||||..+.+ ...+++..|+.++++.+.|++|++++.+..+..+++||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 346889999999999999999976 6999999998765 5678899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
|..|+..+++...++.+++..+..+++.-+.+|.||| ...-+|||||..|||++.+|..||+|||.+-.+...-.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-- 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-- 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence 9999999999998889999999999999999999999 78889999999999999999999999999876642211
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......||+.|||||++....|+.++||||||++..||..|++||++..+-...+-. ...++
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------PT~PP 246 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------PTKPP 246 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------cCCCC
Confidence 123467999999999999999999999999999999999999999876542221110 11233
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..+..|..++.++.++++.||-.+|++|.||-++++|++-
T Consensus 247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi 286 (502)
T KOG0574|consen 247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI 286 (502)
T ss_pred CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence 3344577899999999999999999999999999999753
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=290.73 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred ccccceeeeEEEEEee---cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCC
Q 047140 32 FFICGVIIPVAQFLIS---SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (313)
.||.|+||.||+|... .+..||+|++.... ....+.+.+|+.++++++|+||+++++++.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999754 35679999997653 3345678899999999999999999998864 46899999999999
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc-cccc
Q 047140 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM-TQTQ 186 (313)
Q Consensus 108 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~ 186 (313)
|.+++......+++..++.++.|++.||.||| .++++|+||||+||+++.++.++|+|||++.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999765557899999999999999999999 9999999999999999999999999999987553221111 1111
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||......+......... ..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------------~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--------------------RL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--------------------CC
Confidence 223467999999888889999999999999999996 999997664433221111100 00
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+..+++++.+++.+||..||++||++.++.+.+..+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11335678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=306.46 Aligned_cols=244 Identities=23% Similarity=0.209 Sum_probs=194.8
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHH-HHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999965 58899999997531 222334445554 57888999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|...+.... .+++..+..++.||+.||.||| +.+++||||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence 99998887654 6888999999999999999999 999999999999999999999999999998753211 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------------------~ 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------------------L 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------------------C
Confidence 3468889999999998899999999999999999999999997654332222111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHH----HHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAR----EIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~----~il~~l~ 301 (313)
..+...+..+.+++.+||+.||.+||++. ++++|+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 11234567789999999999999999764 7777765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=299.51 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=202.2
Q ss_pred cccccccccccceeeeEEEEEeec---------------ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS---------------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVIS 88 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (313)
++|++.+.||+|+||.||++.... ...||+|.+... .......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987532 235899998764 3344567889999999999999999999
Q ss_pred eeeeCccceEEEEeecCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceE
Q 047140 89 TCSNEEFKALVLEYMPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157 (313)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil 157 (313)
++..++..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986432 13678889999999999999999 999999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh--CCCCChhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT--RKKPTDEIFNREM 235 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~p~~~~~~~~~ 235 (313)
+++++.++|+|||++................++..|+|||+..+..++.++|+||||+++++|++ +..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999875532221111222344678999999988889999999999999999998 6678765433221
Q ss_pred hhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 236 TLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..... ..+... .. ......+..++..+.+|+.+||..||++|||+++|++.|.
T Consensus 242 ~~~~~-~~~~~~------~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTG-EFFRNQ------GR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHH-Hhhhhc------cc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11100 000000 00 0000012235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=295.60 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=204.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC------c
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE------E 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~ 94 (313)
..+.|++.+.||.|+||.||+|... +++.||+|++.... .....+..|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4568999999999999999999965 58899999997653 3446788899999998 799999999998753 3
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..++|+||+++++|.+++... ...+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998764 346889999999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
...... .......++..|+|||++. ...++.++|+|||||++|+|++|..||................
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~----- 232 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP----- 232 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC-----
Confidence 543221 1223345788899999875 3457889999999999999999999997654332222111000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
........++.++.+|+.+||..||.+|||+.+++.|+|
T Consensus 233 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 233 --------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred --------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 000012235677999999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=296.30 Aligned_cols=272 Identities=25% Similarity=0.368 Sum_probs=206.2
Q ss_pred ccccccccccccceeeeEEEEEee-----cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--Cccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-----SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 96 (313)
.++|++.+.||+|+||.||++..+ ++..|++|.+..........+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 358999999999999999999742 478999999977666667788999999999999999999998754 3468
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++......+++..++.++.|++.||.||| .+|++|+||||+||++++++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999999766556899999999999999999999 9999999999999999999999999999988654
Q ss_pred cccccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-ccccccccc
Q 047140 177 GEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 254 (313)
...... ......++..|+|||+..+..++.++|+||||++++||++|..++....... ......... ......+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF--MRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--hhhcccccccccchHHHHH
Confidence 322111 1111223445999999988889999999999999999999877653321110 000000000 000000000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. . ........+..++..+.+|+.+||..+|++|||+.++++.|..+
T Consensus 238 ~-~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 L-L--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred H-H--hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0 00011112345678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=296.51 Aligned_cols=269 Identities=23% Similarity=0.362 Sum_probs=204.7
Q ss_pred ccc-ccccccccceeeeEEEEEe-----ecceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--cc
Q 047140 25 SDF-QILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EF 95 (313)
Q Consensus 25 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 95 (313)
++| ++.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8899999999999988653 247789999997653 23456788999999999999999999988653 46
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++||||+++++|.+++... .+++..++.++.|++.||.||| +++++|+||||+||++++++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 88999999999999999765 4899999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-Ccccccccccc
Q 047140 176 TGEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-NWLPISTMEVV 253 (313)
Q Consensus 176 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 253 (313)
....... ......++..|+|||...+..++.++||||||+++|+|++|..|+............... ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 4321111 112233456699999998888999999999999999999999997543221111000000 00000111111
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+.. .....+..++..+.+++..||..||++|||+++++..+.++.
T Consensus 238 ~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERG------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcC------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 110 011123456788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=292.09 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=205.1
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee-CccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-EEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 101 (313)
+|++.+.||.|++|.||++..+ +++.|++|.+... .....+.+..|+++++.++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999965 4789999998754 23445678889999999999999999998864 446899999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+++... ...+++..++.++.+++.+|.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999998764 346899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||+..+..++.++|+||||++++++++|..||.................
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---------------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC----------------
Confidence 122334577889999999999999999999999999999999999875443222221111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+...+..+.+++.+||+.||++|||+.++++|+|
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0012346678999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=292.52 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=210.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||.|++|.||+|... ++..+++|++... .......+.+|+++++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999955 5889999998654 233567889999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 103 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 103 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997642 36899999999999999999999 99999999999999999999999999999887653322
Q ss_pred cc--cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 181 SM--TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 181 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. ......++..|+|||++... .++.++|+||||+++++|++|..||................. ... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~----~--- 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP--PSL----E--- 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC--CCc----C---
Confidence 21 12334578889999988766 789999999999999999999999976543322221111100 000 0
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......++..+.+++.+||..||++|||+.+++.|+|
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 229 ------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred ------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 00002346778999999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.30 Aligned_cols=269 Identities=21% Similarity=0.236 Sum_probs=206.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|++|.||++..+ +++.||+|++.... ....+.+.+|+++++.++|+|++++++++..+...++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999965 58999999986542 2234567889999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++++|..++.... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999877777665443 6899999999999999999999 99999999999999999999999999999886643221
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCcccccccccccc---
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWLPISTMEVVDA--- 255 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--- 255 (313)
......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+....+....... ..... ...+..+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhcccccc
Confidence 1223456778999998765 5578999999999999999999999976554332221110 00000 00000000
Q ss_pred ---cccC----hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 ---NLLS----QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ---~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... ..+.. ......+..+.+|+.+||+.||++||++.+++.|+|
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 234 FKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred cccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000 00000 112345788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.09 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=207.3
Q ss_pred ccccccccccccceeeeEEEEEee-cc---eEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SA---MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
+++|+..+.||+|+||.||+|..+ ++ ..+++|.+... .....+.+..|+++++.++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 468889999999999999999965 23 37999998654 23446778899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||++++++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999776557899999999999999999999 999999999999999999999999999998765422
Q ss_pred cccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 YQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... .......+..|+|||++.+..++.++|+||||+++|++++ |..||......+.........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------------- 227 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------------- 227 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-------------
Confidence 1111 1111223456999999988889999999999999999997 999986544322221111000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++.++.+++.+||+.||++||++.++++.+.++
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011224567799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=297.88 Aligned_cols=271 Identities=20% Similarity=0.198 Sum_probs=208.2
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||.|++|.||+|... +++.|++|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999964 68999999997653 34456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+ +++|.+++......+++..++.++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 89999999766567999999999999999999999 99999999999999999999999999999886643321 1
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--ccc---ccccc--
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--IST---MEVVD-- 254 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~-- 254 (313)
......++..|+|||++.+. .++.++||||+|+++++|++|.+||..................+ ... .+..+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 12334578889999987654 46899999999999999999988886544322211111100000 000 00000
Q ss_pred cc-ccChhh-hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 255 AN-LLSQED-IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 255 ~~-~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. ...... .......+.+..+.+++++||+.||++|||+++++.|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 00 000000 000112345688999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.89 Aligned_cols=248 Identities=28% Similarity=0.409 Sum_probs=202.0
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHH
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (313)
+.||.|++|.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 478999999999999766999999998765333 5678899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccccccc
Q 047140 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189 (313)
Q Consensus 110 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 189 (313)
+++......++...+..++.+++.+|.||| .++++|+||+|+||++++++.++|+|||.+.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999765557889999999999999999999 99999999999999999999999999999875432111111112223
Q ss_pred ccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 190 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||................ ....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------------------~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------------------RMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------------CCCCC
Confidence 556999999988889999999999999999999 888886654322221111000 00112
Q ss_pred hhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..++..+.+++.+||..+|.+|||+.++++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=298.02 Aligned_cols=256 Identities=19% Similarity=0.202 Sum_probs=206.0
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.|+..+.||.|+||.||++... +++.||+|.+.... ......+.+|+++++.++|+||+.+.+.+.+++..++|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999965 58999999986541 2234557789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999999888654 336899999999999999999999 9999999999999999999999999999886543211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||................
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~----------------- 217 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV----------------- 217 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-----------------
Confidence 1223468899999999988899999999999999999999999997654322211110000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~~~ 304 (313)
.......+..++.++.+|+.+||+.||++||+ +.+++.|.|-..
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 218 LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 00000112345677899999999999999999 889999977644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.95 Aligned_cols=245 Identities=24% Similarity=0.215 Sum_probs=196.1
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHH-HHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|... +++.||+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999955 5899999999754 1223344555555 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|...+.... .+++..+..++.||+.||.||| +.|++||||||+|||+++++.++|+|||++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence 99998887654 6899999999999999999999 999999999999999999999999999998643211 11223
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|+|++|..||......+......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------------------~ 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------------------L 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC---------------------c
Confidence 4568899999999999999999999999999999999999997654333221111100 0
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH----HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA----REIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~il~~l~~ 302 (313)
..+...+..+.+++++||..||.+||++ .++++|+|-
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 0122356778999999999999999987 478888653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.59 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=206.0
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (313)
.++|.+++.||+|+||.||+|.+. .++.||+|+++.. .....+.+.+|++++..+. ||||++++++|..++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 457889999999999999999843 3568999999764 2333457889999999997 9999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------------------------------------------
Q 047140 96 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 116 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 116 (313)
.++|+||+++|+|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 117 --------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 117 --------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
..++...++.++.|++.||.||| +.+++|+||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 13566778889999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
++++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|||++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999876532211111223346678999999988889999999999999999998 889986543222211
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....... ....+..++.++.+|+.+||..||.+||++++|+..|..+.
T Consensus 353 ~~~~~~~-------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 NAIKRGY-------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCC-------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1110000 00113346788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=298.50 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=203.1
Q ss_pred cccccccccccceeeeEEEEEee-----------------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-----------------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKV 86 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (313)
++|++.+.||+|+||.||++... +...||+|++... .......+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2447899999754 33445788999999999999999999
Q ss_pred eeeeeeCccceEEEEeecCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCce
Q 047140 87 ISTCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156 (313)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 156 (313)
++++.+++..++|+||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999987542 23667889999999999999999 99999999999999
Q ss_pred EecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh--CCCCChhhhhhh
Q 047140 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT--RKKPTDEIFNRE 234 (313)
Q Consensus 157 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~p~~~~~~~~ 234 (313)
++++++.++|+|||++..+..............+..|++||...+..++.++|+|||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876533221111222334567999998888889999999999999999998 778886554322
Q ss_pred hhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 235 MTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...... ....... .......+..++..+.+|+..||+.||++||++.+|++.|.
T Consensus 242 ~~~~~~----------~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTG----------EFFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHH----------HHHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211000 0000000 00000112346678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=292.69 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=209.1
Q ss_pred ccccccccccccceeeeEEEEEeec-ce----EEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-AM----EVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..+|++.+.||+|+||.||+|..++ ++ .+++|.+.... ......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4689999999999999999999643 33 68999887653 3455778899999999999999999999987 6789
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999876657899999999999999999999 99999999999999999999999999999986643
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
............+..|+|||.+....++.++|+||||+++|++++ |..||......+.........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE------------- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-------------
Confidence 222111122223567999999988889999999999999999998 999997654333221111100
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..++..+.+++.+||..||++||++.++++.+..+..
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011123356678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=294.25 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=204.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc----------chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC----------GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
+|.+.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999854 58999999886421 112356788999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++|+||+++++|.+++...+ .++...+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999997764 6889999999999999999999 99999999999999999999999999999876
Q ss_pred cccccccccccccccccccCCCcccccCC--CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGR--ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
..............++..|+|||.+.... ++.++|+||||++++++++|..||................. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~ 232 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-----APP 232 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-----CCc
Confidence 53222111222345778899999887654 78999999999999999999999865433222211110000 000
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+. ......++.++.+++.+||..||.+|||+.++++|+|
T Consensus 233 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 233 IP----------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred CC----------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 00 0012245788999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.17 Aligned_cols=270 Identities=22% Similarity=0.205 Sum_probs=202.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|+||.||+|... +|+.|++|.++... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999965 58999999997542 22335677899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++ +|.+++......+++..++.++.||+.||.||| ..+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 975 888888765557899999999999999999999 99999999999999999999999999999876542211
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc-cCCc-ccc----cccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW-GNNW-LPI----STMEVVDA 255 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~-~~~~-~~~----~~~~~~~~ 255 (313)
......++..|+|||++.+. .++.++|||||||++|+|++|..|+............. .... ... ......+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234567889999987664 46899999999999999999988864322211111000 0000 000 00000000
Q ss_pred cccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... ...........+++++.+++.+||..||.+|||+++++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000 000001112346788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.21 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=206.8
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|++|.||++... ++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 468999999999999999999864 88999999976643 5678889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++.... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999997653 36899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.....+..|+|||......++.++|+||||++++++++ |..||.............. .+
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~----------------- 216 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GY----------------- 216 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CC-----------------
Confidence 12234567999999988889999999999999999997 9999865543322111110 00
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+..+++.+.+++.+||..+|++|||+.++++.|..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 000123457789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=303.11 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=203.2
Q ss_pred ccccccccccccceeeeEEEEEe------ecceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC-c
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI------SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE-E 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 94 (313)
.++|++.+.||.|+||.||+|.. .+++.||||+++... ......+.+|+.++..+ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999973 247899999997642 33456788899999999 789999999988654 5
Q ss_pred cceEEEEeecCCCHHHHHhcCC----------------------------------------------------------
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------- 116 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 116 (313)
..++|+||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 117 --------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 117 --------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
..++...+..++.|++.||.||| +++++|+||||+||++++++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 13567788899999999999999 9999999999999999999999999999987653222111222233
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
++..|+|||...+..++.++|+||||+++|++++ |..||................ .....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~ 303 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------------TRMRA 303 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-------------------CCCCC
Confidence 5567999999988889999999999999999997 999986543221111100000 00001
Q ss_pred hhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 268 ~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
+...++++.+++..||+.||++|||+.++++++..+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22345678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.68 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=205.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
..+|++.+.||+|+||.||++...++..+++|.+.... .....+.+|++++++++|||++++++++......++|+||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35789999999999999999997668889999886542 23457888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++......+++..++.++.+++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999999876556889999999999999999999 99999999999999999999999999998875432211 11
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......+..|+|||...+..++.++|+||||+++|++++ |..||................
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------------------- 218 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------------
Confidence 122334567999999988889999999999999999998 999986544332221110000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
....+...+..+.+|+.+||..+|++|||+.++++++
T Consensus 219 -~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 -RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0001223467799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=301.62 Aligned_cols=266 Identities=18% Similarity=0.192 Sum_probs=191.0
Q ss_pred ccccccceeeeEEEEEee---cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--CccceEEEEeec
Q 047140 30 LNFFICGVIIPVAQFLIS---SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMP 104 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 104 (313)
+++||+|+||.||+|..+ +++.||+|.+.... ....+.+|+++++.++||||+++++++.+ +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999854 46789999986542 23456789999999999999999999854 456899999996
Q ss_pred CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe----cCCCceeEcCCcch
Q 047140 105 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DDNMVAHLSDFSIA 172 (313)
Q Consensus 105 ~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~~ 172 (313)
+ +|.+++... ...+++..+..++.||+.||.||| +++++||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 898887532 125888999999999999999999 9999999999999999 45678999999999
Q ss_pred hhccccccc-ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh------------hh
Q 047140 173 KLLTGEYQS-MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT------------LK 238 (313)
Q Consensus 173 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~------------~~ 238 (313)
......... .......++..|+|||++.+ ..++.++||||+||++|+|++|..||......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 765432211 12234567889999998876 45899999999999999999999999643221000 00
Q ss_pred hccC----Cccc----ccccccc---cccccChhh-hh--hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 239 HWGN----NWLP----ISTMEVV---DANLLSQED-IH--FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 239 ~~~~----~~~~----~~~~~~~---~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... .|.. ....... ......... .. .......+..+.+|+.+||+.||++|||++|+++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0000 0000 0000000 000000000 00 0001123456889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=297.35 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=206.5
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||++..+ +++.||+|.+... .......+.+|++++++++|+||+++++.+..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999965 6899999998754 334456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 103 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 103 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+++++|..++... ...+++..+..++.+++.+|.||| . .+++|+||+|+||++++++.++|+|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999988764 236899999999999999999999 6 59999999999999999999999999998755322
Q ss_pred ccccccccccccccCCCcccccCC------CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGR------ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||............. ...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----------~~~ 223 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----------AIV 223 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----------HHh
Confidence 122335677899999875443 4889999999999999999999996542211110000 000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
+. .....+..++.++.+++.+||..+|++||++.+++.|+|-...
T Consensus 224 ~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 224 DG-------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred hc-------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 00 0011133477889999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=293.38 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=209.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|+..+.||.|++|.||++..+ +++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999966 58999999987653 34567788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++......+++..+..++.|++.+|.||| + .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-- 155 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-- 155 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence 9989999999876457899999999999999999999 8 999999999999999999999999999987653221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.....++..|+|||.+.+..++.++|+||||++++++++|..||........... +..........
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~ 221 (265)
T cd06605 156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF------------ELLQYIVNEPP 221 (265)
T ss_pred --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH------------HHHHHHhcCCC
Confidence 1125577889999999988999999999999999999999999865421000000 00000000000
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. ......++..+.+++.+||..||++|||+.+++.|+|-.
T Consensus 222 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 222 P--RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred C--CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 0 000112677799999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=305.10 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=218.6
Q ss_pred cccccccccceeeeEEEEEeec---ce--EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 27 FQILNFFICGVIIPVAQFLISS---AM--EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~---~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+..++||.|.||.||.|.+.+ |+ -||||.-+.+ .++..+.|..|..++++++||||++++|+|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 3455689999999999999542 33 6899988775 456788999999999999999999999999864 689999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++-|-|..+++.....++......+..||+.||.||| +...|||||...|||+.+...|||+|||+++.+.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999988778999999999999999999999 99999999999999999999999999999997754332
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......-+..|||||.++...++.+||||.||+++||++. |..||.+..+.+.......+
T Consensus 547 -YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG----------------- 608 (974)
T KOG4257|consen 547 -YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG----------------- 608 (974)
T ss_pred -hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-----------------
Confidence 22223445677999999999999999999999999999998 99999888765554433222
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+++.|++||+.|+.|+.+||..||.+||.+.++...|.++...
T Consensus 609 ---eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 609 ---ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ---CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 23344788999999999999999999999999999999988763
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.57 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=203.6
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
++|++...||.|++|.||++..+.+..+++|.+.... ...+.+.+|+++++.++|+|++++++++.. +..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 6799999999999999999997666679999886542 334678889999999999999999998754 56889999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 105 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 105 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 99999999754 345789999999999999999999 99999999999999999999999999999876532211 11
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||...+..++.++|+||||+++|+|++ |..||.............. ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~----------------- 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYR----------------- 221 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC-----------------
Confidence 122345667999999988889999999999999999999 8999976544332211110 000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+...+..+.+++++||..||++||+++++++.+.+
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.88 Aligned_cols=258 Identities=19% Similarity=0.177 Sum_probs=204.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999965 5889999998653 2233456788999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++......+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875557899999999999999999999 99999999999999999999999999999876543221
Q ss_pred cccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.......++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+...........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------- 226 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---------- 226 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----------
Confidence 11223458899999998865 46788999999999999999999999765433322211111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~ 302 (313)
.. .......+++++.+++.+||..+|.+ |++++++++|+|-
T Consensus 227 --~~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 227 --FQ----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred --cc----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 00 00001235678999999999876554 5689999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=292.45 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=203.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 34445568999999999999954 57899999987765566778999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhcccccc
Q 047140 104 PHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~--~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~ 180 (313)
++++|.+++......+ +...+..++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||.+........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998653345 78888999999999999999 999999999999999976 67999999999875532211
Q ss_pred cccccccccccccCCCcccccCC--CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGR--ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......++..|+|||++.+.. ++.++|+||||+++|+|++|..||..............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----------------- 225 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----------------- 225 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-----------------
Confidence 122335778899999886543 78899999999999999999999865322111110000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
........+..+++++.+++++||..+|.+|||+.+++.|+|
T Consensus 226 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 226 -MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred -hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 000011123446778999999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=294.42 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=207.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+.|++.+.||.|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++|+||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 56888899999999999999854 5889999998754 234567889999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++... .+++..+..++.|++.|+.||| .++++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999999988653 5889999999999999999999 99999999999999999999999999999876542211
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||++.+..++.++|+||||+++++|++|..|+............... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------~----- 217 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------S----- 217 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------C-----
Confidence 112235678899999999888999999999999999999999998754332221110000 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.......++..+.+++.+||+.+|.+||++.++++|+|-..
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 -PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00012245677999999999999999999999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=296.90 Aligned_cols=247 Identities=23% Similarity=0.234 Sum_probs=208.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|++|.||++... +++.||+|++... .......+.+|+++++.++||||+++++++.+++..++|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999965 5899999998754 1234567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .++...+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999997764 6899999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||................
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK----------------- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 223457888999999988889999999999999999999999996654322211111000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~ 301 (313)
...+...+..+.+++.+||..||.+|+ ++++++.|+|
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 011233567789999999999999999 9999999987
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.32 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=223.3
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+...+.++||+|.||.|.++....+..||+|.++.. +......|.+|+.+|.+++||||+.++++|..++.+|+|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 456788999999999999999877899999999876 4455689999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSNCIL-DIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+.|+|.+++.++..+. ......+++.||++|++||. +.++||||+.+.|+|++.++++||+|||+++-+.......
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999885443 56677889999999999999 9999999999999999999999999999999765555555
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh--CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT--RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.+....-+..|+|||.+..++++.++|+|+||+++||+++ ...||+.+.+.+....... +.+.. .
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~----------~~~~~---~ 761 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE----------FFRDQ---G 761 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh----------hcCCC---C
Confidence 5666677899999999999999999999999999999888 7899988876555432211 11110 0
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...-+..|.-|+..++++|.+||+.|-++||+++++..+|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111223667999999999999999999999999999998865
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.45 Aligned_cols=257 Identities=19% Similarity=0.249 Sum_probs=207.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|++|.||++... +++.+++|.+... .......+.+|+++++.++|+||+++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999954 6899999988653 2234567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++.. ....+++..++.++.|++.+|.||| +++++|+||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2346899999999999999999999 99999999999999999999999999998876532
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............... .....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~-- 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYP-- 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cCCCC--
Confidence 211 122345778899999998888999999999999999999999998653321111000000 00000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+++.+.+++.+||..||++|||+.+|++.+.++
T Consensus 227 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 -------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 001234677899999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.55 Aligned_cols=271 Identities=21% Similarity=0.342 Sum_probs=205.5
Q ss_pred cccccccccccceeeeEEEEEe-----ecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 96 (313)
+-|++.+.||+|+||.||++.. .++..|++|.+... .......+.+|+++++.++|+||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999973 24789999998754 234456789999999999999999999998775 568
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++......+++..+..++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999999766556899999999999999999999 9999999999999999999999999999988654
Q ss_pred ccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||++.+..++.++||||||+++|+++++..|......... ...............+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL--KMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh--hhcccccccccHHHHHHH
Confidence 32211 111234456779999999888899999999999999999998766432211000 000000000000000000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. ........+..++..+.+|+.+||+.||.+|||+.++++.+.++
T Consensus 239 ~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 L---EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H---HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 00001112345778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=299.64 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=205.9
Q ss_pred cccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
.+|++++.||+|+||.||+|... .+..||+|.+... .....+.+.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 57999999999999999999742 1236899988754 233467888999999999 8999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~ 159 (313)
..++++||+++++|.+++.... ..++...+..++.|++.||.||| .++++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999986532 24677888999999999999999 99999999999999999
Q ss_pred CCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhh
Q 047140 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLK 238 (313)
Q Consensus 160 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~ 238 (313)
.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999876543221111122233457999999999999999999999999999998 8889866543222111
Q ss_pred hccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 239 HWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.... .....+..++..+.+++.+||+.+|++|||+.+++.++..+..
T Consensus 249 ~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 249 LKEG--------------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHcC--------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1000 0001123456779999999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=290.44 Aligned_cols=251 Identities=18% Similarity=0.263 Sum_probs=207.1
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|+||.+|.+... +++.|++|.+... .......+.+|+.+++.++|+||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999954 5889999998753 233456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+.+++|.+.+... ...+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998754 335789999999999999999999 99999999999999999999999999999876543211
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||+..+..++.++|+||||++++++++|..||......+..........
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~----------------- 218 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY----------------- 218 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-----------------
Confidence 11233467789999999888899999999999999999999999865433322211111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++.++.+++.+||+.+|.+||++.++++|+|
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 0113346778999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=294.13 Aligned_cols=256 Identities=21% Similarity=0.243 Sum_probs=202.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeee-----eCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCS-----NEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~ 94 (313)
...++|++.+.||+|+||.||++... +++.+++|++.... .....+.+|+.+++.+ +|+||+++++++. .++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 45789999999999999999999965 58899999886542 2345678899999999 7999999999884 345
Q ss_pred cceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 95 FKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
..++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 68999999999999998753 2346788999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
+....... .......++..|+|||++.. ..++.++|+|||||++|+|++|..||................
T Consensus 171 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--- 245 (286)
T cd06638 171 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP--- 245 (286)
T ss_pred eeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC---
Confidence 87653221 11223457888999998753 457889999999999999999999987654322211110000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
......+..++..+.+++.+||+.||++|||+.++++|+|
T Consensus 246 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 246 ---------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ---------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0000112234667999999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=288.54 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=201.2
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeee-eCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCS-NEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 103 (313)
++|++.+.||+|+||.||++.. .+..|++|.++.. ...+.+.+|+.+++.++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5889999999999999999976 4788999998654 23467889999999999999999999764 456789999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++.... ..+++..+..++.|++.+|+||| +++++|+||||+||++++++.++|+|||++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---- 155 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence 9999999997643 34788999999999999999999 999999999999999999999999999998754321
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......+..|+|||++.+..++.++|||||||++|+|++ |..||......+........ +
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~----------------- 216 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-Y----------------- 216 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-C-----------------
Confidence 122334567999999988889999999999999999998 99998654332221111000 0
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+..++..+.+++.+||..||++|||+++++++|..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 001123467789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=293.79 Aligned_cols=270 Identities=21% Similarity=0.221 Sum_probs=217.7
Q ss_pred hhhhhcchhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeee
Q 047140 9 AFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVI 87 (313)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (313)
||+..+..-+.......+|.....||.|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~ 82 (285)
T cd06648 3 QFRAALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82 (285)
T ss_pred hHHhhhhhcCCCCcchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEE
Confidence 466666655555555567888889999999999999954 5889999998765445566788999999999999999999
Q ss_pred eeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 88 STCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
+++..++..++++||+.+++|.+++... .++...+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~ 157 (285)
T cd06648 83 SSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLS 157 (285)
T ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEc
Confidence 9999999999999999999999998773 5889999999999999999999 9999999999999999999999999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
|||.+........ ......++..|+|||...+..++.++|+||||+++|+|++|..||................
T Consensus 158 d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~---- 231 (285)
T cd06648 158 DFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL---- 231 (285)
T ss_pred ccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC----
Confidence 9998765432211 1223457888999999988889999999999999999999999986543322211111100
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+..++..+.+++.+||+.||++|||+.++++|+|-.
T Consensus 232 --------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 273 (285)
T cd06648 232 --------------PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273 (285)
T ss_pred --------------CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence 000001223567899999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=288.08 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=205.9
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||++...++..+++|.+... ....+.+.+|+++++.++|+||+++.+.+.+ ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4689999999999999999998767788999988754 3345678889999999999999999999887 6789999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++... ...++...+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence 999999999764 345788889999999999999999 9999999999999999999999999999987654221 11
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++....++.++|+||||+++|++++ |..||.............. .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~----------------- 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GY----------------- 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CC-----------------
Confidence 1222335567999999988889999999999999999999 9999976544332211110 00
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...+.++.+++.+||+.||++||++.++++.|..
T Consensus 221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000123456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=293.17 Aligned_cols=255 Identities=22% Similarity=0.249 Sum_probs=204.8
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc------
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE------ 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------ 94 (313)
..++|++.+.||.|++|.||+|..+ +++.+++|++.... ...+.+.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4589999999999999999999965 58899999987653 3456788999999999 7999999999997644
Q ss_pred cceEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 95 FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
..++|+||+++++|.+++... +..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988643 357899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
+........ ......++..|+|||++.. ..++.++||||||++++++++|..||...............
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 233 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---- 233 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc----
Confidence 875432221 1233457888999998753 34678999999999999999999999754332222111100
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......+..+++.+.+++.+||..||++|||+.++++|+|
T Consensus 234 --------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 234 --------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred --------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 00001112346778999999999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.35 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=203.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 96 (313)
.+|++++.||+|+||.||.+... +++.|++|.+... .......+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999965 5899999988643 123456788899999999999999999998764 467
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++++||+++++|.+++.... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999997664 5788889999999999999999 9999999999999999999999999999987653
Q ss_pred ccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||................
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------ 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------------ 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC------------
Confidence 22111 11223347788999999988889999999999999999999999997543222211111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+...+..+.+++++||. +|++||+++++++|+|
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 0011133456778999999994 9999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.37 Aligned_cols=256 Identities=20% Similarity=0.222 Sum_probs=205.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||.|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+..+++.++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999965 48899999987652 233457788999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+........
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997665 6889999999999999999999 99999999999999999999999999998763210000
Q ss_pred -------------cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc
Q 047140 181 -------------SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 181 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
........++..|+|||.+.+..++.++|+||||+++|++++|..||.+....+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~-- 234 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-- 234 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--
Confidence 00111234677899999998888999999999999999999999999754433222111111000
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC---HHHHHHHHHH
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN---AREIVAKLFK 302 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~il~~l~~ 302 (313)
.......++.++.+++.+||+.||++||+ +.++++|+|-
T Consensus 235 ----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 235 ----------------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred ----------------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 00001246777999999999999999998 7888888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=287.84 Aligned_cols=258 Identities=19% Similarity=0.264 Sum_probs=208.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||.|++|.||+|... +++.|++|.++.. .....+.+.+|++++++++|+||+++++++.+++..++|+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999966 6899999988642 2334667889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++.. ....++...++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998864 2346889999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......++..|+|||...+..++.++|+||||+++|+|++|..||............. .....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~ 224 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------------IEKCD 224 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh------------hhcCC
Confidence 21 11223457778999999988889999999999999999999999985432110000000 00000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.. ......++..+.+++.+||..+|++|||+.+|++.+..+.
T Consensus 225 ~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YP-----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC-----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0001246678999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.80 Aligned_cols=258 Identities=24% Similarity=0.267 Sum_probs=209.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccc---hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||.|++|.||+|... +++.||+|.+..... .....+..|+++++.++|+||+++++.+.++...++|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999965 489999999976522 24567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 101 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
||+.+++|.+++... ...+++..+..++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 346899999999999999999999 9999999999999999999999999999987543211
Q ss_pred ccc---------------------------cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh
Q 047140 180 QSM---------------------------TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN 232 (313)
Q Consensus 180 ~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~ 232 (313)
... ......++..|+|||+..+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 100 01123467889999999988899999999999999999999999976544
Q ss_pred hhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC----HHHHHHHHHHHH
Q 047140 233 REMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN----AREIVAKLFKIR 304 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~~il~~l~~~~ 304 (313)
............ ........+..+.+++.+||..||++||| +.+++.|+|-..
T Consensus 238 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 238 DETFSNILKKEV-------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHHHhcCCc-------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 332221111000 00011125778999999999999999999 999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.85 Aligned_cols=256 Identities=21% Similarity=0.225 Sum_probs=203.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC-----c
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE-----E 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~ 94 (313)
...++|++.+.||.|+||.||++... +++.+|+|++... ......+.+|+.+++.+ +|||++++++++... +
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 35789999999999999999999964 5889999998654 23346677899999999 899999999998653 3
Q ss_pred cceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 95 FKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
..++|+||+++++|.+++.. ....+++..++.++.|++.||.||| ..+++|+||+|+||++++++.++|+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 58999999999999998863 2346899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCcccccC-----CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-----RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
+........ ......++..|+|||.+... .++.++|+|||||++|+|++|..||.................
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-- 250 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-- 250 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC--
Confidence 876542211 12234577889999987543 368999999999999999999999976543322221111000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+...+..+.+++.+||+.||++||++.++++|+|
T Consensus 251 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 251 ----------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred ----------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 000112234567999999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=290.25 Aligned_cols=250 Identities=23% Similarity=0.253 Sum_probs=206.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc-----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
+|+..+.||+|++|.||+|..+ +++.|++|.+.... ....+.+.+|+++++.++|+||+++.+++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5778899999999999999966 68999999986542 23557788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++.... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997664 5889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccccccCCCcccccCC-CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......++..|++||.+.... ++.++|+||||+++|++++|..||................
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------------- 218 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--------------- 218 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc---------------
Confidence 123445788899999887766 8999999999999999999999996654322221110000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..+++.+.+++++||..+|.+||++.+++.|+|
T Consensus 219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 000112346778999999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=286.92 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=200.3
Q ss_pred cccccceeeeEEEEEeec-c---eEEEEEEeecccc-hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLISS-A---MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|.... + ..+++|.+..... ...+.+.+|+++++.++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999998542 2 6899999976532 355678899999999999999999998764 467999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc-c
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT-Q 184 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~ 184 (313)
++|.+++.... .+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||.+........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997765 6899999999999999999999 99999999999999999999999999999886643221111 1
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||...+..++.++|+||||+++|++++ |..||......+.........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-------------------- 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-------------------- 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--------------------
Confidence 11223457999999988899999999999999999998 999997665433222111110
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..++..+.+++.+||..||++||++.++++.+....
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00113346778999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=296.59 Aligned_cols=266 Identities=19% Similarity=0.251 Sum_probs=209.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++.+...+..++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 68999999999999999999965 5889999988654 234567888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++...+ .++...+..++.+++.+|.||| . .+++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999887654 6899999999999999999999 6 58999999999999999999999999987654221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++|+|||||++|++++|..||.......... .............. ...
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~-~~~ 229 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIV-QEP 229 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHh-hcc
Confidence 1123467889999999988899999999999999999999999997654321100 00000000000000 000
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
... .....++.++.+|+.+||..||.+|||+.+++++++-+...
T Consensus 230 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 230 PPR-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCC-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 00112567799999999999999999999999998776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=294.90 Aligned_cols=256 Identities=24% Similarity=0.270 Sum_probs=207.2
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
....+.|++.+.||+|+||.||+|... +++.|++|++... .....+.+.+|+++++.++||||+++.++|.+++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 344567999999999999999999965 5899999998643 223446788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+. +++.+.+......+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99999997 4888887665557899999999999999999999 9999999999999999999999999999886543
Q ss_pred cccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.. ....++..|+|||++. ...++.++||||||+++|+|++|..||.................
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 231 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--------- 231 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC---------
Confidence 21 2335677899999874 45678899999999999999999999866543332221111000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..++..+.+++.+||..||++||++.+++.|+|-...
T Consensus 232 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 ----------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 000022356779999999999999999999999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=297.30 Aligned_cols=260 Identities=21% Similarity=0.231 Sum_probs=211.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.....|+....||.|+||.||++... +++.|++|.+..........+.+|+.+++.++||||+++++.+..++..++|+
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34466777889999999999999954 68999999997654445567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 98 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 98 EFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred ecCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999999987653 5789999999999999999999 99999999999999999999999999999875532211
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|+|||||++++|++|..||......+.........
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 233 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP----------------- 233 (297)
T ss_pred --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-----------------
Confidence 1233457889999999998889999999999999999999999986543322211110000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
..........+..+.+++.+||+.+|++||++.++++|+|-....
T Consensus 234 -~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 234 -PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred -CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 000001223567789999999999999999999999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=289.52 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=202.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-----chhHHHHHHHHHHHhcCCCCcceeeeeeeee--Cccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 96 (313)
.+|++.+.||+|+||.||++... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999964 58999999986431 2344678889999999999999999999875 3568
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++++||+++++|.+++.... .++...++.++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999997655 5788999999999999999999 9999999999999999999999999999987543
Q ss_pred ccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||.+.+..++.++|+|||||++|++++|..||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT----------- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-----------
Confidence 21111 111223477889999999988899999999999999999999999976543222221111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..+++.+.+++ .||..+|++||++++++.|++
T Consensus 227 --------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 227 --------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred --------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 0111234566688888 688899999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=286.38 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=196.9
Q ss_pred cccccceeeeEEEEEee----cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeee-eCccceEEEEeec
Q 047140 31 NFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCS-NEEFKALVLEYMP 104 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 104 (313)
+.||+|+||.||+|... ....||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 2457999998543 3345678888999999999999999999775 4566899999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc--cc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ--SM 182 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 182 (313)
+++|.+++.......+...+..++.|++.||.||| ..+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999765545677888999999999999999 99999999999999999999999999999875432110 01
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||...+..++.++||||||+++|+|++ |.+||......+.........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~------------------ 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR------------------ 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC------------------
Confidence 1112335667999999988899999999999999999999 566775543322221111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..+++.+.+++.+||..+|++||++.++++.+..+..
T Consensus 220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000122346779999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=296.94 Aligned_cols=259 Identities=21% Similarity=0.232 Sum_probs=210.1
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
....+.|.....||.|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus 18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 344567777889999999999999854 5889999998766555667788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 98 ~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 98 MEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999999988543 4789999999999999999999 9999999999999999999999999999987553222
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
. ......++..|+|||+..+..++.++|+||||+++|++++|..||............... ...
T Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----------~~~---- 236 (292)
T cd06658 173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN----------LPP---- 236 (292)
T ss_pred c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------CCC----
Confidence 1 122345788899999998889999999999999999999999998654332211110000 000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........+..+.+++.+||..||++|||+.++++|+|-..
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 237 ----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred ----ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 00011235667899999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=294.58 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=206.3
Q ss_pred ccccccccccccceeeeEEEEEee-cce----EEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|++.+.||+|+||.||++... ++. .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 367889999999999999999854 343 57999886542 23345688899999999999999999998765 467
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+++||+++|+|.+++......+++..++.++.|++.||.||| +++++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999876657889999999999999999999 99999999999999999999999999999986643
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
...........++..|+|||++.+..++.++||||||+++|++++ |..||................
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 228 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE------------- 228 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 322212223345678999999998899999999999999999997 899986643222111110000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++||+++++++.+.++...
T Consensus 229 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 -------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011223566789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=288.11 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=206.6
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|++|.||++... +++.+++|.+... .......+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5889999999999999999964 5889999998764 234567888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcchhhcccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 180 (313)
+++++|.+++... +..+++..+..++.+++.+|.||| +++++|+||+|+||+++++ +.++++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999764 345899999999999999999999 9999999999999999865 468999999987654321
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||...+..++.++|+||||+++|+|++|..||.................
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~---------------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF---------------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC----------------
Confidence 12234578889999999988899999999999999999999999866543322221111000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++..+.+++..||..||.+|||+.++++|++
T Consensus 219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 0112346778999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=288.63 Aligned_cols=239 Identities=21% Similarity=0.301 Sum_probs=191.7
Q ss_pred cccccceeeeEEEEEeec-------------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 31 NFFICGVIIPVAQFLISS-------------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
+.||+|+||.||+|.... ...|++|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998431 2368999987665555667888999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc-------eeEcCCc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV-------AHLSDFS 170 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~-------~~l~dfg 170 (313)
+|+||+++++|..++......+++..++.++.|++.||.||| +++++|+||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766557899999999999999999999 999999999999999987664 8999999
Q ss_pred chhhcccccccccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHH-hCCCCChhhhhhhhhhhhccCCccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETF-TRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.+..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.... ....
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~----- 225 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEGQ----- 225 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-HhcC-----
Confidence 8865431 12234677899999876 567899999999999999998 58888765432221110 0000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
.......+.++.+|+.+||+.||.+||++.+|+.++
T Consensus 226 ----------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 ----------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=286.75 Aligned_cols=248 Identities=24% Similarity=0.297 Sum_probs=201.7
Q ss_pred cccccceeeeEEEEEeec--c--eEEEEEEeecccc-hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLISS--A--MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|++|.||+|...+ + ..||+|.+..... ...+.+..|++++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 3 3699999987644 567789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc-c
Q 047140 106 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM-T 183 (313)
Q Consensus 106 ~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~ 183 (313)
++|.+.+.... ..+++..++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 46899999999999999999999 9999999999999999999999999999988764322111 1
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||...+..++.++|+|||||++|+|++ |..||......+.........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------- 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG------------------- 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------------
Confidence 122346678999999988899999999999999999999 999986554333222111100
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..++..+.+++.+||..+|++|||+.+++..+.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000112345677999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.95 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=203.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||+|++... .+...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999965 5899999999753 2334567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 101 EYMPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 101 e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
||++|++|.+++... ....+...+..++.||+.||.||| +.|++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642 123456778899999999999999 9999999999999999999999999999
Q ss_pred chhhccccccc----------------ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhh
Q 047140 171 IAKLLTGEYQS----------------MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234 (313)
Q Consensus 171 ~~~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~ 234 (313)
++......... .......||..|+|||++.+..++.++|||||||++|+|+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99765211000 01112458899999999999999999999999999999999999996643222
Q ss_pred hhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-HHHHHHHHHHHH
Q 047140 235 MTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-AREIVAKLFKIR 304 (313)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~il~~l~~~~ 304 (313)
....... ..+........+++.+.+++.+||..||++||+ ++++++.+....
T Consensus 239 i~~~~~i------------------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYRDVI------------------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhhhhc------------------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111000 000000112346778999999999999999975 455555555543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.21 Aligned_cols=256 Identities=18% Similarity=0.242 Sum_probs=202.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee--Cccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 96 (313)
...++|++++.||.|+||.||+|... ++..||+|++... .......+..|+.+++.++||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999965 5889999998754 23455678899999999999999999999854 3568
Q ss_pred eEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCC-------CCceeCCCCCCceEecC------
Q 047140 97 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYS-------AQVIHCDLKPINVLLDD------ 160 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~-------~~i~h~di~p~nil~~~------ 160 (313)
||||||+++++|.+++... ...+++..++.++.||+.||.||| . .+|+|+||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCccccc
Confidence 9999999999999998653 236899999999999999999999 6 45999999999999964
Q ss_pred -----------CCceeEcCCcchhhcccccccccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 161 -----------NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 161 -----------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
.+.++|+|||++..+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2458999999987653221 1234468999999998854 45789999999999999999999999
Q ss_pred hhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
................ .. ......+.++.+||..||..+|.+||++.+++.++|..
T Consensus 244 ~~~~~~~qli~~lk~~-----------------p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 244 HKANNFSQLISELKRG-----------------PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CcCCcHHHHHHHHhcC-----------------CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 6543322211111000 00 00123467799999999999999999999999987754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.52 Aligned_cols=244 Identities=20% Similarity=0.148 Sum_probs=194.1
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC---CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI---RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
||+|+||.||+|..+ +++.||+|++.... .........|..++... +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 58999999996531 12233445566777655 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+.+.... .+++..+..++.||+.||.||| +++++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 99999887654 6899999999999999999999 9999999999999999999999999999987532211 1123
Q ss_pred ccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhh
Q 047140 186 QTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
...|+..|+|||++.+. .++.++|||||||++|+|++|..||......+.......... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------~~------ 216 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV------------RF------ 216 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC------------CC------
Confidence 45688999999988654 579999999999999999999999976543332211111000 00
Q ss_pred hhhhhhhHHHHHHHHhHhhccCCCCCC----CHHHHHHHHHH
Q 047140 265 FVAKEQCVSFVFNLAIECTVESPEQRI----NAREIVAKLFK 302 (313)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~~il~~l~~ 302 (313)
....+++++.+++++||..||.+|| ++.++++|+|-
T Consensus 217 --~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 217 --PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred --CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 0123567789999999999999998 79999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=294.60 Aligned_cols=273 Identities=21% Similarity=0.221 Sum_probs=207.2
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccc-----hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
+|++.+.||.|++|.||+|... +++.|++|.+..... .....+..|+++++.++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999965 589999999976522 2345677899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+ +++|.+++......+++..++.++.||+.||.||| ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999765546899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC------ccc--cccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN------WLP--ISTM 250 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~------~~~--~~~~ 250 (313)
. ......++..|+|||.+.+ ..++.++|+|||||++++|++|.+||................ +.+ ....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 1 1222345678999998754 467899999999999999999988886544322211111000 000 0000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...........+. .......+..+.+++.+||+.||++|||+.+++.|.|-...
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 235 DYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0000000000000 11123457889999999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=288.70 Aligned_cols=255 Identities=26% Similarity=0.333 Sum_probs=207.3
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|++|.||++... +++.|++|.++.... .....+.+|+++++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5889999999999999999954 689999999976633 3678899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++.... .+++..+..++.+++.+|.||| +.+++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999997654 5788999999999999999999 9999999999999999999999999999988764322111
Q ss_pred c--ccccccccccCCCcccccCC---CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 183 T--QTQTLATIGCIAPEYRRKGR---ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 183 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. .....++..|+|||++.+.. ++.++|+||||++++++++|..||................
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 222 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-------------- 222 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC--------------
Confidence 1 11245678899999988766 8999999999999999999999997553221111110000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+....++..+.+++.+||+.||.+|||+.+++.|+|
T Consensus 223 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 223 ---HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred ---CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 00000011234677899999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=310.76 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=221.0
Q ss_pred cccccccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+-|+|++.||.|+||.||+|..+. +-..|.|++........+.+.-|++||..++||+|+++++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 578999999999999999999764 5566889988877888899999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
+||....++..-+..+.+.++..+..|++.||.||| +++|+|||||..|||++-+|.++|+|||.+...... ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence 999999888777778999999999999999999999 999999999999999999999999999998754322 223
Q ss_pred ccccccccccCCCccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 184 QTQTLATIGCIAPEYR-----RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....||+.|||||+. ...+|+.++||||||++|.||.-+.+|.....+--......
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia------------------ 248 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------------------ 248 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh------------------
Confidence 4567899999999965 46789999999999999999999999987765544433322
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..+..|..++..+.+++.+||..||..||+++++++|+|-.
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 123333444677899999999999999999999999999998854
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.96 Aligned_cols=266 Identities=18% Similarity=0.198 Sum_probs=191.0
Q ss_pred ccccccceeeeEEEEEee---cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--CccceEEEEeec
Q 047140 30 LNFFICGVIIPVAQFLIS---SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMP 104 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 104 (313)
+.+||+|+||.||+|..+ ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999954 35789999986542 23467789999999999999999999854 467899999996
Q ss_pred CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe----cCCCceeEcCCcch
Q 047140 105 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DDNMVAHLSDFSIA 172 (313)
Q Consensus 105 ~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~~ 172 (313)
+ +|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||++ ++++.++|+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 888887532 225788999999999999999999 9999999999999999 56689999999999
Q ss_pred hhccccccc-ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh------------hh
Q 047140 173 KLLTGEYQS-MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT------------LK 238 (313)
Q Consensus 173 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~------------~~ 238 (313)
......... .......++..|+|||++.+ ..++.++|||||||++|+|+||..||......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 866432211 11233457888999998876 45799999999999999999999999643211000 00
Q ss_pred hcc----CCcccc----c---ccccccccccChhhh---hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 239 HWG----NNWLPI----S---TMEVVDANLLSQEDI---HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 239 ~~~----~~~~~~----~---~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
... ..|... . ............... ........+..+.+|+.+||..||++|||+.|+++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000 000000 0 000000000000000 00001123566899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=292.72 Aligned_cols=272 Identities=20% Similarity=0.227 Sum_probs=202.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..++|++.+.||+|+||.||+|... +++.|++|++.... ......+.+|+++++.++|+||+++.+++.++...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3478999999999999999999854 58899999997542 222346678999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+. ++|.+.+......++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 5887777655446788889999999999999999 99999999999999999999999999999875432211
Q ss_pred cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh-hhccCCccc------------
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL-KHWGNNWLP------------ 246 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~-~~~~~~~~~------------ 246 (313)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ..+.....+
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1223346788999998875 457889999999999999999999997654321111 111000000
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......... ..............+..+.+++.+||..||++|||+.+++.|+|
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 237 NYKPEWFLPC-KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred cccchhcccc-CCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 0000000000 00000000011123567899999999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.42 Aligned_cols=270 Identities=25% Similarity=0.259 Sum_probs=219.7
Q ss_pred chhhhhhcchhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCccee
Q 047140 7 ILAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
.+.+++..+. ....+.|++...||.|++|.||++..+ ++..|++|++..... ....+.+|+++++.++|+|+++
T Consensus 5 ~~~~~~~~~~----~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~ 79 (286)
T cd06614 5 KAALKDIVSE----GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79 (286)
T ss_pred hhhHhhhcCC----CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeE
Confidence 3455555443 466788999999999999999999976 588999999987644 4567889999999999999999
Q ss_pred eeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCcee
Q 047140 86 VISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165 (313)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~ 165 (313)
+++.+..+...++|+||+++++|.+++......++...+..++.|++.+|.||| +.|++|+||+|+||++++++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEE
Confidence 999999999999999999999999999876557899999999999999999999 99999999999999999999999
Q ss_pred EcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
|+|||.+........ ......++..|++||++.+..++.++|+||||+++|+|++|..||....+...........
T Consensus 157 l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-- 232 (286)
T cd06614 157 LADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-- 232 (286)
T ss_pred ECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--
Confidence 999998876543221 1122346778999999888889999999999999999999999986544332221111000
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........++..+.+++.+||+.+|.+|||+.+++.++|-..
T Consensus 233 ----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 233 ----------------IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ----------------CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0001112336778999999999999999999999999988655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=290.09 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=205.0
Q ss_pred ccccccccccceeeeEEEEEe-ecceEEEEEEeeccc------chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 26 DFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC------GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
+|++++.||+|++|.||++.. .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588899999999999999985 468999999997532 1235678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 177 (313)
|+||+++++|.+++.... .+++..++.++.|++.||.||| .++++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997655 6889999999999999999999 99999999999999998775 699999999876643
Q ss_pred ccccc--cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQSM--TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......++..|+|||++.+..++.++|+||||++++++++|..||.............. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------~~~- 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK----------IAS- 225 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH----------Hhc-
Confidence 31111 11233577889999999888899999999999999999999999854322111100000 000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......+...+..+.+++.+||..||.+||++.++++|+|
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 00001113346778999999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=293.21 Aligned_cols=271 Identities=19% Similarity=0.208 Sum_probs=202.5
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccc-hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||.|++|.||++..+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+++..++|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 378999999999999999999965 589999999875421 223456789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+.+ +|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 9975 999998776657899999999999999999999 9999999999999999999999999999986542211
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhh-hhhhhhccC--Cccccccccc-----
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNR-EMTLKHWGN--NWLPISTMEV----- 252 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~-~~~~~~~~~--~~~~~~~~~~----- 252 (313)
.......++..|+|||++.+ ..++.++||||+|+++|+|++|..||...... +.....+.. ..........
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11122345778999998765 45789999999999999999999999654421 111100000 0000000000
Q ss_pred -ccc--cccChhhhhhhhhhhhH--HHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 253 -VDA--NLLSQEDIHFVAKEQCV--SFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 253 -~~~--~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
... ......... ......+ ..+.+++.+||..||++|||+.+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 238 FKPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred cccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 000 000000000 0011122 67899999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=289.83 Aligned_cols=238 Identities=23% Similarity=0.266 Sum_probs=190.2
Q ss_pred ccccceeeeEEEEEeec-------------------------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceee
Q 047140 32 FFICGVIIPVAQFLISS-------------------------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKV 86 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (313)
+||+|+||.||+|.... ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13689999876555556678889999999999999999
Q ss_pred eeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----
Q 047140 87 ISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---- 162 (313)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---- 162 (313)
++++.++...++||||+++++|..++......+++..+..++.|++.||.||| +++++|+||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999765557899999999999999999999 99999999999999997654
Q ss_pred ---ceeEcCCcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHH-hCCCCChhhhhhhhhh
Q 047140 163 ---VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETF-TRKKPTDEIFNREMTL 237 (313)
Q Consensus 163 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll-tg~~p~~~~~~~~~~~ 237 (313)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4799999987643211 12346678999998765 56899999999999999985 6999986654322211
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
... .. ...+...+..+.+++.+||..+|++|||+.+++++|
T Consensus 233 ~~~--------------~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 FYE--------------KK--------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH--------------hc--------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 100 00 000112335689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=295.38 Aligned_cols=270 Identities=22% Similarity=0.262 Sum_probs=205.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++|+||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999965 58999999986532 2245667889999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++++|.++..... .+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 999888887665443 5899999999999999999999 9999999999999999999999999999987653322
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCcccccccccccc---
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWLPISTMEVVDA--- 255 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--- 255 (313)
.......++..|+|||+..+ ..++.++||||||+++|+|++|.+||......+....... ..... ......+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP-RHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch-hhHHHhccchH
Confidence 11223457788999998765 4578899999999999999999999965443222111110 00000 00000000
Q ss_pred ---cc---cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 ---NL---LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ---~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. .............++..+.+++.+||..||++||++.++++|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 00 00000011112356788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.25 Aligned_cols=271 Identities=24% Similarity=0.367 Sum_probs=208.7
Q ss_pred cccccccccccceeeeEEEEEee-----cceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeee--Cccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-----SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 96 (313)
++|++.+.||+|+||.||++... +++.||+|++...... ....+.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57888999999999999999853 3789999999766433 56789999999999999999999999877 5678
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++......++...+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876656899999999999999999999 9999999999999999999999999999998764
Q ss_pred ccccccc-ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
....... .....++..|++||...+..++.++|+||||+++++|++|..|+........... ...........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI--GIAQGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc--ccccccccHHHHHHH
Confidence 2221111 1122345569999999888999999999999999999999999755322111100 000000000000000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. .......+..++.++.+++.+||+.||++|||+.++++.+..+
T Consensus 239 -~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 -LK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HH--cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 0001111334678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=284.83 Aligned_cols=252 Identities=25% Similarity=0.314 Sum_probs=210.1
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+++++.++|+|++++++.+..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788999999999999999965 689999999987654566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++......+++..+..++.|++.+|.+|| ..+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999877557899999999999999999999 99999999999999999999999999999876643221 2
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
....++..|++||.+.+..++.++|+||||+++++|++|..||................ ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~ 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG------------------PPG 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC------------------CCC
Confidence 34457788999999988889999999999999999999999987653222211111000 000
Q ss_pred hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 265 FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
......++..+.+++.+||+.||++|||+.+++.|+|
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0011224677999999999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.63 Aligned_cols=279 Identities=21% Similarity=0.151 Sum_probs=208.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 96 (313)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++|+||+++++++.+. +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45679999999999999999999965 589999999975422 2233456799999999999999999998765 468
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+.+ +|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999999965 899888765557899999999999999999999 9999999999999999999999999999987664
Q ss_pred cccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-ccccccc-
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-ISTMEVV- 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~- 253 (313)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+...........+ .......
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3221 1222335677999998765 567899999999999999999999997655433322211110000 0000000
Q ss_pred -----cccccChhhh--hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 254 -----DANLLSQEDI--HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 254 -----~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.......... ........++.+.+++.+||..||++|||+.+++.|+|-....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0000000000 0001123477789999999999999999999999999975433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=301.40 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=211.8
Q ss_pred hhhhhhcccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 17 DVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
+.+...-...|++++.||+||.+.||++...+.+.+|+|+.... ++...+-+.+|+.+|.+| .|.+|+++++|=..+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 34444556799999999999999999999877777888877543 455678899999999999 689999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
+++|||||+-+. +|..+|++.....+...+..+..|++.++.++| ..||||.||||.|+|+-+ |.+||+|||.+.
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 999999998765 999999988766776789999999999999999 999999999999999875 689999999998
Q ss_pred hcccccccccccccccccccCCCcccccC-----------CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKG-----------RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
.+...-.........||..||+||.+... ..+.++|||||||+||+|+.|+.||....+....+.....
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 77655444455667899999999966422 2578999999999999999999999776543332222111
Q ss_pred CcccccccccccccccChhhhhhhhhh-hhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKE-QCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. ..+...+. .-..++.++++.||.+||++|||..++|+|++-.
T Consensus 588 P------------------~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 588 P------------------NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred C------------------CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 1 00001110 0122289999999999999999999999997644
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=292.06 Aligned_cols=257 Identities=23% Similarity=0.251 Sum_probs=210.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999854 5889999998765445567788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++.+. .++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 9999999998764 4788899999999999999999 99999999999999999999999999998765543221
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|++||......++.++|+||||+++|++++|..||................ .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~------------------~ 232 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG------------------T 232 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC------------------C
Confidence 1223457788999999888889999999999999999999999997643322211110000 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+...+..+.+++++||..+|++||++.+++.|.|-...
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 0011123356679999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.17 Aligned_cols=257 Identities=23% Similarity=0.267 Sum_probs=199.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHH-HhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEM-MKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|+||.||++..+ +|+.||+|+++... ......+..|..+ ++.++||||+++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 59999999997652 2233455556665 566799999999999999999999999
Q ss_pred eecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 102 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
|++ ++|.+++.. ....+++..++.++.|++.||.||| ++ +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 588887754 2346899999999999999999999 87 999999999999999999999999999876532
Q ss_pred ccccccccccccccccCCCccccc----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRK----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||............. .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------~ 221 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------------V 221 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH------------H
Confidence 11 1222457788999998764 456889999999999999999999986432111110000 0
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
... .. ......+++++.+++.+||..||.+||++.+++.|+|-....
T Consensus 222 ~~~-----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 222 EEP-----SP-QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred hcC-----CC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 00 000123577899999999999999999999999998876644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.09 Aligned_cols=272 Identities=19% Similarity=0.186 Sum_probs=205.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 98 (313)
.++|++.+.||.|++|.||+|..+ +++.+++|.++.... .....+.+|++++++++||||+++.+++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 368999999999999999999965 588999999975422 2234567899999999999999999999877 88999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+.+ +|.+++......+++..++.++.|++.||.||| ..+++|+||+|+||++++++.++|+|||.+......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999975 999998776657899999999999999999999 999999999999999999999999999998866433
Q ss_pred cccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--c------cc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--I------ST 249 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~------~~ 249 (313)
.. ......++..|+|||.+.+. .++.++|+||||+++++|++|..||..................+ . ..
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 21 12234467789999987654 46899999999999999999999997654332221111100000 0 00
Q ss_pred cccc--cccccChhhhhhhhhhh-hHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 250 MEVV--DANLLSQEDIHFVAKEQ-CVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 250 ~~~~--~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... ..............+.. .++.+.+++++||+.||++|||+.|++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 0000 00000000011111222 4778999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=290.99 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=203.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeee------Cc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSN------EE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~ 94 (313)
..+.|++.+.||.|+||.||+|... +++.+|+|++.... .....+..|+.+++.+ +|+||+++++++.. +.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 3578999999999999999999964 58899999986653 3446688899999998 79999999999853 45
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..+++|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 789999999999999999754 335788889999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
....... ......++..|+|||.+. ...++.++|+|||||++|+|++|..||....+..........
T Consensus 170 ~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~------ 241 (282)
T cd06636 170 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 241 (282)
T ss_pred hhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC------
Confidence 5532211 122345778899999875 346788999999999999999999999765432222111000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.........++..+.+++.+||..||.+|||+.++++|+|
T Consensus 242 -------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 242 -------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred -------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 0000012346778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.62 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=191.6
Q ss_pred cccccceeeeEEEEEee---cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLIS---SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999854 24679999887653 233457888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 107 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 107 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+|.+++.... ...+...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999996532 23566778889999999999999 9999999999999999999999999999986543221111
Q ss_pred cccccccccccCCCcccccC-------CCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-------RESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+........... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~- 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----KLP- 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----CCC-
Confidence 22234466789999987542 35789999999999999996 99999765443322211111000 000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
........++.+.+++..|| .+|.+|||+++|+..|.
T Consensus 232 ---------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 ---------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00011234566889999999 68999999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=286.31 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=191.4
Q ss_pred cccccceeeeEEEEEeec---ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLISS---AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997443 4578999876542 334456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 107 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 107 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+|.+++.... ...++..+..++.||+.||.||| +.+++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 23467788899999999999999 9999999999999999999999999999986543221111
Q ss_pred cccccccccccCCCcccc-------cCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRR-------KGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
......++..|+|||+.. ...++.++|||||||++|+|++ |..||....+.+............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-------- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc--------
Confidence 122234566799999764 3456889999999999999999 788887654433222211111000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
......+..++..+.+++..|| .||++|||+++|++.+
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 -------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000112346677889999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.50 Aligned_cols=271 Identities=21% Similarity=0.226 Sum_probs=207.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|++|.||+|..+ +++.|++|+++.. .......+.+|+++++.++|+||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999965 5889999998654 23445778899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|++++.+..+... ...++...++.++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9988665554443 346899999999999999999999 99999999999999999999999999999876643321
Q ss_pred ccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCccccccccccc--c-
Q 047140 182 MTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWLPISTMEVVD--A- 255 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--~- 255 (313)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+....... ....+ ....... .
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP-SHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH-HHhhhcccCcc
Confidence 122234567889999998887 889999999999999999999999975533222111100 00000 0000000 0
Q ss_pred -------cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 -------NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
............+..++..+.+++++||..||++|||++++++|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 0000111111223345888999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.78 Aligned_cols=253 Identities=22% Similarity=0.256 Sum_probs=210.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccc-hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||.|++|.||+|... +++.|++|++..... .....+.+|++.+..++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999966 499999999977643 4567899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++.... .+++..++.++.|++.+|.||| + .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 99999999997654 6899999999999999999999 9 9999999999999999999999999999876543221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh--h-hhhhhhccCCccccccccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN--R-EMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . +....... ..
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------~~-- 219 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------------GP-- 219 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------------CC--
Confidence 11234577889999999888999999999999999999999999976642 1 11100000 00
Q ss_pred Chhhhhhhhhhh-hHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQ-CVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+.. ++..+.+++..||..+|++||++.++++++|-.
T Consensus 220 -----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 220 -----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred -----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 0001222 677899999999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=284.34 Aligned_cols=250 Identities=28% Similarity=0.453 Sum_probs=203.3
Q ss_pred cccccccccceeeeEEEEEeec-c----eEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 27 FQILNFFICGVIIPVAQFLISS-A----MEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~-~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+++.+.||+|+||.||++.... + ..||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678899999999999999653 3 88999999765332 5678999999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 101 EYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|++++++|.+++...... +++..+..++.|++.||.+|| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765434 899999999999999999999 9999999999999999999999999999987654331
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
... .....++..|+|||.+.+..++.++|+||||+++++|++ |..||................
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------- 221 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--------------- 221 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 111 112235678999999988889999999999999999998 888887643322221111100
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
....+..++.++.+++.+||..||++|||+.++++.+
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011223677899999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.97 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=204.7
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
++|++.+.||.|+||.||+|..+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 68899999999999999999954 2467999988665333 5678999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 98 LVLEYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
+|+||+++++|.+++.... ..+++..+..++.|++.+|.||| +.+++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997543 15889999999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
|++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||.................
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~---- 236 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---- 236 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc----
Confidence 9876432211 111222345667999999888889999999999999999998 8889865443222211110000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||..||++|||+.++++.++
T Consensus 237 ---------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ---------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00012346778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=287.63 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=205.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.|++.+.||.|+||.||+|... +++.|++|.+... .......+.+|+.+++.++ |||++++++++.++...++|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999964 6899999998754 3345567888999999986 999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++... .+++..++.++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998654 6889999999999999999999 99999999999999999999999999999876643321
Q ss_pred cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...............
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~----------------- 217 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----------------- 217 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-----------------
Confidence 1233457888999998764 45789999999999999999999999754332221110000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.... .....++.++.+++.+||+.||++||++.+++.+.|-..
T Consensus 218 -~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 218 -KPPR-LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred -CCCC-CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 0000 001125677999999999999999999999999988744
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=286.68 Aligned_cols=248 Identities=26% Similarity=0.405 Sum_probs=198.5
Q ss_pred cccccceeeeEEEEEeec-------ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISS-------AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+.||+|+||.||++..++ +..+++|.+.... ......+.+|+++++.++||||+++++++......++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886542 24566788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-----ceeEcCCcc
Q 047140 103 MPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-----VAHLSDFSI 171 (313)
Q Consensus 103 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-----~~~l~dfg~ 171 (313)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 234788899999999999999999 99999999999999999887 899999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
+.................+..|+|||++.+..++.++||||||+++|+|++ |..||......+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-------- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--------
Confidence 876533221112222344678999999998899999999999999999998 99998755433322111000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..++..+.+++.+||..+|.+||++.++++.|.
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001113446788999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.72 Aligned_cols=249 Identities=23% Similarity=0.282 Sum_probs=207.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+|++.+.||.|+||.||++... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999965 58999999997542 2456788999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+.+++|.+++.... .+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV-KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 999999999997763 6889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh--hhhhhhccCCcccccccccccccccC
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR--EMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~---- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-------------T---- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-------------c----
Confidence 223345778899999998888999999999999999999999998765431 11100000 0
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH--HHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA--REIVAKLF 301 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~~il~~l~ 301 (313)
.....+...+..+.+++++||+.||.+||++ .++++|+|
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 0011233467889999999999999999999 99988865
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.18 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=207.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+-|++.+.||.|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45778899999999999999854 6889999998644 234456788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++.+. .++...+..++.+++.++.+|| ..+++|+||+|+||++++++.++++|||++........
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999999998754 5789999999999999999999 99999999999999999999999999998865532211
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||...+..++.++|+|||||++|++++|..||................
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN------------------- 217 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-------------------
Confidence 1122356778999999988889999999999999999999999986544322211110000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..++.++.+++.+||..||.+||++.++++|+|-..
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 00012345677999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=287.44 Aligned_cols=239 Identities=24% Similarity=0.293 Sum_probs=192.2
Q ss_pred cccccceeeeEEEEEeec--------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISS--------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+.||.|+||.||+|.... ..+|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 235899988765555567888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc--------eeEcCCcchhh
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV--------AHLSDFSIAKL 174 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~--------~~l~dfg~~~~ 174 (313)
+++|+|.+++......+++..+..++.||+.||.||| +.+++|+||||+||++++++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876657899999999999999999999 999999999999999987765 69999998765
Q ss_pred cccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCC-CCChhhhhhhhhhhhccCCccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRK-KPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
... .....++..|+|||++.+. .++.++|+||||+++|++++|. .|+............ ..
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~---------- 220 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED---------- 220 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc----------
Confidence 432 1223467789999988764 5799999999999999999984 666544332211100 00
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
....+...+.++.+++.+||+.||++|||++++++.|
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0011223456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=284.69 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=196.6
Q ss_pred cccccceeeeEEEEEeec-ce--EEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLISS-AM--EVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||.|+||.||+|..+. +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999653 43 5788888743 234556888999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 106 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 106 ~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
++|.+++.... ..++...+..++.|++.||+||| +.+++|+||||+||++++++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 24788999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
++....... .......+..|+|||++....++.++|+||||+++|+|++ |..||.............. .+
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~----- 228 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY----- 228 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CC-----
Confidence 875322110 1111223456999999988889999999999999999997 9999966543222111100 00
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..++.++.+++.+||..||.+|||+.++++.|..+.
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00012235677899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=294.22 Aligned_cols=272 Identities=18% Similarity=0.192 Sum_probs=202.1
Q ss_pred ccccccccccceeeeEEEEEee---cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccce
Q 047140 26 DFQILNFFICGVIIPVAQFLIS---SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKA 97 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 97 (313)
+|++.+.||+|++|.||+|..+ +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4889999999999999999964 47899999998732 34456778899999999999999999999988 7899
Q ss_pred EEEEeecCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC----CCceeEcCC
Q 047140 98 LVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD----NMVAHLSDF 169 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~----~~~~~l~df 169 (313)
+|+||+++ +|.+.+... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 788777533 226789999999999999999999 999999999999999999 999999999
Q ss_pred cchhhcccccc-cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh---------hh
Q 047140 170 SIAKLLTGEYQ-SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT---------LK 238 (313)
Q Consensus 170 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~---------~~ 238 (313)
|++........ ........++..|+|||++.+ ..++.++|+||||+++++|++|..||......... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543221 111223456788999998765 45789999999999999999999999754332200 00
Q ss_pred hccCCcc-c----------ccccc---cccccccChhhhhhhhh--hhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 239 HWGNNWL-P----------ISTME---VVDANLLSQEDIHFVAK--EQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 239 ~~~~~~~-~----------~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....... . ..... ................. ...+..+.+++.+||..||++|||+.+++.|+|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000000 0 00000 00000000011111111 156778999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=297.87 Aligned_cols=270 Identities=20% Similarity=0.167 Sum_probs=204.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----- 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (313)
.+.++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++|+||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35689999999999999999999955 6899999998643 233456677899999999999999999998643
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
...|+|+||+.+ +|.+.+... ++...+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 888887643 788899999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-cccc---
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPIS--- 248 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~~--- 248 (313)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||................. ....
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 7654321 12234567889999999999999999999999999999999999975432211111100000 0000
Q ss_pred --------------------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 --------------------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+........ ..........+..+.+++.+||+.||++|||+.+++.|+|-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFP--PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccC--cccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00000000000 000000223567789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.32 Aligned_cols=245 Identities=25% Similarity=0.394 Sum_probs=200.5
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
++|++.+.||+|+||.||.+.. +++.|++|.+... ...+.+.+|+.+++.++||||+++++++..++ .++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 5789999999999999999874 5788999998654 23467889999999999999999999987654 799999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 105 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 105 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
+++|.+++.... ..++...++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999997653 35789999999999999999999 999999999999999999999999999988653211
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+........ +
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~------------------ 214 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-Y------------------ 214 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-C------------------
Confidence 112234567999999988899999999999999999998 99999765433222111100 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++..+.+++.+||+.+|..||++++++..+.
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 00012346778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.49 Aligned_cols=256 Identities=26% Similarity=0.344 Sum_probs=216.7
Q ss_pred ccccccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 26 DFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+.+..++||-|.+|.||.|+|+. .-.||||.++.+ ....++|..|+.+++.+.|||+|+++++|..+-.+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44567899999999999999885 668999999766 5678999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 105 HGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 105 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
.|+|.+++...+ ...+.-.+++++.||.+|+.||. .++++||||...|.|+.++..||++|||+++.+.+.....
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 999999998654 34666778899999999999999 9999999999999999999999999999999886543221
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....-++.|.|||-+....++.++|||+||++|||+.| |..||.+.+-.+.+--....
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------------- 482 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------------- 482 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------------
Confidence 112223567999999999999999999999999999999 88999887654443322111
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+...+..|++.+++||+.||+++|.+||+++++-+.++.+..+
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 11122667999999999999999999999999999999877644
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.15 Aligned_cols=254 Identities=18% Similarity=0.229 Sum_probs=205.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee--CccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 100 (313)
+|++.+.||.|+||.||++... ++..|++|.+..+ .....+.+..|+++++.++|+||+++++.+.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999954 5889999998754 23445678889999999999999999998754 45689999
Q ss_pred EeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 101 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 101 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
||+++++|.+++... ...+++..++.++.|++.||.|||..+ +.+++|+||+|+||++++++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 447899999999999999999999432 567999999999999999999999999998876
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......++..|+|||++.+..++.++|+||||+++++|++|..||................
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------------ 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC------------
Confidence 43221 1223457888999999998889999999999999999999999997654322211111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+...+..+.+++.+||..+|++||++.+|++|++
T Consensus 227 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 227 --------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred --------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 00113346678999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=291.08 Aligned_cols=267 Identities=22% Similarity=0.239 Sum_probs=203.2
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||.|++|.||+|... +++.|+||.+.... ......+.+|++++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999965 58999999987542 22345788899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+. ++|..++... ...+++..+..++.|++.||+||| ..+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 5898888653 346899999999999999999999 99999999999999999999999999999875532211
Q ss_pred ccccccccccccCCCcccccCC-CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc-cc----------
Q 047140 182 MTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI-ST---------- 249 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~-~~---------- 249 (313)
......++..|+|||++.+.. ++.++|+||||+++|+|+||..||..................+. ..
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122334577899999876544 58899999999999999999999976543322221111100000 00
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+.. ..... .......++.++.+++.+||+.||++|||++++++|+|
T Consensus 235 ~~~~~~--~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 235 KPSFPK--WARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred Hhhccc--ccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 000000 00000 00012245677899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.62 Aligned_cols=257 Identities=23% Similarity=0.259 Sum_probs=207.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
......|+..+.||+|+||.||++... ++..|++|.+... .......+.+|+++++.++|+|++++++++.++...
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 444567899999999999999999954 5899999998753 223445788899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+.+ +|.+.+......+++..+..++.+++.+|.||| ..+++|+||+|+||++++++.++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 999999975 888888766557899999999999999999999 9999999999999999999999999999876433
Q ss_pred cccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
. .....++..|+|||++. ...++.++|+|||||++|+|++|..||.................
T Consensus 177 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--------- 241 (317)
T cd06635 177 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------- 241 (317)
T ss_pred C------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC---------
Confidence 1 12335777899999874 45678999999999999999999999866433222221111000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.......++..+.+++.+||+.+|.+||++.++++|+|.+...
T Consensus 242 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 ----------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ----------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0001223567799999999999999999999999998865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=281.81 Aligned_cols=254 Identities=24% Similarity=0.284 Sum_probs=210.5
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 100 (313)
+|.+.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999966 68999999997653 24577889999999999999999999999988 8899999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|++++++|.+++.... .+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 7899999999999999999999 99999999999999999999999999999887654332
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
........++..|+|||.+....++.++|+||||++++++++|..||...............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS------------------ 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc------------------
Confidence 11123456788899999998888999999999999999999999998765421111110000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......+...+..+.+++.+||..||.+||++.+++.|+|
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 00001123345778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=287.41 Aligned_cols=262 Identities=20% Similarity=0.203 Sum_probs=203.8
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 100 (313)
++|+..+.||.|++|.||++... +++.+|+|.+.... ......+.+|+++++.++||||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999965 58999999997542 23456788999999999999999999998653 4689999
Q ss_pred EeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++.. ....+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999888653 3346788999999999999999999 99999999999999999999999999999865432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh-hhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM-TLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... .......
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~ 224 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL---------SYIVNMP 224 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH---------HHHhcCC
Confidence 11 1234467789999999888999999999999999999999999975522000 00000 0000000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. .............++.+.+++.+||..||++|||+.|+++|+|-.
T Consensus 225 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 225 N-PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred c-hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 0 000000000123467799999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=290.43 Aligned_cols=275 Identities=19% Similarity=0.244 Sum_probs=203.3
Q ss_pred cccccc--eeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICG--VIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
..||+| +||+||++... +++.||+|++... .....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999965 6999999998754 233457788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc-
Q 047140 106 GSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT- 183 (313)
Q Consensus 106 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~- 183 (313)
++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998764 235889999999999999999999 99999999999999999999999999986544322111100
Q ss_pred ----ccccccccccCCCcccccC--CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-cccc-------
Q 047140 184 ----QTQTLATIGCIAPEYRRKG--RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PIST------- 249 (313)
Q Consensus 184 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~------- 249 (313)
.....++..|+|||++.+. .++.++|+|||||++|+|++|..||.................. +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 1112345669999998763 4789999999999999999999999766443332221111100 0000
Q ss_pred ccc-----------cccc-------ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 250 MEV-----------VDAN-------LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 250 ~~~-----------~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
... .+.. ..............++..+.+|+++||..||++|||+.++++|+|-......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 000 0000 0000111112234577889999999999999999999999999997655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=281.32 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=190.6
Q ss_pred cccccceeeeEEEEEeec-c----------eEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 31 NFFICGVIIPVAQFLISS-A----------MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~-~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999764 3 25888887655332 6788899999999999999999999988 778999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-------ceeEcCCcch
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-------VAHLSDFSIA 172 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-------~~~l~dfg~~ 172 (313)
+||+++++|.+++......++...+..++.|++.||.||| +++++|+||||+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876557899999999999999999999 99999999999999999887 7999999998
Q ss_pred hhcccccccccccccccccccCCCcccccC--CCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKG--RESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
..... .....++..|+|||++... .++.++|+||||+++|++++ |..||........... +..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~~------- 221 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQD------- 221 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hhc-------
Confidence 76532 1223456679999998776 78999999999999999999 5777765532211110 000
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
.... +......+.+++.+||..+|.+|||+.++++.|
T Consensus 222 -----~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 -----QHRL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----CCCC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 001126789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=286.54 Aligned_cols=270 Identities=21% Similarity=0.235 Sum_probs=205.0
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999965 58999999997653 233466778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 104 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 104 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
++ +|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 8988886543 46899999999999999999999 99999999999999999999999999999875532211
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--cccc-----ccc
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--ISTM-----EVV 253 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~ 253 (313)
......++..|++||.+.+ ..++.++|+||||+++|++++|..||......+...........+ .... ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223346778999998765 456899999999999999999999997654332222111100000 0000 000
Q ss_pred cccc-cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANL-LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... .............++..+.+++.+||+.||.+||+++++++|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0000 00000011112345788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.52 Aligned_cols=276 Identities=19% Similarity=0.216 Sum_probs=201.8
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
...++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34468999999999999999999965 58999999986542 222345667999999999999999999987654
Q ss_pred ----cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 95 ----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
..++|+||+.+ +|.+.+......+++..++.++.|++.||.||| .++++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999964 898888776557899999999999999999999 9999999999999999999999999999
Q ss_pred chhhccccccc--ccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh--hccCCcc
Q 047140 171 IAKLLTGEYQS--MTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK--HWGNNWL 245 (313)
Q Consensus 171 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~--~~~~~~~ 245 (313)
++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98765432211 111233467789999987654 468899999999999999999999966543221110 0000000
Q ss_pred cccccc-----cccccccChhh----hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 246 PISTME-----VVDANLLSQED----IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 246 ~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+..... ..+........ .....+...+..+.+++.+||..||.+|||++++++|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 000000 00000000000 000001123466789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.50 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=210.1
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||.|++|.||++... +++.+++|++.... ......+.+|+++++.++|+|++++.+.+..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999965 58999999997653 25667788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 103 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 103 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+++++|.+++... +..++...+..++.+++.||.+|| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999765 357899999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......++..|+|||...+..++.++|+||+|+++++|++|..||.................
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY--------------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC---------------
Confidence 122334577889999999888899999999999999999999999866543332222111110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++..+.+++..||..+|.+|||+.++++|+|
T Consensus 221 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 221 -----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 0012246678999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.23 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=205.5
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|+||.||++..+ ++..+++|.+... .....+.+.+|+++++.++|+||+++++.+.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999965 5889999998654 123446778899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhcccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~ 180 (313)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998654 335789999999999999999999 99999999999999999885 569999999876643221
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||+..+..++.++|+||||++++++++|..||.................
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 219 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---------------- 219 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC----------------
Confidence 12234578889999999888899999999999999999999999875543332222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......+.++.+++.+||..+|++|||+.++++|+|
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 220 ----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 0012235677999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=289.06 Aligned_cols=273 Identities=20% Similarity=0.229 Sum_probs=202.6
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
|.+++.+|.|+++.|+++.. +++.||+|++... .......+..|+++++.++|+||+++++++.+.+..++++||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44555566666665555554 6899999999764 34566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc--
Q 047140 105 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS-- 181 (313)
Q Consensus 105 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 181 (313)
+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999754 346889999999999999999999 999999999999999999999999999988755322111
Q ss_pred ---ccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc--------ccc
Q 047140 182 ---MTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL--------PIS 248 (313)
Q Consensus 182 ---~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 248 (313)
.......++..|+|||++.. ..++.++|+|||||++|+|++|..||.................. +..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 01122345677999998865 35789999999999999999999999765443332221111100 000
Q ss_pred cccccc-----ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVD-----ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...... .................+.++.+++.+||..||++|||++++++|+|-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 000000 0000011111222345678899999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.92 Aligned_cols=267 Identities=18% Similarity=0.187 Sum_probs=199.0
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC--ccceEEEE
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE--EFKALVLE 101 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e 101 (313)
|++.+.||.|+||.||++... +++.||+|++.... .........|+.++.++ +|+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999954 58999999987542 22223445788889888 499999999999887 88999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++ +|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.++|+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 9975 888888765557899999999999999999999 999999999999999999 999999999987654322
Q ss_pred ccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-cccccccccc----
Q 047140 182 MTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTMEVVDA---- 255 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---- 255 (313)
......++..|+|||... +..++.++|+|||||++|+|++|..||......+........... ..........
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 112244678899999764 455789999999999999999999999765432221111100000 0000000000
Q ss_pred --cccChhhh-hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 --NLLSQEDI-HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 --~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
........ -......++..+.+++.+||..||++||++.+++.|+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00000000 00112356889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=285.00 Aligned_cols=248 Identities=19% Similarity=0.210 Sum_probs=199.4
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||.|+||.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++++..++..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 58999999986531 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccccc
Q 047140 109 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187 (313)
Q Consensus 109 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 187 (313)
.+++.... ..+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||.+....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 99987643 36899999999999999999999 9999999999999999999999999999987654211 12234
Q ss_pred ccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhh
Q 047140 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267 (313)
Q Consensus 188 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
.++..|+|||+..+..++.++|+||||+++++|++|..||................ . ......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~---~~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------------L---EMAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------------c---cccccC
Confidence 56778999999988889999999999999999999999986543211110000000 0 000111
Q ss_pred hhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHHH
Q 047140 268 KEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFKI 303 (313)
Q Consensus 268 ~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~~ 303 (313)
+..+++.+.+++.+||+.||++|| ++.+++.|+|-.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 334577899999999999999999 889999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.81 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=217.7
Q ss_pred hhhhhhhc-ccccccccccccceeeeEEEEEe-ecceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeee
Q 047140 16 RDVFRRSQ-TSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTC 90 (313)
Q Consensus 16 ~~~~~~~~-~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (313)
.++|+..- .+.|..++.||.|+||.||.|+. .+.+.||||+...+. .+.-+.+..|+..|++++|||++.+-++|
T Consensus 16 A~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy 95 (948)
T KOG0577|consen 16 ADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY 95 (948)
T ss_pred HHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence 34455433 45788999999999999999994 478999999997653 33446788999999999999999999999
Q ss_pred eeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 91 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
..+...|+|||||-| +..|++.-+.+++.+-.+..|..+.+.||+||| +.+.+|||||..|||+++.|.|||+|||
T Consensus 96 Lre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 96 LREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred eccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecccc
Confidence 999999999999965 999999888778999999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.+....+ .....||+.|||||++. .+.|+-++||||||++..||.-.++|+-.+..-...+.+..+.
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---- 241 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---- 241 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC----
Confidence 9987653 23467999999999886 5679999999999999999999999975554332222221111
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+ ......+++.+.+|+..||+.-|.+|||.+++++|.+-++++
T Consensus 242 -------------sP--tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 242 -------------SP--TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred -------------CC--CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 00 001346888999999999999999999999999998766654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.86 Aligned_cols=276 Identities=20% Similarity=0.182 Sum_probs=203.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----c
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-----E 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 94 (313)
.++++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++|+||+++++++... .
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 35689999999999999999999954 6899999998643 233456678899999999999999999887544 3
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++|+||+.+ +|.+.+... .+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 57999999965 888887654 5899999999999999999999 99999999999999999999999999999876
Q ss_pred ccccccc-ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCccccccc
Q 047140 175 LTGEYQS-MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWLPISTM 250 (313)
Q Consensus 175 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 250 (313)
....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.............. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5332111 11223457888999997654 5689999999999999999999999965432211110000 000000000
Q ss_pred ccccccc-------cChhhhh-hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 251 EVVDANL-------LSQEDIH-FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 251 ~~~~~~~-------~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+... ....... .......+.++.+++.+||+.||++|||+.+++.|+|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0000000 0000000 001123567799999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=281.41 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=202.1
Q ss_pred ccccccccccceeeeEEEEEeec--ceEEEEEEeecc----------cchhHHHHHHHHHHHhc-CCCCcceeeeeeeee
Q 047140 26 DFQILNFFICGVIIPVAQFLISS--AMEVAVKVFNLQ----------CGRAFKSFNIECEMMKS-IRHRNLIKVISTCSN 92 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 92 (313)
+|++.+.||+|+||.||++.... ++.+++|.+... .......+..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999653 789999988642 12234556778888865 699999999999999
Q ss_pred CccceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcC
Q 047140 93 EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
++..++++||+++++|.+++.. ....+++..++.++.|++.+|.||| . .+++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3446899999999999999999999 6 6899999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
||.+....... ......++..|++||...+..++.++|+||||+++|++++|..||................+.+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 232 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-- 232 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--
Confidence 99987654322 2234557888999999998889999999999999999999999986543322221111111000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....++..+.+++.+||..||++||++.++.+++.
T Consensus 233 -----------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 233 -----------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 001235677999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.60 Aligned_cols=269 Identities=22% Similarity=0.217 Sum_probs=202.8
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
|++.+.||.|++|.||+|... +++.|++|++.... ......+.+|+++++.++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999965 69999999987542 223456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+ ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 58999886543 35899999999999999999999 99999999999999999999999999999875532211
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc--------cccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI--------STMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 253 (313)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||..................+. ......
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223457789999987654 568999999999999999999999976543222211111000000 000000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.................++..+.+++.+||+.||.+|||+.+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 000000000001112346678999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.36 Aligned_cols=274 Identities=20% Similarity=0.160 Sum_probs=205.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----c
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-----E 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 94 (313)
+.++|.+.+.||.|+||.||++... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4678999999999999999999954 5899999998653 233455677899999999999999999988654 3
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++|+||+. ++|.+++...+ .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 5799999996 59999887654 6899999999999999999999 99999999999999999999999999999876
Q ss_pred cccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccc-----
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLP----- 246 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~----- 246 (313)
..... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............... ....
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 54321 11223456788999998764 46899999999999999999999999654322111100000 0000
Q ss_pred ---ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ---ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+.................++.++.+++++||+.||++|||++++++|+|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 000000000000000000111235788899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.01 Aligned_cols=244 Identities=23% Similarity=0.251 Sum_probs=201.6
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||.|++|.||++... +++.|++|++.... ....+.+.+|+++++.++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 48999999997542 23457789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
.+++.+.. .++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997654 5889999999999999999999 9999999999999999999999999999988664321 122345
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh--hhhhhhhccCCcccccccccccccccChhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN--REMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
++..|++||.+.+..++.++|+||||+++|++++|..||..... ........ . ......
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~------~~~~~~ 214 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL-------------K------GNGKLE 214 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh-------------c------cCCCCC
Confidence 77889999998888899999999999999999999999976542 11111100 0 000111
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
.+...+..+.+++.+||..||.+||+ +.|+++|+|-
T Consensus 215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 12334678999999999999999999 9999999984
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=280.46 Aligned_cols=296 Identities=20% Similarity=0.237 Sum_probs=221.6
Q ss_pred cchhhhhhcchhhhhhhcccccccccccccceeeeEEEEEeec-----ceEEEEEEeecc--cchhHHHHHHHHHHHhcC
Q 047140 6 NILAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISS-----AMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI 78 (313)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l 78 (313)
.+..|+..+..+..+-..-..|++.+.||+|.+|.||+|+-++ .+.+|||.|+.+ ........-+|+.+++.+
T Consensus 5 ~~~~~~~~~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl 84 (438)
T KOG0666|consen 5 MDYDFKSKLASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL 84 (438)
T ss_pred ccccchhhhhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh
Confidence 3455677766677766777899999999999999999997332 237899999765 234556778899999999
Q ss_pred CCCcceeeeeeeee-CccceEEEEeecCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 047140 79 RHRNLIKVISTCSN-EEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153 (313)
Q Consensus 79 ~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p 153 (313)
+|+|++.+..+|.. +..+++++||.++ +|+.+|+-+ ...++...+..+++||+.++.||| ++-++|||+||
T Consensus 85 ~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKP 160 (438)
T KOG0666|consen 85 KHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKP 160 (438)
T ss_pred cCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCc
Confidence 99999999999977 7789999999987 999999744 346899999999999999999999 99999999999
Q ss_pred CceEecCC----CceeEcCCcchhhcccccccc-cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 154 INVLLDDN----MVAHLSDFSIAKLLTGEYQSM-TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 154 ~nil~~~~----~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
.|||+..+ |.|||+|+|+++.+....... ......-|..|+|||++.+. .|+.+.|+|+.||++.||+|-.+.|
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 99999766 999999999999886554433 34556789999999988765 6899999999999999999998888
Q ss_pred hhhhhhhh------------hhhhcc----CCccc-ccccccccccccChhhhh--------hh--hhhhhHHHHHHHHh
Q 047140 228 DEIFNREM------------TLKHWG----NNWLP-ISTMEVVDANLLSQEDIH--------FV--AKEQCVSFVFNLAI 280 (313)
Q Consensus 228 ~~~~~~~~------------~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~--------~~--~~~~~~~~l~~li~ 280 (313)
.+....-. .+.... ..|.. .+..+. +......+.. .. ....-++...+|+.
T Consensus 241 ~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~--q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~ 318 (438)
T KOG0666|consen 241 KGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEY--QTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQ 318 (438)
T ss_pred cchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcch--HHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHH
Confidence 54321100 011110 01111 000000 0000000000 00 01112445899999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 281 ECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 281 ~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
+||+.||.+|.|++++++|+.-..+.+
T Consensus 319 klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 319 KLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred HHhccCchhhccHHHHhcccccccCCC
Confidence 999999999999999999987666544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.77 Aligned_cols=251 Identities=19% Similarity=0.278 Sum_probs=189.0
Q ss_pred cccccceeeeEEEEEeec---ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 31 NFFICGVIIPVAQFLISS---AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.||+|+||.||++...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.|.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 368999999999998543 2356677765442 334578899999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 107 SLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 107 ~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
+|.+++.... ...+...+..++.||+.||.||| +.+++|+||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 24567778899999999999999 99999999999999999999999999998754321111111
Q ss_pred ccccccccccCCCccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 184 QTQTLATIGCIAPEYRRK-------GRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.....++..|+|||+... ..++.++||||||+++|+|++ |..||......+.......... ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~- 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-----VKLFK- 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-----cccCC-
Confidence 223456788999998642 245789999999999999997 5678865544332222111100 00000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
...+...++.+.+++..|| .+|.+||++.++++.|
T Consensus 232 ---------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 ---------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ---------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 0112235677899999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=295.98 Aligned_cols=277 Identities=19% Similarity=0.168 Sum_probs=207.2
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeee----Ccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 95 (313)
+.++|++.+.||.|++|.||++..+ +++.|++|++.... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4578999999999999999999955 59999999987542 2345677789999999999999999998753 356
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+. ++|.+++.... .+++..++.++.|++.||.||| ..+++|+||||+||++++++.++|+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 899999996 59999887655 5899999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccc--cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-ccccc---
Q 047140 176 TGEYQSM--TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-WLPIS--- 248 (313)
Q Consensus 176 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~--- 248 (313)
....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 4322111 1123457888999998765 468999999999999999999999997654322111100000 00000
Q ss_pred ------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 ------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...............-.......+.++.+++++||+.||.+|||+++++.|+|-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 00000000000000000112345788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=288.05 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=208.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 99 (313)
++|.+.+.||+|++|.||++... +++.|++|++..+ .......+..|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999965 6999999998753 2234567888999999998 99999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
||++++++|.+++...+ .++...++.++.|++.||.+|| ..+++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998765 6899999999999999999999 9999999999999999999999999999987664322
Q ss_pred cc------------------ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc
Q 047140 180 QS------------------MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 180 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~ 241 (313)
.. .......++..|+|||......++.++|+||||++++++++|..||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 11 112233467889999998888899999999999999999999999976542221111110
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH----HHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA----REIVAKLF 301 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~il~~l~ 301 (313)
. ....+..+++.+.+++.+||+.||.+||++ .++++|+|
T Consensus 237 ~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 237 L---------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred c---------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 0 011123457779999999999999999999 99999876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=288.24 Aligned_cols=270 Identities=19% Similarity=0.186 Sum_probs=201.5
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc-----
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF----- 95 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----- 95 (313)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999965 58999999986542 22345678899999999 56999999999977665
Q ss_pred ceEEEEeecCCCHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCc
Q 047140 96 KALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFS 170 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg 170 (313)
.++|+||+++ +|.+++... ...+++..++.++.||+.||.||| .++++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999976 898888643 235799999999999999999999 999999999999999998 8999999999
Q ss_pred chhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--c
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--I 247 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~ 247 (313)
.+..+..... ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||..................+ .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875532211 1122345778999998764 457999999999999999999999997654433222111100000 0
Q ss_pred ---ccccccc---ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 248 ---STMEVVD---ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 248 ---~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....... ......... ......++..+.+++.+||..||.+||++.+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred hCcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0000000 000000000 0112346788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=285.10 Aligned_cols=270 Identities=21% Similarity=0.222 Sum_probs=205.5
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccceEEEE
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKALVLE 101 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 101 (313)
|++.+.||.|++|.||+|... +++.+++|++.... ......+.+|+++++.++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999966 48999999998752 34456788899999999999999999999888 88999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++ +|.+++......+++..++.++.|++.||+||| ..+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 999988776557899999999999999999999 99999999999999999999999999999886643321
Q ss_pred ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc--cccccccccc----
Q 047140 182 MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW--LPISTMEVVD---- 254 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---- 254 (313)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................. .........+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 11223345778999997654 4678999999999999999999999976543322211111000 0000000000
Q ss_pred ccccC----hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 255 ANLLS----QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 255 ~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..... ...........++..+.+++++||..||.+||++++++.++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 00000 000011111224788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=309.53 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=223.8
Q ss_pred ccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+...|.+.||.|.||.|++|+.+. ...||||.++.. .+.....|..|+.||-+++||||+++.++......++|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 4567899999999999999999762 359999999876 44567789999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+|||+.|+|..+|..+...++.-++..+++.|+.|++||- ..++|||||...|||++++-.+|+.|||+++.+.+.
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999999988778999999999999999999999 999999999999999999999999999999976433
Q ss_pred c-ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 Y-QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
- .......-..+..|.|||.+...+++.+|||||+|++|||.++ |..||=++++.+.......
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~--------------- 849 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ--------------- 849 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh---------------
Confidence 2 1111112234578999999999999999999999999999887 9999977776666443322
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
..+++.|..||..|.+||..||++|-..||.+.||+.+|..+..
T Consensus 850 -----gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 850 -----GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -----ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 22344467899999999999999999999999999999998874
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=281.16 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=199.8
Q ss_pred cccccccccceeeeEEEEEee----cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc------
Q 047140 27 FQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE------ 94 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 94 (313)
|++.+.||+|+||.||+|... ++..||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678889999999999999853 3689999998754 2344667889999999999999999999886542
Q ss_pred cceEEEEeecCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
..+++++|+.+++|.+++... ...++...+..++.|++.||+||| +.+++|+||||+||++++++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 247889999999998887432 124788899999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
|.+................++..|++||...+..++.++|||||||++|+|++ |..||......+..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR---- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc----
Confidence 99886532221111222334567999999988889999999999999999999 8899876543322211111100
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+++.+||+.+|.+|||+.++++.+..+
T Consensus 234 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000123567799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.12 Aligned_cols=278 Identities=23% Similarity=0.223 Sum_probs=207.7
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC--c
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE--E 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~ 94 (313)
..+.++|++.+.||+|+||.||+|... +++.+++|++... .......+..|+.+++++ +|+||++++++|... .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 467789999999999999999999965 5889999988542 234456677899999999 999999999998653 4
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++|+||+++ +|..++... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 68999999975 999988765 5788889999999999999999 99999999999999999999999999999886
Q ss_pred ccccccc---ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--c-
Q 047140 175 LTGEYQS---MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--I- 247 (313)
Q Consensus 175 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~- 247 (313)
....... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||..................+ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5432211 12223457888999997754 567899999999999999999999997654332221111110000 0
Q ss_pred -------cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 248 -------STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 248 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......+................++.++.+++.+||+.||.+|||+.+++.|+|-..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 000000000000000001112236788999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.08 Aligned_cols=274 Identities=16% Similarity=0.157 Sum_probs=194.1
Q ss_pred cccccccccccccceeeeEEEEEeec--ceEEEEE------------------EeecccchhHHHHHHHHHHHhcCCCCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISS--AMEVAVK------------------VFNLQCGRAFKSFNIECEMMKSIRHRN 82 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~~ 82 (313)
+.++|++++.||+|+||.||++..+. +...+.| .+.. .......+.+|+++++.++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 1111 1234556889999999999999
Q ss_pred ceeeeeeeeeCccceEEEEeecCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 83 LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
|+++++++.+.+..++|++++. ++|.+++.... .......+..++.||+.||.||| +++|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999995 48877775431 12345677889999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCC-Chhhhh--hhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-TDEIFN--REM 235 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-~~~~~~--~~~ 235 (313)
+.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|||++|..+ +..... ...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986643221 122235689999999999999999999999999999999998754 432211 011
Q ss_pred hhhhcc------CCccc--ccccccccccccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 236 TLKHWG------NNWLP--ISTMEVVDANLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 236 ~~~~~~------~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...... ..+.. ......++..... ............+.++.+++.+||+.||++|||+.|+++|+|-
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 100000 00000 0001111110000 0000111122356678899999999999999999999999984
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=284.46 Aligned_cols=258 Identities=22% Similarity=0.235 Sum_probs=200.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.++. |+||+++++++..+...++++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778889999999999999965 5899999998754 2345567889999999995 9999999999999999999999
Q ss_pred eecCCCHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 102 YMPHGSLEKYLY----SSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 102 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+.. ++.++.. .....+++..+..++.+++.||+||| + .+++|+||+|+||++++++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9854 6655432 12346899999999999999999999 6 499999999999999999999999999987654
Q ss_pred cccccccccccccccccCCCcccccC---CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG---RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||..................+
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 229 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP------- 229 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC-------
Confidence 321 12233577889999988765 68999999999999999999999997653211111000000000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........++..+.+|+.+||+.||++|||+.++++|+|-..
T Consensus 230 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 230 --------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred --------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 0000011346778999999999999999999999999988643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=277.90 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=208.5
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|+++++.++|+|++++++++.+++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999865 588999999977643 4567899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++.... .+++..++.++.|++.+|.+|| +.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 99999999997764 6899999999999999999999 99999999999999999999999999999886643321
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|+|||...+..++.++|+||+|++++++++|..||................
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 215 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD------------------- 215 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------------------
Confidence 1223457888999999888889999999999999999999999986544322221111000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..+++.+.+++.+||..+|++|||+.+++.+.|
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence 00112345778999999999999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=285.50 Aligned_cols=269 Identities=20% Similarity=0.223 Sum_probs=206.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-C-C----cceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-H-R----NLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~ 94 (313)
...++|++...+|+|.||.|-.+... .+..||||+++.- ....+..+-|+++|+++. + | .++++.++|+..+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999944 5789999999765 345566677999999993 2 2 5788889999999
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-------------
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD------------- 160 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~------------- 160 (313)
+.|+|+|.+ |.|+.+++.+. -.+++..+++.+++|++.+++||| ..+++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999 56999999875 347899999999999999999999 999999999999999821
Q ss_pred -------CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh
Q 047140 161 -------NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR 233 (313)
Q Consensus 161 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~ 233 (313)
+..++++|||.++.-.. .......|..|+|||++.+.+++.++||||+||+|.|+.||...|..-.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 34589999999985432 234567889999999999999999999999999999999999998776544
Q ss_pred hh---hhhhcc--------------------CCcccccc----cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccC
Q 047140 234 EM---TLKHWG--------------------NNWLPIST----MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286 (313)
Q Consensus 234 ~~---~~~~~~--------------------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 286 (313)
+- ...... ..|..... ....+. .................|.+|+++||..|
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~--ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP--CKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC--CccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 41 111111 00100000 000000 00000001112345667999999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 047140 287 PEQRINAREIVAKLFK 302 (313)
Q Consensus 287 P~~Rps~~~il~~l~~ 302 (313)
|.+|+|+.|++.|++-
T Consensus 394 P~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 394 PARRITLREALSHPFF 409 (415)
T ss_pred ccccccHHHHhcCHHh
Confidence 9999999999999874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=286.27 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=208.7
Q ss_pred hhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeee
Q 047140 16 RDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCS 91 (313)
Q Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (313)
...|.....+.|+..+.||+|++|.||+|... +++.+++|.+... .......+.+|+++++.++|+|++++.+++.
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HhhhcCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 33445556778999999999999999999965 5889999998643 2234456788999999999999999999999
Q ss_pred eCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
+....++|+||+. +++.+.+......+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++++|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999996 5888887665556899999999999999999999 99999999999999999999999999998
Q ss_pred hhhcccccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
+..... .....++..|+|||.+. ...++.++|||||||++|+|++|..||.................
T Consensus 162 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---- 231 (308)
T cd06634 162 ASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---- 231 (308)
T ss_pred ceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----
Confidence 865432 12335677899999874 34678899999999999999999999865432222111100000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
. ......++..+.+++.+||..+|++||++.+++.|+|....
T Consensus 232 ----------~-----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 ----------P-----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ----------C-----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 00122466779999999999999999999999999986653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=283.51 Aligned_cols=247 Identities=17% Similarity=0.176 Sum_probs=192.2
Q ss_pred ccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHH---hcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 32 FFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMM---KSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
.||+|+||.||++... +++.+|+|.+.... ......+..|..++ ...+|++|+.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4799999999999964 58999999986531 11122333444333 33479999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||||+||++++++.++++|||++...... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence 999999987665 6899999999999999999999 999999999999999999999999999998654321 12
Q ss_pred cccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||... +..++.++|+||+||++|+|++|..||............... . ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------------~---~~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------------L---TV 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---------------h---cC
Confidence 2345888999999876 456899999999999999999999999654321111000000 0 00
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFKIR 304 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~~~ 304 (313)
....+..++.++.+++.+||+.||++|| |+.++++|+|-..
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 0111334677899999999999999999 6999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.51 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=216.5
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
-...|.+.+.||+|.|+.|.+|.+. ++..||||.+.+. +....+.+.+|+++++.++|||||+++++......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3468999999999999999999955 6999999999776 334456789999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||..+|.+.+++.+++ ...+.....++.|+++|++|+| +++|+|||||++|+|++.+.++||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999999988 4555999999999999999999 999999999999999999999999999999987632
Q ss_pred ccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......+|+..|.|||++.+.++ .+.+|+||+|+++|.|+.|..||++..-.+........
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g---------------- 270 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG---------------- 270 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee----------------
Confidence 24456789999999999998877 78999999999999999999999865432221111110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+--.+.+..+|++++|-.+|.+|++.+++.++.|.-.
T Consensus 271 -----k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 271 -----KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred -----eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 11123345677899999999999999999999999988643
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=284.73 Aligned_cols=274 Identities=20% Similarity=0.190 Sum_probs=203.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||.|++|.||++..+ +++.|++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999965 58999999986542 2234567889999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~ 179 (313)
|+++ +|.+.+.... ..+++..++.++.||+.||.||| +++++|+||+|+||++++ ++.++|+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9964 8888775543 23678888999999999999999 999999999999999985 5679999999987543221
Q ss_pred ccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--ccc---cccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--IST---MEVV 253 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~---~~~~ 253 (313)
.......++..|+|||.+.+ ..++.++|+||||+++|+|+||..||......+...........+ ... ....
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 11123346778999998765 457899999999999999999999997654332222111100000 000 0000
Q ss_pred ccc-ccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DAN-LLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~-~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
+.. ... ............++.+.+++.+||+.||++||++.+++.|+|-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 000 000 000001112346778999999999999999999999999987543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=299.31 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=216.5
Q ss_pred cccccccccccceeeeEEEEEeec--ce--EEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS--AM--EVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~--~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
++....++||+|+||.|++|.|.. |+ .||||.+...... ....|.+|+.+|.+|+|+|+++++++..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 456778899999999999999763 44 7899999876443 67899999999999999999999999987 778999
Q ss_pred EEeecCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
+|+++.|+|.+.+.+ ....+-...+..++.||+.|+.||. .++.||||+-..|+|+-....|||+|||+.+-+..+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999987 4456788889999999999999999 999999999999999999999999999999988755
Q ss_pred ccccc-ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 YQSMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
..... .....-...|+|||-+....++-++|+|++||+||||+| |..||-+....+......
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD---------------- 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID---------------- 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----------------
Confidence 44332 233445677999999999999999999999999999999 889998776554433221
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..+..|++++++++..||..+|.+|||+..|.+.+-..+
T Consensus 330 ----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 330 ----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 11223346789999999999999999999999999986655544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=284.21 Aligned_cols=257 Identities=21% Similarity=0.209 Sum_probs=206.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
..|+....||+|+||.||++..+ +++.||+|++..........+.+|+.+++.++|+||+++++.+..++..++|+||+
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 34455568999999999999864 68999999986654455677889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++... .+++..+..++.|++.+|+||| ..|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~ 172 (292)
T cd06657 100 EGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR 172 (292)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cc
Confidence 999999987543 4788999999999999999999 9999999999999999999999999999876543221 11
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||................ +.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------------~~ 234 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------------PP 234 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC------------------Cc
Confidence 223457788999999888889999999999999999999999986543222111100000 00
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.......++..+.+++.+||..||.+||++.+++.|+|-..-.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0001123566789999999999999999999999998865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=290.46 Aligned_cols=279 Identities=18% Similarity=0.146 Sum_probs=206.5
Q ss_pred hhccccccc-ccccccceeeeEEEEEee-cceEEEEEEeecccchh--------------HHHHHHHHHHHhcCCCCcce
Q 047140 21 RSQTSDFQI-LNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRA--------------FKSFNIECEMMKSIRHRNLI 84 (313)
Q Consensus 21 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~ 84 (313)
.++.++|.. .+.||.|+||.||+|..+ +++.||+|++....... ...+.+|+++++.++|+||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 356678875 577999999999999955 58999999986542111 12467899999999999999
Q ss_pred eeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 85 KVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
++++++..++..++|+||+. ++|.+++.... .+++..+..++.|++.||.||| ..+++|+||+|+||++++++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 99999999999999999996 59999987654 6899999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhccccc------------ccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhh
Q 047140 165 HLSDFSIAKLLTGEY------------QSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIF 231 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~ 231 (313)
+|+|||.+....... .........++..|+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654110 01111223457789999988654 46899999999999999999999997654
Q ss_pred hhhhhhhhccCCccc--cccccccc-----ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 232 NREMTLKHWGNNWLP--ISTMEVVD-----ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..+...........+ ........ .................+..+.+++.+||+.||++|||+++++.|+|-..
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 433222111100000 00000000 00000000111112345778999999999999999999999999988643
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=278.81 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=206.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+|++.+.||.|++|.||++..+ +++.+++|.+... .......+.+|+++++.++|+||+++.+++.++...++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999854 6889999999764 234456778899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 103 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 103 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+++++|.+++... ...+++..++.++.|++.||.||| +.|++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 346889999999999999999999 999999999999999999999999999998776433
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|++||.+.+..++.++|+||||++++++++|..||.................
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--------------- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 22234577889999999988899999999999999999999999976543322211111000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..++.++.+++.+||..+|++||++.++++||.
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~ 255 (256)
T cd08530 219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255 (256)
T ss_pred -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence 0012246777999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=284.40 Aligned_cols=269 Identities=21% Similarity=0.196 Sum_probs=206.9
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
|++.+.||.|++|.||++... +++.+++|.+.... ......+..|+++++.++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999965 68999999987652 234567888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++ +|.+++......+++..+..++.|++.+|.||| +.+++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 998888776557899999999999999999999 9999999999999999999999999999987664332 11
Q ss_pred ccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccccccccccc---c--
Q 047140 184 QTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLPISTMEVVD---A-- 255 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~-- 255 (313)
.....++..|+|||.+.+. .++.++|+||||+++|++++|..||......+........ ...+........ .
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234567789999988766 7899999999999999999999999665432221111100 000000000000 0
Q ss_pred -cc-cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 -NL-LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 -~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. .............++.++.+++.+||+.||.+||++.+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 00 00000001123457888999999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=279.65 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=204.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 96 (313)
.+|++.+.||+|+||.||++... +++.|++|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999954 5899999987532 223456788999999999999999999998764 457
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++++||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987655 4788999999999999999999 9999999999999999999999999999987653
Q ss_pred ccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||++.+..++.++|+||||++++++++|..||..............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 223 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-------------- 223 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--------------
Confidence 22111 111234577889999999888899999999999999999999999975433222111110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.+.....+...++.+.+++.+||+ +|..||++.+++.|++
T Consensus 224 -----~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 224 -----QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred -----CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 000111244567889999999999 5799999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=291.21 Aligned_cols=274 Identities=22% Similarity=0.192 Sum_probs=210.3
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----cce
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-----FKA 97 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 97 (313)
+|++.+.||.|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++.+++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999965 48999999987642 445678889999999999999999999998775 789
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+++||+++ +|.+++.... .+++..++.++.+++.||.||| +.|++|+||||+||++++++.++|+|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999974 8999887655 7899999999999999999999 99999999999999999999999999999886643
Q ss_pred ccc-cccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc---------
Q 047140 178 EYQ-SMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--------- 246 (313)
Q Consensus 178 ~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--------- 246 (313)
... ........++..|+|||++.+. .++.++|+||||+++|+|++|..||......+...........+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 221 0112334567789999998877 88999999999999999999999997765433222211110000
Q ss_pred -ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 247 -ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......+..................+..+.+++++||..||.+|||+.+++.|+|-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000000000001112336788999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=281.48 Aligned_cols=247 Identities=25% Similarity=0.270 Sum_probs=201.1
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeecccc---hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQCG---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||.|+||.||++... +++.+++|.+..... .....+.+|+++++.++|+||+++++.+..+...|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999975422 4567788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc------cc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ------SM 182 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~------~~ 182 (313)
.+++.+.+ .+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998765 6899999999999999999999 99999999999999999999999999999875432211 11
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......++..|++||.......+.++|+||||++++++++|..||.................
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI------------------ 218 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc------------------
Confidence 22334567789999999888899999999999999999999999976543322211111000
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCH---HHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINA---REIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~~il~~l~~ 302 (313)
........+..+.+++++||+.+|++|||+ .+++.|+|-
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 000011136789999999999999999999 999988874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=284.80 Aligned_cols=259 Identities=21% Similarity=0.216 Sum_probs=202.8
Q ss_pred hcccccccccccccceeeeEEEEEeec-ceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
..-++|++.+.||.|++|.||+|..++ ++.||+|.++.. .......+..|+.++... .|+||+++++++.++...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345789999999999999999999764 899999999754 223445566777777666 59999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
++||+. ++|.+++......+++..+..++.|++.+|.||| + .+++|+||+|+||++++++.++|+|||.+..+..
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999985 4888887765557899999999999999999999 7 5999999999999999999999999999876532
Q ss_pred ccccccccccccccccCCCcccccCC----CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGR----ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...............
T Consensus 168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 233 (296)
T cd06618 168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ----------- 233 (296)
T ss_pred CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-----------
Confidence 21 122234677899999887553 788999999999999999999999653221111110000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.... .......++.++.+|+.+||..||.+||++.+++.|+|-..
T Consensus 234 -~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 234 -EEPP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred -CCCC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0000 00001135677999999999999999999999999998655
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=274.97 Aligned_cols=258 Identities=20% Similarity=0.201 Sum_probs=209.6
Q ss_pred hhccccccccc-ccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC----
Q 047140 21 RSQTSDFQILN-FFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE---- 93 (313)
Q Consensus 21 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~---- 93 (313)
..++++|++.. .||-|-.|.|-.+.++ +++.+|+|++.. .+..++|+++.-.. .|+|||.+++++.+.
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 48899999875 7899999999999976 599999999853 36677888877665 799999999998643
Q ss_pred ccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec---CCCceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---DNMVAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~---~~~~~~l~df 169 (313)
..+.+|||.++||.|...+..++ ..+++.++..+++||+.|+.||| +.+|.||||||+|+|.. .|..+||+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence 34678999999999999998764 46999999999999999999999 99999999999999996 4567999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh----hhhhccCCcc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM----TLKHWGNNWL 245 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~----~~~~~~~~~~ 245 (313)
|+++.-.... ......-|+.|.|||++....|+..+|+||+|+++|-|+-|.+||.+...... ...+....
T Consensus 209 GFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq-- 283 (400)
T KOG0604|consen 209 GFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ-- 283 (400)
T ss_pred ccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC--
Confidence 9998754322 23344578889999999999999999999999999999999999977643211 11111111
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...-......++++.+++|+.+|+.+|++|.|+.+++.|+|--...
T Consensus 284 ---------------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 284 ---------------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ---------------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 1111122567899999999999999999999999999999976543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=292.41 Aligned_cols=274 Identities=21% Similarity=0.208 Sum_probs=203.3
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC---------
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--------- 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 93 (313)
..+|++.+.||.|+||.||+|... +++.|++|.+..........+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 578999999999999999999954 5899999999776555667788999999999999999999876544
Q ss_pred -----ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCCceeEc
Q 047140 94 -----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLS 167 (313)
Q Consensus 94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~~~~l~ 167 (313)
...++|+||+. ++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++ +++.++++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 4998887643 5889999999999999999999 99999999999999997 45678999
Q ss_pred CCcchhhccccccc-ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 168 DFSIAKLLTGEYQS-MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 168 dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
|||.+......... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||..................
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99998765322111 11122346778999997654 56789999999999999999999999765433222211111000
Q ss_pred c-c-cccc---ccccc----ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 246 P-I-STME---VVDAN----LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 246 ~-~-~~~~---~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. . .... ..... ...............+.++.+|+.+||+.||++|||+.+++.|+|-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 0 0 0000 00000 00000000111234677899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=276.95 Aligned_cols=276 Identities=19% Similarity=0.258 Sum_probs=211.1
Q ss_pred hccccccc-ccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQI-LNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~-~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
++.+-|++ ...||+|+++.|-.+. +.++..+|||++.++.......+.+|++++.+. .|+||++++++|+++..+|+
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 34444544 4578999999999999 668999999999988778889999999999999 69999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhhc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKLL 175 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~~ 175 (313)
|||-+.||+|...|.++. .+++.+..++.++|+.||.||| .+||.|||+||+|||..+. .-+|||||.+..-.
T Consensus 154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999999998776 7999999999999999999999 9999999999999999654 34799999886543
Q ss_pred c--cccc---cccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-
Q 047140 176 T--GEYQ---SMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW- 244 (313)
Q Consensus 176 ~--~~~~---~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~- 244 (313)
. ..-. ....-...|+-.|||||++. ...|+.++|.||||+++|-|+.|.+||.+....+- -|....
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrGe~ 306 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRGEV 306 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCCCc
Confidence 2 1111 11122345788899999653 33589999999999999999999999988754221 111100
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...=...++....-............++.+..++++.+|..||.+|.++.+++.|||..+
T Consensus 307 Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred cHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 000000001110000000001113457899999999999999999999999999999654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=316.02 Aligned_cols=259 Identities=23% Similarity=0.248 Sum_probs=220.0
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
+--+++|+|++.||+|+||-|..++.+ +++.+|+|++++- .......|..|..+|..-+.+.|++++-.|.+++++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 344689999999999999999999976 5899999999762 234567899999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+||||++||+|..++.+.. .+++..++.++..|+.||.-|| +.|+|||||||+|||+|..|.+||+|||....+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999999988 8999999999999999999999 9999999999999999999999999999988876
Q ss_pred cccccccccccccccccCCCcccc----c-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRR----K-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
..+.. ......||+.|.|||++. + +.|+..+|+||+|+++|||+.|..||...+--+.+-.+....
T Consensus 227 ~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk-------- 297 (1317)
T KOG0612|consen 227 ADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK-------- 297 (1317)
T ss_pred CCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh--------
Confidence 44422 234567999999999875 2 568999999999999999999999998887666655444331
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC---HHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN---AREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~~il~~l~~ 302 (313)
....++....+++.+.+||.+.+ -+|+.|.. +.++..||+-
T Consensus 298 ---------~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 298 ---------ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred ---------hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccc
Confidence 11112222457888999999876 47888998 9999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=280.15 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=195.6
Q ss_pred cccccccccc--ccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFF--ICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.|++.+.+ |+|+||.||++..+ ++..+++|.+........ |......+ +|+||+++++.|..++..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3577777776 99999999999954 588999999875421111 23233323 799999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~ 178 (313)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++ .++|+|||.+.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 99999999999998765 7899999999999999999999 99999999999999999998 999999998875432
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||............+...
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 222 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR--------------- 222 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh---------------
Confidence 122357888999999998889999999999999999999999997443222111111000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-HHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-AREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~il~~l~~ 302 (313)
.......+..++..+.+++.+||+.||.+||+ ++++++|+|-
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 223 --QQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred --hcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 00011112357788999999999999999996 6999999873
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=284.27 Aligned_cols=252 Identities=23% Similarity=0.235 Sum_probs=202.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
+..+.|...+.||.|+||.||+|... +++.|++|.+... .......+.+|+++++.++|+|++++++++.++...+
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 33455777888999999999999954 5899999998753 2234457888999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+. ++|.+.+......+++..+..++.|++.+|.||| ..|++|+||+|+||++++++.++|+|||++....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 9999996 4888888766557899999999999999999999 9999999999999999999999999999876432
Q ss_pred ccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
......++..|+|||++. ...++.++|+||||+++|+|++|..||.................
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 237 (313)
T cd06633 173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS---------- 237 (313)
T ss_pred -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------
Confidence 112345778899999874 45678899999999999999999999866543222221111000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......++..+.+++.+||+.+|.+||++.+++.|+|-
T Consensus 238 ---------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 238 ---------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred ---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 000012345678999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=286.68 Aligned_cols=277 Identities=19% Similarity=0.190 Sum_probs=203.2
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc---
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (313)
++..++|++.+.||.|++|.||+|..+ +++.+++|++..... .....+.+|+++++.++|+||+++++++.+..
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 455689999999999999999999965 588999999865422 22345678999999999999999999875433
Q ss_pred -----cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 95 -----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 95 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
.+++|+||+.+ +|...+......+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 888887766557999999999999999999999 999999999999999999999999999
Q ss_pred cchhhccccccccc---------ccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhh
Q 047140 170 SIAKLLTGEYQSMT---------QTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKH 239 (313)
Q Consensus 170 g~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~ 239 (313)
|++........... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99876543221111 112345677999998765 45789999999999999999999999765433221111
Q ss_pred ccCCc--cccc------ccccccccc-cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 240 WGNNW--LPIS------TMEVVDANL-LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 240 ~~~~~--~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+.... .+.. .....+... ...............+.+.+++.+||..||++|||+.+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 11000 0000 000000000 00000000111234577899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=270.50 Aligned_cols=258 Identities=21% Similarity=0.214 Sum_probs=210.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.++.+.+..||.|+.|.||++++. +|...|||..... +.+....+.+.+.++..- ++|.||+++++|..+..+++-|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 346677889999999999999976 4899999999765 556677888888887665 5899999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|.+.. -+..++.....++++..+-.+...+++||.||-. .++++|||+||+|||+|+.|++|+||||.+-++..
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--- 244 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--- 244 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---
Confidence 99843 5666666666679999999999999999999985 78999999999999999999999999999887653
Q ss_pred cccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
........|...|||||-+. ...|+.++||||||++++||.||..||...........+....
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-------------- 310 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-------------- 310 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--------------
Confidence 33455667888999999764 4578999999999999999999999998876544433332221
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
++..+......++.+.+++..||+.|+.+||...++++|++-..
T Consensus 311 ---ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 311 ---EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred ---CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 11112222337888999999999999999999999999976543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=285.01 Aligned_cols=274 Identities=21% Similarity=0.180 Sum_probs=205.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
...++|++.+.||.|+||.||+|..+ +++.|++|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45679999999999999999999975 58899999997542 223456778999999999999999999987654
Q ss_pred ------cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 95 ------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 95 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
..++|+||+++ ++.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 888888766557899999999999999999999 99999999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Ccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWL 245 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~ 245 (313)
||.+........ .......++..|+|||.+.+ ..++.++|||||||++++|++|..||............... ...
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999876543221 11122235667999997764 45688999999999999999999999765433222111110 000
Q ss_pred ccccccc--------ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 246 PISTMEV--------VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 246 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+.....+ .+..... ..........++..+.+++..||+.||.+||++.+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQY-RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred hhhccccccccccccccccccc-ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0000000 0000000 00000112235788999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.76 Aligned_cols=245 Identities=20% Similarity=0.194 Sum_probs=193.9
Q ss_pred cccccceeeeEEEEEee-cceEEEEEEeecccc---hhHHHHHHHHHHH-hcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG---RAFKSFNIECEMM-KSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||.|++|.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999954 589999999875421 1223344555554 345899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999997654 6889999999999999999999 99999999999999999999999999998875432 22
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||...+..++.++|+||||+++|++++|..||................. . ...
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~---~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI--------------N---WPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--------------C---CCC
Confidence 33577889999998888899999999999999999999999976543322211111000 0 000
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH---HHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA---REIVAKLFK 302 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~---~~il~~l~~ 302 (313)
.....++..+.+++.+||..||.+||++ .|+++|+|-
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 0122467889999999999999999955 799999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.90 Aligned_cols=265 Identities=20% Similarity=0.232 Sum_probs=201.0
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcC---CCCcceeeeeeeeeCcc-----
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSI---RHRNLIKVISTCSNEEF----- 95 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 95 (313)
|++.+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.+++++ +|+|++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 48999999997542 22334566787777665 69999999999988776
Q ss_pred ceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.++++|++.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8998886643 35899999999999999999999 99999999999999999999999999999876
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------cccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------WLPI 247 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~~~~ 247 (313)
..... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||......+......... +...
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 54221 1123346778999999998899999999999999999999999997655433222111100 0000
Q ss_pred cc--cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 248 ST--MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 248 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. ........ ...........+..+.+++.+||+.||.+||++.+++.|+|
T Consensus 234 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 234 VSLPRSSFPSYT---PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred cccchhhccccc---ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 00 00000000 00001112245678899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=299.70 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=212.0
Q ss_pred ccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHH
Q 047140 32 FFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 110 (313)
.||+|.+|+||-|+.. +...+|||.++..+....+.+..|+.+.++|+|+|||+++|.+..++++-|.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6899999999999955 477899999988877888999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCCceeEcCCcchhhccccccccccccc
Q 047140 111 YLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSDFSIAKLLTGEYQSMTQTQT 187 (313)
Q Consensus 111 ~l~~~~~~~--~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 187 (313)
++.+.=.++ .+.++..+.+||++||.||| .+.|||||||-+|+|++ -.|.+||.|||-++++.+-. ......
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 998763344 88999999999999999999 99999999999999996 67999999999999875432 234556
Q ss_pred ccccccCCCcccccC--CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 188 LATIGCIAPEYRRKG--RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 188 ~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
.||..|||||++-.+ .|+.++|||||||++.||.||++||-....++...-..+ + .....
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG---------------m---yKvHP 798 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG---------------M---YKVHP 798 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc---------------c---eecCC
Confidence 799999999998755 589999999999999999999999977654433221111 0 01122
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..|...+.++++++.+|+..||-+||+|.+++..++-..
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 346778999999999999999999999999999876543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.07 Aligned_cols=266 Identities=24% Similarity=0.280 Sum_probs=219.2
Q ss_pred hcchhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeee
Q 047140 13 ILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVIST 89 (313)
Q Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (313)
+.+--++-..++-++.-+.++|.|.||.||.|... +|...|+|.+..+. ......+.+|..+++.++|||+|+++++
T Consensus 1223 ~~kla~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1223 LNKLASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred HHHHHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce
Confidence 33444455677788999999999999999999954 69999999997652 3345678899999999999999999999
Q ss_pred eeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 90 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
=.+.+.++|.||||.+|+|.+.+...+ -.++.-...+..|++.|++||| ..|||||||||.||+++.+|.+|++||
T Consensus 1303 EvHRekv~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred eecHHHHHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecc
Confidence 999999999999999999999886553 5667777788999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccc--cccccccccccCCCcccccC---CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc
Q 047140 170 SIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKG---RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~ 244 (313)
|.+..+.++.... ......||+-|||||++.+. .-.-+.|||||||++.||.||+.||...+.........+...
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC
Confidence 9998876553221 22356799999999999754 457789999999999999999999988765444333322211
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..+.|..++.+-.+++..||..||+.|+++.|++.|=.
T Consensus 1459 -------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1459 -------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred -------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 11224557888999999999999999999999998844
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=287.56 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=212.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.|+.-+.||+|+||.|+-++.. +|+.+|.|.+.+. .........+|-.+|++++.+.||.+--+|+..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356677779999999999999965 5999999998653 223345677899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
+..|+||+|.-.|.+.+ +.+++..++.++.+|+.||.+|| ..+||+||+||+|||+|+.|+++|.|+|++..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999887764 46999999999999999999999 999999999999999999999999999999987643
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. ......||.+|||||++.+..|+...|+|||||+||||+.|+.||......... +-+++..+
T Consensus 341 ~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------------eEvdrr~~ 403 (591)
T KOG0986|consen 341 K---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------------EEVDRRTL 403 (591)
T ss_pred C---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------------HHHHHHHh
Confidence 3 334458999999999999999999999999999999999999999776433221 11222211
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLF 301 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~ 301 (313)
.. ....+...++++.+|++.+|..||++|. +++++.+||.
T Consensus 404 ~~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 404 ED---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred cc---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence 11 1122467899999999999999999997 5667877753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.69 Aligned_cols=272 Identities=20% Similarity=0.181 Sum_probs=205.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
++.++|++.+.||.|+||.||++... +++.||+|++... .......+.+|+++++.++|+||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 46789999999999999999999954 6899999998543 2334456889999999999999999999987654
Q ss_pred --cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 95 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..++|+|++ +++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||++++++.++++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999 67999888653 5899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-ccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTM 250 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 250 (313)
...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.................. +....
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 754321 123356778999998775 45889999999999999999999999765432222211110000 00000
Q ss_pred ---------ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 251 ---------EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 251 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....................++..+.+++.+||..||++|||+.+++.|+|-..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 000000000000001112356778999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=277.87 Aligned_cols=245 Identities=18% Similarity=0.177 Sum_probs=191.6
Q ss_pred ccccceeeeEEEEEee-cceEEEEEEeecccc---hhHHHHHHHH---HHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 32 FFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG---RAFKSFNIEC---EMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
.||+|+||.||++... +++.||+|.+..... .....+..|. .+++...||+|+++.+++.++...++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999954 588999999865421 1112233343 34445689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
|++|.+++...+ .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence 999999887654 6899999999999999999999 999999999999999999999999999998755322 12
Q ss_pred cccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||++.+. .++.++|+||+|+++|+|++|..||............... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------LTM 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh------------------hcc
Confidence 234688899999988744 6899999999999999999999999664221111000000 000
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
....+..++..+.+++.+||..||.+|| ++.++++|+|-
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 0111334577899999999999999999 99999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.16 Aligned_cols=273 Identities=21% Similarity=0.177 Sum_probs=204.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee-Cccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-EEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 97 (313)
.++++|++.+.||.|+||.||++... +++.||+|++... .......+..|+++++.++||||+++.++|.. +...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999955 6899999988543 22345678889999999999999999999865 56789
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+++||+ +++|.+++... .++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 999998 55999888654 4788888999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-Ccccccc------
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-NWLPIST------ 249 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-~~~~~~~------ 249 (313)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............... ...++..
T Consensus 161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 1 122346778999998765 56899999999999999999999999664332111100000 0000000
Q ss_pred ---cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 250 ---MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 250 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....................++..+.+++++||+.+|++|||+.+++.|+|-...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00000000000000001123467889999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=293.52 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=207.5
Q ss_pred ccccccceeeeEEEEEee-cceEEEEEEeec----ccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc--ceEEEEe
Q 047140 30 LNFFICGVIIPVAQFLIS-SAMEVAVKVFNL----QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF--KALVLEY 102 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~ 102 (313)
...||+|+|-+||+|... .|-.||=-.++. +++...+.+..|+++|+.|+|+||++++.++.+... ..+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 448999999999999954 466665322221 246677999999999999999999999999987655 7799999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+.+|+|..++++++ ..+...+..|++||+.||.|||.. .-.|+|||||.+||+++- .|.|||+|+|+|+.+...
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999999887 688899999999999999999943 347999999999999974 599999999999976532
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......||+.|||||+.. ..|+...||||||++++||.|+..||+.+.++...+.+......|..+..+
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--------- 268 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--------- 268 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc---------
Confidence 234478999999999887 889999999999999999999999999998877766665554433332221
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
-.+++++||.+||.. .++|||+.|+|.+++-..+
T Consensus 269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 ---------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 145689999999999 9999999999999876554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=290.71 Aligned_cols=272 Identities=20% Similarity=0.189 Sum_probs=206.0
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc---
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF--- 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 95 (313)
.+.++|++.+.||.|++|.||+|... +++.||+|++... .......+.+|+.+++.++|+||+++.+++..+..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 46789999999999999999999965 5889999998653 23344667789999999999999999998866554
Q ss_pred ---ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 96 ---KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
.++|+||+ +++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||++++++.++|+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 56999988764 5899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-ccc--
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PIS-- 248 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~-- 248 (313)
...... .....++..|+|||...+ ..++.++||||||+++|++++|..||.................. +..
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 765322 223456778999998754 46789999999999999999999999755433222111110000 000
Q ss_pred -------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 -------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......................++..+.+++.+||..||++|||+.++++|+|-..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 00000000000000001111235788999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=280.39 Aligned_cols=265 Identities=16% Similarity=0.162 Sum_probs=190.9
Q ss_pred hhhhhcccccccccccccceeeeEEEEEeec----ceEEEEEEeecccchhH-----------HHHHHHHHHHhcCCCCc
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQCGRAF-----------KSFNIECEMMKSIRHRN 82 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~ 82 (313)
.......++|++.+.||+|+||.||+|...+ +..+++|+......... .....+...+..++|++
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 3344556899999999999999999999543 45677776543321110 11122334456678999
Q ss_pred ceeeeeeeeeCc----cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 83 LIKVISTCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 83 i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
++++++++.... ..+++++++. .++.+.+.... ..++..+..++.|++.||.||| +.+++||||||+|||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill 159 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 999998775543 3467888774 47777765543 4578889999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhccccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR 233 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~ 233 (313)
+.++.++|+|||+++.+...... .......+|..|+|||+..+..++.++|||||||++++|++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999866422111 1112245889999999999999999999999999999999999999766321
Q ss_pred hhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 234 EMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
......... +..... .........++..+.+++..||+.+|++||+++++++.+
T Consensus 240 ~~~~~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHAAKC--------DFIKRL-----HEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHhHH--------HHHHHh-----hhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100000 000000 000011234678899999999999999999999998765
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.30 Aligned_cols=268 Identities=24% Similarity=0.240 Sum_probs=205.3
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
|+..+.||+|++|.||+|... +++.+++|++.... ....+.+..|+++++.++|+||+++++++.+.+..++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 667889999999999999965 49999999997652 334567788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
+ ++|.+++......+++..+..++.+++.+|.||| ..+++|+||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 4999999876457899999999999999999999 99999999999999999999999999999876543221 1
Q ss_pred ccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc--ccccc---cc--ccc
Q 047140 184 QTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL--PISTM---EV--VDA 255 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~---~~--~~~ 255 (313)
......+..|+|||.+.+. .++.++|+||||++++++++|..||.................. ..... .. .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2223456779999988766 7899999999999999999999999765433222111110000 00000 00 000
Q ss_pred cccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.... ..... ......+..+.+++.+||..||++||++.+++.|+|
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 235 TFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 0000 00000 111234778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=277.87 Aligned_cols=267 Identities=17% Similarity=0.188 Sum_probs=200.7
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeecccc-hhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEEEee
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
|++.+.||+|++|.||+|... +++.|+||.+..... .......+|+..+..++ |+||+++++++.+++..++|+||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999965 488999999865422 22334556899999998 999999999999999999999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++|.+.+.... ..+++..+..++.|++.+|.||| +++++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 679998887653 46899999999999999999999 9999999999999999999999999999987553221
Q ss_pred cccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------cccc-cccccc
Q 047140 183 TQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------WLPI-STMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~ 253 (313)
......++..|+|||++. ...++.++|+||||+++++|++|..||................ |... ......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 122345778899999774 4567999999999999999999999996654332221111100 0000 000000
Q ss_pred cccccCh--hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANLLSQ--EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+...... .... ......+..+.+++++||+.||++|||+.|++.|+|
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 234 GFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 0000000 0000 011123677999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=286.26 Aligned_cols=267 Identities=19% Similarity=0.185 Sum_probs=198.9
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----- 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 94 (313)
+.++|.+.+.||.|+||.||+|... +++.||+|++... .......+.+|+++++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4578999999999999999999954 6899999998653 2223456788999999999999999999987543
Q ss_pred -cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..++|+||+.. +|.+... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred ceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 35899999964 7777653 25789999999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-cccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-WLPISTME 251 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 251 (313)
.... ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||................ .......+
T Consensus 166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 5422 1223456778999998765 468899999999999999999999997654322211111100 00000000
Q ss_pred cccc----------cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVDA----------NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.... ........ .......+..+.+++.+||+.||++||++++++.|+|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 0000 00000000 00112356778999999999999999999999999664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=278.55 Aligned_cols=255 Identities=21% Similarity=0.237 Sum_probs=200.9
Q ss_pred ccccccccccceeeeEEEEEee----cceEEEEEEeeccc----chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC----GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
+|++.+.||.|+||.||.+... +|..||+|+++... ....+.+.+|+++++.+ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999852 58899999997532 23346778899999999 689999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999997654 6889999999999999999999 9999999999999999999999999999987653
Q ss_pred cccccccccccccccccCCCcccccC--CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG--RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
... ........++..|+|||..... .++.++|+||||+++|+|++|..||........... ...
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------~~~ 222 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE-------------ISR 222 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH-------------HHH
Confidence 221 1112234578889999988653 467899999999999999999999853211100000 000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
.... .....+..++..+.+++++||..||++|| ++.+++.|+|-
T Consensus 223 ~~~~----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 223 RILK----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred Hhhc----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 0000 00011334677789999999999999997 89999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=271.87 Aligned_cols=242 Identities=27% Similarity=0.262 Sum_probs=200.4
Q ss_pred cccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 33 FICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 33 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
||.|++|.||++... +++.+++|++.... ......+..|+++++.++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 48999999987642 22456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
.+++.... .+++..+..++.|++.+|.||| ..+++|+||+|+||++++++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99997765 5899999999999999999999 9999999999999999999999999999987654321 1223445
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
++..|+|||...+..++.++|+||||+++|++++|..||............... ....+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---------------------PLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---------------------CCCCC
Confidence 778899999998888999999999999999999999999655432211111100 01113
Q ss_pred hhhHHHHHHHHhHhhccCCCCCCCH---HHHHHHHH
Q 047140 269 EQCVSFVFNLAIECTVESPEQRINA---REIVAKLF 301 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rps~---~~il~~l~ 301 (313)
...+..+.+++++||..||++||++ .+++.|+|
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 3346778999999999999999999 89888875
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=284.86 Aligned_cols=272 Identities=19% Similarity=0.195 Sum_probs=202.1
Q ss_pred hhcccccccccccccceeeeEEEEEe-ecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE---- 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (313)
..++++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34668999999999999999999985 468999999987532 22345677899999999999999999988643
Q ss_pred --ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 94 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
...+++++++ +++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3467888887 67998887654 4889999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-Ccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-NWLPIST 249 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 249 (313)
+..... ......++..|+|||...+ ..++.++|+|||||++|+|++|..||............... ...+...
T Consensus 167 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 167 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432 1223456788999998765 56889999999999999999999999654332221111000 0000000
Q ss_pred ccccccc----c----cChhhhhh-hhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 250 MEVVDAN----L----LSQEDIHF-VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 250 ~~~~~~~----~----~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+... . ........ ......+..+.+++.+||+.||.+||++.+++.|+|-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 0000000 0 00000000 00113467789999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.89 Aligned_cols=273 Identities=19% Similarity=0.136 Sum_probs=199.4
Q ss_pred ccccccccccceeeeEEEEEee-c--ceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC----cc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-S--AMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE----EF 95 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 95 (313)
+|++.+.||.|+||.||++... . +..||+|++... .....+.+.+|+++++.+ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999954 4 779999998653 223356678899999999 699999999875432 45
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.+++++++. ++|.+.+.... .+++..++.++.||+.||.||| ..|++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899885 59999886554 6899999999999999999999 999999999999999999999999999999765
Q ss_pred cccccc--ccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-ccc-ccc
Q 047140 176 TGEYQS--MTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPI-STM 250 (313)
Q Consensus 176 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~-~~~ 250 (313)
...... .......++..|+|||+..+ ..++.++|+||||+++|++++|..||................. .+. ...
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 11123457888999997765 5689999999999999999999999976442221111000000 000 000
Q ss_pred ccccc-------cccChh-hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 251 EVVDA-------NLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 251 ~~~~~-------~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..... ...... .........++..+.+++.+||+.||++|||+.+++.|+|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 00000 000000 000011123467899999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=304.38 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=195.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
.+...+|+.+..||+||||.||+++++ +|+.+|||+++.. .......+.+|+.+|.+|+|||+|+++..+.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 457789999999999999999999977 7999999999876 3455678899999999999999999976542110
Q ss_pred --------------------------------------------------------------------------------
Q 047140 95 -------------------------------------------------------------------------------- 94 (313)
Q Consensus 95 -------------------------------------------------------------------------------- 94 (313)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 047140 95 -----------------------------------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 139 (313)
Q Consensus 95 -----------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH 139 (313)
.+||-||||+-..|.+++......-.....|+++++|+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 057889999886666666655421146788999999999999999
Q ss_pred cCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc---c-------------ccccccccccccccccCCCcccccC-
Q 047140 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT---G-------------EYQSMTQTQTLATIGCIAPEYRRKG- 202 (313)
Q Consensus 140 ~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~---~-------------~~~~~~~~~~~~~~~y~aPE~~~~~- 202 (313)
+.|++||||||.||++++++.|||+|||+++... . .......+...||..|+|||++.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999999998621 0 0111134456789999999988755
Q ss_pred --CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHh
Q 047140 203 --RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280 (313)
Q Consensus 203 --~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 280 (313)
.|+.++|+||||++++||+. ||...-.+............+.. ..+ .....+.-..+|+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f---------------~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADF---------------FDPEHPEEASLIR 852 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccc---------------ccccchHHHHHHH
Confidence 49999999999999999996 46554433333222222111111 000 1112333568999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 047140 281 ECTVESPEQRINAREIVAK 299 (313)
Q Consensus 281 ~~l~~dP~~Rps~~~il~~ 299 (313)
.|++.||.+||||.|+|+.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHhcCCCccCCCHHHHhhc
Confidence 9999999999999999976
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=269.82 Aligned_cols=250 Identities=20% Similarity=0.195 Sum_probs=211.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
-++|+-++.||+|.||.|-+++-+ +++.+|+|++++. ......+-..|-++|+..+||.+..+.-.|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468999999999999999999965 6999999999876 345566667799999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||..||.|.-.+.... .+++...+.+-..|++||.||| +++||+||+|.+|.|+|++|.+||.|||+.+.-...
T Consensus 247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~- 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY- 321 (516)
T ss_pred EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc-
Confidence 99999999988876654 6889999999999999999999 999999999999999999999999999998753322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......+||+.|+|||++....|..+.|+|.+|+++|||+.|+.||...+......-+..
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------------------ 382 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------------------ 382 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------------------
Confidence 2234456899999999999999999999999999999999999999976543222111111
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKL 300 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l 300 (313)
.....|+.+++++..|+..+|..||++|. .+.+|.+|.
T Consensus 383 ---ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 383 ---EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred ---hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 11223667889999999999999999997 567777774
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=276.68 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=198.1
Q ss_pred ccccccccccceeeeEEEEEee----cceEEEEEEeeccc----chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC----GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
+|++.+.||.|++|.||++... +++.||+|+++... ......+.+|++++.++ +|+||+++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999998842 46889999987532 22345678899999999 699999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+.+.... .+++..+..++.|++.+|.||| ..+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999987654 6889999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccccccccccccccCCCcccccCC--CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGR--ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
.... .......++..|+|||...+.. .+.++|+||||+++|+|++|..||............. .....
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~---------~~~~~ 226 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS---------RRILK 226 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH---------HHHHc
Confidence 3221 1122345788899999887654 7889999999999999999999985321110000000 00000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH---HHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA---REIVAKLF 301 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~---~~il~~l~ 301 (313)
.....+..++..+.+++.+||+.||++|||+ .+++.|+|
T Consensus 227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 227 --------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred --------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0011123456779999999999999999995 45577764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.23 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=197.6
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc-----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999854 3455666665431 122344566789999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
+||+++++|.+.+.. ....+++..++.++.|++.||.||| +.+++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3346899999999999999999999 999999999999999975 569999999887653
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... ......++..|+|||...+..++.++|+||||+++|+|++|..||................
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~------------- 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP------------- 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-------------
Confidence 2211 1223446778999999888888999999999999999999999986543222211111000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+..++.++.+++.+||..||++||++.++++|+|
T Consensus 222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 00012346778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=284.96 Aligned_cols=252 Identities=19% Similarity=0.225 Sum_probs=210.4
Q ss_pred ccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCC
Q 047140 30 LNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
.+.||+|.||+||-|.+. +|+.||||++.+- .+.....+++|+.+|++++||.||.+-..|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999965 6999999999753 2344578999999999999999999999999999999999999764
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhhccccccccc
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
-|+.++.+....+++.....++.||+.||.||| -++|+|+|+||+|||+.+. ..+||||||+++..++. ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sF 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SF 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---hh
Confidence 455555555557999999999999999999999 9999999999999999765 47999999999987643 34
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
.....||+.|+|||++.+..|+..-|+||.|+++|--++|..||....+........+-.+.+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~---------------- 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPN---------------- 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCC----------------
Confidence 5567899999999999999999999999999999999999999977544333322211111111
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...+++..+.+||..+|++.=.+|.|..+.+.|+|....+
T Consensus 787 ---PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 787 ---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ---chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 1356788899999999999999999999999999976654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=288.50 Aligned_cols=244 Identities=22% Similarity=0.207 Sum_probs=201.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
..+..|+....+|.|+|+.|-.+... +++..++|++.... ....+|..++... +||||+++.+++.++.+.|+|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 35678999999999999999999954 68899999997652 2233466666565 899999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe-cCCCceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL-DDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~-~~~~~~~l~dfg~~~~~~~~ 178 (313)
||.+.|+-+.+.+.... .++ ..+..|+++|+.|+.||| .+|++|||+||+|||+ ++.|.++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988888887654 233 777889999999999999 9999999999999999 68999999999999876533
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh-hhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR-EMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.....-|..|.|||+....++++++|+||||++||+|++|..||...... +.......
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~---------------- 528 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM---------------- 528 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC----------------
Confidence 12234677899999999999999999999999999999999999654332 11111100
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
. .....+++.+++|++.||+.||.+|+++.++..|+|-
T Consensus 529 -~------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 -P------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -C------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 0 0015678999999999999999999999999999997
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=298.08 Aligned_cols=145 Identities=24% Similarity=0.299 Sum_probs=132.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|.+.++||+|+||.||+|... +++.||||++... .......+..|+.++..++|+||++++.++....+.|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 5899999999753 2334567888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
||+.+++|.+++...+ .+++..++.++.||+.||.||| ..+|+|+||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997655 6888999999999999999999 9999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=241.68 Aligned_cols=268 Identities=21% Similarity=0.215 Sum_probs=209.8
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.|+-.++||+|.+|+||+++.. +++.||+|....+ ++..-....+|+-+++.+.|+||++++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5666789999999999999955 5899999999875 333456778899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
|.. +|..+..+-+..++.+.++.++.|++.+|.|.| ++++.|||+||.|.+++.+|.+|++|||+++-++-...
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr-- 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-- 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence 965 999999887778999999999999999999999 99999999999999999999999999999998764321
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhc---c----CCcccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHW---G----NNWLPISTMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~---~----~~~~~~~~~~~~ 253 (313)
.......|..|++|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..+....+. . ..|.. +.++-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps--~t~lp 234 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS--MTKLP 234 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc--cccCC
Confidence 23345678899999988765 47999999999999999998 777787764433322211 1 11211 12222
Q ss_pred cccccCh---hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANLLSQ---EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
|-...+. ...-...-++....-++|++++|.-+|.+|.+++.+++|+.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy 285 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY 285 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence 2111111 11111122344555689999999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=265.07 Aligned_cols=227 Identities=20% Similarity=0.150 Sum_probs=183.4
Q ss_pred ceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHHHHhc
Q 047140 36 GVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS 114 (313)
Q Consensus 36 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (313)
|.++.||++..+ +++.+|+|.+.... ....|...+....||||+++++++.+++..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 58999999997652 223344555556799999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccC
Q 047140 115 SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI 194 (313)
Q Consensus 115 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 194 (313)
.. .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 54 5899999999999999999999 999999999999999999999999999987655322 12233466799
Q ss_pred CCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHH
Q 047140 195 APEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 274 (313)
Q Consensus 195 aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (313)
|||...+..++.++|+||+|+++|+|++|..|+........ . ......+..++..
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------~------~~~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------T------HTTLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------c------ccccCCcccCCHH
Confidence 99999888899999999999999999999988643211000 0 0000112345677
Q ss_pred HHHHHhHhhccCCCCCCCH-----HHHHHHHH
Q 047140 275 VFNLAIECTVESPEQRINA-----REIVAKLF 301 (313)
Q Consensus 275 l~~li~~~l~~dP~~Rps~-----~~il~~l~ 301 (313)
+.+++.+||+.||++||++ ++++.|+|
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 9999999999999999996 88888876
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=285.47 Aligned_cols=275 Identities=23% Similarity=0.221 Sum_probs=203.6
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc------cc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE------FK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 96 (313)
--+...+.||+|+||.||+++++ +|+.||||.++.. ....++..-+|++++++++|+|||+++++=+... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34566779999999999999955 6999999999874 4456778889999999999999999998865443 45
Q ss_pred eEEEEeecCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec--C--CCceeEcCCc
Q 047140 97 ALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--D--NMVAHLSDFS 170 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~--~--~~~~~l~dfg 170 (313)
.+|||||.||||...+.+. ...+++..++.++..++.||.||| .+||+||||||.||++- . ....||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 7999999999999999765 346999999999999999999999 99999999999999983 2 3367999999
Q ss_pred chhhcccccccccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh-hhccCCcc-cc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL-KHWGNNWL-PI 247 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~-~~~~~~~~-~~ 247 (313)
.|+.+..+. ......||..|++||+.. +..++..+|.|||||++|++.||..||.....+.... ..|...-. +.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999876433 345678999999999998 5889999999999999999999999997765442211 11111100 00
Q ss_pred ccccccccccc----Chh--hhhhhhhhhhHHHHHHHHhHhhccCCCCCC--CHHHHHHHHHHHHH
Q 047140 248 STMEVVDANLL----SQE--DIHFVAKEQCVSFVFNLAIECTVESPEQRI--NAREIVAKLFKIRD 305 (313)
Q Consensus 248 ~~~~~~~~~~~----~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--s~~~il~~l~~~~~ 305 (313)
........... ... +..-.........+...+..+|..+|.+|. ...+..+.+.++..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00000000000 000 000011223445567778889999999999 66666555555443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.34 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=200.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+...|+....||+|+||.||+|... ++..||+|.+..... ....|++.+++++||||++++++|.++...++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456778889999999999999964 689999999864322 12346889999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++|+|.+++. .+++..+..++.|++.||+|||..++.+++||||||+||+++.++..++. |+......
T Consensus 764 y~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 764 YIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred CCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 999999999996 37888999999999999999995555699999999999999998887765 44433221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-cccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-WLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|||||||++|||+||+.||............|... .........+++.....
T Consensus 834 -~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 834 -TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1122357789999999999999999999999999999999999985432221111111111 00111112222222111
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
. ........++.+++.+||+.||++||||.++++.++.+...
T Consensus 913 ~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 913 V----SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred C----CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 0 11223455688999999999999999999999999988654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=280.65 Aligned_cols=259 Identities=20% Similarity=0.214 Sum_probs=222.3
Q ss_pred hhhhcccccccccccccceeeeEEEEEeecc-eEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLISSA-MEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
|....-.+.+++..||.|+||.|=++..++. ..+|+|++++. .....+++..|-.+|...+.|.||+++..|.+..
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 3344456788889999999999999996543 34899999764 4566788999999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
++|+.||-|-||.|+..+...+ .++..+...+..-++.|+.||| ++||++|||||+|.|++.+|.+||.|||+++.
T Consensus 494 yvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 9999999999999999998877 7888888999999999999999 99999999999999999999999999999998
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
+.... ......||+.|.|||++.+...+.++|.||||+++|||++|.+||++.++-..+..+.....
T Consensus 570 i~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------- 636 (732)
T KOG0614|consen 570 IGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------- 636 (732)
T ss_pred hccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh----------
Confidence 86443 34567899999999999999999999999999999999999999999887666554432210
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFKI 303 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~~ 303 (313)
....|..+.....+|++++.+.+|.+|.. +.+|.+|-|-.
T Consensus 637 ---------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 637 ---------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ---------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 11124567778999999999999999986 88999998753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=260.57 Aligned_cols=285 Identities=17% Similarity=0.220 Sum_probs=211.7
Q ss_pred hhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee--
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-- 92 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 92 (313)
-.++.-.+.|+-..++|+|.||.||+|+.+ .|+.||+|+.--+ ....-....+|+.+|+.+.|+|++.+++.|..
T Consensus 10 ~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 10 EPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 344555678999999999999999999965 4888998876432 12223455679999999999999999998843
Q ss_pred ------CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 93 ------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 93 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
...+|+|+++|++ +|..++.+....++..++..+++++..+|.|+| ...|+|||+||.|+|++.+|.+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEe
Confidence 2348999999987 999999888678999999999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccc--cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc---
Q 047140 167 SDFSIAKLLTGEYQ--SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW--- 240 (313)
Q Consensus 167 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~--- 240 (313)
+|||+++.+..... .........|..|++||.+.+ ..++++.|+|+.||++.||+|+.+.+++....+....+.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999977643222 222344556899999997765 578999999999999999999999998776544322111
Q ss_pred ----cCCccccc---ccccccccccChhhhh----hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 241 ----GNNWLPIS---TMEVVDANLLSQEDIH----FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 241 ----~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.+.|+... +.+.++..-....... ...+=--.++..+|+..+|..||.+|+++++++.|-|-..+.
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 11222211 1111110000000000 000111245688999999999999999999999997655443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=268.68 Aligned_cols=274 Identities=23% Similarity=0.239 Sum_probs=210.2
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC--CCCcceeeeeeeeeCc----cceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI--RHRNLIKVISTCSNEE----FKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~l 98 (313)
...+..+.+|+|.||.||+|... ++.||||+|+.+ ..+.+.+|-+|.+.. +|+||++++++-..+. .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 45667889999999999999974 699999999854 557788888888764 8999999998865444 6899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------GYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~------~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
|++|-+.|+|.++++.+. +++....+++..++.||+|||. .++..|+|||||..|||+.+|+...|+|||++
T Consensus 286 Vt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999999999885 8999999999999999999994 33456999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCC------CCcchhHHHHHHHHHHHhCCCCChhh--hhhhhhhhhc-cCC
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE------STNGDVYSFGIMLMETFTRKKPTDEI--FNREMTLKHW-GNN 243 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~DiwslG~~l~~lltg~~p~~~~--~~~~~~~~~~-~~~ 243 (313)
.++.........-...||..|||||++.+.-. -.+.||||+|.++||+++.-.-+... .+-+.-+... ...
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 99876655555556889999999998875432 24789999999999999865433211 1111111100 111
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
-..+.+.+.+-+...+......+..-....-+.+.+..||..||+.|.|+.=+.+.++++.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 1112333444443333333444444455667999999999999999999999988888775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=286.21 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=217.8
Q ss_pred ccccccccccceeeeEEEEEe-ecce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLI-SSAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~-~~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
...-.+.||+|+||+||+|.+ +.|+ +||||++... ......++.+|+-+|.+++|||+++++++|.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 344567899999999999994 4444 8999998654 4556788999999999999999999999998765 8899
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
++|+++|+|.++++.++..+.....+.|..||++|+.||| .+.+|||||-..|||+.+-..+|+.|||+++.+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998878999999999999999999999 9999999999999999999999999999999887666
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
...........+.|+|-|.+....++.++|||||||++||++| |..|+.+....+......
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle------------------ 914 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE------------------ 914 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh------------------
Confidence 5555555556778999999999999999999999999999999 999998765443322111
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...++..|+.|+.+++-++.+||..|+..||+++++...+.+.-
T Consensus 915 --~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 915 --KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11124447789999999999999999999999999998876654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=264.78 Aligned_cols=270 Identities=23% Similarity=0.316 Sum_probs=212.2
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC--CCCcceeeeeeeeeCc----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI--RHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~---- 94 (313)
+++.++..+.+.+|+|.||.||+|.+. |+.||||+|... +...+.+|.++++.. +|+||+.+++.--.++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 788899999999999999999999985 899999999754 335667899998774 9999999998864332
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-----GYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-----~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
.++||++|-+.|||.|++... .++....++++..+++||++||. +....|+|||||..|||+.++|...|+|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 589999999999999999885 58999999999999999999992 22346999999999999999999999999
Q ss_pred cchhhcccccccc--cccccccccccCCCcccccCCC------CCcchhHHHHHHHHHHHhC----------CCCChhhh
Q 047140 170 SIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKGRE------STNGDVYSFGIMLMETFTR----------KKPTDEIF 231 (313)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~------~~~~DiwslG~~l~~lltg----------~~p~~~~~ 231 (313)
|++.......+.. ......||..|||||++...-. -..+||||||.++||+... ..||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998775432221 2345679999999998864421 3468999999999998852 36887776
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
+.+..+..........+ .+....+.+....+-..+.++|+.||..+|..|.||--+.+.+.++.+
T Consensus 441 p~DPs~eeMrkVVCv~~---------~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQK---------LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHHHhcceeecc---------cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 66655544433222222 222222233334455668899999999999999999999998888764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.51 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=209.7
Q ss_pred ccccccccccceeeeEEEEEee--c------ceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 26 DFQILNFFICGVIIPVAQFLIS--S------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~--~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
+..+.+.||.|.||.|++|... . ...||||.++.. .....+.+..|+++++.+ .|+||+.++++|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3456679999999999999843 1 358999999765 335678899999999998 79999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 96 KALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
+++|.||+..|+|..++...+ ..++...++.++.||+.|++||+ +.+++|||+-..|||+++
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence 999999999999999998665 34888999999999999999999 999999999999999999
Q ss_pred CCceeEcCCcchhhcccccccccc-cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhh
Q 047140 161 NMVAHLSDFSIAKLLTGEYQSMTQ-TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLK 238 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~ 238 (313)
+..+||+|||+++........... ....-+..|||||.+....++.+|||||||+++||++| |..||.+.........
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 999999999999865432222111 11114556999999999999999999999999999999 8999977431111121
Q ss_pred hccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 239 HWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
... .......|..|+.+++++|+.||+.+|++||+++++...+....
T Consensus 534 ~l~-------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 534 FLK-------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHh-------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 11122236678999999999999999999999999999988853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=261.10 Aligned_cols=130 Identities=24% Similarity=0.286 Sum_probs=112.5
Q ss_pred cccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCC--------CCcceeeeeeee----
Q 047140 25 SDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR--------HRNLIKVISTCS---- 91 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 91 (313)
.+|-+.++||+|.|++||+|. ....+.||+|+.+.. ....+....|+.+|++++ ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 689999999999999999999 446889999998654 455677788999999983 248999999995
Q ss_pred eCccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
++.++|||+|++ |.+|..+|... -+.++...+..|++||+.||.|||. ..||+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 466899999999 66999999755 3468999999999999999999996 5699999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.20 Aligned_cols=275 Identities=21% Similarity=0.209 Sum_probs=212.5
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCC------Ccceeeeeeee
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH------RNLIKVISTCS 91 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~ 91 (313)
++....++|.+....|+|-||+|..|... .|..||||++.+. +.-...=..|+++|++|+. .|+++++..|.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34455789999999999999999999955 4889999999765 2223445679999999952 48999999999
Q ss_pred eCccceEEEEeecCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcC
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSD 168 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~d 168 (313)
..+++|||+|.+ .-+|.+++++.+. .+....+..++.|+..||..|- ..|++|.||||+|||++.. ..+||||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeecc
Confidence 999999999999 4699999987653 4777899999999999999999 9999999999999999865 5689999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLP 246 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~ 246 (313)
||.+.....+ ....+..+..|.|||++.+.+|+...|+||.||+|||+.||...|++..+-++....... .+..
T Consensus 581 fGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 581 FGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred Cccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9999876533 345567788899999999999999999999999999999999999887665553221111 0000
Q ss_pred ---------------------ccccccccc-------cccChhhhhhh---------hhhhhHHHHHHHHhHhhccCCCC
Q 047140 247 ---------------------ISTMEVVDA-------NLLSQEDIHFV---------AKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 247 ---------------------~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
.....+-+. ...+...+... .....-..+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 000000000 11111111111 11234567999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 047140 290 RINAREIVAKLFK 302 (313)
Q Consensus 290 Rps~~~il~~l~~ 302 (313)
|.|..++|+||+-
T Consensus 737 Rit~nqAL~HpFi 749 (752)
T KOG0670|consen 737 RITVNQALKHPFI 749 (752)
T ss_pred cCCHHHHhcCCcc
Confidence 9999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=277.41 Aligned_cols=255 Identities=21% Similarity=0.245 Sum_probs=216.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeee-----eCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCS-----NEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~ 96 (313)
++-|++...+|.|.+|.||++... +++.+|+|+.... .+..+++..|.++|+.+ .|||++.++++|. .++.+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 568999999999999999999954 6999999988665 34457788899999998 7999999999984 34679
Q ss_pred eEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 97 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
+||||||.||+..|++++- +..+.+..+..|++.++.|+.+|| .+.++|||||-.|||++.++.|||+|||.+..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 9999999999999999754 557899999999999999999999 999999999999999999999999999999877
Q ss_pred ccccccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
..... ......||+.|||||++. ...|+.++|+||||++..||--|.+|+.++.+.-..+.+
T Consensus 174 dsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I----------- 240 (953)
T KOG0587|consen 174 DSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----------- 240 (953)
T ss_pred ecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-----------
Confidence 54322 234567999999999885 335688999999999999999999999888765554432
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.+.++..+..+.+.+..+-++|..||..|-++||+..++++|++.
T Consensus 241 -------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 241 -------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred -------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 223344444577899999999999999999999999999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=281.69 Aligned_cols=273 Identities=17% Similarity=0.111 Sum_probs=175.6
Q ss_pred cccccccccccccceeeeEEEEEee-c----ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeee------ee
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-S----AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVIST------CS 91 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 91 (313)
..++|++.+.||+|+||.||+|... + +..||+|++...... +....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3579999999999999999999964 4 689999987643211 111111 1122222233222222 24
Q ss_pred eCccceEEEEeecCCCHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~ 152 (313)
.+...++|+||+++++|.+++...... .....+..++.|++.||.||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 556789999999999999998754311 123346689999999999999 9999999999
Q ss_pred CCceEecC-CCceeEcCCcchhhcccccccccccccccccccCCCcccccC----------------------CCCCcch
Q 047140 153 PINVLLDD-NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG----------------------RESTNGD 209 (313)
Q Consensus 153 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D 209 (313)
|+|||+++ ++.+||+|||++..+.... ........++..|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5899999999997653222 1122345678899999955322 2344669
Q ss_pred hHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC
Q 047140 210 VYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 210 iwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
||||||++|||+++..++.......... ..............+...........+..........++|+.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQ-LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHH-HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999877754432111000 000000000001111111000001111111223445679999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 047140 290 RINAREIVAKLFKIR 304 (313)
Q Consensus 290 Rps~~~il~~l~~~~ 304 (313)
|||+.++++|+|-..
T Consensus 441 R~ta~e~L~Hpff~~ 455 (566)
T PLN03225 441 RISAKAALAHPYFDR 455 (566)
T ss_pred CCCHHHHhCCcCcCC
Confidence 999999999998643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=263.00 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=210.7
Q ss_pred hhcccccccccccccceeeeEEEEEe-ecceEEEEEEeeccc-------chhHHHHHHHHHHHhcCCCCcceeeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC-------GRAFKSFNIECEMMKSIRHRNLIKVISTCSN 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (313)
....++|-.+.+||+|||+.||+|.. ..++.||+|+-.... ........+|..+.+.|+||.||+++++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 45567999999999999999999994 358899999975431 2234567789999999999999999999964
Q ss_pred -CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcC
Q 047140 93 -EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSD 168 (313)
Q Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~d 168 (313)
...+|-|+|||+|.+|.-+++.+. .+++...+.|+-||+.||.||... +..|+|-||||.|||+-+ -|.+||.|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 467899999999999998887765 899999999999999999999943 568999999999999964 47899999
Q ss_pred Ccchhhccccccccc-----ccccccccccCCCcccc-c---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhh
Q 047140 169 FSIAKLLTGEYQSMT-----QTQTLATIGCIAPEYRR-K---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKH 239 (313)
Q Consensus 169 fg~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~-~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~ 239 (313)
||+++++.+....-. .....||.+|++||.+. + ...+.+.||||.|+++|.++.|+.||...-........
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999998865432211 23456899999999654 2 24588999999999999999999999655433332211
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...++.....++..+.++.++.++|++||...-++|....++..++.-+
T Consensus 697 ---------------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 697 ---------------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred ---------------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 1112223333444556788899999999999999999999998886544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.28 Aligned_cols=241 Identities=27% Similarity=0.289 Sum_probs=196.1
Q ss_pred eeeeEEEEEee-cceEEEEEEeecccchh-HHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHHHHhc
Q 047140 37 VIIPVAQFLIS-SAMEVAVKVFNLQCGRA-FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS 114 (313)
Q Consensus 37 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (313)
+||.||++... +++.+++|++....... .+.+.+|++.++.++|+|++++++.+..+...++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997764433 68899999999999999999999999999999999999998899999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccC
Q 047140 115 SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI 194 (313)
Q Consensus 115 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 194 (313)
.. .++...++.++.+++.++.+|| +.+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 55 3889999999999999999999 9999999999999999999999999999988764321 223445777899
Q ss_pred CCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHH
Q 047140 195 APEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 274 (313)
Q Consensus 195 aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (313)
+||...+..++.++|+||||++++++++|..||................... .......++..
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-----------------FPPPEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-----------------CccccccCCHH
Confidence 9999988888999999999999999999999986632221111111000000 00000115678
Q ss_pred HHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 275 VFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 275 l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+.+++.+||..||++||++.++++++|
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhCCC
Confidence 999999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.76 Aligned_cols=250 Identities=20% Similarity=0.205 Sum_probs=205.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+|+-+..||.|+||.|-+|.-+ +.+.+|||+++++. ....+--..|-++|.-. +-|.++++..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47889999999999999999955 57899999998751 22333344577777666 567889999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+.||+|...++.-+ .+.++....++..|+-+|-||| ++||++||||.+|||++.+|.+||+|||+.+.-.-
T Consensus 429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-- 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-- 502 (683)
T ss_pred EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc--
Confidence 99999999999998777 6788888999999999999999 99999999999999999999999999999875321
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.........||+.|+|||++...+|+.+.|+||+|++||||+.|.+||++.+..+....+.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~------------------- 563 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM------------------- 563 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------------------
Confidence 2223455779999999999999999999999999999999999999999887655433221
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLF 301 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~ 301 (313)
..+...|...+.++.++++..|...|.+|... .+|-.|+.
T Consensus 564 --ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~F 608 (683)
T KOG0696|consen 564 --EHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPF 608 (683)
T ss_pred --HccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcc
Confidence 11122356678889999999999999999743 45666643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.02 Aligned_cols=269 Identities=17% Similarity=0.185 Sum_probs=186.1
Q ss_pred cccccccccccccceeeeEEEEEe-----------------ecceEEEEEEeecccchhHHH--------------HHHH
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI-----------------SSAMEVAVKVFNLQCGRAFKS--------------FNIE 71 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e 71 (313)
..++|++.++||+|+||.||+|.. .+++.||||++........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999863 135689999987543222222 3346
Q ss_pred HHHHhcCCCCcc-----eeeeeeeee--------CccceEEEEeecCCCHHHHHhcCC----------------------
Q 047140 72 CEMMKSIRHRNL-----IKVISTCSN--------EEFKALVLEYMPHGSLEKYLYSSN---------------------- 116 (313)
Q Consensus 72 ~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------- 116 (313)
+..+.+++|+++ ++++++|.. .+..++|+||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766544 667777643 345799999999999999886421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCC
Q 047140 117 -CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIA 195 (313)
Q Consensus 117 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 195 (313)
...++..++.++.|++.+|.||| ..+++||||||+||+++.++.++|+|||++....... .........++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence 12355678889999999999999 9999999999999999999999999999987543221 111122234678999
Q ss_pred CcccccCC----------------------CCCcchhHHHHHHHHHHHhCCC-CChhhhhhhhhhhhccCCccccccccc
Q 047140 196 PEYRRKGR----------------------ESTNGDVYSFGIMLMETFTRKK-PTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 196 PE~~~~~~----------------------~~~~~DiwslG~~l~~lltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
||.+.... .....|+||+||++++|++|.. |+................... ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r-- 454 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WR-- 454 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HH--
Confidence 99775332 1234699999999999999875 765432221111111100000 00
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCC---CCCCCHHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP---EQRINAREIVAKLFKI 303 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~~il~~l~~~ 303 (313)
...............++..++|+.+||..+| .+|+|++|+++|+|-.
T Consensus 455 ----~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 455 ----MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ----hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0000111112234567889999999999876 6899999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=249.25 Aligned_cols=260 Identities=22% Similarity=0.199 Sum_probs=202.5
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++.+.+..||+|+||+|++..++ +|+..|||++.... ......++.|.+...+- ++||||++++.+..++..++-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 45667789999999999999966 69999999998764 35667888888877655 79999999999999999999999
Q ss_pred eecCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 102 YMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 102 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+- +|..+-+. ....+++..+-.+..-.+.||.||-. ..+|+|||+||+|||++..|.+||||||.+-.+.+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9964 66544321 23468898888888889999999985 67899999999999999999999999999876643
Q ss_pred ccccccccccccccccCCCcccc--cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRR--KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
. .......|...|+|||-+. ...++.+||+||||+++||+.||..||..................+..
T Consensus 221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l------- 290 (361)
T KOG1006|consen 221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL------- 290 (361)
T ss_pred H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee-------
Confidence 2 2344556888999999775 335899999999999999999999999876553333322211111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.... .....+..+..++..||.+|-++||...++++++.-..
T Consensus 291 --~~~~-----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 291 --LFDK-----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred --cCcc-----cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 0000 01236777999999999999999999999999876543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=267.45 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=206.5
Q ss_pred ccccccccccccceeeeEEEEE-eecceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
...|..++.||-|+||.|.++. ..+...+|+|.+.+. ......+++.|..||..-+++.||+++-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3467889999999999999999 445789999999765 234567889999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc---
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT--- 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~--- 176 (313)
|+|++||++..+|-..+ -+++...+.++..+..|+++.| ..|++||||||+|||||.+|.+||.|||+.+-+.
T Consensus 708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999998776 6888889999999999999999 9999999999999999999999999999985220
Q ss_pred ------ccc-------------------------------ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHH
Q 047140 177 ------GEY-------------------------------QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219 (313)
Q Consensus 177 ------~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 219 (313)
... .........||..|+|||++....++..+|+||.|++|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000 0001123448899999999999999999999999999999
Q ss_pred HHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC---CHHHH
Q 047140 220 TFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI---NAREI 296 (313)
Q Consensus 220 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~i 296 (313)
|+.|+.||-...+.+.......+. ..+.+....+++.+..++|.++. .+++.|. .+++|
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~-----------------~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~v 925 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWR-----------------NFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQV 925 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehh-----------------hccccccccccCHHHHHHHHHHh-cChhhhhcccchhhh
Confidence 999999998777665554433221 12223334567778888887633 3555665 46668
Q ss_pred HHHHH
Q 047140 297 VAKLF 301 (313)
Q Consensus 297 l~~l~ 301 (313)
..|+|
T Consensus 926 KaHpf 930 (1034)
T KOG0608|consen 926 KAHPF 930 (1034)
T ss_pred hcCcc
Confidence 88865
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=248.43 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=222.6
Q ss_pred ccccccccccccceeeeEEEEEe------ecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-cc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI------SSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-EF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 95 (313)
..+++....+-+|.||.||.|.+ .+.+.|.+|.++.. ++-....+..|.-++..+.|||+.++.+++.++ ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 45678888899999999999953 34567888888654 445567788888888889999999999998554 56
Q ss_pred ceEEEEeecCCCHHHHHh-----c--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 96 KALVLEYMPHGSLEKYLY-----S--SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~-----~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
.++++.+...|+|..++. . ..+.++..++..++.|++.|++||| +.+++|.||...|.++++.-.+||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEecc
Confidence 788899999999999997 1 2345778888999999999999999 99999999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
=.+++.+-+.+..........+..||+||.+.+..++.++|+||||+++|||+| |..|+.+.++.++......+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy---- 515 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY---- 515 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----
Confidence 999998766655555556667888999999999999999999999999999999 999999988877765443222
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
+...|.+||++++.+|.-||..+|++||+++|+..-|.++..++.+
T Consensus 516 ----------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 516 ----------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred ----------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 2334678999999999999999999999999999999998887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=233.35 Aligned_cols=268 Identities=19% Similarity=0.249 Sum_probs=201.8
Q ss_pred hcccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeC--ccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNE--EFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~ 97 (313)
...++|++.+++|+|-++.||.|. ..++++++||+++.- ....+.+|+.+|+.|+ ||||++++++..+. ....
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 345799999999999999999999 456899999999754 4478899999999996 99999999999765 4568
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhcc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLT 176 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~ 176 (313)
+|+|+.++.+...+-. .++...+...+.+++.||.|+| +.||.|||+||.|+|++. .-.++|+|||++..+.
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998877766543 4788899999999999999999 999999999999999984 5679999999998876
Q ss_pred cccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhh-hhhhhhh---------------hh
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEI-FNREMTL---------------KH 239 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~-~~~~~~~---------------~~ 239 (313)
+... ..-...+..|-.||++.. ..++.+-|+|||||++..|+..+.||-.. ++.+..- ..
T Consensus 185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 4432 223456777889997664 56789999999999999999998887332 2221111 01
Q ss_pred ccCCcccccccccccccccCh--hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQ--EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..-. .+.....++++..... ...........++++.+|+.++|..|..+|+||.|++.|++-.
T Consensus 262 Y~i~-Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 262 YQID-LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HccC-CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 1101 1122222222211110 0111111223568899999999999999999999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=266.95 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=194.6
Q ss_pred cccccccccceeee-EEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeec
Q 047140 27 FQILNFFICGVIIP-VAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 27 y~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
|.-.+.+|.|+-|+ ||+|.+ .++.||||++-.+ ......+|+..|+.- +||||+++++.=.+.++.||..|+|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34455778888875 899998 4889999998644 345677899999888 79999999999999999999999997
Q ss_pred CCCHHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---C--CceeEcCCcchhhcc
Q 047140 105 HGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---N--MVAHLSDFSIAKLLT 176 (313)
Q Consensus 105 ~~~L~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~--~~~~l~dfg~~~~~~ 176 (313)
. +|.+++...... ......+.++.|+++||++|| +.+||||||||.||||+. + ..++|.|||+++++.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 999999874211 111345788999999999999 999999999999999975 3 478999999999986
Q ss_pred ccccccc-ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC-CCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 177 GEYQSMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
....... .....||.+|.|||++.....+.++||+||||++|+.++| ..||.+...++.....-....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L---------- 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL---------- 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce----------
Confidence 5543322 3456799999999999999889999999999999999995 899988766555432211110
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
....+ .-..++.+||.+|++.||..||+|.+++.||
T Consensus 733 ---------~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 733 ---------VHLEP-LPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ---------eeecc-CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 00001 1111789999999999999999999999995
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=238.05 Aligned_cols=258 Identities=21% Similarity=0.231 Sum_probs=210.0
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
..-++|++++.||+|++..|-+++++ +.+.+|+|++++. ..+..+....|-.+.++. +||.+|-+..+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34578999999999999999999965 5889999999875 445678888899999888 899999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|.||.+||+|.-.++.+. .++++..+.+...|+.||.||| .+||++||+|.+|+|++..|.+||.|+|..+.-.
T Consensus 327 ffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999987776665 7999999999999999999999 9999999999999999999999999999987543
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhh--hhhhhhhhccCCccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIF--NREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
.. ........||+.|.|||++.+..|....|+|+||++++||..|+.||+-.. +++.....+ +.+++-
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy--------lfqvil 472 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY--------LFQVIL 472 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH--------HHHHHh
Confidence 22 224456789999999999999999999999999999999999999996432 221111100 000000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC------CHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI------NAREIVAKL 300 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~~il~~l 300 (313)
......|...+..+..+++..|+.||++|. .++++..|.
T Consensus 473 -------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ 517 (593)
T KOG0695|consen 473 -------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA 517 (593)
T ss_pred -------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence 011223455667788899999999999996 467777764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=237.27 Aligned_cols=269 Identities=21% Similarity=0.200 Sum_probs=202.8
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-- 93 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (313)
...++..+|.-++.+|.|.- .|..+... .+++|++|+.... +........+|..++..++|+||++++.+|.-.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34567889999999999988 66666633 5899999998654 333456677899999999999999999999533
Q ss_pred ----ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 94 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 94 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
..+|+|||++.. +|...+.. .++-.++..++.|++.|+++|| +.||+||||||+||++..++.+||.||
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccc
Confidence 357999999965 99998873 4567889999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc-CCccc--
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG-NNWLP-- 246 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~-~~~~~-- 246 (313)
|+++.-... .....+..+..|.|||++.+..+.+.+||||+||++.||++|...|.+....+....... ..-..
T Consensus 163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 999864422 345667788999999999999999999999999999999999998876543222111110 00000
Q ss_pred ---------------------ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 247 ---------------------ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 247 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....+.+....-. ........-...+.+++.+||..||++|.|+.++|.||.
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~---~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFP---VVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCccccc---ccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 0000000000000 000011223566899999999999999999999999974
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=220.62 Aligned_cols=211 Identities=31% Similarity=0.422 Sum_probs=183.8
Q ss_pred cccceeeeEEEEEeec-ceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHH
Q 047140 33 FICGVIIPVAQFLISS-AMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110 (313)
Q Consensus 33 lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 110 (313)
||.|++|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 899999999866332 35678999999999999999999999999899999999999899999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhccccccccccccccc
Q 047140 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189 (313)
Q Consensus 111 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 189 (313)
++......++...++.++.+++.++.+|| ..+++|+||+|.||+++. ++.++|+||+.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 99876346889999999999999999999 999999999999999999 89999999999876543211 1233457
Q ss_pred ccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhh
Q 047140 190 TIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK 268 (313)
Q Consensus 190 ~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (313)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7789999988877 889999999999999999
Q ss_pred hhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 269 ~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
..+.+++..|+..||++||++.+++++|
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2378999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=216.42 Aligned_cols=209 Identities=22% Similarity=0.243 Sum_probs=172.0
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+....+..||+|++|.|-+.++. +|...|+|.+... +........+|+.+..+- .+|.+|.+++.....+.+++-|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345666789999999999888854 7999999999876 344566788888887665 8999999999999999999999
Q ss_pred EeecCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
|.++. ||..+-. ..+..+++..+-+++..+..||.|||. +..++|||+||+|||++.+|.+|+||||.+-.+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99965 7765443 345589999999999999999999995 67899999999999999999999999999876643
Q ss_pred ccccccccccccccccCCCcccc----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRR----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK 238 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~ 238 (313)
. ....-..|...|+|||.+. +..|+.++||||||+++.||.+++.||+....+.....
T Consensus 202 S---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 202 S---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred h---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 2 2223345778899999664 44789999999999999999999999987655444433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-34 Score=232.92 Aligned_cols=276 Identities=21% Similarity=0.211 Sum_probs=202.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----cc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-----FK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 96 (313)
-+.+.-+.||.|.||.||.+..+ +|+.|++|++.+- +-.....+.+|+.+|..++|.|++..++...-.. .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45667789999999999999854 7999999999763 3445678889999999999999998887764332 36
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+++|++.. +|..+|-+.. .++...+.-++.||+.+|.||| +.+|.||||||.|.|++++..+||||||+++...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence 899999954 9988886655 7888899999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh---hhccCCc-------c
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL---KHWGNNW-------L 245 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~---~~~~~~~-------~ 245 (313)
... ...-....-|..|+|||++.+. .|+.+.||||.||++.|++..+..|....+.+... ......- .
T Consensus 208 ~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 322 2233345567889999988765 68999999999999999999888886655432211 1110000 0
Q ss_pred cccccccccccccChhh-hh--hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQED-IH--FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
......++....+.... .. ...+....-+..+++..++..||..|.+..+++.|+..-+-+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 00011111111110000 00 011223344577889999999999999999999987654433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=251.26 Aligned_cols=265 Identities=24% Similarity=0.336 Sum_probs=219.3
Q ss_pred chhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 15 SRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
+.+++++.=.++|+....+|.|++|.||+++.+ +++..|+|+++........-+..|+-+++..+|+||+.+++.+...
T Consensus 5 ~~disrrnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 5 KSDISRRNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred cchhhhcCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 456667777889999999999999999999954 7999999999988777888889999999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..+++.||||.+|+|.+.-.-.+ ++++.++....+..+.+|+||| +.|-+|||||-.||++++.|.+|+.|||.+-
T Consensus 85 dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchh
Confidence 99999999999999998655444 7899999999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCccc---ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYR---RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
.+..... ......|++.|||||+. ..+.|...+|+|++|+...|+---.+|.-...+....+---.+.+.+..
T Consensus 161 qitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-- 236 (829)
T KOG0576|consen 161 QITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-- 236 (829)
T ss_pred hhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc--
Confidence 7653322 23456799999999965 4678999999999999999988877775444332222211111111111
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+...++.+.+|++.+|..+|++||++..++.|+.
T Consensus 237 --------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 237 --------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred --------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence 1124457888999999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=241.58 Aligned_cols=196 Identities=21% Similarity=0.292 Sum_probs=170.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcCC---CCcceeeeeeeee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIR---HRNLIKVISTCSN 92 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 92 (313)
.+|+..+.+|.|+||.|++|.++ +...|+||.+.++. ....-.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 47999999999999999999977 47899999997651 111223556999999997 9999999999999
Q ss_pred CccceEEEEee-cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 93 EEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 93 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
++++|++||.- +|-+|.++|..+. .+++.....+++||+.|+++|| ..||+|||||-+|++++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 99999999974 5679999998776 7899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCCh
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTD 228 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~ 228 (313)
+.... ........||..|.|||++.+.+| ...-|||+||+++|.+.....||.
T Consensus 717 aa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 87543 222344679999999999998887 777899999999999999998874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=215.39 Aligned_cols=199 Identities=26% Similarity=0.324 Sum_probs=173.8
Q ss_pred cccccccccceeeeEEEEEeec-ceEEEEEEeecccch-hHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 27 FQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGR-AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
|.+.+.||.|++|.||++.... ++.+++|.+...... ..+.+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999999764 899999999876544 67889999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++......+++..+..++.+++.++.+|| +.+++|+|++|.||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999999876533789999999999999999999 99999999999999999999999999999876643320 122
Q ss_pred cccccccccCCCccc-ccCCCCCcchhHHHHHHHHHHHhCCCCChh
Q 047140 185 TQTLATIGCIAPEYR-RKGRESTNGDVYSFGIMLMETFTRKKPTDE 229 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~p~~~ 229 (313)
....++..|++||.. ....++.++|+|+||++++++++|..||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334567789999988 677788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=215.78 Aligned_cols=257 Identities=18% Similarity=0.218 Sum_probs=195.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeee-eeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVIST-CSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~l 98 (313)
...+.|+|.+.||.|-||.+-++.++ +.+.+++|-+... .....+|.+|...--.| .|.||+.-+++ |+..+...+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 44689999999999999999999976 5889999988765 34457788888877667 68999988765 677778889
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec--CCCceeEcCCcchhhcc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--DNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg~~~~~~ 176 (313)
++||++-|+|..-+...+ +.+.....++.|+++|+.|+| ++++||||||.+|||+- +.-++||||||+.+..+
T Consensus 100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999999998887654 788889999999999999999 99999999999999983 33589999999988654
Q ss_pred cccccccccccccccccCCCcccccC-----CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKG-----RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
... ........|.+||+.... ...+.+|+|.||++++.++||..||...+..+..+-.|. .|......
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~-~w~~rk~~- 247 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE-QWLKRKNP- 247 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH-HHhcccCc-
Confidence 322 233456678999965432 347889999999999999999999986544333221110 01111110
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCC---CCHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR---INAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~~il~~l~~ 302 (313)
.........++.+..+.++-|..+|++| .++.+....+|.
T Consensus 248 -----------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 248 -----------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred -----------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 1111133467778999999999999999 666666665553
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=228.88 Aligned_cols=272 Identities=21% Similarity=0.281 Sum_probs=198.8
Q ss_pred hhcccccccccccccceeeeEEEEEe-e---cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-S---SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
..+.+.|....+||.|+|++||++.. . .++.||+|.+... .....+.+|++.|..+ -+.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 44567899999999999999999983 3 4789999999765 2346788999999999 68999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcchhh
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKL 174 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~ 174 (313)
+++|+||+++....++.. .++...+..+++.++.||.++| .+||+||||||+|++.+.. +.-.|+|||++..
T Consensus 110 v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred eEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999988888776 3678899999999999999999 9999999999999999855 6789999999972
Q ss_pred ccccc------------------------------------------ccccccccccccccCCCccccc-CCCCCcchhH
Q 047140 175 LTGEY------------------------------------------QSMTQTQTLATIGCIAPEYRRK-GRESTNGDVY 211 (313)
Q Consensus 175 ~~~~~------------------------------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw 211 (313)
..... .+.......||++|+|||++.. ...++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0000113448999999997764 4568999999
Q ss_pred HHHHHHHHHHhCCCCChhhhhhhhhh----hhc------------cC--Cccccc----------ccccccccccChhh-
Q 047140 212 SFGIMLMETFTRKKPTDEIFNREMTL----KHW------------GN--NWLPIS----------TMEVVDANLLSQED- 262 (313)
Q Consensus 212 slG~~l~~lltg~~p~~~~~~~~~~~----~~~------------~~--~~~~~~----------~~~~~~~~~~~~~~- 262 (313)
|.|++++.++++..||-......... ... .. .|.... ...+......+...
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999984332111100 000 00 011000 00000000000000
Q ss_pred -hhhhhhh-hhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 263 -IHFVAKE-QCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 263 -~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....... -.+..+.+|+.+||..||.+|.||+++|+|+.
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 1111122 23458999999999999999999999999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=202.37 Aligned_cols=171 Identities=21% Similarity=0.171 Sum_probs=131.3
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
|+|.+++...+..+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 5899999876667999999999999999999999 777 999999999999999 9988754321
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
...++..|+|||++.+..++.++|||||||++|||++|..||................. ........
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-------------PADDPRDR 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-------------ccCCcccc
Confidence 12578899999999999999999999999999999999999965432211111110000 00000000
Q ss_pred hhhhhhHH--HHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 266 VAKEQCVS--FVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 266 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
..+...+. .+.+++.+||..||.+||++.++++|++....+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 01222333 6999999999999999999999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=250.76 Aligned_cols=202 Identities=16% Similarity=0.228 Sum_probs=145.3
Q ss_pred cCCC-Ccceeeeeee-------eeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 047140 77 SIRH-RNLIKVISTC-------SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIH 148 (313)
Q Consensus 77 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h 148 (313)
.++| +||++++++| .....++.++|++ +++|.+++......+++..++.++.||+.||.||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4455 5788888877 2334577888988 55999999876557999999999999999999999 999999
Q ss_pred CCCCCCceEecC-------------------CCceeEcCCcchhhcccccc-------c-------ccccccccccccCC
Q 047140 149 CDLKPINVLLDD-------------------NMVAHLSDFSIAKLLTGEYQ-------S-------MTQTQTLATIGCIA 195 (313)
Q Consensus 149 ~di~p~nil~~~-------------------~~~~~l~dfg~~~~~~~~~~-------~-------~~~~~~~~~~~y~a 195 (313)
|||||+|||++. ++.+|++|||+++....... . .......+|..|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566677776653211000 0 00011346788999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHH
Q 047140 196 PEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275 (313)
Q Consensus 196 PE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 275 (313)
||++.+..++.++|||||||++|||++|..|+............ . . .... ........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---~--------~-----~~~~------~~~~~~~~ 241 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---R--------V-----LPPQ------ILLNWPKE 241 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---h--------h-----cChh------hhhcCHHH
Confidence 99999999999999999999999999999887543211110000 0 0 0000 00112335
Q ss_pred HHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 276 FNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 276 ~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.+++.+||..||.+||++.++++|+|-..
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 68889999999999999999999998643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=193.53 Aligned_cols=267 Identities=16% Similarity=0.126 Sum_probs=212.1
Q ss_pred hcccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcCCC-CcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 99 (313)
-....|.+.++||+|+||.+|.|. ..+|+.||||+-+... ....+..|..+.+.|++ ..|+.+..++.+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 456799999999999999999999 5679999999876553 23567779999999965 7888888899999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~~~ 176 (313)
|+++ |.+|+++++-..+.++..+++-++.|++.-++|+| .++++||||||+|+|+.-+ ..+.++|||+++.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999 77999999877778999999999999999999999 9999999999999999633 568999999999875
Q ss_pred cccc-----cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQ-----SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
.... ........||..|.+-....+...+.+.|+=|+|.++.++..|..||.+.......... +.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----------Ek 235 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----------EK 235 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----------HH
Confidence 4332 22344566889999988888889999999999999999999999999887654332221 11
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
+.+..+ ...-.......|.++.-.+..|-..--++-|...-+-+.+..+...+
T Consensus 236 I~EkK~---s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 236 ISEKKM---STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHhhc---CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 111111 11112224456788888999999888889898888777766655443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=196.78 Aligned_cols=267 Identities=15% Similarity=0.079 Sum_probs=217.2
Q ss_pred cccccccccccccceeeeEEEEE-eecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFL-ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+.-.|.++++||+|+||.++.|. .-++++||||.-+.. .....+..|.+..+.| ..+.|+..+-+...+-+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 45689999999999999999999 447999999976554 3457788899999998 5799999999989999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-----CceeEcCCcchhhc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-----MVAHLSDFSIAKLL 175 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-----~~~~l~dfg~~~~~ 175 (313)
|++ |.+|+|++.-.++.++..++.-++.|++.-++++| .++.++|||||+|+||..- ..+.++|||+++.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999 77999999988889999999999999999999999 9999999999999999743 45889999999988
Q ss_pred cccccccc-----ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 176 TGEYQSMT-----QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 176 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
........ .....||-.||+-....+.+.+.+.|+=|||=++++.|.|..||.+.+...-.....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---------- 249 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---------- 249 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----------
Confidence 65443332 334568999999999999999999999999999999999999999876433222111
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
.+-+. ++...-.......|.++...++..-..+-.+-|..+-+...+.++.+++-
T Consensus 250 KIGe~---Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGET---KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred Hhccc---cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 11111 11111122345578888888988888899999999999888888877653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=200.46 Aligned_cols=262 Identities=19% Similarity=0.162 Sum_probs=201.0
Q ss_pred ccccccccccceeeeEEEEEeec--ceEEEEEEeecccchhHHHHHHHHHHHhcCCC----Ccceeeeeee-eeCccceE
Q 047140 26 DFQILNFFICGVIIPVAQFLISS--AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH----RNLIKVISTC-SNEEFKAL 98 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~l 98 (313)
+|.+.++||+|+||.||.+...+ ...+|+|............+..|..++..+.. ++++.+++.. ..+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999654 35789998876533322367789999988862 6899999999 57888999
Q ss_pred EEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-----CceeEcCCcch
Q 047140 99 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-----MVAHLSDFSIA 172 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-----~~~~l~dfg~~ 172 (313)
||+.+ |.+|.++..... ..++..++..++.|++.+|.+|| +.|++||||||+|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 779999886554 68999999999999999999999 9999999999999999865 46899999999
Q ss_pred h--hcccccc-----ccc-ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc
Q 047140 173 K--LLTGEYQ-----SMT-QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 173 ~--~~~~~~~-----~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~ 244 (313)
+ .+..... ... .....||..|+++....+.+.+.+.|+||++.++.++..|..||................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~- 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP- 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh-
Confidence 8 4322211 111 123559999999999999999999999999999999999999986654322211100000
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....... .....+..+.++...+-..+..++|....+...+.......
T Consensus 254 ---------~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 ---------RKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---------hhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0000000 11234566777777777799999999999999988777653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=196.70 Aligned_cols=165 Identities=19% Similarity=0.135 Sum_probs=127.0
Q ss_pred hcccccccccccccceeeeEEEEEee--cceEEEEEEeecc-----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQ-----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
...++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++|+|++..+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 34678999999999999999999864 4778899987532 123456789999999999999998533222 4
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCceEecCCCceeEcCCcchh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL-KPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di-~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..++||||++|++|.. +... . ...++.+++.+|.||| +.||+|||| ||+|||++.++.++|+|||+++
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 5799999999999963 2111 1 1467889999999999 999999999 9999999999999999999998
Q ss_pred hccccccccc------ccccccccccCCCcccc
Q 047140 174 LLTGEYQSMT------QTQTLATIGCIAPEYRR 200 (313)
Q Consensus 174 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~ 200 (313)
.+........ .....++..|.|||+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 6643211111 12445677789999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=214.71 Aligned_cols=260 Identities=17% Similarity=0.151 Sum_probs=193.4
Q ss_pred ccccccccceeeeEEEEEee-cceEEEEEEee-----cccchhH-HHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 28 QILNFFICGVIIPVAQFLIS-SAMEVAVKVFN-----LQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~-----~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.....+|.|.+|.|+.+... ..+..+.|.+. ....... ..+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45668899999987777733 24434444332 1111111 12566777777889999988887776665444559
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|||++ +|..++.... .++...+-.+++|++.|+.|+| ..|+.|||+||+|++++.+|.+||+|||.+..+.-...
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99998 9999998764 5788889999999999999999 99999999999999999999999999999987654433
Q ss_pred c--ccccccccccccCCCcccccCCCCC-cchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 181 S--MTQTQTLATIGCIAPEYRRKGREST-NGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 181 ~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. .......|+..|+|||+..+..|.+ ..||||.|+++..|.+|+.||......+..+... .....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------------~~~~~ 543 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------------NYSDQ 543 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------------ccccc
Confidence 3 3456778999999999999999855 5799999999999999999986654443322000 00000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.............++..-+.++.+||+.||.+|.|+++|++..|-..
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 11111111223456777899999999999999999999999998654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-23 Score=183.71 Aligned_cols=257 Identities=30% Similarity=0.355 Sum_probs=198.9
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeecccc---hhHHHHHHHHHHHhcCCCC-cceeeeeeeeeCccceEEEEe
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCG---RAFKSFNIECEMMKSIRHR-NLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 102 (313)
|.+...||.|+|+.||.+... ..+++|.+..... .....+.+|..+++.+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778889999999999999965 7889999976522 1467889999999999888 799999999777778999999
Q ss_pred ecCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhccccc
Q 047140 103 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 103 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 179 (313)
+.++++.+++.... ..++......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 26889999999999999999999 99999999999999999988 79999999987554332
Q ss_pred ccc----cccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhh---hhhhhhccCCcccccc
Q 047140 180 QSM----TQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNR---EMTLKHWGNNWLPIST 249 (313)
Q Consensus 180 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~---~~~~~~~~~~~~~~~~ 249 (313)
... ......++..|++||.+.+ ...+...|+||+|++++++++|..||...... ............+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2356678999999999887 57899999999999999999999997655431 1111111000000
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAK 299 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~ 299 (313)
.......... .......+.+++..++..+|..|.+..+...+
T Consensus 234 --~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSN------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccc------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000 02234578899999999999999999988876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=210.64 Aligned_cols=250 Identities=21% Similarity=0.201 Sum_probs=185.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccc-hhHHHHHHHHHH--HhcCCCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCG-RAFKSFNIECEM--MKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..+|...+.||++.|=.|.+|.+..|. |+||++-++.+ .....+.++++- ...+++||.+.+.-+-+.+...|||=
T Consensus 22 ~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 22 SVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence 337888899999999999999987787 99999976642 233344443333 44459999999999888888899999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc-cccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL-TGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~-~~~~ 179 (313)
+|..+ +|.|++.... .+..-+..-++.|++.||..+| ..||+|||||.+|||+++=.++.|.||..-+.. .+.+
T Consensus 101 qyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 99976 9999997665 6778888889999999999999 999999999999999999999999999876532 1222
Q ss_pred cccccc----ccccccccCCCcccccC----------C-CCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 180 QSMTQT----QTLATIGCIAPEYRRKG----------R-ESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 180 ~~~~~~----~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
+..... ....-.+|.|||-+... + .+++-||||+||++.|+++ |++||.-..- .....++.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL---~aYr~~~~ 252 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL---LAYRSGNA 252 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---HhHhccCc
Confidence 111111 22244679999965431 1 4678899999999999998 7888854311 11111101
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAK 299 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~ 299 (313)
...+.....-.+..+++++..|++.||++|.+|++.|+.
T Consensus 253 -----------------~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 -----------------DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----------------cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111112223468999999999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=177.20 Aligned_cols=177 Identities=14% Similarity=0.145 Sum_probs=137.2
Q ss_pred hhhhhhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchh---HHH------HHHHHHHHhcCCCCcceeee
Q 047140 17 DVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRA---FKS------FNIECEMMKSIRHRNLIKVI 87 (313)
Q Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~------~~~e~~~l~~l~h~~i~~~~ 87 (313)
++.-.-+.++|++.+.+|.|+||.||++.. ++..+|+|++....... .+. +.+|++.+.+++|++|..+.
T Consensus 23 ~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 23 EIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 445566789999999999999999999765 57789999997542222 122 67899999999999999998
Q ss_pred eeeeeC--------ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec
Q 047140 88 STCSNE--------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159 (313)
Q Consensus 88 ~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~ 159 (313)
.++... +..++||||++|.+|.+... +++ ....+++.++..+| ..|++|||++|+||+++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVS 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEe
Confidence 886543 35789999999999988732 233 24569999999999 99999999999999999
Q ss_pred CCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHH
Q 047140 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221 (313)
Q Consensus 160 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll 221 (313)
++| ++++|||......... ....+.....+..++|+||||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~--------------a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRK--------------AKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchh--------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence 988 9999999876442111 0011445556678999999999876554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=176.27 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=193.3
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++.+...+|.....|..|+|++. |..+++|+++.. .......|..|.-.|+.+.||||+.+++.|.+.-++.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 34556678889999999999985 666777888654 345667888899999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc--CCcchhhccccc
Q 047140 103 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS--DFSIAKLLTGEY 179 (313)
Q Consensus 103 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~--dfg~~~~~~~~~ 179 (313)
++.|+|...+.... --.+..+..+++.+++.+++|||.. ..-|.---+....+++|++-+.+|. |--++..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 99999999997653 2356778899999999999999942 1123334678889999998776654 4333321
Q ss_pred ccccccccccccccCCCcccccCCC---CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRE---STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
......++.|++||.+...+- -.++|+|||++++||+-|...||.+.++-+.-...
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------------- 401 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------------- 401 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------------
Confidence 223446778999998876653 45789999999999999999999887764443221
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+..+...|+..+...-.|+.-|++.||.+||.+..|+-.|+..
T Consensus 402 --aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 402 --ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 122333444667788899999999999999999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=168.96 Aligned_cols=139 Identities=14% Similarity=0.106 Sum_probs=108.9
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccch--h------------------------HHHHHHHHHHHhcCCCCcc
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR--A------------------------FKSFNIECEMMKSIRHRNL 83 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 83 (313)
.+.||+|++|.||+|..++|++||||+++..... . ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5689999999999999778999999999764211 0 1122349999999987776
Q ss_pred eeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeCCCCCCceEecCCC
Q 047140 84 IKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~~i~h~di~p~nil~~~~~ 162 (313)
.....+.. . ..++||||++|+++....... ..++...+..++.|++.+|.++ | ..|++||||||+|||++ ++
T Consensus 82 ~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL-K-SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe-c-CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 43332222 2 238999999887776554333 3688999999999999999999 8 89999999999999998 47
Q ss_pred ceeEcCCcchhhc
Q 047140 163 VAHLSDFSIAKLL 175 (313)
Q Consensus 163 ~~~l~dfg~~~~~ 175 (313)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=171.33 Aligned_cols=232 Identities=19% Similarity=0.195 Sum_probs=149.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCC----------Ccceeeeeee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRH----------RNLIKVISTC 90 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~ 90 (313)
.....++.||.|+++.||.+... +++++|+|++... .....+.+.+|.-....+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35677889999999999999965 5899999999654 22345666666655555322 1233222222
Q ss_pred e---------eC---c-----cceEEEEeecCCCHHHHHhc---CC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 047140 91 S---------NE---E-----FKALVLEYMPHGSLEKYLYS---SN---CILDIFQRLNIMIDVASALEYLHFGYSAQVI 147 (313)
Q Consensus 91 ~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~ 147 (313)
. .. . ..+++|+-+. +||.+++.. .. ..+.......+..|++..+++|| ..|++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence 1 11 1 2366777774 599888752 11 12333444667789999999999 99999
Q ss_pred eCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCccccc--------CCCCCcchhHHHHHHHHH
Q 047140 148 HCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--------GRESTNGDVYSFGIMLME 219 (313)
Q Consensus 148 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~ 219 (313)
|+||+|+|++++++|.+.|+||+.....+.... . ...+..|.+||.... ..++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999988776543221 1 234466889996533 346889999999999999
Q ss_pred HHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCC
Q 047140 220 TFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290 (313)
Q Consensus 220 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 290 (313)
++.|..||........... .+....+.++.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999976543222111 111123578889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=162.49 Aligned_cols=141 Identities=18% Similarity=0.152 Sum_probs=111.0
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccch--------------------------hHHHHHHHHHHHhcCCCCc
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR--------------------------AFKSFNIECEMMKSIRHRN 82 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~ 82 (313)
+.+.||+|++|.||+|...+|+.||||+++..... .......|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999999999768999999999764211 0223457899999999888
Q ss_pred ceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCC
Q 047140 83 LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDN 161 (313)
Q Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~ 161 (313)
+.....+.... .++||||++|+++....... ..++......++.|++.++.++| . .|++|+||||+||+++ +
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 75444433332 48999999887554432222 25778889999999999999999 8 9999999999999999 8
Q ss_pred CceeEcCCcchhhcc
Q 047140 162 MVAHLSDFSIAKLLT 176 (313)
Q Consensus 162 ~~~~l~dfg~~~~~~ 176 (313)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-24 Score=189.64 Aligned_cols=224 Identities=21% Similarity=0.172 Sum_probs=184.4
Q ss_pred cccceeeeEEEEEee----cceEEEEEEeeccc--chhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEEEeecC
Q 047140 33 FICGVIIPVAQFLIS----SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 33 lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+|.|.+|.|+++..- .+.-+++|+.+... ......-..|..++...+ ||.++++...++.+..++++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 689999999997732 37788999887641 112225566888888886 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
|+|...+.... .+.+.....+...++.++..+| +.+++|+|+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 99998887766 5677778888999999999999 999999999999999999999999999999876533321
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
.|+..|||||++. ....++|.||||+++++|+||..||.... ... .....+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----~~~---------------------Il~~~~ 204 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----MKR---------------------ILKAEL 204 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----HHH---------------------Hhhhcc
Confidence 7899999999998 77889999999999999999999997611 000 011123
Q ss_pred hhhhhhHHHHHHHHhHhhccCCCCCCCH
Q 047140 266 VAKEQCVSFVFNLAIECTVESPEQRINA 293 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 293 (313)
..+...+..+.+++..++..+|..|...
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3366788889999999999999999866
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=188.16 Aligned_cols=198 Identities=21% Similarity=0.148 Sum_probs=162.4
Q ss_pred hcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 98 (313)
.....|.|.+.+|.|++|+||.|...+|+.||+|+-+..+.. +|.--.+++.+|+ -+.|..+..++...+..++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 345689999999999999999999878999999998766543 2223344555554 2345555555566666789
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-------CCCceeEcCCcc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-------DNMVAHLSDFSI 171 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-------~~~~~~l~dfg~ 171 (313)
|+||.+.|+|.++++.. ..+++..+..++.|++..+..|| ..+|+||||||+|+|+. ....++|+|||.
T Consensus 772 v~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999999999999844 37899999999999999999999 99999999999999994 345689999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p 226 (313)
+..+....+........++..+-.+|+..+.+++..+|.|.|+-+++-||.|...
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9877554444455567788899999999999999999999999999999998654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=156.00 Aligned_cols=184 Identities=14% Similarity=0.073 Sum_probs=138.2
Q ss_pred ccccccccceeeeEEEEEeecceEEEEEEeecccchhH-----HHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEEE
Q 047140 28 QILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAF-----KSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.+...|++|+||+|+.+.- .+.+++.+.+.... ... ..+.+|+++|+++. ++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~-~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAP-WWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccch-hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997775 58889988886652 222 25789999999995 5889999886 33689999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL-KPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di-~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+.|.+|...+.. ....++.|++.+|.++| ..|++|+|| ||+|||++.++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999888654321 11357789999999999 999999999 79999999999999999999985443221
Q ss_pred -----c-cc-----ccccccccccCCCcccccC-CCC-CcchhHHHHHHHHHHHhCCCCCh
Q 047140 181 -----S-MT-----QTQTLATIGCIAPEYRRKG-RES-TNGDVYSFGIMLMETFTRKKPTD 228 (313)
Q Consensus 181 -----~-~~-----~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~~l~~lltg~~p~~ 228 (313)
. .. ......+..|++|+...-. ..+ .+.+.++.|+.+|.++|+..++-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00 1122256667777743322 333 67899999999999999998853
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=174.04 Aligned_cols=214 Identities=28% Similarity=0.380 Sum_probs=163.6
Q ss_pred HhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-eeCCCCC
Q 047140 75 MKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQV-IHCDLKP 153 (313)
Q Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i-~h~di~p 153 (313)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+......++......++++++.+|.||| ...| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 46789999999999999999999999999999999999988778899999999999999999999 5544 9999999
Q ss_pred CceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccC-------CCCCcchhHHHHHHHHHHHhCCCC
Q 047140 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-------RESTNGDVYSFGIMLMETFTRKKP 226 (313)
Q Consensus 154 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~lltg~~p 226 (313)
.|.+++....+|+.|||+.....................|.|||.+... ..+.+.|+||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765431111222333456679999987653 147789999999999999999999
Q ss_pred Chhhhhhhh----hhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 227 TDEIFNREM----TLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 227 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
|........ ...... . . ..............++++..++..||..+|+.||+++++-..+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-~-----------~--~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-G-----------G--SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cccccccCChHHHHHHHHh-c-----------C--CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 976432211 111000 0 0 000000011111455679999999999999999999999888776
Q ss_pred HHH
Q 047140 303 IRD 305 (313)
Q Consensus 303 ~~~ 305 (313)
+..
T Consensus 224 ~~~ 226 (484)
T KOG1023|consen 224 INK 226 (484)
T ss_pred hcc
Confidence 654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-22 Score=175.30 Aligned_cols=177 Identities=24% Similarity=0.331 Sum_probs=128.4
Q ss_pred ceEEEEeecCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 96 KALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
+|+.|++|.-.+|.+++... ....+......++.|++.++.| ++.+|+|+||.||++..++.+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence 46778888888999999643 3356777889999999999997 688999999999999999999999999988
Q ss_pred hccccc----ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccc
Q 047140 174 LLTGEY----QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 174 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
...... .........+|..||+||.+.+..|+.++||||||++++|+++ =..+++....... .....+.+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d---~r~g~ip~-- 479 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD---IRDGIIPP-- 479 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh---hhcCCCCh--
Confidence 664332 1122345668999999999999999999999999999999998 2333333221111 00011100
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.+ ..+ .+.-..|+..++...|.+||++.+...+.+
T Consensus 480 ---------------~~--~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 480 ---------------EF--LQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred ---------------HH--hhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 00 001 122458999999999999997666655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=152.25 Aligned_cols=134 Identities=13% Similarity=0.168 Sum_probs=106.1
Q ss_pred cccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-----CCCcceeeeeeeeeCc---cce
Q 047140 27 FQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-----RHRNLIKVISTCSNEE---FKA 97 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~ 97 (313)
.+-...||+|+||.||. ++ ++.. +||++........+.+.+|+.+++.+ +||||+++++++.++. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34467899999999996 44 3444 69998765444567789999999999 5799999999998873 433
Q ss_pred -EEEEe--ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceeCCCCCCceEecCC----CceeEcCC
Q 047140 98 -LVLEY--MPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAQVIHCDLKPINVLLDDN----MVAHLSDF 169 (313)
Q Consensus 98 -lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l-~~lH~~~~~~i~h~di~p~nil~~~~----~~~~l~df 169 (313)
+|+|| +.+++|.+++... .+++. ..++.+++.++ .||| +++|+|+||||+|||++.. +.++|+||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 4578999999764 35555 35678888777 9999 9999999999999999743 37999995
Q ss_pred c
Q 047140 170 S 170 (313)
Q Consensus 170 g 170 (313)
+
T Consensus 154 ~ 154 (210)
T PRK10345 154 I 154 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=154.33 Aligned_cols=142 Identities=18% Similarity=0.113 Sum_probs=111.5
Q ss_pred cccccccccccceeeeEEEEE--eecceEEEEEEeecccch------------------------hHHHHHHHHHHHhcC
Q 047140 25 SDFQILNFFICGVIIPVAQFL--ISSAMEVAVKVFNLQCGR------------------------AFKSFNIECEMMKSI 78 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l 78 (313)
.-|.+.+.||.|++|.||+|. ..+|+.||+|++...... ....+..|++.+..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999998 457999999999754210 112356799999999
Q ss_pred CCC--cceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceeCCCCCCc
Q 047140 79 RHR--NLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ-VIHCDLKPIN 155 (313)
Q Consensus 79 ~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-i~h~di~p~n 155 (313)
.+. .++++++. . ..++||||++|.+|........ ......+..++.|++.++.+|| ..| ++|+||||+|
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence 653 34444443 2 3589999999888876543332 4566677899999999999999 999 9999999999
Q ss_pred eEecCCCceeEcCCcchhhc
Q 047140 156 VLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 156 il~~~~~~~~l~dfg~~~~~ 175 (313)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=156.74 Aligned_cols=205 Identities=18% Similarity=0.254 Sum_probs=146.4
Q ss_pred CCCcceeeeeeeee---------------------------CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 047140 79 RHRNLIKVISTCSN---------------------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 131 (313)
Q Consensus 79 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i 131 (313)
+|||||+++++|.+ +..+|+||..++. +|..++-... .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999988743 2247899999976 9999997664 5667777899999
Q ss_pred HHHHHHHhcCCCCCceeCCCCCCceEec--CCC--ceeEcCCcchhhcccccc--cc--cccccccccccCCCcccccCC
Q 047140 132 ASALEYLHFGYSAQVIHCDLKPINVLLD--DNM--VAHLSDFSIAKLLTGEYQ--SM--TQTQTLATIGCIAPEYRRKGR 203 (313)
Q Consensus 132 ~~~l~~lH~~~~~~i~h~di~p~nil~~--~~~--~~~l~dfg~~~~~~~~~~--~~--~~~~~~~~~~y~aPE~~~~~~ 203 (313)
++|+.||| ++|+.|||+|.+|||+. +++ .+.++|||+.---...+. .. ......|+-..+|||+....+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999984 443 568899998643221111 11 112334677789999876443
Q ss_pred C------CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHH
Q 047140 204 E------STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 277 (313)
Q Consensus 204 ~------~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 277 (313)
- -.++|.|+.|.+.||+++...||............+ ++......+..++..+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-------------------qe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-------------------QESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-------------------hhhhCCCCcccCChHHHH
Confidence 2 357999999999999999999997732111110000 111222335678999999
Q ss_pred HHhHhhccCCCCCCCHHHHHHH----HHHHHHHhh
Q 047140 278 LAIECTVESPEQRINAREIVAK----LFKIRDSLL 308 (313)
Q Consensus 278 li~~~l~~dP~~Rps~~~il~~----l~~~~~~~~ 308 (313)
++...|+.||++|+++.=+... ||...+.++
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vk 523 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVK 523 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHHHhcCchHHH
Confidence 9999999999999987654433 555555443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-19 Score=146.20 Aligned_cols=134 Identities=19% Similarity=0.209 Sum_probs=113.4
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccc--------hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCG--------RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
+.||+|++|.||+|.. .+..|++|+...... .....+.+|++++..++|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 678899998654311 1124577899999999999988777777777788999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
++|++|.+.+.... . ....++.+++.+|.++| ..+++|+|++|.|||++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986543 2 77889999999999999 99999999999999999 78899999998763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=173.71 Aligned_cols=212 Identities=23% Similarity=0.224 Sum_probs=153.0
Q ss_pred hcccccccccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
-..++|+.++.+..|++|.||.++++. .+.+|+| +++++. +.+. ++....+|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee----------------
Confidence 346799999999999999999999774 7788884 443321 1110 22222333222
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc-
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY- 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~- 179 (313)
|+-...++..+ .++. +++.+++||| .-||+|+|+||+|.+++.-|.+|+.|||+++.-....
T Consensus 136 -----gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -----chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 46666666654 2333 2278999999 9999999999999999999999999999987432110
Q ss_pred ------------ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-ccc
Q 047140 180 ------------QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-WLP 246 (313)
Q Consensus 180 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~~~ 246 (313)
.........+|+.|.|||++....|....|+|++|+++|+.+-|..||.+..+.+..-...... .++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 0111234579999999999999999999999999999999999999998876554433222211 111
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA 293 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 293 (313)
+. ....+.++.+++..+|+.+|..|.-.
T Consensus 279 E~-------------------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 279 EE-------------------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred cc-------------------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 10 23467789999999999999999743
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=142.26 Aligned_cols=137 Identities=19% Similarity=0.123 Sum_probs=108.8
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeecccch----------------------hHHHHHHHHHHHhcCCCC--
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR----------------------AFKSFNIECEMMKSIRHR-- 81 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~-- 81 (313)
.|.+.+.||.|+||.||++..++|+.||||++...... .......|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47888999999999999999878999999987643210 112356788888888776
Q ss_pred cceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC
Q 047140 82 NLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161 (313)
Q Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~ 161 (313)
.++..++ .+..++||||++|++|...... .....++.+++.++.++| ..|++|+||+|+||+++++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence 3444443 2345899999999998765421 234678899999999999 9999999999999999999
Q ss_pred CceeEcCCcchhhcc
Q 047140 162 MVAHLSDFSIAKLLT 176 (313)
Q Consensus 162 ~~~~l~dfg~~~~~~ 176 (313)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=141.65 Aligned_cols=130 Identities=16% Similarity=0.213 Sum_probs=106.4
Q ss_pred ccccceeeeEEEEEeecceEEEEEEeeccc---c-----hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 32 FFICGVIIPVAQFLISSAMEVAVKVFNLQC---G-----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.||+|+||.||++.. ++..|++|...... + .....+.+|++++..++|+++....-++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 479999999999995 57889999865321 1 11355778999999998887665555555666789999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
+|++|.+.+..... .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 78999999999999 99999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=159.10 Aligned_cols=137 Identities=17% Similarity=0.158 Sum_probs=111.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc---c-----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ---C-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
...|...+.||+|+||.||++.... ..+++|+.... . ....+.+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445668899999999999998643 33444443211 0 1123568889999999999999988888877778
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.++||||++|++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 34678999999999999 9999999999999999 678999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-20 Score=171.37 Aligned_cols=263 Identities=21% Similarity=0.229 Sum_probs=207.9
Q ss_pred ccccccccccccceeeeEEEEEee--cceEEEEEEeecc--cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 98 (313)
...|.+.+-||.|+|+.|-..... ....++.|.+... .......+..|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 568899999999999999888853 2556677766544 2344555666888877886 9999999999999999999
Q ss_pred EEEeecCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhcc
Q 047140 99 VLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLT 176 (313)
Q Consensus 99 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~ 176 (313)
++++..|+++.+.+ .......+.......+.|+..++.|+|. ..+++|+|++|+|.+++..+ ..++.|||++..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999988 5444356777788899999999999996 67899999999999999999 99999999999876
Q ss_pred c-cccccccccccc-ccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 G-EYQSMTQTQTLA-TIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
. ...........| +..|.|||...+. ...+..|+||.|+++..+++|..|+.........+..|.+..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~--------- 247 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK--------- 247 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---------
Confidence 5 444444455567 9999999988885 457889999999999999999999877665554443333221
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...........+....+++.+++..+|..|.+.+++..++|...
T Consensus 248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00011113345666889999999999999999999999888765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.2e-17 Score=132.81 Aligned_cols=137 Identities=20% Similarity=0.161 Sum_probs=97.8
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchh--HHH----------------------HHHHHHHHhcCCCC--c
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRA--FKS----------------------FNIECEMMKSIRHR--N 82 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--~ 82 (313)
+.+.||+|+||.||+|...+++.||||++....... ... ...|.+.+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999997779999999987542111 111 13455555555333 2
Q ss_pred ceeeeeeeeeCccceEEEEeecCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecC
Q 047140 83 LIKVISTCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDD 160 (313)
Q Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~ 160 (313)
+.++++. ...++||||++++++... +.... . ......++.+++.++.++| . .+++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 4444443 236899999988443211 11111 1 1567889999999999999 8 9999999999999999
Q ss_pred CCceeEcCCcchhhcc
Q 047140 161 NMVAHLSDFSIAKLLT 176 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~ 176 (313)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=123.53 Aligned_cols=135 Identities=18% Similarity=0.214 Sum_probs=112.3
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC--CcceeeeeeeeeCccceEEEEeecCC
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
+.+.+|.|.++.||++... +..+++|....... ...+..|..+++.+++ .++++++.++...+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4578999999999999974 47899999866532 4678889999999976 58999999988888899999999887
Q ss_pred CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.+..+ +......++.+++.++..+|.....+++|+|++|.||++++.+.++++||+.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4556677899999999999932225799999999999999999999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-16 Score=130.97 Aligned_cols=134 Identities=16% Similarity=0.137 Sum_probs=103.8
Q ss_pred cccc-cceeeeEEEEEeecceEEEEEEeeccc-------------chhHHHHHHHHHHHhcCCCCcc--eeeeeeeeeC-
Q 047140 31 NFFI-CGVIIPVAQFLISSAMEVAVKVFNLQC-------------GRAFKSFNIECEMMKSIRHRNL--IKVISTCSNE- 93 (313)
Q Consensus 31 ~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~- 93 (313)
..|| .|+.|+||.+... +..++||.+.... ......+.+|++++..++|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4576 7888999998864 7789999885321 1223567889999999988775 6777765433
Q ss_pred cc---ceEEEEeecC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 94 EF---KALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 94 ~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
.. .++|+|+++| .+|.+++... .++.. .+.+++.+|.+|| ..||+|+||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 22 3599999987 6899888653 34443 3568999999999 999999999999999999999999999
Q ss_pred cchhh
Q 047140 170 SIAKL 174 (313)
Q Consensus 170 g~~~~ 174 (313)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-14 Score=131.92 Aligned_cols=184 Identities=16% Similarity=0.155 Sum_probs=139.8
Q ss_pred ccccccccccceeeeEEE-EEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 26 DFQILNFFICGVIIPVAQ-FLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~-~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
-|++ ...+-++.+ +|. |.. .++.+|.|...+...........+.++.|+.++||||++++..++.....|+|+|.+
T Consensus 14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 4555 333333333 453 443 368899999998876666777888999999999999999999999999999999998
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
. .|..+++.. ....+...+.||+.||.|||. ..+++|++|.-+.|+++..|..||++|.++........ .
T Consensus 92 ~--Pl~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~ 161 (690)
T KOG1243|consen 92 R--PLETVLKEL----GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--P 161 (690)
T ss_pred c--cHHHHHHHh----HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--c
Confidence 3 677777754 366777889999999999984 78999999999999999999999999998865543221 1
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg 223 (313)
.....--..|..|+.+.... ...|.|.|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 11122223355666443322 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.9e-16 Score=128.78 Aligned_cols=205 Identities=18% Similarity=0.235 Sum_probs=144.2
Q ss_pred HHhcCCCCcceeeeeeeeeCc-----cceEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 047140 74 MMKSIRHRNLIKVISTCSNEE-----FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQ 145 (313)
Q Consensus 74 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 145 (313)
-|-++.|.||++++.++.+.. ...+++||+..|++..+++.. ...+......+|..||++||.|||.. .-.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344557999999999997654 478999999999999999753 34677888899999999999999943 568
Q ss_pred ceeCCCCCCceEecCCCceeEcCCcchhhcccc--cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC
Q 047140 146 VIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE--YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223 (313)
Q Consensus 146 i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg 223 (313)
++|+++..+.|++..+|.+|++--.-....... ..........+..+|.+||.-.....+.++|||+||+...+|..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999999988743222111100 011112233466789999988878888899999999999999987
Q ss_pred CCCC-hhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 224 KKPT-DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 224 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...- .+.+....... +.... .......-..++++|+...|..||+|.+++.|+-.
T Consensus 279 Eiq~tnseS~~~~ee~--------------ia~~i----------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEEN--------------IANVI----------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred eeccCCCcceeehhhh--------------hhhhe----------eeccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 7552 11111000000 00000 00011113468999999999999999999999755
Q ss_pred H
Q 047140 303 I 303 (313)
Q Consensus 303 ~ 303 (313)
+
T Consensus 335 f 335 (458)
T KOG1266|consen 335 F 335 (458)
T ss_pred e
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-15 Score=135.91 Aligned_cols=264 Identities=21% Similarity=0.181 Sum_probs=193.6
Q ss_pred hcchhhhhhhccccccccccccc--ceeeeEEEEEe--e-cceEEEEEEee--cccchhHHHHHHHHHHHhcC-CCCcce
Q 047140 13 ILSRDVFRRSQTSDFQILNFFIC--GVIIPVAQFLI--S-SAMEVAVKVFN--LQCGRAFKSFNIECEMMKSI-RHRNLI 84 (313)
Q Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l-~h~~i~ 84 (313)
.+.+..+-......|.+.+.+|. |.+|.||.+.. . ++..+|+|.-+ ...+.....=.+|+...+.+ .|+|.+
T Consensus 102 ~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v 181 (524)
T KOG0601|consen 102 IYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPV 181 (524)
T ss_pred ccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCcccccc
Confidence 33444445555667888999999 99999999986 3 47889999843 22223333334566666666 689999
Q ss_pred eeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 85 KVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~----~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
+....+...+..++-+|++. .+|..+.......++...++..+.+... ||..+| ..+++|-|++|.||+..+
T Consensus 182 ~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 182 RDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS 257 (524)
T ss_pred ccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence 99999999999999999995 6999888877767889999999999988 999999 999999999999999999
Q ss_pred C-CceeEcCCcchhhccccccccc---ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh
Q 047140 161 N-MVAHLSDFSIAKLLTGEYQSMT---QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT 236 (313)
Q Consensus 161 ~-~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~ 236 (313)
+ ...+++|||+...+........ .....+...|++||... .-++...|++++|.++.+...+..+......
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---- 332 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN---- 332 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----
Confidence 9 8899999999987754432111 12225667799999655 5677899999999999998887766432211
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..|... +...++.+ ....-+.++...+..|++.+|-.|++++.+..+..
T Consensus 333 -----~~W~~~------r~~~ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~ 381 (524)
T KOG0601|consen 333 -----SSWSQL------RQGYIPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV 381 (524)
T ss_pred -----CCcccc------ccccCchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence 111110 01001111 11223445666899999999999999999887744
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=131.64 Aligned_cols=141 Identities=19% Similarity=0.198 Sum_probs=97.1
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHH----------------------------------------HHH
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFK----------------------------------------SFN 69 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------------------------------------~~~ 69 (313)
.+.||.|++|.||+|..++|+.||||+.......... .+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4679999999999999889999999998653111000 123
Q ss_pred HHHHHHhcC----CCCcceeeeeee-eeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 047140 70 IECEMMKSI----RHRNLIKVISTC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFGYS 143 (313)
Q Consensus 70 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~-~l~~lH~~~~ 143 (313)
+|++.+.++ ++.+-+.+-.++ ......++||||++|++|.+.........+ ...++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 344434333 222223332232 223346899999999999887653321222 2345566655 467889 9
Q ss_pred CCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
.|++|+|++|.||++++++.++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-13 Score=126.39 Aligned_cols=146 Identities=17% Similarity=0.129 Sum_probs=90.7
Q ss_pred cccccccccccceeeeEEEEEeec-ceEEEEEEeecccch----------------------------------hHHHHH
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGR----------------------------------AFKSFN 69 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~----------------------------------~~~~~~ 69 (313)
..|+. +.||+|++|.||+|..++ |+.||||+....-.. ....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 46776 799999999999999876 999999999753110 011122
Q ss_pred H------HHHHHhcC----CCCcceeeeeeeee-CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHH
Q 047140 70 I------ECEMMKSI----RHRNLIKVISTCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEY 137 (313)
Q Consensus 70 ~------e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~-~l~~ 137 (313)
+ |+.-+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++-.-.....+... ++...+. -+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 2 33222222 12222332233222 2345799999999999875321111122222 1222111 1233
Q ss_pred HhcCCCCCceeCCCCCCceEecCCC----ceeEcCCcchhhccc
Q 047140 138 LHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDFSIAKLLTG 177 (313)
Q Consensus 138 lH~~~~~~i~h~di~p~nil~~~~~----~~~l~dfg~~~~~~~ 177 (313)
+. ..|++|+|++|.||+++.+| .++++|||.+..+.+
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44 68999999999999999888 999999999876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.9e-13 Score=106.45 Aligned_cols=127 Identities=20% Similarity=0.182 Sum_probs=94.5
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEeecCCCH
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
.+.++.|.++.||++... +..+++|+...... ....+..|+.+++.+.+.++ ++++.... ...++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 457788999999998864 78899998765421 22345789999998855444 45554433 335799999999877
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-----eeCCCCCCceEecCCCceeEcCCcchh
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQV-----IHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i-----~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.+. . . .....+.+++.+|..|| ..++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~----~--~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D--F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c--c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 1 11345678999999999 7775 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.1e-12 Score=108.91 Aligned_cols=271 Identities=13% Similarity=0.039 Sum_probs=171.9
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeee------eeeCc-cceE
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVIST------CSNEE-FKAL 98 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~------~~~~~-~~~l 98 (313)
...++.||+|+-+.+|..- .-...+.|+.-...+..... .++.|... .||-+-.-+.+ ..+.+ ...+
T Consensus 13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4567899999999988743 22234557775443322222 23333333 55543321211 11222 2567
Q ss_pred EEEeecCC-CHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 99 VLEYMPHG-SLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 99 v~e~~~~~-~L~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
.|..+.|- ...++... +-....+...++.+++++.+.+-|| ..|.+-||++++|+|+++++.|.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 77777553 22222221 1124678889999999999999999 999999999999999999999999985433
Q ss_pred hhcccccccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCChhhhhh----hhhhhhccC
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNR----EMTLKHWGN 242 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg-~~p~~~~~~~----~~~~~~~~~ 242 (313)
.... .....-...+...|++||... +-.-+..+|.|.||+++++++.| +.||++.-.. .........
T Consensus 165 qi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 2221 122233456888999999665 34567889999999999999986 9999775211 111101111
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccC--CCCCCCHHHHHHHHHHHHHHhhccCC
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES--PEQRINAREIVAKLFKIRDSLLRNVG 312 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d--P~~Rps~~~il~~l~~~~~~~~~~~~ 312 (313)
. .....-++..-.......+...-+++++..|...|+... |.-|||++-.+..+.++.+++++++.
T Consensus 242 g----~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 242 G----RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred c----eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0 000001111111122222334567888999999999864 67899999999999999999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.3e-12 Score=100.80 Aligned_cols=136 Identities=20% Similarity=0.158 Sum_probs=99.2
Q ss_pred ccccccceeeeEEEEEeec-------ceEEEEEEeecc-------------c---------chhHHHH----HHHHHHHh
Q 047140 30 LNFFICGVIIPVAQFLISS-------AMEVAVKVFNLQ-------------C---------GRAFKSF----NIECEMMK 76 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~-------------~---------~~~~~~~----~~e~~~l~ 76 (313)
...||.|-=+.||.|...+ +..+|||+.+.. . ......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999998442 479999999732 0 0112223 37999999
Q ss_pred cCCC--CcceeeeeeeeeCccceEEEEeecCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeCCCC
Q 047140 77 SIRH--RNLIKVISTCSNEEFKALVLEYMPHGSLEK-YLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAQVIHCDLK 152 (313)
Q Consensus 77 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~~i~h~di~ 152 (313)
++.. -++++++.+ ..-++||||+.+..+.. .++.. .++......+..+++.+|..+ | ..|++|||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 9843 566777764 34679999997643322 12221 345556677889999999998 8 9999999999
Q ss_pred CCceEecCCCceeEcCCcchhhc
Q 047140 153 PINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 153 p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
+.|||++ ++.+.++|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.5e-13 Score=121.61 Aligned_cols=250 Identities=18% Similarity=0.101 Sum_probs=180.4
Q ss_pred ccccccccccccceeeeEEEEEee--cceEEEEEEeecccc--hhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
..+|.....||.|.|+.|+..... ++..+++|.....-. .....-..|+-+...+ .|.+++.....|......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999998854 477888888865421 2222334466666666 68899998888888888889
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 177 (313)
-.|||+++++...+.-. ..+++...+++..|++.++.++| +..++|+|++|+||++..+ +..+++||+....+.-
T Consensus 344 p~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred chhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccce
Confidence 99999998887766322 25778888999999999999999 9999999999999999886 7889999998864321
Q ss_pred cccccccccccccccc-CCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGC-IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
. .......+..| .+|+......+..+.|++|||..+.+.++|...-........ . -.
T Consensus 420 ~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i--------------~~- 477 (524)
T KOG0601|consen 420 S----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---I--------------RS- 477 (524)
T ss_pred e----cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---e--------------ec-
Confidence 0 01111223333 355566677889999999999999999998765322110000 0 00
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
............+..+...+...|+..||++.++..+.....+
T Consensus 478 ------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 478 ------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0001112234668889999999999999999998887766554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-12 Score=124.49 Aligned_cols=252 Identities=21% Similarity=0.204 Sum_probs=177.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
++..+.+.+.+-+-+|+++.++.+.-. +|...++|+..... ....+....+-.++-..++|-++....-+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345668888888999999999998733 45445555543321 11122333333444334556666666666667788
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
+++++|+.+++|...+.+.+ ..+....+..+..+..++++|| ...+.|+|++|.|.+...+|..++.||+.....+
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred chhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999999888776 3444445556667888999999 8889999999999999999999999998332110
Q ss_pred ------cc---------------c--------ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 177 ------GE---------------Y--------QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 177 ------~~---------------~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
+. . .........++..|.+||...+......+|+|+.|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 001123345788999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHH
Q 047140 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAR 294 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 294 (313)
....+......+.... ..-...+...+....+++...+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~------------------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRD------------------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCC------------------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8776544432111111 000011344577789999999999999999887
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.8e-11 Score=91.41 Aligned_cols=142 Identities=15% Similarity=0.146 Sum_probs=108.2
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecc---cc-----hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ---CG-----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
....+-+|+=+.|+++.+ +|+.++||.=... .+ -....-.+|+++|.++.--.|.-..-+|.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567888999999999987 4887777754322 11 12455677899998886556655555676777778999
Q ss_pred EeecC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeEcCCcchhh
Q 047140 101 EYMPH-GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHLSDFSIAKL 174 (313)
Q Consensus 101 e~~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~ 174 (313)
||++| .++.+++.... ..........+++++-..+.-|| .++++||||..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888887653 23344444789999999999999 99999999999999997665 357999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.7e-11 Score=92.06 Aligned_cols=131 Identities=18% Similarity=0.213 Sum_probs=99.0
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecc---cchh-----HHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQ---CGRA-----FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+.+|+=+.++.+.+. |.++++|.=..+ .+.. ...-.+|+.++.++.--.|.-..-++.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999998763 555777754332 2222 23455688999888655555555556666667799999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
++|..|.+.+... ...++..+-.-+.-|| ..||+|+|+.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888765 1456777888888999 99999999999999998775 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.3e-11 Score=99.36 Aligned_cols=141 Identities=16% Similarity=0.136 Sum_probs=106.4
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccc-hhHHHHHHHHHHHhcCCC--CcceeeeeeeeeCc---cceEEEEeec
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRH--RNLIKVISTCSNEE---FKALVLEYMP 104 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~ 104 (313)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++ .++++++.+..... ..++|+|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46889999999999876668999998765421 134577889999999965 44677887776542 5689999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY------------------------------------------ 142 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~------------------------------------------ 142 (313)
|.++.+.+.. ..++......++.+++.+|..||...
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9887765432 13566667777778888888887310
Q ss_pred -----------CCCceeCCCCCCceEecC--CCceeEcCCcchh
Q 047140 143 -----------SAQVIHCDLKPINVLLDD--NMVAHLSDFSIAK 173 (313)
Q Consensus 143 -----------~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~ 173 (313)
...++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 234799999999999998 6678999998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.5e-10 Score=89.59 Aligned_cols=125 Identities=22% Similarity=0.215 Sum_probs=82.6
Q ss_pred eEEEEEeecceEEEEEEeeccc--------------------------chhHHHHHHHHHHHhcCCCC--cceeeeeeee
Q 047140 40 PVAQFLISSAMEVAVKVFNLQC--------------------------GRAFKSFNIECEMMKSIRHR--NLIKVISTCS 91 (313)
Q Consensus 40 ~V~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 91 (313)
.||.|...++.++|+|+..... ........+|++.|..+... ++++++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999987420 01134567799999999655 567776542
Q ss_pred eCccceEEEEeec--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 92 NEEFKALVLEYMP--HGSLEKYLYSSNCILDIFQRLNIMIDVASALE-YLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 92 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
..++||||++ |..+..+.... ++......++.+++..+. -+| ..|++|||+++.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3579999998 65554433322 113344566777777444 468 9999999999999999988 999999
Q ss_pred Ccchhhc
Q 047140 169 FSIAKLL 175 (313)
Q Consensus 169 fg~~~~~ 175 (313)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-09 Score=94.18 Aligned_cols=213 Identities=13% Similarity=0.128 Sum_probs=150.3
Q ss_pred eeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeee----eCccceEEEEeecC-CCHHHHH
Q 047140 39 IPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCS----NEEFKALVLEYMPH-GSLEKYL 112 (313)
Q Consensus 39 g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l 112 (313)
.+.|++..+ +|..|++|++.............-++.++++.|.|+|++.++|. .+..+++|++|+++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 567888844 79999999993321112223345688999999999999999986 23467899999864 4666554
Q ss_pred hc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 113 YS--------------SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 113 ~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
-. .+...++..+|.++.|+..||.++| +.|..-+-+.|.+|+++.+.+++|...|....+...
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 21 1235788999999999999999999 999999999999999998888998887765543211
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. .+| ..--.+-|.-.||.++..|.||...--..+...
T Consensus 447 ~--------------~~~-----le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~------------------------ 483 (655)
T KOG3741|consen 447 P--------------TEP-----LESQQQNDLRDLGLLLLALATGTENSNRTDSTQ------------------------ 483 (655)
T ss_pred C--------------Ccc-----hhHHhhhhHHHHHHHHHHHhhcccccccccchH------------------------
Confidence 1 011 112346788999999999999865421100000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
.......-..++.++++++.....-++.+ -++.+++.+.
T Consensus 484 --~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 484 --SSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --HHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 00001123467888999999999999887 4788877663
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-09 Score=91.43 Aligned_cols=130 Identities=15% Similarity=0.120 Sum_probs=94.9
Q ss_pred eEEEEEeecceEEEEEEeecccch-hH----------HHHHHHHHHHhcCCCCcc--eeeeeeeee-----CccceEEEE
Q 047140 40 PVAQFLISSAMEVAVKVFNLQCGR-AF----------KSFNIECEMMKSIRHRNL--IKVISTCSN-----EEFKALVLE 101 (313)
Q Consensus 40 ~V~~~~~~~~~~vaiK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e 101 (313)
.|.+... .|+.+.||......-. .. ..+.+|...+..+...+| +..+++... ....++|+|
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3556554 5788999977543211 11 136788888888854333 444556543 234789999
Q ss_pred eecCC-CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-------CCceeEcCCcch
Q 047140 102 YMPHG-SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-------NMVAHLSDFSIA 172 (313)
Q Consensus 102 ~~~~~-~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-------~~~~~l~dfg~~ 172 (313)
++++. +|.+++... ....+......++.+++..+.-|| ..|++|+|+++.|||++. +..+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99875 899988532 224566777899999999999999 999999999999999975 467899999977
Q ss_pred h
Q 047140 173 K 173 (313)
Q Consensus 173 ~ 173 (313)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.9e-11 Score=109.57 Aligned_cols=154 Identities=19% Similarity=0.182 Sum_probs=107.4
Q ss_pred HHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc-------ccccccccccCCCcccc
Q 047140 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT-------QTQTLATIGCIAPEYRR 200 (313)
Q Consensus 128 ~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~ 200 (313)
+.+++.|+.|+|. +.++||++|.|++|.++.++.+||+.|+......+...... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3345599999995 67999999999999999999999999998875544221111 11222456699999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHhCCCC-ChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHH
Q 047140 201 KGRESTNGDVYSFGIMLMETFTRKKP-TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 279 (313)
Q Consensus 201 ~~~~~~~~DiwslG~~l~~lltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 279 (313)
+...+.++|++|+|+++|.+..|..+ +............. . . ..-.......+++.++.+=+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-~--------------~--~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-N--------------L--LNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-c--------------c--cccccccccccCcHHHHHHH
Confidence 99999999999999999999965554 33221111110000 0 0 00001112367889999999
Q ss_pred hHhhccCCCCCCCHHHHHHHH
Q 047140 280 IECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 280 ~~~l~~dP~~Rps~~~il~~l 300 (313)
.+++..|+..||++..+...+
T Consensus 246 ~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred HHHhcCCcccCcchhhhhccc
Confidence 999999999999887776543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.1e-09 Score=85.95 Aligned_cols=135 Identities=20% Similarity=0.144 Sum_probs=97.5
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeecccc----------------------hhHHHHHHHHHHHhcCCCC--c
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCG----------------------RAFKSFNIECEMMKSIRHR--N 82 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~ 82 (313)
+.++..||-|-=|.||.|..++|.+++||.-+.... .......+|.++|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345679999999999999988899999998763210 1233467799999998544 7
Q ss_pred ceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 83 LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
+++.+++- .-.+|||+++|--|...- ++....-.++..|+.-+.-+- ..|++|||+++=||+++++|
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 77777653 346999999885554432 122233334444555554444 68899999999999999999
Q ss_pred ceeEcCCcchhh
Q 047140 163 VAHLSDFSIAKL 174 (313)
Q Consensus 163 ~~~l~dfg~~~~ 174 (313)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.2e-08 Score=81.24 Aligned_cols=122 Identities=20% Similarity=0.198 Sum_probs=90.6
Q ss_pred ceEEEEEEeecc-c------chhHHHHHHHHHHHhcCCCC--cceeeeeeeeeCc----cceEEEEeecCC-CHHHHHhc
Q 047140 49 AMEVAVKVFNLQ-C------GRAFKSFNIECEMMKSIRHR--NLIKVISTCSNEE----FKALVLEYMPHG-SLEKYLYS 114 (313)
Q Consensus 49 ~~~vaiK~~~~~-~------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~ 114 (313)
++.+.+|..... . +.......+|...+..+... ..++.+++..... ..++|+|.+++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654321 0 11234567788888777433 3456666665532 358999999874 79998876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeEcCCcchhh
Q 047140 115 SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHLSDFSIAKL 174 (313)
Q Consensus 115 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~ 174 (313)
... .+......++.+++..+.-|| ..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 112 ~~~-~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 112 WEQ-LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hcc-cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 442 566778889999999999999 99999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=93.25 Aligned_cols=143 Identities=18% Similarity=0.164 Sum_probs=91.3
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchh------------------------------H----H------HHH
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRA------------------------------F----K------SFN 69 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------------------------------~----~------~~~ 69 (313)
...++.++-|.||+|+.++|+.||||+....-... . + .+.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 36889999999999999999999999987531100 0 0 022
Q ss_pred HHHHHHhcC----CCCcceeeeeee-eeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 047140 70 IECEMMKSI----RHRNLIKVISTC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 144 (313)
Q Consensus 70 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 144 (313)
.|..-+.++ +...-+.+=.++ +.-+.-.++|||++|-.+.+.........+...+.....+..-- .+= ..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~--q~~---~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR--QLL---RD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH--HHH---hc
Confidence 233333222 111112222222 22344679999999988888753332345544444333333222 222 56
Q ss_pred CceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 145 QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 145 ~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
|+.|+|.+|.||+++.+|.+.+.|||....+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.9e-08 Score=77.80 Aligned_cols=141 Identities=15% Similarity=0.031 Sum_probs=105.7
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecc------cchhHHHHHHHHHHHhcCCCC--cceeeeeeee-e----Ccc
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ------CGRAFKSFNIECEMMKSIRHR--NLIKVISTCS-N----EEF 95 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~-~----~~~ 95 (313)
..-.-|+||-|.|+..... |+.+-+|.-..- -+.....|.+|...++.+... +++++. ++. . ...
T Consensus 22 e~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 22 EEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 3445577999999997764 557888987521 133567899999999999543 344544 332 1 124
Q ss_pred ceEEEEeecC-CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc--eeEcCCcc
Q 047140 96 KALVLEYMPH-GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV--AHLSDFSI 171 (313)
Q Consensus 96 ~~lv~e~~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg~ 171 (313)
.+||+|-+++ .+|.+++.... .+.+......++.+++.++.-|| ..|+.|+|+.+.||+++.+|. +.++||..
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 6799997753 58988886542 24577778899999999999999 999999999999999987777 99999987
Q ss_pred hhh
Q 047140 172 AKL 174 (313)
Q Consensus 172 ~~~ 174 (313)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.4e-07 Score=75.30 Aligned_cols=142 Identities=18% Similarity=0.169 Sum_probs=93.4
Q ss_pred hhhhhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHH---------HHHHHHHhcCC---CCccee
Q 047140 18 VFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSF---------NIECEMMKSIR---HRNLIK 85 (313)
Q Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~~i~~ 85 (313)
+...-...+|.+.+.+-......|.+-.+ +|..+++|..........+.+ .+.+..+..++ ......
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 44455678999999998877777777665 578899999876533322222 22333333332 222233
Q ss_pred eeeeee-----eCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 86 VISTCS-----NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 86 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
++.+.. .-...++++||++|..|.+... +++ .+...+..++.-+| ..|+.|||.+|.|+++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEEC
Confidence 222221 1223568999999987766432 222 24566778899999 999999999999999996
Q ss_pred CCceeEcCCcchh
Q 047140 161 NMVAHLSDFSIAK 173 (313)
Q Consensus 161 ~~~~~l~dfg~~~ 173 (313)
++ ++++||+...
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 65 8999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.1e-07 Score=77.43 Aligned_cols=137 Identities=9% Similarity=0.003 Sum_probs=84.7
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeeeeeeeeCccceEEEEeecCCC-
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVISTCSNEEFKALVLEYMPHGS- 107 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~- 107 (313)
..||.|..+.||+. .+..+++|...... ......+|.++++.+... .+++.+.+..+++...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999983 25567889876532 334568899999998543 35788888888878889999998863
Q ss_pred HHHHHh--------------c-----CC---CCCCHHHHH-HHHH----------HHHHH-HHHHh-cCCCCCceeCCCC
Q 047140 108 LEKYLY--------------S-----SN---CILDIFQRL-NIMI----------DVASA-LEYLH-FGYSAQVIHCDLK 152 (313)
Q Consensus 108 L~~~l~--------------~-----~~---~~~~~~~~~-~~~~----------~i~~~-l~~lH-~~~~~~i~h~di~ 152 (313)
+...+. . +. ...+..... .+.. .+... ..+|. .......+|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211111 0 00 011111000 0000 00000 11111 0113457899999
Q ss_pred CCceEecCCCceeEcCCcchh
Q 047140 153 PINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 153 p~nil~~~~~~~~l~dfg~~~ 173 (313)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.1e-07 Score=74.89 Aligned_cols=78 Identities=15% Similarity=0.278 Sum_probs=56.5
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeeeeeeee---CccceEEEEeec
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVISTCSN---EEFKALVLEYMP 104 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~lv~e~~~ 104 (313)
++.++.|..+.||.....+ ..+++|..... .....+..|..+++.+... .+++++..... ....++++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578889999999999765 58999987554 4567778899998888432 45677764433 334689999999
Q ss_pred CCCHHH
Q 047140 105 HGSLEK 110 (313)
Q Consensus 105 ~~~L~~ 110 (313)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-06 Score=74.28 Aligned_cols=137 Identities=16% Similarity=0.083 Sum_probs=84.9
Q ss_pred ccccee-eeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecCCCHHH
Q 047140 33 FICGVI-IPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110 (313)
Q Consensus 33 lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 110 (313)
|..|.. ..||+.... +..+++|+..... ...+.+|+++++.+ ++-.+++++.+...++..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 788998754 4788999876542 34567799998888 34557788888877667889999999877764
Q ss_pred HHhc-----------------CC-----CCCCHH--HHHHH-----------------------HHHHHHHHHHHh-cCC
Q 047140 111 YLYS-----------------SN-----CILDIF--QRLNI-----------------------MIDVASALEYLH-FGY 142 (313)
Q Consensus 111 ~l~~-----------------~~-----~~~~~~--~~~~~-----------------------~~~i~~~l~~lH-~~~ 142 (313)
.... +. ..+... ..... ...+...|.... ...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 3210 00 011100 00000 111111111111 001
Q ss_pred CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3458999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9e-07 Score=81.45 Aligned_cols=140 Identities=18% Similarity=0.185 Sum_probs=89.9
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccch-------------------------------hHHH------HHHHH
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR-------------------------------AFKS------FNIEC 72 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-------------------------------~~~~------~~~e~ 72 (313)
.+.||..+.+.|++|+.++|+.||||+-...-.. .... |..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4689999999999999999999999998643110 0011 11222
Q ss_pred HHH----hcCCCCc------ceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 047140 73 EMM----KSIRHRN------LIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 142 (313)
Q Consensus 73 ~~l----~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 142 (313)
+-. +.+.|-+ |++++..+.. ...|+|||++|..+.|.-.-....++...+..-+.+...-+-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf----- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF----- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----
Confidence 211 1222333 4444444433 3679999999976655432222236666555544444333333
Q ss_pred CCCceeCCCCCCceEecC----CCceeEcCCcchhhcc
Q 047140 143 SAQVIHCDLKPINVLLDD----NMVAHLSDFSIAKLLT 176 (313)
Q Consensus 143 ~~~i~h~di~p~nil~~~----~~~~~l~dfg~~~~~~ 176 (313)
..|++|+|-+|.||++.+ ++.+.+.|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 457999999999999984 5789999999987553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-06 Score=71.86 Aligned_cols=135 Identities=21% Similarity=0.209 Sum_probs=89.3
Q ss_pred ccccceeeeEEEEEeecceEEEEEEeecccch------------------------hHHHHHHHHHHHhcC--CCCccee
Q 047140 32 FFICGVIIPVAQFLISSAMEVAVKVFNLQCGR------------------------AFKSFNIECEMMKSI--RHRNLIK 85 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l--~h~~i~~ 85 (313)
.|+.|--+.||.|...++..+|+|++...... ......+|+.-|.++ -+-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 55556667899999878999999999753100 112234466666665 2344555
Q ss_pred eeeeeeeCccceEEEEeecCCCH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCc
Q 047140 86 VISTCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMV 163 (313)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~ 163 (313)
.+.+.. ..+||||+..... .=.++ ...++......+..+++..+.-|- . .++||+||+.=|||++ ++.
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~---~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLY---KEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHH---HhcCcccccchhhheEEE-CCe
Confidence 555543 4699999854210 00000 112233356667777777777776 4 8999999999999999 889
Q ss_pred eeEcCCcchhhcc
Q 047140 164 AHLSDFSIAKLLT 176 (313)
Q Consensus 164 ~~l~dfg~~~~~~ 176 (313)
+.++||+-+....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.2e-06 Score=66.43 Aligned_cols=128 Identities=17% Similarity=0.203 Sum_probs=93.0
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeeccc----------------chhHHHHHHHHHHHhcCC------CCcceeee
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQC----------------GRAFKSFNIECEMMKSIR------HRNLIKVI 87 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~ 87 (313)
...||+|+.-.||. ++.....+||+..... ........+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45789999999998 7777888999997654 122455666666665555 78999999
Q ss_pred eeeeeCccceEEEEeec------CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC
Q 047140 88 STCSNEEFKALVLEYMP------HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161 (313)
Q Consensus 88 ~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~ 161 (313)
|+.+++.-..+|+|.+. ..+|.+++.... ++. .....+.++. .||- ..+|+.+|++|.||++..+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEEec
Confidence 99999988899999863 237888885553 555 4444444444 4555 7789999999999999643
Q ss_pred --C--ceeEcC
Q 047140 162 --M--VAHLSD 168 (313)
Q Consensus 162 --~--~~~l~d 168 (313)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1e-07 Score=87.46 Aligned_cols=190 Identities=17% Similarity=0.207 Sum_probs=136.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCc-ceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN-LIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 102 (313)
++-|..-+.+++++.+.+++.+-...+.+..+.+... ....-++++|.+++||| .+..++-++-+.+.++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3445555677889999999988433444445544332 44566899999999999 66667777777889999999
Q ss_pred ecCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+.++ +-..........+.......+.+.-+.+++++| +..-+|+| ||+..+ +..+..||+....+...
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcc---
Confidence 9776 222222222223445556666777788999999 66668887 666554 78899999988766532
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~ 229 (313)
.......++..++|||+.....+....|+|++|.--.++.-|.+|-..
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 234556789999999999999999999999999877777777777543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.1e-06 Score=64.10 Aligned_cols=131 Identities=18% Similarity=0.144 Sum_probs=91.4
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEeec
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~ 104 (313)
.-+..+.|+.|.+|.||++.+. |.++|+|+-..++ ....+..|+++|+.+.-.++ ++++.+..+ .+.|||+.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 3456779999999999999985 6689999876653 45788899999999876555 344444332 35599999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC-CceEecCCCceeEcCCcchhh
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP-INVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p-~nil~~~~~~~~l~dfg~~~~ 174 (313)
|..|.+..... +..++. .++..-.-|- ..||-|+.|+- ...++-.++.+.|+||..++.
T Consensus 96 G~~L~~~~~~~----~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG----DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc----cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887654321 233333 4445544455 78899998874 444444445999999998874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.1e-05 Score=61.17 Aligned_cols=102 Identities=23% Similarity=0.251 Sum_probs=80.1
Q ss_pred HHHHHHhcCCC-CcceeeeeeeeeCccceEEEEeecCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 047140 70 IECEMMKSIRH-RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAQV 146 (313)
Q Consensus 70 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 146 (313)
.|.-+++.+++ +++++++|+|.+ .+|+|+...+++.+.-.. +-...++..+.+++.+++..+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47778888865 699999999963 589999976655422000 00135889999999999999999995544668
Q ss_pred eeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 147 ~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.-.|++|+|+-++++|.+|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.4e-05 Score=79.16 Aligned_cols=78 Identities=13% Similarity=0.206 Sum_probs=56.8
Q ss_pred ccccccceeeeEEEEEeecc---eEEEEEEeeccc-chhHHHHHHHHHHHhcCC-CCcc--eeeeeeeeeC---ccceEE
Q 047140 30 LNFFICGVIIPVAQFLISSA---MEVAVKVFNLQC-GRAFKSFNIECEMMKSIR-HRNL--IKVISTCSNE---EFKALV 99 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 99 (313)
...++.|.+..+|+.....+ ..+++|+.+... ......+.+|+++++.+. |.++ ++++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56778899999999875543 467888765432 123356889999999994 6654 7888888764 467899
Q ss_pred EEeecCCC
Q 047140 100 LEYMPHGS 107 (313)
Q Consensus 100 ~e~~~~~~ 107 (313)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.5e-05 Score=66.80 Aligned_cols=73 Identities=5% Similarity=-0.002 Sum_probs=46.4
Q ss_pred cccccceee-eEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC---cceeeeeeeeeC---ccceEEEEee
Q 047140 31 NFFICGVII-PVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR---NLIKVISTCSNE---EFKALVLEYM 103 (313)
Q Consensus 31 ~~lg~G~~g-~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~ 103 (313)
..++.|+.. .||+. +..+++|..... .....+..|.+++..+... .++++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666665 58874 234677875542 2345788899999888532 455555544332 2358899999
Q ss_pred cCCCHH
Q 047140 104 PHGSLE 109 (313)
Q Consensus 104 ~~~~L~ 109 (313)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 886663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-05 Score=78.85 Aligned_cols=203 Identities=20% Similarity=0.211 Sum_probs=136.0
Q ss_pred HHHHHHHHHHHhcCCCCcceeeeeeeeeCcc----ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 047140 65 FKSFNIECEMMKSIRHRNLIKVISTCSNEEF----KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 140 (313)
Q Consensus 65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 140 (313)
.....-|.+.+..+.|+|++.++.+...... ..+..+++...++...+..-+ ..+..+.+.+..+...+|.++|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH-
Confidence 3444457777788899999999988755432 345567888888888877665 6888999999999999999999
Q ss_pred CCCCCceeCCCCCC---ceEecCCCceeEc--CCcchhhcccccccccccccccccccCCCcccccCCC--CCcchhHHH
Q 047140 141 GYSAQVIHCDLKPI---NVLLDDNMVAHLS--DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE--STNGDVYSF 213 (313)
Q Consensus 141 ~~~~~i~h~di~p~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Diwsl 213 (313)
.....|.-+..+ +--.+..+.+... ||+.+..+.... .......+..+.+||....... +...|+|.+
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHH
Confidence 765555444443 3333455566666 888776554322 1122233444667776655544 445799999
Q ss_pred HHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH
Q 047140 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA 293 (313)
Q Consensus 214 G~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 293 (313)
|.....+..|..+-...... ..+ .+........+...+|+.-|+++|+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~----------------~~~--------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP----------------VSL--------------LDVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHhhhhhcCcccccccch----------------hhh--------------hccccchhhhhhhhhhcchhhhhccch
Confidence 99999988876552111000 000 011122257789999999999999999
Q ss_pred HHHHHHHHHHH
Q 047140 294 REIVAKLFKIR 304 (313)
Q Consensus 294 ~~il~~l~~~~ 304 (313)
.+++.|+..-.
T Consensus 429 ~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 429 LELLTHPFLRF 439 (1351)
T ss_pred hhhhhchhccc
Confidence 99999976543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.6e-05 Score=65.71 Aligned_cols=80 Identities=10% Similarity=-0.029 Sum_probs=58.1
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC---CcceeeeeeeeeC---ccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH---RNLIKVISTCSNE---EFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv 99 (313)
.-.-.+.||.|..+.||.....++ .+++|..+.. .....+..|.+.|+.+.. -.++++++++.++ +..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334566899999999999875445 4777775431 123578889999998843 4688889887543 568999
Q ss_pred EEeecCCCH
Q 047140 100 LEYMPHGSL 108 (313)
Q Consensus 100 ~e~~~~~~L 108 (313)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.7e-05 Score=67.39 Aligned_cols=135 Identities=13% Similarity=0.123 Sum_probs=76.3
Q ss_pred cccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEeecCCCHHHH
Q 047140 33 FICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGSLEKY 111 (313)
Q Consensus 33 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 111 (313)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ ++++..+. -++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45577788998773 577888997654322211235678999988854333 44444432 3699999988654321
Q ss_pred --------------Hh---cC---CCCCCHH-HHHHHHHHH---------HHHHHHHh-c----CCCCCceeCCCCCCce
Q 047140 112 --------------LY---SS---NCILDIF-QRLNIMIDV---------ASALEYLH-F----GYSAQVIHCDLKPINV 156 (313)
Q Consensus 112 --------------l~---~~---~~~~~~~-~~~~~~~~i---------~~~l~~lH-~----~~~~~i~h~di~p~ni 156 (313)
+. .. +..++.. .+..+..++ ...+..+- . .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11 00 1111111 111111111 11111111 0 0023589999999999
Q ss_pred EecCCCceeEcCCcchh
Q 047140 157 LLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 157 l~~~~~~~~l~dfg~~~ 173 (313)
++++++ +.++||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.2e-05 Score=61.09 Aligned_cols=125 Identities=25% Similarity=0.355 Sum_probs=90.2
Q ss_pred ccccccccccccee-eeEEEEEeecceEEEEEEeec---ccc------------------hhHHHHHHHHHHHhcCC---
Q 047140 25 SDFQILNFFICGVI-IPVAQFLISSAMEVAVKVFNL---QCG------------------RAFKSFNIECEMMKSIR--- 79 (313)
Q Consensus 25 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 79 (313)
..++-++.||.|.- |.||++.+ .|+.+|+|++.. ..+ .....|..|++...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 99999998 488999999432 100 22346788988888774
Q ss_pred CCcc--eeeeeeeeeC---c---------------cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 047140 80 HRNL--IKVISTCSNE---E---------------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 139 (313)
Q Consensus 80 h~~i--~~~~~~~~~~---~---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH 139 (313)
+..+ ++++++..-. + ...||-||.+... .+.. .-+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 3455 8999987322 0 1246777765422 1222 23556778888999
Q ss_pred cCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 140 FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 140 ~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999998 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.9e-05 Score=63.65 Aligned_cols=73 Identities=18% Similarity=0.233 Sum_probs=47.7
Q ss_pred cccccceeeeEEEEEeec--ceEEEEEEeecccchhHHHHHHHHHHHhcCCCC-cceeeeeeeeeCccceEEEEeecCCC
Q 047140 31 NFFICGVIIPVAQFLISS--AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR-NLIKVISTCSNEEFKALVLEYMPHGS 107 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (313)
+.|..|-...+|++...+ ++.+++|+...... ......+|+.+++.+... -.++++..+. -.+++||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456778888999988653 67899998754322 222334688888888433 3445544433 238999998866
Q ss_pred H
Q 047140 108 L 108 (313)
Q Consensus 108 L 108 (313)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00055 Score=61.56 Aligned_cols=76 Identities=18% Similarity=0.013 Sum_probs=54.1
Q ss_pred ccccccceeeeEEEEEeecc-eEEEEEEeecc-----c--chhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceE
Q 047140 30 LNFFICGVIIPVAQFLISSA-MEVAVKVFNLQ-----C--GRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 98 (313)
.+.||.|.+..||++...+| +.|+||.-... . +...+....|.+.|+.+. -.++++++.+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46789999999999997666 58999985421 0 224456777888888862 245677777643 45679
Q ss_pred EEEeecCCC
Q 047140 99 VLEYMPHGS 107 (313)
Q Consensus 99 v~e~~~~~~ 107 (313)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0001 Score=64.10 Aligned_cols=140 Identities=16% Similarity=0.118 Sum_probs=81.9
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeeeee------eeeCccceEEEE
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVIST------CSNEEFKALVLE 101 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e 101 (313)
.+.+..|....+|+.... +..+++|+.... ....+..|+++++.+.+. .+++++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777877899998754 457888987642 234566788888887433 24444432 123445689999
Q ss_pred eecCCCHHH-----------HHh---c--CC--CC----CCHHHHH------------HHHHHHHHHHHHHhc----CCC
Q 047140 102 YMPHGSLEK-----------YLY---S--SN--CI----LDIFQRL------------NIMIDVASALEYLHF----GYS 143 (313)
Q Consensus 102 ~~~~~~L~~-----------~l~---~--~~--~~----~~~~~~~------------~~~~~i~~~l~~lH~----~~~ 143 (313)
+++|..+.. .+. . .. .. ....... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 110 0 00 00 0000000 011112233334331 012
Q ss_pred CCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.+++|+|+.|.|+++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998878999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=3.5e-05 Score=66.03 Aligned_cols=145 Identities=19% Similarity=0.153 Sum_probs=97.2
Q ss_pred hhhhhhcchhhhhhhcccccccccccccceeeeEEEEEeecceEEEEEEeeccc--------ch--------------hH
Q 047140 8 LAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--------GR--------------AF 65 (313)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~--------------~~ 65 (313)
+++|++..+.++ +.++..||-|-=+.||.+....|++.++|.-.... .. ..
T Consensus 82 LAlktL~~R~~v-------~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 82 LALKTLSNRGSV-------ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred HHHHHHHhcchh-------hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 345555444333 45677999999999999998889999999765321 00 11
Q ss_pred HHHHHHHHHHhcCCC--CcceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 047140 66 KSFNIECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 143 (313)
Q Consensus 66 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 143 (313)
-...+|+..|+.|.. =.+++.+++ +.-|+|||++.|..|...-.- .+..++..-+. .-+--|- .
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly~~lm---~~Iv~la---~ 220 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPTLYDDLM---GLIVRLA---N 220 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec----CChHHHHHHHH---HHHHHHH---H
Confidence 234557888887732 234455444 335799999988777654321 23333333333 3333444 8
Q ss_pred CCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
+|++|+|.+-=|||+++++.++++||--..
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999999996543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00027 Score=61.57 Aligned_cols=73 Identities=16% Similarity=0.225 Sum_probs=47.9
Q ss_pred ccccceeeeEEEEEeec-------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCc-ceeeeeeeeeCccceEEEEee
Q 047140 32 FFICGVIIPVAQFLISS-------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN-LIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.+..|-...+|+....+ ++.+++|+..... .......+|.++++.+.... .++++..+.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45557777899887644 4789999976542 23345577888888884333 3456665542 3689998
Q ss_pred cCCCHH
Q 047140 104 PHGSLE 109 (313)
Q Consensus 104 ~~~~L~ 109 (313)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 886654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00051 Score=60.99 Aligned_cols=142 Identities=15% Similarity=0.181 Sum_probs=81.9
Q ss_pred ccccccccccceeeeEEEEEeec-----ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEE
Q 047140 26 DFQILNFFICGVIIPVAQFLISS-----AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALV 99 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 99 (313)
..++. .+..|-...+|++...+ ++.|++|+.......... ...|..+++.+...++ +++++.+..+ .|
T Consensus 38 ~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 38 ALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred cEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 33433 44448888999987532 368999988665433333 3678999988854334 4566666433 68
Q ss_pred EEeecCCCHHHH----------H----h---cCC----C-CCCHHHHHHHHHHH-----------------HHHHHH---
Q 047140 100 LEYMPHGSLEKY----------L----Y---SSN----C-ILDIFQRLNIMIDV-----------------ASALEY--- 137 (313)
Q Consensus 100 ~e~~~~~~L~~~----------l----~---~~~----~-~~~~~~~~~~~~~i-----------------~~~l~~--- 137 (313)
.+|+++.+|... + . ... . ......+..+..++ ...+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999977665321 0 0 000 0 11112222332211 111111
Q ss_pred -Hhc-CCCCCceeCCCCCCceEecC-CCceeEcCCcchh
Q 047140 138 -LHF-GYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAK 173 (313)
Q Consensus 138 -lH~-~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~ 173 (313)
+.. .....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 110 11346899999999999986 4789999998765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00059 Score=59.27 Aligned_cols=139 Identities=14% Similarity=0.108 Sum_probs=88.8
Q ss_pred ccccccccceeeeEEEEEeecceEEEEEEeec--ccchhHHHHHHHHHHHhcCC--CCcceeeeeeeeeCc--cceEEEE
Q 047140 28 QILNFFICGVIIPVAQFLISSAMEVAVKVFNL--QCGRAFKSFNIECEMMKSIR--HRNLIKVISTCSNEE--FKALVLE 101 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~--~~~lv~e 101 (313)
.+...+..|-...+|.... ++++++++ .+. ..........+|+.+++.+. -......++.|.++. ..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344443343344555443 37888888 442 23345677788999998874 345566777777665 6799999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHhcCC--------------------------------------
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIM-IDVASALEYLHFGY-------------------------------------- 142 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~-~~i~~~l~~lH~~~-------------------------------------- 142 (313)
|++|..+.+...... .. ...+ ..++..|.-||.-+
T Consensus 106 ~veGe~~~~~~~~~~----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 106 WVEGEVVWSALPPES----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EecceeccCcCCccc----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 998864443322111 11 1122 36666666666311
Q ss_pred -----------------CCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 143 -----------------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 143 -----------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
...++|||+.+.|++++..+-+-+.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 11289999999999999998899999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0005 Score=60.12 Aligned_cols=142 Identities=18% Similarity=0.193 Sum_probs=80.9
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeeeeee------eeCccceEEE
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVISTC------SNEEFKALVL 100 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~------~~~~~~~lv~ 100 (313)
..+.++.|....+|+....++ .+++|+..... ....+..|.+++..|... ++++++... ..++..++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 356777777789999876445 57789765421 123455677777777422 234444321 2245578999
Q ss_pred EeecCCCHH-----------HHHh---cCCCCC--------CHH---HHH------------HHHHHHHHHHHHHhc---
Q 047140 101 EYMPHGSLE-----------KYLY---SSNCIL--------DIF---QRL------------NIMIDVASALEYLHF--- 140 (313)
Q Consensus 101 e~~~~~~L~-----------~~l~---~~~~~~--------~~~---~~~------------~~~~~i~~~l~~lH~--- 140 (313)
+|++|..+. ..+. .....+ ... ... .....+...+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999874431 1110 000000 000 000 001122334444431
Q ss_pred -CCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 141 -GYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 141 -~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
....+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 014789999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0018 Score=55.87 Aligned_cols=75 Identities=21% Similarity=0.163 Sum_probs=47.9
Q ss_pred ccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC---CCCcceeeeeeeeeCccceEEEEeec
Q 047140 28 QILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI---RHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+-.+.++-|....+|+.. .+++.+++|+-.. .....+..|.+-|+.| .--.+++++++...++..++|+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345577878888888877 4588899998763 2335677788888777 34567889998888777899999986
Q ss_pred CC
Q 047140 105 HG 106 (313)
Q Consensus 105 ~~ 106 (313)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 54
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=58.42 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=75.3
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeeeee------eeeCccceEEEE
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVIST------CSNEEFKALVLE 101 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e 101 (313)
.+.++.|....+|.....+| .+++|++... ....+..|.++++.|... .+++++.. ...++..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566677788999886555 6888987521 123344455666665321 23343321 123456789999
Q ss_pred eecCCCHH-----------HHHhc---CCC--------CCC--H-HHH------------HHHHHH-HHHHHHHHhcC--
Q 047140 102 YMPHGSLE-----------KYLYS---SNC--------ILD--I-FQR------------LNIMID-VASALEYLHFG-- 141 (313)
Q Consensus 102 ~~~~~~L~-----------~~l~~---~~~--------~~~--~-~~~------------~~~~~~-i~~~l~~lH~~-- 141 (313)
+++|..+. ..+.. ... ... . ... ...+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886331 11110 000 000 0 000 011111 11112222200
Q ss_pred --CCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 142 --YSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 142 --~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
-..+++|+|+.|.||+++.+....++||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 14589999999999999977666899998765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00059 Score=62.13 Aligned_cols=167 Identities=19% Similarity=0.201 Sum_probs=101.1
Q ss_pred HHHHHHHHHHhcCCCCcceeeeeeeeeC-ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 047140 66 KSFNIECEMMKSIRHRNLIKVISTCSNE-EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 144 (313)
Q Consensus 66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 144 (313)
..+....++++.++|+|+...+.+-... ....+|+|++. -||++.+..+. +-..... .+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s~~-----------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDESLL-----------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhhhc-----------------cc
Confidence 5567788999999999999999876432 45789999994 59999887553 1111100 11
Q ss_pred CceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCC
Q 047140 145 QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224 (313)
Q Consensus 145 ~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~ 224 (313)
++.| .|+ ...+| .+... | |- +..+++||||+|.++.++.-|.
T Consensus 87 ~~~~-----~~~-------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 87 GVLH-----LNI-------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccce-----ehh-------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 2222 111 22223 11110 0 10 0114999999999999999999
Q ss_pred CCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 047140 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAK 299 (313)
Q Consensus 225 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~ 299 (313)
..+......+.......-...+..... ...+....-.++..+.++..+|+...|..||...++.++
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~---------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~ 194 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLS---------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR 194 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHH---------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence 888776554443332221111111111 111113345678889999999999999999977766554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.002 Score=55.37 Aligned_cols=31 Identities=32% Similarity=0.584 Sum_probs=25.5
Q ss_pred CCceeCCCCCCceEecCCCc-eeEcCCcchhh
Q 047140 144 AQVIHCDLKPINVLLDDNMV-AHLSDFSIAKL 174 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~-~~l~dfg~~~~ 174 (313)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00054 Score=56.41 Aligned_cols=30 Identities=33% Similarity=0.464 Sum_probs=21.4
Q ss_pred CCceeCCCCCCceEe-cCCCceeEcCCcchh
Q 047140 144 AQVIHCDLKPINVLL-DDNMVAHLSDFSIAK 173 (313)
Q Consensus 144 ~~i~h~di~p~nil~-~~~~~~~l~dfg~~~ 173 (313)
...+|.|+.|.|||+ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358999999999999 888999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0085 Score=53.94 Aligned_cols=81 Identities=12% Similarity=-0.048 Sum_probs=54.9
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecc-----c--chhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceE
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ-----C--GRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 98 (313)
..+.+|-|....||+.... +..++||.-... . +........|.+.|+.+. -.++++++.++.+. .++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 3668899999999998763 557999987621 1 113344455677776663 24788888888844 568
Q ss_pred EEEeecC--CCHHHHH
Q 047140 99 VLEYMPH--GSLEKYL 112 (313)
Q Consensus 99 v~e~~~~--~~L~~~l 112 (313)
+||++++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999966 3455544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0032 Score=55.32 Aligned_cols=142 Identities=15% Similarity=0.116 Sum_probs=91.7
Q ss_pred ccccccccceeeeEEEEEeecceEEEEEEeecc------------------------cch--hHHHHHHHHHHHhcCCCC
Q 047140 28 QILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ------------------------CGR--AFKSFNIECEMMKSIRHR 81 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------------------------~~~--~~~~~~~e~~~l~~l~h~ 81 (313)
+|-++|..|-=+.||.|...+|..+|||+++.+ ++. ..-....|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345677778888999999888999999998732 111 122344566666666544
Q ss_pred cceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC
Q 047140 82 NLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161 (313)
Q Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~ 161 (313)
.|+-. .-..-.+ -.|||+++.. +=+-.-.-....++...+..+..+++.-+.-|=. ..+.||.||.-=|+|+.+
T Consensus 227 GIP~P-ePIlLk~-hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 227 GIPCP-EPILLKN-HVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD- 300 (520)
T ss_pred CCCCC-Cceeeec-ceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-
Confidence 43211 1111111 3599999843 3222222223357777788888888877776653 668999999999999865
Q ss_pred CceeEcCCcchhhc
Q 047140 162 MVAHLSDFSIAKLL 175 (313)
Q Consensus 162 ~~~~l~dfg~~~~~ 175 (313)
|.+.++|-+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 57888888776543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0026 Score=51.94 Aligned_cols=103 Identities=16% Similarity=0.135 Sum_probs=68.2
Q ss_pred EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHH
Q 047140 51 EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 129 (313)
Q Consensus 51 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 129 (313)
+..+|++..- +--...-+.++.+++.++. .|+++..- ++..+.++.|.|--.. .... .++.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~-N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INFS-NFIT 148 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cchh-HHHH
Confidence 4566666432 2213455678888888875 57777743 4445678999984311 1111 1111
Q ss_pred HHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 130 ~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
--+.+|...|.. ..+.+|||..|+|||-|+.|.+||.|-+..
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 224667788843 568999999999999999999999998754
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.011 Score=52.36 Aligned_cols=79 Identities=15% Similarity=0.017 Sum_probs=49.7
Q ss_pred ccccceeeeEEEEEeecc-eEEEEEEeecc-------cchhHHHHHHHHHHHhcCC--CC-cceeeeeeeeeCccceEEE
Q 047140 32 FFICGVIIPVAQFLISSA-MEVAVKVFNLQ-------CGRAFKSFNIECEMMKSIR--HR-NLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 100 (313)
.+|-|....||++..+.+ +.|+||.-... -+....+..-|.+.|+... .| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578899999999997544 68999986421 1233455666888887762 23 34454433 334456999
Q ss_pred EeecC-CCHHHHH
Q 047140 101 EYMPH-GSLEKYL 112 (313)
Q Consensus 101 e~~~~-~~L~~~l 112 (313)
|+++. ..|.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99843 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0063 Score=53.79 Aligned_cols=77 Identities=14% Similarity=0.262 Sum_probs=47.9
Q ss_pred ccccccccccceeeeEEEEEeec----ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 100 (313)
..++....| |-...+|+....+ +..|++|+....... .-...+|..+++.+...++ +++++++..+ +|.
T Consensus 16 ~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~ 89 (330)
T PLN02421 16 DFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQ 89 (330)
T ss_pred ceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eee
Confidence 444444444 7778899887432 237999987654332 2233568888888855444 4566665422 588
Q ss_pred EeecCCCH
Q 047140 101 EYMPHGSL 108 (313)
Q Consensus 101 e~~~~~~L 108 (313)
+|++|..|
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 99877654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.071 Score=47.02 Aligned_cols=71 Identities=10% Similarity=0.037 Sum_probs=44.3
Q ss_pred ceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC--cceeee---e--eeeeCccceEEEEeecCCC
Q 047140 36 GVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR--NLIKVI---S--TCSNEEFKALVLEYMPHGS 107 (313)
Q Consensus 36 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~---~--~~~~~~~~~lv~e~~~~~~ 107 (313)
+.-..||+....++..+++|+.... ......+..|.+.+..|... .++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4556799988777888999987543 22445667788888777321 122211 1 1233456778999987753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.025 Score=49.52 Aligned_cols=31 Identities=19% Similarity=0.268 Sum_probs=27.8
Q ss_pred CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..+++|+|+.++|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.028 Score=49.08 Aligned_cols=29 Identities=28% Similarity=0.300 Sum_probs=25.1
Q ss_pred CCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 678899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.00049 Score=69.99 Aligned_cols=163 Identities=9% Similarity=-0.089 Sum_probs=114.6
Q ss_pred HHHHHHHHhcCCCCcceeeeeeeee--CccceEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 047140 68 FNIECEMMKSIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY 142 (313)
Q Consensus 68 ~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ 142 (313)
...|..-++...|+++.....-... ....+..++++.+|.+.+.+-+. .+.+...-+....++.+.+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3334445555678877665554422 23467889999999999999654 223444555555555466666655211
Q ss_pred --CCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHH
Q 047140 143 --SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220 (313)
Q Consensus 143 --~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 220 (313)
+.--+|+++++.|.++..+-+++++++|+.+...+. ....+...+++-|++|++.+...++.++|+|..|+-+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 123689999999999999999999999999843322 1122334566678888988888999999999999999999
Q ss_pred HhCCCCChhhhh
Q 047140 221 FTRKKPTDEIFN 232 (313)
Q Consensus 221 ltg~~p~~~~~~ 232 (313)
..|..+|.....
T Consensus 1434 s~~n~~fi~flq 1445 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQ 1445 (2724)
T ss_pred hcccHHHHHHHH
Confidence 999998855443
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.015 Score=49.02 Aligned_cols=79 Identities=14% Similarity=0.063 Sum_probs=54.2
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee-cCCCH
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM-PHGSL 108 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L 108 (313)
...+..|..+.|+.++..+|+++++|+....... ..+. .....|+..+-...+++++.-.+. -.|++|.+ ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~-~~E~-~g~~~L~~w~G~GaVrll~~d~~~--~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA-EHEA-RGEAALRWWNGRGAVRLLAADPER--GALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccc-hhhh-hHHhHhheeCCCCceeeecccccc--chhhhhhccCCCch
Confidence 3456678999999999888999999998654211 1111 122457777878889999876443 45888888 55577
Q ss_pred HHHH
Q 047140 109 EKYL 112 (313)
Q Consensus 109 ~~~l 112 (313)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.043 Score=49.28 Aligned_cols=81 Identities=16% Similarity=0.057 Sum_probs=52.3
Q ss_pred ccccccceeeeEEEEEeec-ceEEEEEEeecc------cchhHHHHHHHHHHHhcCC--CC-cceeeeeeeeeCccceEE
Q 047140 30 LNFFICGVIIPVAQFLISS-AMEVAVKVFNLQ------CGRAFKSFNIECEMMKSIR--HR-NLIKVISTCSNEEFKALV 99 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 99 (313)
.+.||-|....||++..++ ++.|+||.-... -+...++..-|.+.|+... .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6688999999999999643 568999976421 1334566677888888763 24 35555544 33345688
Q ss_pred EEeecC-CCHHHHH
Q 047140 100 LEYMPH-GSLEKYL 112 (313)
Q Consensus 100 ~e~~~~-~~L~~~l 112 (313)
||+++. ..|.+.+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 998843 2344444
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.035 Score=48.81 Aligned_cols=134 Identities=22% Similarity=0.236 Sum_probs=76.9
Q ss_pred eeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc------eeee----eeeeeCccceEEEEeecCC
Q 047140 37 VIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL------IKVI----STCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 37 ~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i------~~~~----~~~~~~~~~~lv~e~~~~~ 106 (313)
.-..+|+....+|+. ++|+.... .....+..|.+.+..|.-..| ...- .....+.+..-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 556789988777776 88988765 345666778888888732222 1111 1112212677889999887
Q ss_pred CHHH------------HHh---c--------CCC---CCCHH----H---------HHHHHHHHHHHHHHHhc----CCC
Q 047140 107 SLEK------------YLY---S--------SNC---ILDIF----Q---------RLNIMIDVASALEYLHF----GYS 143 (313)
Q Consensus 107 ~L~~------------~l~---~--------~~~---~~~~~----~---------~~~~~~~i~~~l~~lH~----~~~ 143 (313)
.+.+ .+. . +.. ...+. . -.....++...+..+.. ...
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7662 010 0 000 01111 0 01122233333333331 002
Q ss_pred CC---ceeCCCCCCceEecCCCc-eeEcCCcchh
Q 047140 144 AQ---VIHCDLKPINVLLDDNMV-AHLSDFSIAK 173 (313)
Q Consensus 144 ~~---i~h~di~p~nil~~~~~~-~~l~dfg~~~ 173 (313)
.+ ++|+|+.|.||+++.+.. +.++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998874 8999998654
|
|
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.094 Score=43.04 Aligned_cols=122 Identities=18% Similarity=0.145 Sum_probs=84.3
Q ss_pred eeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC--CcceeeeeeeeeCccceEEEEeecCCCHHHHHhcCC
Q 047140 39 IPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSN 116 (313)
Q Consensus 39 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 116 (313)
+.||+....+.--+.+|+-... ....+..|.+.++-+.- -.+.+++++-.+.+.-|++|+-++|.++...-.
T Consensus 33 ~~v~rl~a~~r~g~~~k~~~~~---~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~~--- 106 (266)
T COG3231 33 AGVFRLFADSRPGLYLKIASSG---PAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPRY--- 106 (266)
T ss_pred CeEEEEeccCCCceEEEEecCc---chhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchhh---
Confidence 5678766555556677765432 34677788888887742 345667777777888899999998877643221
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCC---------------------------------------------------
Q 047140 117 CILDIFQRLNIMIDVASALEYLHFGYSAQ--------------------------------------------------- 145 (313)
Q Consensus 117 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--------------------------------------------------- 145 (313)
.++.+ +..-.++.+|..|| ...
T Consensus 107 -~~~p~---r~v~~la~aLR~LH---~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~L~~~r 179 (266)
T COG3231 107 -ALDPK---RAVPLLAEALRRLH---ELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDELEARR 179 (266)
T ss_pred -cCCHH---HHHHHHHHHHHHHh---cCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHHHHhcC
Confidence 12332 34455677888888 322
Q ss_pred -------ceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 146 -------VIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 146 -------i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
++|||-..-|++++....--++|+|..-
T Consensus 180 p~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrlG 214 (266)
T COG3231 180 PAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRLG 214 (266)
T ss_pred CchhhceeecCcccCcceEecCCceEEeeecCccc
Confidence 8999999999999988777788887653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.046 Score=49.23 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=45.2
Q ss_pred cccccceeeeEEEEEeecc--e-----EEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISSA--M-----EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~--~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~ 102 (313)
+.+..|-...+|++...++ . .|.++..... ....-.-..|.++++.+...++ +++++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3454588889999875432 1 2555543222 2222233568999999955444 566666653 599999
Q ss_pred ecCCCH
Q 047140 103 MPHGSL 108 (313)
Q Consensus 103 ~~~~~L 108 (313)
++|.+|
T Consensus 131 IeGr~l 136 (383)
T PTZ00384 131 VEGNTM 136 (383)
T ss_pred eccccC
Confidence 988665
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.053 Score=46.98 Aligned_cols=70 Identities=16% Similarity=0.083 Sum_probs=43.5
Q ss_pred ccceeeeEEEEEeec---------ceEEEEEEeeccc-----chhHHHHHHHHHHHhcCC-------------CCcceee
Q 047140 34 ICGVIIPVAQFLISS---------AMEVAVKVFNLQC-----GRAFKSFNIECEMMKSIR-------------HRNLIKV 86 (313)
Q Consensus 34 g~G~~g~V~~~~~~~---------~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~-------------h~~i~~~ 86 (313)
|.|-.|.+|++...- ...++||..+... ......+.+|+.+.+.+- ....+++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 667778888877421 3478999886221 113456778888777641 1234566
Q ss_pred eeeeeeCccceEEEEee
Q 047140 87 ISTCSNEEFKALVLEYM 103 (313)
Q Consensus 87 ~~~~~~~~~~~lv~e~~ 103 (313)
+..-.+....+||+|-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 65555555678999876
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.16 Score=42.00 Aligned_cols=76 Identities=22% Similarity=0.232 Sum_probs=52.0
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceEEEEeecC
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
..+.+.-|.--..|.... ...++.+|+-.. .....|..|+.-|+.|. .-.+.+++.+..+.++.|+|+||++.
T Consensus 20 er~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 20 EREEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 344444444444455443 367899997443 34567788888777773 35678889998999999999999976
Q ss_pred CCH
Q 047140 106 GSL 108 (313)
Q Consensus 106 ~~L 108 (313)
+.+
T Consensus 96 ~~~ 98 (286)
T COG3001 96 GPL 98 (286)
T ss_pred CCC
Confidence 544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 313 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-23 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-57
Identities = 81/260 (31%), Positives = 125/260 (48%), Gaps = 14/260 (5%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ +VA+K + + + F E E + RH +L+ +I C L+ +YM +
Sbjct: 60 LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 106 GSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
G+L+++LY S+ + QRL I I A L YLH +IH D+K IN+LLD+N
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENF 176
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
V ++DF I+K T Q+ T T+G I PEY KGR + DVYSFG++L E
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 223 RKKPTDEIFNREMT-LKHWGNNWLPIST-MEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
+ + REM L W ++VD NL + + K + A+
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAV 290
Query: 281 ECTVESPEQRINAREIVAKL 300
+C S E R + +++ KL
Sbjct: 291 KCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-51
Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 27/264 (10%)
Query: 51 EVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK + + + F E EM+ HRNL+++ C + LV YM +GS+
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 110 KYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L S LD +R I + A L YLH ++IH D+K N+LLD+ A +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF +AKL+ + T TIG IAPEY G+ S DV+ +G+ML+E T ++
Sbjct: 176 GDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 227 TDEIF---NREMTLKHW-------GNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 276
D + ++ L W +VD +L ++ +E V +
Sbjct: 235 FDLARLANDDDVMLLDWVKGLLKEKK------LEALVDVDLQG----NYKDEE--VEQLI 282
Query: 277 NLAIECTVESPEQRINAREIVAKL 300
+A+ CT SP +R E+V L
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-48
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 22/265 (8%)
Query: 51 EVAVKVFNLQCGRA----FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
VAVK + F+ E ++M +H NL++++ S+ + LV YMP+G
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 107 SLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
SL L L R I A+ + +LH IH D+K N+LLD+ A
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTA 172
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+SDF +A+ Q++ ++ + T +APE R G + D+YSFG++L+E T
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGL 231
Query: 225 KPTDEIFNR-EMTLKHWGNNWL--PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIE 281
D +R L + + +D + D + E ++A +
Sbjct: 232 PAVD--EHREPQLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQ 282
Query: 282 CTVESPEQRINAREIVAKLFKIRDS 306
C E +R + +++ L ++ S
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-48
Identities = 61/258 (23%), Positives = 117/258 (45%), Gaps = 24/258 (9%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+VAVK+ N+ + ++F E +++ RH N++ + + + A+V ++ SL
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSL 106
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L++S ++ + ++I A ++YLH + +IH DLK N+ L ++ + D
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPE---YRRKGRESTNGDVYSFGIMLMETFTRKK 225
F +A + S Q +I +APE + S DVY+FGI+L E T +
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
P I NR+ ++ G L +V + C + L EC +
Sbjct: 224 PYSNINNRDQIIEMVGRGSLSPDLSKV---------------RSNCPKRMKRLMAECLKK 268
Query: 286 SPEQRINAREIVAKLFKI 303
++R + I+A++ ++
Sbjct: 269 KRDERPSFPRILAEIEEL 286
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-47
Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 21/271 (7%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLEYMPHG 106
VAVK+F +Q ++++ E + ++H N+++ I L+ + G
Sbjct: 49 YVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-------FGYSAQVIHCDLKPINVLLD 159
SL +L ++ ++ + +I +A L YLH G+ + H D+K NVLL
Sbjct: 108 SLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFG 214
+N+ A ++DF +A + + T +APE D+Y+ G
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225
Query: 215 IMLMETFTRKKPTDEIFNREMTLKHW--GNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
++L E +R D + M G + EVV + K +
Sbjct: 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM 285
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ + EC E R++A + ++ ++
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 35/263 (13%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK--ALVLEYMPHG 106
++ VKV ++ R + FN EC ++ H N++ V+ C + L+ +MP+G
Sbjct: 35 DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94
Query: 107 SLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
SL L+ +D Q + +D+A + +LH + L +V++D++M A
Sbjct: 95 SLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTAR 153
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG---DVYSFGIMLMETFT 222
+S + S + +APE +K E TN D++SF ++L E T
Sbjct: 154 ISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
R+ P + +S ME+ ++ E + V L C
Sbjct: 207 REVPFAD-----------------LSNMEIGMK--VALEGLRPTIPPGISPHVSKLMKIC 247
Query: 283 TVESPEQRINAREIVAKLFKIRD 305
E P +R IV L K++D
Sbjct: 248 MNEDPAKRPKFDMIVPILEKMQD 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 32/265 (12%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+VAVK+ Q F E +MK +RH N++ + + ++V EY+ GSL
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 109 EKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
+ L+ S LD +RL++ DVA + YLH + ++H +LK N+L+D +
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCI---APEYRRKGRESTNGDVYSFGIMLMETFTR 223
DF +++L + S + G APE R + DVYSFG++L E T
Sbjct: 181 CDFGLSRLKASTFLSSK-----SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT 283
++P WGN ++ +VV A + + V + C
Sbjct: 236 QQP-------------WGN----LNPAQVVAA--VGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 284 VESPEQRINAREIVAKLFKIRDSLL 308
P +R + I+ L + S +
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 46/267 (17%), Positives = 102/267 (38%), Gaps = 37/267 (13%)
Query: 51 EVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
EVA+++ +++ K+F E + RH N++ + C + A++ +L
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+ + +LD+ + I ++ + YLH + ++H DLK NV D+ V ++D
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITD 172
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCI---APEYRRKGRESTNG---------DVYSFGIM 216
F + + + + G + APE R+ T DV++ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 217 LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 276
E R+ P F + + + + + +++ +
Sbjct: 233 WYELHAREWP----F-KTQP---------AEAIIWQMGTGMKPN-----LSQIGMGKEIS 273
Query: 277 NLAIECTVESPEQRINAREIVAKLFKI 303
++ + C E+R +++ L K+
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-43
Identities = 57/270 (21%), Positives = 110/270 (40%), Gaps = 45/270 (16%)
Query: 51 EVAVKVFNLQCGRA-------FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
VA+K L F+ F E +M ++ H N++K+ N +V+E++
Sbjct: 46 VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFV 103
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---- 159
P G L L + +L +M+D+A +EY+ + ++H DL+ N+ L
Sbjct: 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDE 162
Query: 160 -DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI---APE--YRRKGRESTNGDVYSF 213
+ A ++DF +++ S++ +G APE + + D YSF
Sbjct: 163 NAPVCAKVADFGLSQQ---SVHSVS-----GLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273
++L T + P DE ++ I + ++ +E + E C
Sbjct: 215 AMILYTILTGEGPFDEY------------SYGKIKFINMI-----REEGLRPTIPEDCPP 257
Query: 274 FVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ N+ C P++R + IV +L ++
Sbjct: 258 RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-43
Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 37/271 (13%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+ +K ++F E ++M+ + H N++K I ++ + EY+ G+L
Sbjct: 37 VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ S + QR++ D+AS + YLH S +IH DL N L+ +N ++DF
Sbjct: 97 IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 171 IAKLLTGEYQSMTQTQ---------TLATIGCI---APEYRRKGRESTNGDVYSFGIMLM 218
+A+L+ E + +G APE DV+SFGI+L
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 219 ETFTRKKPTDEI--FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 276
E R + + L G C F
Sbjct: 214 EIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP--------------------PNCPPSFF 253
Query: 277 NLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+ + C PE+R + ++ L +R L
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-43
Identities = 64/260 (24%), Positives = 98/260 (37%), Gaps = 30/260 (11%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VA+K + K+F +E + + H N++K+ C N LV+EY GSL
Sbjct: 33 DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYN 88
Query: 111 YLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLS 167
L+ + ++ + + + YLH +IH DLKP N+LL V +
Sbjct: 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF A T + +APE S DV+S+GI+L E TR+KP
Sbjct: 149 DFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
DEI M V + + +L C + P
Sbjct: 204 DEIGG------------PAFRIMWAVHNGT------RPPLIKNLPKPIESLMTRCWSKDP 245
Query: 288 EQRINAREIVAKLFKIRDSL 307
QR + EIV + +
Sbjct: 246 SQRPSMEEIVKIMTHLMRYF 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-42
Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 43/268 (16%)
Query: 51 EVAVKVFNLQC----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
EVAVK + ++ E ++ ++H N+I + C E LV+E+ G
Sbjct: 32 EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD------- 159
L + L + +N + +A + YLH +IH DLK N+L+
Sbjct: 92 PLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149
Query: 160 -DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI---APEYRRKGRESTNGDVYSFGI 215
N + ++DF +A+ +T ++ G APE R S DV+S+G+
Sbjct: 150 LSNKILKITDFGLARE-------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
+L E T + P + I + V ++ + C
Sbjct: 203 LLWELLTGEVP-------------FRG----IDGLAVAYG--VAMNKLALPIPSTCPEPF 243
Query: 276 FNLAIECTVESPEQRINAREIVAKLFKI 303
L +C P R + I+ +L I
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-41
Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 31/280 (11%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEM--MKSIRHRNLIKVISTCSNEEFK----ALVLEYMP 104
+VAVKVF S+ E E+ +RH N++ I+ L+ +Y
Sbjct: 62 KVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYSAQVIHCDLKPINVLLD 159
+GSL YL S+ LD L + S L +LH + H DLK N+L+
Sbjct: 119 NGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI---APE------YRRKGRESTNGDV 210
N ++D +A + + +G PE R + D+
Sbjct: 177 KNGTCCIADLGLAVKFISDTNEVDIPPN-TRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 211 YSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE--DI-HFVA 267
YSFG++L E R + E L + S ++ + + + + +
Sbjct: 236 YSFGLILWEVARRCVSGGIV--EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293
Query: 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
++C+ + L EC +P R+ A + L K+ +S
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 62/291 (21%), Positives = 101/291 (34%), Gaps = 36/291 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMK--SIRHRNLIKVISTC-----SNEEFKALVLEYM 103
VAVKVF+ ++F E + + + H N+ + I LV+EY
Sbjct: 38 PVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH------FGYSAQVIHCDLKPINVL 157
P+GSL KYL D + V L YLH Y + H DL NVL
Sbjct: 95 PNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI------APEY-------RRKGRE 204
+ ++ +SDF ++ LTG + A I + APE R
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 205 STNGDVYSFGIMLMETFTRKKPTDEIFN-REMTLKHWGNNWLPISTME----VVDANLLS 259
D+Y+ G++ E F R + E + + + V
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
+ + V + +C + E R+ A+ ++ ++ RN
Sbjct: 273 KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-38
Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 35/278 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEM--MKSIRHRNLIKVISTCSNEEFKA----LVLEYMP 104
VAVK+F+ + KS+ E E+ +RH N++ I++ + L+ Y
Sbjct: 33 NVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYSAQVIHCDLKPINVLLD 159
GSL YL LD L I++ +AS L +LH + H DLK N+L+
Sbjct: 90 MGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI---APE------YRRKGRESTNGDV 210
N ++D +A + + + +G APE D+
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNN-PRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 211 YSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME--VVDANL---LSQEDIHF 265
++FG++L E R + + + N M V +
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR---- 262
Query: 266 VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ ++ + L EC ++P R+ A I L KI
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 31/279 (11%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEM--MKSIRHRNLIKVISTCSNEEFKA----LVLEYMP 104
EVAVK+F+ + +S+ E E+ +RH N++ I+ + + LV +Y
Sbjct: 67 EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYSAQVIHCDLKPINVLLD 159
HGSL YL + + + + + AS L +LH + H DLK N+L+
Sbjct: 124 HGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI---APE-----YRRKGRESTN-GDV 210
N ++D +A ++ +G APE K ES D+
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 211 YSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE--DI-HFVA 267
Y+ G++ E R + L ++ S E+ + +I +
Sbjct: 241 YAMGLVFWEIARRCSIGGIH--EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298
Query: 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
+ + + + EC + R+ A I L ++
Sbjct: 299 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 27/256 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+ VAVK + + F E +MK I+H NL++++ C+ E ++ E+M +G+L
Sbjct: 246 LTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL N + L + ++SA+EYL IH +L N L+ +N + ++D
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +++L+TG+ + I APE + S DV++FG++L E T P
Sbjct: 362 FGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
I ++ + + E C V+ L C +P
Sbjct: 421 PGIDLSQVYELLEKDYRME--------------------RPEGCPEKVYELMRACWQWNP 460
Query: 288 EQRINAREIVAKLFKI 303
R + EI +
Sbjct: 461 SDRPSFAEIHQAFETM 476
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 69/268 (25%), Positives = 108/268 (40%), Gaps = 47/268 (17%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VAVK F E ++K H N++++I C+ ++ +V+E + G
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L + L + L ++ D A+ +EYL S IH DL N L+ + V +SD
Sbjct: 200 LTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISD 256
Query: 169 FSIAKLLT-GEYQSMTQTQTLATIGCI---APEYRRKGRESTNGDVYSFGIMLMETFTR- 223
F +++ G Y + + + + APE GR S+ DV+SFGI+L ETF+
Sbjct: 257 FGMSREEADGVYAASGGLRQVP----VKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVF 276
P + +S + FV K E C VF
Sbjct: 313 ASP------------YPN-----LSNQQT----------REFVEKGGRLPCPELCPDAVF 345
Query: 277 NLAIECTVESPEQRINAREIVAKLFKIR 304
L +C P QR + I +L IR
Sbjct: 346 RLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 292 TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL 349
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L L + Q +++ +AS + Y+ +H DL+ N+L+ +N+V ++D
Sbjct: 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 406
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +A+L+ + Q I APE GR + DV+SFGI+L E T+ + P
Sbjct: 407 FGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ NRE ++ V+ +C + +L +C + P
Sbjct: 466 PGMVNRE--------------VLDQVE------RGYRMPCPPECPESLHDLMCQCWRKEP 505
Query: 288 EQRINAREIVAKLFKI 303
E+R + A L
Sbjct: 506 EERPTFEYLQAFLEDY 521
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 209 TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL 266
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L L + Q +++ +AS + Y+ +H DL+ N+L+ +N+V ++D
Sbjct: 267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 323
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +A+L+ + Q I APE GR + DV+SFGI+L E T+ + P
Sbjct: 324 FGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ NRE ++ V+ +C + +L +C + P
Sbjct: 383 PGMVNRE--------------VLDQVE------RGYRMPCPPECPESLHDLMCQCWRKEP 422
Query: 288 EQRINAREIVAKLFKI 303
E+R + A L
Sbjct: 423 EERPTFEYLQAFLEDY 438
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 44/188 (23%), Positives = 88/188 (46%), Gaps = 6/188 (3%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ V +KV + G ++F++ + S+ H ++++++ C + LV +Y+P GSL
Sbjct: 43 IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL 101
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
++ L LN + +A + YL ++H +L NVLL ++D
Sbjct: 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVAD 158
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +A LL + + + ++ I +A E G+ + DV+S+G+ + E T +P
Sbjct: 159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218
Query: 228 DEIFNREM 235
+ E+
Sbjct: 219 AGLRLAEV 226
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 62/268 (23%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGS 107
VAVK + F E E++KS++H N++K C + + L++EY+P+GS
Sbjct: 71 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L YL +D + L + +EYL + + IH DL N+L+++ +
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 187
Query: 168 DFSIAKLL---TGEYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
DF + K+L Y+ + APE + + S DV+SFG++L E
Sbjct: 188 DFGLTKVLPQDKEYYKVKEPGESPIFWY-------APESLTESKFSVASDVWSFGVVLYE 240
Query: 220 TFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 279
FT + + M + + + +++ L + + + C ++ +
Sbjct: 241 LFTYIEKSKSPPAEFMRMIG-NDKQGQMIVFHLIE---LLKNNGRLPRPDGCPDEIYMIM 296
Query: 280 IECTVESPEQRINAREIVAKLFKIRDSL 307
EC + QR + R++ ++ +IRD +
Sbjct: 297 TECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 61/274 (22%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGS 107
VAVK + F E E++KS++H N++K C + + L++EY+P+GS
Sbjct: 40 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L YL +D + L + +EYL + + IH DL N+L+++ +
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 156
Query: 168 DFSIAKLL---TGEYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
DF + K+L ++ + APE + + S DV+SFG++L E
Sbjct: 157 DFGLTKVLPQDKEFFKVKEPGESPIFWY-------APESLTESKFSVASDVWSFGVVLYE 209
Query: 220 TFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 279
FT + + M + + + +++ L + + + C ++ +
Sbjct: 210 LFTYIEKSKSPPAEFMRMIG-NDKQGQMIVFHLIE---LLKNNGRLPRPDGCPDEIYMIM 265
Query: 280 IECTVESPEQRINAREIVAKLFKIRDSLLRNVGG 313
EC + QR + R++ ++ D + N+ G
Sbjct: 266 TECWNNNVNQRPSFRDLALRV----DQIRDNMAG 295
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 52/273 (19%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VA+K + + + F E E+M + H L+++ C + LV E+M HG L
Sbjct: 33 DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
YL + + L + +DV + YL A VIH DL N L+ +N V +SDF
Sbjct: 92 DYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 148
Query: 170 SIAKLLTG-EYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
+ + + +Y S T T+ +PE R S+ DV+SFG+++ E F+
Sbjct: 149 GMTRFVLDDQYTSSTGTKFPVKWA-------SPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201
Query: 224 -KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFV 275
K P + N E+ + ++ + V
Sbjct: 202 GKIPYENRSNSEV---------------------------VEDISTGFRLYKPRLASTHV 234
Query: 276 FNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308
+ + C E PE R ++ +L +I +S L
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 33/261 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGSLE 109
+VAVK ++ ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 218 KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F + K E S T L + APE R+ + ST DV+SFGI+L E ++ + P
Sbjct: 333 FGLTK----EASSTQDTGKLP-VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
I ++ + V+ + A + C V+++ C
Sbjct: 388 PRIPLKD--------------VVPRVE------KGYKMDAPDGCPPAVYDVMKNCWHLDA 427
Query: 288 EQRINAREIVAKLFKIRDSLL 308
R ++ +L IR L
Sbjct: 428 ATRPTFLQLREQLEHIRTHEL 448
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 42/272 (15%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-FKALVLEYMPHGS 107
++ A+K + + ++F E +M+ + H N++ +I E ++L YM HG
Sbjct: 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L +++ S + ++ + VA +EYL + +H DL N +LD++ ++
Sbjct: 110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVA 166
Query: 168 DFSIAKLLTGE--YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-K 224
DF +A+ + Y + A E + R +T DV+SFG++L E TR
Sbjct: 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFN 277
P I ++ HF+A+ E C ++
Sbjct: 227 PPYRHIDPFDL---------------------------THFLAQGRRLPQPEYCPDSLYQ 259
Query: 278 LAIECTVESPEQRINAREIVAKLFKIRDSLLR 309
+ +C P R R +V ++ +I +LL
Sbjct: 260 VMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 42/273 (15%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL-VLEYMP 104
+ AVK N F E +MK H N++ ++ C E L VL YM
Sbjct: 51 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
HG L ++ + + + + VA ++YL S + +H DL N +LD+
Sbjct: 111 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTV 167
Query: 165 HLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
++DF +A+ + Y +T + +A E + + +T DV+SFG++L E T
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
Query: 223 R-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 274
R P ++ ++ ++ + E C
Sbjct: 228 RGAPPYPDVNTFDI---------------------------TVYLLQGRRLLQPEYCPDP 260
Query: 275 VFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
++ + ++C E R + E+V+++ I +
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-30
Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 9/188 (4%)
Query: 50 MEVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VAVK L+ F E +MK I+H NL++++ C+ E ++ E+M +G+L
Sbjct: 39 LTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 109 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
YL N + L + ++SA+EYL IH DL N L+ +N + ++
Sbjct: 97 LDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA 153
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
DF +++L+TG+ + I APE + S DV++FG++L E T P
Sbjct: 154 DFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
Query: 227 TDEIFNRE 234
I +
Sbjct: 213 YPGIDLSQ 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 20/193 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVK + ++F E +MK+++H L+K+ + + E ++ E+M GSL
Sbjct: 213 TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL 270
Query: 110 KYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L S + + ++ +A + ++ IH DL+ N+L+ ++V ++D
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIAD 327
Query: 169 FSIAKLLTG-EYQSMTQTQTLATIGCI-----APEYRRKGRESTNGDVYSFGIMLMETFT 222
F +A+++ EY T APE G + DV+SFGI+LME T
Sbjct: 328 FGLARVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
Query: 223 R-KKPTDEIFNRE 234
+ P + N E
Sbjct: 381 YGRIPYPGMSNPE 393
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 56/281 (19%), Positives = 111/281 (39%), Gaps = 50/281 (17%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHG 106
+VAVK + G E E+++++ H N++K C+ + L++E++P G
Sbjct: 51 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
SL++YL + +++ Q+L + + ++YL S Q +H DL NVL++ +
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 167
Query: 167 SDFSIAKLL---TGEYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLM 218
DF + K + Y APE + + DV+SFG+ L
Sbjct: 168 GDFGLTKAIETDKEYYTVKDDRDSPVFWY-------APECLMQSKFYIASDVWSFGVTLH 220
Query: 219 ETFT---RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK------- 268
E T +F + + H ++ + ++ + +
Sbjct: 221 ELLTYCDSDSSPMALFLKMIGPTHGQ-----MTVTRL----------VNTLKEGKRLPCP 265
Query: 269 EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309
C V+ L +C P R + + ++ ++LL+
Sbjct: 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-30
Identities = 61/269 (22%), Positives = 97/269 (36%), Gaps = 36/269 (13%)
Query: 50 MEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
+ VAVK L A F E M S+ HRNLI++ K +V E P G
Sbjct: 47 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
SL L + + VA + YL S + IH DL N+LL + +
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 162
Query: 167 SDFSIAKLLTG---EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
DF + + L Y + APE + S D + FG+ L E FT
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 220
Query: 224 -KKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN--LLSQEDIHFVAKEQCVSFVFNLAI 280
++P + + + +D L + + C ++N+ +
Sbjct: 221 GQEPWIGLNGSQ--------------ILHKIDKEGERLPRPED-------CPQDIYNVMV 259
Query: 281 ECTVESPEQRINAREIVAKLFKIRDSLLR 309
+C PE R + L + + + +R
Sbjct: 260 QCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 6/187 (3%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL 103
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
Y+ + LN + +A + YL +++H DL NVL+ ++D
Sbjct: 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITD 160
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +AKLL E + I +A E + DV+S+G+ + E T KP
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 228 DEIFNRE 234
D I E
Sbjct: 221 DGIPASE 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 57/282 (20%), Positives = 108/282 (38%), Gaps = 56/282 (19%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL-VLEYMP 104
+ AVK N F E +MK H N++ ++ C E L VL YM
Sbjct: 115 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPINVLLDDN 161
HG L ++ + + + + VA +++L F +H DL N +LD+
Sbjct: 175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEK 228
Query: 162 MVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCI-----APEYRRKGRESTNGDVYSFGI 215
++DF +A+ + E+ S+ T + A E + + +T DV+SFG+
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNK----TGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284
Query: 216 MLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK------ 268
+L E TR P ++ ++ ++ +
Sbjct: 285 LLWELMTRGAPPYPDVNTFDI---------------------------TVYLLQGRRLLQ 317
Query: 269 -EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309
E C ++ + ++C E R + E+V+++ I + +
Sbjct: 318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 58/192 (30%), Positives = 89/192 (46%), Gaps = 18/192 (9%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVK+ + + F E + M + H L+K CS E +V EY+ +G L
Sbjct: 33 YDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
YL S L+ Q L + DV + +L S Q IH DL N L+D ++ +SDF
Sbjct: 92 NYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDF 148
Query: 170 SIAKLLTG-EYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
+ + + +Y S T+ + APE + S+ DV++FGI++ E F+
Sbjct: 149 GMTRYVLDDQYVSSVGTKFPVKWS-------APEVFHYFKYSSKSDVWAFGILMWEVFSL 201
Query: 224 -KKPTDEIFNRE 234
K P D N E
Sbjct: 202 GKMPYDLYTNSE 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 6/188 (3%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K R + F E +M H N+I++ + +V EYM +GSL
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+ +L + + I Q + ++ V + + YL +H DL NVL+D N+V +SD
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 169 FSIAKLLTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F ++++L + T T I APE S+ DV+SFG+++ E ++P
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
Query: 227 TDEIFNRE 234
+ NR+
Sbjct: 255 YWNMTNRD 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 38/275 (13%)
Query: 47 SSAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-----LV 99
++++VAVK L R + F E MK H N+I+++ C + ++
Sbjct: 60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 100 LEYMPHGSLEKYL-----YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
L +M +G L YL + + + L M+D+A +EYL + +H DL
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAAR 176
Query: 155 NVLLDDNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N +L D+M ++DF ++K + +G+Y + IA E ++ DV++F
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWIAIESLADRVYTSKSDVWAF 235
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
G+ + E TR P + N EM + ++ + L Q E C+
Sbjct: 236 GVTMWEIATRGMTPYPGVQNHEM-YDY------------LLHGHRLKQ-------PEDCL 275
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
++ + C P R + +L K+ +SL
Sbjct: 276 DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 59/264 (22%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K + F E +M H N+I++ S + ++ EYM +G+L
Sbjct: 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+K+L + + Q + ++ +A+ ++YL + +H DL N+L++ N+V +SD
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 169 FSIAKLLTGEYQSMTQTQ-TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F ++++L + ++ T I APE + ++ DV+SFGI++ E T ++P
Sbjct: 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 279
+W +S EV + + C S ++ L
Sbjct: 251 ------------YWE-----LSNHEV----------MKAINDGFRLPTPMDCPSAIYQLM 283
Query: 280 IECTVESPEQRINAREIVAKLFKI 303
++C + +R +IV+ L K+
Sbjct: 284 MQCWQQERARRPKFADIVSILDKL 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 61/271 (22%), Positives = 117/271 (43%), Gaps = 44/271 (16%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K + + + F E +M H N+I++ + + +V EYM +GSL
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+ +L + + Q + ++ +AS ++YL +H DL N+L++ N+V +SD
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSD 190
Query: 169 FSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F + ++L + T I +PE + ++ DV+S+GI+L E + ++P
Sbjct: 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 279
+W +S +V I V + C + ++ L
Sbjct: 251 ------------YWE-----MSNQDV----------IKAVDEGYRLPPPMDCPAALYQLM 283
Query: 280 IECTVESPEQRINAREIVAKLFKIRDSLLRN 310
++C + R +IV+ L D L+RN
Sbjct: 284 LDCWQKDRNNRPKFEQIVSIL----DKLIRN 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 59/275 (21%), Positives = 97/275 (35%), Gaps = 41/275 (14%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGS 107
VAVK + F E +++K++ ++K ++ LV+EY+P G
Sbjct: 53 ALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L +L LD + L + +EYL S + +H DL N+L++ ++
Sbjct: 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIA 169
Query: 168 DFSIAKLL---TGEYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
DF +AKLL Y Q APE S DV+SFG++L E
Sbjct: 170 DFGLAKLLPLDKDYYVVREPGQSPIFWY-------APESLSDNIFSRQSDVWSFGVVLYE 222
Query: 220 TFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQC 271
FT K + + M + + + C
Sbjct: 223 LFTYCDKS-------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC 269
Query: 272 VSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
+ V L C SP+ R + + +L +
Sbjct: 270 PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 58/275 (21%), Positives = 111/275 (40%), Gaps = 43/275 (15%)
Query: 50 MEVAVKVFNLQCGRAFKS---FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
++VA+KV L+ G E ++M + + ++++I C E LV+E G
Sbjct: 38 IDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGG 94
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPINVLLDDNMV 163
L K+L + + ++ V+ ++YL +F +H DL NVLL +
Sbjct: 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLAARNVLLVNRHY 148
Query: 164 AHLSDFSIAKLLT---GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
A +SDF ++K L Y + ++ + APE + S+ DV+S+G+ + E
Sbjct: 149 AKISDFGLSKALGADDSYYTA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206
Query: 221 FTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN-LLSQEDIHFVAKEQCVSFVFNL 278
+ +KP ++ E M ++ + +C ++ L
Sbjct: 207 LSYGQKPYKKMKGPE--------------VMAFIEQGKRMEC-------PPECPPELYAL 245
Query: 279 AIECTVESPEQRINAREIVAKLFKIRDSLLRNVGG 313
+C + E R + + ++ SL V G
Sbjct: 246 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 36/272 (13%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHG 106
VAVK G + + E ++++++ H ++IK C + + LV+EY+P G
Sbjct: 61 EMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
SL YL + + + Q L + + YLH + IH DL NVLLD++ + +
Sbjct: 121 SLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI 175
Query: 167 SDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-- 222
DF +AK + EY + + + APE ++ + DV+SFG+ L E T
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSP-VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 223 -RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 274
+ F + + ++ + + + + ++C +
Sbjct: 235 DSSQSPPTKFLELIGIAQGQ-----MTVLRL----------TELLERGERLPRPDKCPAE 279
Query: 275 VFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
V++L C R ++ L + +
Sbjct: 280 VYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 6/187 (3%)
Query: 50 MEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL 103
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
Y+ + LN + +A + YL +++H DL NVL+ ++D
Sbjct: 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITD 160
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPT 227
F +AKLL E + I +A E + DV+S+G+ + E T KP
Sbjct: 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 228 DEIFNRE 234
D I E
Sbjct: 221 DGIPASE 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 57/271 (21%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGSLE 109
+VAVK ++ ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 46 KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 160
Query: 169 FSIAKLLTGEYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
F + K + + T APE R+ + ST DV+SFGI+L E ++
Sbjct: 161 FGLTKE---ASSTQDTGKLPVKWT-------APEALREKKFSTKSDVWSFGILLWEIYSF 210
Query: 224 -KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFV 275
+ P + I +V + V K + C V
Sbjct: 211 GRVP------------YPR-----IPLKDV----------VPRVEKGYKMDAPDGCPPAV 243
Query: 276 FNLAIECTVESPEQRINAREIVAKLFKIRDS 306
+ + C R + ++ +L I+
Sbjct: 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VA+K+ + + F E ++M ++ H L+++ C+ + ++ EYM +G L
Sbjct: 49 YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
YL Q L + DV A+EYL S Q +H DL N L++D V +SDF
Sbjct: 108 NYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 170 SIAKLLTG-EYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
+++ + EY S ++ + PE + S+ D+++FG+++ E ++
Sbjct: 165 GLSRYVLDDEYTSSVGSKFPVRWS-------PPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217
Query: 224 -KKPTDEIFNRE 234
K P + N E
Sbjct: 218 GKMPYERFTNSE 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 47 SSAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA------L 98
S ++VAVK+ + F E MK H ++ K++ K +
Sbjct: 49 GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108
Query: 99 VLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153
+L +M HG L +L +S L + + M+D+A +EYL S IH DL
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAA 165
Query: 154 INVLLDDNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYS 212
N +L ++M ++DF +++ + +G+Y + + +A E + + DV++
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQG-CASKLPVKWLALESLADNLYTVHSDVWA 224
Query: 213 FGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQC 271
FG+ + E TR + P I N E+ + ++ N L Q +C
Sbjct: 225 FGVTMWEIMTRGQTPYAGIENAEI-YNY------------LIGGNRLKQ-------PPEC 264
Query: 272 VSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+ V++L +C P+QR + + +L I L
Sbjct: 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 57/275 (20%), Positives = 111/275 (40%), Gaps = 43/275 (15%)
Query: 50 MEVAVKVFNLQCGRAFKS---FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
++VA+KV L+ G E ++M + + ++++I C E LV+E G
Sbjct: 364 IDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGG 420
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPINVLLDDNMV 163
L K+L + + ++ V+ ++YL +F +H +L NVLL +
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHY 474
Query: 164 AHLSDFSIAKLLT---GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
A +SDF ++K L Y + ++ + APE + S+ DV+S+G+ + E
Sbjct: 475 AKISDFGLSKALGADDSYYTA--RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 532
Query: 221 FTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL-LSQEDIHFVAKEQCVSFVFNL 278
+ +KP ++ E M ++ + +C ++ L
Sbjct: 533 LSYGQKPYKKMKGPE--------------VMAFIEQGKRMEC-------PPECPPELYAL 571
Query: 279 AIECTVESPEQRINAREIVAKLFKIRDSLLRNVGG 313
+C + E R + + ++ SL V G
Sbjct: 572 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVK Q + +F E +MK ++H+ L+++ + + E ++ EYM +GSL
Sbjct: 38 TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV 95
Query: 110 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L + + L I + L++ +A + ++ IH DL+ N+L+ D + ++D
Sbjct: 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152
Query: 169 FSIAKLLTG-EYQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
F +A+L+ EY + + T APE G + DV+SFGI+L E T
Sbjct: 153 FGLARLIEDNEYTAREGAKFPIKWT-------APEAINYGTFTIKSDVWSFGILLTEIVT 205
Query: 223 R-KKPTDEIFNRE 234
+ P + N E
Sbjct: 206 HGRIPYPGMTNPE 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 49/275 (17%)
Query: 47 SSAMEVAVKVFNLQCG----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
VAVK+ L+ E +M+ + + ++++I C E + LV+E
Sbjct: 42 KVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEM 98
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
G L KYL N + + ++ V+ ++YL + +H DL NVLL
Sbjct: 99 AELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQH 154
Query: 163 VAHLSDFSIAKLLTGE---YQSMTQTQ-----TLATIGCIAPEYRRKGRESTNGDVYSFG 214
A +SDF ++K L + Y++ T + APE + S+ DV+SFG
Sbjct: 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWY-------APECINYYKFSSKSDVWSFG 207
Query: 215 IMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL-LSQEDIHFVAKEQCV 272
+++ E F+ +KP + E +++ + C
Sbjct: 208 VLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMGC-------PAGCP 246
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307
+++L C E R + +L +
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 55/281 (19%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
M VAVK A K F E E++ +++H +++K C + + +V EYM HG L
Sbjct: 46 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 110 KYL---------------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
K+L + L + Q L+I +AS + YL S +H DL
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATR 162
Query: 155 NVLLDDNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N L+ N++ + DF +++ + + +Y + T+ I + PE + +T DV+SF
Sbjct: 163 NCLVGANLLVKIGDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSF 221
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK---- 268
G++L E FT K+P + +S EV I + +
Sbjct: 222 GVILWEIFTYGKQP------------WFQ-----LSNTEV----------IECITQGRVL 254
Query: 269 ---EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
C V+++ + C P+QR+N +EI L + +
Sbjct: 255 ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 53/267 (19%), Positives = 99/267 (37%), Gaps = 43/267 (16%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VA+K + F E M+ H +++K+I + +++E G L
Sbjct: 44 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL 102
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L LD+ + +++AL YL S + +H D+ NVL+ N L D
Sbjct: 103 RSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 159
Query: 169 FSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F +++ + Y ++ I +APE R ++ DV+ FG+ + E KP
Sbjct: 160 FGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 279
+ N ++ I + C +++L
Sbjct: 218 FQGVKNNDV---------------------------IGRIENGERLPMPPNCPPTLYSLM 250
Query: 280 IECTVESPEQRINAREIVAKLFKIRDS 306
+C P +R E+ A+L I +
Sbjct: 251 TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 55/281 (19%), Positives = 114/281 (40%), Gaps = 50/281 (17%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K N R F E +MK ++++++ S + +++E M G L
Sbjct: 56 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 109 EKYL---------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
+ YL + + + + ++A + YL+ + + +H DL N ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 172
Query: 160 DNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLM 218
++ + DF + + + +Y + L + ++PE + G +T DV+SFG++L
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231
Query: 219 ETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQ 270
E T ++P + G +S +V + FV + +
Sbjct: 232 EIATLAEQP------------YQG-----LSNEQV----------LRFVMEGGLLDKPDN 264
Query: 271 CVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRNV 311
C +F L C +P+ R + EI++ + + + R V
Sbjct: 265 CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 60/283 (21%)
Query: 50 MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
M VAVK A + F E E++ ++H+++++ C+ +V EYM HG L
Sbjct: 72 MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 110 KYLYSS--------------NCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLK 152
++L S L + Q L + VA+ + YL HF +H DL
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLA 185
Query: 153 PINVLLDDNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
N L+ +V + DF +++ + + +Y + +T+ I + PE + +T DV+
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 212 SFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-- 268
SFG++L E FT K+P + +S E I + +
Sbjct: 245 SFGVVLWEIFTYGKQP------------WYQ-----LSNTEA----------IDCITQGR 277
Query: 269 -----EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
C V+ + C P+QR + +++ A+L + +
Sbjct: 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95
GV V + EV +KV + +SF MM + H++L+ C +
Sbjct: 27 GVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86
Query: 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
LV E++ GSL+ YL + ++I +L + +A+A+ +L +IH ++ N
Sbjct: 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKN 143
Query: 156 VLLD--------DNMVAHLSDFSIAK-LLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-S 205
+LL + LSD I+ +L + I + PE + +
Sbjct: 144 ILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-------LQERIPWVPPECIENPKNLN 196
Query: 206 TNGDVYSFGIMLMETFTR-KKPTDEIFNRE 234
D +SFG L E + KP + ++
Sbjct: 197 LATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 46/278 (16%)
Query: 48 SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
S ++VAVK C + F +E ++ H+N+++ I + +++E M G
Sbjct: 59 SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 107 SLEKYLYSS------NCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPINVL 157
L+ +L + L + L++ D+A +YL HF IH D+ N L
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNCL 172
Query: 158 LD---DNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
L VA + DF +A+ + Y + + + PE +G ++ D +SF
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 231
Query: 214 GIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
G++L E F+ P N+E+ L+ V + + C
Sbjct: 232 GVLLWEIFSLGYMPYPSKSNQEV-LEF------------VTSGGRMDP-------PKNCP 271
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
V+ + +C PE R N I+ ++ + ++
Sbjct: 272 GPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQD 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 55/264 (20%), Positives = 102/264 (38%), Gaps = 43/264 (16%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+ VAVK C + F E +MK++ H +++K+I E +++E P+G L
Sbjct: 41 INVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGEL 99
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL + L + + + + A+ YL S +H D+ N+L+ L D
Sbjct: 100 GHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGD 156
Query: 169 FSIAKLLTG-EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F +++ + +Y + T I ++PE R +T DV+ F + + E + K+P
Sbjct: 157 FGLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 279
+ N+++ I + K + C ++ L
Sbjct: 215 FFWLENKDV---------------------------IGVLEKGDRLPKPDLCPPVLYTLM 247
Query: 280 IECTVESPEQRINAREIVAKLFKI 303
C P R E+V L +
Sbjct: 248 TRCWDYDPSDRPRFTELVCSLSDV 271
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 33/183 (18%), Positives = 71/183 (38%), Gaps = 22/183 (12%)
Query: 51 EVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKA-----LVLEYMP 104
V +K ++ E + + + H +++++ + + + +V+EY+
Sbjct: 108 PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
SL++ L + + + ++++ AL YLH S +++ DLKP N++L + +
Sbjct: 168 GQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLK 221
Query: 165 HLSDFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR 223
L D + T G APE + + D+Y+ G L
Sbjct: 222 -LIDLGAVS-------RINSFGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLD 272
Query: 224 KKP 226
Sbjct: 273 LPT 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 51 EVAVKVFNLQCGR--AFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+VA+K + F E + H+N++ +I ++ LV+EY+ +
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L +Y+ S+ L + +N + +++ H +++H D+KP N+L+D N +
Sbjct: 98 LSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIF 153
Query: 168 DFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF IAK L+ S+TQT L T+ +PE + D+YS GI+L E + P
Sbjct: 154 DFGIAKALSE--TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
S ++VAVK C + F +E ++ H+N+++ I + ++LE M
Sbjct: 99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158
Query: 106 GSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPINV 156
G L+ +L + L + L++ D+A +YL HF IH D+ N
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNC 212
Query: 157 LLD---DNMVAHLSDFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYS 212
LL VA + DF +A+ + Y + + + PE +G ++ D +S
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 213 FGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQC 271
FG++L E F+ P N+E+ L+ V + + C
Sbjct: 272 FGVLLWEIFSLGYMPYPSKSNQEV-LEF------------VTSGGRMDP-------PKNC 311
Query: 272 VSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
V+ + +C PE R N I+ ++
Sbjct: 312 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 54/267 (20%), Positives = 99/267 (37%), Gaps = 43/267 (16%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
M VA+K + F E M+ H +++K+I + +++E G L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL 477
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L LD+ + +++AL YL S + +H D+ NVL+ N L D
Sbjct: 478 RSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 534
Query: 169 FSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKP 226
F +++ + Y ++ I +APE R ++ DV+ FG+ + E KP
Sbjct: 535 FGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 279
+ N ++ I + C +++L
Sbjct: 593 FQGVKNNDV---------------------------IGRIENGERLPMPPNCPPTLYSLM 625
Query: 280 IECTVESPEQRINAREIVAKLFKIRDS 306
+C P +R E+ A+L I +
Sbjct: 626 TKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 12/184 (6%)
Query: 51 EVAVKV--FNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLEYM 103
+VAVKV +L +F F E + ++ H ++ V T E +V+EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
+L + + + + + ++ D AL + H +IH D+KP N+++
Sbjct: 99 DGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNA 154
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF IA+ + S+TQT + T ++PE R DVYS G +L E T
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 223 RKKP 226
+ P
Sbjct: 215 GEPP 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 45/276 (16%)
Query: 48 SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105
A+ VAVK+ + E EMMK I +H+N+I ++ C+ + +++EY
Sbjct: 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 106 GSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
G+L +YL + + ++ +A +EYL S + IH D
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRD 228
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG 208
L NVL+ +N V ++DF +A+ + Y+ T + +APE +
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 209 DVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267
DV+SFG+++ E FT P I E+ K + + + + +
Sbjct: 287 DVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKL------------LKEGHRMDK------- 326
Query: 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
C + ++ + +C P QR +++V L +I
Sbjct: 327 PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 53/284 (18%), Positives = 108/284 (38%), Gaps = 52/284 (18%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ VAVK+ + E ++K + H ++IK+ CS + L++EY +
Sbjct: 51 AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 110
Query: 106 GSLEKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYLHFGY 142
GSL +L S L + ++ ++ ++YL
Sbjct: 111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--- 167
Query: 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRR 200
+++H DL N+L+ + +SDF +++ + Y ++Q + +A E
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK--RSQGRIPVKWMAIESLF 225
Query: 201 KGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259
+T DV+SFG++L E T P I + + + +
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-FNL------------LKTGHRME 272
Query: 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ + C ++ L ++C + P++R +I L K+
Sbjct: 273 R-------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 10/180 (5%)
Query: 51 EVAVKVFNLQCGR--AFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
VA+K+ + F++ E ++ +++ + + + + +
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L L L + + I+ + SAL+ H +A H D+KP N+L+ + A+L
Sbjct: 121 LAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLV 176
Query: 168 DFSIAKLLTGEYQSMTQTQT-LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF IA T E +TQ + T+ +APE + + D+Y+ +L E T P
Sbjct: 177 DFGIASATTDE--KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 63/288 (21%), Positives = 118/288 (40%), Gaps = 45/288 (15%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93
+ + + A+ VAVK+ + E EMMK I +H+N+I ++ C+ +
Sbjct: 54 AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113
Query: 94 EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYL 138
+++EY G+L +YL + + ++ +A +EYL
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173
Query: 139 HFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAP 196
S + IH DL NVL+ +N V ++DF +A+ + Y+ T + +AP
Sbjct: 174 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAP 228
Query: 197 EYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255
E + DV+SFG+++ E FT P I E+ K + +
Sbjct: 229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKL------------LKEG 275
Query: 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+ + + C + ++ + +C P QR +++V L +I
Sbjct: 276 HRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 51/257 (19%), Positives = 101/257 (39%), Gaps = 36/257 (14%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMK-SIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+VAVK +C F + E ++++ S H N+I+ T + +F+ + +E +L+
Sbjct: 50 DVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL-----DDNMVA 164
+Y+ + + + ++ S L +LH S ++H DLKP N+L+ + A
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEY---RRKGRESTNGDVYSFGIMLMET 220
+SDF + K L S ++ + T G IAPE K + D++S G +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 221 FTRKK-PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 279
+ P + R+ + + + + K
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLH-----PEKHEDVIARELIEK----------- 266
Query: 280 IECTVESPEQRINAREI 296
P++R +A+ +
Sbjct: 267 --MIAMDPQKRPSAKHV 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 46/276 (16%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP 104
+AM VAVK+ ++ E +++ + H N++ ++ C+ ++ EY
Sbjct: 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110
Query: 105 HGSLEKYL-----------------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVI 147
+G L +L LD+ L+ VA + +L S I
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCI 167
Query: 148 HCDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRES 205
H DL N+LL + + DF +A+ + Y + + +APE +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV--KGNARLPVKWMAPESIFNCVYT 225
Query: 206 TNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264
DV+S+GI L E F+ P + K + + +
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------------IKEGFRMLS---- 269
Query: 265 FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
E + ++++ C P +R ++IV +
Sbjct: 270 ---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 45/285 (15%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93
I + + + +VAVK+ + E EMMK I +H+N+I ++ C+ +
Sbjct: 88 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147
Query: 94 EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYL 138
+++EY G+L +YL + L ++ VA +EYL
Sbjct: 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 139 HFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAP 196
S + IH DL NVL+ ++ V ++DF +A+ + Y+ T + +AP
Sbjct: 208 A---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK--TTNGRLPVKWMAP 262
Query: 197 EYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255
E + DV+SFG++L E FT P + E+ K + +
Sbjct: 263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKL------------LKEG 309
Query: 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ + + C + ++ + +C P QR +++V L
Sbjct: 310 HRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 55/285 (19%), Positives = 114/285 (40%), Gaps = 74/285 (25%)
Query: 50 MEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K + G + F E + ++H N++ ++ + ++ +++ Y HG L
Sbjct: 40 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 109 EKYL---------------YSSNCILDIFQRLNIMIDVASALEYL---HFGYSAQVIHCD 150
++L + L+ ++++ +A+ +EYL H +H D
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKD 153
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQ-----TLATIGCIAPEYRRKGR 203
L NVL+ D + +SD + + + Y+ + + APE G+
Sbjct: 154 LATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM-------APEAIMYGK 206
Query: 204 ESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262
S + D++S+G++L E F+ +P + G S +V
Sbjct: 207 FSIDSDIWSYGVVLWEVFSYGLQP------------YCG-----YSNQDV---------- 239
Query: 263 IHFVAK-------EQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ + + C ++V+ L IEC E P +R ++I ++L
Sbjct: 240 VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 50/286 (17%)
Query: 47 SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
VAVK+ + F E +M + N++K++ C+ + L+ EYM +
Sbjct: 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 134
Query: 106 GSLEKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYLHFGY 142
G L ++L S L ++L I VA+ + YL
Sbjct: 135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--- 191
Query: 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIA-KLLTGEYQSMTQTQTLATIGCIAPEYRRK 201
+ +H DL N L+ +NMV ++DF ++ + + +Y I + PE
Sbjct: 192 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA-DGNDAIPIRWMPPESIFY 250
Query: 202 GRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260
R +T DV+++G++L E F+ +P + + E+ + + V D N+L+
Sbjct: 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-IYY------------VRDGNILAC 297
Query: 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
E C ++NL C + P R + I L ++ +
Sbjct: 298 -------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 22/193 (11%)
Query: 47 SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP 104
+ ++VAVK+ ++ E ++M + +H N++ ++ C++ ++ EY
Sbjct: 74 DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 105 HGSLEKYL-------------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL 151
+G L +L +N L+ VA + +L S IH D+
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDV 190
Query: 152 KPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
NVLL + VA + DF +A+ + Y + + +APE + D
Sbjct: 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIV--KGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 210 VYSFGIMLMETFT 222
V+S+GI+L E F+
Sbjct: 249 VWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-22
Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 41/207 (19%)
Query: 47 SSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP 104
+++VAVK+ + ++ E +MM + H N++ ++ C+ L+ EY
Sbjct: 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132
Query: 105 HGSLEKYL----------------------YSSNCILDIFQRLNIMIDVASALEYLHFGY 142
+G L YL +L L VA +E+L
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--- 189
Query: 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQ-----TLATIGCIA 195
+H DL NVL+ V + DF +A+ + Y + A
Sbjct: 190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM-------A 242
Query: 196 PEYRRKGRESTNGDVYSFGIMLMETFT 222
PE +G + DV+S+GI+L E F+
Sbjct: 243 PESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 53/275 (19%), Positives = 102/275 (37%), Gaps = 45/275 (16%)
Query: 47 SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKA-LVLEYM 103
++ VAVK+ ++ E +++ I H N++ ++ C+ +++E+
Sbjct: 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 114
Query: 104 PHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIH 148
G+L YL S L + + VA +E+L S + IH
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH 171
Query: 149 CDLKPINVLLDDNMVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGREST 206
DL N+LL + V + DF +A+ + +Y + + +APE +
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPETIFDRVYTI 229
Query: 207 NGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265
DV+SFG++L E F+ P + E + + + +
Sbjct: 230 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------LKEGTRMRA----- 272
Query: 266 VAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
+ ++ ++C P QR E+V L
Sbjct: 273 --PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-22
Identities = 64/293 (21%), Positives = 114/293 (38%), Gaps = 76/293 (25%)
Query: 50 MEVAVKVFNLQCG---RAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPH 105
M+ A+K ++ + F E E++ + H N+I ++ C + + L +EY PH
Sbjct: 53 MDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 106 GSLEKYL---------------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
G+L +L S+ L Q L+ DVA ++YL Q IH D
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRD 167
Query: 151 LKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ-----TLATIGCIAPEYRRKGRES 205
L N+L+ +N VA ++DF +++ Y T + A E +
Sbjct: 168 LAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWM-------AIESLNYSVYT 219
Query: 206 TNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264
TN DV+S+G++L E + P + G ++ E+
Sbjct: 220 TNSDVWSYGVLLWEIVSLGGTP------------YCG-----MTCAEL----------YE 252
Query: 265 FVAK-------EQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310
+ + C V++L +C E P +R + +I+ L + +L
Sbjct: 253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL----NRMLEE 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 50/281 (17%), Positives = 92/281 (32%), Gaps = 48/281 (17%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLE 101
+ A+K + + E +M + H N++++++ C E L+L
Sbjct: 51 LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 102 YMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
+ G+L + + Q L +++ + LE +H + H DLKP N+LL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILL 167
Query: 159 DDNMVAHLSDFSIAKLLTGEYQS---MTQTQTLATIGC----IAPE------YRRKGRES 205
D L D + Q A C APE + +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 206 TNGDVYSFGIMLMETFTRKKPTDEIFNREMT--LKHWGNNWLPISTMEVVDANLLSQEDI 263
DV+S G +L + P D +F + + L +P S S
Sbjct: 228 ---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-------HSSALW 277
Query: 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304
+ P QR + ++++L ++
Sbjct: 278 QLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 39/180 (21%), Positives = 65/180 (36%), Gaps = 13/180 (7%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+ AVK L+ R E + ++ + + + +E + GSL +
Sbjct: 85 QCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDF 169
+ C L + L + LEYLH + +++H D+K NVLL + A L DF
Sbjct: 140 LIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCI---APEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
A L + + G APE D++S M++ P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 54/255 (21%), Positives = 97/255 (38%), Gaps = 38/255 (14%)
Query: 51 EVAVKVFNL--QCGRAFKSFNIECEMMKSIRHRNLIK----VISTCSNEEFKALVLEYMP 104
EVA + F E EM+K ++H N+++ ST ++ LV E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMV 163
G+L+ YL ++ I + + L++LH + +IH DLK N+ +
Sbjct: 113 SGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGS 170
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLMET 220
+ D +A L + A IG +APE + + DVY+FG+ ++E
Sbjct: 171 VKIGDLGLATL-------KRASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEM 222
Query: 221 FTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
T + P E N + + P S + E +
Sbjct: 223 ATSEYPYSECQNAAQIYRRVTSGVKPAS-----FDKVAIPEVKEIIEG------------ 265
Query: 281 ECTVESPEQRINARE 295
C ++ ++R + ++
Sbjct: 266 -CIRQNKDERYSIKD 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKY 111
+A+K + R + + E + K ++H+N+++ + + S F + +E +P GSL
Sbjct: 50 IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 112 LYSSNCILDIFQRL--NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSD 168
L S L ++ + L+YLH Q++H D+K NVL++ + V +SD
Sbjct: 110 LRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISD 166
Query: 169 FSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNG--DVYSFGIMLMETFTRKK 225
F +K L G T+T T+ +APE KG D++S G ++E T K
Sbjct: 167 FGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
Query: 226 P 226
P
Sbjct: 224 P 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 51/261 (19%), Positives = 102/261 (39%), Gaps = 39/261 (14%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNL--IKVISTCSNEEFKALVLEYMPHG 106
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D M+ L
Sbjct: 141 DLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KL 195
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-----------YRRKGRESTNGDVYSFGI 215
DF IA + + S+ + + + + PE + K + S DV+S G
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
+L K P +I N+ L + I ++ ++ +
Sbjct: 256 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-----EKDLQDVLKC------- 303
Query: 276 FNLAIECTVESPEQRINAREI 296
C P+QRI+ E+
Sbjct: 304 ------CLKRDPKQRISIPEL 318
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 39/261 (14%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNL--IKVISTCSNEEFKALVLEYMPHG 106
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D M+ L
Sbjct: 113 DLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KL 167
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-----------YRRKGRESTNGDVYSFGI 215
DF IA + + S+ + + T+ + PE + K + S DV+S G
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
+L K P +I N+ L + I ++ ++ +
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FPDIPEKDLQDVLKC------- 275
Query: 276 FNLAIECTVESPEQRINAREI 296
C P+QRI+ E+
Sbjct: 276 ------CLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 39/261 (14%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNL--IKVISTCSNEEFKALVLEYMPHG 106
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D M+ L
Sbjct: 94 DLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KL 148
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-----------YRRKGRESTNGDVYSFGI 215
DF IA + + S+ + + T+ + PE + K + S DV+S G
Sbjct: 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208
Query: 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275
+L K P +I N+ L + I ++ ++ +
Sbjct: 209 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FPDIPEKDLQDVLKC------- 256
Query: 276 FNLAIECTVESPEQRINAREI 296
C P+QRI+ E+
Sbjct: 257 ------CLKRDPKQRISIPEL 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 53/276 (19%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK + +E + + +S H N+I+ + + + F + LE +L+
Sbjct: 41 PVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96
Query: 110 KYLYSSNCILDIFQRL------NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---- 159
+ S N + + +++ +AS + +LH S ++IH DLKP N+L+
Sbjct: 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSR 153
Query: 160 ---------DNMVAHLSDFSIAKLLT-GEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNG 208
+N+ +SDF + K L G+ T + T G APE +
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 209 -------DVYSFGIMLMETFTRKK-PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260
D++S G + ++ K P + ++RE + + M+ + L
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII---RGIFSLDEMKCLHDRSLIA 270
Query: 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREI 296
E +++ P +R A ++
Sbjct: 271 EATDLISQ-------------MIDHDPLKRPTAMKV 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 29/190 (15%), Positives = 65/190 (34%), Gaps = 16/190 (8%)
Query: 49 AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM-PHGS 107
+ + + N + + F +++K + + +I+V + + Y +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 108 LEKYL------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
L+ + S++ L RL + + V L LH ++H L+P++++LD
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 247
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFGIM 216
L+ F G + A A G+ D ++ G+
Sbjct: 248 GGVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 217 LMETFTRKKP 226
+ + P
Sbjct: 307 IYWIWCADLP 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 30/206 (14%), Positives = 61/206 (29%), Gaps = 18/206 (8%)
Query: 48 SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+ + +KV F E +K +K S + LV E +G+
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 108 L----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
L Y + ++ ++ + + +E +H ++IH D+KP N +L + +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL 210
Query: 164 AH-----------LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYS 212
L D + + + T T G E + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 213 FGIMLMETFTRKKPTDEIFNREMTLK 238
+ + E +
Sbjct: 271 VAATVYCMLFGTYMKVKNEGGECKPE 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 25/190 (13%)
Query: 46 ISSAMEVAVKVFN-LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLE 101
+ A+KVFN + R E E++K + H+N++K + + L++E
Sbjct: 31 KKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK-VLIME 89
Query: 102 YMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL- 158
+ P GSL L + L + L ++ DV + +L ++H ++KP N++
Sbjct: 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRV 146
Query: 159 ---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNG------ 208
D V L+DF A+ L + Q ++ T + P+ Y R +
Sbjct: 147 IGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY---LHPDMYERAVLRKDHQKKYGAT 203
Query: 209 -DVYSFGIML 217
D++S G+
Sbjct: 204 VDLWSIGVTF 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 52/280 (18%), Positives = 96/280 (34%), Gaps = 55/280 (19%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIK--------------VISTCSNEEFK 96
+K +A + E + + + H N++ S + K
Sbjct: 38 TYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93
Query: 97 AL--VLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153
L +E+ G+LE+++ LD L + + ++Y+H S ++I+ DLKP
Sbjct: 94 CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKP 150
Query: 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
N+ L D + DF + L + + TL ++PE D+Y+
Sbjct: 151 SNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY---MSPEQISSQDYGKEVDLYAL 207
Query: 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273
G++L E E L+ IS + +++ + K
Sbjct: 208 GLILAELLHVCDTAFETSKFFTDLRD-----GIISDI-------FDKKEKTLLQK----- 250
Query: 274 FVFNLAIECTVESPEQRINAREIVAKLF---KIRDSLLRN 310
+ PE R N EI+ L K + R+
Sbjct: 251 --------LLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 54/292 (18%), Positives = 105/292 (35%), Gaps = 41/292 (14%)
Query: 50 MEVAVKVFN-LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMPH 105
A+KVFN + R E E++K + H+N++K + + L++E+ P
Sbjct: 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK-VLIMEFCPC 93
Query: 106 GSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----D 159
GSL L + L + L ++ DV + +L ++H ++KP N++ D
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGED 150
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRESTNG-------DVY 211
V L+DF A+ L + Q ++ T + P+ Y R + D++
Sbjct: 151 GQSVYKLTDFGAARELEDDEQFVSLYGTEEY---LHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 212 SFGIMLMETFTRKKP---------TDEIFNREMTLKHWGNNWLPISTMEVV---DANLLS 259
S G+ T P E+ + +T K G ++
Sbjct: 208 SIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV 267
Query: 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRNV 311
+ + + N+ E+ + A+ I ++ +V
Sbjct: 268 SCSLSRGLQVLLTPVLANIL----EADQEKCWGFDQFFAETSDILHRMVIHV 315
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 38/180 (21%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
+ A K+ L + ++E + +S+ H++++ + +F +VLE
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
SL + + + R + + +YLH +VIH DLK N+ L++++
Sbjct: 97 CRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 152
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYSFGIML 217
+ DF +A + + + C IAPE K S DV+S G ++
Sbjct: 153 EVKIGDFGLATKV------EYDGERKKVL-CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 50 MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIK---VISTCSN---EEFKALVLEY 102
+VA+K + + + + +E ++MK + H N++ V + L +EY
Sbjct: 40 EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 103 MPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD- 159
G L KYL + + C L ++ D++SAL YLH ++IH DLKP N++L
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQP 156
Query: 160 --DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
++ + D AK + Q + +APE + + + D +S
Sbjct: 157 GPQRLIHKIIDLGYAK-------ELDQGELCTEF-VGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 213 FGIMLMETFTRKKPTDEIFNREMTLKH 239
FG + E T +P +
Sbjct: 209 FGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 9/163 (5%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRL 125
E +++ ++H N+++ + L V+EY G L + L
Sbjct: 55 EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 126 NIMIDVASALEYLH--FGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
+M + AL+ H V+H DLKP NV LD L DF +A++L + S
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFA 173
Query: 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+T + T ++PE + + D++S G +L E P
Sbjct: 174 KTF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 3e-18
Identities = 30/285 (10%), Positives = 67/285 (23%), Gaps = 58/285 (20%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLI---------------------KV 86
+ A+KVF + + + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 87 ISTCSNEEFKA-----LVLEYM-----PHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 136
++ A L++ S ++Y I + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 137 YLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAP 196
L S ++H P N+ + + L D S + T+ + AP
Sbjct: 209 NLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------TRGPASSVPVTYAP 259
Query: 197 EYRRKGRESTNG---DVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253
+T + + G+ + + P F + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F--------GLVTPGIKGSWKRP 307
Query: 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVA 298
+ + + F + FV L +R+ E +
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 38/180 (21%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
+ A K+ L + ++E + +S+ H++++ + +F +VLE
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
SL + + + R + + +YLH +VIH DLK N+ L++++
Sbjct: 123 CRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDL 178
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYSFGIML 217
+ DF +A + + + C IAPE K S DV+S G ++
Sbjct: 179 EVKIGDFGLATKV------EYDGERKKVL-CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 33/157 (21%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMI 129
E ++ +++H N+++ + +V++Y G L K + + Q L+ +
Sbjct: 73 EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA 189
+ AL+++H +++H D+K N+ L + L DF IA++L + +
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACI-G 187
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
T ++PE + D+++ G +L E T K
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 44/220 (20%), Positives = 81/220 (36%), Gaps = 44/220 (20%)
Query: 51 EVAVKVFN---LQCGRAFKSFNI--------------ECEMMKSIRHRNLIKVISTCSNE 93
A+K + L+ R F N E +++ I++ + +N
Sbjct: 56 FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115
Query: 94 EFKALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQV 146
+ ++ EYM + S+ K+ + C + I I+ V ++ Y+H +
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNI 173
Query: 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRK 201
H D+KP N+L+D N LSDF ++ + + + + + PE+
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGS----RGTYEFMPPEF-FS 223
Query: 202 GRESTNG---DVYSFGIMLMETFTRKKPTDEIFNREMTLK 238
S NG D++S GI L F P +
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 11/181 (6%)
Query: 52 VAVK---VFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K +F+L +A E +++K + H N+IK ++ + +VLE G L
Sbjct: 60 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 109 EKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
+ + + + + SALE++H S +V+H D+KP NV + V
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
L D + + + + + + T ++PE + + D++S G +L E +
Sbjct: 177 LGDLGLGRFFSSK-TTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 226 P 226
P
Sbjct: 235 P 235
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 41/180 (22%), Positives = 80/180 (44%), Gaps = 18/180 (10%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
I + +EVA+K+ + + + E ++ ++H +++++ + + + LVLE
Sbjct: 33 IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+G + +YL + + + M + + + YLH S ++H DL N+LL NM
Sbjct: 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNM 149
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYSFGIML 217
++DF +A L + T+ C I+PE + DV+S G M
Sbjct: 150 NIKIADFGLATQL------KMPHEKHYTL-CGTPNYISPEIATRSAHGLESDVWSLGCMF 202
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 13/178 (7%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
S +A+KV L+ E E+ +RH N++++ + L+LEY
Sbjct: 31 KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
P G++ + L + + + ++A+AL Y H S +VIH D+KP N+LL
Sbjct: 91 APLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVIHRDIKPENLLLGSAG 146
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTL-ATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
++DF + + L T+ + PE D++S G++ E
Sbjct: 147 ELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 42/233 (18%), Positives = 71/233 (30%), Gaps = 46/233 (19%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 133
K +H +++ L E SL+++ + L Q + D
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIG 192
AL +LH S ++H D+KP N+ L L DF + L + +
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPR 221
Query: 193 CIAPE-----YRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247
+APE Y DV+S G+ ++E + G W +
Sbjct: 222 YMAPELLQGSYGTA------ADVFSLGLTILEVACNMELPHG-----------GEGWQQL 264
Query: 248 --STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVA 298
+ LS E + P+ R A ++A
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVM-------------MLEPDPKLRATAEALLA 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 46/177 (25%), Positives = 89/177 (50%), Gaps = 13/177 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
S +VAVK+ +L+ + + E +M+ +H N++++ + E +++E++
Sbjct: 67 KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
G+L + S L+ Q + V AL YLH + VIH D+K ++LL +
Sbjct: 127 GALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVK 181
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLME 219
LSDF ++ + + + ++L +G +APE + +T D++S GIM++E
Sbjct: 182 LSDFGFCAQIS---KDVPKRKSL--VGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 39/195 (20%), Positives = 78/195 (40%), Gaps = 30/195 (15%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIK-------------VISTCSNEEFKA 97
A+K + E ++ S+ H+ +++ ++ +
Sbjct: 33 YYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
+ +EY +G+L ++S N + + + AL Y+H S +IH DLKP+N+
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIF 148
Query: 158 LDDNMVAHLSDFSIAKLLT-------GEYQSMTQTQTLATIGC-----IAPE-YRRKGRE 204
+D++ + DF +AK + + Q++ + T +A E G
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 205 STNGDVYSFGIMLME 219
+ D+YS GI+ E
Sbjct: 209 NEKIDMYSLGIIFFE 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 13/177 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+++ EVA++ NLQ + E +M+ ++ N++ + + + +V+EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
GSL + + +D Q + + ALE+LH S QVIH D+K N+LL +
Sbjct: 102 GSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLME 219
L+DF +T ++ T+ +G +APE + D++S GIM +E
Sbjct: 157 LTDFGFCAQIT---PEQSKRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 30/196 (15%), Positives = 69/196 (35%), Gaps = 27/196 (13%)
Query: 49 AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM-PHGS 107
+ + + N + + F +++K + + +I+V + + Y +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 108 LEKYL------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
L+ + S++ L RL + + V L LH ++H L+P++++LD
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 242
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEY-----------RRKGRESTNGDV 210
L+ F S + G PE R+ + + D
Sbjct: 243 GGVFLTGFEHLVRDGARVVSSV------SRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 211 YSFGIMLMETFTRKKP 226
++ G+++ + P
Sbjct: 297 WALGLVIYWIWCADLP 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-17
Identities = 39/242 (16%), Positives = 89/242 (36%), Gaps = 18/242 (7%)
Query: 3 QHSNILAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVK---VFNL 59
+ N + + R+V ++ I+ +F + P ++ + L
Sbjct: 40 RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99
Query: 60 QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI- 118
+ +++ M +N + + S + + + ++ +L+ ++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 119 -LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177
+ L+I I +A A+E+LH S ++H DLKP N+ + V + DF + +
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 178 EYQ-----SMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
+ + + T ++PE S D++S G++L E
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 228 DE 229
E
Sbjct: 277 ME 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ VA+K ++ + E +M+ +++K + +V+EY
Sbjct: 51 KETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
GS+ + N L + I+ LEYLH + IH D+K N+LL+ A
Sbjct: 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAK 165
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLME 219
L+DF +A LT +M + T+ IG +APE ++ + D++S GI +E
Sbjct: 166 LADFGVAGQLT---DTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 32/187 (17%), Positives = 66/187 (35%), Gaps = 19/187 (10%)
Query: 46 ISSAMEVAVKVFNL--QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
+ V V+ NL E + K H N++ +T + +V +M
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 104 PHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+GS + + ++ I+ V AL+Y+H +H +K ++L+ +
Sbjct: 109 AYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDG 165
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI--------APEYRRKGRESTNG--DVYS 212
+LS + + + + +PE ++ + + D+YS
Sbjct: 166 KVYLSGLRSNLSMI---SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 213 FGIMLME 219
GI E
Sbjct: 223 VGITACE 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 33/188 (17%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
+ +A+KV L+ E E+ +RH N++++ + + + L+LE+
Sbjct: 36 KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95
Query: 103 MPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYSAQVIHCDLKPINV 156
P G L K L R + M ++A AL Y H +VIH D+KP N+
Sbjct: 96 APRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENL 145
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVY 211
L+ ++DF + + +T+ C + PE D++
Sbjct: 146 LMGYKGELKIADFGWSVHAPSL-----RRRTM----CGTLDYLPPEMIEGKTHDEKVDLW 196
Query: 212 SFGIMLME 219
G++ E
Sbjct: 197 CAGVLCYE 204
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 39/182 (21%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ A KV + + + +E E++ + H ++K++ ++ +++E+ P
Sbjct: 41 KETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
G+++ + + L Q + + AL +LH S ++IH DLK NVL+
Sbjct: 101 GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIR 157
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG-----DVYSFGIML 217
L+DF ++ +++ + + IG +APE D++S GI L
Sbjct: 158 LADFGVSAKNL---KTLQKRDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 218 ME 219
+E
Sbjct: 213 IE 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 33/193 (17%), Positives = 73/193 (37%), Gaps = 28/193 (14%)
Query: 52 VAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA------------L 98
A+K L A + E + + + H +++ + + +
Sbjct: 33 YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 99 VLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
++ +L+ ++ + + L+I + +A A+E+LH S ++H DLKP N+
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNI 149
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC----------IAPEYRRKGREST 206
+ V + DF + + + + T + ++PE S
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 207 NGDVYSFGIMLME 219
D++S G++L E
Sbjct: 210 KVDIFSLGLILFE 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 15/186 (8%)
Query: 46 ISSAMEVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+VA+K NL +C + E + M H N++ ++ ++ LV++ +
Sbjct: 37 APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96
Query: 105 HGSL-------EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
GS+ + +LD I+ +V LEYLH IH D+K N+L
Sbjct: 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNIL 153
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIG--C-IAPEYRRKGRE-STNGDVYSF 213
L ++ ++DF ++ L +G C +APE + R D++SF
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 214 GIMLME 219
GI +E
Sbjct: 214 GITAIE 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 46 ISSAMEVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ VA+K+ +L + + E ++ + K + + +++EY+
Sbjct: 44 NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
GS L LD Q I+ ++ L+YLH S + IH D+K NVLL ++
Sbjct: 104 GGSALDLL--EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEV 158
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLMETF 221
L+DF +A LT + + T +G +APE ++ + D++S GI +E
Sbjct: 159 KLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213
Query: 222 TRKKP 226
+ P
Sbjct: 214 RGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 56/280 (20%), Positives = 96/280 (34%), Gaps = 49/280 (17%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCS-------NEEFKALVLEY 102
E A+K ++ E MK + H N+++ S S + + L+L
Sbjct: 55 EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114
Query: 103 MPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
+ G L ++L S L L I A++++H +IH DLK N+LL +
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSN 173
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIG-----CIAPEYR--------RKGRESTN 207
L DF A ++ Q A + P YR
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 208 GDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267
D+++ G +L R+ P F L+ +V+
Sbjct: 234 QDIWALGCILYLLCFRQHP----FEDGAKLR-------------IVNGKYSIPPHDTQ-- 274
Query: 268 KEQCVSFVF-NLAIECTVESPEQRINAREIVAKLFKIRDS 306
VF +L +PE+R++ E+V +L +I +
Sbjct: 275 -----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 23/181 (12%)
Query: 51 EVAVKVFN----LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--LVLEYMP 104
AVK+ + + E ++++ +RH+N+I+++ NEE + +V+EY
Sbjct: 32 RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV 91
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
G E + Q + LEYLH S ++H D+KP N+LL
Sbjct: 92 CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTL 148
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNG---DVYSFGIM 216
+S +A+ T T PE G ++ +G D++S G+
Sbjct: 149 KISALGVAEA----LHPFAADDTCRT-SQGSPAFQPPEIAN-GLDTFSGFKVDIWSAGVT 202
Query: 217 L 217
L
Sbjct: 203 L 203
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 69 NIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
E ++M + H +K+ T ++E L Y +G L KY+ + R
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188
++ SALEYLH +IH DLKP N+LL+++M ++DF AK+L+ E + +
Sbjct: 138 -EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSF 192
Query: 189 -ATIGCIAPEYRRKGRESTNGDVYSFGIMLME 219
T ++PE + + D+++ G ++ +
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 37/179 (20%), Positives = 76/179 (42%), Gaps = 14/179 (7%)
Query: 52 VAVKVFNLQCGRA-FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+A K+ +L+ A E +++ ++ ++ ++ +E+M GSL++
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ + + I V L YL +++H D+KP N+L++ L DF
Sbjct: 121 -VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 171 IAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
++ L SM + +G ++PE + S D++S G+ L+E + P
Sbjct: 178 VSGQLI---DSMANS----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 36/183 (19%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEM--MKSIRHRNLIK---VISTCSNEEFKALVLEYMPH 105
EVA+K+ + + E+ MK + H N++K VI T + L++EY
Sbjct: 42 EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLY--LIMEYASG 98
Query: 106 GSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
G + YL + + + F+++ SA++Y H +++H DLK N+LLD
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH---QKRIVHRDLKAENLLLDA 149
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSFG 214
+M ++DF G T L C APE ++ K + DV+S G
Sbjct: 150 DMNIKIADF-------GFSNEFTVGGKLDAF-CGAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 215 IML 217
++L
Sbjct: 202 VIL 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 31/187 (16%)
Query: 46 ISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
+ + E A + N + R + E + + ++H N++++ + S E L+ + +
Sbjct: 33 VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92
Query: 104 PHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
G L + YS S+CI I A+ + H V+H +LKP
Sbjct: 93 TGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH---QMGVVHRNLKPE 139
Query: 155 NVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDV 210
N+LL L+DF +A + GE Q+ A T G ++PE RK D+
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKPVDL 196
Query: 211 YSFGIML 217
++ G++L
Sbjct: 197 WACGVIL 203
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 32/182 (17%)
Query: 51 EVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMPHG 106
VAVK+ ++ + ++ E + K + H N++K N ++ L LEY G
Sbjct: 34 AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY--LFLEYCSGG 90
Query: 107 SLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
L + + F +L + + YLH + H D+KP N+LLD+
Sbjct: 91 ELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH---GIGITHRDIKPENLLLDER 141
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSFGI 215
+SDF +A + ++ + + L + C +APE +R+ + DV+S GI
Sbjct: 142 DNLKISDFGLATV----FRYNNRERLLNKM-CGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 216 ML 217
+L
Sbjct: 197 VL 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 42/198 (21%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMP 104
+ ++ E AVK+ Q G E EM+ + HRN++++I E+ LV E M
Sbjct: 35 LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 105 HGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGYSAQVIHCDLK 152
GS+ + ++ DVASAL++LH + + H DLK
Sbjct: 95 GGSI-------------LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLK 138
Query: 153 PINVLL---DDNMVAHLSDFSIAKLLT-GEYQSMTQTQTLATI----GCIAPEYRRKGRE 204
P N+L + + DF + + S T L T +APE E
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 205 STNG-----DVYSFGIML 217
+ D++S G++L
Sbjct: 199 EASIYDKRCDLWSLGVIL 216
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-14
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 31/185 (16%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ A+K S E ++K I+H N++ + + LV++ +
Sbjct: 31 RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSG 90
Query: 106 GSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
G L E+ +Y+ S I + SA++YLH ++H DLKP N+
Sbjct: 91 GELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH---ENGIVHRDLKPENL 137
Query: 157 LL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYS 212
L ++N ++DF ++K+ T T G +APE + S D +S
Sbjct: 138 LYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWS 192
Query: 213 FGIML 217
G++
Sbjct: 193 IGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 41/196 (20%), Positives = 76/196 (38%), Gaps = 42/196 (21%)
Query: 46 ISSAMEVAVKV-----FNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
+ + AVK+ F G + + E + ++H ++++++ T S++ +V
Sbjct: 46 RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 101 EYMPHGSL---------EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVI 147
E+M L ++YS S+ + I AL Y H +I
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------EALRYCH---DNNII 152
Query: 148 HCDLKPINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRK 201
H D+KP VLL +++ L F +A L +G +APE ++
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-----RVGTPHFMAPEVVKR 207
Query: 202 GRESTNGDVYSFGIML 217
DV+ G++L
Sbjct: 208 EPYGKPVDVWGCGVIL 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 36/184 (19%)
Query: 51 EVAVKVFNLQCGRAFKSF-NI--ECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMP 104
VAVK+ +++ RA NI E + K + H N++K N ++ L LEY
Sbjct: 34 AVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY--LFLEYCS 88
Query: 105 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
G L + + F +L + + YLH + H D+KP N+LLD
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH---GIGITHRDIKPENLLLD 139
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSF 213
+ +SDF +A + ++ + + L + C +APE +R+ + DV+S
Sbjct: 140 ERDNLKISDFGLATV----FRYNNRERLLNKM-CGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 214 GIML 217
GI+L
Sbjct: 195 GIVL 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-14
Identities = 25/182 (13%), Positives = 49/182 (26%), Gaps = 38/182 (20%)
Query: 51 EVAVKVFNLQCGRA--FKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+VA+ + Q + I + +V+ +V E++ GS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L++ +S + M +A+A + H A V P V + + L+
Sbjct: 118 LQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA 171
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
+ + D+ G L + P
Sbjct: 172 YPATM----------------------PDA----NPQD---DIRGIGASLYALLVNRWPL 202
Query: 228 DE 229
E
Sbjct: 203 PE 204
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-14
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 37/184 (20%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMP 104
+VAVK+ N ++ E + +K RH ++IK VIST + F +V+EY+
Sbjct: 38 KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFF--MVMEYVS 94
Query: 105 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
G L Y+ + +FQ++ SA++Y H V+H DLKP NVLLD
Sbjct: 95 GGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH---RHMVVHRDLKPENVLLD 145
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSF 213
+M A ++DF ++ + M+ + L T C APE + D++S
Sbjct: 146 AHMNAKIADFGLSNM-------MSDGEFLRTS-CGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 214 GIML 217
G++L
Sbjct: 198 GVIL 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 39/222 (17%), Positives = 79/222 (35%), Gaps = 64/222 (28%)
Query: 65 FKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV-LEYMPHGSLEKYL---------- 112
++ E +++ I H N++ ++ C+ +V +E+ G+L YL
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 113 ------------YSSNCILDIFQRLNIMI------------------------------D 130
Y +D+ +RL+ + D
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
Query: 131 VASALEYLHFGY----------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180
+ + + + S + IH DL N+LL + V + DF +A+ + +
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ + + +APE + DV+SFG++L E F+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 45/197 (22%), Positives = 81/197 (41%), Gaps = 41/197 (20%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNI---------ECEMMKSI-RHRNLIKVISTCSNEEF 95
+ E AVK+ ++ G +F + + E ++++ + H N+I++ T F
Sbjct: 39 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98
Query: 96 KALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQV 146
LV + M G L EK S + + + LH +
Sbjct: 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL----------EVICALH---KLNI 145
Query: 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRES 205
+H DLKP N+LLDD+M L+DF + L + + + T +APE ++
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKL--REVCGTPSYLAPEIIECSMNDN 202
Query: 206 TNG-----DVYSFGIML 217
G D++S G+++
Sbjct: 203 HPGYGKEVDMWSTGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 32/162 (19%)
Query: 71 ECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMPHGSLEKYL----YSSNCILDIFQ 123
E ++K + H N++K V+ + + +V E + G + + S + FQ
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183
D+ +EYLH ++IH D+KP N+L+ ++ ++DF ++ G ++
Sbjct: 145 ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-DALL 194
Query: 184 QTQTLATIGC-----IAPEYRRKGRESTNG---DVYSFGIML 217
+APE + R+ +G DV++ G+ L
Sbjct: 195 SNT------VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 30/186 (16%)
Query: 46 ISSAMEVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
++ +E A K+ N R F+ E + + ++H N++++ + E F LV + +
Sbjct: 51 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 110
Query: 104 PHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
G L + YS S+CI I ++ Y H S ++H +LKP
Sbjct: 111 TGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPE 157
Query: 155 NVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
N+LL L+DF +A + + ++ T G ++PE +K S D++
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 212 SFGIML 217
+ G++L
Sbjct: 215 ACGVIL 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H+N++++ +++ LV E+ L+KY S N LD + +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ L + H S V+H DLKP N+L++ N L++F +A+ + + + T
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVT 164
Query: 191 IGCIAPE-------YRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+ P+ Y ST+ D++S G + E +P
Sbjct: 165 LWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 37/188 (19%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYMP 104
S AVK+ + R + E +K H N++K+ ++ LV+E +
Sbjct: 33 KKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 105 HGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGYSAQVIHCDLK 152
G L F+R+ IM + SA+ ++H V+H DLK
Sbjct: 90 GGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLK 133
Query: 153 PINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGD 209
P N+L +DN+ + DF A+L + Q + T+ APE + + D
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDESCD 191
Query: 210 VYSFGIML 217
++S G++L
Sbjct: 192 LWSLGVIL 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 30/185 (16%)
Query: 52 VAVKVFNLQCGRAFKSFNIECE---MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+AVK + + + +M+S +++ E + +E M S
Sbjct: 50 MAVKRIRSTVDEKEQK-QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSF 107
Query: 109 EKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+K+ + + I + AL +L ++IH D+KP N+LLD +
Sbjct: 108 DKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSG 163
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG-----DVYSFG 214
L DF I+ L S+ +T+ GC +APE R S G DV+S G
Sbjct: 164 NIKLCDFGISGQLV---DSIAKTR---DAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLG 216
Query: 215 IMLME 219
I L E
Sbjct: 217 ITLYE 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 37/184 (20%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMP 104
+VAVK+ N ++ E + +K RH ++IK VIST ++ F +V+EY+
Sbjct: 43 KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIF--MVMEYVS 99
Query: 105 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
G L Y+ + + +FQ++ S ++Y H V+H DLKP NVLLD
Sbjct: 100 GGELFDYICKNGRLDEKESRRLFQQI------LSGVDYCH---RHMVVHRDLKPENVLLD 150
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSF 213
+M A ++DF ++ + M+ + L T C APE + D++S
Sbjct: 151 AHMNAKIADFGLSNM-------MSDGEFLRTS-CGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 214 GIML 217
G++L
Sbjct: 203 GVIL 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 45/183 (24%), Positives = 71/183 (38%), Gaps = 22/183 (12%)
Query: 46 ISSAMEVAVKVFNLQCGRA---FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
+ ++ VA+K + ++ ++ E ++ +RH N I+ E LV+EY
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
GS L L + + L YLH S +IH D+K N+LL +
Sbjct: 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPG 191
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG---DVYSFGIM 216
+ L DF A M + +G +APE E DV+S GI
Sbjct: 192 LVKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242
Query: 217 LME 219
+E
Sbjct: 243 CIE 245
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 38/155 (24%), Positives = 61/155 (39%), Gaps = 19/155 (12%)
Query: 74 MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCIL-DIFQRLNIMIDVA 132
++KS +++ T + +E M + + I I + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIV 134
Query: 133 SALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIG 192
AL YL + VIH D+KP N+LLD+ L DF I+ L + + + G
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDR---SAG 186
Query: 193 C--------IAPEYRRKGRESTNGDVYSFGIMLME 219
C I P K DV+S GI L+E
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 49/185 (26%), Positives = 72/185 (38%), Gaps = 41/185 (22%)
Query: 51 EVAVKVFNLQCGRAFKSFNI--ECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMPH 105
VAVK A N+ E +S+RH N+++ VI T A+++EY
Sbjct: 47 LVAVKYIERG---AAIDENVQREIINHRSLRHPNIVRFKEVILT---PTHLAIIMEYASG 100
Query: 106 GSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
G L + + ++ FQ+L S + Y H S Q+ H DLK N LLD
Sbjct: 101 GELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---SMQICHRDLKLENTLLDG 151
Query: 161 NMVAHL--SDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYS 212
+ L DF +K + IAPE R+ + DV+S
Sbjct: 152 SPAPRLKICDFGYSKS-------SVLHSQPKST-VGTPAYIAPEVLLRQEYDGKIADVWS 203
Query: 213 FGIML 217
G+ L
Sbjct: 204 CGVTL 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-13
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 30/186 (16%)
Query: 46 ISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
++ +E A K+ N + R F+ E + + ++H N++++ + E F LV + +
Sbjct: 28 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87
Query: 104 PHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
G L + YS S+CI I ++ Y H S ++H +LKP
Sbjct: 88 TGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPE 134
Query: 155 NVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
N+LL L+DF +A + + ++ T G ++PE +K S D++
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIW 191
Query: 212 SFGIML 217
+ G++L
Sbjct: 192 ACGVIL 197
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-13
Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 4/114 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++++ + H N+I ++ ++ +LV ++M LE + ++ +L M+
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
LEYLH ++H DLKP N+LLD+N V L+DF +AK ++ T
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 45/160 (28%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++M+ + H L+ + + +EE +V++ + G L +L + + +L I +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-E 123
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA- 189
+ AL+YL + ++IH D+KP N+LLD++ H++DF+IA +L E TQ T+A
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 190 TIGCIAPE-YRRKGRESTNGDV--YSFGIMLMETFTRKKP 226
T +APE + + + V +S G+ E ++P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-13
Identities = 36/134 (26%), Positives = 57/134 (42%), Gaps = 6/134 (4%)
Query: 52 VAVKVFNL-QCGRAFKSFNI-ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K F + K + E M+K ++H NL+ ++ + LV EY H ++
Sbjct: 31 VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVL 89
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L + +I A+ + H IH D+KP N+L+ + V L DF
Sbjct: 90 HELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDF 146
Query: 170 SIAKLLTGEYQSMT 183
A+LLTG
Sbjct: 147 GFARLLTGPSDYYD 160
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 28/184 (15%)
Query: 47 SSAMEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
+ E AVKV + ++ +S E +++K + H N++K+ ++ + LV E
Sbjct: 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 104 PHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
G L + +S I ++ V S + Y+H +++H DLKP N+LL
Sbjct: 109 TGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---KNKIVHRDLKPENLLL 159
Query: 159 ---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSF 213
+ + DF ++ S + T IAPE + DV+S
Sbjct: 160 ESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLHGTYDEKC---DVWST 213
Query: 214 GIML 217
G++L
Sbjct: 214 GVIL 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNI-----ECEMMKSIRHRNLIKVISTCSNEEFKA 97
+ +VA+++ + G A ++ E E++K + H +IK+ + E++
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-Y 215
Query: 98 LVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
+VLE M G L F + A++YLH +IH DLK
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLK 266
Query: 153 PINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPE------YRRKG 202
P NVLL +++ + ++DF +K+L GE M TL T +APE
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGTPTYLAPEVLVSVGTAGYN 322
Query: 203 RESTNGDVYSFGIML 217
R D +S G++L
Sbjct: 323 RAV---DCWSLGVIL 334
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K + H N++ +I +E LV E+M L+K L + L Q +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT 190
+ + + H +++H DLKP N+L++ + L+DF +A+ +S T + T
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 191 IGCIAPE-------YRRKGRESTNGDVYSFGIMLMETFTRK 224
+ AP+ Y ST+ D++S G + E T K
Sbjct: 183 LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 39/189 (20%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
++ ME AVK+ + + I +++ +H N+I + + ++ +V E M
Sbjct: 44 KATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 106 GSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGYSAQVIHCDLKP 153
G L ++ ++ + +EYLH + V+H DLKP
Sbjct: 101 GEL-------------LDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 154 INVLL----DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNG 208
N+L + + DF AK L E + T T +APE +
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAAC 201
Query: 209 DVYSFGIML 217
D++S G++L
Sbjct: 202 DIWSLGVLL 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 38/136 (27%), Positives = 61/136 (44%), Gaps = 27/136 (19%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYSAQVIHCDL 151
+ +E M SL+K+ ++D Q + I + + ALE+LH VIH D+
Sbjct: 83 ICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDV 136
Query: 152 KPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG 208
KP NVL++ + DF I+ L + + GC +APE R + G
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYLV---DDVAKDI---DAGCKPYMAPE-RINPELNQKG 189
Query: 209 -----DVYSFGIMLME 219
D++S GI ++E
Sbjct: 190 YSVKSDIWSLGITMIE 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 46 ISSAMEVAVKVFN---LQCGRAFKSFNI-----ECEMMKSIRHRNLIKVISTCSNEEFKA 97
+ +VA+K+ + G A ++ E E++K + H +IK+ + E++
Sbjct: 32 RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-Y 90
Query: 98 LVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
+VLE M G L F + A++YLH +IH DLK
Sbjct: 91 IVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLK 141
Query: 153 PINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPE------YRRKG 202
P NVLL +++ + ++DF +K+L GE M TL T +APE
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGTPTYLAPEVLVSVGTAGYN 197
Query: 203 RESTNGDVYSFGIML 217
R D +S G++L
Sbjct: 198 RAV---DCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 37/181 (20%), Positives = 70/181 (38%), Gaps = 22/181 (12%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
++ K N + E +M + H LI + ++ L+LE++
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 106 GSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
G L E Y S + I N M L+++H ++H D+KP N++
Sbjct: 133 GELFDRIAAEDYKMSEAEVI-------NYMRQACEGLKHMH---EHSIVHLDIKPENIMC 182
Query: 159 DDNMVAHL--SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
+ + + DF +A L + + + T AT APE + D+++ G++
Sbjct: 183 ETKKASSVKIIDFGLATKLNPD-EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 217 L 217
Sbjct: 240 G 240
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 47 SSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ +E A+K+ + E ++K + H N++K+ ++ LV+E
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 105 HGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL- 158
G L + ++ I+ V S + YLH ++H DLKP N+LL
Sbjct: 120 GGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLE 170
Query: 159 --DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFG 214
+ + + + DF ++ + + L T IAPE RK + DV+S G
Sbjct: 171 SKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYIAPEVLRKKYDEKC---DVWSIG 224
Query: 215 IMLMETFTRKKP-----TDEIFNR 233
++L P EI +
Sbjct: 225 VILFILLAGYPPFGGQTDQEILRK 248
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 6/135 (4%)
Query: 52 VAVKVFNL-QCGRAFKSFNI-ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K F + K + E +++K +RH NL+ ++ C ++ LV E++ H ++
Sbjct: 53 VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TIL 111
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
L LD + + + + + H S +IH D+KP N+L+ + V L DF
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDF 168
Query: 170 SIAKLLTGEYQSMTQ 184
A+ L +
Sbjct: 169 GFARTLAAPGEVYDD 183
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 28/114 (24%), Positives = 56/114 (49%), Gaps = 4/114 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N++ + E+ LV EY+ L++YL I+++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ L Y H +V+H DLKP N+L+++ L+DF +A+ + ++
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 13/160 (8%)
Query: 71 ECEMMKSIRHRNLIK---VISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 125
E ++ H N++ + LV E M L + ++ ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQ 137
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185
M + L LH A V+H DL P N+LL DN + DF++A+ + +T
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKT 191
Query: 186 QTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRK 224
+ APE + + T D++S G ++ E F RK
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-12
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 33/186 (17%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
+ + A K F E E+MKS+ H N+I++ T + LV+E
Sbjct: 31 KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 106 GSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL-- 158
G L K ++ + I + DV SA+ Y H V H DLKP N L
Sbjct: 91 GELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNVAHRDLKPENFLFLT 141
Query: 159 -DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATI----GCIAPEYRRK--GRESTNGDVY 211
+ L DF +A + + T ++P+ G E D +
Sbjct: 142 DSPDSPLKLIDFGLAAR-------FKPGKMMRTKVGTPYYVSPQVLEGLYGPEC---DEW 191
Query: 212 SFGIML 217
S G+M+
Sbjct: 192 SAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 27/183 (14%)
Query: 47 SSAMEVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ E AVKV N + + E E++K + H N++K+ + +V E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 105 HGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL- 158
G L ++ +S + I+ V S + Y+H ++H DLKP N+LL
Sbjct: 105 GGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLE 155
Query: 159 --DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFG 214
+ + + DF ++ + M + T IAPE R + DV+S G
Sbjct: 156 SKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAPEVLRGTYDEKC---DVWSAG 209
Query: 215 IML 217
++L
Sbjct: 210 VIL 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-12
Identities = 26/114 (22%), Positives = 55/114 (48%), Gaps = 4/114 (3%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++H N++K+ ++ LV E++ L+K L L+ + ++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ + + Y H +V+H DLKP N+L++ ++DF +A+ + T
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 32/188 (17%)
Query: 52 VAVK----VFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKV----ISTCSNEEFKA--LV 99
VA+K F Q RA++ E +MK + H+N+I + S EEF+ +V
Sbjct: 53 VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 100 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
+E M ++ L ++Q L +++LH SA +IH DLKP N+
Sbjct: 109 MELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNI 158
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
++ + + DF +A+ G M T + T APE N D++S G +
Sbjct: 159 VVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 217 LMETFTRK 224
+ E
Sbjct: 216 MGEMIKGG 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 30/160 (18%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 121
E ++ + H N+IK+ +LVLE + G L EK YS ++ + I
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 122 FQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLTGE 178
A+ YLH ++H DLKP N+L + ++DF ++K++
Sbjct: 158 L----------EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EH 203
Query: 179 YQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIML 217
M T+ T G APE R D++S GI+
Sbjct: 204 QVLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 25/184 (13%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIK------VISTCSNEEFKALVLEYMP 104
A+KV ++ G + E M+K HRN+ + ++ LV+E+
Sbjct: 52 AAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 105 HGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
GS+ + + L I ++ L +LH +VIH D+K NVLL +N
Sbjct: 111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGC---IAPEYRRKGRESTNG-----DVYSFGI 215
L DF ++ L +++ + T IG +APE D++S GI
Sbjct: 168 VKLVDFGVSAQLD---RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 216 MLME 219
+E
Sbjct: 223 TAIE 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 56/204 (27%)
Query: 46 ISSAMEVAVKVFNL--------QCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFK 96
++ E AVK+ + Q ++ E +++ + H ++I +I + + F
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGYSA 144
LV + M G L F L +IM + A+ +LH +
Sbjct: 176 FLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---AN 219
Query: 145 QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-Y 198
++H DLKP N+LLDDNM LSDF + + + L + C +APE
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCH-------LEPGEKLREL-CGTPGYLAPEIL 271
Query: 199 RRKGRESTNG-----DVYSFGIML 217
+ E+ G D+++ G++L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 38/184 (20%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKALVLEYMP 104
+VA+K + L+ E +K +RH ++IK VI+T + +V+EY
Sbjct: 36 KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIV--MVIEYA- 91
Query: 105 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
G L Y+ + FQ++ A+EY H +++H DLKP N+LLD
Sbjct: 92 GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIEYCH---RHKIVHRDLKPENLLLD 142
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPE-YRRKGRESTNGDVYSF 213
DN+ ++DF ++ + MT L T C APE K DV+S
Sbjct: 143 DNLNVKIADFGLSNI-------MTDGNFLKTS-CGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 214 GIML 217
GI+L
Sbjct: 195 GIVL 198
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 37/254 (14%), Positives = 85/254 (33%), Gaps = 64/254 (25%)
Query: 71 ECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLN 126
E + +H ++++ S + ++ + EY GSL + + I+ F + +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186
+++ V L Y+H S ++H D+KP N+ + + + + + + M +
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK-- 174
Query: 187 TLATIGCI----------------APE-------YRRKGRESTNGDVYSFGIMLMETFTR 223
+ +G + A E + K D+++ + ++
Sbjct: 175 -IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPK------ADIFALALTVVCAAGA 227
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAIEC 282
+ G+ W I + +LSQE +
Sbjct: 228 EPLPRN-----------GDQWHEIRQGRLPRIPQVLSQEFTELLKV-------------M 263
Query: 283 TVESPEQRINAREI 296
PE+R +A +
Sbjct: 264 IHPDPERRPSAMAL 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 27/183 (14%)
Query: 47 SSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ E AVKV N + + E E++K + H N++K+ + +V E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 105 HGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL- 158
G L ++ +S + I+ V S + Y+H ++H DLKP N+LL
Sbjct: 105 GGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLE 155
Query: 159 --DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRK-GRESTNGDVYSFG 214
+ + + DF ++ + M + T IAPE R + DV+S G
Sbjct: 156 SKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAPEVLRGTYDEKC---DVWSAG 209
Query: 215 IML 217
++L
Sbjct: 210 VIL 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 37/181 (20%), Positives = 63/181 (34%), Gaps = 22/181 (12%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
++ A K ++ E + M +RH L+ + ++ ++ E+M
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 106 GSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
G L E S + M V L ++H +H DLKP N++
Sbjct: 239 GELFEKVADEHNKMSEDEAV-------EYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288
Query: 159 DDNMVAHL--SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
L DF + L + QS+ T T APE D++S G++
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPK-QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 217 L 217
Sbjct: 346 S 346
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 42/188 (22%), Positives = 71/188 (37%), Gaps = 39/188 (20%)
Query: 51 EVAVKVFN--------LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102
EV VK +E ++ + H N+IKV+ N+ F LV+E
Sbjct: 51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110
Query: 103 MPHGSLEKYLY-SSNCILD------IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
G L+ + + + LD IF++L SA+ YL +IH D+K N
Sbjct: 111 HGSG-LDLFAFIDRHPRLDEPLASYIFRQL------VSAVGYLR---LKDIIHRDIKDEN 160
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEY------RRKGRESTNGD 209
+++ ++ L DF A + + + T C EY +
Sbjct: 161 IVIAEDFTIKLIDFGSAAY-------LERGKLFYTF-CGTIEYCAPEVLMGNPYRGPELE 212
Query: 210 VYSFGIML 217
++S G+ L
Sbjct: 213 MWSLGVTL 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 19/171 (11%)
Query: 73 EMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 132
++ + ++ + + + +L+ M G L +L + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302
Query: 133 SALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TI 191
LE++H + V++ DLKP N+LLD++ +SD +A + + + T
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTH 354
Query: 192 GCIAPE-YRRKGRESTNGDVYSFGIMLMETFT--------RKKPTDEIFNR 233
G +APE ++ ++ D +S G ML + + K EI
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 25/157 (15%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 125
E ++KS+ H N+IK+ ++++ LV E+ G L ++ + +I ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ- 154
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLTGEYQSM 182
+ S + YLH ++H D+KP N+LL + + + DF ++ + +
Sbjct: 155 -----ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYKL 205
Query: 183 TQTQTLATIGCIAPE-YRRK-GRESTNGDVYSFGIML 217
L T IAPE ++K + DV+S G+++
Sbjct: 206 --RDRLGTAYYIAPEVLKKKYNEKC---DVWSCGVIM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 37/180 (20%), Positives = 74/180 (41%), Gaps = 22/180 (12%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
++ +++A K+ + + + E +M + H NLI++ ++ LV+EY+ G
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 107 SL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
L E Y + + I M + + ++H ++H DLKP N+L
Sbjct: 172 ELFDRIIDESYNLTELDTI-------LFMKQICEGIRHMH---QMYILHLDLKPENILCV 221
Query: 160 DNMVAHL--SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIML 217
+ + DF +A+ + + T +APE S D++S G++
Sbjct: 222 NRDAKQIKIIDFGLARRYKPR-EKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 6e-11
Identities = 28/115 (24%), Positives = 57/115 (49%), Gaps = 5/115 (4%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMI 129
E ++K + H N++K++ E LV E++ L+K++ +S + + + +
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 130 DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ L + H S +V+H DLKP N+L++ L+DF +A+ ++ T
Sbjct: 111 QLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 31/167 (18%), Positives = 69/167 (41%), Gaps = 20/167 (11%)
Query: 52 VAVK----VFN--LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKA--LVL 100
VA+K VF + C R + E ++ + H +++K ++ E+F +VL
Sbjct: 81 VAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
E +K + + ++ + ++ ++ ++Y+H SA ++H DLKP N L++
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTN 207
+ + DF +A+ + +Q + +
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 32/188 (17%)
Query: 52 VAVK----VFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVI----STCSNEEFKA--LV 99
VA+K F RA++ E +MK + H+N+I ++ + EEF+ LV
Sbjct: 90 VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 100 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
+E M ++ L ++Q L +++LH SA +IH DLKP N+
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNI 195
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
++ + + DF +A+ G M T + T APE N D++S G +
Sbjct: 196 VVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 217 LMETFTRK 224
+ E K
Sbjct: 253 MGEMVRHK 260
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 46/222 (20%), Positives = 73/222 (32%), Gaps = 53/222 (23%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNI-----ECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
+ A+K+ N R ++ E +MK + H N+ ++ +E++ LV+
Sbjct: 48 NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRL----------------------------------- 125
E G L L +
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 126 ----NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL--SDFSIAKLLTG-- 177
NIM + SAL YLH + + H D+KP N L N + DF ++K
Sbjct: 168 KLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNG--DVYSFGIML 217
+ T T +APE ES D +S G++L
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 19/149 (12%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFGYSAQVIHCDLKPI 154
LV+ M G + ++Y+ + F R + S LE+LH +I+ DLKP
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSF 213
NVLLDD+ +SD +A L T+T+ A T G +APE + D ++
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 214 GIMLMETFT---------RKKPTDEIFNR 233
G+ L E K E+ R
Sbjct: 376 GVTLYEMIAARGPFRARGEKVENKELKQR 404
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 28/190 (14%)
Query: 48 SAMEVAVK----VFN--LQCGRAFKSFNIECEMMKSIRHRNLIKV----ISTCSNEEFKA 97
+ + VAVK F + R ++ E ++K ++H N+I + S EEF
Sbjct: 53 TGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFND 108
Query: 98 --LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
LV M L + D Q ++ + L+Y+H SA +IH DLKP N
Sbjct: 109 VYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH---SADIIHRDLKPSN 162
Query: 156 VLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFG 214
+ ++++ + DF +A+ E T +AT APE D++S G
Sbjct: 163 LAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 217
Query: 215 IMLMETFTRK 224
++ E T +
Sbjct: 218 CIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 35/189 (18%)
Query: 52 VAVK----VFNLQ--CGRAFKSFNIECEMMKSIRHRNLIK----VISTCSNEEFKA--LV 99
VA+K F + RA++ E ++K ++H N+I S F LV
Sbjct: 52 VAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 100 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
+ +M + ++Q L L+Y+H SA V+H DLKP N+
Sbjct: 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNL 157
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGI 215
++++ + DF +A+ E T + T APE D++S G
Sbjct: 158 AVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212
Query: 216 MLMETFTRK 224
++ E T K
Sbjct: 213 IMAEMLTGK 221
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 28/119 (23%), Positives = 53/119 (44%), Gaps = 9/119 (7%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRL 125
E +MK ++H N++++ E LV E+M + L+KY+ S L++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 126 NIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184
+ L + H +++H DLKP N+L++ L DF +A+ + +
Sbjct: 112 YFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 26/185 (14%)
Query: 46 ISSAMEVAVKVFN-LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
SS +E +K N + + E E++KS+ H N+IK+ + +V+E
Sbjct: 44 RSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103
Query: 105 HGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL--- 158
G L + + S+ +M + +AL Y H S V+H DLKP N+L
Sbjct: 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDT 160
Query: 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATI----GCIAPEYRRK--GRESTNGDVYS 212
+ + DF +A+L + +APE ++ + D++S
Sbjct: 161 SPHSPIKIIDFGLAEL-------FKSDEHSTNAAGTALYMAPEVFKRDVTFKC---DIWS 210
Query: 213 FGIML 217
G+++
Sbjct: 211 AGVVM 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 68 FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 127
F E ++M ++++ ++ + +V+EYMP G L + ++
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDV 165
Query: 128 MIDVA--------SALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179
A AL+ +H S IH D+KP N+LLD + L+DF + E
Sbjct: 166 PEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 180 QSMTQTQTLATIGCIAPE-YRRKGRESTNG---DVYSFGIMLME 219
T + T I+PE + +G + G D +S G+ L E
Sbjct: 223 MVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 38/179 (21%), Positives = 75/179 (41%), Gaps = 22/179 (12%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI- 129
E ++++ + R ++ + ++ LVL M G L+ ++Y + F +
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFY 291
Query: 130 --DVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
++ LE LH ++++ DLKP N+LLDD+ +SD +A +
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKG 344
Query: 188 LA-TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT---------RKKPTDEIFNREMT 236
T+G +APE + R + + D ++ G +L E +K +E+
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 20/136 (14%)
Query: 52 VAVK-VFNLQCGRAFKSFNIECEMMKSIRHRNLIK----VISTCSNEEFKAL--VLEYMP 104
VA+K V + FK N E ++M+ + H N+++ S+ ++ L VL+Y+P
Sbjct: 82 VAIKKVLQDKR---FK--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 136
Query: 105 ---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-D 160
+ Y + + I+ +L M + +L Y+H S + H D+KP N+LLD D
Sbjct: 137 ETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPD 192
Query: 161 NMVAHLSDFSIAKLLT 176
V L DF AK L
Sbjct: 193 TAVLKLCDFGSAKQLV 208
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 22/185 (11%)
Query: 52 VAVK---VFN--LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKA--LVLE 101
VA+K F C R + E +++ RH N+I +I + E+ K +V +
Sbjct: 55 VAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110
Query: 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
M L K L + + + + + L+Y+H SA V+H DLKP N+LL+
Sbjct: 111 LME-TDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQ-TQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLME 219
+ DF +A++ ++ T+ +AT APE + T D++S G +L E
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 220 TFTRK 224
+ +
Sbjct: 225 MLSNR 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 28/119 (23%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E ++K ++HRN+I++ S + L+ EY + L+KY+ N + + + +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQ 140
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH-----LSDFSIAKLLTGEYQSMTQ 184
+ + + + H S + +H DLKP N+LL + + + DF +A+ + T
Sbjct: 141 LINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 39/191 (20%), Positives = 77/191 (40%), Gaps = 41/191 (21%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLE 101
+ + A+K+ +A + + ++ +++ ++ N +++E
Sbjct: 51 RRTGQKCALKLLY-DSPKARQEVDH---HWQASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 102 YMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLHFGYSAQVIHCD 150
M G L I +R + IM D+ +A+++LH S + H D
Sbjct: 107 CMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRD 153
Query: 151 LKPINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGREST 206
+KP N+L + + V L+DF AK T QT T +APE +
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDK 208
Query: 207 NGDVYSFGIML 217
+ D++S G+++
Sbjct: 209 SCDMWSLGVIM 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 31/162 (19%), Positives = 63/162 (38%), Gaps = 20/162 (12%)
Query: 52 VAVK----VFN--LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKA--LVL 100
VA+K +F + C R + E ++ ++ +I+ +I +F +VL
Sbjct: 54 VAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
E L+K + + + + I+ ++ ++H + +IH DLKP N LL+
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQ 164
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG 202
+ + DF +A+ + E + K
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 20/136 (14%)
Query: 51 EVAVK-VFNLQCGRAFKSFNIECEMMKSIRHRNLIK----VISTCSNEEFKA--LVLEYM 103
EVA+K V + FK N E ++M+ ++H N++ S ++ LVLEY+
Sbjct: 66 EVAIKKVLQDKR---FK--NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120
Query: 104 PHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD- 159
P ++ + + + M + +L Y+H S + H D+KP N+LLD
Sbjct: 121 PE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDP 176
Query: 160 DNMVAHLSDFSIAKLL 175
+ V L DF AK+L
Sbjct: 177 PSGVLKLIDFGSAKIL 192
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 36/171 (21%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIF 122
E ++++ ++H N++ +I C + LV ++ H L L + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 123 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182
+ +M + + L Y+H +++H D+K NVL+ + V L+DF +A+ + S
Sbjct: 125 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 183 TQ--TQTLATIGCIAPE-------YRRKGRESTNGDVYSFGIMLMETFTRK 224
T + T+ PE Y D++ G ++ E +TR
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 16/169 (9%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 130
E +++++ L+K+ + + +V+EY+ G + +L + R
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-Q 149
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL-A 189
+ EYLH S +I+ DLKP N+L+D ++DF AK + G +T TL
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 200
Query: 190 TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
T +APE + D ++ G+++ E P +I+ +
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 41/198 (20%)
Query: 52 VAVK---VFN--LQCGRAFKSFNIECEMMKSIRHRNLIK---VISTCSNEEFKA--LVLE 101
VA+K F+ L R + E +++K +H N+I + S E F ++ E
Sbjct: 39 VAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94
Query: 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
M L + + S+ + D + + A++ LH + VIH DLKP N+L++ N
Sbjct: 95 LMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSN 148
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQ--------TQTLATIGCIAPE-------YRRKGREST 206
+ DF +A+++ ++ + +AT APE Y S
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SR 202
Query: 207 NGDVYSFGIMLMETFTRK 224
DV+S G +L E F R+
Sbjct: 203 AMDVWSCGCILAELFLRR 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 39/187 (20%), Positives = 69/187 (36%), Gaps = 29/187 (15%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNI------ECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
S+ +E A K + RA + E +++ + H N+I + N L+L
Sbjct: 35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 101 EYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
E + G L +K S + + + + YLH + ++ H DLKP
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH---TKKIAHFDLKPE 144
Query: 155 NVLL----DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDV 210
N++L L DF +A + + T +APE D+
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 211 YSFGIML 217
+S G++
Sbjct: 202 WSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 43/187 (22%), Positives = 70/187 (37%), Gaps = 29/187 (15%)
Query: 47 SSAMEVAVKVFN------LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
+ E A K + G + + E +++ IRH N+I + N+ L+L
Sbjct: 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 101 EYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
E + G L EK + + + + YLH S ++ H DLKP
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH---SKRIAHFDLKPE 137
Query: 155 NVLLDDNMVAH----LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDV 210
N++L D V + L DF IA + T +APE D+
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADM 194
Query: 211 YSFGIML 217
+S G++
Sbjct: 195 WSIGVIT 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 38/192 (19%), Positives = 71/192 (36%), Gaps = 44/192 (22%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNIECE---MMKSIRHRNLIKVISTCSNEEFKA----LV 99
+ + A+K+ E ++ + ++++++ N +V
Sbjct: 85 RTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 100 LEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLHFGYSAQVIH 148
+E + G L I R + IM + A++YLH S + H
Sbjct: 138 MECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAH 184
Query: 149 CDLKPINVLL---DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRES 205
D+KP N+L N + L+DF AK T T T +APE +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYD 241
Query: 206 TNGDVYSFGIML 217
+ D++S G+++
Sbjct: 242 KSCDMWSLGVIM 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 35/186 (18%)
Query: 51 EVAVKVFN----LQCGRAFKSFNI--ECEMMKSIRHR--NLIKVISTCSNEEFKALVLEY 102
VA+K G + E ++K + +I+++ + L+LE
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 103 -MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
P L ++ + + R + V A+ + H + V+H D+K N+L+D N
Sbjct: 130 PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 185
Query: 162 -MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRK----GRESTNGDVY 211
L DF LL PE+ R GR + V+
Sbjct: 186 RGELKLIDFGSGALLKDTV--------YTDF-DGTRVYSPPEWIRYHRYHGRSA---AVW 233
Query: 212 SFGIML 217
S GI+L
Sbjct: 234 SLGILL 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 38/187 (20%), Positives = 69/187 (36%), Gaps = 29/187 (15%)
Query: 47 SSAMEVAVKVFN------LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100
S+ +E A K + G + + E +++ + H N+I + N L+L
Sbjct: 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 101 EYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154
E + G L +K S + + + + YLH + ++ H DLKP
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH---TKKIAHFDLKPE 144
Query: 155 NVLL----DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDV 210
N++L L DF +A + + T +APE D+
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 211 YSFGIML 217
+S G++
Sbjct: 202 WSIGVIT 208
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 52 VAVK----VFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVI----STCSNEEFKA--LV 99
VA+K F L RA++ E ++K +RH N+I ++ + ++F LV
Sbjct: 53 VAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
+ +M L K + L + ++ + L Y+H +A +IH DLKP N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVN 162
Query: 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLM 218
++ + DF +A+ E T + T APE T D++S G ++
Sbjct: 163 EDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 219 ETFTRK 224
E T K
Sbjct: 218 EMITGK 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 74 MMKSIRHRN---LIKVISTCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNI 127
+++ H N L+ V +T + LV E++ L YL + L ++
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
M L++LH + ++H DLKP N+L+ L+DF +A++ + + M T
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPV 179
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+ T+ APE + +T D++S G + E F RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 74 MMKSIRHRN---LIKVISTCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCILDIFQRLNI 127
+++ H N L V + + LV E++ L YL + ++
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 128 MIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQT 187
M + L++LH S +V+H DLKP N+L+ + L+DF +A++ + + M T
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+ T+ APE + +T D++S G + E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/181 (17%), Positives = 68/181 (37%), Gaps = 23/181 (12%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
SS K ++ G E ++ RHRN++ + + + E ++ E++
Sbjct: 27 TSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 106 GSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
+ + + + + + V AL++LH S + H D++P N++
Sbjct: 86 LDIFERINTSAFELNEREIV-------SYVHQVCEALQFLH---SHNIGHFDIRPENIIY 135
Query: 159 DDNMVAHL--SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
+ + +F A+ L + APE + ST D++S G +
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPG-DNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 217 L 217
+
Sbjct: 193 V 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 36/157 (22%), Positives = 60/157 (38%), Gaps = 23/157 (14%)
Query: 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 124
E ++K I+H N+I + N+ L+LE + G L EK +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT------ 117
Query: 125 LNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DDNMVAHLSDFSIAKLLTGEYQ 180
+ + + + YLH S Q+ H DLKP N++L + DF +A +
Sbjct: 118 -EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGN 172
Query: 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIML 217
T +APE D++S G++
Sbjct: 173 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 31/194 (15%)
Query: 52 VAVK--VFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVI------------STCSNEEF 95
VA+K V A + E ++++ + H N++KV S E
Sbjct: 39 VAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 96 KA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153
+ +V EYM L L + + + M + L+Y+H SA V+H DLKP
Sbjct: 95 NSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLRGLKYIH---SANVLHRDLKP 148
Query: 154 INVLLD-DNMVAHLSDFSIAKLLTGEYQSMTQ-TQTLATIGCIAPEYRRKGRESTNG-DV 210
N+ ++ +++V + DF +A+++ Y ++ L T +P T D+
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208
Query: 211 YSFGIMLMETFTRK 224
++ G + E T K
Sbjct: 209 WAAGCIFAEMLTGK 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 13/114 (11%)
Query: 74 MMKSIRHRNLIK---VISTCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQ 123
+ + H N+++ T + + +V+EY+P H Y I
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 124 RLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSDFSIAKLLT 176
++ + + ++ LH S V H D+KP NVL++ + L DF AK L+
Sbjct: 132 KV-FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 31/169 (18%), Positives = 61/169 (36%), Gaps = 33/169 (19%)
Query: 68 FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 127
F E +++ + + + + ++ LV++Y G L L +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFED 170
Query: 128 MID----------VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLL 175
+ + A++ +H +H D+KP N+L+D N H L+DF L
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKL 225
Query: 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-----DVYSFGIMLME 219
+ + + T I+PE + D +S G+ + E
Sbjct: 226 MEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 31/185 (16%)
Query: 51 EVAVKVFN----LQCGRAFKSFNI--ECEMMKSIR----HRNLIKVISTCSNEEFKALVL 100
+VA+KV L S E ++ + H +I+++ +E LVL
Sbjct: 58 QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 101 EY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159
E +P L Y+ + + R V +A+++ H S V+H D+K N+L+D
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILID 173
Query: 160 -DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEY-RRKGRESTNGDVYS 212
A L DF LL E PE+ R + V+S
Sbjct: 174 LRRGCAKLIDFGSGALLHDEP--------YTDF-DGTRVYSPPEWISRHQYHALPATVWS 224
Query: 213 FGIML 217
GI+L
Sbjct: 225 LGILL 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 35/184 (19%), Positives = 71/184 (38%), Gaps = 25/184 (13%)
Query: 47 SSAMEVAVKVFN--LQCGRAFKSFNIECEMMKSIRHR-NLIKVISTCSNEEFKALVLEYM 103
S+ E A K + E +++ + +I + N L+LEY
Sbjct: 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
Query: 104 PHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
G + C+ ++ + + ++ + + YLH ++H DLKP N+
Sbjct: 112 AGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNI 162
Query: 157 LLDDNMVAH---LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSF 213
LL + DF +++ + G + + + T +APE +T D+++
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 214 GIML 217
GI+
Sbjct: 220 GIIA 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 18/132 (13%)
Query: 69 NIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 128
N E M+ + H +I++ T + + ++++Y+ G L L S + +
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 113
Query: 129 IDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQ 186
+V ALEYLH S +I+ DLKP N+LLD N H ++DF AK + T
Sbjct: 114 -EVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTY 161
Query: 187 TLATIGCIAPEY 198
TL C P+Y
Sbjct: 162 TL----CGTPDY 169
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 34/196 (17%), Positives = 67/196 (34%), Gaps = 49/196 (25%)
Query: 64 AFKSFNIE-------CEM--MKSIRHRNLIKVISTCSNEEFKA--LVLEYMPHGSLEKYL 112
A K E+ ++ ++H N+I + + + L+ +Y H L +
Sbjct: 52 ALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 110
Query: 113 --------YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
L +++ + + YLH + V+H DLKP N+L+
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE 167
Query: 165 H----LSDFSIAKLLTGEYQSMTQTQTLATIGCI-----APE-------YRRKGRESTNG 208
++D A+L + S + + APE Y +
Sbjct: 168 RGRVKIADMGFARL----FNSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAI 217
Query: 209 DVYSFGIMLMETFTRK 224
D+++ G + E T +
Sbjct: 218 DIWAIGCIFAELLTSE 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 36/165 (21%), Positives = 59/165 (35%), Gaps = 40/165 (24%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----------VASALEYLHFGYSAQVI 147
LV+EY G L L + I + A++ +H +
Sbjct: 138 LVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDSVH---RLGYV 184
Query: 148 HCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPE-YRRKGRE 204
H D+KP N+LLD H L+DF L + + + T ++PE + G
Sbjct: 185 HRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGG 241
Query: 205 STNG------DVYSFGIMLMETFTRKKP-----TDEIFNREMTLK 238
G D ++ G+ E F + P T E + + + K
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-08
Identities = 30/158 (18%), Positives = 56/158 (35%), Gaps = 48/158 (30%)
Query: 47 SSAMEVAVKVFNLQCGRAFKSFNIECE---MMKSIRHRNLIKVISTCSNEEFKA----LV 99
+ + A+K+ E ++ + ++++++ N +V
Sbjct: 41 RTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 100 LEYMPHGSLEKYLYSSNCILDIFQRL--------------NIMIDVASALEYLHFGYSAQ 145
+E + G L F R+ IM + A++YLH S
Sbjct: 94 MECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 146 VIHCDLKPINVLL---DDNMVAHLSDFSIAK-LLTGEY 179
+ H D+KP N+L N + L+DF AK +Y
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY 175
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 41/202 (20%), Positives = 80/202 (39%), Gaps = 39/202 (19%)
Query: 52 VAVK-VFN-----LQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKA--LVLEY 102
VAVK +F+ R F+ E ++ + H N++ +++ + + LV +Y
Sbjct: 37 VAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
M L + ++ IL+ + ++ + ++YLH S ++H D+KP N+LL+
Sbjct: 93 MET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAEC 146
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCI-------------------APEYRRKGR 203
++DF +++ + APE
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 204 ESTNG-DVYSFGIMLMETFTRK 224
+ T G D++S G +L E K
Sbjct: 207 KYTKGIDMWSLGCILGEILCGK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 32/116 (27%), Positives = 49/116 (42%), Gaps = 19/116 (16%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTL 188
+ ALE+LH +I+ D+K N+LLD N H L+DF ++K +
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-FC 221
Query: 189 ATIGCIAPEYRRKGRESTNGDV--YSFGIMLME---------TFTRKKPTDEIFNR 233
TI +AP+ R G + V +S G+++ E K EI R
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 24/145 (16%)
Query: 91 SNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVI 147
S ++ +++EY+P H L+ ++ S I + + + A+ ++H S +
Sbjct: 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGIC 163
Query: 148 HCDLKPINVLLD-DNMVAHLSDFSIAKLLTGEYQSMTQTQTLAT-------IGCIAPEYR 199
H D+KP N+L++ + L DF AK L + + + + A EY
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY- 219
Query: 200 RKGRESTNGDVYSFGIMLMETFTRK 224
+ + D++S G + E K
Sbjct: 220 -----TPSIDLWSIGCVFGELILGK 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 12/142 (8%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY G L +L + R ++ SAL+YLH + V++ DLK N++
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLM 281
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL-ATIGCIAPEYRRKGRESTNGDVYSFGIM 216
LD + ++DF + K + + +T T +APE D + G++
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 217 LMETFTRKKP-----TDEIFNR 233
+ E + P +++F
Sbjct: 339 MYEMMCGRLPFYNQDHEKLFEL 360
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 25/148 (16%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY+ G L ++ S + ++ L++LH S +++ DLK N+L
Sbjct: 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH---SKGIVYRDLKLDNIL 150
Query: 158 LDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDV 210
LD + H ++DF + K ++M T C IAPE + + + D
Sbjct: 151 LDKD--GHIKIADFGMCK------ENMLGDAKTNTF-CGTPDYIAPEILLGQKYNHSVDW 201
Query: 211 YSFGIMLMETFTRKKP-----TDEIFNR 233
+SFG++L E + P +E+F+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI-KVISTCSNEEFKALVLEYMP 104
+ + VA+K+ ++ ++E K + + I +V ++ A+VLE +
Sbjct: 31 LYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87
Query: 105 HG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----- 158
G SLE + + L I I + S +EY+H S +I+ D+KP N L+
Sbjct: 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGN 143
Query: 159 -DDNMVAHLSDFSIAK 173
++ H+ DF++AK
Sbjct: 144 KTQQVI-HIIDFALAK 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 24/115 (20%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTL 188
+ASAL YLH S +++ DLKP N+LLD H L+DF + K +++ T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK------ENIEHNSTT 196
Query: 189 ATIGC-----IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
+T C +APE K D + G +L E P T E+++
Sbjct: 197 STF-CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 41/192 (21%), Positives = 80/192 (41%), Gaps = 42/192 (21%)
Query: 52 VAVKVFNL-QCGRAFKSFNIECEMMKSIR-HRNLIKVIST-CSNEEFK-ALVLEYMPHGS 107
V VK+ + + + E ++++++R N+I + ALV E++ +
Sbjct: 64 VVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 119
Query: 108 LEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMV 163
++ + + +++ L AL+Y H S ++H D+KP NV++D ++
Sbjct: 120 FKQLYQTLTDYDIRFYMYEILK-------ALDYCH---SMGIMHRDVKPHNVMIDHEHRK 169
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTL--ATIGCIAPE-------YRRKGRESTNGDVYSFG 214
L D+ +A E+ Q + A+ PE Y + D++S G
Sbjct: 170 LRLIDWGLA-----EFYHPGQEYNVRVASRYFKGPELLVDYQMY------DYSLDMWSLG 218
Query: 215 IMLMETFTRKKP 226
ML RK+P
Sbjct: 219 CMLASMIFRKEP 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 24/115 (20%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTL 188
++ AL +LH +I+ DLKP N++L+ H L+DF + K +S+
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK------ESIHDGTVT 178
Query: 189 ATIGC-----IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
T C +APE + + D +S G ++ + T P + ++
Sbjct: 179 HTF-CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 24/115 (20%)
Query: 131 VASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH--LSDFSIAKLLTGEYQSMTQTQTL 188
+A AL++LH S +I+ DLKP N+LLD+ H L+DF ++K +S+ +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK------ESIDHEKKA 183
Query: 189 ATIGC-----IAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-----TDEIFNR 233
+ C +APE + + + D +SFG+++ E T P E
Sbjct: 184 YSF-CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 21/146 (14%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY+ G L ++ + ++A L +L S +I+ DLK NV+
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVM 474
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
LD ++DF + K +++ T T C IAPE + D ++
Sbjct: 475 LDSEGHIKIADFGMCK------ENIWDGVTTKTF-CGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 213 FGIMLMETFTRKKP-----TDEIFNR 233
FG++L E + P DE+F
Sbjct: 528 FGVLLYEMLAGQAPFEGEDEDELFQS 553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 21/146 (14%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY G L +L + R ++ SALEYLH S V++ D+K N++
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLM 137
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
LD + ++DF + K + ++ T+ T C +APE D +
Sbjct: 138 LDKDGHIKITDFGLCK------EGISDGATMKTF-CGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 213 FGIMLMETFTRKKP-----TDEIFNR 233
G+++ E + P + +F
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 21/146 (14%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+E++ G L ++ S + R ++ SAL +LH +I+ DLK NVL
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DKGIIYRDLKLDNVL 156
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
LD L+DF + K + + T AT C IAPE ++ D ++
Sbjct: 157 LDHEGHCKLADFGMCK------EGICNGVTTATF-CGTPDYIAPEILQEMLYGPAVDWWA 209
Query: 213 FGIMLMETFTRKKP-----TDEIFNR 233
G++L E P D++F
Sbjct: 210 MGVLLYEMLCGHAPFEAENEDDLFEA 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 16/127 (12%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY+ G L ++ + + R +++ AL YLH +I+ DLK NVL
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 142
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
LD L+D+ + K + + T +T C IAPE R + D ++
Sbjct: 143 LDSEGHIKLTDYGMCK------EGLRPGDTTSTF-CGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 213 FGIMLME 219
G+++ E
Sbjct: 196 LGVLMFE 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 27/149 (18%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFGYSAQVIHCDLKPI 154
V+EY+ G L ++ F ++A L +L S +I+ DLK
Sbjct: 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 150
Query: 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGD 209
NV+LD ++DF + K +++ T T C IAPE + D
Sbjct: 151 NVMLDSEGHIKIADFGMCK------ENIWDGVTTKTF-CGTPDYIAPEIIAYQPYGKSVD 203
Query: 210 VYSFGIMLMETFTRKKP-----TDEIFNR 233
++FG++L E + P DE+F
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 16/127 (12%)
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
V+EY+ G L ++ + + R +++ AL YLH +I+ DLK NVL
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 185
Query: 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGC-----IAPEYRRKGRESTNGDVYS 212
LD L+D+ + K + + T +T C IAPE R + D ++
Sbjct: 186 LDSEGHIKLTDYGMCK------EGLRPGDTTSTF-CGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 213 FGIMLME 219
G+++ E
Sbjct: 239 LGVLMFE 245
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI-KVISTCSNEEFKALVLEYMP 104
+ + +VA+K + E K + I V LV++ +
Sbjct: 32 LLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 89
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL------ 158
SLE L + + + ++ +H +++ D+KP N L+
Sbjct: 90 P-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSK 145
Query: 159 DDNMVAHLSDFSIAK 173
+ NM+ ++ DF + K
Sbjct: 146 NANMI-YVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 18/87 (20%), Positives = 42/87 (48%), Gaps = 10/87 (11%)
Query: 91 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHC 149
+ + ++ ++++ G L+K ++ L + + + LEY+H + +H
Sbjct: 122 NGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHG 176
Query: 150 DLKPINVLL---DDNMVAHLSDFSIAK 173
D+K N+LL + + V +L D+ +A
Sbjct: 177 DIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 22/97 (22%), Positives = 37/97 (38%), Gaps = 13/97 (13%)
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH------LSDFSIAKLLTGEYQSMTQTQT 187
L+Y+H +IH D+KP NVL++ ++D A Y + QT+
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 188 LATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+PE D++S ++ E T
Sbjct: 201 YR-----SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 31/132 (23%), Positives = 61/132 (46%), Gaps = 10/132 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI-KVISTCSNEEFKALVLEYMP 104
I++ EVA+K+ ++ +IE ++ K ++ I + + ++ +V+E +
Sbjct: 31 IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 88
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDN 161
SLE + + L + + S +EY+H S IH D+KP N L+
Sbjct: 89 P-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKG 144
Query: 162 MVAHLSDFSIAK 173
+ ++ DF +AK
Sbjct: 145 NLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 21/92 (22%)
Query: 91 SNEEFKALVLEYMPHG-SLEKYL-----YSSNCILDIFQRLNIMIDVASALEYLHFGYSA 144
++ +V+E + G L+K + + +L + R M+DV LEY+H
Sbjct: 122 KGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR---MLDV---LEYIH---EN 170
Query: 145 QVIHCDLKPINVLL---DDNMVAHLSDFSIAK 173
+ +H D+K N+LL + + V +L+D+ ++
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 8e-05
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 6/77 (7%)
Query: 98 LVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
+VLE+ G LE+ + + +I+ + ++L + H DL NV
Sbjct: 139 IVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193
Query: 157 LLDDNMVAHLSDFSIAK 173
LL + L K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/132 (22%), Positives = 59/132 (44%), Gaps = 10/132 (7%)
Query: 46 ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI-KVISTCSNEEFKALVLEYMP 104
I + EVA+K+ N++ E ++ + ++ I V ++ LV++ +
Sbjct: 29 IQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
SLE + L + L + + + +E++H S +H D+KP N L+ A
Sbjct: 87 P-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRA 142
Query: 165 H---LSDFSIAK 173
+ + DF +AK
Sbjct: 143 NQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 21/86 (24%), Positives = 40/86 (46%), Gaps = 11/86 (12%)
Query: 93 EEFKALVLEYMPHG-SLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCD 150
++++ LVL + G SL+ L S +L L + + ALE+LH + +H +
Sbjct: 130 DKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGN 184
Query: 151 LKPINVLL---DDNMVAHLSDFSIAK 173
+ N+ + D + V L+ + A
Sbjct: 185 VTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 42/196 (21%), Positives = 72/196 (36%), Gaps = 23/196 (11%)
Query: 52 VAVKVFNLQCGRAFKSFNIECEMMKSIR-----HRNLIKVISTCSNEEFKA-------LV 99
VA+KV ++ E ++KS+R N V+ + + +V
Sbjct: 65 VAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMV 123
Query: 100 LEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
E + H L K++ SN L ++ I+ V L+YLH ++IH D+KP N+
Sbjct: 124 FEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLH--TKCRIIHTDIKPENI 178
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
LL N + A ++T A + E N + I
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 217 LME--TFTRKKPTDEI 230
+ + K T++I
Sbjct: 239 DLGNACWVHKHFTEDI 254
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 14/28 (50%), Positives = 16/28 (57%), Gaps = 3/28 (10%)
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDN 161
AL YL + H DLKP N+LLDD
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDP 173
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 12/28 (42%), Positives = 17/28 (60%), Gaps = 3/28 (10%)
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDN 161
AL +LH Q+ H DLKP N+L ++
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNS 159
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 10/28 (35%), Positives = 17/28 (60%), Gaps = 3/28 (10%)
Query: 134 ALEYLHFGYSAQVIHCDLKPINVLLDDN 161
++ +LH S ++ H DLKP N+L +
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQS 154
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 13/35 (37%), Positives = 18/35 (51%), Gaps = 3/35 (8%)
Query: 127 IMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN 161
+ L+ LH ++IHCDLKP N+LL
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQ 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.12 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.59 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.44 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.8 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-61 Score=413.47 Aligned_cols=267 Identities=25% Similarity=0.363 Sum_probs=223.6
Q ss_pred hhhhhhc-ccccccccccccceeeeEEEEEee------cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeee
Q 047140 17 DVFRRSQ-TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVIST 89 (313)
Q Consensus 17 ~~~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (313)
+.+...+ .++|.+.+.||+|+||.||+|.+. ++..||||+++.......+.|.+|++++++++|||||+++++
T Consensus 4 d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 4 DTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp GGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 3333333 368999999999999999999853 478999999987766677889999999999999999999999
Q ss_pred eeeCccceEEEEeecCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceE
Q 047140 90 CSNEEFKALVLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157 (313)
Q Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil 157 (313)
|.+++..++||||+++|+|.+++...+ ..+++..+..++.||+.||.||| +++|+||||||+|||
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCL 160 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEE
Confidence 999999999999999999999997542 36899999999999999999999 999999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMT 236 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~ 236 (313)
+++++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||+| |..||.+....+..
T Consensus 161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987654433333344568999999999999999999999999999999999 89999877654433
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....... ....+..+++++.+|+.+||+.||++|||+++|...|+.+.+.
T Consensus 241 ~~i~~~~--------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECITQGR--------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHTC--------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCC--------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 2221111 0112456788999999999999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-61 Score=419.58 Aligned_cols=271 Identities=18% Similarity=0.264 Sum_probs=215.7
Q ss_pred CccchhhhhhcchhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCC
Q 047140 4 HSNILAFKTILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRH 80 (313)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h 80 (313)
+|+.+++.+ .+.+..+. ++|++++.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++|
T Consensus 7 ~ssgvd~gt---en~~f~sm-e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H 82 (350)
T 4b9d_A 7 HSSGVDLGT---ENLYFQSM-EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82 (350)
T ss_dssp C-------C---CCCBCSCC-CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC
T ss_pred CCCCccCCC---cccCCCcc-cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC
Confidence 456665543 23333333 68999999999999999999965 5999999999764 34456789999999999999
Q ss_pred CcceeeeeeeeeCccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec
Q 047140 81 RNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159 (313)
Q Consensus 81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~ 159 (313)
||||+++++|.+++.+|||||||+||+|.+++... +..+++..++.++.||+.||.||| ++||+||||||+|||++
T Consensus 83 pnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~ 159 (350)
T 4b9d_A 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLT 159 (350)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEEC
T ss_pred CCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEEC
Confidence 99999999999999999999999999999999754 345799999999999999999999 99999999999999999
Q ss_pred CCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhh
Q 047140 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKH 239 (313)
Q Consensus 160 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~ 239 (313)
++|.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.....
T Consensus 160 ~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 160 KDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp TTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 999999999999987643211 123456999999999999999999999999999999999999999876554443332
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...... ..+..+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 238 ~~~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 238 ISGSFP--------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp HHTCCC--------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred HcCCCC--------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 222110 11335678899999999999999999999999999854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=417.90 Aligned_cols=256 Identities=21% Similarity=0.213 Sum_probs=218.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.+.|++.++||+|+||.||+|..+ +|+.||||++........+.+.+|+++++.++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 357999999999999999999965 6999999999876555567788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
|+||+|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 153 ~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence 9999999999764 5899999999999999999999 99999999999999999999999999999987653321
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+......... .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------------~ 287 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------------P 287 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------------C
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------------C
Confidence 2345679999999999999999999999999999999999999997765433322221110 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+..+++++.+|+.+||..||++|||++|+++|+|-..
T Consensus 288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 011123457888999999999999999999999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-61 Score=415.06 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=215.3
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++++.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||++++++|.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3568999999999999999999965 6999999999754 23346788999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||++||+|.+++.+.+ .+++..++.++.||+.||.||| +++|+||||||+|||++++|.+||+|||+++.+...
T Consensus 110 vmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999998765 6999999999999999999999 999999999999999999999999999999877543
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.........
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------------- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------------- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---------------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 33333445679999999999999999999999999999999999999997765443332222111
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAK 299 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~ 299 (313)
...+..+++++.+|+.+||..||++|||++|++.+
T Consensus 251 ------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 ------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 01134567789999999999999999999985433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-60 Score=412.73 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=213.8
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|.+.++||+|+||.||+|.+. +++.||||+++.......+.|.+|++++++++|||||+++++|.+++..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357889999999999999999853 47899999998776667788999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc
Q 047140 98 LVLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~ 163 (313)
|||||+++|+|.+++.... .++++..++.++.||+.||.||| +++|+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 9999999999999997542 35899999999999999999999 999999999999999999999
Q ss_pred eeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccC
Q 047140 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~ 242 (313)
+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||+| |+.||......+........
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987654333333345668999999999999999999999999999999999 89999876554433221111
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
. ....+..+++++.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus 277 ~--------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 R--------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp C--------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C--------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 0 1112456888999999999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-60 Score=408.55 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=212.7
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++++++++||+|+||.||+|.++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 367889999999999999999864 35999999753 34556789999999999999999999999865 46899999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
||++|+|.+++......+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999877668999999999999999999999 999999999999999999999999999999866433323
Q ss_pred ccccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.......||+.|+|||++.+ .+++.++|||||||++|||+||..||.....................
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------- 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---------- 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC----------
Confidence 33345679999999998863 46899999999999999999999999876544333222211111100
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
....+..+++.+.+|+.+||+.||++|||+++|+++++.+...+.
T Consensus 259 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 -----LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -----STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -----cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 011234678889999999999999999999999999998876553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-60 Score=400.88 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=200.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999954 6999999999754 2334567899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+ +|+|.+++...+ .+++..+..++.||+.||.||| ++||+||||||+|||+++++.+||+|||+++......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 679999998765 7999999999999999999999 9999999999999999999999999999998654322
Q ss_pred cccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..............
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~---------------- 228 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV---------------- 228 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 2334679999999999988876 689999999999999999999997654433222111111
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 011344678899999999999999999999999999963
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=400.73 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=207.4
Q ss_pred ccc-ccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee----Cccc
Q 047140 25 SDF-QILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEFK 96 (313)
Q Consensus 25 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 96 (313)
.+| +..++||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++|||||+++++|.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 77788999999999999965 5899999999754 34456789999999999999999999999965 3568
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecC-CCceeEcCCcchh
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDD-NMVAHLSDFSIAK 173 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~-~~~~~l~dfg~~~ 173 (313)
||||||++||+|.+++...+ .+++..+..++.||+.||.||| +++ |+||||||+|||++. +|.+||+|||+++
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999998765 7899999999999999999999 888 999999999999984 7999999999997
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
..... ......||+.|+|||++.+ .++.++|||||||++|||+||..||.+................+
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~------- 248 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 248 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-------
Confidence 54321 2334579999999998865 69999999999999999999999997654433322221111000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 249 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 249 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 111334567799999999999999999999999999853
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=406.56 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=216.1
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
+++++.+.||+|+||.||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++++|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 56788899999999999999852 4689999999754 2344678999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 98 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
+||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 9999999999999996432 35889999999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhcc
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~ 241 (313)
.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||+| |..||.+....+.......
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987654433333445678999999999999999999999999999999999 8999987765444322211
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. ....+..++.++.+|+.+||+.||++|||+++|+++|+++
T Consensus 263 ~~--------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 RQ--------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TC--------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CC--------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 0112456888999999999999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=419.14 Aligned_cols=256 Identities=21% Similarity=0.207 Sum_probs=219.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.+.|++.+.||+|+||.||+|..+ +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999965 5999999999876555567789999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
|+||+|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence 9999999999765 4899999999999999999999 99999999999999999999999999999987653321
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......||..|+|||++.+..|+.++|||||||++|||++|..||.+....+..........
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------------ 364 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------------ 364 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------------------
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------------
Confidence 23456799999999999999999999999999999999999999977654433322211100
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+..+++++.+|+.+||..||++|||++|+++|+|-..
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 001113456788999999999999999999999999998643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=407.04 Aligned_cols=257 Identities=20% Similarity=0.175 Sum_probs=213.3
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.+.|++.++||+|+||.||+|..+ +|+.||||+++.+.. ..+|+.+++.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 357889999999999999999965 599999999976522 24699999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 181 (313)
++||+|.+++...+ .+++..+..++.||+.||.||| +++|+||||||+|||++.+| .+||+|||+++.+......
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999998765 6999999999999999999999 99999999999999999987 5999999999876433211
Q ss_pred c---cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 182 M---TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 182 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||................
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--------------- 272 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--------------- 272 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC---------------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC---------------
Confidence 1 1223569999999999999999999999999999999999999997654433322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
......+..+++++.+|+.+||..||++|||+.|++++++......
T Consensus 273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0011124567889999999999999999999999999998877653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=405.38 Aligned_cols=253 Identities=22% Similarity=0.240 Sum_probs=208.0
Q ss_pred cccccccccccccceeeeEEEEEee----cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
-+++|++++.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||++++++|.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3578999999999999999999853 37899999997541 22344678899999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+||||++||+|.+++.+.+ .+++..+..++.||+.||.||| ++||+||||||+|||++++|.+||+|||+++...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999998765 7999999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.........
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------- 242 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK------------- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 322 12334679999999999999999999999999999999999999998765544333221111
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..+++++.+|+++||..||++||| ++|+++|+|-
T Consensus 243 --------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 243 --------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred --------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 0113457788999999999999999998 4799999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=400.08 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=216.4
Q ss_pred ccccccccccccceeeeEEEEEeec------ceEEEEEEeeccc-chhHHHHHHHHHHHhcCCC-Ccceeeeeeeee-Cc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRH-RNLIKVISTCSN-EE 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~ 94 (313)
.++|++++.||+|+||.||+|.+.. ++.||||.+.... ....+.+.+|++++.+++| ||||+++++|.+ ++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 4689999999999999999998542 4689999997653 3446779999999999965 899999999976 46
Q ss_pred cceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD 159 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~ 159 (313)
.+++|||||++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeC
Confidence 7899999999999999997532 34889999999999999999999 99999999999999999
Q ss_pred CCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhh
Q 047140 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLK 238 (313)
Q Consensus 160 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~ 238 (313)
+++.+||+|||+++.+.............+|..|+|||++.+..++.++|||||||++|||+| |..||.+....+....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987654333333345568899999999999999999999999999999998 9999987643322211
Q ss_pred hccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 239 HWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.... ......+..+++++.+|+.+||+.||++|||+++|++||..+.+.-
T Consensus 300 ~i~~-------------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 300 RLKE-------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HHHH-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHc-------------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 1110 0111224567888999999999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=388.71 Aligned_cols=276 Identities=19% Similarity=0.196 Sum_probs=204.0
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----cceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----FKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 98 (313)
|.++|.+.+.||+|+||.||+|.+ +|+.||||++.... ........|+..+.+++||||++++++|.+++ .+||
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 457899999999999999999987 68999999997652 22223344566667889999999999998654 5799
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceeCCCCCCceEecCCCceeEcCCc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------QVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~--------~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
||||+++|+|.+++... .+++..+..++.|++.||.||| ++ +|+||||||+|||+++++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 99999999999999865 4899999999999999999999 76 89999999999999999999999999
Q ss_pred chhhcccccccc--cccccccccccCCCcccccC------CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 171 IAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKG------RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 171 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
+++......... ......||..|+|||++.+. .++.++|||||||++|||+||..||......+..+.....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998764332211 12345699999999988754 3577999999999999999998887543322211111100
Q ss_pred Cc-ccccccc-cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 243 NW-LPISTME-VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 243 ~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.. ....... .......+. .........++..+.+|+.+||+.||++||||.+|++.|+.+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~-~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPN-IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCC-CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHhcccCCCC-CCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00 0000000 011111110 011111234677899999999999999999999999999988754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=385.06 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=195.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-------
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE------- 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 94 (313)
.++|++++.||+|+||.||+|..+ +++.||||+++... ....+.+.+|++++++++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999965 69999999997653 345577899999999999999999999997544
Q ss_pred -----cceEEEEeecCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 95 -----FKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 95 -----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
++|+|||||++|+|.+++..... ..+...++.++.||+.||.||| ++||+||||||+|||++.+|.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999986542 3456778999999999999999 9999999999999999999999999
Q ss_pred CCcchhhcccccccc----------cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh
Q 047140 168 DFSIAKLLTGEYQSM----------TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL 237 (313)
Q Consensus 168 dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~ 237 (313)
|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++ ||..........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999998765432111 1123469999999999999999999999999999999996 775433221111
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....... . .......++.+.+|+.+||+.||++|||+.|+++|+|-
T Consensus 238 ~~~~~~~----------------~---p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 238 TDVRNLK----------------F---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHTTC----------------C---CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhcCC----------------C---CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1100000 0 01123345567899999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=395.19 Aligned_cols=277 Identities=22% Similarity=0.192 Sum_probs=212.8
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN------ 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 92 (313)
.+.++|++++.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+++|+.++||||+++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 34578999999999999999999965 6999999999754 23445678899999999999999999998754
Q ss_pred CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
.+.+||||||++ |+|.+++...+ .+++..+..++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 357899999996 58999997765 7999999999999999999999 999999999999999999999999999999
Q ss_pred hhccccc--ccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-cc
Q 047140 173 KLLTGEY--QSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-IS 248 (313)
Q Consensus 173 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~ 248 (313)
+.+.... .........||..|+|||++.+. .++.++||||+||++|||++|..||.+....+...........+ ..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8664321 12223456799999999998775 56999999999999999999999998765443332221111100 00
Q ss_pred ccccccc--------cccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVDA--------NLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~~--------~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+.. .... ...........+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 0000000 0000 00000111234678899999999999999999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=380.89 Aligned_cols=272 Identities=18% Similarity=0.196 Sum_probs=205.2
Q ss_pred hcccccccccccccceeeeEEEEEee----cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
.+.++|++++.||+|+||.||+|..+ +++.||+|.+.... ....+.+|+++++.+ +||||++++++|.+++++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 46789999999999999999999854 47899999986653 235678899999998 699999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcchhhc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIAKLL 175 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~ 175 (313)
|+||||++|++|.+++. .+++..+..++.||+.||.||| ++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999984 4899999999999999999999 9999999999999999877 89999999999754
Q ss_pred cccccc--------------------------ccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCCh
Q 047140 176 TGEYQS--------------------------MTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTD 228 (313)
Q Consensus 176 ~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~ 228 (313)
...... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 322110 011234699999999998775 58999999999999999999999995
Q ss_pred hhhhhhhhhhhcc---------------------C-Cccccccccccccc---------c---cChhhhhhhhhhhhHHH
Q 047140 229 EIFNREMTLKHWG---------------------N-NWLPISTMEVVDAN---------L---LSQEDIHFVAKEQCVSF 274 (313)
Q Consensus 229 ~~~~~~~~~~~~~---------------------~-~~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~~ 274 (313)
...+......... . .............. . .............++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 4332111100000 0 00000000000000 0 00000011122456788
Q ss_pred HHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 275 VFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 275 l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
+.+|+++||..||++|||++|+++|+|-
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 9999999999999999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=401.94 Aligned_cols=257 Identities=16% Similarity=0.185 Sum_probs=221.0
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+.++|++++.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++||||++++++|.+++.+|||||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4478999999999999999999965 699999999987766667789999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC--CceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN--MVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~--~~~~l~dfg~~~~~~~~~ 179 (313)
||+||+|.+++......+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999999766557999999999999999999999 9999999999999999854 899999999998765332
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........+..
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 375 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------------- 375 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC-------------
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC-------------
Confidence 2334579999999999999999999999999999999999999998766554433332222110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......+++++.+||.+||..||++|||+.|+++|+|-
T Consensus 376 ----~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 376 ----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp ----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 011134567889999999999999999999999999883
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=396.71 Aligned_cols=253 Identities=17% Similarity=0.189 Sum_probs=208.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHH---HHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFK---SFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
-++|++++.||+|+||.||+|..+ +|+.||||++.+.. ..... ....++++++.++||||++++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999965 59999999997531 11122 233446777888999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|+||||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999998765 6999999999999999999999 9999999999999999999999999999998764
Q ss_pred cccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.. ......||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+........... ..
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----------~i--- 406 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----------MT--- 406 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----------HH---
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------hh---
Confidence 32 2334679999999999864 579999999999999999999999997654322111000 00
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
.......+..+++++.+|+.+||..||++|++ ++||++|+|-
T Consensus 407 -----~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 407 -----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp -----HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 00011124457888999999999999999998 7999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=351.83 Aligned_cols=257 Identities=23% Similarity=0.252 Sum_probs=217.5
Q ss_pred hcccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
...++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 3467899999999999999999995 469999999998765555678899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++... .+++..++.++.|++.||.||| ++|++||||||+|||++.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999999765 4899999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----------------- 232 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG----------------- 232 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-----------------
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence 2334568999999999999999999999999999999999999997654433222111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+..++..+.+|+.+||..||++|||++++++|+|-.
T Consensus 233 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 233 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp -SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 001111345778899999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=355.64 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=215.4
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568999999999999999999964 6999999999764 344567788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++++|.+++...+ .+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999997765 6899999999999999999999 9999999999999999999999999999998664322
Q ss_pred ccccccccccccccCCCcccccCCCC-CcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRES-TNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......++..|+|||++.+..+. .++|||||||++|+|++|..||.................
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------- 231 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-------------- 231 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------
Confidence 23445689999999999888764 799999999999999999999977654333222211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+..++.++.+|+++||..||++|||++++++|+|-.
T Consensus 232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 11234677899999999999999999999999998853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=346.39 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=221.2
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++++.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 479999999999999999999965 5899999998776667778899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999886668999999999999999999999 9999999999999999999999999999997654322111
Q ss_pred ------------cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 183 ------------TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 183 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
......|+..|+|||++.+..++.++||||||+++|+|++|..|+............
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------- 234 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------- 234 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----------
Confidence 111446889999999999999999999999999999999999998654322211100
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
..........+..+++.+.+++.+||..||++|||+.++++.+..+...+.
T Consensus 235 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 -------NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -------CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001111111245677889999999999999999999999999999987754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=351.33 Aligned_cols=259 Identities=17% Similarity=0.211 Sum_probs=218.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 35689999999999999999999965 5899999999765 345567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC--CCceeEcCCcchhhcccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD--NMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~~~ 178 (313)
||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+|||++. ++.++|+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999999877667999999999999999999999 999999999999999987 789999999999876432
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 220 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-------------- 220 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC--------------
Confidence 2 22345688999999999988889999999999999999999999976544333222111110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........++.++.+|+.+||..||++|||+.++++|+|-..
T Consensus 221 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 221 ---TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 0011123457888999999999999999999999999999643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=354.29 Aligned_cols=259 Identities=19% Similarity=0.242 Sum_probs=217.4
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccch------hHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGR------AFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
..+.++|++++.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 356788999999999999999999965 5999999999765221 356789999999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----ceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~----~~~l~df 169 (313)
+..++||||+++++|.+++...+ .+++..++.++.||+.||.||| +.|++|+||||+|||+++++ .++|+||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999997655 7899999999999999999999 99999999999999998877 7999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........+
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----- 235 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY----- 235 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 9998664322 23345689999999999999999999999999999999999999976544333222211110
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.........+++.+.+|+.+||..||++|||+.++++|+|-.
T Consensus 236 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 236 ------------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp ------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred ------------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 001112345778899999999999999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=339.13 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=218.7
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 47899999999999999999998788899999997653 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence 999999999877667999999999999999999999 9999999999999999999999999999998654322 112
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~------------------- 224 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------------- 224 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------------------
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-------------------
Confidence 234456778999999999999999999999999999999 999997655443322211110
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++|||+.++++++.++.++
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0011234577799999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=351.13 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=217.7
Q ss_pred ccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
.++|++++.||+|+||.||+|... ++..||+|+++.. .....+.+.+|+++++.+ +||||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999853 3568999999765 334567899999999999 899999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
+..|+||||+++|+|.+++.... ..++...++.++.||+.||.||| +++++||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999997643 24788999999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
+.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986654332222334456788999999999999999999999999999999 999997654333221
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
...... ....+..++.++.+++.+||..||++|||+.+++++|..+.....
T Consensus 317 ~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 317 LLKEGH--------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHTTC--------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHhcCC--------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111100 011134577889999999999999999999999999999876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=348.16 Aligned_cols=252 Identities=20% Similarity=0.213 Sum_probs=213.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999965 5999999999764 233456788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999997655 6899999999999999999999 9999999999999999999999999999987543221
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......||..|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------- 221 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------------- 221 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------------
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 12334568999999999999999999999999999999999999997654332222111100
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..+++++.+|+.+||..||++|| ++.++++|+|-
T Consensus 222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 011335678899999999999999999 99999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=346.63 Aligned_cols=275 Identities=31% Similarity=0.441 Sum_probs=222.7
Q ss_pred hcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
...++|++.+.||+|+||.||+|..++++.||+|++........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 45689999999999999999999987799999999987666667889999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 102 YMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+++++|.+++.... ..+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999986543 35899999999999999999999 999999999999999999999999999998765433
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh-hccC-Cccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK-HWGN-NWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~ 256 (313)
..........++..|+|||++.+..++.++||||||+++|+|++|..||....+.+.... .+.. ..........++..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 222223345588999999999888999999999999999999999999976543322110 0000 00001111111111
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
. ....+..++..+.+++.+||..||++|||+.+++++|+.+..
T Consensus 273 ~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 273 L------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp C------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 1 111234578889999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=346.13 Aligned_cols=278 Identities=21% Similarity=0.210 Sum_probs=215.3
Q ss_pred hhhhcccccccccccccceeeeEEEEEeecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
....+.++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++.+++..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 3456778999999999999999999998789999999997542 23456788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+++ +|.+.+......+++..++.++.|++.||.||| +.|++||||||+|||++.++.+||+|||++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999975 899988877667999999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC--cccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN--WLPISTMEVV 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 253 (313)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+......... ..+.......
T Consensus 171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 222 12234567899999998876 568999999999999999999999997655433322211100 0000000000
Q ss_pred c------ccc-cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 254 D------ANL-LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 254 ~------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
+ ... .............+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0 000 000001111234567889999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=339.36 Aligned_cols=259 Identities=26% Similarity=0.359 Sum_probs=217.6
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||++..+++..||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 57899999999999999999998788899999997653 23467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++...+..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 999999999877667999999999999999999999 99999999999999999999999999999976543321 12
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||.................
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 223 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------------------ 223 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------------------
Confidence 233456678999999998899999999999999999999 9999976654433322211110
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
...+..+++.+.+++.+||..||++|||+.+++++++.+.++.
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0012335677999999999999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=347.31 Aligned_cols=277 Identities=21% Similarity=0.238 Sum_probs=212.0
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----cceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----FKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 99 (313)
.++|++.+.||+|+||.||+|... ++.||||++.... ........|+.+++.++||||+++++++.+.. .+++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 479999999999999999999864 8999999997653 33445566899999999999999999998754 36999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceeCCCCCCceEecCCCceeEcCC
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA----------QVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~----------~i~h~di~p~nil~~~~~~~~l~df 169 (313)
|||+++++|.+++... .+++..++.++.|++.||.||| +. +++|+||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999765 4899999999999999999999 88 9999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccC-----CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc--cC
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-----RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW--GN 242 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~--~~ 242 (313)
|++................++..|+|||++.+. .++.++|||||||++|+|++|..||............. ..
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876544333333445789999999988763 45668899999999999999999997643221110000 00
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
..........+.................++.++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000000000011111111123346778999999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=356.66 Aligned_cols=260 Identities=26% Similarity=0.332 Sum_probs=217.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468999999999999999999976 6899999998754 23445678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++++|.+++...+..++...++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++.........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999877667999999999999999999999 999999999999999999999999999998764332222
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||++.+..++.++||||||+++|||++ |..||......+.........
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 332 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----------------- 332 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-----------------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 12222335677999999998899999999999999999998 999998765443322111110
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+|+.+||+.||++|||++++++.|..+.++
T Consensus 333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0111345778899999999999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=359.69 Aligned_cols=263 Identities=19% Similarity=0.235 Sum_probs=216.2
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
....+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 34566789999999999999999999965 69999999997652 3345678899999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec---CCCceeEcCCcch
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---DNMVAHLSDFSIA 172 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~~ 172 (313)
.++||||+.+++|.+.+...+ .+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999999998765 6999999999999999999999 99999999999999998 4688999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 161 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 231 (444)
T 3soa_A 161 IEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD------- 231 (444)
T ss_dssp BCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred EEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------
Confidence 76643221 223457899999999999999999999999999999999999999765443332222111110
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........+++++.+|+.+||..||++|||+.++++|+|-..
T Consensus 232 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 232 ----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 000112356788999999999999999999999999998644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=349.93 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=211.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 345579999999999999999999964 68999999997541 22345788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+ +|+|.+++...+ .+++..++.++.|++.||.||| +.|++||||||+|||+++++.+||+|||++....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999999 679999887655 6899999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
... ......++..|+|||++.+..+ +.++|||||||++|+|++|..||...............
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 223 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC------------- 223 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-------------
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------
Confidence 322 2334568999999999988776 78999999999999999999999764332221111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..+++.+.+|+++||..||.+|||++|+++|+|-.
T Consensus 224 --------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 263 (336)
T 3h4j_B 224 --------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263 (336)
T ss_dssp --------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred --------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence 0111344677899999999999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=337.08 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=215.9
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..++|++.+.||+|+||.||++...++..||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 357999999999999999999998888899999997653 2346788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence 9999999999876557999999999999999999999 9999999999999999999999999999998664322 11
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------ 238 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------------ 238 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------------------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc------------------
Confidence 2233446778999999998899999999999999999998 999997765433322221110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+++.+||..||++|||+.+++++++++.++
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0011234567799999999999999999999999999998865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=344.37 Aligned_cols=262 Identities=25% Similarity=0.364 Sum_probs=217.1
Q ss_pred cccccccccccccceeeeEEEEEee----cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|... .+..||||++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3578999999999999999999964 3456999999765 3445678999999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++++|.+++......+++..++.++.|++.||.||| +.+++||||||+|||++.++.++|+|||++.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999877667999999999999999999999 99999999999999999999999999999987643
Q ss_pred cccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.... .......++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------------ 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY------------ 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC------------
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence 2211 11223345678999999998999999999999999999999 999997765443322221110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..++..+.+|+.+||..||++|||+.++++.|..+....
T Consensus 272 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 --------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred --------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 01113457788999999999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=345.66 Aligned_cols=257 Identities=18% Similarity=0.230 Sum_probs=214.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
.+.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678999999999999999999965 589999999976422 13577899999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----ceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~----~~~l~dfg 170 (313)
..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999997654 6899999999999999999999 99999999999999999887 89999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||......+..........
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------ 234 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------ 234 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC------
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC------
Confidence 998664221 22345689999999999999999999999999999999999999976543332221111100
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........++..+.+|+.+||..||++|||+.++++|+|-
T Consensus 235 -----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 235 -----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp -----------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred -----------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 00011234567889999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=341.88 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=208.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||+|.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46899999999999999999986 58899999997652 3445678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 102 YMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
|+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999986542 3899999999999999999999 999 99999999999999999999999999975432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..||......+.........
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------- 255 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------------- 255 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC--------------
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 21 12234568999999999999999999999999999999999999997765433322111000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.....+..++..+.+|+.+||..||++|||++++++.|..+.++.
T Consensus 256 -----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 -----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 001113456788999999999999999999999999999887653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=349.61 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=212.6
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4579999999999999999999965 68999999997542 233466889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+|||++.++.++|+|||++..+.....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999987654 6899999999999999999999 99999999999999999999999999999986643333
Q ss_pred cccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
........++..|+|||++.+..+ +.++|||||||++|+|++|..||............+....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------- 225 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------------- 225 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC---------------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc---------------
Confidence 333345678999999999887765 7889999999999999999999976543322222111110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........++..+.+|+.+||..||++|||+.|+++|+|-.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 00011245677889999999999999999999999998853
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=346.80 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=217.7
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4679999999999999999999965 3489999999765 33456788999999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~ 152 (313)
.++||||+++++|.+++.... ..+++..++.++.||+.||.||| +++++|+|||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 999999999999999997642 46899999999999999999999 9999999999
Q ss_pred CCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhh
Q 047140 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIF 231 (313)
Q Consensus 153 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~ 231 (313)
|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987644332223344567888999999998899999999999999999999 999997655
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhccC
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRNV 311 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~~~ 311 (313)
..+.......... ...+..++..+.+++.+||..||++|||+.+++++|..+.+++...+
T Consensus 282 ~~~~~~~~~~~~~--------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~~ 341 (343)
T 1luf_A 282 HEEVIYYVRDGNI--------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTV 341 (343)
T ss_dssp HHHHHHHHHTTCC--------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC------
T ss_pred hHHHHHHHhCCCc--------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhhc
Confidence 4333222111110 01134567889999999999999999999999999999988776554
Q ss_pred C
Q 047140 312 G 312 (313)
Q Consensus 312 ~ 312 (313)
|
T Consensus 342 ~ 342 (343)
T 1luf_A 342 G 342 (343)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=350.04 Aligned_cols=259 Identities=18% Similarity=0.272 Sum_probs=215.6
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..+.++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345678999999999999999999965 5899999999764 3345677899999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhh
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKL 174 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~ 174 (313)
+||||+.+++|.+.+.... .+++..++.++.||+.||.||| +++|+|+||||+|||++.+ +.+||+|||++..
T Consensus 105 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999997655 6899999999999999999999 9999999999999999865 4599999999986
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
..... ......++..|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------- 248 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------- 248 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 64321 223456899999999999999999999999999999999999999765443322221111100
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........+++++.+|+.+||..||++|||+.++++|+|-.
T Consensus 249 --------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 249 --------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp --------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred --------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 00011235678899999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.05 Aligned_cols=260 Identities=22% Similarity=0.313 Sum_probs=216.2
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+.+++.++||||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 578999999999999999999942 4678999999654 334556788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeEc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHLS 167 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l~ 167 (313)
++||||+++++|.+++.... ..++...++.++.||+.||.||| ++||+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 35899999999999999999999 99999999999999999555 59999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+..........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-- 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999986643333333344567889999999999999999999999999999998 9999977654433222211110
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...+..++..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 305 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 ------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 011345677899999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=341.52 Aligned_cols=279 Identities=23% Similarity=0.366 Sum_probs=215.7
Q ss_pred hcccccccccccccceeeeEEEEEe-----ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--c
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--E 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 94 (313)
-..++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+++++.++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3468999999999999999999984 25889999999877666778899999999999999999999998654 4
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 589999999999999999887667999999999999999999999 99999999999999999999999999999987
Q ss_pred ccccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 175 LTGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 175 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..|+............. ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN-DKQGQMIVFHLI 242 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT-TCCTHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC-ccccchhHHHHH
Confidence 6433211 11223446677999999999999999999999999999999999986543221111000 000000000000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.. . ........+..+++++.+++.+||..||++|||+.++++.+..+.+++
T Consensus 243 ~~-~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 EL-L--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HH-H--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HH-H--hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 0 000111224567889999999999999999999999999999998765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=341.54 Aligned_cols=249 Identities=24% Similarity=0.248 Sum_probs=212.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999965 59999999997642 23456788899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++++|.+++.... .+++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 99999999999998765 6899999999999999999999 99999999999999999999999999999976532
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......||..|+|||++.+..++.++|+|||||++|+|++|..||................
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------------- 219 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE---------------- 219 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC----------------
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence 1234568999999999999999999999999999999999999997654433222211110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..++.++.+++.+||..||++|| +++++++|+|-
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 011234677899999999999999999 99999999884
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=350.72 Aligned_cols=252 Identities=20% Similarity=0.201 Sum_probs=209.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+ +++.||||+++.. .......+..|.++++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999965 5899999999764 233456788899999988 79999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||++|++|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++......
T Consensus 102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999997765 6899999999999999999999 999999999999999999999999999998753322
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. .......||..|+|||++.+..++.++|||||||++|+|++|..||......+.........
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------------- 240 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 1 12334568999999999998899999999999999999999999997765443332221111
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH------HHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA------REIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~il~~l~~ 302 (313)
...+..++..+.+|+++||..||++||++ .++++|+|-
T Consensus 241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 01123467789999999999999999999 899999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=338.55 Aligned_cols=272 Identities=19% Similarity=0.235 Sum_probs=209.8
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5899999999999999999998779999999996542 22346788999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++ +|.+++......+++..++.++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 976 999999876667999999999999999999999 99999999999999999999999999999987643211
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-------Cccccccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-------NWLPISTMEVVD 254 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 254 (313)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......+........ .|.........+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 22344678999999988754 5899999999999999999999999775543332211110 010000000000
Q ss_pred ccccChh-hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 255 ANLLSQE-DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....... .........+++++.+|+.+||..||++|||++++++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 0000000 00011123467889999999999999999999999999884
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=347.98 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=219.9
Q ss_pred cccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeee
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSN 92 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 92 (313)
..++|++++.||+|+||.||+|... .+..||+|++... .......+.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3579999999999999999999853 2468999999765 334557889999999999 99999999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceE
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil 157 (313)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence 999999999999999999997653 35899999999999999999999 999999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMT 236 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~ 236 (313)
+++++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987654332233344556788999999999999999999999999999999 99999765443332
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....... ....+..++.++.+|+.+||..||++|||+.+++++|+.+......
T Consensus 304 ~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 304 KLLKEGH--------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHTTC--------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHcCC--------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 2111110 0011235678899999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=350.60 Aligned_cols=281 Identities=16% Similarity=0.188 Sum_probs=215.1
Q ss_pred hhhhcccccccccccccc--eeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 19 FRRSQTSDFQILNFFICG--VIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
......++|++.+.||+| +||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 334456799999999999 99999999976 6999999999765 234567788899999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 EFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
+..++||||+++++|.+++... ...+++..++.++.||+.||.||| +++|+||||||+|||++.++.++|+|||.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999999999765 346899999999999999999999 999999999999999999999999999988
Q ss_pred hhccccccc-----ccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 173 KLLTGEYQS-----MTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 173 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
......... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 654322111 11223467888999999887 57899999999999999999999999876544443332221110
Q ss_pred ccc---------c-------------ccccc---ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHH
Q 047140 246 PIS---------T-------------MEVVD---ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300 (313)
Q Consensus 246 ~~~---------~-------------~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l 300 (313)
... . ..... .............+..+++.+.+|+.+||+.||++|||++++++|+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000 0 00000 0000000111123455788899999999999999999999999998
Q ss_pred HH
Q 047140 301 FK 302 (313)
Q Consensus 301 ~~ 302 (313)
|-
T Consensus 336 ~f 337 (389)
T 3gni_B 336 FF 337 (389)
T ss_dssp GG
T ss_pred HH
Confidence 74
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=350.88 Aligned_cols=258 Identities=17% Similarity=0.207 Sum_probs=216.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.++...++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 45678999999999999999999965 58999999998765556678899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC--CCceeEcCCcchhhcccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD--NMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~~~ 178 (313)
||+++++|.+++......+++..++.++.||+.||.||| +.|++||||||+|||++. ++.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999877667999999999999999999999 999999999999999974 478999999999876432
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. ......+|..|+|||++.+..++.++|||||||++|+|++|..||................+..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------------ 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------
Confidence 2 2233468999999999999999999999999999999999999997754433322211111100
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......++.++.+|+.+||..||++|||+.++++|+|-
T Consensus 270 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 270 -----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp -----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 000123467889999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=348.51 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=212.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
.+.++|++.+.||+|+||.||+|..+ +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44678999999999999999999965 58999999996431 1235778999999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc---eeEcCC
Q 047140 96 KALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV---AHLSDF 169 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~---~~l~df 169 (313)
.++||||+++++|.+.+... +..+++..++.++.||+.||.||| +++++||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998888643 335899999999999999999999 999999999999999987654 999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
|++....... .......+|..|+|||++.+..++.++|||||||++|+|++|..||.......... .....
T Consensus 178 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-i~~~~------ 248 (351)
T 3c0i_A 178 GVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEG-IIKGK------ 248 (351)
T ss_dssp TTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHH-HHHTC------
T ss_pred cceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHH-HHcCC------
Confidence 9998764322 12234568999999999999999999999999999999999999997643211110 00000
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..........++.++.+|+.+||..||++|||+.++++|+|-..
T Consensus 249 -----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 249 -----------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp -----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -----------CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 00011112456788999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=342.64 Aligned_cols=272 Identities=30% Similarity=0.403 Sum_probs=216.1
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
....++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 45578999999999999999999997789999999997652 22234688999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCC---CceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 100 LEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA---QVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~---~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +. +++|+||||+|||++.++.++|+|||++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999997653 34899999999999999999999 88 99999999999999999999999999998
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh---hhhhccCC-cccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM---TLKHWGNN-WLPIST 249 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~---~~~~~~~~-~~~~~~ 249 (313)
...... ........++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+... ......
T Consensus 183 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 183 LMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp ECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred ccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 654322 2223344589999999999888899999999999999999999999965432211 11111111 111111
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+... ....+...+..+.+++.+||+.||++|||+.+++++|+.
T Consensus 262 ~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 262 EALVDVDL------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCTTC------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhcChhh------ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 12222111 111234567889999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=336.69 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=213.2
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
+..+.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 4556789999999999999999999955 5899999998543 33456788999999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++||||+++++|.+++...+ .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 999999999999999998765 6899999999999999999999 999999999999999999999999999999866
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||.................
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 229 (294)
T 4eqm_A 162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----------- 229 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-----------
T ss_pred ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-----------
Confidence 43221 122345689999999999999999999999999999999999999977654333222211110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-CHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-NAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~il~~l~~~~ 304 (313)
.......+..+++.+.+++.+||..||++|| +++++...+..+.
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 230 -----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111112345778899999999999999999 7777777776654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=337.77 Aligned_cols=272 Identities=20% Similarity=0.206 Sum_probs=209.2
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999965 5899999999754 23345778899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++ ++.+.+......+++..++.++.|++.||.||| ++|++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9975 777777766567999999999999999999999 9999999999999999999999999999998654222
Q ss_pred ccccccccccccCCCcccccCC-CCCcchhHHHHHHHHHHHhCCCCChhh-hhhhhhhhhcc-------CCcccc-cccc
Q 047140 182 MTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRKKPTDEI-FNREMTLKHWG-------NNWLPI-STME 251 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~p~~~~-~~~~~~~~~~~-------~~~~~~-~~~~ 251 (313)
.......++..|+|||++.+.. ++.++|||||||++|+|++|..||... ...+....... ..|... ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 1233456789999999887765 799999999999999999988875332 22211111110 000000 0000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...................++..+.+|+.+||+.||++|||++|+++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 000000000111111233577889999999999999999999999999884
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=340.77 Aligned_cols=254 Identities=21% Similarity=0.234 Sum_probs=213.7
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
.|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 4788889999999999999966 699999999987655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccc
Q 047140 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQ 184 (313)
Q Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 184 (313)
+++|.+++... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 126 ~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 198 (321)
T 2c30_A 126 GGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 198 (321)
T ss_dssp SCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CB
T ss_pred CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--cc
Confidence 99999998754 5899999999999999999999 99999999999999999999999999999876543221 22
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (313)
....++..|+|||++.+..++.++||||||+++|+|++|..||................ ...
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~------------------~~~ 260 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP------------------PPK 260 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------------CCC
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------CCC
Confidence 34568999999999999999999999999999999999999997654333221111100 000
Q ss_pred hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 265 FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
......++..+.+++.+||..||++|||+.++++|+|-..
T Consensus 261 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 261 LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 0112346778999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=337.40 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=217.1
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3579999999999999999999852 3589999999764 34456788999999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~ 152 (313)
.++||||+++++|.+++.... ..+++..++.++.||+.||.||| +++++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 999999999999999997643 24889999999999999999999 9999999999
Q ss_pred CCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhh
Q 047140 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIF 231 (313)
Q Consensus 153 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~ 231 (313)
|+||++++++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986643332222334456788999999998889999999999999999999 999997654
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
............ ....+..+++.+.+++.+||..||++|||+.++++++..+..+
T Consensus 258 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLFNLLKTGH--------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHHHHHHTTC--------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHhhcCC--------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 332221111100 0011345678899999999999999999999999999988764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=350.83 Aligned_cols=262 Identities=20% Similarity=0.203 Sum_probs=209.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++++.||+|+||.||+|..+ +++.||+|+++.. .....+.+..|..++.++ +||||++++++|.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3578999999999999999999965 5899999999764 233445688899999887 8999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++|+|.+++...+ .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999998765 6899999999999999999999 99999999999999999999999999999975322
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. ........||..|+|||++.+..++.++|+|||||++|+|++|..||............ ....+...
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~---------~~~~~~~~- 273 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQV- 273 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C---------CHHHHHHH-
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh---------hHHHHHHH-
Confidence 1 12234567899999999999999999999999999999999999999643221110000 00000000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH------HHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA------REIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~il~~l~~ 302 (313)
........+..++.++.+|+++||+.||++||++ +++++|+|-
T Consensus 274 --i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 274 --ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp --HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred --HhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 0000111234578889999999999999999985 899999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=347.35 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=214.3
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
..++|++++.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++..+ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4579999999999999999999732 4689999999765 334456789999999999 8899999999998754
Q ss_pred -cceEEEEeecCCCHHHHHhcCCC--------------------------------------------------------
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSNC-------------------------------------------------------- 117 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 117 (313)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 58999999999999999976532
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc
Q 047140 118 ---------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL 188 (313)
Q Consensus 118 ---------~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 188 (313)
.+++..++.++.|++.||.||| +++++|+||||+|||++.++.++|+|||++................
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1889999999999999999999 9999999999999999999999999999998664433323334456
Q ss_pred cccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhh
Q 047140 189 ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267 (313)
Q Consensus 189 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
++..|+|||++.+..++.++||||||+++|+|++ |..||................ .....
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~ 317 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------------TRMRA 317 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-------------------CCCCC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-------------------CCCCC
Confidence 7888999999999999999999999999999998 999997654322211111100 00111
Q ss_pred hhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 268 ~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
+..+++.+.+++.+||..||++|||+.++++||..+.+.
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 334677899999999999999999999999999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=333.24 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=215.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..+.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 356789999999999999999999965 5899999999764 3345677889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc---eeEcCCcchhh
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV---AHLSDFSIAKL 174 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~---~~l~dfg~~~~ 174 (313)
+|+||+++++|.+.+.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++. ++|+|||.+..
T Consensus 82 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999999887664 6899999999999999999999 999999999999999986655 99999999976
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..||...................
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 226 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-------- 226 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC--------
Confidence 54322 2234568999999999999999999999999999999999999997654433322211111000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.......+++.+.+|+.+||+.||++|||+.++++|+|-..
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 227 ---------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp ---------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred ---------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 00012346778999999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=344.35 Aligned_cols=250 Identities=19% Similarity=0.175 Sum_probs=214.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4579999999999999999999965 59999999997542 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.++|+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999998765 6899999999999999999999 999999999999999999999999999999865422
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....||..|+|||++.+..++.++|+|||||++|+|++|..||......+.........
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------- 254 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------------- 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 234568999999999999999999999999999999999999997654433322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..++..+.+|+.+||..||++||+ ++++++|+|-
T Consensus 255 ------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 255 ------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 0113356788999999999999999998 9999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=331.75 Aligned_cols=263 Identities=22% Similarity=0.303 Sum_probs=207.1
Q ss_pred hcccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
...++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345799999999999999999998642 457999998754 3445678899999999999999999999985 4568
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999999877667999999999999999999999 9999999999999999999999999999998764
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+..........
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----------- 235 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----------- 235 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----------
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-----------
Confidence 3221 11223345678999999998999999999999999999997 9999976544332221111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
...+..+++.+.+++.+||..||++|||+.+++++++.+.++.++
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 280 (281)
T 1mp8_A 236 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 280 (281)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 011345778899999999999999999999999999999877553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=338.18 Aligned_cols=275 Identities=18% Similarity=0.198 Sum_probs=212.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc--cce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--FKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 97 (313)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 45689999999999999999999965 48999999997642 234567789999999999999999999998765 779
Q ss_pred EEEEeecCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe----cCCCceeEcCCcc
Q 047140 98 LVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DDNMVAHLSDFSI 171 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~ 171 (313)
+||||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986532 3899999999999999999999 9999999999999999 7788899999999
Q ss_pred hhhcccccccccccccccccccCCCcccc--------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh----h
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRR--------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK----H 239 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~----~ 239 (313)
+....... ......++..|+|||++. +..++.++|||||||++|+|++|..||........... .
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 98664322 223456899999999876 57789999999999999999999999975432211111 1
Q ss_pred ccCCccccccccc---cccc--ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEV---VDAN--LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 240 ~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.... ........ .... .....+........++..+.+++.+||+.||++|||++|+++|+.+.
T Consensus 240 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0000 00000000 0000 00001111122456788899999999999999999999999999853
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=329.36 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=217.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+++..++|+||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 478999999999999999999987888999999976532 3467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence 999999999877667899999999999999999999 9999999999999999999999999999998654321 112
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~------------------- 222 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------------- 222 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------------------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence 233456778999999998899999999999999999999 899997654433222111110
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++|||+.++++++.++.++
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0001234567799999999999999999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=331.41 Aligned_cols=258 Identities=22% Similarity=0.214 Sum_probs=215.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 46789999999999999999999965 47899999998765556778999999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++.... .+++..++.++.|++.||.||| +++++|+||||+||++ +.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred eccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999987655 6899999999999999999999 9999999999999999 7889999999999876543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. ......++..|+|||++.+. ++.++||||||+++|+|++|..||......+...........
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 225 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT------------ 225 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 22 23345688999999987654 899999999999999999999999775543332222111100
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........+++.+.+++.+||..||++|||+.++++|+|-..
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 226 -----FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 000112356788999999999999999999999999999644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=341.84 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=213.5
Q ss_pred cccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
..++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3579999999999999999999952 3678999999754 234557889999999999 9999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~ 152 (313)
..++||||+++++|.+++..... .+++..++.++.||+.||.||| +.|++|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999976542 3788999999999999999999 9999999999
Q ss_pred CCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhh
Q 047140 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIF 231 (313)
Q Consensus 153 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~ 231 (313)
|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654332223344557788999999998999999999999999999998 999997654
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
............. ....+..+++.+.+|+.+||..||.+|||+.+++++|+.+.+....
T Consensus 280 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 280 VDANFYKLIQNGF-------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CSHHHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cHHHHHHHHhcCC-------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 3222211111100 0011334678899999999999999999999999999998776543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=331.19 Aligned_cols=255 Identities=23% Similarity=0.267 Sum_probs=211.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999965 47899999996541 2235678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+.+.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999997654 6899999999999999999999 999999999999999999999999999988654322
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
......++..|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------- 222 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------------
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC----------------
Confidence 223456889999999999999999999999999999999999999765433322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+|+.+||..||++|||+.++++|+|-....
T Consensus 223 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 223 -----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 0111334677899999999999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=345.48 Aligned_cols=253 Identities=21% Similarity=0.225 Sum_probs=212.2
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|..+ +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999975 58999999997642 23456778899999876 9999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||++||+|.+++...+ .+++..++.++.||+.||.||| ++|++||||||+|||++.+|.+||+|||++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999998755 6899999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......||..|+|||++.+..++.++|+|||||++|+|++|..||......+.........
T Consensus 171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------- 234 (345)
T 1xjd_A 171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------------- 234 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 11 12344568999999999999999999999999999999999999997654433322211110
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHH-HHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAR-EIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~il~~l~~ 302 (313)
...+..++.++.+|+.+||..||++||++. ++++|+|-
T Consensus 235 -------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 235 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 011234677899999999999999999998 99999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=335.75 Aligned_cols=265 Identities=20% Similarity=0.298 Sum_probs=219.2
Q ss_pred cccccccccccccceeeeEEEEEe------ecceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI------SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357999999999999999999984 247899999997653 34567889999999999 9999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceE
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil 157 (313)
..++||||+++++|.+++..... .+++..++.++.|++.||.||| +++++|+||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 99999999999999999976532 4899999999999999999999 999999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMT 236 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~ 236 (313)
++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987654332222334556778999999999999999999999999999999 99999765432221
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
........ ....+..++..+.+++.+||..||.+|||+.++++++..+.++...
T Consensus 258 ~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 258 YKMIKEGF-------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHTC-------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHHhccCC-------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 11110000 0011234677899999999999999999999999999998877543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=344.49 Aligned_cols=260 Identities=22% Similarity=0.378 Sum_probs=205.9
Q ss_pred ccccccccccccceeeeEEEEEee----cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|++++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 4778999999765 34456789999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++...+..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++......
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999887667999999999999999999999 999999999999999999999999999999876432
Q ss_pred ccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 YQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... .......++..|+|||++.+..++.++||||||+++||+++ |..||......+.........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~------------- 267 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY------------- 267 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-------------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 211 11122334678999999999999999999999999999998 999997654433222111100
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++||++.++++.|..+...
T Consensus 268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111235678899999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=347.02 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=210.2
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999965 5889999999754 223456788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+.||+|.+++.... .+++..++.++.||+.||.||| +.||+||||||+|||++.+|.++|+|||++......
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 99999999999998754 6899999999999999999999 999999999999999999999999999999865432
Q ss_pred ccccccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.......||..|+|||++.+ ..++.++|||||||++|+|++|..||............. .+
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-----------~~--- 232 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-----------TF--- 232 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-----------HH---
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-----------HH---
Confidence 22345678999999998864 458999999999999999999999996433211110000 00
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-HHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-AREIVAKLFK 302 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~~il~~l~~ 302 (313)
.......+..++..+.+|+.+||..||++||+ ++++++|+|-
T Consensus 233 ----~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 233 ----ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred ----hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 00001113456788999999999999999998 8999998774
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=335.26 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=203.2
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--------------------------hhHHHHHHHHHHH
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--------------------------RAFKSFNIECEMM 75 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l 75 (313)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3579999999999999999999965 589999999975421 1235688999999
Q ss_pred hcCCCCcceeeeeeeee--CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 047140 76 KSIRHRNLIKVISTCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153 (313)
Q Consensus 76 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p 153 (313)
+.++||||+++++++.+ ++..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +++++|+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 165 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP 165 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 99999999999999986 5678999999999999876543 36899999999999999999999 99999999999
Q ss_pred CceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCC---CCCcchhHHHHHHHHHHHhCCCCChhh
Q 047140 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR---ESTNGDVYSFGIMLMETFTRKKPTDEI 230 (313)
Q Consensus 154 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~p~~~~ 230 (313)
+|||++.++.+||+|||++........ ......++..|+|||++.+.. .+.++|||||||++|+|++|..||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999986543221 223456899999999987665 378899999999999999999999765
Q ss_pred hhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.............. .......+++.+.+|+.+||..||++|||+.++++|+|-
T Consensus 244 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 244 RIMCLHSKIKSQAL-------------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp SHHHHHHHHHHCCC-------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred cHHHHHHHHhcccC-------------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 33222111110000 000123467789999999999999999999999999984
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=345.05 Aligned_cols=252 Identities=18% Similarity=0.209 Sum_probs=206.9
Q ss_pred ccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecCCCH
Q 047140 30 LNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (313)
.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 668999999999999964 5999999999876556677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe--cCCCceeEcCCcchhhcccccccccccc
Q 047140 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL--DDNMVAHLSDFSIAKLLTGEYQSMTQTQ 186 (313)
Q Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 186 (313)
.+++......+++..++.++.||+.||.||| +.+++||||||+|||+ +.++.+||+|||++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence 9999776657899999999999999999999 9999999999999999 567899999999998664322 2234
Q ss_pred cccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhh
Q 047140 187 TLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 187 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (313)
..++..|+|||++.+..++.++|||||||++|+|++|..||......+.........+.. ...
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-----------------~~~ 310 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL-----------------EDE 310 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS-----------------CSG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----------------Chh
Confidence 468999999999998899999999999999999999999997765443322222111100 001
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+++++.+|+.+||..||++|||+.++++|+|-..
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 12346788999999999999999999999999998543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=341.60 Aligned_cols=283 Identities=20% Similarity=0.230 Sum_probs=212.8
Q ss_pred chhhhhhhcccccccc-cccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeee
Q 047140 15 SRDVFRRSQTSDFQIL-NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCS 91 (313)
Q Consensus 15 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 91 (313)
+.+.++..+.++|++. +.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp CSCSSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4566777888999995 78999999999999954 6999999999876555667889999999985 7999999999999
Q ss_pred eCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc---eeEcC
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV---AHLSD 168 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~---~~l~d 168 (313)
+++..++||||+++++|.+++.... .+++..++.++.|++.||.||| +++++|+||||+||+++.++. +||+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 9999999999999999999997764 6899999999999999999999 999999999999999998776 99999
Q ss_pred Ccchhhcccccc-----cccccccccccccCCCccccc-----CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhh
Q 047140 169 FSIAKLLTGEYQ-----SMTQTQTLATIGCIAPEYRRK-----GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLK 238 (313)
Q Consensus 169 fg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~ 238 (313)
||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999876532211 111123458899999998875 4578999999999999999999999976543221100
Q ss_pred hccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 239 HWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.... .+........................++..+.+|+.+||..||++|||++++++|+|-.
T Consensus 238 ~~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 238 RGEA--CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp ---C--CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred cccc--chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 0000 00000000000000000000011234678899999999999999999999999998854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=339.47 Aligned_cols=253 Identities=20% Similarity=0.216 Sum_probs=203.5
Q ss_pred cccccccccccccceeeeEEEEEe----ecceEEEEEEeeccc----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI----SSAMEVAVKVFNLQC----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
..++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357999999999999999999996 368999999997541 234456788999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
..++||||+++++|.+++...+ .+++..++.++.||+.||.||| ++|++||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999997655 6889999999999999999999 99999999999999999999999999999875
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------- 237 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK----------- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 43221 12234568999999999999999999999999999999999999997654333222111110
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..++..+.+|+.+||..||++|| ++.++++|+|-
T Consensus 238 ----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 238 ----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred ----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 011234677899999999999999999 89999999884
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=340.08 Aligned_cols=261 Identities=20% Similarity=0.201 Sum_probs=210.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999965 5899999999764 234566788999999988 89999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++...+ .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++......
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999997655 6899999999999999999999 999999999999999999999999999998753322
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. .......||..|+|||++.+..++.++|+|||||++|+|++|..||............ .........
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--------~~~~~~~~i-- 231 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------TEDYLFQVI-- 231 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHH--
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc--------cHHHHHHHH--
Confidence 1 1234457899999999999999999999999999999999999999653211100000 000000000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH------HHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA------REIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~~il~~l~~ 302 (313)
.......+..++..+.+|+.+||..||++||++ .++++|+|-
T Consensus 232 --~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 232 --LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp --HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred --HcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 000011234577889999999999999999995 899999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=338.35 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=208.6
Q ss_pred cccccccccccccceeeeEEEEEee-cce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
..++|++.+.||+|+||.||+|... +++ +||+|.+... .......+.+|+.+++.++||||++++++|.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3578999999999999999999954 344 4688887543 2345578899999999999999999999998765 7
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+|++.+++|.+++......+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8999999999999999887668999999999999999999999 9999999999999999999999999999998775
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
............++..|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------------ 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------ 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC------------
Confidence 4433333344556788999999999999999999999999999999 999997654333222111110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++|||+.++++++..+...
T Consensus 237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111344677899999999999999999999999999887643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=342.45 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=203.6
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCC--CcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRH--RNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+++++.++| +||+++++++.+++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 46789999999999999999999878999999999754 33445778999999999976 999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|||+ .+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||++......
T Consensus 87 v~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9995 5779999998765 6899999999999999999999 99999999999999997 678999999999876543
Q ss_pred cccccccccccccccCCCccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRK-----------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
..........++..|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------- 233 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------- 233 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH-------
Confidence 32223345568999999998864 678899999999999999999999997543221111100
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
++.. .....+...+..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 234 -----~~~~------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 234 -----IDPN------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp -----HCTT------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred -----hcCC------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 0000 00011233456789999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=337.60 Aligned_cols=258 Identities=18% Similarity=0.234 Sum_probs=215.4
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
..+.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345688999999999999999999965 589999999976422 1357789999999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----ceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~----~~~l~df 169 (313)
+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999997654 6899999999999999999999 99999999999999999887 7999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
|++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||......+..........
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----- 235 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----- 235 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----
Confidence 9997654322 22345688999999999999999999999999999999999999976544333222111110
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........++..+.+|+.+||..||++|||+.++++|+|-
T Consensus 236 ------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 236 ------------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp ------------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred ------------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 00011234567889999999999999999999999999884
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=342.11 Aligned_cols=253 Identities=20% Similarity=0.192 Sum_probs=212.4
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3579999999999999999999976 4899999999764 223456788899999988 8999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999998655 6899999999999999999999 99999999999999999999999999999875432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......||..|+|||++.+..++.++|+|||||++|+|++|..||......+.........
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------- 237 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-------------- 237 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 11 12334568999999999999999999999999999999999999997654433322211110
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..++.++.+|+.+||..||++||+ +.++++|+|-
T Consensus 238 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 238 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 0113356788999999999999999994 6999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=353.12 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=214.4
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|.+++.||+|+||.||+|... +|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999965 69999999997542 234567889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++++|.+++...+ .+++..++.++.||+.||.||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999997654 6899999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.. ......++..|+|||++.+..+ +.++|||||||++|+|++|..||.................
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------ 233 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------------ 233 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC------------
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc------------
Confidence 21 2334568999999999988765 7899999999999999999999976543333222111110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..+..++.++.+|+.+||..||++|||+.++++|+|-.
T Consensus 234 ---------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 234 ---------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 11234567899999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=342.81 Aligned_cols=256 Identities=19% Similarity=0.205 Sum_probs=197.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 45678999999999999999999976 58899999997652 3467888999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCcchhhccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~~~ 177 (313)
||+++++|.+++...+ .+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.+||+|||++.....
T Consensus 128 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999997665 6899999999999999999999 999999999999999975 88999999999986543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..||................. .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~------------~ 268 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE------------Y 268 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC------------C
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC------------C
Confidence 21 22345688999999999999999999999999999999999999976543322211111000 0
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........++..+.+|+.+||..||++|||+.++++|+|-
T Consensus 269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00000123467789999999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=337.52 Aligned_cols=255 Identities=18% Similarity=0.227 Sum_probs=204.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 94 (313)
+..++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||++++++|.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 34578999999999999999999976 6999999999754 3345678999999999999999999999986543
Q ss_pred ----------------------------------------------------cceEEEEeecCCCHHHHHhcCC--CCCC
Q 047140 95 ----------------------------------------------------FKALVLEYMPHGSLEKYLYSSN--CILD 120 (313)
Q Consensus 95 ----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~--~~~~ 120 (313)
..++||||+++++|.+++.... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 3799999999999999998653 2356
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc----------ccccccccc
Q 047140 121 IFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS----------MTQTQTLAT 190 (313)
Q Consensus 121 ~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~ 190 (313)
...++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++......... .......++
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6678999999999999999 999999999999999999999999999999876533211 112335689
Q ss_pred cccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhh
Q 047140 191 IGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQ 270 (313)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (313)
..|+|||++.+..++.++||||||+++|+|++|..|+............ .........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~ 297 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRN----------------------LKFPLLFTQ 297 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHT----------------------TCCCHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhc----------------------cCCCccccc
Confidence 9999999999999999999999999999999998886443221111000 000011234
Q ss_pred hHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 271 CVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 271 ~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.++.+.+|+.+||+.||++|||+.++++|+|
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 5667899999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=335.06 Aligned_cols=249 Identities=18% Similarity=0.111 Sum_probs=201.3
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.++||+|+||.||+|... +++.||||++... ..........|+..+..+ +|+||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 378999999999999999999976 6999999998653 223334455566666555 999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+ +++|.+++...+..+++..++.++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 56999999877767999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||++.+ .++.++|||||||++|+|++|..|+........... .
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~----~---------------- 267 (311)
T 3p1a_A 212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ----G---------------- 267 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT----T----------------
T ss_pred ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc----c----------------
Confidence 2234458999999998876 789999999999999999999766544322111100 0
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
......+..+++++.+++.+||..||++|||++++++|+|-
T Consensus 268 --~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 268 --YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred --CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 00011234578889999999999999999999999999883
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=337.69 Aligned_cols=275 Identities=21% Similarity=0.277 Sum_probs=198.0
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 478999999999999999999965 58999999997652 2334678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 102 YMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|++ ++|.+++.... ..+++..+..++.||+.||.||| +.|++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 49999886532 35899999999999999999999 9999999999999999999999999999998654
Q ss_pred cccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-------Cccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-------NWLPIS 248 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 248 (313)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ .|....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3211 2234567899999998876 46899999999999999999999999765543322111100 000000
Q ss_pred ccccccccccC------hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 TMEVVDANLLS------QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 ~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........... ........+..++.++.+|+.+||..||++|||+.++++|+|-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 00000000000 000011112356788999999999999999999999999988543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=334.82 Aligned_cols=277 Identities=21% Similarity=0.207 Sum_probs=207.7
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-----chhHHHHHHHHHHHhcC---CCCcceeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-----GRAFKSFNIECEMMKSI---RHRNLIKVISTCS 91 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 91 (313)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 455789999999999999999999954 68999999997432 11234566777777766 5999999999997
Q ss_pred eCc-----cceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCcee
Q 047140 92 NEE-----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165 (313)
Q Consensus 92 ~~~-----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~ 165 (313)
... ..++|+|++. ++|.+++.... ..+++..++.++.|++.||.||| +++++|+||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence 765 5799999997 59999998664 24899999999999999999999 99999999999999999999999
Q ss_pred EcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
|+|||++...... .......+|..|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999865422 2234456899999999999999999999999999999999999999776544332221110000
Q ss_pred --ccccccc---cccccc-ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 246 --PISTMEV---VDANLL-SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 246 --~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....... ...... ............+++.+.+|+.+||..||++|||+.++++|+|-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 0000000 000000 0001111123457888999999999999999999999999998554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=336.47 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=199.4
Q ss_pred cccccccccccccceeeeEEEEEeec-ce---EEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISS-AM---EVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~---~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
..++|++++.||+|+||.||+|.... +. .||+|++... .....+.+.+|+++++.++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35789999999999999999999653 32 8999999764 345567899999999999999999999999877655
Q ss_pred ------eEEEEeecCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCcee
Q 047140 97 ------ALVLEYMPHGSLEKYLYSSN-----CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165 (313)
Q Consensus 97 ------~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~ 165 (313)
++|+||+++++|.+++.... ..+++..++.++.|++.||.||| ++|++|+||||+||++++++.++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999996432 25899999999999999999999 99999999999999999999999
Q ss_pred EcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCc
Q 047140 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~ 244 (313)
|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..........
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 999999987644332223334456778999999999999999999999999999999 9999977554433222211110
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...+..+++.+.+|+.+||..||++|||+.++++.++++...
T Consensus 258 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 258 --------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011335677899999999999999999999999998888754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=338.69 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=209.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 456789999999999999999999964 6999999999764 234456788999999999999999999999876544
Q ss_pred ----eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 97 ----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 97 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
|+||||+++++|.+++...+ .+++..++.++.|++.||.||| +++++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred CcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997665 6899999999999999999999 999999999999999999999999999999
Q ss_pred hhccccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 173 KLLTGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 173 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.................
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------
Confidence 866433221 122334589999999999999999999999999999999999999977654333222211110
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........++.++.+++.+||..||++||++.+++.+.|...
T Consensus 237 ----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 ----------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0011113457888999999999999999999999998887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=345.18 Aligned_cols=258 Identities=20% Similarity=0.209 Sum_probs=201.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
..++|++.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3579999999999999999999966 68999999997652 334668899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc--eeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV--AHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~ 179 (313)
|+++++|.+++...+ .+++..++.++.|++.||.||| ++|++||||||+||+++.++. +||+|||++......
T Consensus 97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 999999999997655 6899999999999999999999 999999999999999987765 999999998743321
Q ss_pred ccccccccccccccCCCcccccCCCCCc-chhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTN-GDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.......++..|+|||++.+..++.+ +|||||||++|+|++|..||............... +....
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---------~~~~~-- 238 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR---------ILSVK-- 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH---------HHTTC--
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH---------HhcCC--
Confidence 12234568999999999988877655 89999999999999999999765432221111000 00000
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........++..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 239 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 239 ----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp ----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 00011224577899999999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=331.03 Aligned_cols=270 Identities=12% Similarity=0.051 Sum_probs=219.2
Q ss_pred hhcccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.++...++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 34678999999999999999999995 469999999986542 335678899999999 89999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc-----eeEcCCcchh
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV-----AHLSDFSIAK 173 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~-----~~l~dfg~~~ 173 (313)
|+||+ +++|.+++...+..+++..++.++.|++.||.||| +++++|+||||+||+++.++. ++|+|||++.
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999 88999999877667999999999999999999999 999999999999999987776 9999999998
Q ss_pred hccccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 174 LLTGEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 174 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~--------- 230 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--------- 230 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH---------
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH---------
Confidence 76533221 1123456899999999999999999999999999999999999999764321111000
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
..+... ............+++.+.+++.+||..||++|||++++++.+..+.+++..
T Consensus 231 -~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 231 -ERIGEK---KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -HHHHHH---HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -HHHHhh---ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 000000 000011111235788999999999999999999999999999999887654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=340.17 Aligned_cols=263 Identities=19% Similarity=0.213 Sum_probs=209.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
..+.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 356689999999999999999999965 5889999999754 2345678999999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 047140 95 FKALVLEYMPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIMIDVASAL 135 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~~~~~i~~~l 135 (313)
..++||||+++++|.+++... ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521 11236778899999999999
Q ss_pred HHHhcCCCCCceeCCCCCCceEecCCC--ceeEcCCcchhhccccccc--ccccccccccccCCCccccc--CCCCCcch
Q 047140 136 EYLHFGYSAQVIHCDLKPINVLLDDNM--VAHLSDFSIAKLLTGEYQS--MTQTQTLATIGCIAPEYRRK--GRESTNGD 209 (313)
Q Consensus 136 ~~lH~~~~~~i~h~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 209 (313)
.||| +.+++|+||||+||+++.++ .++|+|||++..+...... .......++..|+|||++.+ ..++.++|
T Consensus 182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999 99999999999999998776 8999999999865432111 12234568899999998865 67899999
Q ss_pred hHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC
Q 047140 210 VYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 210 iwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
|||||+++|+|++|..||......+.......... .........+++.+.+|+.+||..||++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL-----------------CFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------CTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc-----------------ccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999977654433322221110 0001112346788999999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 047140 290 RINAREIVAKLFKI 303 (313)
Q Consensus 290 Rps~~~il~~l~~~ 303 (313)
|||+.++++|+|--
T Consensus 322 Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 322 RFDAMRALQHPWIS 335 (345)
T ss_dssp SCCHHHHHHSHHHH
T ss_pred CCCHHHHhcChhhc
Confidence 99999999999853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=328.26 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=217.7
Q ss_pred cccccccc-ccccceeeeEEEEEee---cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILN-FFICGVIIPVAQFLIS---SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|.+.+ .||+|+||.||+|... ++..||+|++... .....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 46777777 9999999999999853 5788999999764 345567899999999999999999999999 4556899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999876667999999999999999999999 999999999999999999999999999999866432
Q ss_pred ccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 179 YQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 179 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------------- 230 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------- 230 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-------------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-------------
Confidence 211 11223345788999999988889999999999999999998 999997654433222111110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~~ 310 (313)
....+..+++.+.+++.+||..||++|||+.+++++|+.+..+....
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 00113457788999999999999999999999999999999886654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=330.04 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=193.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3468999999999999999999964 69999999997542 1234678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999877667999999999999999999999 999999999999999999999999999998765422
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||.............. .
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------~--- 227 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------------A--- 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------S---
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------c---
Confidence 11 12234678899999999988999999999999999999999999965432221111000 0
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..++.++.+++.+||..||++|||++++++|+|-.....
T Consensus 228 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 271 (278)
T 3cok_A 228 -----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271 (278)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred -----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence 00113346778999999999999999999999999998665443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=333.77 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=208.8
Q ss_pred hcccccccccccccceeeeEEEEEeec-c-------eEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLISS-A-------MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
-..++|++.+.||+|+||.||+|.... + ..||+|++........+.+.+|+++++.++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 346799999999999999999999553 3 57999999776666778899999999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc--------ee
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV--------AH 165 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~--------~~ 165 (313)
+..++||||+++++|.+++......+++..++.++.||+.||.||| +++++|+||||+|||++.++. ++
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999887666999999999999999999999 999999999999999998887 99
Q ss_pred EcCCcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCC-CCChhhhhhhhhhhhccCC
Q 047140 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRK-KPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~-~p~~~~~~~~~~~~~~~~~ 243 (313)
|+|||++...... ....++..|+|||++.+ ..++.++||||||+++|+|++|. +|+............ ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR 234 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc
Confidence 9999998754321 23447788999998887 67899999999999999999954 454443222211111 000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
...+...+.++.+|+.+||+.||++|||+.++++++..+...
T Consensus 235 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 235 ---------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ---------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 001122345688999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=351.30 Aligned_cols=258 Identities=20% Similarity=0.214 Sum_probs=212.2
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|..+++.++||||++++++|.+++.+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999966 58999999997531 1233457889999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||++||+|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.+|.+||+|||++......
T Consensus 147 V~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999999765 4899999999999999999999 999999999999999999999999999999765432
Q ss_pred cccccccccccccccCCCcccccCC----CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGR----ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
.. .......||..|+|||++.+.. ++.++|||||||++|+|++|..||................
T Consensus 222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------- 289 (410)
T 3v8s_A 222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK----------- 289 (410)
T ss_dssp SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----------
T ss_pred Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-----------
Confidence 21 1223456999999999987665 7899999999999999999999997654433322211100
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFKI 303 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~~ 303 (313)
.....+....++.++.+|+.+||..+|++ ||++++|++|+|-.
T Consensus 290 ------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 290 ------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp ------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred ------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 00011112346788999999999999988 99999999999853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=352.91 Aligned_cols=259 Identities=20% Similarity=0.212 Sum_probs=213.2
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|..++..++||||++++++|.+++.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 4579999999999999999999976 48999999997531 2223448889999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++|+|.+++......+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999876557999999999999999999999 999999999999999999999999999999765432
Q ss_pred cccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.. .......||..|+|||++. ...++.++|||||||++|||++|..||......+.........
T Consensus 229 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------- 297 (437)
T 4aw2_A 229 GT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK---------- 297 (437)
T ss_dssp SC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----------
T ss_pred CC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----------
Confidence 21 1223357899999999886 5578999999999999999999999997665443332221100
Q ss_pred cccccChhhhhh-hhhhhhHHHHHHHHhHhhccCCCC--CCCHHHHHHHHHH
Q 047140 254 DANLLSQEDIHF-VAKEQCVSFVFNLAIECTVESPEQ--RINAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~--Rps~~~il~~l~~ 302 (313)
..... .....+++++.+|+++||..+|++ ||+++++++|+|-
T Consensus 298 -------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 298 -------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp -------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred -------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 00000 001236788999999999998888 9999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=330.53 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=200.9
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
....++|++.+.||+|+||.||+|... ..||+|++... .....+.+.+|+++++.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 334678999999999999999999853 35999999754 344567899999999999999999999965 4556899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|+||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999999877668999999999999999999999 999999999999999999999999999999765433
Q ss_pred cccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..........++..|+|||++. +..++.++||||||+++|+|++|..||.....................
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 246 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------- 246 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-------
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-------
Confidence 2232334456899999999886 667888999999999999999999999765443322221111100000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.......+++.+.+|+.+||..||++|||+.++++.++++.
T Consensus 247 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 247 --------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00012356788999999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=329.01 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=213.3
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3478999999999999999999965 6899999999754 2345678899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999886554 6899999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
........++..|+|||++.+..+ +.++||||||+++|+|++|..||............+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 225 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------------- 225 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC---------------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc---------------
Confidence 222344568899999999887665 7789999999999999999999976543322221111100
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........++..+.+|+.+||..||++|||++++++|+|-
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 0001123567789999999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=353.45 Aligned_cols=252 Identities=20% Similarity=0.204 Sum_probs=203.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||++++++|.+++.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999965 5899999999754 233456778899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
|||+++++|.+++.... .+++..+..++.||+.||.||| + .||+||||||+|||++.++.+||+|||++......
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999997665 6899999999999999999999 8 89999999999999999999999999998754322
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. .......||..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------------- 365 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------------- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------------
Confidence 1 12334678999999999999999999999999999999999999997654433322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..+++++.+|+.+||..||++|| +++++++|+|-
T Consensus 366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 011334678899999999999999999 99999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=352.70 Aligned_cols=258 Identities=20% Similarity=0.246 Sum_probs=213.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 56789999999999999999999965 6899999999653 23345778899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec---CCCceeEcCCcchhhc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---DNMVAHLSDFSIAKLL 175 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~~~~~ 175 (313)
|+||+.+++|.+.+.... .+++..++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999999987665 6899999999999999999999 99999999999999995 4567999999999866
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|..||......+.........+
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------- 239 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY----------- 239 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 4322 2334568999999998875 589999999999999999999999976654333222211111
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........+++.+.+|+.+||..||++|||+.++++|+|-..
T Consensus 240 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 240 ------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0011123456788999999999999999999999999999654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=326.45 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=208.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee----C
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN----E 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 93 (313)
....+.|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. +
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567999999999999999999965 5889999999754 34556788999999999999999999999865 4
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEec-CCCceeEcCCc
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLD-DNMVAHLSDFS 170 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~-~~~~~~l~dfg 170 (313)
...++||||+++++|.+++.... .++...++.++.|++.||.||| +.+ ++|+||||+||+++ +++.++|+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred ceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 56899999999999999997654 6899999999999999999999 988 99999999999998 78999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++...... ......++..|+|||++. ..++.++||||||+++|+|++|..||..................
T Consensus 178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 247 (290)
T 1t4h_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----- 247 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----
T ss_pred Cccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-----
Confidence 99754322 223456889999999876 45899999999999999999999999765443332221111100
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+...++++.+++.+||..||++|||++++++|+|-
T Consensus 248 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 248 -------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp -------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred -------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 011123455779999999999999999999999999884
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=343.29 Aligned_cols=256 Identities=22% Similarity=0.332 Sum_probs=203.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCC--CCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIR--HRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+++++.++ ||||+++++++..++.+++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999777999999999754 3345678899999999996 59999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|| +.+++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++..+....
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 55779999998765 6889999999999999999999 99999999999999995 5899999999998765433
Q ss_pred ccccccccccccccCCCccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK-----------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.........++..|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~--------- 279 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA--------- 279 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH---------
Confidence 2222344568999999998865 36889999999999999999999999754322111110
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
+++... ....+...+..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 280 ---~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 280 ---IIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp ---HHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ---HhCccc------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 000000 0001223456789999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=334.99 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=216.4
Q ss_pred cccccccccccccceeeeEEEEEee--------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeee
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS--------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSN 92 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 92 (313)
..++|++++.||+|+||.||+|... ++..||+|++... .......+.+|+++++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3579999999999999999999852 4678999999765 334567789999999999 99999999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceE
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil 157 (313)
++..++|+||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 999999999999999999997653 24889999999999999999999 999999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMT 236 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~ 236 (313)
++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999986643322222334456778999999988889999999999999999999 99999765433322
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
....... ....+..++..+.+++.+||..||.+|||+.+++++|..+.....
T Consensus 270 ~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 KLLKEGH--------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHTC--------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhcCC--------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1111100 001133567789999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=330.42 Aligned_cols=256 Identities=22% Similarity=0.243 Sum_probs=206.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
++.++|++.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 46689999999999999999999965 58999999997652 33467889999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchh
Q 047140 100 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAK 173 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~ 173 (313)
|||+++++|.+.+... +..+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999988643 347899999999999999999999 9999999999999999 456889999999997
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
...... ......++..|+|||++. ..++.++||||||+++|+|++|..||...................
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------- 244 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------- 244 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-------
Confidence 654322 233456889999999875 568899999999999999999999997654433322111100000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
......+++.+.+|+.+||..||++|||+.|+++|+|-
T Consensus 245 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 245 -----------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp -----------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred -----------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 00012256778999999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=333.43 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=215.6
Q ss_pred hcccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
...++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 44679999999999999999999854 3789999999754 2344567889999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCcee
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~ 165 (313)
..++||||+++++|.+++.... ..++...++.++.|++.||.||| ++|++|+||||+||+++.++.++
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999997532 35689999999999999999999 99999999999999999999999
Q ss_pred EcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCc
Q 047140 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~ 244 (313)
|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.................
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 999999986644332222334456788999999999999999999999999999999 8999976544333222111110
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...+..++..+.+++.+||..||++|||+.++++++..+.+
T Consensus 259 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 259 --------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00123567889999999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=332.25 Aligned_cols=258 Identities=18% Similarity=0.221 Sum_probs=211.6
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
..+.++|++.+.||+|+||.||++... +++.||+|++..........+.+|+++++.++||||+++++++.+++..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 356689999999999999999999965 6999999999876444556788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~~ 176 (313)
+||+++++|.+++...+ .+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999987655 6899999999999999999999 9999999999999999 778999999999987543
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||..................
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----------- 225 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE----------- 225 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----------
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 21 223345889999999999999999999999999999999999999765433222211111000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........++..+.+++.+||..||++|||+.++++|+|-.
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 226 ------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 00011235678899999999999999999999999999853
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=333.87 Aligned_cols=273 Identities=19% Similarity=0.192 Sum_probs=206.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999965 58999999986542 334567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.... .+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999988888876554 6899999999999999999999 99999999999999999999999999999976543221
Q ss_pred cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccccc-----cccc
Q 047140 181 SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLPIS-----TMEV 252 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~~~-----~~~~ 252 (313)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+........ ...+.. ....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2234468889999998876 66799999999999999999999999776543332211100 000000 0000
Q ss_pred ccccccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 253 VDANLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 253 ~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....... ...........++..+.+|+.+||..||++|||++++++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 0000000 0000011123577889999999999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=338.46 Aligned_cols=260 Identities=18% Similarity=0.202 Sum_probs=188.9
Q ss_pred ccccc---ccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEE
Q 047140 25 SDFQI---LNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~---~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++ .+.||+|+||.||+|..+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 34555 378999999999999965 5899999999754 3456778999999996 99999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~~~ 176 (313)
|||+++++|.+++.... .+++..++.++.|++.||.||| +++++||||||+||+++.++ .++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 85 MELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp ECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999998765 7999999999999999999999 99999999999999998765 89999999997554
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... .......++..|+|||++.+..++.++||||||+++|+|++|..||........... ..+.....
T Consensus 161 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----------~~~~~~~i 228 (325)
T 3kn6_A 161 PDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS----------AVEIMKKI 228 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC----------HHHHHHHH
T ss_pred CCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc----------HHHHHHHH
Confidence 321 122344578999999999999999999999999999999999999976532111000 00000000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..............+++++.+|+.+||..||++|||++++++|+|-.
T Consensus 229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 00000111112345788899999999999999999999999998854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=336.34 Aligned_cols=266 Identities=17% Similarity=0.147 Sum_probs=214.9
Q ss_pred cccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
+.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +||||+++++++.+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 467899999999999999999995 469999999987652 234678899999999 9999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc-----eeEcCCcchhhc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV-----AHLSDFSIAKLL 175 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~-----~~l~dfg~~~~~ 175 (313)
||+ +++|.+++......+++..++.++.|++.||.||| +.+++||||||+|||++.++. ++|+|||++..+
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999 88999999876668999999999999999999999 999999999999999998887 999999999876
Q ss_pred ccccccc-----cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 176 TGEYQSM-----TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 176 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~---------- 230 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ---------- 230 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH----------
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH----------
Confidence 4332111 1235568999999999999999999999999999999999999997653221111000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
.+.... ...........++ ++.+++..||..||.+||+++++.+.+.++.++..
T Consensus 231 ~i~~~~---~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 231 KIGDTK---RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHH---HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhh---ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 000000 0000001122355 89999999999999999999999999998887753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=337.95 Aligned_cols=258 Identities=20% Similarity=0.315 Sum_probs=208.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceE----EEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAME----VAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|++.+.||+|+||.||+|... +++. |++|.+.... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999954 4543 7888875432 233456778999999999999999999986 45688
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+.+++|.+++......+++..++.++.|++.||.||| +.+++||||||+|||++.++.++|+|||++.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877557899999999999999999999 99999999999999999999999999999987754
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
...........++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------- 234 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE------------- 234 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-------------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-------------
Confidence 443333445567789999999999999999999999999999999 999997754333222111110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..++.++.+++.+||..||++|||+.++++++..+..
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001123355668899999999999999999999999988754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=338.97 Aligned_cols=253 Identities=23% Similarity=0.257 Sum_probs=210.5
Q ss_pred cccccccccccccceeeeEEEEEe-ecceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..+.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 346799999999999999999995 469999999997542 3345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+. |+|.+.+......+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++.....
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 999997 5899888766667999999999999999999999 99999999999999999999999999999876532
Q ss_pred cccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.....++..|+|||++. ...++.++|||||||++|+|++|..||..................
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------- 271 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------- 271 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------
Confidence 22346899999999874 567899999999999999999999999765433322211111000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+..+++.+.+|+.+||..||++|||++++++|+|-..
T Consensus 272 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 272 ---------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0012345777999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=346.16 Aligned_cols=276 Identities=19% Similarity=0.240 Sum_probs=201.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCc--
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEE-- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-- 94 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 355689999999999999999999954 6999999998643 3455677889999999996 999999999997544
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.+|+||||++ ++|.+++... .++...+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 7899999997 4999999764 5899999999999999999999 99999999999999999999999999999976
Q ss_pred ccccc-------------------ccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhh
Q 047140 175 LTGEY-------------------QSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234 (313)
Q Consensus 175 ~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~ 234 (313)
+.... .........+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53210 0111234568999999998876 678999999999999999999999997765433
Q ss_pred hhhhhccCCcccc-c-cc--------ccccc----------cccC------hhhhhhhhhhhhHHHHHHHHhHhhccCCC
Q 047140 235 MTLKHWGNNWLPI-S-TM--------EVVDA----------NLLS------QEDIHFVAKEQCVSFVFNLAIECTVESPE 288 (313)
Q Consensus 235 ~~~~~~~~~~~~~-~-~~--------~~~~~----------~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 288 (313)
...........+. . .. ..+.. .... ...........+++++.+|+.+||..||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 3222211000000 0 00 00000 0000 00000001125678899999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 047140 289 QRINAREIVAKLFK 302 (313)
Q Consensus 289 ~Rps~~~il~~l~~ 302 (313)
+|||++|+++|+|-
T Consensus 319 ~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 319 KRISANDALKHPFV 332 (388)
T ss_dssp GSCCHHHHTTSTTT
T ss_pred cCCCHHHHhCCHHH
Confidence 99999999999883
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=329.19 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred cccccccccccccceeeeEEEEEee----cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc--
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-- 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (313)
..++|++++.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3579999999999999999999854 3558999999754 3345577899999999999999999999997765
Q ss_pred ---cceEEEEeecCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeE
Q 047140 95 ---FKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166 (313)
Q Consensus 95 ---~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l 166 (313)
..++|+||+++++|.+++.. ....+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999853 2346899999999999999999999 999999999999999999999999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 266 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-- 266 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence 99999986643322222334456778999999999999999999999999999999 889987654433222111110
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
....+..+++.+.+++.+||..||++|||+.+++++|..+.+++.
T Consensus 267 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 267 ------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 001134567789999999999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=327.27 Aligned_cols=260 Identities=25% Similarity=0.335 Sum_probs=218.4
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
..++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4678999999999999999999976 4889999999765 3456788999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999764 346899999999999999999999 99999999999999999999999999999987653321
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------------- 229 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------------- 229 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------------
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------------
Confidence 12233456778999999999999999999999999999999 999997654332222111100
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..+++.+.+|+.+||..||++|||+.++++.+..+..+.
T Consensus 230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01113456788999999999999999999999999999887664
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=350.50 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=214.7
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|..+++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 56899999999999999999998778899999997653 34678999999999999999999999987 56789999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|.+++.... ..++...++.++.||+.||.||| +++++||||||+|||++.++.+||+|||+++....... .
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 340 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence 9999999997542 35788999999999999999999 99999999999999999999999999999987643221 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++....++.++||||||+++|||++ |..||......+.........
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------ 402 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------------------ 402 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC------------------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 1233446778999999998999999999999999999999 999998765443322211110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+|+.+||..||++|||+.+|++.|+++...
T Consensus 403 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0111345788899999999999999999999999999877543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=326.99 Aligned_cols=253 Identities=20% Similarity=0.225 Sum_probs=213.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999965 58899999996542 22346788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+++++|.+++...+ .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 99999999999997765 6899999999999999999999 999999999999999999999999999998654322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------------- 228 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD---------------- 228 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------------
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc----------------
Confidence 2234568899999999999999999999999999999999999997654333222111110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...+..++..+.+++.+||..||.+|||+.++++|+|-...
T Consensus 229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 01123467789999999999999999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=353.45 Aligned_cols=258 Identities=20% Similarity=0.244 Sum_probs=216.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.+.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45678999999999999999999965 6999999999654 2345678899999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhh
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKL 174 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~ 174 (313)
+|+||+.+++|.+.+.... .+++..++.++.||+.||.||| +++++||||||+|||+ +.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999997765 6899999999999999999999 9999999999999999 5678999999999987
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
+.... ......++..|+|||++.+ .++.++|||||||++|+|++|..||......+..........
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 244 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY---------- 244 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 65322 2234568999999998876 689999999999999999999999977654433222211111
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........+++.+.+|+.+||..||++|||+.++++|+|-..
T Consensus 245 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 245 -------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp -------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred -------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 0011123457788999999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=337.91 Aligned_cols=276 Identities=22% Similarity=0.278 Sum_probs=217.2
Q ss_pred ccccccccccccceeeeEEEEEe-----ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeee--eCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCS--NEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 96 (313)
.++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+++++.++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47999999999999999999984 258899999998776667788999999999999999999999986 45678
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999876557999999999999999999999 9999999999999999999999999999998664
Q ss_pred ccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||.................. ........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP--ALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC--HHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc--cHHHHHHH
Confidence 32211 1223345777899999999888999999999999999999999998765443222111111000 00000000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
. ........+..+++.+.+|+.+||..||++|||+.+++++|+.+....
T Consensus 257 ~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 L---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp H---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred h---hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0 000111124467888999999999999999999999999999887654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=324.88 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=199.7
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeeccc----chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||+|.. .++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999996 48999999987542 22356788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceeCCCCCCceEecC--------CCceeEcC
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ---VIHCDLKPINVLLDD--------NMVAHLSD 168 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~---i~h~di~p~nil~~~--------~~~~~l~d 168 (313)
|||+++++|.+++... .+++..++.++.|++.||.||| +++ ++|+||||+||+++. ++.++|+|
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998644 6899999999999999999999 888 899999999999986 77899999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
||++....... .....++..|+|||++.+..++.++||||||+++|+|++|..||.................
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 231 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL---- 231 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC----
T ss_pred CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC----
Confidence 99998654322 2245688999999999999999999999999999999999999977654433322211111
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..+++.+.+++.+||+.||++|||+.+++++|..+
T Consensus 232 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 ---------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011345678899999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=337.20 Aligned_cols=283 Identities=12% Similarity=0.101 Sum_probs=215.7
Q ss_pred hcchhhhhhhcccccccccccccceeeeEEEEEeec------ceEEEEEEeecccchh-----------HHHHHHHHHHH
Q 047140 13 ILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQCGRA-----------FKSFNIECEMM 75 (313)
Q Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l 75 (313)
+..++.+.....++|++.+.||+|+||.||+|.... ++.||||++....... ...+..|+..+
T Consensus 23 ~~~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp CCTTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 344555556667799999999999999999998654 4789999987653211 11233455667
Q ss_pred hcCCCCcceeeeeeeeeC----ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 047140 76 KSIRHRNLIKVISTCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL 151 (313)
Q Consensus 76 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di 151 (313)
..++|+||+++++++.+. ...++||||+ +++|.+++......+++..++.++.||+.||.||| +.+|+||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl 178 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI 178 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence 778899999999999775 4589999999 88999999887668999999999999999999999 999999999
Q ss_pred CCCceEec--CCCceeEcCCcchhhccccccccc-----ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCC
Q 047140 152 KPINVLLD--DNMVAHLSDFSIAKLLTGEYQSMT-----QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224 (313)
Q Consensus 152 ~p~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~ 224 (313)
||+|||++ .++.+||+|||+++.+........ .....+|..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 889999999999976643321111 12344899999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 225 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.||................. ......+.+. ......++.++.+++..||..||++||++.++++.+..+.
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIRY-RENIASLMDK---------CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHHH-HHCHHHHHHH---------HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCccccccCHHHHHHHHHHh-hhhHHHHHHH---------hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 99986432211111000000 0000000000 0001356888999999999999999999999999999988
Q ss_pred HHhhc
Q 047140 305 DSLLR 309 (313)
Q Consensus 305 ~~~~~ 309 (313)
.+...
T Consensus 329 ~~~~~ 333 (364)
T 3op5_A 329 KAIGS 333 (364)
T ss_dssp HHTTC
T ss_pred HHcCC
Confidence 77543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=339.47 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=209.2
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcCCCCcceeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIRHRNLIKVISTCS 91 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (313)
....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999999954 69999999997642 113346778999999999999999999999
Q ss_pred eCccceEEEEeecCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 92 NEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
+.+..++|+||+.+| +|.+++.... .+++..++.++.||+.||.||| +++++|+||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999998666 9999997765 6899999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
++....... ......++..|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------- 238 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------- 238 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence 998654322 2234568999999999988776 8899999999999999999999965321100
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.. ...+..+++++.+|+.+||..||++|||+.++++|+|-
T Consensus 239 -----~~--------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 239 -----AA--------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp -----TC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred -----hc--------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00 00122367789999999999999999999999999884
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=346.16 Aligned_cols=279 Identities=16% Similarity=0.141 Sum_probs=206.4
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC---
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--- 93 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (313)
...+.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3467899999999999999999999965 5899999999753 334567889999999999999999999999776
Q ss_pred --ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 94 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.||| +.|++||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 56899999996 59999997654 6899999999999999999999 99999999999999999999999999999
Q ss_pred hhhccccccc--------------------ccccccccccccCCCccc-ccCCCCCcchhHHHHHHHHHHHhCCCCChhh
Q 047140 172 AKLLTGEYQS--------------------MTQTQTLATIGCIAPEYR-RKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230 (313)
Q Consensus 172 ~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~p~~~~ 230 (313)
++........ .......+|..|+|||++ ....++.++|||||||++|||++|..||...
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9876432211 112456789999999985 5667999999999999999999866555332
Q ss_pred hhhhh-hhh------------------------------hccCCc-------ccccccccccccccChhhhhhhhhhhhH
Q 047140 231 FNREM-TLK------------------------------HWGNNW-------LPISTMEVVDANLLSQEDIHFVAKEQCV 272 (313)
Q Consensus 231 ~~~~~-~~~------------------------------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (313)
..... .+. ...... ........+.................++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 11000 000 000000 0000000000000000000001123578
Q ss_pred HHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 273 SFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 273 ~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
+++.+|+.+||..||++|||++|+++|+|-.
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 8899999999999999999999999998853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=351.30 Aligned_cols=259 Identities=20% Similarity=0.271 Sum_probs=213.1
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc-------------hhHHHHHHHHHHHhcCCCCcceee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-------------RAFKSFNIECEMMKSIRHRNLIKV 86 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~ 86 (313)
..+.++|++++.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 456789999999999999999999965 588999999975421 235678899999999999999999
Q ss_pred eeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---c
Q 047140 87 ISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---V 163 (313)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~ 163 (313)
++++.++...++||||+++++|.+.+.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999999987655 6899999999999999999999 99999999999999998776 6
Q ss_pred eeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
+||+|||++....... ......++..|+|||++. ..++.++|||||||++|+|++|..||......+.........
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999998664322 233456899999999876 468999999999999999999999997765443322221111
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
. .........+++++.+|+.+||..||++|||++++++|+|-..
T Consensus 264 ~-----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 264 Y-----------------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp C-----------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred C-----------------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 0 0011123457888999999999999999999999999999643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=335.95 Aligned_cols=273 Identities=18% Similarity=0.228 Sum_probs=205.0
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
....++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 455679999999999999999999954 69999999997542 223456778999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-----CCCceeEcCCcch
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-----DNMVAHLSDFSIA 172 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-----~~~~~~l~dfg~~ 172 (313)
+||||+++ +|.+++.... .+++..++.++.||+.||.||| +++++|+||||+|||++ .++.+||+|||++
T Consensus 110 lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999975 9999998765 6899999999999999999999 99999999999999994 4556999999999
Q ss_pred hhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-------c
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-------W 244 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-------~ 244 (313)
........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||......+......... +
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 87643221 22344678999999988764 48999999999999999999999997765433322211100 0
Q ss_pred cc----ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 245 LP----ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 245 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.. ........ ...........+..+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 263 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 263 PGVTALPDWKQSFP--KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp TTGGGSTTCCTTCC--CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhh--hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 00 00000000 0011112222344577889999999999999999999999999884
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=348.00 Aligned_cols=259 Identities=21% Similarity=0.228 Sum_probs=212.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|++.+.||+|+||.||++..+ +++.||+|++... .....+.+.+|..++..++||||++++++|.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34689999999999999999999975 6999999999753 1223456888999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++|+|.+++...+..+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|||++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999876557999999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCcccc-------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRR-------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
... .......||..|+|||++. ...++.++|+|||||++|||++|..||......+.........
T Consensus 215 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------- 286 (412)
T 2vd5_A 215 DGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK------- 286 (412)
T ss_dssp TSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-------
T ss_pred CCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------
Confidence 221 1123356899999999887 3568999999999999999999999997765443322211100
Q ss_pred ccccccccChhhhh-hhhhhhhHHHHHHHHhHhhccCCCCC---CCHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIH-FVAKEQCVSFVFNLAIECTVESPEQR---INAREIVAKLFK 302 (313)
Q Consensus 251 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~~il~~l~~ 302 (313)
.... ...+..++.++.+|+++||. +|++| |+++++++|+|-
T Consensus 287 ----------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 287 ----------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp ----------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred ----------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 0000 00123577889999999999 99998 599999999884
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=345.45 Aligned_cols=252 Identities=28% Similarity=0.375 Sum_probs=211.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-cceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE-FKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 468999999999999999999874 7899999997653 4578899999999999999999999987665 78999999
Q ss_pred ecCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++|+|.+++...+. .++...++.++.|++.||.||| +++++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999986543 4799999999999999999999 999999999999999999999999999998754321
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||++.+..++.++||||||+++|||++ |..||......+........
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------------------ 402 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------------ 402 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT------------------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 122356788999999999999999999999999999998 99999765443322211110
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.....+..+++.+.+|+.+||+.||++|||+.+++..|+.+...
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00112446788899999999999999999999999999988754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=350.10 Aligned_cols=277 Identities=18% Similarity=0.167 Sum_probs=193.4
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----- 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (313)
.+.++|++++.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 45689999999999999999999965 6899999999653 334567888999999999999999999999443
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred ceEEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 56899999985 69999997654 6999999999999999999999 9999999999999999999999999999998
Q ss_pred hccccccc-------------------------ccccccccccccCCCccc-ccCCCCCcchhHHHHHHHHHHHh-----
Q 047140 174 LLTGEYQS-------------------------MTQTQTLATIGCIAPEYR-RKGRESTNGDVYSFGIMLMETFT----- 222 (313)
Q Consensus 174 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~llt----- 222 (313)
........ .......+|..|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 65422110 112345679999999976 56679999999999999999999
Q ss_pred ------CCCCChhhhhhhhhhhhccCC---------------------ccccc---------ccccccccccChhhhhhh
Q 047140 223 ------RKKPTDEIFNREMTLKHWGNN---------------------WLPIS---------TMEVVDANLLSQEDIHFV 266 (313)
Q Consensus 223 ------g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~---------~~~~~~~~~~~~~~~~~~ 266 (313)
|.++|.+.............. ..... ..................
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 556664432110000000000 00000 000000000000000011
Q ss_pred hhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 267 AKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 267 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....++.++.+|+.+||..||++|||++|+++|+|-.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 1234578899999999999999999999999999853
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=332.53 Aligned_cols=264 Identities=21% Similarity=0.317 Sum_probs=215.4
Q ss_pred cccccccccccccceeeeEEEEEe------ecceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI------SSAMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEE 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (313)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 357999999999999999999984 246899999997653 33456788999999999 7999999999987754
Q ss_pred -cceEEEEeecCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
..++|+||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEE
Confidence 58999999999999999986542 2789999999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999986644332223344557788999999999999999999999999999998 999997654322211
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
...... .....+..+++.+.+++.+||..||++|||+.+++++|..+.+...
T Consensus 262 ~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 262 RRLKEG-------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHhccC-------------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 110000 0001123467789999999999999999999999999999887644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=323.83 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=210.0
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--ccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 99 (313)
.++|++.+.||+|+||.||+|... ++.||+|++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 478999999999999999999974 889999999765 234567799999999999999999999999887 788999
Q ss_pred EEeecCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
|||+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||||+||++++++.++++||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999987643 5899999999999999999999 999 9999999999999999999999888765422
Q ss_pred cccccccccccccccccCCCcccccCCCCC---cchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGREST---NGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.....++..|+|||++.+..++. ++||||||+++|+|++|..||.................
T Consensus 165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------- 228 (271)
T 3kmu_A 165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL--------- 228 (271)
T ss_dssp -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC---------
T ss_pred -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC---------
Confidence 22346788999999988765544 79999999999999999999977654433222211110
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..++..+.+++.+||..||++|||++++++.+..+.+
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ----------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001134567889999999999999999999999999988754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=348.38 Aligned_cols=271 Identities=20% Similarity=0.167 Sum_probs=203.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
.+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 34679999999999999999999955 5999999999754 3445677889999999999999999999996553
Q ss_pred --cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 95 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..|+||||+++ +|.+.+.. .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||++
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 56999999976 67777753 4889999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc------
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP------ 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~------ 246 (313)
+..... .......+|..|+|||++.+..++.++|||||||++|+|++|..||.+....+...........+
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 866432 12344678999999999999999999999999999999999999997754332221111100000
Q ss_pred ---ccccccccccc-cChh-----------hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ---ISTMEVVDANL-LSQE-----------DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ---~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
......+.... .... +.........+.++.+|+.+||..||++|||++|+++|+|-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 00000000000 0000 00001122347789999999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=325.55 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=211.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
+.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3478999999999999999999966 589999999976421 135788999999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----ceeEcCCcc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDFSI 171 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~----~~~l~dfg~ 171 (313)
.++|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999997654 6899999999999999999999 99999999999999998877 899999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
+....... ......++..|+|||++.+..++.++||||||+++|+|++|..||......+.........
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 227 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN-------- 227 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc--------
Confidence 87654321 2234458889999999998999999999999999999999999997654333222111100
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..........+++.+.+++.+||..||++|||+.++++|+|-..
T Consensus 228 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 228 ---------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ---------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ---------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 00011123456788999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=327.59 Aligned_cols=268 Identities=25% Similarity=0.315 Sum_probs=211.0
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeecc----cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ----CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.|..++.||+|+||.||+|.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 344458999999999999986 5889999998653 23456788999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 99999999999743 346899999999999999999999 9999999999999999999999999999987654333
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-cccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 258 (313)
.........++..|+|||.+.+ .++.++||||||+++|+|++|..||................. ........++....
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 2222334568999999998764 578999999999999999999999976543322111100000 00001111111110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
..+..++..+.+++.+||..||++|||+.+++++|+.+..
T Consensus 267 -------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 267 -------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1134567889999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=331.32 Aligned_cols=257 Identities=19% Similarity=0.245 Sum_probs=209.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
...++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++|+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 45689999999999999999999976 58999999997765566788899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999999998876567999999999999999999999 9999999999999999999999999999876542211
Q ss_pred cccccccccccccCCCccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 181 SMTQTQTLATIGCIAPEYR-----RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.......++..|+|||++ .+..++.++||||||+++|+|++|..||.................
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 239 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP----------- 239 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-----------
Confidence 112334688899999987 466789999999999999999999999976544332221111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.....+..++..+.+++.+||..||++|||+.++++|+|
T Consensus 240 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 240 -------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp -------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred -------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 001113456788999999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=329.84 Aligned_cols=272 Identities=24% Similarity=0.322 Sum_probs=208.0
Q ss_pred hhhhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC--CCCcceeeeeeeeeC---
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI--RHRNLIKVISTCSNE--- 93 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~--- 93 (313)
....+.++|++.+.||+|+||.||+|... ++.||||++.... ......|.+++..+ +||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34556789999999999999999999874 8999999996542 23445566666554 999999999999877
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceeCCCCCCceEecCCCce
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------QVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~--------~i~h~di~p~nil~~~~~~~ 164 (313)
...++||||+++++|.+++... .+++..++.++.|++.||.||| +. +++|+||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 6789999999999999999765 4899999999999999999999 88 99999999999999999999
Q ss_pred eEcCCcchhhcccccccc--cccccccccccCCCcccccCCCCCc------chhHHHHHHHHHHHhC----------CCC
Q 047140 165 HLSDFSIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKGRESTN------GDVYSFGIMLMETFTR----------KKP 226 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~~l~~lltg----------~~p 226 (313)
||+|||++.......... ......++..|+|||++.+...... +|||||||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654322111 1124468999999999987776665 9999999999999999 555
Q ss_pred ChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
|............. ...+.................+++++.+|+.+||..||++|||+.+++++|..+.++
T Consensus 262 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 262 YHDLVPSDPSYEDM---------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTSCSSCCHHHH---------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhhhcCCCCchhhh---------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 54432211111000 000000001111111122346888999999999999999999999999999999876
Q ss_pred hh
Q 047140 307 LL 308 (313)
Q Consensus 307 ~~ 308 (313)
..
T Consensus 333 ~~ 334 (337)
T 3mdy_A 333 QD 334 (337)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=333.88 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=207.0
Q ss_pred cccccccccccccceeeeEEEEEee-cce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
..++|++.+.||+|+||.||+|... +++ +|++|.+... .......+.+|+.+++.++||||+++++++.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 3578999999999999999999954 455 4577777543 3345678899999999999999999999998765 7
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|++++.+++|.+++......+++..++.++.|++.||.||| +++++||||||+|||++.++.++|+|||++....
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8999999999999999887667999999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
............++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------------ 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------ 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------------
Confidence 4433333344556778999999999999999999999999999999 999997654433222111110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++.++.+++.+||..||++|||+.++++.+..+...
T Consensus 237 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 --------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111344677899999999999999999999999999988743
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=331.95 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=211.8
Q ss_pred hhcccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
....++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999832 4778999999654 344566788999999999999999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCce
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVA 164 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~ 164 (313)
...++||||+++++|.+++.... ..++...++.++.|++.||.||| +.+++|+||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999998653 35889999999999999999999 999999999999999984 4469
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999999986643332223334567888999999998999999999999999999998 999997654333222111110
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
. ...+..++..+.+++.+||..||++|||+.+++++|+.+...
T Consensus 263 ~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 263 R--------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp C--------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C--------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0 001235677899999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=340.21 Aligned_cols=253 Identities=24% Similarity=0.228 Sum_probs=203.0
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHH-HhcCCCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEM-MKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..+ ++.++||||++++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4579999999999999999999966 58899999997652 2334556667776 46789999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 9999999999999997755 6889999999999999999999 99999999999999999999999999999986432
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......||..|+|||++.+..++.++|+|||||++|||++|..||......+.........
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------- 255 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------- 255 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------------
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------
Confidence 21 12344578999999999999999999999999999999999999997654433322211110
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH----HHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA----REIVAKLFK 302 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~~il~~l~~ 302 (313)
...+..++..+.+|+.+||..||++||++ .++++|+|-
T Consensus 256 -------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 256 -------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred -------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 01123467789999999999999999987 688888763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=329.20 Aligned_cols=262 Identities=24% Similarity=0.280 Sum_probs=209.0
Q ss_pred hhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 17 DVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
+.+.....++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+++.
T Consensus 21 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 21 DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp ---------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred hhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 3445566789999999999999999999965 58999999997653 34678899999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+++++|.+++......+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999999999999765557999999999999999999999 999999999999999999999999999999765
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 176 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (314)
T 3com_A 176 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP------------ 241 (314)
T ss_dssp BTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred hhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC------------
Confidence 43211 2234568889999999999999999999999999999999999997654332221110000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+..++..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 242 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 242 ------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp ------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 000111344678899999999999999999999999998854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=350.87 Aligned_cols=258 Identities=20% Similarity=0.242 Sum_probs=209.8
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+.++|++.+.||+|+||.||+|..+ ++..||+|++.... ......+.+|+.+++.++||||++++++|.+.+..++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35568999999999999999999965 58899999997642 2345678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhhc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKLL 175 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~~ 175 (313)
||||+++++|.+.+.... .+++..++.++.||+.||.||| ++||+||||||+|||++.. +.+||+|||++...
T Consensus 114 v~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999887654 6899999999999999999999 9999999999999999764 55999999999866
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.... ......++..|+|||++. ..++.++|||||||++|+|++|..||......+............
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------- 256 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--------- 256 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence 5322 233456899999999876 568999999999999999999999997765543332222111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.......+++.+.+|+.+||..||++|||+.++++|+|-..
T Consensus 257 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 257 --------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 00112356788999999999999999999999999999654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=338.05 Aligned_cols=273 Identities=19% Similarity=0.193 Sum_probs=206.1
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccc-hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 58999999999999999999965 689999999975422 1222445799999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+++ +|.+++...+..+++..++.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 975 999999887767999999999999999999999 9999999999999999999999999999987543221 1
Q ss_pred cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Cccccccccccccc---
Q 047140 183 TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLPISTMEVVDAN--- 256 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--- 256 (313)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ..............
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2234467899999998876 56899999999999999999999999776543332221110 00000000000000
Q ss_pred ---c-cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 ---L-LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ---~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. .............++.++.+|+.+||..||++|||++|+++|+|-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 0 0000011122345678899999999999999999999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=323.49 Aligned_cols=259 Identities=21% Similarity=0.313 Sum_probs=211.1
Q ss_pred cccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..++|++.+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45799999999999999999998542 346999999765 344567889999999999999999999998754 568
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+++++|.+++......++...++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877667999999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||................
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~------------- 231 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD------------- 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-------------
T ss_pred cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-------------
Confidence 22 112233456778999999998999999999999999999998 999996544332221111100
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+++.+||..||++|||+.+++++|..+.+.
T Consensus 232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0011234677899999999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=331.67 Aligned_cols=273 Identities=21% Similarity=0.342 Sum_probs=211.9
Q ss_pred ccccccccccccceeeeEEEEEe-----ecceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--cc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE--EF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 95 (313)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 46799999999999999999983 25899999999754 233457889999999999999999999999876 66
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++||||+++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999766667999999999999999999999 999999999999999999999999999999876
Q ss_pred cccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 176 TGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 176 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+................ .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 254 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG--QMTVTRLVN 254 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG--GGHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc--ccCHHHHHH
Confidence 433211 12334557788999999999999999999999999999999999875543221111000000 000000000
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
. . ........+..+++.+.+|+.+||..||++|||+.++++.+..+.
T Consensus 255 ~-~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 T-L--KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H-H--HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-H--hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 0 000011123467888999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=332.09 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=213.9
Q ss_pred hhhhhhcccccccccccccceeeeEEEEEee-cceE--EEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeee
Q 047140 17 DVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAME--VAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCS 91 (313)
Q Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~--vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 91 (313)
..|-....++|++.+.||+|+||.||+|... ++.. |++|.+... .....+.+.+|+++++++ +||||+++++++.
T Consensus 17 ~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 17 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 3344444579999999999999999999965 4664 499998753 334556788999999999 9999999999999
Q ss_pred eCccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCce
Q 047140 92 NEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156 (313)
Q Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ni 156 (313)
+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +++++|+||||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NI 173 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 173 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceE
Confidence 9999999999999999999997643 36899999999999999999999 99999999999999
Q ss_pred EecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhh
Q 047140 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREM 235 (313)
Q Consensus 157 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~ 235 (313)
+++.++.++|+|||++...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 9999999999999998743221 12233446778999999988889999999999999999998 9999976654333
Q ss_pred hhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 236 TLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
........ ....+..+++.+.+|+.+||..||++|||+.++++++..+.++.+
T Consensus 251 ~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 251 YEKLPQGY--------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHGGGTC--------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhhcCC--------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22111100 001123567789999999999999999999999999999887644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=332.22 Aligned_cols=277 Identities=21% Similarity=0.332 Sum_probs=217.1
Q ss_pred ccccc-ccccccccceeeeEEEEEee-----cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeC--
Q 047140 23 QTSDF-QILNFFICGVIIPVAQFLIS-----SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-- 93 (313)
Q Consensus 23 ~~~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (313)
+.++| ++.+.||+|+||.||++.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 45566 99999999999999888642 58899999997653 34567789999999999999999999999874
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++||||+++++|.+++.... +++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 57899999999999999997654 899999999999999999999 9999999999999999999999999999998
Q ss_pred hccccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-cccccc
Q 047140 174 LLTGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTME 251 (313)
Q Consensus 174 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 251 (313)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||.................. ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 76433211 1223445777899999999889999999999999999999999998765432221111110000 000000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhcc
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRN 310 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~~ 310 (313)
.+.. ......+..++..+.+|+.+||..||++|||+.++++.|..+.+++...
T Consensus 263 ~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 263 LLER------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHhc------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 0000 0011123467888999999999999999999999999999999887643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=325.06 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=212.5
Q ss_pred cccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeee-eeCccc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTC-SNEEFK 96 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 96 (313)
...+|++.+.||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++ ..++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34689999999999999999998542 336899998754 344567889999999999999999999986 455688
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++||||+++++|.+++......++...++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999999877667899999999999999999999 9999999999999999999999999999998664
Q ss_pred cccc--cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 177 GEYQ--SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 177 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.... ........++..|+|||.+.+..++.++||||||+++|+|++ |.+||......+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~---------- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----------
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----------
Confidence 3221 112234456778999999999999999999999999999999 566665543332222111110
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....+..++..+.+++.+||..||++|||+.++++.+.++.+.+..
T Consensus 250 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0011234677899999999999999999999999999999886543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=340.84 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=206.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+|++++.++ +||||+++++++.+++..|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 45689999999999999999999965 599999999976532 234688888887 899999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC----CceeEcCCcchhhc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN----MVAHLSDFSIAKLL 175 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~~~ 175 (313)
|||+++|+|.+.+...+ .+++..+..++.||+.||.||| ++|++||||||+|||+.++ +.+||+|||++...
T Consensus 95 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp ECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999997765 6899999999999999999999 9999999999999998543 35999999999865
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhh---hhhhhhccCCccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNR---EMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 252 (313)
..... ......++..|+|||++.+..++.++|||||||++|+|++|..||...... +..........
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------- 240 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF-------- 240 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--------
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--------
Confidence 43221 223456789999999998888899999999999999999999999753211 11100000000
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.........+++++.+|+++||..||++|||+.++++|+|-..
T Consensus 241 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 241 ---------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ---------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ---------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 0000112456788999999999999999999999999999743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=329.91 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=209.3
Q ss_pred ccccccccccccceeeeEEEEEeec-----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|++.+.||+|+||.||+|.... +..||+|++... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4688999999999999999998653 346999999765 3344567889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999877667999999999999999999999 99999999999999999999999999999987643
Q ss_pred cccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
.... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------------ 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------------ 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------------
Confidence 2211 11222345678999999999999999999999999999999 999997654433222111110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++||++.+++++++.+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011234677899999999999999999999999999988765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=326.85 Aligned_cols=268 Identities=25% Similarity=0.327 Sum_probs=204.6
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhc--CCCCcceeeeeeeeeC----c
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKS--IRHRNLIKVISTCSNE----E 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~ 94 (313)
..+.++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.+. .
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45678999999999999999999987 6899999999754 23455567777766 7999999999997543 4
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
..++||||+++++|.+++... .+++..++.++.|++.||.|||.. .+.+++||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 589999999999999999654 589999999999999999999932 1468999999999999999999999999
Q ss_pred cchhhcccccccc--cccccccccccCCCcccccC------CCCCcchhHHHHHHHHHHHhC----------CCCChhhh
Q 047140 170 SIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKG------RESTNGDVYSFGIMLMETFTR----------KKPTDEIF 231 (313)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg----------~~p~~~~~ 231 (313)
|++.......... ......++..|+|||++.+. .++.++|||||||++|+|++| ..||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654322111 12234689999999998876 445799999999999999999 77775543
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.......... ....................++..+.+|+.+||..||++|||+.++++.|..+
T Consensus 238 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMR---------KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHH---------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhh---------HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2211111000 00000000001111112345788899999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=323.58 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=214.2
Q ss_pred hhcccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
......|++.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 3444578888999999999999998542 337999999754 33456788999999999999999999999987655
Q ss_pred c-eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 96 K-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 96 ~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
. ++|+||+.+++|.+++......+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 5 9999999999999999887667899999999999999999999 99999999999999999999999999999976
Q ss_pred ccccc--ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCC-ChhhhhhhhhhhhccCCcccccccc
Q 047140 175 LTGEY--QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-TDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 175 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
..... .........++..|+|||.+.+..++.++||||||+++|+|++|..| |................
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------- 245 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------- 245 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--------
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--------
Confidence 54322 11223345578889999999999999999999999999999995555 44333222211111100
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....+..+++.+.+++.+||..||.+|||+.++++.+..+.+++..
T Consensus 246 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 ------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111334677899999999999999999999999999999887643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=326.25 Aligned_cols=257 Identities=19% Similarity=0.223 Sum_probs=215.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
....++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 345689999999999999999999966 4889999998754 234567788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999999887654 6899999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......+.........
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 231 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------- 231 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-------------
Confidence 2221 2234568889999999998899999999999999999999999997654333222111110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+..++..+.+++.+||..||++|||++++++|+|-..
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 232 --------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence 0112345677999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=337.43 Aligned_cols=271 Identities=21% Similarity=0.168 Sum_probs=209.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-----CCcceeeeeeeeeCc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-----HRNLIKVISTCSNEE 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~ 94 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... ......+..|+++++.++ ||||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 345689999999999999999999964 6899999999754 344566778999999986 999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-------------
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD------------- 160 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~------------- 160 (313)
..++||||+ +++|.+++.... ..++...++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 889999997653 35899999999999999999999 999999999999999975
Q ss_pred ------------CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCCh
Q 047140 161 ------------NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228 (313)
Q Consensus 161 ------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~ 228 (313)
++.+||+|||++..... ......++..|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 78999999999975432 2234568999999999999999999999999999999999999997
Q ss_pred hhhhhhhhhhhccCCc--cccc--------ccccccccc---------cChh------hhhhhhhhhhHHHHHHHHhHhh
Q 047140 229 EIFNREMTLKHWGNNW--LPIS--------TMEVVDANL---------LSQE------DIHFVAKEQCVSFVFNLAIECT 283 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~~~---------~~~~------~~~~~~~~~~~~~l~~li~~~l 283 (313)
.....+.......... .... ....++... .... ..........++.+.+|+.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 6543322111110000 0000 000000000 0000 0000011223477889999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 047140 284 VESPEQRINAREIVAKLF 301 (313)
Q Consensus 284 ~~dP~~Rps~~~il~~l~ 301 (313)
+.||++|||++++++|+|
T Consensus 341 ~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp CSSGGGSCCHHHHTTSGG
T ss_pred cCChhhCCCHHHHhcCcc
Confidence 999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=326.18 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=207.0
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccch-------hHHHHHHHHHHHhcCCCCcceeeeeeeeeC
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGR-------AFKSFNIECEMMKSIRHRNLIKVISTCSNE 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (313)
...++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44679999999999999999999964 6899999999654211 116788999999999999999999999766
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecCCCc-----eeE
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDDNMV-----AHL 166 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~~~~-----~~l 166 (313)
. ++||||+++++|.+.+......+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++. ++|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 4 6999999999999999877768999999999999999999999 999 999999999999988776 999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccc--cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRR--KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~ 244 (313)
+|||++..... ......++..|+|||++. ...++.++||||||+++|+|++|..||...............
T Consensus 171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-- 243 (287)
T 4f0f_A 171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-- 243 (287)
T ss_dssp CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH--
T ss_pred CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh--
Confidence 99999875432 223456889999999883 456789999999999999999999999765432221110000
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
. .......+..+++.+.+++.+||..||++|||+.++++.|.++
T Consensus 244 ---------~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ---------E------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------H------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------c------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 0000111345678899999999999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=333.45 Aligned_cols=264 Identities=21% Similarity=0.314 Sum_probs=215.8
Q ss_pred ccccccccccccceeeeEEEEEeec-c-----eEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-A-----MEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
.++|++.+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999542 3 47999999765 234567789999999999 89999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 96 KALVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
.++||||+++++|.+++... ...+++..++.++.|++.||.||| +++++|+||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence 99999999999999999753 235789999999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhcc
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWG 241 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~ 241 (313)
.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999986644332222334556778999999998999999999999999999999 9999976543222111110
Q ss_pred CCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 242 NNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
... ....+..++..+.+++.+||..||.+|||+.+++++|.++..+..+
T Consensus 282 ~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 330 (333)
T 2i1m_A 282 DGY-------------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330 (333)
T ss_dssp HTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cCC-------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence 000 0011234567899999999999999999999999999998876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=333.97 Aligned_cols=275 Identities=21% Similarity=0.246 Sum_probs=209.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3469999999999999999999965 48999999986542 33456678999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++++|.+++.... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......
T Consensus 103 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 99999888887765544 6899999999999999999999 9999999999999999999999999999997654322
Q ss_pred ccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC--Ccccc--------c
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN--NWLPI--------S 248 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~--~~~~~--------~ 248 (313)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||......+........ ...+. .
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 22345688899999988765 7899999999999999999999999776543322211100 00000 0
Q ss_pred -ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 -TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........ .............+++.+.+|+.+||..||++|||++|+++|+|-..
T Consensus 257 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 257 VFAGVRLPE-IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GGTTCCCCC-CSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccccCcc-ccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 00000000 00011111122357888999999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=334.66 Aligned_cols=278 Identities=18% Similarity=0.224 Sum_probs=211.0
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeee------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSN------ 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 92 (313)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 44579999999999999999999964 68999999986542 2234567889999999999999999999977
Q ss_pred --CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 93 --EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
++..++||||+++ +|.+.+......+++..++.++.|++.||.||| ++|++||||||+|||++.++.++|+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999975 888888877667999999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccc--cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CC--
Q 047140 171 IAKLLTGEYQ--SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NN-- 243 (313)
Q Consensus 171 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~-- 243 (313)
++..+..... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.............. ..
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986542221 112234567899999998876 4579999999999999999999999977554332221111 00
Q ss_pred ---cccccccccccccc----cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 244 ---WLPISTMEVVDANL----LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 244 ---~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
+............. ..............++.+.+|+.+||..||++|||++|+++|+|-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 00000000000000 0000001111122366799999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=337.08 Aligned_cols=276 Identities=18% Similarity=0.247 Sum_probs=216.4
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
....++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 445679999999999999999999965 5899999999765 34456788999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||||+++++|.+++.... .+++..+..++.|++.||.||| +. +++|+||||+||+++.++.++|+|||++.....
T Consensus 109 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999997765 6899999999999999999999 85 899999999999999999999999999876532
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC---cc---------
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN---WL--------- 245 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~---~~--------- 245 (313)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||................ ..
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2 2234568899999999999999999999999999999999999997654332211110000 00
Q ss_pred -------------cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 246 -------------PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 246 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.....+..+.... ..........++.++.+|+.+||+.||++|||++++++|+|-....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVN--EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHH--SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhc--cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 0000000000000 0000001234678899999999999999999999999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=344.98 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=202.6
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcCCCCcceeeeee
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIRHRNLIKVIST 89 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (313)
+...+.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||++++++
T Consensus 129 ~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp SCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred cchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34566789999999999999999999965 58999999997541 1122357889999999999999999999
Q ss_pred eeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC---ceeE
Q 047140 90 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM---VAHL 166 (313)
Q Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~---~~~l 166 (313)
+..+ ..++||||+++++|.+++.... .+++..++.++.|++.||.||| +++++||||||+|||++.++ .+||
T Consensus 209 ~~~~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 209 FDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EESS-EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EecC-ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence 8654 4789999999999999887654 6899999999999999999999 99999999999999997544 5999
Q ss_pred cCCcchhhcccccccccccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 9999998764321 2234568999999998753 567889999999999999999999997543221111111000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...........+++.+.+|+.+||..||++|||++++++|+|-...
T Consensus 361 ----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 361 ----------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp ----------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ----------------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0000011234567889999999999999999999999999986443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=322.93 Aligned_cols=254 Identities=23% Similarity=0.286 Sum_probs=204.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34579999999999999999999976 69999999997542 234567889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+++++|.+++.... .+++..++.++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999997665 6899999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.. ......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||................
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 227 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------- 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------
Confidence 21 1234467889999999887765 689999999999999999999997654322221111000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+++.+||+.||++|||+.++++|+|-.
T Consensus 228 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 228 --------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 001234567799999999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=336.73 Aligned_cols=271 Identities=21% Similarity=0.197 Sum_probs=204.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc---
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (313)
..+.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 345789999999999999999999964 6999999999653 3345677889999999999999999999997663
Q ss_pred ---cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 95 ---FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 95 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
..|+||||+ +++|.+++... .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 77999999764 5899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-ccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPIST 249 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~~~ 249 (313)
++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.......... .+...
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9865321 234568899999998877 6789999999999999999999999976544332221111000 00000
Q ss_pred ---------cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 ---------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+.................+++.+.+|+.+||..||++|||+.++++|+|-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 00000000000000011123567889999999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.03 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=211.6
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcC-CCCcceeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSI-RHRNLIKVISTC 90 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 90 (313)
..+.++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445678999999999999999999975 69999999997542 12245678899999999 899999999999
Q ss_pred eeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 91 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
......++||||+++++|.+++.... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++.++|+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999999999997654 6899999999999999999999 9999999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCccccc------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRK------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW 244 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~ 244 (313)
++..+.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 987664322 2334568999999998763 3578999999999999999999999966433222211111000
Q ss_pred ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 245 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........++..+.+++.+||..||++|||+.++++|+|-
T Consensus 323 -----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 323 -----------------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp -----------------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred -----------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 00011123567789999999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=349.46 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=214.6
Q ss_pred ccccccccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||+|..+. +..||||++.... ...+.+.+|++++++++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4679999999999999999999764 8999999997653 3467889999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++... ...++...++.++.||+.||.||| +++++||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 9999999999764 346899999999999999999999 99999999999999999999999999999986643221
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||++.+..++.++||||||+++|||++ |..||......+........
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~------------------ 435 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------------ 435 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT------------------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------------
Confidence 12223445678999999998899999999999999999999 99999775443322111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+..+++.+.+|+.+||+.||++|||+.++++.|..+.
T Consensus 436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 001123457888999999999999999999999999988763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=322.86 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=213.9
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+++++.++||||+++++++.+ +..++|+||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 47899999999999999999998778899999997653 345778899999999999999999999874 4589999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++++|.+++.... ..+++..++.++.|++.||.||| ++|++|+||||+||++++++.++|+|||++........ .
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 9999999997542 25899999999999999999999 99999999999999999999999999999986643221 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------------ 227 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------------ 227 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------------
Confidence 2233456778999999988889999999999999999999 999997654433222111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..+++.+.+++.+||..||++|||+.++++.+..+....
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 00112356788999999999999999999999999999987664
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=331.26 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=194.0
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3579999999999999999999954 68999999987542 344567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 101 EYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 101 e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999964 2346899999999999999999999 9999999999999999999999999999997
Q ss_pred hcccccc---cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 174 LLTGEYQ---SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 174 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
....... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||................... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS--L 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC--T
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc--c
Confidence 6543211 111233468889999998875 568999999999999999999999997754433322211111000 0
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. ..........++..+.+++.+||..||.+|||+.++++|+|-.
T Consensus 248 ~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 292 (303)
T 2vwi_A 248 ET---------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292 (303)
T ss_dssp TC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred cc---------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence 00 0000111234677899999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.95 Aligned_cols=255 Identities=19% Similarity=0.226 Sum_probs=214.8
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
...++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+++..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45679999999999999999999965 4889999999754 2345678899999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||+++++|.+++.... .+++..++.++.||+.||.||| +++++|+||||+||+++.++.++|+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999999987654 6899999999999999999999 99999999999999999999999999999976542
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||......+.........
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 257 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-------------- 257 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC--------------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC--------------
Confidence 221 2234568889999999999899999999999999999999999997654332221111100
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+|+.+||..||++|||++++++|+|-.
T Consensus 258 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 258 -------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred -------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 011234567799999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.69 Aligned_cols=259 Identities=19% Similarity=0.229 Sum_probs=199.7
Q ss_pred hcccccccc-cccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhc-CCCCcceeeeeeeee----Cc
Q 047140 22 SQTSDFQIL-NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKS-IRHRNLIKVISTCSN----EE 94 (313)
Q Consensus 22 ~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~ 94 (313)
.+.++|.+. +.||+|+||.||++... +++.||||++... ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 345677776 68999999999999965 5899999999643 356678888744 589999999999876 56
Q ss_pred cceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg 170 (313)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 7899999999999999998653 36899999999999999999999 999999999999999997 7899999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++....... ......+|..|+|||++.+..++.++|||||||++|+|++|..||............. .
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---------~ 277 (400)
T 1nxk_A 210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------T 277 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---------H
T ss_pred cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---------H
Confidence 998654221 2234567899999999999999999999999999999999999996543221100000 0
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.+.... ..........++.++.+|+++||..||++|||+.++++|+|-..
T Consensus 278 ~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 278 RIRMGQ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHTC----CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHcCc----ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 000000 00000012357788999999999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=333.32 Aligned_cols=269 Identities=20% Similarity=0.166 Sum_probs=202.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (313)
.+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 35679999999999999999999955 5899999999753 3345677889999999999999999999997654
Q ss_pred --cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 95 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.||| ++|++||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 88888863 4889999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc------
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP------ 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~------ 246 (313)
....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+................+
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8654221 2234568899999999999999999999999999999999999997765433222211110000
Q ss_pred ------------------ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ------------------ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
............ +.........+..+.+|+.+||..||++|||++++++|+|--
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLF---PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGS---CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccC---cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 000000000000 000111234578899999999999999999999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=334.21 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=210.7
Q ss_pred hhcccccccc-cccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 21 RSQTSDFQIL-NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 21 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
..+.++|.+. +.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.+ +||||+++++++.+++.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4566788887 89999999999999965 5999999999764 233457788999999999 56999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCcc
Q 047140 96 KALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFSI 171 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 171 (313)
.++||||+++++|.+++... ...+++..++.++.|++.||.||| +.|++||||||+||+++. ++.++|+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999988654 347899999999999999999999 999999999999999987 78999999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
+....... ......++..|+|||++.+..++.++||||||+++|+|++|..||......+..........
T Consensus 181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------- 250 (327)
T 3lm5_A 181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV------- 250 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------
T ss_pred ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc-------
Confidence 98664322 22345689999999999999999999999999999999999999976554433222111110
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........++..+.+|+.+||..||++|||++++++|+|-
T Consensus 251 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 251 ----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp ----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred ----------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 00001123567789999999999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.82 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=204.9
Q ss_pred cccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeee-eCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCS-NEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 98 (313)
..|++.+.||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 468888999999999999999542 347899998654 3456678999999999999999999999875 4567899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++......++...++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877667899999999999999999999 999999999999999999999999999999865432
Q ss_pred ccc--ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 179 YQS--MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 179 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
... .......++..|+|||++.+..++.++||||||+++|+|++ |.+||......+.........
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~------------ 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------------ 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC------------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC------------
Confidence 211 11233456778999999999999999999999999999999 777886654332222111110
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....+..++..+.+++.+||..||++|||+.+++++|..+...+..
T Consensus 314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0011345678899999999999999999999999999999877543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=345.88 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=208.8
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|..+.+..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46899999999999999999998777889999997653 335678999999999999999999999876 6789999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|.+++... +..++...++.++.|++.||.||| +++++||||||+|||+++++.+||+|||++........ .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 999999999753 346899999999999999999999 99999999999999999999999999999986643221 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------ 398 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------ 398 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 1223446778999999998999999999999999999999 999998765443322211110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..+++.+.+|+.+||..||++|||++++++.|..+..
T Consensus 399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 011134578889999999999999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.14 Aligned_cols=274 Identities=22% Similarity=0.244 Sum_probs=207.4
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc-----hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44579999999999999999999965 589999999975321 123467889999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999976 999999877667899999999999999999999 999999999999999999999999999999876
Q ss_pred ccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-------Cccc-
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-------NWLP- 246 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-------~~~~- 246 (313)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||......+........ .|..
T Consensus 163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 123345688999999988654 5799999999999999999999999776543332222110 0100
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+.+........ ........++.++.+|+.+||..||++|||+.|+++|+|-
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGI-PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TSSTTCCCCCCCCCC-CHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccCcccccccccCCC-ChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 000000000000000 0111224567889999999999999999999999999884
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=324.03 Aligned_cols=263 Identities=17% Similarity=0.140 Sum_probs=204.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
....++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 344679999999999999999999965 6899999999754 233457788999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999998654 6899999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------- 251 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI------------- 251 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC-------------
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC-------------
Confidence 3221 12234568889999999999999999999999999999999999997654432211111000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-CHHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-NAREIVAKLFKIRDS 306 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~il~~l~~~~~~ 306 (313)
......+..++..+.+++.+||..||++|| +++++++.++.+.+.
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 252 -----PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -----CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -----CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 000111345677899999999999999999 999999998876544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.10 Aligned_cols=269 Identities=17% Similarity=0.136 Sum_probs=209.8
Q ss_pred hcccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeee-eeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTC-SNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 99 (313)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+++++.++|++++..+..+ .++...++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 5678999999999999999999995 469999999876542 234578899999999888777666655 667788999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~~ 176 (313)
|||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ ++++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 88999999876667999999999999999999999 9999999999999999 788999999999998764
Q ss_pred ccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
..... .......++..|+|||++.+..++.++|||||||++|+|++|..||............ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~ 229 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------ER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH----------HH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh----------hh
Confidence 33221 1223456899999999999999999999999999999999999999764322111100 00
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
..... ...........+++.+.+++..||..||++|||++++++.+..+..+...
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 230 ISEKK---MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHH---HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhccc---ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00000 00001111245678899999999999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=323.57 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=202.8
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||++.. .++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 36899999999999999999987 4789999998654 345788999999999999999999999874 489999999
Q ss_pred cCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCC---CCceeCCCCCCceEecCCCc-eeEcCCcchhhccc
Q 047140 104 PHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYS---AQVIHCDLKPINVLLDDNMV-AHLSDFSIAKLLTG 177 (313)
Q Consensus 104 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---~~i~h~di~p~nil~~~~~~-~~l~dfg~~~~~~~ 177 (313)
++++|.+++..... .++...++.++.|++.||.||| + ++++|+||||+||+++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH---SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH---TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH---hCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999986542 4788999999999999999999 7 89999999999999998886 79999999876532
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 219 (307)
T 2eva_A 159 H-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-------------- 219 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--------------
T ss_pred c-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--------------
Confidence 2 223458899999999999999999999999999999999999997543221111000000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
......+..++..+.+++.+||..||++|||++++++++..+...+.
T Consensus 220 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 220 ----GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ----TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ----CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00001123467789999999999999999999999999998876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=324.73 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=216.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
...+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45578999999999999999999854 58999999997652 34567889999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999998754 5899999999999999999999 9999999999999999999999999999997654322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 235 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---------------- 235 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------------
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC----------------
Confidence 1 2234568889999999999999999999999999999999999997654332221111000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+|+.+||..||++|||+.++++|+|-....
T Consensus 236 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 236 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ----CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ----CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 0001234677799999999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=327.32 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=209.0
Q ss_pred ccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeee----eCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCS----NEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~l 98 (313)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999996 469999999997766667788999999999999999999999996 3357899
Q ss_pred EEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 99 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
|+||+++++|.+++.. .+..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999975 3457899999999999999999999 999999999999999999999999999987654
Q ss_pred ccccccc-------cccccccccccCCCcccccCC---CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 176 TGEYQSM-------TQTQTLATIGCIAPEYRRKGR---ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 176 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||..............
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh----
Confidence 3211100 011234688999999887554 68999999999999999999999976432211110000
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.. .........++..+.+++.+||..||.+|||+.+++++++.+...
T Consensus 261 --------~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 261 --------QN------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------HC------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------hc------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 000011234677899999999999999999999999999987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=323.73 Aligned_cols=252 Identities=14% Similarity=0.166 Sum_probs=205.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
....++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 345689999999999999999999965 6999999999764 234566788899999999 999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC------------
Q 047140 97 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN------------ 161 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~------------ 161 (313)
++||||+++++|.+++... ...+++..++.++.||+.||.||| +++++|+||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999764 246899999999999999999999 9999999999999999844
Q ss_pred -------CceeEcCCcchhhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhh
Q 047140 162 -------MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNR 233 (313)
Q Consensus 162 -------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~ 233 (313)
..++|+|||.+...... ....++..|+|||++.+. .++.++||||||+++|+|++|.+++......
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999998765422 233588999999988765 5678999999999999999999876443221
Q ss_pred hhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 234 EMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
..... ... ...+..+++.+.+++.+||..||++|||+.++++|+|-..
T Consensus 238 ~~~~~---~~~--------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 238 HEIRQ---GRL--------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHT---TCC--------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHHc---CCC--------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 11100 000 0112346788999999999999999999999999988543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=322.07 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=211.8
Q ss_pred cccccccc-ccccceeeeEEEEEee---cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILN-FFICGVIIPVAQFLIS---SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
.++|++.+ .||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 47899998 9999999999999642 4789999999764 234467899999999999999999999999 556789
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 9999999999999998754 6899999999999999999999 99999999999999999999999999999976543
Q ss_pred ccccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 178 EYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 178 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+..........
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 22111 1222345678999999988889999999999999999999 9999977654333221111100
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
...+..+++.+.+++.+||..||++|||+.++++.+..+..+..
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 01134567889999999999999999999999999999987754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=328.72 Aligned_cols=279 Identities=20% Similarity=0.213 Sum_probs=207.1
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeee------
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCS------ 91 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 91 (313)
....+.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 34567889999999999999999999966 49999999998776667788999999999999999999999873
Q ss_pred --------eCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCC
Q 047140 92 --------NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNM 162 (313)
Q Consensus 92 --------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~ 162 (313)
+....++|+||++ ++|.+++... .+++..++.++.|++.||.||| ++|++|+||||+||+++ +++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 3467899999997 5999998754 5899999999999999999999 99999999999999997 567
Q ss_pred ceeEcCCcchhhcccccc-cccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc
Q 047140 163 VAHLSDFSIAKLLTGEYQ-SMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW 240 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~ 240 (313)
.+||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.............
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999986543211 112233456888999998765 678999999999999999999999997765433222111
Q ss_pred cCCcc--ccccccc-------ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 241 GNNWL--PISTMEV-------VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 241 ~~~~~--~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..... .....+. ..................++.++.+|+.+||..||++|||++++++|+|--
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 11000 0000000 000000000001112245788899999999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=342.72 Aligned_cols=245 Identities=14% Similarity=0.104 Sum_probs=195.2
Q ss_pred ccccccccccccceeeeEEEEEe-ecceEEEEEEeecc---cchhHHHHHHHHH---HHhcCCCCcceeee-------ee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQ---CGRAFKSFNIECE---MMKSIRHRNLIKVI-------ST 89 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 89 (313)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++ +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999995 46999999999743 3445678899995 55555899999998 66
Q ss_pred eeeCc-----------------cceEEEEeecCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 047140 90 CSNEE-----------------FKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGYSAQV 146 (313)
Q Consensus 90 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 146 (313)
+.+.+ ..++||||+ +|+|.+++...+. .+++..++.++.||+.||.||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55543 278999999 5799999976431 2235788899999999999999 9999
Q ss_pred eeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccC-----------CCCCcchhHHHHH
Q 047140 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-----------RESTNGDVYSFGI 215 (313)
Q Consensus 147 ~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~ 215 (313)
+||||||+|||++.++.+||+|||++..... ......+ ..|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 1223456 899999999877 8999999999999
Q ss_pred HHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHH
Q 047140 216 MLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINARE 295 (313)
Q Consensus 216 ~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 295 (313)
++|+|++|..||............. . ....+++++.+|+.+||..||++|||+.+
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~-------------~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF-------------R------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG-------------S------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh-------------h------------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 9999999999997654322111100 0 01346778999999999999999999999
Q ss_pred HHHHHHHH
Q 047140 296 IVAKLFKI 303 (313)
Q Consensus 296 il~~l~~~ 303 (313)
+++|+|-.
T Consensus 357 ~l~hp~f~ 364 (377)
T 3byv_A 357 AMETPEYE 364 (377)
T ss_dssp HHTSHHHH
T ss_pred HhhChHHH
Confidence 99998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=323.44 Aligned_cols=260 Identities=20% Similarity=0.188 Sum_probs=195.8
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3579999999999999999999964 69999999997642 22233444555567888999999999999999999999
Q ss_pred EEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 100 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
|||+++ +|.+++.. ....+++..++.++.|++.||.||| ++ |++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999975 88887754 3457999999999999999999999 87 9999999999999999999999999999866
Q ss_pred ccccccccccccccccccCCCccc----ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYR----RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
.... ......++..|+|||++ .+..++.++||||||+++|+|++|..||...............
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 228 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--------- 228 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH---------
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc---------
Confidence 4322 22334688999999985 5667899999999999999999999999753222111111000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
.... ......++..+.+++.+||+.||++|||+.++++|+|-.....
T Consensus 229 ---~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 229 ---EPSP------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp ---SCCC------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred ---cCCC------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 0000 0012346778999999999999999999999999999766543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=352.68 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=212.9
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+++.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999965 6999999999754 12335668899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
||||++||+|.+++...+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999997654 35899999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||............. ..+.
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----------~~i~--- 402 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------RLVK--- 402 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH----------HHHH---
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH----------HHhh---
Confidence 22 2234578999999999999899999999999999999999999997643211100000 0000
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFKI 303 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~~ 303 (313)
......+..++.++.+|+.+||..||++|| +++++++|+|-.
T Consensus 403 ----~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 403 ----EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred ----cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 000011345678899999999999999999 899999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=327.26 Aligned_cols=277 Identities=23% Similarity=0.369 Sum_probs=218.5
Q ss_pred cccccccccccccceeeeEEEEEe-----ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc--c
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLI-----SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--F 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 95 (313)
..++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 456899999999999999999984 258999999998776667788999999999999999999999987654 7
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999999887667999999999999999999999 999999999999999999999999999999876
Q ss_pred cccccc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC--ccccccccc
Q 047140 176 TGEYQS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN--WLPISTMEV 252 (313)
Q Consensus 176 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 252 (313)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+................ .......+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 433211 11223446677999999998889999999999999999999999986542211110000000 000000000
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
+.. ......+..++.++.+++.+||..||++|||+.++++.+..+.+++.
T Consensus 276 ~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 276 LKN------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHT------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhc------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 000 00111234678889999999999999999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=324.96 Aligned_cols=256 Identities=19% Similarity=0.248 Sum_probs=208.9
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee--Cccce
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFKA 97 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 97 (313)
..++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+ +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4579999999999999999999965 5899999999764 34456788999999999999999999998854 56789
Q ss_pred EEEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceeCCCCCCceEecCCCceeEcCC
Q 047140 98 LVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQ-----VIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~h~di~p~nil~~~~~~~~l~df 169 (313)
+||||+++++|.+++... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 999999999999999753 335899999999999999999999 888 999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
|++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||.................
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----- 233 (279)
T 2w5a_A 161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----- 233 (279)
T ss_dssp CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----
T ss_pred chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-----
Confidence 99987543211 12234578899999999988999999999999999999999999976543322211111100
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..++..+.+++.+||+.||++|||+.++++++|..
T Consensus 234 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 ---------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 011234678899999999999999999999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.65 Aligned_cols=275 Identities=20% Similarity=0.190 Sum_probs=205.7
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeeccc-----------chhHHHHHHHHHHHhcCCCCcceeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC-----------GRAFKSFNIECEMMKSIRHRNLIKVIST 89 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (313)
..+.++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 56678999999999999999999997779999999996531 1224788999999999999999999999
Q ss_pred eee-----CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 90 CSN-----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 90 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
+.. ....++||||+. ++|.+.+......+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCE
Confidence 854 336799999997 5999999877667999999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 174 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 174 TICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp EECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 999999997543222 2334568888999998876 678999999999999999999999997654332222111100
Q ss_pred ccc----------ccccccccccccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 244 WLP----------ISTMEVVDANLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 244 ~~~----------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..+ ............. ...........+++.+.+|+.+||..||++|||+.++++|+|-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 000 0000000000000 0001111234567889999999999999999999999999884
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=321.43 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=209.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee-------
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN------- 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 92 (313)
....++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 455678999999999999999999975 69999999997653 346689999999999999999999864
Q ss_pred ---------CccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC
Q 047140 93 ---------EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162 (313)
Q Consensus 93 ---------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~ 162 (313)
....++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||++++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence 44589999999999999999754 346899999999999999999999 99999999999999999999
Q ss_pred ceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 163 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+............
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--- 233 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD--- 233 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHT---
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhc---
Confidence 99999999987654322 223456889999999999999999999999999999999999997653221110000
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
...+..++..+.+++.+||..||++|||+.+++++|+.+.....+
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 001223567789999999999999999999999999998766544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.29 Aligned_cols=275 Identities=19% Similarity=0.166 Sum_probs=210.8
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----cc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-----EF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 95 (313)
+.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4579999999999999999999965 6899999999754 334457888999999999999999999999665 36
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+|++.+ +|.+++... .+++..++.++.|++.||.||| ++|++|+||||+||+++.++.++|+|||++...
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 8999999975 999998765 4899999999999999999999 999999999999999999999999999999866
Q ss_pred ccccccc-cccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--ccccc
Q 047140 176 TGEYQSM-TQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--ISTME 251 (313)
Q Consensus 176 ~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 251 (313)
....... ......++..|+|||++. +..++.++|||||||++|+|++|..||......+...........+ .....
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 4332211 123457899999999765 4558999999999999999999999997765433322211100000 00000
Q ss_pred cc--------cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 252 VV--------DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 252 ~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. .................++.++.+|+.+||..||++|||++++++|+|-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 00 00000000001111245678899999999999999999999999999853
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=323.84 Aligned_cols=257 Identities=19% Similarity=0.237 Sum_probs=206.3
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc----chhHHHHHHHHHHHhcCCCCcceeeeeee--eeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC----GRAFKSFNIECEMMKSIRHRNLIKVISTC--SNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 95 (313)
..++|++++.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4579999999999999999999964 58899999997542 23457889999999999999999999998 44568
Q ss_pred ceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhh
Q 047140 96 KALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKL 174 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 174 (313)
.++||||++++ |.+++... ...+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||.+..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999874 77777653 446899999999999999999999 99999999999999999999999999999986
Q ss_pred cccccccccccccccccccCCCcccccCCC--CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRE--STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
..............++..|+|||++.+... +.++||||||+++|+|++|..||................
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--------- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--------- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC---------
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC---------
Confidence 643322223344568899999998876543 789999999999999999999997654322211111100
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+..++..+.+++.+||..||++|||+.++++|+|-..
T Consensus 230 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 230 ------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp ------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred ------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 0112346778999999999999999999999999998643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.16 Aligned_cols=277 Identities=14% Similarity=0.119 Sum_probs=208.3
Q ss_pred hcchhhhhhhcccccccccccccceeeeEEEEEee----cceEEEEEEeecccch-----------hHHHHHHHHHHHhc
Q 047140 13 ILSRDVFRRSQTSDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQCGR-----------AFKSFNIECEMMKS 77 (313)
Q Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~ 77 (313)
+-++..+.....++|++.+.||+|+||.||+|... ++..||+|++...... ....+.+|+..++.
T Consensus 25 l~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~ 104 (345)
T 2v62_A 25 FPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104 (345)
T ss_dssp CCTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHT
T ss_pred CCCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcc
Confidence 33455555556789999999999999999999965 5789999999765321 11235678888999
Q ss_pred CCCCcceeeeeeeee----CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 047140 78 IRHRNLIKVISTCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153 (313)
Q Consensus 78 l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p 153 (313)
++||||+++++++.+ +...++||||+ +++|.+++...+ .+++..++.++.||+.||.||| +.+++||||||
T Consensus 105 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp 179 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKA 179 (345)
T ss_dssp CSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred ccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCH
Confidence 999999999999988 77899999999 889999998765 7899999999999999999999 99999999999
Q ss_pred CceEecCCC--ceeEcCCcchhhccccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 047140 154 INVLLDDNM--VAHLSDFSIAKLLTGEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226 (313)
Q Consensus 154 ~nil~~~~~--~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p 226 (313)
+|||++.++ .++|+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999887 9999999999766432211 111345689999999999999999999999999999999999999
Q ss_pred ChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
|................. ... .............++..+.+++..||..||++|||+.++++.|+.+.
T Consensus 260 f~~~~~~~~~~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 260 WEQNLKDPVAVQTAKTNL---------LDE-LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TGGGTTCHHHHHHHHHHH---------HHT-TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccccccccHHHHHHHHhh---------ccc-ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 965322111111000000 000 00000000001257788999999999999999999999999987653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=330.29 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=205.9
Q ss_pred hhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc--------chhHHHHHHHHHHHhcCCCCcceeeeee
Q 047140 19 FRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIRHRNLIKVIST 89 (313)
Q Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (313)
+...+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||++++++
T Consensus 4 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp CCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 34566789999999999999999999965 58999999986531 1223457889999999999999999999
Q ss_pred eeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc---eeE
Q 047140 90 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV---AHL 166 (313)
Q Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~---~~l 166 (313)
+..+. .++||||+++++|.+++.... .+++..++.++.||+.||.||| +++++|+||||+||+++.++. ++|
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence 97665 899999999999999987654 6899999999999999999999 999999999999999987664 999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
+|||++....... ......++..|+|||++. ...++.++|||||||++|+|++|..||...............
T Consensus 159 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~- 234 (322)
T 2ycf_A 159 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 234 (322)
T ss_dssp CCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-
T ss_pred ccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-
Confidence 9999987654221 122345889999999864 567899999999999999999999999754332111110000
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. ..........++..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 235 -----------~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~ 279 (322)
T 2ycf_A 235 -----------GK----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279 (322)
T ss_dssp -----------TC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred -----------Cc----cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence 00 0000112345678899999999999999999999999998743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=322.89 Aligned_cols=259 Identities=23% Similarity=0.280 Sum_probs=211.3
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---------chhHHHHHHHHHHHhcCC-CCcceeeee
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---------GRAFKSFNIECEMMKSIR-HRNLIKVIS 88 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 88 (313)
.....++|++.+.||+|+||.||+|..+ +++.||||++.... ....+.+.+|+++++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999965 58999999997542 123567889999999995 999999999
Q ss_pred eeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 89 TCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
++.+++..++|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999997654 6899999999999999999999 99999999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCcccc------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRR------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
||++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||...............
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99987654322 223456888999999874 456789999999999999999999999665433222111111
Q ss_pred CcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 243 NWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
... ........++..+.+++.+||..||++|||+.++++|+|-
T Consensus 245 ~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 245 NYQ-----------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp CCC-----------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred Ccc-----------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 100 0001123567889999999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=336.21 Aligned_cols=272 Identities=20% Similarity=0.180 Sum_probs=193.7
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE---- 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 356789999999999999999999954 6999999999653 334567788999999999999999999998654
Q ss_pred --ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcc
Q 047140 94 --EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSI 171 (313)
Q Consensus 94 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 171 (313)
...++|+|++ +++|.+++... .+++..++.++.||+.||.||| +.|++||||||+||+++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred cCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 67999988763 5899999999999999999999 99999999999999999999999999999
Q ss_pred hhhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc----
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP---- 246 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~---- 246 (313)
++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+................+
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865321 234568899999998876 678999999999999999999999997765432221111100000
Q ss_pred ------ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 247 ------ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 247 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+.................+++.+.+|+.+||..||++|||+.++++|+|-.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 000000000000000000111234678899999999999999999999999998843
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.66 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=211.0
Q ss_pred cccccc-ccccceeeeEEEEEee---cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 26 DFQILN-FFICGVIIPVAQFLIS---SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 26 ~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++.+.. .||+|+||.||+|.+. ++..||||+++.. .....+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999864 4678999999764 33456789999999999999999999999976 5689999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++......+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999877667999999999999999999999 99999999999999999999999999999987643221
Q ss_pred cc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 181 SM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 181 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.. ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.........
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------------- 556 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------------- 556 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---------------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 11 1122335578999999999999999999999999999998 999998765443322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....+..++..+.+|+..||..||++||++.++++.|..+..++..
T Consensus 557 -----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 557 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 0112345788899999999999999999999999999998877654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=335.91 Aligned_cols=270 Identities=21% Similarity=0.226 Sum_probs=204.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-------- 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 92 (313)
...++|++.+.||+|+||.||+|... +++.||||++..+.. ...+|+++++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34679999999999999999999954 699999999875422 22369999999999999999999844
Q ss_pred ------------------------------CccceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 047140 93 ------------------------------EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH 139 (313)
Q Consensus 93 ------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH 139 (313)
+.+.++||||+++ +|.+.+.. .+..+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3348899999975 88877753 3457999999999999999999999
Q ss_pred cCCCCCceeCCCCCCceEec-CCCceeEcCCcchhhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHH
Q 047140 140 FGYSAQVIHCDLKPINVLLD-DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIML 217 (313)
Q Consensus 140 ~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l 217 (313)
+.|++||||||+||+++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999997 68999999999998664322 23345678899999988765 589999999999999
Q ss_pred HHHHhCCCCChhhhhhhhhhhhccCCccc--ccc------cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC
Q 047140 218 METFTRKKPTDEIFNREMTLKHWGNNWLP--IST------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 218 ~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
|+|++|..||......+...........+ ... ..................+..++.++.+|+.+||..||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998765433322211100000 000 0000000011111222234557888999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 047140 290 RINAREIVAKLFK 302 (313)
Q Consensus 290 Rps~~~il~~l~~ 302 (313)
|||+.|+++|+|-
T Consensus 313 R~t~~e~l~hp~f 325 (383)
T 3eb0_A 313 RINPYEAMAHPFF 325 (383)
T ss_dssp SCCHHHHHTSGGG
T ss_pred CCCHHHHhcCHHH
Confidence 9999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=320.71 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=205.7
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
.....++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3445678999999999999999999954 6899999999753 34456788899999999999999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 96 KALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
.++|+||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999864 3446899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh-h-hccCCccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL-K-HWGNNWLPISTM 250 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~-~-~~~~~~~~~~~~ 250 (313)
........ ......++..|+|||++.+..++.++||||||+++|+|++|..||.......... . .......
T Consensus 184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 256 (310)
T 2wqm_A 184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP----- 256 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-----
T ss_pred eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-----
Confidence 76543221 1233468889999999999999999999999999999999999996543211100 0 0000000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
......++.++.+++.+||..||++|||+.++++++..+.+...
T Consensus 257 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 --------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp --------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 00023467789999999999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=321.02 Aligned_cols=269 Identities=17% Similarity=0.137 Sum_probs=214.2
Q ss_pred hcccccccccccccceeeeEEEEEe-ecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeee-eeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLI-SSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTC-SNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 99 (313)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ .++...++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4678999999999999999999996 469999999987653 235688899999999988776666655 566788999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~~ 176 (313)
+||+ +++|.+++......+++..++.++.|++.||.||| +++++|+||||+||++ ++++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 88999999866667999999999999999999999 9999999999999999 488999999999998765
Q ss_pred cccccc-----cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQSM-----TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
...... ......++..|+|||++.+..++.++||||||+++|+|++|..||............ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~ 229 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------ER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH----------HH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh----------hh
Confidence 332211 123456899999999999999999999999999999999999999764321110000 00
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
+.... ...........+++.+.+++.+||+.||++|||++++++.+..+..+...
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 230 ISEKK---MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHH---HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hcccc---cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00000 00001112245788899999999999999999999999999999887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=339.74 Aligned_cols=274 Identities=16% Similarity=0.172 Sum_probs=209.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC------CCCcceeeeeeeeeC
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI------RHRNLIKVISTCSNE 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 93 (313)
..+..+|++.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345678999999999999999999865 5899999999765 34456677788888776 577999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc--eeEcCCc
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV--AHLSDFS 170 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg 170 (313)
+..++|+||+. ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 59999987653 35899999999999999999999 999999999999999999987 9999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc----
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP---- 246 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~---- 246 (313)
++..... ......++..|+|||++.+..++.++|||||||++|+|++|..||......+...........+
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9865432 2234568899999999999999999999999999999999999997654432221111000000
Q ss_pred ----cccccccccc---------------------------c---cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC
Q 047140 247 ----ISTMEVVDAN---------------------------L---LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN 292 (313)
Q Consensus 247 ----~~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 292 (313)
......++.. . ..........+...++.+.+|+++||..||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0000000000 0 00000011112234678999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 047140 293 AREIVAKLFKIR 304 (313)
Q Consensus 293 ~~~il~~l~~~~ 304 (313)
++|+++|+|-..
T Consensus 403 a~e~L~Hpw~~~ 414 (429)
T 3kvw_A 403 PGQALRHPWLRR 414 (429)
T ss_dssp HHHHHTSTTTC-
T ss_pred HHHHhCChhhcc
Confidence 999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=330.25 Aligned_cols=269 Identities=19% Similarity=0.225 Sum_probs=205.9
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeee--Cccc
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSN--EEFK 96 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~ 96 (313)
....++|++.+.||+|+||.||+|... +++.||+|++... ..+.+.+|+++++.++ ||||+++++++.+ ....
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 344679999999999999999999854 6899999999754 3467889999999996 9999999999987 6678
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLL 175 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~ 175 (313)
++||||+.+++|.+++. .+++..++.++.|++.||.||| ++|++|+||||+|||++.++ .++|+|||++...
T Consensus 109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999885 3789999999999999999999 99999999999999999776 8999999999765
Q ss_pred ccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc-------------
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG------------- 241 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~------------- 241 (313)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 4322 2334568888999998876 6789999999999999999999999943221111000000
Q ss_pred --CCcccccccccccccccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 242 --NNWLPISTMEVVDANLLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 242 --~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.................. ...........++.++.+|+.+||+.||++|||++++++|+|-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 000000000000000000 0000111133468889999999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=331.14 Aligned_cols=279 Identities=23% Similarity=0.266 Sum_probs=201.7
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHH--HhcCCCCcceeeeeeeee-----Cccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEM--MKSIRHRNLIKVISTCSN-----EEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~ 96 (313)
.++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47999999999999999999976 68999999997542 2334445555 445899999999985532 3357
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceeCCCCCCceEecCCCceeEc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA---------QVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~---------~i~h~di~p~nil~~~~~~~~l~ 167 (313)
++||||+++++|.+++.... .++..++.++.||+.||.||| +. +++||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999997664 588899999999999999999 88 99999999999999999999999
Q ss_pred CCcchhhcccccc------cccccccccccccCCCccccc-------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhh
Q 047140 168 DFSIAKLLTGEYQ------SMTQTQTLATIGCIAPEYRRK-------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234 (313)
Q Consensus 168 dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~ 234 (313)
|||++..+..... ........+|..|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999986543211 111224468999999998876 355678999999999999999977764332211
Q ss_pred hhhhhcc---CCccc-cccccccccc-ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 235 MTLKHWG---NNWLP-ISTMEVVDAN-LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 235 ~~~~~~~---~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
....... ..... ......+... .....+........+++.+.+|+.+||..||++|||+.++++.|..+.+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 1000000 00000 0000000000 00000111111234677899999999999999999999999999999988766
Q ss_pred cC
Q 047140 310 NV 311 (313)
Q Consensus 310 ~~ 311 (313)
+-
T Consensus 323 ~~ 324 (336)
T 3g2f_A 323 NK 324 (336)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.32 Aligned_cols=276 Identities=12% Similarity=0.107 Sum_probs=214.7
Q ss_pred chhhhhhhcccccccccccccceeeeEEEEEeec---------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCccee
Q 047140 15 SRDVFRRSQTSDFQILNFFICGVIIPVAQFLISS---------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
.++++.....++|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|+++++.++||||++
T Consensus 32 ~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp TTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHH
T ss_pred CCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhh
Confidence 3444444456899999999999999999999653 789999998754 45778999999999999987
Q ss_pred ---------------eeeeeee-CccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 047140 86 ---------------VISTCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIH 148 (313)
Q Consensus 86 ---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h 148 (313)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.||+.||.||| +++++|
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH 182 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVH 182 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBC
T ss_pred hhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccC
Confidence 5667765 67889999999 88999999875 347999999999999999999999 999999
Q ss_pred CCCCCCceEecCCC--ceeEcCCcchhhcccccccc-----cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHH
Q 047140 149 CDLKPINVLLDDNM--VAHLSDFSIAKLLTGEYQSM-----TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221 (313)
Q Consensus 149 ~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll 221 (313)
+||||+||+++.++ .++|+|||++..+....... ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999998 99999999998664332111 113346889999999999999999999999999999999
Q ss_pred hCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 222 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
+|..||................+. ......... ......++..+.+|+.+||..||++|||++++++.|.
T Consensus 263 ~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 263 YGFLPWTNCLPNTEDIMKQKQKFV-DKPGPFVGP---------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHH-HSCCCEECT---------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred hCCCCcccCCcCHHHHHHHHHhcc-CChhhhhhh---------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 999999876422111111000000 000000000 0001245788999999999999999999999999999
Q ss_pred HHHHHhhc
Q 047140 302 KIRDSLLR 309 (313)
Q Consensus 302 ~~~~~~~~ 309 (313)
.+.++...
T Consensus 333 ~~~~~~~~ 340 (352)
T 2jii_A 333 ALLQDLRV 340 (352)
T ss_dssp HHHHHTTC
T ss_pred HHHHhcCC
Confidence 99887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=355.41 Aligned_cols=252 Identities=20% Similarity=0.192 Sum_probs=214.3
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++++.||+|+||.||+|..+ +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999965 5889999999754 233456778899999988 79999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++|+|.+++...+ .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999998765 6899999999999999999999 999999999999999999999999999999754322
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
. .......||..|+|||++.+..++.++||||||+++|||++|..||......+.........
T Consensus 496 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------------- 558 (674)
T 3pfq_A 496 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------------- 558 (674)
T ss_dssp T--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------------
T ss_pred C--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------------
Confidence 1 12345678999999999999999999999999999999999999998765544433222211
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCH-----HHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINA-----REIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~~il~~l~~ 302 (313)
...+..++.++.+|+++||+.||++||++ ++|++|+|-
T Consensus 559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 01134567889999999999999999998 999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.66 Aligned_cols=260 Identities=10% Similarity=0.044 Sum_probs=190.5
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcC--CCCcceeee-------eee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSI--RHRNLIKVI-------STC 90 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 90 (313)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999965 69999999998753 23456677785444444 699988755 444
Q ss_pred eeC-----------------ccceEEEEeecCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCce
Q 047140 91 SNE-----------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGYSAQVI 147 (313)
Q Consensus 91 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~~~~~i~~~l~~lH~~~~~~i~ 147 (313)
... ...|+||||++ ++|.+++...+..++...+ ..++.||+.||.||| +++|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 33799999998 7999999875444555555 778899999999999 99999
Q ss_pred eCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCC
Q 047140 148 HCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKK 225 (313)
Q Consensus 148 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~ 225 (313)
||||||+|||++.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865421 113456689999999987 678999999999999999999999
Q ss_pred CChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 226 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
||............ ...... .............+++.+.+|+.+||..||++|||+.++++|+|-..
T Consensus 292 Pf~~~~~~~~~~~~------~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 292 PFGLVTPGIKGSWK------RPSLRV------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp STTBCCTTCTTCCC------BCCTTS------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCcCcccccchh------hhhhhh------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 99776432211000 000000 00001111112457888999999999999999999999999988544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.60 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=212.1
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+...+|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3578999999999999999999975 59999999997542 2335678899999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 99 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
||||++||+|.+++... ...+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999754 336899999999999999999999 999999999999999999999999999999865
Q ss_pred ccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDA 255 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (313)
..... ......||..|+|||++.+..++.++|+|||||++|+|++|..||............. ..+...
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~---------~~i~~~ 408 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---------QRVLEQ 408 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH---------HHHHHC
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH---------HHHhhc
Confidence 43221 1233478999999999999999999999999999999999999997643211100000 000000
Q ss_pred cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 256 NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
....+..++.++.+|+.+||..||++||+ ++++++|+|-
T Consensus 409 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 409 --------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred --------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 01113457788999999999999999996 5899999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=321.74 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=200.7
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-------- 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 92 (313)
++.++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45679999999999999999999965 6999999999754 3456788999999999999999999998865
Q ss_pred -----CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 93 -----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 93 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
.+..++|+||+++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence 45689999999999999999877667889999999999999999999 9999999999999999999999999
Q ss_pred CCcchhhcccccc------------cccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhh
Q 047140 168 DFSIAKLLTGEYQ------------SMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNRE 234 (313)
Q Consensus 168 dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~ 234 (313)
|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++ ||.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 9999876542210 1112344588899999998764 68999999999999999998 443322111
Q ss_pred hhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 235 MTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........... ......+...+..+.+++.+||..||.+|||+.++++|+|-
T Consensus 236 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 236 NILKKLRSVSI----------------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp HHHHHHHSTTC----------------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred HHHHhcccccc----------------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 11111100000 00000123456778999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=338.48 Aligned_cols=278 Identities=18% Similarity=0.205 Sum_probs=214.1
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc--cce
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--FKA 97 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 97 (313)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45689999999999999999999965 48999999997642 234567789999999999999999999998765 679
Q ss_pred EEEEeecCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe----cCCCceeEcCCcc
Q 047140 98 LVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DDNMVAHLSDFSI 171 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~ 171 (313)
+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999997653 23899999999999999999999 9999999999999999 7778899999999
Q ss_pred hhhcccccccccccccccccccCCCccccc--------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh----hhhh
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRK--------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM----TLKH 239 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~----~~~~ 239 (313)
+....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ....
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 98664322 2234568999999998765 4678899999999999999999999975432211 1111
Q ss_pred ccCCcccccccccc---cc--cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVV---DA--NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 240 ~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.... .+....... .. ......+........++..+.+++.+||..||++|||+.++++.+.++.++
T Consensus 240 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1110 000000000 00 000000111122356788899999999999999999999999999887654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=318.57 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=203.6
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-ccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE-EFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||++.. +++.||+|++... ...+.+.+|+++++.++||||+++++++.+. +..++|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 47999999999999999999986 4889999999764 3457788999999999999999999997554 578999999
Q ss_pred ecCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++++|.+++..... .+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 999999999976532 3789999999999999999999 999999999999999999999999999998765322
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~----------------- 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------------
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 122356778999999998999999999999999999998 999997654322221111000
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..+++.+.+++.+||..||++|||+.++++.|..+...
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0111345678899999999999999999999999999998765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=326.29 Aligned_cols=257 Identities=20% Similarity=0.227 Sum_probs=204.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeee------C
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSN------E 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~ 93 (313)
...++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 45689999999999999999999964 68999999997653 3456788999999998 89999999999977 4
Q ss_pred ccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 EFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
+..++||||+++++|.+++... ...+++..++.++.||+.||.||| +.|++|+||+|+||+++.++.++|+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 6789999999999999999765 346899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPI 247 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 247 (313)
........ ......++..|+|||++. +..++.++|||||||++|+|++|..||..................
T Consensus 177 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 252 (326)
T 2x7f_A 177 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP-- 252 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred eecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--
Confidence 76543211 123346889999999886 567899999999999999999999999765433322211110000
Q ss_pred cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 248 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......++..+.+|+.+||..||++|||+.++++|+|-.
T Consensus 253 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 253 -----------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp -----------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred -----------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 001234577899999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=331.97 Aligned_cols=269 Identities=18% Similarity=0.166 Sum_probs=206.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc--
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK-- 96 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-- 96 (313)
.+.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 45689999999999999999999965 5999999999764 334467888999999999999999999999877655
Q ss_pred ----eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 97 ----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 97 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
++|+||+. ++|.+.+.. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred ceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 589887743 4899999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-ccc-
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-IST- 249 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~- 249 (313)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+...........+ ...
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 865422 234567899999998877 688999999999999999999999997754433322211100000 000
Q ss_pred --------cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 --------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.....................+++.+.+|+.+||..||++|||++++++|+|-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 00000000000000111234568889999999999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=319.10 Aligned_cols=259 Identities=20% Similarity=0.241 Sum_probs=212.2
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
..+.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 456689999999999999999999965 6899999999754 2335678889999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC---CceeEcCCcchhh
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN---MVAHLSDFSIAKL 174 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~~~~ 174 (313)
+|+|++++++|.+.+.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.+ +.++|+|||++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999887654 6899999999999999999999 9999999999999999754 4799999999986
Q ss_pred cccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 175 LTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
..... ......++..|+|||++.+ .++.++||||||+++|+|++|..||......+...........
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 240 (287)
T 2wei_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA--------- 240 (287)
T ss_dssp BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 64322 2233457888999998775 4899999999999999999999999765443322211111100
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........++..+.+++.+||..||++|||+.++++|+|-..
T Consensus 241 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 241 --------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp --------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred --------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 001112356788999999999999999999999999998643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=324.80 Aligned_cols=257 Identities=20% Similarity=0.215 Sum_probs=192.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeee--------eC
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCS--------NE 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~ 93 (313)
..+|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999965 68999999997766666778899999999995 999999999994 34
Q ss_pred ccceEEEEeecCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEecCCCceeEcCC
Q 047140 94 EFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~~~~~~~l~df 169 (313)
...++|+||+. |+|.+++.. ....+++..++.++.||+.||.||| +.+ ++|+||||+|||++.++.++|+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999996 599998865 3346899999999999999999999 999 999999999999999999999999
Q ss_pred cchhhcccccccc----------cccccccccccCCCccc---ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh
Q 047140 170 SIAKLLTGEYQSM----------TQTQTLATIGCIAPEYR---RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT 236 (313)
Q Consensus 170 g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~ 236 (313)
|++.......... ......++..|+|||++ .+..++.++||||||+++|+|++|..||.........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 9998664322110 11134578889999988 5667899999999999999999999999654322111
Q ss_pred hhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 237 LKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
..... ......++..+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 263 ~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 263 NGKYS-----------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ---CC-----------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cCccc-----------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 10000 0011233455889999999999999999999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=335.05 Aligned_cols=271 Identities=19% Similarity=0.182 Sum_probs=206.5
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC--------CCcceeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR--------HRNLIKVISTCS 91 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~ 91 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 345689999999999999999999854 5899999999754 345677889999999985 788999999997
Q ss_pred ----eCccceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCC---
Q 047140 92 ----NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNM--- 162 (313)
Q Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~--- 162 (313)
++...++||||+ +++|.+.+... ...+++..++.++.||+.||.||| ++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 566899999999 45777766544 356999999999999999999999 88 999999999999999775
Q ss_pred ----------------------------------------------ceeEcCCcchhhcccccccccccccccccccCCC
Q 047140 163 ----------------------------------------------VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAP 196 (313)
Q Consensus 163 ----------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 196 (313)
.++|+|||++...... .....+|..|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999765422 2344689999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh---------hhhccC---------C----ccc--cccccc
Q 047140 197 EYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT---------LKHWGN---------N----WLP--ISTMEV 252 (313)
Q Consensus 197 E~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~---------~~~~~~---------~----~~~--~~~~~~ 252 (313)
|++.+..++.++|||||||++|+|++|..||......... ...... . +.. ......
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999999754321110 000000 0 000 000000
Q ss_pred ccccccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 253 VDANLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 253 ~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
....... ........+...+..+.+|+.+||..||++|||++++++|+|
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 0000000 000011123557788999999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.54 Aligned_cols=257 Identities=21% Similarity=0.232 Sum_probs=206.8
Q ss_pred cccccccccccceeeeEEEEEee----cceEEEEEEeeccc----chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQC----GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
++|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|+++++.+ +||||+++++++.+++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 69999999999999999999962 68999999986531 23345677899999999 79999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++||||+++++|.+++.... .+++..++.++.||+.||.||| +++|+|+||||+|||++.++.+||+|||++..+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999997655 6899999999999999999999 999999999999999999999999999999765
Q ss_pred ccccccccccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
.... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~------------- 275 (355)
T 1vzo_A 210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------------- 275 (355)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-------------
T ss_pred ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH-------------
Confidence 4322 112234568999999999875 357899999999999999999999996532211110000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFKI 303 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~~ 303 (313)
... .......+..++..+.+|+.+||..||++|| |+.++++|+|-.
T Consensus 276 ~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 276 RRI----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp HHH----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred HHH----hccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 000 0000112345677899999999999999999 999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=329.76 Aligned_cols=278 Identities=21% Similarity=0.191 Sum_probs=210.7
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC----
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE---- 93 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (313)
...+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++..+
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 3456789999999999999999999965 5999999999654 334556788999999999999999999988654
Q ss_pred -ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 94 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
...++|+||+. ++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67899999997 5999998764 5899999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccc--------cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC
Q 047140 173 KLLTGEYQSM--------TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 173 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~ 243 (313)
.......... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8654321111 1123457889999998754 678999999999999999999999997765432221111000
Q ss_pred cc---ccc--------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 244 WL---PIS--------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 244 ~~---~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.. ... ..+...................++.++.+|+.+||..||++|||++++++|+|-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 000 0000000000000001112245788899999999999999999999999998854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=321.16 Aligned_cols=257 Identities=23% Similarity=0.267 Sum_probs=204.9
Q ss_pred ccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeec
Q 047140 26 DFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (313)
+|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3444559999999999999964 588999999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcchhhccccccc
Q 047140 105 HGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 105 ~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999997653 24678899999999999999999 999999999999999987 89999999999876543211
Q ss_pred ccccccccccccCCCcccccCC--CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 182 MTQTQTLATIGCIAPEYRRKGR--ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||++.+.. ++.++||||||+++|+|++|..||...............
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------------- 240 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM----------------- 240 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-----------------
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-----------------
Confidence 123456888999999887643 789999999999999999999999764332211110000
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.......+..++..+.+++.+||..||++|||+.++++|+|-...
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 241 -FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 000001134567889999999999999999999999999886543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=347.61 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=213.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|.+..+..||||+++... ...+.+.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 46899999999999999999998777889999997653 335678999999999999999999999876 6789999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
.+++|.+++... +..+++..++.++.||+.||.||| +++++||||||+|||+++++.+||+|||++........ .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-H
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-e
Confidence 999999999753 346899999999999999999999 99999999999999999999999999999986643211 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++||||||+++|||++ |..||......+.........
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------------ 481 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------ 481 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 1223446778999999998999999999999999999999 999997765443322211110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..++..+.+||.+||..||++|||+.+|++.|..+..
T Consensus 482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 011134577889999999999999999999999999987653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=330.36 Aligned_cols=269 Identities=18% Similarity=0.268 Sum_probs=210.7
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccch-----------------hHHHHHHHHHHHhcCCCCccee
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGR-----------------AFKSFNIECEMMKSIRHRNLIK 85 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~ 85 (313)
..++|++.+.||+|+||.||+|.. +++.||+|++...... ..+.+.+|+++++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999999998 8999999999754211 1178899999999999999999
Q ss_pred eeeeeeeCccceEEEEeecCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceE
Q 047140 86 VISTCSNEEFKALVLEYMPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVL 157 (313)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil 157 (313)
+++++.+++..++||||+++++|.++ +... ...+++..++.++.|++.||.||| + .|++|+||+|+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 99999999999999999999999998 5442 457899999999999999999999 8 99999999999999
Q ss_pred ecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccC-CCCC-cchhHHHHHHHHHHHhCCCCChhhhhhhh
Q 047140 158 LDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-REST-NGDVYSFGIMLMETFTRKKPTDEIFNREM 235 (313)
Q Consensus 158 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~lltg~~p~~~~~~~~~ 235 (313)
++.++.++|+|||.+...... ......++..|+|||++.+. .++. ++||||||+++|+|++|..||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999865432 23445688999999998877 5655 99999999999999999999976654222
Q ss_pred hhhhccCC-c-ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 236 TLKHWGNN-W-LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 236 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........ . .+......... .. ..........++..+.+|+.+||..||.+|||+.++++|+|-
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYP-LT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTT-TC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHhccCcCCccchhhhhcc-cc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 21111111 1 00000000000 00 000011124578889999999999999999999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.82 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=202.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCC--CCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIR--HRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 99 (313)
.++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+++++.++ |+||+++++++.+++..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 5689999999999999999999877999999999754 3345678899999999996 59999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|| +.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||++++ +.++|+|||++.......
T Consensus 107 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred Ee-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 99 45779999998765 6899999999999999999999 999999999999999964 899999999998764333
Q ss_pred ccccccccccccccCCCccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK-----------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.........++..|+|||++.+ ..++.++||||||+++|+|++|..||.............
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-------- 252 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-------- 252 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH--------
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH--------
Confidence 2222334568999999998865 467889999999999999999999996543221111100
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.+... ....+...+..+.+++.+||..||++|||+.++++|+|-..
T Consensus 253 ----~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 253 ----IDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp ----HCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ----Hhccc------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 00000 00112234677999999999999999999999999998654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=319.60 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=204.3
Q ss_pred cccccccccccccceeeeEEEEEee--cc--eEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS--SA--MEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF 95 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (313)
..++|++.+.||+|+||.||+|.+. ++ ..||+|++... .....+.+.+|+++++.++||||+++++++.++.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3579999999999999999999854 23 36999998754 3455678899999999999999999999998765
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++|+||+++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 88999999999999999876557999999999999999999999 999999999999999999999999999998766
Q ss_pred ccccccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 176 TGEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 176 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.................
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--------- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC---------
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC---------
Confidence 4332211 1223456778999999988889999999999999999999 9999977654333222111110
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
....+..++..+.+++.+||..||++|||+.++++++.++...
T Consensus 243 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 ----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0011235678899999999999999999999999999887654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=324.59 Aligned_cols=252 Identities=13% Similarity=0.061 Sum_probs=204.5
Q ss_pred ccccccccccccceeeeEEEEE------eecceEEEEEEeecccchhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCc
Q 047140 24 TSDFQILNFFICGVIIPVAQFL------ISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEE 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~ 94 (313)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ...+..|.++++.++ |+||+++++++..++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 5789999999999999999994 3468899999997653 345677788887776 899999999999999
Q ss_pred cceEEEEeecCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC----------
Q 047140 95 FKALVLEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---------- 160 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---------- 160 (313)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974 3446999999999999999999999 999999999999999998
Q ss_pred -CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhh
Q 047140 161 -NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKH 239 (313)
Q Consensus 161 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~ 239 (313)
++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-- 295 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP-- 295 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE--
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee--
Confidence 89999999999976543222333445678999999999999999999999999999999999999986543211100
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCC-CCHHHHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR-INAREIVAKLFKIRDS 306 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~~il~~l~~~~~~ 306 (313)
..... ....++.+.+++..||+.+|.+| |++.++.+.+..+.++
T Consensus 296 --------------~~~~~---------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 296 --------------EGLFR---------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp --------------CSCCT---------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------chhcc---------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00000 00135668899999999999999 5677777777776655
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=322.53 Aligned_cols=271 Identities=21% Similarity=0.251 Sum_probs=208.4
Q ss_pred hcccccccccccccceeeeEEEEEee--cceEEEEEEeecccc--hhHHHHHHHHHHHhcC---CCCcceeeeeeee---
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSI---RHRNLIKVISTCS--- 91 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 91 (313)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45689999999999999999999963 589999999975421 2223556677777666 8999999999987
Q ss_pred --eCccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 92 --NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 92 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
.....++|+||+. ++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999997 59999997653 35899999999999999999999 99999999999999999999999999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC------
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN------ 242 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~------ 242 (313)
||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99987654221 233456889999999999999999999999999999999999999765443322111100
Q ss_pred -Ccccc--cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 243 -NWLPI--STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 243 -~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.|... ........ ............++..+.+|+.+||..||++|||+.++++|+|-
T Consensus 241 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 241 EDWPRDVALPRQAFHS---KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp GGSCTTCSSCGGGSCC---CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ccCccccccchhhhcc---cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 00000 00000000 00000111234578889999999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=322.45 Aligned_cols=273 Identities=21% Similarity=0.277 Sum_probs=210.4
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhc--CCCCcceeeeeeeeeCc----
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKS--IRHRNLIKVISTCSNEE---- 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~---- 94 (313)
..+.++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 45678999999999999999999987 5899999999654 33567788888887 79999999999998876
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
..++|+||+++++|.+++... .+++..++.++.|++.||.|||.. ++.+++|+||||+||+++.++.++|+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 789999999999999999765 489999999999999999999921 1368999999999999999999999999
Q ss_pred cchhhcccccccc--cccccccccccCCCcccccCC------CCCcchhHHHHHHHHHHHhC----------CCCChhhh
Q 047140 170 SIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRKGR------ESTNGDVYSFGIMLMETFTR----------KKPTDEIF 231 (313)
Q Consensus 170 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg----------~~p~~~~~ 231 (313)
|++.......... ......++..|+|||++.+.. ++.++||||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997664332111 223456889999999887653 33689999999999999999 67775543
Q ss_pred hhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 232 NREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
........... ......... ..........++..+.+|+.+||..||++|||+.+++++|..+.++..
T Consensus 272 ~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 272 PSDPSVEEMRK--------VVCEQKLRP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CSSCCHHHHHH--------HHTTSCCCC-CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred cCcccHHHHHH--------HHHHHHhCC-CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 22111100000 000000000 000111123567889999999999999999999999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.33 Aligned_cols=272 Identities=17% Similarity=0.189 Sum_probs=209.7
Q ss_pred hhcccccccccccccceeeeEEEEEe-e-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCC------cceeeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLI-S-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR------NLIKVISTCSN 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~ 92 (313)
..+.++|++.+.||+|+||.||+|.. . +++.||+|++... ....+.+.+|+++++.++|+ +++++++++.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34568999999999999999999985 3 5899999999754 34567788999999988665 49999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-----------
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD----------- 160 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~----------- 160 (313)
++..++||||+ +++|.+++...+ ..+++..++.++.|++.||.||| +++++|+||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 779999997654 36889999999999999999999 999999999999999987
Q ss_pred --------CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh
Q 047140 161 --------NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN 232 (313)
Q Consensus 161 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~ 232 (313)
++.++|+|||++..... ......++..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 66899999999875432 12345688999999999999999999999999999999999999976543
Q ss_pred hhhhhhhcc--CCcccc-----ccccc-----cccc-----------ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC
Q 047140 233 REMTLKHWG--NNWLPI-----STMEV-----VDAN-----------LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 233 ~~~~~~~~~--~~~~~~-----~~~~~-----~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
.+....... ...... ..... .+.. ...............++++.+|+.+||..||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 322111100 000000 00000 0000 000000001112346788999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 047140 290 RINAREIVAKLFK 302 (313)
Q Consensus 290 Rps~~~il~~l~~ 302 (313)
|||+.|+++|+|-
T Consensus 320 Rpt~~ell~hp~f 332 (339)
T 1z57_A 320 RITLREALKHPFF 332 (339)
T ss_dssp SCCHHHHTTSGGG
T ss_pred ccCHHHHhcCHHH
Confidence 9999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=346.00 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=205.8
Q ss_pred cccccceeeeEEEEEee---cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS---SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
+.||+|+||.||+|.+. .++.||||+++.. .....+.+.+|+++++.++||||+++++++.++ ..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 47999999999999653 4789999999764 234467899999999999999999999999754 57899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc-ccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS-MTQ 184 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 184 (313)
++|.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 6899999999999999999999 999999999999999999999999999999876433211 112
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....++..|+|||++.+..++.++|||||||++|||++ |..||......+..........
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------------- 590 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------------- 590 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 23345678999999999999999999999999999998 9999987655433222211110
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
...+..++.++.+|+..||..||++|||++++++.|.++..++
T Consensus 591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1113457888999999999999999999999999999988765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=337.47 Aligned_cols=280 Identities=16% Similarity=0.155 Sum_probs=192.8
Q ss_pred hhhhccccccc-ccccccceeeeEEEEEee---cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee--
Q 047140 19 FRRSQTSDFQI-LNFFICGVIIPVAQFLIS---SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-- 92 (313)
Q Consensus 19 ~~~~~~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 92 (313)
-...+.+.|++ +++||+|+||.||+|..+ +++.||||++.... ....+.+|+++++.++||||+++++++..
T Consensus 14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 34556678887 558999999999999965 47899999997542 23567889999999999999999999954
Q ss_pred CccceEEEEeecCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe----cC
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL----DD 160 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~----~~ 160 (313)
+...++||||+.+ +|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||+ +.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTT
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCC
Confidence 6789999999965 898888532 124899999999999999999999 9999999999999999 67
Q ss_pred CCceeEcCCcchhhccccccc-ccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh---
Q 047140 161 NMVAHLSDFSIAKLLTGEYQS-MTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREM--- 235 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~--- 235 (313)
++.+||+|||++......... .......+|..|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 799999999999876432211 123345689999999988874 589999999999999999999999965432100
Q ss_pred ------hhhhccC-Ccccc-cccccccc--------cccChh-------hhhhhhhhhhHHHHHHHHhHhhccCCCCCCC
Q 047140 236 ------TLKHWGN-NWLPI-STMEVVDA--------NLLSQE-------DIHFVAKEQCVSFVFNLAIECTVESPEQRIN 292 (313)
Q Consensus 236 ------~~~~~~~-~~~~~-~~~~~~~~--------~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 292 (313)
....... ..... ....+... ...... ..........+..+.+|+.+||..||++|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 0000000 00000 00000000 000000 0000001122667899999999999999999
Q ss_pred HHHHHHHHHHHH
Q 047140 293 AREIVAKLFKIR 304 (313)
Q Consensus 293 ~~~il~~l~~~~ 304 (313)
++|+++|+|-..
T Consensus 328 a~e~L~hp~f~~ 339 (405)
T 3rgf_A 328 SEQAMQDPYFLE 339 (405)
T ss_dssp HHHHHTSGGGTS
T ss_pred HHHHhcChhhcc
Confidence 999999999654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.14 Aligned_cols=271 Identities=21% Similarity=0.208 Sum_probs=203.3
Q ss_pred hhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc------
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE------ 94 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 94 (313)
.....+|++.+.||+|+||.||+|....+..||+|++..... ...+|+++++.++||||++++++|...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 445678999999999999999999977666699998865421 1236999999999999999999996543
Q ss_pred cceEEEEeecCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCCceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg 170 (313)
..++||||+++ ++.+.+. .....+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 38899999976 5544443 22447899999999999999999999 99999999999999999 79999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc--c
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP--I 247 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~--~ 247 (313)
+++...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.+....+...........+ .
T Consensus 188 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 188 SAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998654322 22345678999999988664 58999999999999999999999998765433322211100000 0
Q ss_pred c----ccccccc--cccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 248 S----TMEVVDA--NLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 248 ~----~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
. ....... ......+.....+..+++++.+|+.+||..||++|||+.++++|+|-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 0 0000000 00111111222234577889999999999999999999999999884
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=324.40 Aligned_cols=283 Identities=17% Similarity=0.141 Sum_probs=199.3
Q ss_pred hhhhhhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 16 RDVFRRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
.........++|++.+.||+|+||.||+|... +++.||||++... .........+++.+..++||||++++++|...+
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 33444555679999999999999999999965 5899999998654 233455667888889999999999999996643
Q ss_pred c-------ceEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCc
Q 047140 95 F-------KALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMV 163 (313)
Q Consensus 95 ~-------~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~ 163 (313)
. .++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||. ++.+++|+||||+|||++. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCc
Confidence 3 7899999976 66655542 34468999999999999999999993 2679999999999999996 899
Q ss_pred eeEcCCcchhhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC
Q 047140 164 AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN 242 (313)
Q Consensus 164 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~ 242 (313)
+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||...............
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999998664322 22345678999999988655 4899999999999999999999999776543332221110
Q ss_pred Ccc-ccc----------ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 243 NWL-PIS----------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 243 ~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
... +.. ......................++.++.+|+.+||+.||++|||+.++++|+|-..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 000 000 00000000001111111112336788999999999999999999999999988543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=330.88 Aligned_cols=267 Identities=21% Similarity=0.192 Sum_probs=201.3
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC------ccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE------EFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 96 (313)
..+|++.+.||+|+||.||+|... +++.||||++.... ....+|+++++.++|+||++++++|... .++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 447999999999999999999975 59999999986542 2234699999999999999999998542 247
Q ss_pred eEEEEeecCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-CceeEcCCcch
Q 047140 97 ALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN-MVAHLSDFSIA 172 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~ 172 (313)
++|+||+++ +|.+.+.. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 899999975 77766642 3457899999999999999999999 9999999999999999965 67899999999
Q ss_pred hhcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-----
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP----- 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~----- 246 (313)
+.+.... ......++..|+|||++.+. .++.++|||||||++|||++|..||.+....+...........+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8654322 22345688999999988764 78999999999999999999999997765433222111100000
Q ss_pred ----ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ----ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...... ..............+...+.++.+|+.+||..||++|||+.|+++|+|-
T Consensus 282 ~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 282 REMNPNYTEF-KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHCSCCCCC-CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhhChhhhhh-ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 000000 0000000111111233567889999999999999999999999999885
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=324.30 Aligned_cols=269 Identities=18% Similarity=0.148 Sum_probs=204.6
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc---
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF--- 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 95 (313)
.+.++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 35689999999999999999999965 5999999999654 33446778899999999999999999999987654
Q ss_pred ---ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 96 ---KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
.++||||+. ++|.+++.. .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||++
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 488877643 4899999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-ccccc-
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPIST- 249 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~~~- 249 (313)
...... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||......+.......... .+...
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 765322 233567889999998876 6789999999999999999999999976543322111110000 00000
Q ss_pred --------cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 250 --------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 250 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+.................++..+.+|+.+||..||++|||++++++|+|-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00000000000000011123568889999999999999999999999999884
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.69 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=211.7
Q ss_pred ccccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++++.||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4689999999999999999998642 567999998754 33455788999999999999999999999854 56899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++++|.+++......+++..++.++.|++.||.||| +++++||||||+|||++.++.+||+|||++......
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999877667899999999999999999999 999999999999999999999999999999866432
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......++..|+|||++.+..++.++||||||+++|||++ |..||......+.........
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-------------- 609 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------- 609 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC--------------
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 21 11223446678999999998999999999999999999997 999997765433322111110
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..++..+.+|+.+||..||++|||+.++++.|..+.++.
T Consensus 610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01113457788999999999999999999999999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=316.48 Aligned_cols=261 Identities=20% Similarity=0.221 Sum_probs=187.2
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHH-HHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+..|.. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999965 69999999997652 233445555665 677789999999999999999999999
Q ss_pred EeecCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 101 EYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 101 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
||+++ +|.+++.. ....+++..+..++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 88888763 2346899999999999999999999 88 9999999999999999999999999999765
Q ss_pred ccccccccccccccccccCCCccc----ccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYR----RKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
.... ......++..|+|||++ .+..++.++||||||+++|+|++|..||..................
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP------ 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC------
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC------
Confidence 4322 22234688899999988 4667899999999999999999999999754321111110000000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
..........++..+.+|+.+||..||++|||+.++++|+|-....
T Consensus 248 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 248 ---------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ---------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ---------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 0000001234677899999999999999999999999999976543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.22 Aligned_cols=267 Identities=15% Similarity=0.111 Sum_probs=213.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCC-CcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 99 (313)
.+.++|++++.||+|+||.||+|... +++.||||++..... ...+..|+++++.++| +++..+..++.+....++|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 45789999999999999999999954 699999999876532 2457789999999976 5566666667778889999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe---cCCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL---DDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~~ 176 (313)
|||+ +++|.+++......+++..++.++.||+.||.||| +++|+||||||+|||+ +.++.+||+|||++..+.
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 88999999876667999999999999999999999 9999999999999999 688999999999998765
Q ss_pred cccccc-----cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQSM-----TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
...... ......++..|+|||++.+..++.++|||||||++|+|++|..||............. .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----------~ 227 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----------K 227 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH----------H
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH----------H
Confidence 432211 1225568999999999999999999999999999999999999997654321111100 0
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
+..... ..........++.++.+|+..||..||++||++.+|++.|..+..+.
T Consensus 228 i~~~~~---~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 228 ISEKKV---ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHH---HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Hhhccc---cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 000000 00111123457888999999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=322.35 Aligned_cols=273 Identities=20% Similarity=0.197 Sum_probs=207.8
Q ss_pred hhcccccccccccccceeeeEEEEEee-cc-eEEEEEEeecccchhHHHHHHHHHHHhcCCCCc------ceeeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SA-MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN------LIKVISTCSN 92 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~ 92 (313)
..+.++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+++++.++|++ ++.+.+++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 446789999999999999999999964 34 79999999754 345677888999999987665 8999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe-------------
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL------------- 158 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~------------- 158 (313)
.+..++||||+ +++|.+.+.... ..+++..++.++.||+.||.||| +++++|+||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999 557777776543 46899999999999999999999 9999999999999999
Q ss_pred ------cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhh
Q 047140 159 ------DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFN 232 (313)
Q Consensus 159 ------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~ 232 (313)
+.++.++|+|||++..... ......++..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 5678999999999875432 12345689999999999999999999999999999999999999976543
Q ss_pred hhhhhhhcc--CCcccc-----cccccc-------ccc---------ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCC
Q 047140 233 REMTLKHWG--NNWLPI-----STMEVV-------DAN---------LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289 (313)
Q Consensus 233 ~~~~~~~~~--~~~~~~-----~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 289 (313)
.+....... ...... ...... +.. ...............+..+.+|+.+||..||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 322111100 000000 000000 000 000000001112345678999999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 047140 290 RINAREIVAKLFKI 303 (313)
Q Consensus 290 Rps~~~il~~l~~~ 303 (313)
|||++++++|+|-.
T Consensus 325 Rpt~~e~l~hp~f~ 338 (355)
T 2eu9_A 325 RITLAEALLHPFFA 338 (355)
T ss_dssp SCCHHHHTTSGGGG
T ss_pred CcCHHHHhcChhhc
Confidence 99999999998844
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.74 Aligned_cols=274 Identities=17% Similarity=0.149 Sum_probs=206.0
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-CC-----cceeeeeeeeeC
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HR-----NLIKVISTCSNE 93 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~ 93 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345679999999999999999999965 5899999999754 344567778899888874 44 499999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec--CCCceeEcCCc
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--DNMVAHLSDFS 170 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg 170 (313)
+..|+||||+.+ +|.+++.... ..+++..++.++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999965 9999997653 4689999999999999999999921 26899999999999995 47889999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-c---
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-P--- 246 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~--- 246 (313)
++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||......+........... +
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865422 23456888999999999999999999999999999999999999865443322111110000 0
Q ss_pred ----ccccccccc----------------cccChh--hh-----------------hhhhhhhhHHHHHHHHhHhhccCC
Q 047140 247 ----ISTMEVVDA----------------NLLSQE--DI-----------------HFVAKEQCVSFVFNLAIECTVESP 287 (313)
Q Consensus 247 ----~~~~~~~~~----------------~~~~~~--~~-----------------~~~~~~~~~~~l~~li~~~l~~dP 287 (313)
......+.. ...... .. .........+.+.+|+.+||..||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 000000000 000000 00 000011234679999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 047140 288 EQRINAREIVAKLFK 302 (313)
Q Consensus 288 ~~Rps~~~il~~l~~ 302 (313)
++|||++|+++|+|-
T Consensus 362 ~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 362 KTRIQPYYALQHSFF 376 (382)
T ss_dssp TTSCCHHHHTTSGGG
T ss_pred hhCCCHHHHhcCccc
Confidence 999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=320.39 Aligned_cols=259 Identities=18% Similarity=0.201 Sum_probs=181.7
Q ss_pred hccccccccc-ccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee----Ccc
Q 047140 22 SQTSDFQILN-FFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEF 95 (313)
Q Consensus 22 ~~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 95 (313)
.+.++|.+.+ .||+|+||.||+|... +++.||||++.... ... ......++.++||||+++++++.. +..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 5678999965 6999999999999966 59999999996542 111 222334566799999999999976 456
Q ss_pred ceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCcc
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFSI 171 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 171 (313)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +++++|+||||+||+++. ++.++|+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998653 46899999999999999999999 999999999999999986 45599999999
Q ss_pred hhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 172 AKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
+...... ......++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 245 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-------- 245 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh--------
Confidence 8765422 2234467889999999988889999999999999999999999997654322211000000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
. .............++..+.+|+.+||..||++|||+.++++|+|-..
T Consensus 246 --~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 246 --R---LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --h---ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 00000000112356788999999999999999999999999999654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.62 Aligned_cols=270 Identities=14% Similarity=0.141 Sum_probs=203.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-----------CCcceeeeeeee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-----------HRNLIKVISTCS 91 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 91 (313)
.++|++.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999964 6999999999754 345567888999999886 789999999998
Q ss_pred eCc----cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEec------
Q 047140 92 NEE----FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLD------ 159 (313)
Q Consensus 92 ~~~----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~------ 159 (313)
..+ ..++|+|++ +++|.+++... ...+++..++.++.||+.||.||| ++ |++|+||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 78999999764 345899999999999999999999 88 999999999999995
Q ss_pred CCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh---
Q 047140 160 DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT--- 236 (313)
Q Consensus 160 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~--- 236 (313)
..+.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3448999999999765422 23346889999999999999999999999999999999999999754321100
Q ss_pred ---hhhc--cCCccc----------------ccccccccccccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC
Q 047140 237 ---LKHW--GNNWLP----------------ISTMEVVDANLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN 292 (313)
Q Consensus 237 ---~~~~--~~~~~~----------------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 292 (313)
.... ...... .....+....... ........+..++.++.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0000 000000 0000000000000 000111123567889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 047140 293 AREIVAKLFKI 303 (313)
Q Consensus 293 ~~~il~~l~~~ 303 (313)
++++++|+|-.
T Consensus 328 ~~ell~hp~f~ 338 (373)
T 1q8y_A 328 AGGLVNHPWLK 338 (373)
T ss_dssp HHHHHTCGGGT
T ss_pred HHHHhhChhhh
Confidence 99999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=320.90 Aligned_cols=247 Identities=20% Similarity=0.201 Sum_probs=205.3
Q ss_pred hhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcCC--CCcceeeeeeee
Q 047140 21 RSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSIR--HRNLIKVISTCS 91 (313)
Q Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 91 (313)
..+.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 456789999999999999999999954 689999999976421 12245667999999996 599999999999
Q ss_pred eCccceEEEEeecC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCCceeEcCC
Q 047140 92 NEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHLSDF 169 (313)
Q Consensus 92 ~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~~~~l~df 169 (313)
+++..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++ +++.+||+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999975 79999997654 6899999999999999999999 99999999999999999 7899999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS 248 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
|++...... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||......... .
T Consensus 195 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~------~----- 259 (320)
T 3a99_A 195 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG------Q----- 259 (320)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC------C-----
T ss_pred ccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc------c-----
Confidence 998765432 2234568899999998877665 78899999999999999999999654321100 0
Q ss_pred ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 249 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+..+++++.+|+.+||..||++|||++++++|+|-
T Consensus 260 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 260 ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp ----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ----------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 00123456789999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=315.33 Aligned_cols=256 Identities=20% Similarity=0.193 Sum_probs=188.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccc--hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999965 689999999976522 22334445556778889999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
||+ ++.+..+.......+++..++.++.|++.||.||| ++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 55777666654557899999999999999999999 85 99999999999999999999999999987654321
Q ss_pred ccccccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhh-hhccCCcccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTL-KHWGNNWLPISTMEVV 253 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 253 (313)
......++..|+|||++. ...++.++||||||+++|+|++|..||.......... .......
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 247 (318)
T 2dyl_A 180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP--------- 247 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC---------
T ss_pred ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC---------
Confidence 223446889999999884 5568899999999999999999999997632211111 1100000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
........++.++.+++.+||..||.+|||++++++|+|-..
T Consensus 248 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 248 ---------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ---------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ---------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 000011246778999999999999999999999999998644
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=319.54 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=203.4
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||+|... ..||+|++... .....+.+.+|+.+++.++||||+++++++.++...++|+|
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 578999999999999999999864 35999998754 22334567789999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc--
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY-- 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 179 (313)
|+++++|.+++...+..+++..++.++.|++.||.||| +.+++|+||||+||+++ ++.++|+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999999999877667899999999999999999999 99999999999999998 6799999999976543211
Q ss_pred -ccccccccccccccCCCccccc---------CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccc
Q 047140 180 -QSMTQTQTLATIGCIAPEYRRK---------GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIST 249 (313)
Q Consensus 180 -~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 249 (313)
.........++..|+|||++.+ ..++.++||||||+++|+|++|..||...................
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 262 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--- 262 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---
Confidence 1112233458889999998764 357889999999999999999999997654433322211110000
Q ss_pred cccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 250 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
.....++..+.+++.+||..||++|||+.++++.+..+.++..
T Consensus 263 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 263 ----------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp ----------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred ----------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0011355668999999999999999999999999998887643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=327.54 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=196.2
Q ss_pred hhhcccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceE
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 98 (313)
.....+.|.+.+.||+|+||+||.+...+|+.||||++..+ ..+.+.+|+++++.+ +||||+++++++.+++..++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 34566778888999999999998776667999999998754 235677899999876 89999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC-----------
Q 047140 99 VLEYMPHGSLEKYLYSSNCI------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN----------- 161 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~----------- 161 (313)
||||++ ++|.+++...... .++..++.++.||+.||.||| +++|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCC
Confidence 999996 5999999765421 123345789999999999999 9999999999999999754
Q ss_pred --CceeEcCCcchhhcccccccc--cccccccccccCCCccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCChh
Q 047140 162 --MVAHLSDFSIAKLLTGEYQSM--TQTQTLATIGCIAPEYRRK-------GRESTNGDVYSFGIMLMETFT-RKKPTDE 229 (313)
Q Consensus 162 --~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~p~~~ 229 (313)
+.++|+|||++.......... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 489999999998765332111 1224568999999998865 568999999999999999999 9999966
Q ss_pred hhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........... ..... .........++.++.+|+.+||..||++|||+.++++|+|-
T Consensus 243 ~~~~~~~i~~~--~~~~~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 243 KYSRESNIIRG--IFSLD--------------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp TTTHHHHHHHT--CCCCC--------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred chhhHHHHhcC--CCCcc--------------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 53332211110 00000 00001123467889999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=316.98 Aligned_cols=249 Identities=21% Similarity=0.229 Sum_probs=196.6
Q ss_pred hhhcccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcC----CCCcceeeee
Q 047140 20 RRSQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSI----RHRNLIKVIS 88 (313)
Q Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~~~ 88 (313)
.....++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3556789999999999999999999854 688999999975421 1233456688888888 8999999999
Q ss_pred eeeeCccceEEEEe-ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec-CCCceeE
Q 047140 89 TCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHL 166 (313)
Q Consensus 89 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~-~~~~~~l 166 (313)
++.+.+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++ +++.++|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 78899999998755 6899999999999999999999 99999999999999999 8899999
Q ss_pred cCCcchhhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc
Q 047140 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL 245 (313)
Q Consensus 167 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~ 245 (313)
+|||++...... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 182 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------- 248 (312)
T 2iwi_A 182 IDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA--------- 248 (312)
T ss_dssp CCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT---------
T ss_pred EEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh---------
Confidence 999998866432 2234568889999998877666 45899999999999999999999654221100
Q ss_pred cccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 246 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+++.+||..||++|||++++++|+|-.
T Consensus 249 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 249 ------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp ------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred ------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 0001234677799999999999999999999999998743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=326.75 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=194.5
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
..+|++.+.||+|+||.|+.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.++...|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 457999999999999997765555799999999965422 2356799999999 899999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---C--CceeEcCCcchhhccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---N--MVAHLSDFSIAKLLTG 177 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~--~~~~l~dfg~~~~~~~ 177 (313)
+. ++|.+++...........++.++.||+.||.||| +.+|+||||||+|||++. + ..++|+|||++.....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 96 5999999877655666667899999999999999 999999999999999953 2 3578999999986643
Q ss_pred cccc-ccccccccccccCCCcccc---cCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 178 EYQS-MTQTQTLATIGCIAPEYRR---KGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 178 ~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
.... .......+|..|+|||++. ...++.++|||||||++|+|++ |..||.................
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-------- 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL-------- 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC--------
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc--------
Confidence 2211 1223456899999999987 4567889999999999999999 9999865433222211110000
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........+..+.+|+.+||+.||++|||+.++++|+|-
T Consensus 248 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 248 ----------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp ----------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred ----------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 0000122356678999999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=336.92 Aligned_cols=274 Identities=20% Similarity=0.214 Sum_probs=204.4
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeee------C
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN------E 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 93 (313)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34479999999999999999999964 5999999998764 34556778999999999999999999999765 6
Q ss_pred ccceEEEEeecCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCc---eeEcC
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV---AHLSD 168 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~---~~l~d 168 (313)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.|++|+||||+||+++.++. ++|+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999998653 25888999999999999999999 999999999999999997765 89999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-ccc
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW-LPI 247 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~ 247 (313)
||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||................. ...
T Consensus 168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 168 LGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 99998664322 23345789999999999999999999999999999999999999966432211100000000 000
Q ss_pred cccccccccc--cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 248 STMEVVDANL--LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 248 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......... ....+........++..+.+++.+||..||++|||++++++|+|
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 0000000000 00000011123457889999999999999999999999888866
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=300.36 Aligned_cols=239 Identities=18% Similarity=0.262 Sum_probs=188.7
Q ss_pred hcccccccc-cccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHH-hcCCCCcceeeeeeeee----Cc
Q 047140 22 SQTSDFQIL-NFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMM-KSIRHRNLIKVISTCSN----EE 94 (313)
Q Consensus 22 ~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~ 94 (313)
.+.++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|++++ +.++||||+++++++.+ +.
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 456778887 78999999999999964 6899999999643 4566788888 55699999999999987 67
Q ss_pred cceEEEEeecCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg 170 (313)
..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 8999999999999999998653 46899999999999999999999 999999999999999998 7899999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++.... +..++.++|||||||++|+|++|..||...............
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-------- 213 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-------- 213 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS--------
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH--------
Confidence 886432 234677899999999999999999999665432211110000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
+. .............++.++.+|+.+||..||++|||+.++++|+|-...
T Consensus 214 --~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 --IR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp --SC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred --Hh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 000001111224578889999999999999999999999999997543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=295.40 Aligned_cols=234 Identities=15% Similarity=0.069 Sum_probs=189.8
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
+.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++..++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999965 48999999997652 3445788999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||++|++|.+++... .....+..++.|++.||.||| ++|++|+||||+|||++++|.++|++++.
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~------- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPAT------- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence 99999999999999643 356678889999999999999 99999999999999999999999985532
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
++ +++.++|||||||++|+|++|..||............... ..
T Consensus 176 ---------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------~~ 219 (286)
T 3uqc_A 176 ---------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD--------------TA 219 (286)
T ss_dssp ---------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC--------------TT
T ss_pred ---------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH--------------hc
Confidence 22 3688999999999999999999999765432211100000 00
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
............+++++.+++.+||..||++| |+.++++.|..+...
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00001111234578889999999999999999 999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=328.18 Aligned_cols=239 Identities=18% Similarity=0.218 Sum_probs=194.5
Q ss_pred hcccccccccccccceeeeEEEEEee--cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCcc---
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS--SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF--- 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 95 (313)
.+.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+++++.++||||+++++++.+.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 45689999999999999999999965 5899999998654 33456678899999999999999999999988765
Q ss_pred --ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 96 --KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.|+||||++|++|.+++.. .+++..++.++.||+.+|.||| ++||+||||||+|||++.+ .+||+|||++.
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 5899999999999999999999 9999999999999999985 89999999997
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
..... ....+|..|+|||++.+.. +.++|||||||++|+|++|..||........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------ 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc------------------
Confidence 65422 3456899999999887654 8899999999999999999988764211000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.. .......++.+.+++.+||..||++||+..+.+.+.+
T Consensus 285 -----~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 285 -----PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp -----CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred -----cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 00 0011234567899999999999999997666666544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=311.61 Aligned_cols=244 Identities=14% Similarity=0.093 Sum_probs=185.5
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCC-Cccee-------------
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRH-RNLIK------------- 85 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~------------- 85 (313)
.++|..++.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346889999999999999999954 69999999997432 2235778999999999976 32211
Q ss_pred --------eeeeeee-----CccceEEEEeecCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 047140 86 --------VISTCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQV 146 (313)
Q Consensus 86 --------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 146 (313)
+..++.. ....+++++.+ +++|.+++. ..+..+++..++.++.|++.||.||| +++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 1111111 12356777766 569999984 22445778899999999999999999 9999
Q ss_pred eeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCccc----------ccCCCCCcchhHHHHHH
Q 047140 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYR----------RKGRESTNGDVYSFGIM 216 (313)
Q Consensus 147 ~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~~ 216 (313)
+||||||+|||++.++.+||+|||+++..... .....+ ..|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998765422 233456 899999988 55567889999999999
Q ss_pred HHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHH
Q 047140 217 LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREI 296 (313)
Q Consensus 217 l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~i 296 (313)
+|+|++|..||............ .. ....+++.+.+|+.+||..||++|||+.++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~-------------~~------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI-------------FR------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG-------------GS------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH-------------Hh------------hcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999765432211110 00 012456789999999999999999999999
Q ss_pred HHHHHH
Q 047140 297 VAKLFK 302 (313)
Q Consensus 297 l~~l~~ 302 (313)
++|+|-
T Consensus 362 l~~~~~ 367 (413)
T 3dzo_A 362 METPEY 367 (413)
T ss_dssp TTSHHH
T ss_pred HhCHHH
Confidence 998653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.53 Aligned_cols=247 Identities=15% Similarity=0.120 Sum_probs=189.3
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeeccc--------chhHHHHHHHHHHHhcCC---------CCcceee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIR---------HRNLIKV 86 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~ 86 (313)
.++|++.+.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 57899999999999999999997 68999999997652 223467888999988885 5555555
Q ss_pred eee-----------------eee-------------CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 047140 87 IST-----------------CSN-------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 136 (313)
Q Consensus 87 ~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~ 136 (313)
.++ |.+ ++..|+||||+++|++.+.+.. ..+++..++.++.||+.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 544 443 6789999999999877666644 35899999999999999999
Q ss_pred HHhcCCCCCceeCCCCCCceEecCCC--------------------ceeEcCCcchhhcccccccccccccccccccCCC
Q 047140 137 YLHFGYSAQVIHCDLKPINVLLDDNM--------------------VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAP 196 (313)
Q Consensus 137 ~lH~~~~~~i~h~di~p~nil~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 196 (313)
|||. +.+|+||||||+|||++.++ .+||+|||+++.... ....||..|+||
T Consensus 176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence 9992 37999999999999999887 899999999986542 234689999999
Q ss_pred cccccCCCCCcchhHHHHHH-HHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHH
Q 047140 197 EYRRKGRESTNGDVYSFGIM-LMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 275 (313)
Q Consensus 197 E~~~~~~~~~~~DiwslG~~-l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 275 (313)
|++.+.. +.++|||||+++ .+++++|..||............. .... ..........+..+++++
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM------------LKQM-TFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH------------HHTC-CCSSCCCSHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh------------hhhh-ccCcccchhhhhhcCHHH
Confidence 9998766 899999998777 778999999997642111100000 0000 000000111245688999
Q ss_pred HHHHhHhhccCCCCCCCHHHHH-HHHH
Q 047140 276 FNLAIECTVESPEQRINAREIV-AKLF 301 (313)
Q Consensus 276 ~~li~~~l~~dP~~Rps~~~il-~~l~ 301 (313)
.+|+++||..| |++|++ +|+|
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred HHHHHHHhccC-----CHHHHHhcCCC
Confidence 99999999987 999999 9987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-33 Score=264.99 Aligned_cols=185 Identities=18% Similarity=0.115 Sum_probs=131.9
Q ss_pred cccceeeeEEEEE-eecceEEEEEEeecc----------cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEE
Q 047140 33 FICGVIIPVAQFL-ISSAMEVAVKVFNLQ----------CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 33 lg~G~~g~V~~~~-~~~~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.|++|.+..++ .-.|+.+++|++... .....+.+.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666555 225889999999754 123456799999999999 7999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||++|++|.+++...+ .++.. .++.||+.||.|+| ++||+||||||+|||++++|.+||+|||+++.......
T Consensus 322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999998765 56654 47899999999999 99999999999999999999999999999986643221
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~ 227 (313)
......||..|+|||++.+ .+..++|+||+|+++++++++..++
T Consensus 395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred --cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2334569999999998875 4667899999999998887766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=229.83 Aligned_cols=185 Identities=15% Similarity=0.115 Sum_probs=146.1
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeeccc--------chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--------GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
..+.||+|+||.||++.. .++.+++|+..... ....+.+.+|++++++++||||+++..++.+.+..|+||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 57889999864421 112455889999999999999997776776778889999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++++|.+++.. +..++.|++.+|.||| +++|+||||||+|||+++ .+||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999999875 5689999999999999 999999999999999999 999999999987654322
Q ss_pred cc-----cccccccccccCCCccccc--CCCCCcchhHHHHHHHHHHHhCCCCCh
Q 047140 181 SM-----TQTQTLATIGCIAPEYRRK--GRESTNGDVYSFGIMLMETFTRKKPTD 228 (313)
Q Consensus 181 ~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p~~ 228 (313)
.. ......+|..|+|||++.. ..|+..+|+|+...-..+-..++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 11 1134568999999999986 567888999999999888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=192.52 Aligned_cols=133 Identities=17% Similarity=0.117 Sum_probs=109.7
Q ss_pred ccccccccccceeeeEEEEEeecceEEEEEEeecccc------------------hhHHHHHHHHHHHhcCCCCcceeee
Q 047140 26 DFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCG------------------RAFKSFNIECEMMKSIRHRNLIKVI 87 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (313)
.|.+++.||+|+||.||+|...+|+.||+|+++.... .....+.+|+++++.++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4455699999999999999986699999999964321 13567889999999998 4 6666
Q ss_pred eeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 88 STCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
+++.. +..++||||++|++|.+ +.. .....++.|++.||.||| +.|++||||||+|||++ ++.++|+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 65544 56799999999999988 422 124469999999999999 99999999999999999 9999999
Q ss_pred CCcchhh
Q 047140 168 DFSIAKL 174 (313)
Q Consensus 168 dfg~~~~ 174 (313)
|||+++.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3e-21 Score=163.33 Aligned_cols=138 Identities=17% Similarity=0.161 Sum_probs=107.3
Q ss_pred ccccccccccceeeeEEEEEe-ecceE--EEEEEeecccch------------------------hHHHHHHHHHHHhcC
Q 047140 26 DFQILNFFICGVIIPVAQFLI-SSAME--VAVKVFNLQCGR------------------------AFKSFNIECEMMKSI 78 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l 78 (313)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 67988 999997543111 123678899999999
Q ss_pred CCCcc--eeeeeeeeeCccceEEEEeecC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 047140 79 RHRNL--IKVISTCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL 151 (313)
Q Consensus 79 ~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di 151 (313)
+|+++ +.++.. +..++||||+.+ | +|.+.... .++..+..++.|++.+|.|||. ..|++||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 87754 444432 357899999942 3 77776533 2244567899999999999994 579999999
Q ss_pred CCCceEecCCCceeEcCCcchhhc
Q 047140 152 KPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 152 ~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-19 Score=157.58 Aligned_cols=136 Identities=13% Similarity=0.131 Sum_probs=98.0
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeecccc--------------hhH--------HHHHHHHHHHhcCCCCcce
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCG--------------RAF--------KSFNIECEMMKSIRHRNLI 84 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~h~~i~ 84 (313)
|++++.||.|++|.||+|...+|+.||||+++.... ... -....|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 899999999999999999988899999999753200 000 1123455666666433322
Q ss_pred eeeeeeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC--
Q 047140 85 KVISTCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-- 162 (313)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-- 162 (313)
+...+.. ...++||||++|++|.++.. ......++.|++.+|.+|| ..|+|||||||.|||++++|
T Consensus 177 -vp~p~~~-~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 -VPEPIAQ-SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp -CCCEEEE-ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred -CCeeeec-cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence 1111111 23479999999988865432 1223567899999999999 99999999999999998876
Q ss_pred --------ceeEcCCcchhh
Q 047140 163 --------VAHLSDFSIAKL 174 (313)
Q Consensus 163 --------~~~l~dfg~~~~ 174 (313)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=7.6e-14 Score=117.93 Aligned_cols=142 Identities=13% Similarity=0.047 Sum_probs=111.1
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
..|++...++.|+.+.||++... +..+++|+...........+.+|+++++.+ .+.+++++++++.+++..++|||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46888888998999999998753 688999998753222234688899999988 4677889999999888899999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY----------------------------------------- 142 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------------- 142 (313)
+|.+|.+.+.. ......++.+++.+|..||...
T Consensus 93 ~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99998876321 1223467888999999999310
Q ss_pred ---------------CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 ---------------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ---------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0458999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=2e-12 Score=108.83 Aligned_cols=137 Identities=15% Similarity=0.053 Sum_probs=100.3
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCc--ceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN--LIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~ 102 (313)
..|.+....+.|..+.||++...+|+.+++|+.... ....+..|+++++.+.+.+ ++++++++.+++..++|||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 456655444566679999998666788999997643 2345778999998885434 56788888888888999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY---------------------------------------- 142 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---------------------------------------- 142 (313)
++|.+|. ... .+. ..++.+++..|..||...
T Consensus 97 i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998874 211 121 256777788888888311
Q ss_pred ---------------CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 ---------------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ---------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++|+|++|.|||+++++.+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999887667799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=8.1e-11 Score=103.92 Aligned_cols=142 Identities=13% Similarity=0.156 Sum_probs=104.9
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEee--ccc-chhHHHHHHHHHHHhcCC--CCcceeeeeeeeeC---ccceEEE
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFN--LQC-GRAFKSFNIECEMMKSIR--HRNLIKVISTCSNE---EFKALVL 100 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~ 100 (313)
..+.++.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +.++++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567888999999998864 4678889876 331 122456788999999986 45688999988776 4578999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-------------------------------------- 142 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------------------------------------- 142 (313)
|+++|..+.+.. -..++......++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999987774311 123577788889999999999999410
Q ss_pred -----------------CCCceeCCCCCCceEecCCCc--eeEcCCcchhh
Q 047140 143 -----------------SAQVIHCDLKPINVLLDDNMV--AHLSDFSIAKL 174 (313)
Q Consensus 143 -----------------~~~i~h~di~p~nil~~~~~~--~~l~dfg~~~~ 174 (313)
...++|+|++|.|||++.++. +.++||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.1e-10 Score=100.55 Aligned_cols=189 Identities=16% Similarity=0.083 Sum_probs=120.9
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCc--ceeeeeeeeeCc---cceEEEEee
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRN--LIKVISTCSNEE---FKALVLEYM 103 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~ 103 (313)
.+.++.|....||++. ..+++|+.... .....+.+|.++++.+ .+.. +++++.....++ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458889999998854 45889986432 3457788999999887 3332 455555544333 358999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY----------------------------------------- 142 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------------- 142 (313)
+|.+|.+.... .++......++.+++..+..||...
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888653322 3566667777778888777777310
Q ss_pred --------------CCCceeCCCCCCceEecC--CCceeEcCCcchhhcccccccccccccccccccCCCcccc----c-
Q 047140 143 --------------SAQVIHCDLKPINVLLDD--NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRR----K- 201 (313)
Q Consensus 143 --------------~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~- 201 (313)
...++|+|++|.||++++ .+.+.++||+.+..-.+..+- ........-..|+... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHHHHHc
Confidence 134799999999999998 556789999987643211100 0000000001222110 0
Q ss_pred CCC---------CCcchhHHHHHHHHHHHhCCCCChhh
Q 047140 202 GRE---------STNGDVYSFGIMLMETFTRKKPTDEI 230 (313)
Q Consensus 202 ~~~---------~~~~DiwslG~~l~~lltg~~p~~~~ 230 (313)
... ....+.|+++.++|.+.+|..+|...
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 000 12368999999999999999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.3e-08 Score=84.39 Aligned_cols=133 Identities=16% Similarity=0.017 Sum_probs=97.4
Q ss_pred cccceee-eEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEEEEeecCCCHH
Q 047140 33 FICGVII-PVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109 (313)
Q Consensus 33 lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (313)
+..|..+ .||+.... .+..+++|+-+.. ....+.+|...|+.+ .+-.+.+++.++.+++..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3335444 68887754 3678999987643 456788899999888 3445788999999999999999999998887
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 047140 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGY----------------------------------------------- 142 (313)
Q Consensus 110 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------------------- 142 (313)
+...... .....+..++...|.-||...
T Consensus 109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 7654321 223346667777777777210
Q ss_pred --------CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 --------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 --------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0017999999999999988777899999775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.4e-07 Score=81.15 Aligned_cols=135 Identities=13% Similarity=0.078 Sum_probs=90.5
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCC---cceeeeeeee-eCccceEEEEeecC
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHR---NLIKVISTCS-NEEFKALVLEYMPH 105 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~ 105 (313)
...++.|....||+. +..+++|+-.. ......+..|.++++.+.+. .+++++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 446777888889886 56788898432 34557889999999999642 3567777764 44567899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-------------------------------------------- 141 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------------------------------------------- 141 (313)
.++.+..-. .++......++.++...|..||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 887663211 123333334444444444444411
Q ss_pred -------------CCCCceeCCCCCCceEecC---CCc-eeEcCCcchh
Q 047140 142 -------------YSAQVIHCDLKPINVLLDD---NMV-AHLSDFSIAK 173 (313)
Q Consensus 142 -------------~~~~i~h~di~p~nil~~~---~~~-~~l~dfg~~~ 173 (313)
....++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1345799999999999987 355 5899999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=3.7e-07 Score=80.18 Aligned_cols=81 Identities=6% Similarity=-0.029 Sum_probs=56.5
Q ss_pred ccccc-ccceeeeEEEEEee-------cceEEEEEEeeccc---chhHHHHHHHHHHHhcCC-C--CcceeeeeeeeeC-
Q 047140 29 ILNFF-ICGVIIPVAQFLIS-------SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIR-H--RNLIKVISTCSNE- 93 (313)
Q Consensus 29 ~~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~- 93 (313)
..+.| +.|....+|+.... ++..+++|+..... ......+..|+.+++.+. + -.+++++.++.++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 78888999988754 26789999865432 001245778899988883 2 3577888887665
Q ss_pred --ccceEEEEeecCCCHH
Q 047140 94 --EFKALVLEYMPHGSLE 109 (313)
Q Consensus 94 --~~~~lv~e~~~~~~L~ 109 (313)
+..++|||+++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999886653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.31 E-value=7.5e-06 Score=65.59 Aligned_cols=140 Identities=12% Similarity=0.012 Sum_probs=96.6
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQT 185 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 185 (313)
-+|.+++...+.+++++++|.++.|.+.+|.-+-. +..-...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999988899999999999999999887720 11212344567899999999998885 2111
Q ss_pred ccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhhhhh
Q 047140 186 QTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHF 265 (313)
Q Consensus 186 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (313)
.....+.+||... ...+.+.-|||||++||..+--..|=..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e------------------------------------ 138 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE------------------------------------ 138 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE------------------------------------
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc------------------------------------
Confidence 1122356888653 4556788899999999999985555110
Q ss_pred hhhhhhHHHHHHHHhHhhcc-------------------------CCCCCCCHHHHHHHHH
Q 047140 266 VAKEQCVSFVFNLAIECTVE-------------------------SPEQRINAREIVAKLF 301 (313)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~-------------------------dP~~Rps~~~il~~l~ 301 (313)
+..+++.|.+|+..|..- .|..|++..+|++.-.
T Consensus 139 --E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 139 --ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp --EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred --chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 234677788888888755 3568999999998744
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=4.3e-06 Score=72.72 Aligned_cols=138 Identities=15% Similarity=0.075 Sum_probs=76.9
Q ss_pred cccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC--Ccceeeee------eeeeCccceEEEEe
Q 047140 31 NFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVIS------TCSNEEFKALVLEY 102 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~------~~~~~~~~~lv~e~ 102 (313)
..|+.|..+.||++...++ .+++|+.... . ..+..|.++++.+.. -.+++++. +...++..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455577889999886544 4889988753 1 233445565655521 13344443 12345667899999
Q ss_pred ecCCCHH-----------HHH---hc--CCC--C---------CCHHH-------------------------------H
Q 047140 103 MPHGSLE-----------KYL---YS--SNC--I---------LDIFQ-------------------------------R 124 (313)
Q Consensus 103 ~~~~~L~-----------~~l---~~--~~~--~---------~~~~~-------------------------------~ 124 (313)
++|.++. ..+ .. ... + ..+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9885431 111 10 000 0 01110 0
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 125 LNIMIDVASALEYLHF----------GYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 125 ~~~~~~i~~~l~~lH~----------~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..+...+..++.+|+. .....++|+|+++.|||++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223334555541 015789999999999999888899999998654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.23 E-value=5.7e-06 Score=70.37 Aligned_cols=79 Identities=9% Similarity=-0.015 Sum_probs=58.1
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC---CcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH---RNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e 101 (313)
........+|.|..+.||+....+|+.|++|+.+.........+..|++.|+.|.. -.+++++.+. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34456778899999999999988899999998765544444567889999988842 2345555542 3479999
Q ss_pred eecCCC
Q 047140 102 YMPHGS 107 (313)
Q Consensus 102 ~~~~~~ 107 (313)
++.++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=8.3e-06 Score=72.66 Aligned_cols=75 Identities=13% Similarity=0.031 Sum_probs=49.5
Q ss_pred ccccccceeeeEEEEEee-cceEEEEEEeecccc-------hhHHHHHHHHHHHhcCCC--C-cceeeeeeeeeCccceE
Q 047140 30 LNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-------RAFKSFNIECEMMKSIRH--R-NLIKVISTCSNEEFKAL 98 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~l 98 (313)
.+.+|.|..+.||++... +++.+++|....... ...+.+..|.++++.+.. + .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568899999999999754 467899998653211 123456778898887732 3 34456544 3445689
Q ss_pred EEEeecCC
Q 047140 99 VLEYMPHG 106 (313)
Q Consensus 99 v~e~~~~~ 106 (313)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-05 Score=68.89 Aligned_cols=76 Identities=14% Similarity=0.068 Sum_probs=60.2
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCC---CCcceeeeeeeeeCccceEEEEeecC
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR---HRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
-.+.++.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+++++.++...+..++|||+++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356788899999999875 4677889987643 3567888999998883 36788999988888889999999988
Q ss_pred CCH
Q 047140 106 GSL 108 (313)
Q Consensus 106 ~~L 108 (313)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=9.1e-05 Score=63.25 Aligned_cols=72 Identities=8% Similarity=0.025 Sum_probs=45.0
Q ss_pred cccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEee-cCC
Q 047140 29 ILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYM-PHG 106 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~~ 106 (313)
-.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+ ++++..+ ...-++++||+ +|.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3677888999999998 55888987654211 1223467877777632222 4666543 33357999999 665
Q ss_pred CH
Q 047140 107 SL 108 (313)
Q Consensus 107 ~L 108 (313)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=65.11 Aligned_cols=142 Identities=13% Similarity=0.127 Sum_probs=82.0
Q ss_pred ccccccccccceeeeEEEEEeec--------ceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccc
Q 047140 26 DFQILNFFICGVIIPVAQFLISS--------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFK 96 (313)
Q Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 96 (313)
..+ .+.+..|-...+|++...+ ++.+++|+.... ........+|.++++.+. +.-.+++++.+.++
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--- 126 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG--- 126 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE---
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc---
Confidence 444 3456568888899988642 468999986432 123455668999998883 32236777766542
Q ss_pred eEEEEeecCCCHHH--------------HHh---cC----CCCCC--HHHHHHHHHHHHH-------------------H
Q 047140 97 ALVLEYMPHGSLEK--------------YLY---SS----NCILD--IFQRLNIMIDVAS-------------------A 134 (313)
Q Consensus 97 ~lv~e~~~~~~L~~--------------~l~---~~----~~~~~--~~~~~~~~~~i~~-------------------~ 134 (313)
+|+||++|.+|.. .+. .. +.... ...+.++..++.. .
T Consensus 127 -~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 127 -RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp -EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred -cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 9999998754421 111 11 11111 2344445444321 1
Q ss_pred HHH----Hh-cCCCCCceeCCCCCCceEecCC----CceeEcCCcchh
Q 047140 135 LEY----LH-FGYSAQVIHCDLKPINVLLDDN----MVAHLSDFSIAK 173 (313)
Q Consensus 135 l~~----lH-~~~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~ 173 (313)
+.. |. ......++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 22 1113469999999999999876 789999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=62.73 Aligned_cols=140 Identities=11% Similarity=0.073 Sum_probs=73.1
Q ss_pred ccccccceeee-EEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC--CcceeeeeeeeeCccceEEEEeecCC
Q 047140 30 LNFFICGVIIP-VAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVISTCSNEEFKALVLEYMPHG 106 (313)
Q Consensus 30 ~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (313)
.+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+++++.+..+. -++++|++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 34555454443 6676543367788886544311 234456777766632 3456677664333 37899999776
Q ss_pred CHHHHHhcCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH---
Q 047140 107 SLEKYLYSSN-------------------------CILDIFQRL-------NIM-------------IDVASALEYL--- 138 (313)
Q Consensus 107 ~L~~~l~~~~-------------------------~~~~~~~~~-------~~~-------------~~i~~~l~~l--- 138 (313)
.+.+.+.... ..++..... .+. ..+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654442110 011111110 000 0111112222
Q ss_pred hcCCCCCceeCCCCCCceEecCC----CceeEcCCcchhh
Q 047140 139 HFGYSAQVIHCDLKPINVLLDDN----MVAHLSDFSIAKL 174 (313)
Q Consensus 139 H~~~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~~ 174 (313)
.......++|+|+.+.|||++.+ +.+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 01115689999999999999874 6899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00033 Score=62.73 Aligned_cols=77 Identities=12% Similarity=0.090 Sum_probs=45.4
Q ss_pred CCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccccccccc--cccccCCCcccccCC---CCCcchhHHHHHHH
Q 047140 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTL--ATIGCIAPEYRRKGR---ESTNGDVYSFGIML 217 (313)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~---~~~~~DiwslG~~l 217 (313)
...++|+|++|.|||++.++ +.++||+.+..-.+..+ ..... -...|++|+...... .....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 78899999999999999877 99999988763221110 00000 012345555433111 11234455777777
Q ss_pred HHHHhC
Q 047140 218 METFTR 223 (313)
Q Consensus 218 ~~lltg 223 (313)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00082 Score=57.84 Aligned_cols=138 Identities=14% Similarity=0.111 Sum_probs=78.4
Q ss_pred ccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCC--Ccceeeeee-----eeeCccceEEEEeec
Q 047140 32 FFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH--RNLIKVIST-----CSNEEFKALVLEYMP 104 (313)
Q Consensus 32 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~-----~~~~~~~~lv~e~~~ 104 (313)
.++ |....||+....+|+.+++|...... .....+..|..+++.+.. -.+++++.. ...++..++++++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77788999876667789999986431 123456678888877732 224444443 122445578999998
Q ss_pred CCCHH-----H------HH---hc----C----CCCCCHHHH----------------------HHHHHHHHHHHHHHhc
Q 047140 105 HGSLE-----K------YL---YS----S----NCILDIFQR----------------------LNIMIDVASALEYLHF 140 (313)
Q Consensus 105 ~~~L~-----~------~l---~~----~----~~~~~~~~~----------------------~~~~~~i~~~l~~lH~ 140 (313)
|..+. . .+ .. . ....+.... ...+..++..+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74321 1 11 00 0 001111110 1112222222222210
Q ss_pred -CCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 141 -GYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 141 -~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.....++|+|+++.|||++ + .+.++||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 0156789999999999999 4 89999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00023 Score=61.19 Aligned_cols=141 Identities=15% Similarity=0.129 Sum_probs=76.2
Q ss_pred ccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCc--ceeeeee------eeeCccceEEEE
Q 047140 30 LNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN--LIKVIST------CSNEEFKALVLE 101 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e 101 (313)
.+.++.|....+|+....++ .+++|+.... ...+.+..|..+++.+.... +++++.. ...++..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34566788889999886555 6888988652 12234556777777763222 3344322 122355689999
Q ss_pred eecCCCHH-----------HH---HhcC----CCC----CCHHHHHH---------------HHHHHHHHHHHHhc----
Q 047140 102 YMPHGSLE-----------KY---LYSS----NCI----LDIFQRLN---------------IMIDVASALEYLHF---- 140 (313)
Q Consensus 102 ~~~~~~L~-----------~~---l~~~----~~~----~~~~~~~~---------------~~~~i~~~l~~lH~---- 140 (313)
+++|..+. +. +... ... .....-.. +...+...+..+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99875431 00 1100 000 01100000 00112333444431
Q ss_pred CCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 141 GYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 141 ~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
....+++|+|+.+.|||++.++.+.++||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 113579999999999999987666899998664
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00046 Score=62.47 Aligned_cols=74 Identities=12% Similarity=0.152 Sum_probs=47.2
Q ss_pred ccccccceeeeEEEEEeec-ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEEEeecCCC
Q 047140 30 LNFFICGVIIPVAQFLISS-AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVLEYMPHGS 107 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 107 (313)
.+.|+.|-...+|++...+ +..+++|+......... ....|..+++.|...++ +++++.+.. .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4467778888999988654 47899998754322211 12578899988854444 577777632 36999998743
Q ss_pred H
Q 047140 108 L 108 (313)
Q Consensus 108 L 108 (313)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0003 Score=63.20 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=47.8
Q ss_pred ccccccceeeeEEEEEeec--------ceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc-eeeeeeeeeCccceEEE
Q 047140 30 LNFFICGVIIPVAQFLISS--------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL-IKVISTCSNEEFKALVL 100 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 100 (313)
.+.|+.|....+|++...+ +..+++|+...... .+.+..|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4466778888999988652 47899998843211 1344578888888843333 667766543 3899
Q ss_pred EeecCCC
Q 047140 101 EYMPHGS 107 (313)
Q Consensus 101 e~~~~~~ 107 (313)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987633
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00081 Score=59.06 Aligned_cols=73 Identities=10% Similarity=0.182 Sum_probs=44.2
Q ss_pred ccccccceeeeEEEEEeecc---------eEEEEEEeecccchhHHHHHHHHHHHhcCCCCc-ceeeeeeeeeCccceEE
Q 047140 30 LNFFICGVIIPVAQFLISSA---------MEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRN-LIKVISTCSNEEFKALV 99 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~~---------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 99 (313)
...++.|....+|++...++ ..+++|+...... .......|.++++.+...+ .+++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 44667788889999886532 6889998754322 2122457888888874333 44666544 2 3689
Q ss_pred EEeecCCC
Q 047140 100 LEYMPHGS 107 (313)
Q Consensus 100 ~e~~~~~~ 107 (313)
+||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0024 Score=55.39 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=27.0
Q ss_pred CCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 144 AQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 144 ~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 569999999999999988889999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0065 Score=53.97 Aligned_cols=29 Identities=28% Similarity=0.343 Sum_probs=24.6
Q ss_pred CceeCCCCCCceEe------cCCCceeEcCCcchh
Q 047140 145 QVIHCDLKPINVLL------DDNMVAHLSDFSIAK 173 (313)
Q Consensus 145 ~i~h~di~p~nil~------~~~~~~~l~dfg~~~ 173 (313)
.++|+|+.+.|||+ +++..+.++||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 456779999998875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0042 Score=55.55 Aligned_cols=73 Identities=8% Similarity=0.191 Sum_probs=47.1
Q ss_pred ccccccceeeeEEEEEeec--------ceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEE
Q 047140 30 LNFFICGVIIPVAQFLISS--------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 100 (313)
.+.+..|-...+|+....+ ++.+++|+..... ...-...+|..+++.+. +.-.+++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3456667788899988653 5789999875432 22223356888888873 322456665432 36899
Q ss_pred EeecCCC
Q 047140 101 EYMPHGS 107 (313)
Q Consensus 101 e~~~~~~ 107 (313)
||++|.+
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.38 E-value=0.99 Score=36.07 Aligned_cols=117 Identities=10% Similarity=0.107 Sum_probs=77.8
Q ss_pred CCCcceeeeeeeeeCccceEEEEeecCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceeCCCCCCce
Q 047140 79 RHRNLIKVISTCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALE-YLHFGYSAQVIHCDLKPINV 156 (313)
Q Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~~i~h~di~p~ni 156 (313)
.||++ -...-.+++.+.+.++.-+++ ++. .+. ..+....++++.+|+.... +++ .-.|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 56777 333445566666666665332 334 333 4678889999999888666 444 457888999999
Q ss_pred EecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhh
Q 047140 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIF 231 (313)
Q Consensus 157 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~ 231 (313)
+++.++.+++...|.-..+ +|. ..+..-=.-..=|++..++.+...|+..-
T Consensus 116 ~f~~~~~p~i~hRGi~~~l-------------------pP~-----e~~ee~fl~qyKali~all~~K~~Fe~l~ 166 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL-------------------PPD-----EWDDERLLREVKATVLALTEGEYRFDEYL 166 (219)
T ss_dssp EECTTCCEEESCCEETTTB-------------------SSC-----SCCHHHHHHHHHHHHHHHTTCSSCHHHHH
T ss_pred EEeCCCcEEEEEcCCcccC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 9999999999998864322 121 11111123356688889999988887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.20 E-value=0.66 Score=36.95 Aligned_cols=125 Identities=9% Similarity=0.143 Sum_probs=82.5
Q ss_pred HHHHHhcCCCCcceeeeeeeeeCccceEEEEeec-CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 047140 71 ECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP-HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHC 149 (313)
Q Consensus 71 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~ 149 (313)
|+.+|.. .||+.+.. .+-.+++.+.+.++.-+ +.++.. +. ..+....++++.+|+....+++ .-+|-
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf 103 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTF 103 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEEC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEE
Confidence 4444433 57878766 45555565555555543 222222 22 4678899999999998875555 34788
Q ss_pred CCCCCceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChh
Q 047140 150 DLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229 (313)
Q Consensus 150 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~ 229 (313)
-++|+|++++.++.+++...|.-..+. |. ..+...=.-..=|++..++++...|+.
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999999999988643221 11 112222234567888999999999877
Q ss_pred hh
Q 047140 230 IF 231 (313)
Q Consensus 230 ~~ 231 (313)
.-
T Consensus 160 l~ 161 (215)
T 4ann_A 160 LV 161 (215)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.80 E-value=0.17 Score=45.76 Aligned_cols=61 Identities=8% Similarity=-0.031 Sum_probs=17.7
Q ss_pred ccccccccceeeeEEEEEeec-ceEEEE------EEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeee
Q 047140 28 QILNFFICGVIIPVAQFLISS-AMEVAV------KVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCS 91 (313)
Q Consensus 28 ~~~~~lg~G~~g~V~~~~~~~-~~~vai------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (313)
.+.+.+| ||.||++.+.. ..+||+ |..+.. .......+.+|..+++.++|+|+++.+++-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456666 99999999753 468888 665432 1223456778889999999999998877653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 313 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-55
Identities = 63/262 (24%), Positives = 116/262 (44%), Gaps = 24/262 (9%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
+VAVK+ N+ + ++F E +++ RH N++ + + A+V ++ SL
Sbjct: 32 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 90
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+L+ ++ + ++I A ++YLH +IH DLK N+ L +++ + D
Sbjct: 91 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGD 147
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRKK 225
F +A + + S Q +I +APE + K S DVY+FGI+L E T +
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
P I NR+ + G +L +V + C + L EC +
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKV---------------RSNCPKAMKRLMAECLKK 252
Query: 286 SPEQRINAREIVAKLFKIRDSL 307
++R +I+A + + SL
Sbjct: 253 KRDERPLFPQILASIELLARSL 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-45
Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 24/256 (9%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VA+K + + F E E+M + H L+++ C + LV E+M HG L
Sbjct: 31 KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
YL + + L + +DV + YL A VIH DL N L+ +N V +SDF
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230
+ + + + + + T + +PE R S+ DV+SFG+++ E F+ K E
Sbjct: 147 MTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
+ ++ + + L S V+ + C E PE R
Sbjct: 206 RSNSEVVEDISTGF------RLYKPRLASTH-------------VYQIMNHCWKERPEDR 246
Query: 291 INAREIVAKLFKIRDS 306
++ +L +I +S
Sbjct: 247 PAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-45
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 26/251 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VAVK Q + +F E +MK ++H+ L+++ + + E ++ EYM +GSL
Sbjct: 39 KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVD 96
Query: 111 YLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+L + + I L I + L++ +A + ++ IH DL+ N+L+ D + ++DF
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
+A+L+ + + I APE G + DV+SFGI+L E T +
Sbjct: 154 GLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
+++ + V + C ++ L C E PE
Sbjct: 213 GMTNPEVIQNLERGYRM-------------------VRPDNCPEELYQLMRLCWKERPED 253
Query: 290 RINAREIVAKL 300
R + + L
Sbjct: 254 RPTFDYLRSVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-44
Identities = 53/266 (19%), Positives = 105/266 (39%), Gaps = 25/266 (9%)
Query: 50 MEVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
++VA+KV +A + E ++M + + ++++I C E LV+E G L
Sbjct: 37 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPL 95
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
K+L + + ++ V+ ++YL +H DL NVLL + A +SD
Sbjct: 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISD 152
Query: 169 FSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
F ++K L + ++ + APE + S+ DV+S+G+ + E + +
Sbjct: 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK- 211
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
P M+ + ++ +C ++ L +C +
Sbjct: 212 ------------------PYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKW 253
Query: 288 EQRINAREIVAKLFKIRDSLLRNVGG 313
E R + + ++ SL V G
Sbjct: 254 EDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-43
Identities = 53/253 (20%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VA+K+ + + F E ++M ++ H L+++ C+ + ++ EYM +G L
Sbjct: 30 DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
YL Q L + DV A+EYL Q +H DL N L++D V +SDF
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230
+++ + + + + + + PE + S+ D+++FG+++ E ++ K E
Sbjct: 146 LSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
Query: 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
F T +H +L S++ V+ + C E ++R
Sbjct: 205 FTNSETAEHIAQGLRL------YRPHLASEK-------------VYTIMYSCWHEKADER 245
Query: 291 INAREIVAKLFKI 303
+ +++ + +
Sbjct: 246 PTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-43
Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 52 VAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K + + F E +M H N+I + + ++ E+M +GSL+
Sbjct: 57 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+L ++ + Q + ++ +A+ ++YL +H DL N+L++ N+V +SDF
Sbjct: 117 FLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 173
Query: 171 IAKLLTGEYQSMTQTQTL---ATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
+++ L + T T L I APE + + ++ DV+S+GI++ E + +
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER- 232
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
P M D ++D C S + L ++C +
Sbjct: 233 ------------------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDR 274
Query: 288 EQRINAREIVAKLFKIRDSLLRN 310
R +IV L D ++RN
Sbjct: 275 NHRPKFGQIVNTL----DKMIRN 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-43
Identities = 68/256 (26%), Positives = 108/256 (42%), Gaps = 31/256 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK-ALVLEYMPHGSLE 109
+VAVK ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 32 KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89
Query: 110 KYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 146
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F + K S TQ + APE R+ + ST DV+SFGI+L E ++ +
Sbjct: 147 FGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-- 199
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
P + + D ++ A + C V+ + C
Sbjct: 200 -----------------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAA 242
Query: 289 QRINAREIVAKLFKIR 304
R + ++ +L I+
Sbjct: 243 MRPSFLQLREQLEHIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-42
Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 28/251 (11%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
A KV + + + + +E +++ S H N++K++ E +++E+ G+++
Sbjct: 39 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ L Q + AL YLH ++IH DLK N+L + L+DF
Sbjct: 99 VMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG 155
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEY-----RRKGRESTNGDVYSFGIMLMETFTRKK 225
++ T Q T +APE + DV+S GI L+E +
Sbjct: 156 VSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
P E+ + LK + ++ S F+ K C +
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLAQPSRW-----SSNFKDFLKK-------------CLEK 255
Query: 286 SPEQRINAREI 296
+ + R ++
Sbjct: 256 NVDARWTTSQL 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-42
Identities = 54/274 (19%), Positives = 102/274 (37%), Gaps = 21/274 (7%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLEYMPHG 106
EVAVK+F+ + R++ E +RH N++ I+ + + LV +Y HG
Sbjct: 28 EVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYSAQVIHCDLKPINVLLDDN 161
SL YL + + + + + AS L +LH + H DLK N+L+ N
Sbjct: 87 SLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
Query: 162 MVAHLSDFSIAKLL--TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG------DVYSF 213
++D +A + + + T +APE + D+Y+
Sbjct: 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204
Query: 214 GIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM-EVVDANLLSQEDIHFVAKEQCV 272
G++ E R + ++ + + M +VV L + + +
Sbjct: 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL 264
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
+ + EC + R+ A I L ++
Sbjct: 265 RVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 59/251 (23%), Positives = 106/251 (42%), Gaps = 26/251 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 43 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLD 100
Query: 111 YLYSSNCILDIF-QRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+L Q +++ +AS + Y+ +H DL+ N+L+ +N+V ++DF
Sbjct: 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADF 157
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
+A+L+ + + + I APE GR + DV+SFGI+L E T+ +
Sbjct: 158 GLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
L + E ++ + +L +C + PE+
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPES-------------------LHDLMCQCWRKEPEE 257
Query: 290 RINAREIVAKL 300
R + A L
Sbjct: 258 RPTFEYLQAFL 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 55/264 (20%), Positives = 106/264 (40%), Gaps = 26/264 (9%)
Query: 50 MEVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKA-LVLEYMPHGS 107
+ AVK N F E +MK H N++ ++ C E +VL YM HG
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L ++ + + + + VA +++L + +H DL N +LD+ ++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 168 DFSIAKLLTGE--YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
DF +A+ + + +T + +A E + + +T DV+SFG++L E TR
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
P P + D + + + E C ++ + ++C
Sbjct: 233 P-------------------PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHP 273
Query: 286 SPEQRINAREIVAKLFKIRDSLLR 309
E R + E+V+++ I + +
Sbjct: 274 KAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-41
Identities = 51/276 (18%), Positives = 96/276 (34%), Gaps = 45/276 (16%)
Query: 49 AMEVAVKVFNLQCGRAF-KSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHG 106
+++VAVK+ + + ++ E +MM + H N++ ++ C+ L+ EY +G
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 107 SLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGYSA 144
L YL S +L L VA +E+L
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FK 183
Query: 145 QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE 204
+H DL NVL+ V + DF +A+ + + + + + +APE +G
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 205 STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIH 264
+ DV+S+GI+L E F+ + L Q
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK------------------LIQNGFK 285
Query: 265 FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKL 300
++ + C +R + + + L
Sbjct: 286 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-41
Identities = 51/248 (20%), Positives = 95/248 (38%), Gaps = 24/248 (9%)
Query: 51 EVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK+ ++ + ++ E + K + H N++K + L LEY G L
Sbjct: 32 AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+ + + + + + YLH + H D+KP N+LLD+ +SDF
Sbjct: 92 DRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEY-RRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
+A + + + T+ +APE +R+ + DV+S GI+L + P D
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
+ + W ++ + + + + K VE+P
Sbjct: 208 QPSDSCQEYSDWKEKKTYLNPWKKI-----DSAPLALLHK-------------ILVENPS 249
Query: 289 QRINAREI 296
RI +I
Sbjct: 250 ARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-41
Identities = 55/260 (21%), Positives = 114/260 (43%), Gaps = 24/260 (9%)
Query: 49 AMEVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+ VA+K + F E +M H N+I++ S + ++ EYM +G+
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L+K+L + + Q + ++ +A+ ++YL + +H DL N+L++ N+V +S
Sbjct: 96 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 152
Query: 168 DFSIAKLL-TGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF ++++L + T + I APE + ++ DV+SFGI++ E T +
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
+ +K + + + M+ A ++ L ++C +
Sbjct: 213 PYWELSNHEVMKAINDGFRLPTPMDCPSA-------------------IYQLMMQCWQQE 253
Query: 287 PEQRINAREIVAKLFKIRDS 306
+R +IV+ L K+ +
Sbjct: 254 RARRPKFADIVSILDKLIRA 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-40
Identities = 51/276 (18%), Positives = 100/276 (36%), Gaps = 40/276 (14%)
Query: 47 SSAMEVAVKVFNLQCGRAF-KSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMP 104
+AM VAVK+ ++ E +++ + H N++ ++ C+ ++ EY
Sbjct: 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110
Query: 105 HGSLEKYLYSS-----------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVI 147
+G L +L LD+ L+ VA + +L S I
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCI 167
Query: 148 HCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTN 207
H DL N+LL + + DF +A+ + + + + + +APE +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 208 GDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVA 267
DV+S+GI L E F+ + +E ++
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------------------IKEGFRMLS 269
Query: 268 KEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
E + ++++ C P +R ++IV + K
Sbjct: 270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 3e-40
Identities = 61/261 (23%), Positives = 104/261 (39%), Gaps = 25/261 (9%)
Query: 44 FLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103
++ VAVK + F E +MK I+H NL++++ C+ E ++ E+M
Sbjct: 37 VWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95
Query: 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
+G+L YL N + L + ++SA+EYL IH DL N L+ +N
Sbjct: 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENH 152
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ ++DF +++L+TG+ I APE + S DV++FG++L E T
Sbjct: 153 LVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
+ + ++D E C V+ L C
Sbjct: 212 YGMSPYPGIDLSQVYELL-------------------EKDYRMERPEGCPEKVYELMRAC 252
Query: 283 TVESPEQRINAREIVAKLFKI 303
+P R + EI +
Sbjct: 253 WQWNPSDRPSFAEIHQAFETM 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 3e-40
Identities = 60/277 (21%), Positives = 107/277 (38%), Gaps = 46/277 (16%)
Query: 51 EVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VAVK+ + F E +M + N++K++ C+ + L+ EYM +G L
Sbjct: 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 110 KYLYSSNC-----------------------ILDIFQRLNIMIDVASALEYLHFGYSAQV 146
++L S + L ++L I VA+ + YL +
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161
Query: 147 IHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGREST 206
+H DL N L+ +NMV ++DF +++ + I + PE R +T
Sbjct: 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 207 NGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFV 266
DV+++G++L E F+ E + + V D N+L+
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY------------VRDGNILACP----- 264
Query: 267 AKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
E C ++NL C + P R + I L ++
Sbjct: 265 --ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-40
Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 27/253 (10%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VAVK+ + E +M+ + + ++++I C E + LV+E G L
Sbjct: 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPL 94
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
KYL + + + ++ V+ ++YL + +H DL NVLL A +SD
Sbjct: 95 NKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISD 150
Query: 169 FSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
F ++K L + + APE + S+ DV+SFG+++ E F+ +
Sbjct: 151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK- 209
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
P M+ + + ++ C +++L C
Sbjct: 210 ------------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 288 EQRINAREIVAKL 300
E R + +L
Sbjct: 252 ENRPGFAAVELRL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 9e-40
Identities = 47/270 (17%), Positives = 101/270 (37%), Gaps = 31/270 (11%)
Query: 51 EVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
+A K+ +L+ A ++ E +++ ++ ++ ++ +E+M GSL+
Sbjct: 33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+ L + + + I V L YL +++H D+KP N+L++ L DF
Sbjct: 93 QVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 149
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP--- 226
++ L + T ++PE + S D++S G+ L+E + P
Sbjct: 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 227 -----------------TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKE 269
E R T +++ S + LL K
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 270 QCVSF---VFNLAIECTVESPEQRINAREI 296
F + +C +++P +R + +++
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-39
Identities = 49/256 (19%), Positives = 85/256 (33%), Gaps = 31/256 (12%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHG 106
+ K + + E +++ ++H N+++ + L V+EY G
Sbjct: 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90
Query: 107 SLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH--FGYSAQVIHCDLKPINVLLDDN 161
L + LD L +M + AL+ H V+H DLKP NV LD
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221
L DF +A++L + T ++PE + + D++S G +L E
Sbjct: 151 QNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 222 TRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIE 281
P +E+ K + I S E + +
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIP-------YRYSDELNEIITR------------- 248
Query: 282 CTVESPEQRINAREIV 297
R + EI+
Sbjct: 249 MLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 3e-39
Identities = 52/253 (20%), Positives = 88/253 (34%), Gaps = 35/253 (13%)
Query: 51 EVAVKVFNL---QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
VA+K + Q ++ E ++ +RH N I+ E LV+EY +
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
+ L + + L YLH S +IH D+K N+LL + + L
Sbjct: 102 SDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEY---RRKGRESTNGDVYSFGIMLMETFTRK 224
DF A ++ + T +APE +G+ DV+S GI +E RK
Sbjct: 158 DFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTV 284
P + N + + S+ +FV C
Sbjct: 212 PPLFNMNAMSALYHIAQNESPALQSGHW------SEYFRNFVDS-------------CLQ 252
Query: 285 ESPEQRINAREIV 297
+ P+ R + ++
Sbjct: 253 KIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 50/256 (19%), Positives = 99/256 (38%), Gaps = 24/256 (9%)
Query: 49 AMEVAVKVFNL-QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G
Sbjct: 38 KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGC 96
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L Y+ + LN + +A + YL +++H DL NVL+ ++
Sbjct: 97 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKIT 153
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF +AKLL E + I +A E + DV+S+G+ + E T
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK- 212
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
P + + + + ++ C V+ + ++C +
Sbjct: 213 ------------------PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 254
Query: 288 EQRINAREIVAKLFKI 303
+ R RE++ + K+
Sbjct: 255 DSRPKFRELIIEFSKM 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-38
Identities = 52/260 (20%), Positives = 102/260 (39%), Gaps = 32/260 (12%)
Query: 45 LISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVI----STCSNEEFKAL 98
+ +EVA + + F E EM+K ++H N+++ ST ++ L
Sbjct: 30 DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89
Query: 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158
V E M G+L+ YL ++ I + + L++LH + +IH DLK N+ +
Sbjct: 90 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFI 147
Query: 159 DD-NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIML 217
+ D +A L + + T +APE + + DVY+FG+ +
Sbjct: 148 TGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCM 202
Query: 218 METFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 277
+E T + P E N + + P S +V +
Sbjct: 203 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------------------E 244
Query: 278 LAIECTVESPEQRINAREIV 297
+ C ++ ++R + ++++
Sbjct: 245 IIEGCIRQNKDERYSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-38
Identities = 61/259 (23%), Positives = 91/259 (35%), Gaps = 26/259 (10%)
Query: 50 MEVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
+ VAVK L A F E M S+ HRNLI++ K +V E P G
Sbjct: 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
SL L + + VA + YL S + IH DL N+LL + +
Sbjct: 96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 152
Query: 167 SDFSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKK 225
DF + + L + + Q APE + S D + FG+ L E FT +
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVE 285
N L + +E E C ++N+ ++C
Sbjct: 213 EPWIGLNGSQILHK------------------IDKEGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 286 SPEQRINAREIVAKLFKIR 304
PE R + L + +
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (344), Expect = 3e-38
Identities = 41/248 (16%), Positives = 82/248 (33%), Gaps = 25/248 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
A K ++ E + M +RH L+ + ++ ++ E+M G L +
Sbjct: 53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL--DDNMVAHLSD 168
+ + + + + M V L ++H +H DLKP N++ + L D
Sbjct: 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F + L + T T APE D++S G++ + P
Sbjct: 170 FGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
+ E +W + + +S++ F+ K + P
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAF----SGISEDGKDFIRK-------------LLLADPN 269
Query: 289 QRINAREI 296
R+ +
Sbjct: 270 TRMTIHQA 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 4e-38
Identities = 52/250 (20%), Positives = 100/250 (40%), Gaps = 32/250 (12%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
+A+KV L+ E E+ +RH N++++ + L+LEY P G+
Sbjct: 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
+ + L + D + + ++A+AL Y H S +VIH D+KP N+LL ++
Sbjct: 93 VYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF + ++ T+ + PE D++S G++ E K P
Sbjct: 149 DFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ +E + IS +E + +++ +++ +P
Sbjct: 205 EANTYQETYKR--------ISRVEFTFPDFVTEGARDLISR-------------LLKHNP 243
Query: 288 EQRINAREIV 297
QR RE++
Sbjct: 244 SQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 7e-38
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 26/258 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
EVA++ NLQ + E +M+ ++ N++ + + + +V+EY+ GSL
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170
+ + D Q + + ALE+LH S QVIH D+K N+LL + L+DF
Sbjct: 107 VVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEI 230
+T E + T +APE + D++S GIM +E + P
Sbjct: 162 FCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
Query: 231 FNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQR 290
N + E LS F+ + C E+R
Sbjct: 220 NPLRALYLIATNGTPELQNPEK-----LSAIFRDFLNR-------------CLDMDVEKR 261
Query: 291 INAREIVA-KLFKIRDSL 307
+A+E++ + KI L
Sbjct: 262 GSAKELLQHQFLKIAKPL 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 42/279 (15%)
Query: 50 MEVAVKVFNLQCGR-AFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALVLEYMPHGS 107
M+ A+K + + F E E++ + H N+I ++ C + + L +EY PHG+
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 108 LEKYLYSSNCI---------------LDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
L +L S + L Q L+ DVA ++YL Q IH DL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLA 154
Query: 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYS 212
N+L+ +N VA ++DF +++ G+ + +T + +A E +TN DV+S
Sbjct: 155 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211
Query: 213 FGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
+G++L E + + + C
Sbjct: 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------------------EKPLNCD 252
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRNV 311
V++L +C E P +R + +I+ L ++ + V
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-37
Identities = 54/271 (19%), Positives = 111/271 (40%), Gaps = 32/271 (11%)
Query: 51 EVAVKVFNLQCG-RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K N R F E +MK ++++++ S + +++E M G L+
Sbjct: 52 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111
Query: 110 KYLY---------SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
YL + + + + ++A + YL+ + + +H DL N ++ +
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 168
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+ + DF + + + + L + ++PE + G +T DV+SFG++L E
Sbjct: 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
Query: 221 FTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
T + + + E L+ V++ LL + D C +F L
Sbjct: 229 ATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD-------NCPDMLFELMR 269
Query: 281 ECTVESPEQRINAREIVAKLFKIRDSLLRNV 311
C +P+ R + EI++ + + + R V
Sbjct: 270 MCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 133 bits (335), Expect = 5e-37
Identities = 41/248 (16%), Positives = 84/248 (33%), Gaps = 25/248 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
K N + E +M + H LI + ++ L+LE++ G L
Sbjct: 56 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--DNMVAHLSD 168
+ + + + + +N M L+++H ++H D+KP N++ + + D
Sbjct: 116 RIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 172
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F +A L + T AT APE + D+++ G++ + P
Sbjct: 173 FGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
+ E +W + +S E F+ + P
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN-------------LLQKEPR 272
Query: 289 QRINAREI 296
+R+ +
Sbjct: 273 KRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 129 bits (324), Expect = 4e-36
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 30/264 (11%)
Query: 51 EVAVKVFNLQCGR---AFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA----LVLEYM 103
+VAVKV R + F E + ++ H ++ V T E +V+EY+
Sbjct: 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93
Query: 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMV 163
+L +++ + + + ++ D AL + H +IH D+KP N+++
Sbjct: 94 DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNA 149
Query: 164 AHLSDFSIAKLLTGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF IA+ + S+TQT + T ++PE R DVYS G +L E T
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
+ P + +H + +P S LS + V K
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSA----RHEGLSADLDAVVLK-------------A 252
Query: 283 TVESPEQRI-NAREIVAKLFKIRD 305
++PE R A E+ A L ++ +
Sbjct: 253 LAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-36
Identities = 52/259 (20%), Positives = 95/259 (36%), Gaps = 25/259 (9%)
Query: 48 SAMEVAVKVFNLQCGRAFKS-FNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
A+ VA+K + + F E M+ H +++K+I + E +++E G
Sbjct: 34 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 92
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L +L LD+ + +++AL YL S + +H D+ NVL+ N L
Sbjct: 93 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKL 149
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
DF +++ + L I +APE R ++ DV+ FG+ + E
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
+ + N C +++L +C
Sbjct: 209 PFQGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWAYD 249
Query: 287 PEQRINAREIVAKLFKIRD 305
P +R E+ A+L I +
Sbjct: 250 PSRRPRFTELKAQLSTILE 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-36
Identities = 54/264 (20%), Positives = 96/264 (36%), Gaps = 28/264 (10%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
E A+K+ + E ++M + H +K+ T ++E L Y +G
Sbjct: 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L KY+ D ++ SALEYLH +IH DLKP N+LL+++M ++
Sbjct: 95 LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF AK+L+ E + + T ++PE + + D+++ G ++ + P
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ K I +E + V K V
Sbjct: 211 RAGNEYLIFQK--------IIKLEYDFPEKFFPKARDLVEK-------------LLVLDA 249
Query: 288 EQRINAREIVAKLFKIRDSLLRNV 311
+R+ E+ +V
Sbjct: 250 TKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 36 GVIIPVAQFLISSAMEVAVKVFNLQCG-RAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93
I + + + +VAVK+ + E EMMK I +H+N+I ++ C+ +
Sbjct: 32 AEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91
Query: 94 EFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIMIDVASALEYL 138
+++EY G+L +YL ++ L ++ VA +EYL
Sbjct: 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 151
Query: 139 HFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEY 198
S + IH DL NVL+ ++ V ++DF +A+ + T + +APE
Sbjct: 152 A---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208
Query: 199 RRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258
+ DV+SFG++L E FT E K
Sbjct: 209 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL------------------ 250
Query: 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303
+E C + ++ + +C P QR +++V L +I
Sbjct: 251 -KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-33
Identities = 42/248 (16%), Positives = 91/248 (36%), Gaps = 26/248 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
K ++ G E ++ RHRN++ + + + E ++ E++ + +
Sbjct: 32 TYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--DNMVAHLSD 168
+ +S L+ + ++ + V AL++LH S + H D++P N++ + + +
Sbjct: 91 RINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F A+ L APE + ST D++S G ++ + P
Sbjct: 148 FGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPE 288
N+++ + +S E + FV + V+ +
Sbjct: 205 AETNQQIIENIMNAEYTFDEEAF----KEISIEAMDFVDR-------------LLVKERK 247
Query: 289 QRINAREI 296
R+ A E
Sbjct: 248 SRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-31
Identities = 51/274 (18%), Positives = 96/274 (35%), Gaps = 39/274 (14%)
Query: 51 EVAVKVFNLQCGRA-FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL--VLEYMPHGS 107
VAVK+ + ++ E +++ I H + + + L ++E+ G+
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 108 LEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLK 152
L YL S L + + VA +E+L S + IH DL
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 161
Query: 153 PINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYS 212
N+LL + V + DF +A+ + + + + + +APE + DV+S
Sbjct: 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 213 FGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
FG++L E F+ + +E A +
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRR------------------LKEGTRMRAPDYTT 263
Query: 273 SFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306
++ ++C P QR E+V L + +
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (287), Expect = 1e-30
Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 40/262 (15%)
Query: 51 EVAVKVFNLQCGRAFKSFNI---------ECEMMKSIR-HRNLIKVISTCSNEEFKALVL 100
E AVK+ ++ G +F + + E ++++ + H N+I++ T F LV
Sbjct: 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
+ M G L YL + L + IM + + LH ++H DLKP N+LLDD
Sbjct: 90 DLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 145
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG------DVYSFG 214
+M L+DF + L + T +APE + D++S G
Sbjct: 146 DMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 215 IMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 274
+++ P + + L+ + + E D S V++
Sbjct: 203 VIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDD---YSDTVKDLVSR------ 252
Query: 275 VFNLAIECTVESPEQRINAREI 296
V P++R A E
Sbjct: 253 -------FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-29
Identities = 38/247 (15%), Positives = 81/247 (32%), Gaps = 22/247 (8%)
Query: 51 EVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K + S E ++ I+H N++ + + L+++ + G L
Sbjct: 36 LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95
Query: 110 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169
+ ++ V A++YLH + LD++ +SDF
Sbjct: 96 DRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154
Query: 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE 229
++K+ + T G +APE + S D +S G++ P +
Sbjct: 155 GLSKMED---PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211
Query: 230 IFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQ 289
+ ++ + + S + +S F+ + PE+
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYW----DDISDSAKDFIRH-------------LMEKDPEK 254
Query: 290 RINAREI 296
R +
Sbjct: 255 RFTCEQA 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 43/254 (16%), Positives = 91/254 (35%), Gaps = 31/254 (12%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTC----SNEEFKALVLEYMPHG 106
+ A+K+ C +A + + ++ + ++++++ + + +V+E + G
Sbjct: 39 KFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 94
Query: 107 SLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---DNM 162
L + + + IM + A++YLH S + H D+KP N+L N
Sbjct: 95 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNA 151
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ L+DF AK T T T +APE + + D++S G+++
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
P ++ + + + +S+E +
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN-------------L 255
Query: 283 TVESPEQRINAREI 296
P QR+ E
Sbjct: 256 LKTEPTQRMTITEF 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 49/251 (19%), Positives = 90/251 (35%), Gaps = 31/251 (12%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECE-MMKSIRHRNLIKVISTCSNEEFKALVLEYMPHG 106
A+K + + +E + + H L + T +E V+EY+ G
Sbjct: 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88
Query: 107 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHL 166
L ++ S + D+ + ++ L++LH S +++ DLK N+LLD + +
Sbjct: 89 DLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 144
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP 226
+DF + K T IAPE + + + D +SFG++L E + P
Sbjct: 145 ADFGMCKEN--MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 227 TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVES 286
+ E + L +E + K V
Sbjct: 203 FHG-QDEEELFHSIRMDNPFYP-------RWLEKEAKDLLVK-------------LFVRE 241
Query: 287 PEQRINAREIV 297
PE+R+ R +
Sbjct: 242 PEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 2e-28
Identities = 51/252 (20%), Positives = 94/252 (37%), Gaps = 33/252 (13%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
A+KV + + + N E M+ + H +I++ T + + ++++Y+ G
Sbjct: 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GG 89
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L + +V ALEYLH S +I+ DLKP N+LLD N ++
Sbjct: 90 ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF AK + ++ T IAPE + + D +SFGI++ E P
Sbjct: 147 DFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ + K I E+ +++ +++
Sbjct: 202 YDSNTMKTYEK--------ILNAELRFPPFFNEDVKDLLSR-------------LITRDL 240
Query: 288 EQRINAREIVAK 299
QR+ + +
Sbjct: 241 SQRLGNLQNGTE 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 3e-28
Identities = 42/259 (16%), Positives = 88/259 (33%), Gaps = 33/259 (12%)
Query: 51 EVAVKVFNL------QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
A+K + Q + I ++ + ++ + + + +L+ M
Sbjct: 31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
G L +L + ++ LE++H + V++ DLKP N+LLD++
Sbjct: 91 GGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 146
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTR 223
+SD +A + + + T G +APE +KG ++ D +S G ML +
Sbjct: 147 RISDLGLACDFSKKKPHASVG----THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 224 KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECT 283
P + ++ + + + S E +
Sbjct: 203 HSPFRQHKTKDKHEIDRMTLTMAVELPDSF-----SPELRSLLEG-------------LL 244
Query: 284 VESPEQRINAREIVAKLFK 302
+R+ A+ K
Sbjct: 245 QRDVNRRLGCLGRGAQEVK 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 107 bits (267), Expect = 7e-28
Identities = 46/256 (17%), Positives = 100/256 (39%), Gaps = 15/256 (5%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
A+K L+ + E ++K ++H N++K+ ++ LV E++ L
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDL 86
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+K L L+ + ++ + + + Y H +V+H DLKP N+L++ ++D
Sbjct: 87 KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD 143
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F +A+ G + + + ST D++S G + E
Sbjct: 144 FGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 229 EIFNREMTLKHW-------GNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NLAI 280
+ + ++ + NW ++ + D N E + + + + + +L
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 281 ECTVESPEQRINAREI 296
+ P QRI A++
Sbjct: 263 KMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 9e-28
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 27/263 (10%)
Query: 51 EVAVKVFNLQC-----GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105
VA+K L ++ E ++++ + H N+I ++ ++ +LV ++M
Sbjct: 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
+ ++ +L M+ LEYLH ++H DLKP N+LLD+N V
Sbjct: 85 DLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLK 140
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRK 224
L+DF +AK T + T APE R D+++ G +L E R
Sbjct: 141 LADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 225 KPTDEIFNREM-----------TLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVS 273
+ + T + W + + + I A + +
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 274 FVFNLAIECTVESPEQRINAREI 296
+ + +P RI A +
Sbjct: 259 LIQG----LFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-27
Identities = 45/258 (17%), Positives = 83/258 (32%), Gaps = 26/258 (10%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
EVA+K+ ++ +IE ++ K ++ I I C E +++ + SLE
Sbjct: 34 EVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED 91
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL---LDDNMVAHLS 167
+ + L + + S +EY+H S IH D+KP N L + ++
Sbjct: 92 LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 148
Query: 168 DFSIAKLLTGE-----YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
DF +AK T + +S D+ S G +LM
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIEC 282
P + K+ + +ST V E ++ C
Sbjct: 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF-------------C 255
Query: 283 TVESPEQRINAREIVAKL 300
+ + + +
Sbjct: 256 RSLRFDDKPDYSYLRQLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 6e-27
Identities = 47/256 (18%), Positives = 94/256 (36%), Gaps = 14/256 (5%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K L + E ++K + H N++K++ E LV E++
Sbjct: 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+ S+ + + + + + L + H S +V+H DLKP N+L++ L+D
Sbjct: 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 145
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F +A+ ++ T + + ST D++S G + E TR+
Sbjct: 146 FGLARAFGVPVRTYT-HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 229 EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF--------NLAI 280
+ + + P + ++ + Q S V +L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS 264
Query: 281 ECTVESPEQRINAREI 296
+ P +RI+A+
Sbjct: 265 QMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 9e-27
Identities = 50/261 (19%), Positives = 96/261 (36%), Gaps = 18/261 (6%)
Query: 51 EVAVKVFNLQCGRAF-KSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLE 109
VA+K + + + + E +++ RH N+I + + + Y+ +
Sbjct: 35 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94
Query: 110 KYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
LY L + + L+Y+H SA V+H DLKP N+LL+ +
Sbjct: 95 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 151
Query: 168 DFSIAKLLT-GEYQSMTQTQTLATIGCIAPEYRRKGRESTN-GDVYSFGIMLMETFTRKK 225
DF +A++ + T+ +AT APE + T D++S G +L E + +
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211
Query: 226 PTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF----------V 275
+ G P NL ++ + + + V +
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
Query: 276 FNLAIECTVESPEQRINAREI 296
+L + +P +RI +
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 22/271 (8%)
Query: 42 AQFLISSAMEVAVKVFNLQCGRAFKSFNIECE-----MMKSIRHRNLIKVISTCSNEEFK 96
A+ L + VA+K +Q G + E +++ H N++++ C+
Sbjct: 26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85
Query: 97 A-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDL 151
LV E++ + ++M + L++LH S +V+H DL
Sbjct: 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDL 142
Query: 152 KPINVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVY 211
KP N+L+ + L+DF +A++ + M T + T+ APE + +T D++
Sbjct: 143 KPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 199
Query: 212 SFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAK--E 269
S G + E F RK + + K LP D L Q A+ E
Sbjct: 200 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 259
Query: 270 QCVSFVFNLAIE----CTVESPEQRINAREI 296
+ V+ + L + C +P +RI+A
Sbjct: 260 KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-26
Identities = 46/263 (17%), Positives = 89/263 (33%), Gaps = 26/263 (9%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTC------SNEEFKALVLEYMP 104
VA+K + N E ++M+ + H N++++ +E + LVL+Y+P
Sbjct: 47 LVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102
Query: 105 HGSLE--KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP-INVLLDDN 161
++ + L + M + +L Y+H S + H D+KP +L D
Sbjct: 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDT 159
Query: 162 MVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETF 221
V L DF AK L +++ + +++ DV+S G +L E
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217
Query: 222 TRKKP------TDEIFNREMTLKHWGNNWLPISTMEVVDANL--LSQEDIHFVAKEQCVS 273
+ D++ L + + + V + +
Sbjct: 218 LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277
Query: 274 FVFNLAIECTVESPEQRINAREI 296
L +P R+ E
Sbjct: 278 EAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-25
Identities = 48/256 (18%), Positives = 90/256 (35%), Gaps = 34/256 (13%)
Query: 51 EVAVKVFNL------QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMP 104
+ A K + G + + E ++K I+H N+I + N+ L+LE +
Sbjct: 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
G L + + L + + + + + YLH S Q+ H DLKP N++L D V
Sbjct: 97 GGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVP 152
Query: 165 ----HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+ DF +A + T +APE D++S G++
Sbjct: 153 KPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 221 FTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAI 280
+ P +E N+ + S F+ +
Sbjct: 210 LSGASPFLGDTKQETLANVSAVNYEFEDEYF----SNTSALAKDFIRR------------ 253
Query: 281 ECTVESPEQRINAREI 296
V+ P++R+ ++
Sbjct: 254 -LLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 6e-25
Identities = 48/264 (18%), Positives = 83/264 (31%), Gaps = 50/264 (18%)
Query: 46 ISSAMEVAVKVFNLQCGRAF------KSFNIECEMMKSIR--HRNLIKVISTCSNEEFKA 97
+S + VA+K + +E ++K + +I+++ +
Sbjct: 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85
Query: 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVL 157
L+LE + L + V A+ + H + V+H D+K N+L
Sbjct: 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENIL 142
Query: 158 LD-DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGI 215
+D + L DF LL T T PE+ R R + V+S GI
Sbjct: 143 IDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 216 MLMETFTRKKP---TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
+L + P +EI ++ + +S E H +
Sbjct: 199 LLYDMVCGDIPFEHDEEIIRGQVFFRQR-----------------VSSECQHLIRW---- 237
Query: 273 SFVFNLAIECTVESPEQRINAREI 296
C P R EI
Sbjct: 238 ---------CLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 1e-23
Identities = 45/257 (17%), Positives = 95/257 (36%), Gaps = 16/257 (6%)
Query: 51 EVAVKVFNLQCG--RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSL 108
VA+K L S E ++K ++H+N++++ +++ LV E+
Sbjct: 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 109 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168
+ + + + D + + + L + H V+H DLKP N+L++ N L++
Sbjct: 89 KYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLAN 144
Query: 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTD 228
F +A+ + + + + ST+ D++S G + E +P
Sbjct: 145 FGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 229 EIFNREMTLKH--------WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NLA 279
+ + LK W ++ + + V ++ +L
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 280 IECTVESPEQRINAREI 296
+P QRI+A E
Sbjct: 264 QNLLKCNPVQRISAEEA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.1 bits (233), Expect = 6e-23
Identities = 31/269 (11%), Positives = 76/269 (28%), Gaps = 32/269 (11%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGSLEK 110
+VA+K + E K + I + E +++ + SLE
Sbjct: 32 QVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLED 89
Query: 111 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH----- 165
L + + + ++ +H +++ D+KP N L+ +
Sbjct: 90 LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIY 146
Query: 166 LSDFSIAKLL----TGEYQSMTQTQTLA-TIGCIAPEYRRKGRESTNGDVYSFGIMLMET 220
+ DF + K T ++ + + L+ T ++ +S D+ + G + M
Sbjct: 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206
Query: 221 FTRK--KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 278
+ + + G E+ +
Sbjct: 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---------------GFPEEFYKY 251
Query: 279 AIECTVESPEQRINAREIVAKLFKIRDSL 307
+ + + + K+ + L
Sbjct: 252 MHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 2e-22
Identities = 50/252 (19%), Positives = 88/252 (34%), Gaps = 30/252 (11%)
Query: 51 EVAVKVFNLQCGRA---FKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
A+K+ + A E ++++ RH L + + V+EY G
Sbjct: 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
L +L S + + ++ SALEYLH S V++ D+K N++LD + ++
Sbjct: 92 LFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKIT 147
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF + K + +M T +APE D + G+++ E + P
Sbjct: 148 DFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
Query: 228 DEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESP 287
+ + T LS E +A + P
Sbjct: 206 YNQDHERLFELILMEEIRFPRT--------LSPEAKSLLAG-------------LLKKDP 244
Query: 288 EQRINAREIVAK 299
+QR+ AK
Sbjct: 245 KQRLGGGPSDAK 256
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 5e-22
Identities = 45/255 (17%), Positives = 83/255 (32%), Gaps = 27/255 (10%)
Query: 51 EVAVKVFN----LQCGRAFKSFNIECEMMKSIRHR-NLIKVISTCSNEEFKALVLEYMPH 105
A+KV +Q + + E ++++ IR L+ + E L+L+Y+
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAH 165
G L +L F + I V + L + +I+ D+K N+LLD N
Sbjct: 114 GELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 166 LSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRK 224
L+DF ++K + R D +S G+++ E T
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTV 284
P F + I E +S + + +
Sbjct: 230 SP----FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR-------------LLM 272
Query: 285 ESPEQRINAREIVAK 299
+ P++R+ A
Sbjct: 273 KDPKKRLGCGPRDAD 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 6e-22
Identities = 46/270 (17%), Positives = 97/270 (35%), Gaps = 28/270 (10%)
Query: 51 EVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA--------LVL 100
+VA+K ++ + E ++++ ++H N++ +I C + LV
Sbjct: 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160
++ H + + +M + + L Y+H +++H D+K NVL+
Sbjct: 97 DFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITR 152
Query: 161 NMVAHLSDFSIAKLLTGEYQSMTQTQT--LATIGCIAPEYRRKGRESTNG-DVYSFGIML 217
+ V L+DF +A+ + S T + T+ PE R+ D++ G ++
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 218 METFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF--- 274
E +TR + + N E + V ++
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 275 --------VFNLAIECTVESPEQRINAREI 296
+L + V P QRI++ +
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 7e-22
Identities = 50/264 (18%), Positives = 98/264 (37%), Gaps = 28/264 (10%)
Query: 51 EVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA------LVLEY 102
+VA+K Q K E ++K +RH N+I ++ + +E LV+ +
Sbjct: 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
M G+ L L + ++ + L Y+H +A +IH DLKP N+ ++++
Sbjct: 105 M--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDC 158
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF +A+ + S + R + D++S G ++ E T
Sbjct: 159 ELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF-------- 274
K + + + P + + ++ + + + + F
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274
Query: 275 --VFNLAIECTVESPEQRINAREI 296
NL + V EQR+ A E
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 88.7 bits (219), Expect = 1e-20
Identities = 36/200 (18%), Positives = 76/200 (38%), Gaps = 13/200 (6%)
Query: 51 EVAVKVFN---LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPHGS 107
A+K+ + + + + E +++++ L+K+ + + +V+EY+ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167
+ +L + EYLH S +I+ DLKP N+L+D ++
Sbjct: 128 MFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPT 227
DF AK + G ++ T +APE + D ++ G+++ E P
Sbjct: 184 DFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 228 DEIFNREMTLKHWGNNWLPI 247
+ + +
Sbjct: 239 FAD-QPIQIYEKIVSGKVRF 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 4e-20
Identities = 46/262 (17%), Positives = 95/262 (36%), Gaps = 24/262 (9%)
Query: 51 EVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----EFKALVLEYMP 104
VAVK + Q K E ++K ++H N+I ++ + EF + L
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 105 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164
G+ + L ++ + L+Y+H SA +IH DLKP N+ ++++
Sbjct: 105 MGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 160
Query: 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK 224
+ DF +A+ E T + D++S G ++ E T +
Sbjct: 161 KILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 225 KPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSF---------- 274
+ + P + + ++ ++ I + + ++F
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 275 VFNLAIECTVESPEQRINAREI 296
+L + V ++RI A +
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.3 bits (210), Expect = 1e-19
Identities = 48/268 (17%), Positives = 98/268 (36%), Gaps = 35/268 (13%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFK--ALVLEYMPHGS 107
+V VK+ K E ++++++R N+I + + + ALV E++ +
Sbjct: 62 KVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118
Query: 108 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD-DNMVAHL 166
++ + L + M ++ AL+Y H S ++H D+KP NV++D ++ L
Sbjct: 119 FKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRL 171
Query: 167 SDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNG-DVYSFGIMLMETFTRKK 225
D+ +A+ +A+ PE + D++S G ML RK+
Sbjct: 172 IDWGLAEFYH---PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 226 PTD-------------EIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCV 272
P ++ E + + + S++ +
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 273 SFVFNLAIE----CTVESPEQRINAREI 296
V A++ + R+ ARE
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 9e-18
Identities = 44/208 (21%), Positives = 79/208 (37%), Gaps = 18/208 (8%)
Query: 51 EVAVKVFN--LQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK------ALVLEY 102
VA+K + Q K E +MK + H+N+I +++ + ++ LV+E
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM 162
M + D + ++ + +++LH SA +IH DLKP N+++ +
Sbjct: 104 MDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDC 156
Query: 163 VAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT 222
+ DF +A+ S T + T APE N D++S G ++ E
Sbjct: 157 TLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 223 RKKPTDEIFNREMTLKHWGNNWLPISTM 250
K + K P
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEF 241
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.2 bits (191), Expect = 6e-17
Identities = 35/192 (18%), Positives = 68/192 (35%), Gaps = 19/192 (9%)
Query: 51 EVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK-------------- 96
VA+K+ ++ E ++++ + + K S +N K
Sbjct: 40 HVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98
Query: 97 -ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPIN 155
+V E + L + + + I + L+Y+H +IH D+KP N
Sbjct: 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 156
Query: 156 VLLD-DNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFG 214
VL++ + +L IA L + T ++ T +PE D++S
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 216
Query: 215 IMLMETFTRKKP 226
++ E T
Sbjct: 217 CLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.0 bits (129), Expect = 2e-09
Identities = 23/183 (12%), Positives = 56/183 (30%), Gaps = 31/183 (16%)
Query: 51 EVAVKVFNL----------QCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEF----K 96
E VK + + F++ R L K+ + +
Sbjct: 26 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85
Query: 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINV 156
A+++E + + + ++ + + + ++H DL NV
Sbjct: 86 AVLMELIDAKE--------LYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV 134
Query: 157 LLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIM 216
L+ + + + DF + + E + + I + R R D+ S
Sbjct: 135 LVSEEGI-WIIDFPQSVEVGEE---GWREILERDVRNIITYFSRTYRTEK--DINSAIDR 188
Query: 217 LME 219
+++
Sbjct: 189 ILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-60 Score=402.12 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=213.1
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++++.||+|+||.||+|..+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999965 59999999997652 2345678899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++|+|.+++.... .+++..++.++.||+.||.||| ++||+||||||+|||+++++.+||+|||+++........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999997654 7999999999999999999999 999999999999999999999999999999876544333
Q ss_pred ccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.................
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~---------------- 223 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------------- 223 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC----------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Confidence 33445679999999999988776 6789999999999999999999976543322221111110
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........+++++.+|+.+||+.||++|||++|+++|+|-
T Consensus 224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 0011134567889999999999999999999999999984
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-59 Score=396.75 Aligned_cols=251 Identities=23% Similarity=0.266 Sum_probs=216.3
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++++.||+|+||.||+|..+ +++.||+|++... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 5899999999753 2334567889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+++|+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||+++++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 9999999999998765 6899999999999999999999 999999999999999999999999999999765432
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~----------------- 220 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----------------- 220 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 2234569999999999999999999999999999999999999997765443332221111
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
...+..+++++.+|+.+||..||++|||++|+++|+|-..
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1113456788999999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=400.03 Aligned_cols=255 Identities=23% Similarity=0.248 Sum_probs=217.7
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++++.++||||++++++|.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 358999999999999999999954 6999999999876555567899999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++||+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++.+.... .
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 9999999988764 5899999999999999999999 9999999999999999999999999999998764332 1
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
......||..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------------~ 233 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------------T 233 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC------------------S
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------------C
Confidence 2345579999999999999999999999999999999999999997655433322211110 0
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.....+..+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 01112445788899999999999999999999999998853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=399.13 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=217.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
+.|++++.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999965 68999999998776667788999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++|+|.+++......+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++........ .
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence 999999998766657999999999999999999999 99999999999999999999999999999876532211 2
Q ss_pred ccccccccccCCCcccc-----cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 184 QTQTLATIGCIAPEYRR-----KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.....||..|+|||++. +..++.++|||||||++|+|++|..||.+....+..........
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------------- 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------------- 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 23457899999999874 45678999999999999999999999987655443332221110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.....+..+++++.+|+.+||+.||++|||++|+++|+|-
T Consensus 233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred ----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0111234678889999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=392.94 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=212.2
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++++.||+|+||.||+|.++ ..||||+++.. .+...+.+.+|++++++++||||+++++++.+ ..+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 468999999999999999999864 35999999654 34567789999999999999999999998765 46899999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
|+++|+|.+++...+..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877667999999999999999999999 999999999999999999999999999999876543333
Q ss_pred ccccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 182 MTQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
.......||..|+|||++.+ ..++.++|||||||++|||+||..||.+.................
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------ 228 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------------ 228 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC------------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------
Confidence 33345678999999998864 357899999999999999999999998765433322221111100
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
+.....+..+++++.+|+.+||..||++|||+++|+++|+.+...++
T Consensus 229 ---p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 229 ---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00111234678899999999999999999999999999999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=389.47 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=208.1
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++++.||+|+||.||+|...+++.||||+++... ...+.+.+|++++++++||||++++++|.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46899999999999999999998888899999997653 34567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++|+|.+++......+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999999887778999999999999999999999 99999999999999999999999999999987643322 22
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC-CCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....+|..|+|||++.+..++.++|||||||++|||+|+ .+||......+........
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------------------- 218 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-------------------- 218 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT--------------------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc--------------------
Confidence 3345688999999999999999999999999999999995 5555544332222111110
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.....+..+++++.+|+.+||+.||++|||+++|+++|+++.+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00112345678899999999999999999999999999988653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=392.15 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=202.4
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee--CccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN--EEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+ +|+.||+|++... .+...+.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999965 5899999999764 34456778999999999999999999999865 456899
Q ss_pred EEEeecCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceeCCCCCCceEecCCCceeEcCCc
Q 047140 99 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAQ-----VIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
||||+++|+|.+++... +..+++..++.++.||+.||.||| +++ |+||||||+|||+++++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 99999999999998642 447999999999999999999999 655 9999999999999999999999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
+++.+..... ......||+.|+|||++.+..++.++|||||||++|||+||..||.+....+..........
T Consensus 160 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~------ 231 (269)
T d2java1 160 LARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------ 231 (269)
T ss_dssp HHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------
T ss_pred ceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence 9987653221 22345789999999999999999999999999999999999999977654433222111110
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..+++++.+|+.+||+.||++|||++|+++|||
T Consensus 232 --------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 232 --------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 0113456788999999999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-58 Score=397.85 Aligned_cols=275 Identities=18% Similarity=0.236 Sum_probs=215.0
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
.++|++.+.||+|+||.||+|... +|+.||+|+++.. .+...+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999965 6999999999765 34456788999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|++||+|.+++.+.+ .+++..++.++.|++.||.||| ++ +|+||||||+|||++++|.+||+|||++......
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999998765 6899999999999999999999 74 8999999999999999999999999999876432
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc--c---ccc-------
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW--L---PIS------- 248 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~--~---~~~------- 248 (313)
......||..|+|||++.+..++.++||||+||++|||++|+.||................. . +..
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 22345799999999999999999999999999999999999999976543222111000000 0 000
Q ss_pred -ccccccccc-cChhhh-h--------hhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 249 -TMEVVDANL-LSQEDI-H--------FVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 249 -~~~~~~~~~-~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.....+... ...... . .......+.++.+|+.+||..||++|||++|+++|+|-....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000000 000000 0 000123577899999999999999999999999999976544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=394.34 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=211.5
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+++|++++.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||++++++|.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 3478999999999999999999965 6999999999753 23345678999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||++||+|.+++...+ .+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+++.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999999987765 6999999999999999999999 999999999999999999999999999999876543
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
..........||..|+|||++.+..++.++|||||||++|+|++|..||.+....+..........
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-------------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--------------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--------------
Confidence 333333445799999999999999999999999999999999999999976544333222211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
..+..+++++.+|+++||..||++|||++|++.+.|
T Consensus 228 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 -------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 113356778999999999999999999999765544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=382.78 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=205.8
Q ss_pred ccc-ccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee----Cccc
Q 047140 25 SDF-QILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN----EEFK 96 (313)
Q Consensus 25 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 96 (313)
.+| +..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||++++++|.+ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 67778999999999999965 5889999999754 34456788999999999999999999999865 3568
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCceEec-CCCceeEcCCcchh
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPINVLLD-DNMVAHLSDFSIAK 173 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--i~h~di~p~nil~~-~~~~~~l~dfg~~~ 173 (313)
|+||||+++|+|.+++.+.. .+++..++.++.||+.||.||| +++ |+||||||+|||++ +++.+||+|||+++
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999997765 6899999999999999999999 888 99999999999996 57899999999997
Q ss_pred hcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..................+
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------- 231 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 231 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-------
Confidence 54322 2234579999999998865 59999999999999999999999997654433322221111000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
...+..+++++.+|+.+||+.||++|||++|+++|+|
T Consensus 232 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 232 -----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp -----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -----------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 1113346677999999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-58 Score=394.85 Aligned_cols=257 Identities=16% Similarity=0.215 Sum_probs=201.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.+.|++++.||+|+||.||+|..+ +++.||||++.... ......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45678999999999999999999965 58999999997652 23345678899999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec---CCCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD---DNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~~~~~~ 176 (313)
|||++||+|.+++...+ .+++..+..++.||+.||.||| +++|+||||||+|||+. +++.+||+|||++....
T Consensus 86 mE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999997765 7999999999999999999999 99999999999999995 57899999999998654
Q ss_pred cccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 177 GEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 177 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+..........
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------------ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------------ 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC------------
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC------------
Confidence 322 23345699999999999999999999999999999999999999977654443332222111
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 227 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 227 -----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred -----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 00111234577889999999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=380.88 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=218.6
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++++.||+|+||.||+|.+++++.||||+++.+. ...+.+.+|++++++++||||++++++|.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 47899999999999999999998888899999998753 34568999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccccc
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSMT 183 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 183 (313)
++|+|.+++......+++..++.++.|++.||.||| ++||+||||||+|||+++++.+||+|||+++...... ...
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 999999998877667899999999999999999999 9999999999999999999999999999998664332 222
Q ss_pred ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhh
Q 047140 184 QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQED 262 (313)
Q Consensus 184 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
.....+|..|+|||++.+..++.++|||||||++|||+| |..||......+.........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~------------------- 218 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------------- 218 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-------------------
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-------------------
Confidence 334568889999999999999999999999999999998 899998776554433222111
Q ss_pred hhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 263 IHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....+..+++.+.+|+++||+.||++|||++++++||.+
T Consensus 219 -~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 011234567789999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-57 Score=398.09 Aligned_cols=257 Identities=16% Similarity=0.185 Sum_probs=218.9
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+-++|++++.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||++++++|.+++.+|+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4568999999999999999999965 699999999987666667889999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC--CCceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD--NMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~~~~ 179 (313)
|++||+|.+++......+++..++.++.||+.||.||| ++|++||||||+|||++. ++.+||+|||++..+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999999766557999999999999999999999 999999999999999964 5789999999998765322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........+..
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 244 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------------- 244 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-------------
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 2334678999999999999999999999999999999999999997765444332222211100
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 245 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 245 ----DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp ----CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 011124567889999999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-56 Score=385.45 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=207.4
Q ss_pred ccccccccccccceeeeEEEEEee-cc---eEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SA---MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.++|++.+.||+|+||.||+|..+ ++ ..||||.+... .....+.+.+|++++++++||||++++++|.+++.+++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 578999999999999999999965 23 36899988654 34456789999999999999999999999999999999
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
||||+++|+|.+++......+++..+..++.||+.||.||| +++++||||||+|||+++++.+||+|||+++.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999887667999999999999999999999 999999999999999999999999999999876543
Q ss_pred ccccc---ccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 179 YQSMT---QTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 179 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
..... .....+|..|+|||++.+..++.++|||||||++|||+| |..||......+.........
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY----------- 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 22111 122457889999999999999999999999999999998 899998765544332221111
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
....+..+++.+.+|+.+||+.||++|||+++|+++|+.+..
T Consensus 251 ---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ---------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 011234578889999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-57 Score=397.77 Aligned_cols=257 Identities=17% Similarity=0.206 Sum_probs=219.3
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+.++|++++.||+|+||.||+|... +|+.||||++..........+.+|++++++++||||++++++|.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4568999999999999999999964 699999999987655566788899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEec--CCCceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLD--DNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg~~~~~~~~~ 179 (313)
|++||+|.+.+...+..+++..++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999988877767999999999999999999999 99999999999999998 67899999999998765322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||++.+..++.++|||||||++|+|++|..||.+....+............
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------------- 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-------------
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 2334568999999999999999999999999999999999999998765544332222111100
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 248 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 248 ----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp ----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ----CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 001123567889999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=385.95 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=217.2
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeeccc------chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC------GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (313)
.+.++|++++.||+|+||.||+|..+ +|+.||||+++... ....+.+.+|++++++++||||++++++|.+++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 35678999999999999999999965 69999999997531 123578899999999999999999999999999
Q ss_pred cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC----ceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM----VAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~----~~~l~dfg 170 (313)
..|+||||+++|+|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+|||++.++ .+|++|||
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999997765 6999999999999999999999 99999999999999998776 59999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.+....+..........
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------ 233 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------ 233 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC------
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------
Confidence 998764322 23345688899999999999999999999999999999999999987654433322211110
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
......+..++.++.+|+++||..||++|||++|+++|+|-.
T Consensus 234 -----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 234 -----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp -----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred -----------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 111122346788899999999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-57 Score=388.91 Aligned_cols=251 Identities=22% Similarity=0.235 Sum_probs=210.2
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
.+.|++++.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 346999999999999999999954 69999999997542 33456788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
||||.+|+|..++...+ .+++..++.++.||+.||.||| ++||+||||||+|||+++++.+||+|||++.....
T Consensus 94 ~E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 99999988876665544 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred ccccccccccccccCCCccccc---CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRK---GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+...........
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~----------- 232 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------- 232 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 234569999999998864 45899999999999999999999999766544333222211100
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
...+..+++++.+|+.+||..||++|||++++++|+|-.
T Consensus 233 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 233 --------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp --------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 001234678899999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=380.54 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=218.4
Q ss_pred ccccccc-ccccceeeeEEEEEee---cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILN-FFICGVIIPVAQFLIS---SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|.+.. +||+|+||.||+|.+. ++..||||+++.. .....+.+.+|++++++++||||+++++++.++ ..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 5677777 4999999999999854 3568999999764 345567899999999999999999999999754 57999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++|+|.+++......+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||+++.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998776668999999999999999999999 9999999999999999999999999999998765432
Q ss_pred cc-ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 180 QS-MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 180 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
.. .......+|..|+|||++.+..++.++|||||||++|||+| |..||......+.........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-------------- 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------------- 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 21 12234457889999999999999999999999999999998 999998765444322221111
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhccC
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLRNV 311 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~~~ 311 (313)
....+..+++++.+|+.+||..||++|||+.+|++.|.....++.++.
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 011245678889999999999999999999999999988887765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-56 Score=380.90 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=213.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++|++.+.||+|+||.||+|.+. +++.||||+++.+. ...+.+.+|++++++++||||++++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 468999999999999999999976 58999999997653 3457789999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 103 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 103 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
+++|+|.+++... ...+++..++.++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++...... .
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence 9999999999754 457899999999999999999999 9999999999999999999999999999998765432 1
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.......++..|+|||++.+..++.++|||||||++|||++|..|+................
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------------------ 232 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------------ 232 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------------------
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC------------------
Confidence 22334557889999999999999999999999999999999766654332222211111110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
.....+..+++++.+|+.+||..||++|||++++++.|+.+.
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 011123457888999999999999999999999999887764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=386.56 Aligned_cols=251 Identities=20% Similarity=0.212 Sum_probs=216.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++++.||+|+||.||+|..+ +++.||||+++.. .....+.+.+|+.+|+.++||||++++++|.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 68999999999999999999965 6999999999754 2334577889999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||++||+|.+++...+ .+++..++.++.||+.||.||| ++||+||||||+|||++++|.+||+|||+++......
T Consensus 85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999998766 6899999999999999999999 9999999999999999999999999999998654322
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.........
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~----------------- 221 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------------- 221 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-----------------
Confidence 12345679999999999999999999999999999999999999998765443322221111
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
...+..+++++.+|+++||+.||++|++ ++++++|+|-
T Consensus 222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 1123457788999999999999999994 9999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=376.86 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=210.8
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 36899999999999999999998888899999997653 345679999999999999999999998865 4579999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|.+++... ...+++..++.++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 999999987644 235899999999999999999999 9999999999999999999999999999998765332 22
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCC-ChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKP-TDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++.+..++.++|||||||++|||+||..| +......+........
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------------------- 226 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------------------- 226 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 23445688899999999989999999999999999999996554 4433322222111110
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+..+++++.+|+.+||+.||++|||++++++.|+++..
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0111234577889999999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=384.22 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=210.8
Q ss_pred cccccccccccceeeeEEEEEeec------ceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccc
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS------AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (313)
++|++++.||+|+||.||+|.... ...||+|.+... .......+.+|+.++.++ +||||++++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999999642 237999998654 334556788999999998 899999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 047140 97 ALVLEYMPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPI 154 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~ 154 (313)
++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997543 24788999999999999999999 999999999999
Q ss_pred ceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhh
Q 047140 155 NVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNR 233 (313)
Q Consensus 155 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~ 233 (313)
|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333345567899999999999999999999999999999998 89999775443
Q ss_pred hhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 234 EMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........... ....+..+++++.+|+.+||+.||++|||++||+++|..
T Consensus 274 ~~~~~~~~~~~-------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 ANFYKLIQNGF-------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCC-------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 32222111110 111244578889999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-55 Score=382.01 Aligned_cols=248 Identities=24% Similarity=0.247 Sum_probs=213.6
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (313)
++|++++.||+|+||.||+|+.+ +|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 58999999999999999999965 5999999999754 2334577899999999999999999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
||+.||+|..++.... .+++..++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 9999999999887765 6788999999999999999999 999999999999999999999999999999875432
Q ss_pred cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccCh
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.....||..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----------------- 217 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------------- 217 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------------
Confidence 234579999999999999999999999999999999999999997765443332221111
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..+++++.+++.+||..||++|+ |++++++|+|-
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 011345678899999999999999996 99999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=373.76 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=206.0
Q ss_pred cccccceeeeEEEEEee---cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEeecC
Q 047140 31 NFFICGVIIPVAQFLIS---SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYMPH 105 (313)
Q Consensus 31 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (313)
++||+|+||.||+|.+. +++.||||+++.. .+...+.+.+|++++++++||||++++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999864 3578999999654 344567899999999999999999999999754 57899999999
Q ss_pred CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc-ccc
Q 047140 106 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS-MTQ 184 (313)
Q Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 184 (313)
|+|.+++.... .+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999997765 6899999999999999999999 999999999999999999999999999999866433221 122
Q ss_pred cccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChhhh
Q 047140 185 TQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQEDI 263 (313)
Q Consensus 185 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
....+|..|+|||++.+..++.++|||||||++|||+| |..||.+....+.........
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-------------------- 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------------------- 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------------
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 34568889999999999999999999999999999998 899998765544322221111
Q ss_pred hhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHh
Q 047140 264 HFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSL 307 (313)
Q Consensus 264 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~ 307 (313)
....+..+++++.+|+.+||+.||++|||+++|++.|+....++
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 01123457888999999999999999999999998887766543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=382.19 Aligned_cols=256 Identities=16% Similarity=0.202 Sum_probs=216.5
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
+.++|++++.||+|+||.||+|..+ +++.||||+++... .....+.+|+++|+.++||||++++++|.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999965 68999999997763 344568899999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCC--CceeEcCCcchhhccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDN--MVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~--~~~~l~dfg~~~~~~~~~ 179 (313)
||+|++|.+++...+..+++..++.++.||+.||.||| ++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999877667999999999999999999999 9999999999999999854 589999999998654322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
......++..|+|||...+..++.++|||||||++|+|++|..||......+..........
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~--------------- 220 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY--------------- 220 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------------
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence 23345688899999999999999999999999999999999999977654433322221111
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.........+++++.+|+.+||..||++|||++|+++|+|-
T Consensus 221 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 221 --TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp --CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred --CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00111234577889999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=371.80 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=206.4
Q ss_pred ccccccccccccceeeeEEEEEeec-c----eEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS-A----MEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
+++|++.+.||+|+||.||+|.++. + ..||||++... .......+.+|++++++++||||+++++++.+++..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4689999999999999999999653 2 47999999754 3344567899999999999999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+|+||+.++++.+.+......+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999998877778999999999999999999999 99999999999999999999999999999987643
Q ss_pred ccc-cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQ-SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
... ........+|..|+|||++.+..++.++|||||||++|||++|..|+................
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------------- 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------------- 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------------
Confidence 321 112234457889999999999999999999999999999999665543332222111111110
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 0111234577889999999999999999999999999987764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=371.34 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=207.8
Q ss_pred cccccccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++++.||+|+||.||+|.+.. +..||||.++.. .....+.+.+|++++++++||||+++++++.+ +.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 689999999999999999998642 457899998654 34456789999999999999999999999964 578999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++|+|.+++......+++..++.++.||+.||.||| +++++||||||+||++++++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998877668999999999999999999999 9999999999999999999999999999998764332
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccccccc
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLL 258 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (313)
........+|..|+|||++.+..++.++|||||||++|||++ |.+||......+..........
T Consensus 163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------------- 227 (273)
T d1mp8a_ 163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------- 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------
T ss_pred -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 122334567889999999999999999999999999999998 8999987655443322211110
Q ss_pred ChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 259 SQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 259 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
...+..+++.+.+|+.+||..||++|||+.+|+++|..+.++-++
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhC
Confidence 112446788899999999999999999999999999998776543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-55 Score=372.67 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=213.8
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeeccc---------chhHHHHHHHHHHHhcCC-CCcceeeeeeeee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---------GRAFKSFNIECEMMKSIR-HRNLIKVISTCSN 92 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (313)
.++|++++.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999964 69999999997642 123456888999999996 9999999999999
Q ss_pred CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
++.+|+||||+++|+|.+++...+ .+++..++.++.||+.||+||| ++||+||||||+|||+++++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999998765 7999999999999999999999 999999999999999999999999999999
Q ss_pred hhcccccccccccccccccccCCCcccc------cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRR------KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
....... ......||..|+|||++. ...++.++||||+||++|+|++|..||.+................
T Consensus 158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~- 233 (277)
T d1phka_ 158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ- 233 (277)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 8765322 234467899999999875 345688999999999999999999999876554433222221110
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........+++++.+|+.+||+.||++|||++|+++|+|-
T Consensus 234 ----------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 234 ----------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp ----------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred ----------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 0011134578889999999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-55 Score=383.18 Aligned_cols=249 Identities=18% Similarity=0.172 Sum_probs=214.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEE
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
-++|++++.||+|+||.||+|..+ +|+.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 378999999999999999999965 6999999999753 223456788999999999999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
+||+.+|+|.+.+...+ .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999997765 6899999999999999999999 999999999999999999999999999999876432
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.....||..|+|||++.+..++.++|||||||++|+|+||..||.+..............
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------------- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------------- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC----------------
Confidence 234578999999999999999999999999999999999999997765433332221111
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
...+..+++++.+|+++||..||++|+ |++++++|+|-
T Consensus 255 -----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 011345678899999999999999995 99999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-54 Score=382.49 Aligned_cols=252 Identities=17% Similarity=0.184 Sum_probs=206.6
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc---c---hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccce
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC---G---RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKA 97 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (313)
++|++++.||+|+||.||+|... +|+.||||++.... . ........++++++.++||||++++++|.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 58999999999999999999965 59999999996531 1 11222334577888889999999999999999999
Q ss_pred EEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccc
Q 047140 98 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTG 177 (313)
Q Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 177 (313)
+||||++||+|.+++.... .+++..++.++.||+.||.||| +++++||||||+|||++.+|.+||+|||+++.+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999998765 6899999999999999999999 99999999999999999999999999999986643
Q ss_pred ccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccccccc
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDAN 256 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (313)
. ......||..|+|||++.. ..++.++|||||||++|+|+||..||................
T Consensus 160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~------------- 222 (364)
T d1omwa3 160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------- 222 (364)
T ss_dssp S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-------------
T ss_pred C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------
Confidence 2 2344579999999998864 568999999999999999999999997654322211110000
Q ss_pred ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCC-----HHHHHHHHHH
Q 047140 257 LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRIN-----AREIVAKLFK 302 (313)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~~il~~l~~ 302 (313)
......+..+++++.+|+.+||..||++||| |+++++|+|-
T Consensus 223 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 223 -----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp -----SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred -----cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 0001113457788999999999999999999 7999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=374.64 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=209.2
Q ss_pred cccccccccccceeeeEEEEEee-cce----EEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAM----EVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (313)
.+|++++.||+|+||.||+|.+. +|+ +||+|.+... .....+.+.+|++++++++||||++++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999864 344 6899988653 334567899999999999999999999999875 4678
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGE 178 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 178 (313)
++|++.+++|.+.+......+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999999888778999999999999999999999 999999999999999999999999999999877544
Q ss_pred cccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccc
Q 047140 179 YQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANL 257 (313)
Q Consensus 179 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (313)
..........+|..|+|||++.+..++.++|||||||++|||+| |..||......+........
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 43333444568999999999999999999999999999999998 78898765443322211111
Q ss_pred cChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 258 LSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+..+++.+.+|+.+||..||++|||+.+++++++.+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0111245678889999999999999999999999999987754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=377.43 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=207.1
Q ss_pred hccccccccc-ccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhc-CCCCcceeeeeeeee----Cc
Q 047140 22 SQTSDFQILN-FFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKS-IRHRNLIKVISTCSN----EE 94 (313)
Q Consensus 22 ~~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~ 94 (313)
.+.++|++.+ .||+|+||.||+|... +++.||||+++.. ..+.+|++++.+ .+||||++++++|.+ +.
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 4567899875 5999999999999964 6999999999653 456789998765 489999999999976 46
Q ss_pred cceEEEEeecCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCc
Q 047140 95 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFS 170 (313)
Q Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg 170 (313)
.+|+|||||+||+|.+++... ...+++..++.++.||+.||.||| ++||+||||||+|||+++ ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence 789999999999999999765 346999999999999999999999 999999999999999985 5679999999
Q ss_pred chhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 171 IAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||..||.+..............
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------- 229 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------- 229 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-------
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-------
Confidence 998665322 2345679999999999999999999999999999999999999997654322211110000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
..............+++++.+|+++||+.||++|||+.|+++|+|-.
T Consensus 230 ------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 230 ------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp ------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred ------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 00000001112345788899999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=377.68 Aligned_cols=251 Identities=21% Similarity=0.227 Sum_probs=211.7
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHh-cCCCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMK-SIRHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++++.||+|+||.||+|..+ +++.||||++... .....+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999965 6999999999753 2234456677777765 68999999999999999999999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEY 179 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 179 (313)
|||+++|+|.+++.... .+++..++.++.||+.||.||| +++++||||||+|||+++++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999997665 6899999999999999999999 9999999999999999999999999999998654322
Q ss_pred ccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccccccccC
Q 047140 180 QSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLS 259 (313)
Q Consensus 180 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (313)
.......||..|+|||++.+..++.++|||||||++|+|++|..||.+....+.........
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------------- 219 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------------- 219 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------------
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 22334578999999999999999999999999999999999999998765544332221110
Q ss_pred hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHH-HHHHHHHH
Q 047140 260 QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAR-EIVAKLFK 302 (313)
Q Consensus 260 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~il~~l~~ 302 (313)
...+..+++++.+|+++||..||++|||+. ++++|+|-
T Consensus 220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 111345678899999999999999999995 89999873
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-54 Score=367.37 Aligned_cols=262 Identities=20% Similarity=0.301 Sum_probs=208.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc---
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE--- 94 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 94 (313)
.+.++|++.+.||+|+||.||+|... +++.||||+++.. .......+.+|+++++.++||||+++++++.+.+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 35678999999999999999999964 6999999999754 3345667899999999999999999999997654
Q ss_pred -cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..|+||||++|++|.+++...+ .+++..++.++.||+.||.||| ++|++||||||+|||++.++..+++|||.+.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence 4789999999999999987765 6899999999999999999999 9999999999999999999999999999886
Q ss_pred hcccccc-cccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccccc
Q 047140 174 LLTGEYQ-SMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEV 252 (313)
Q Consensus 174 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (313)
....... ........||..|+|||++.+..++.++|||||||++|+|+||..||......+...........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~------- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI------- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-------
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-------
Confidence 5432221 12233456899999999999999999999999999999999999999876554433322211110
Q ss_pred ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-CHHHHHHHHHHHH
Q 047140 253 VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-NAREIVAKLFKIR 304 (313)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~~il~~l~~~~ 304 (313)
........+++++.+++.+||..||++|| |+++++..+..++
T Consensus 233 ----------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ----------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111245778899999999999999999 8888888877664
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=369.02 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=214.2
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeeccc-chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQC-GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++++.||+|+||.||+|..+ +++.||||+++... ....+.+.+|++++++++||||++++++|.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999864 35789999997653 33467799999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 047140 97 ALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 153 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p 153 (313)
++|+||+++|+|.+++.... ..++...++.++.|++.||+||| +++++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcc
Confidence 99999999999999996421 24788899999999999999999 99999999999
Q ss_pred CceEecCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCC-CCChhhhh
Q 047140 154 INVLLDDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK-KPTDEIFN 232 (313)
Q Consensus 154 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~p~~~~~~ 232 (313)
+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999998765443333344556888999999999999999999999999999999985 67876655
Q ss_pred hhhhhhhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 233 REMTLKHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.+.......... ...+..++.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 249 ~e~~~~v~~~~~--------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 EEVIYYVRDGNI--------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHTTCC--------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHcCCC--------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 444332211110 111345778899999999999999999999999998875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=370.40 Aligned_cols=272 Identities=21% Similarity=0.210 Sum_probs=208.4
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++++.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||++++++|.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999964 69999999996542 2235678899999999999999999999999999999999
Q ss_pred eecCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccc
Q 047140 102 YMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQ 180 (313)
Q Consensus 102 ~~~~~~L~~~l-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 180 (313)
|+.+ ++.+.+ ......+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9976 554444 444557999999999999999999999 9999999999999999999999999999998764322
Q ss_pred cccccccccccccCCCcccccCC-CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-----cccccc--
Q 047140 181 SMTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-----ISTMEV-- 252 (313)
Q Consensus 181 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~-- 252 (313)
.......++..|+|||++.... ++.++|+|||||++|+|++|..||......+...........+ ......
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 2334457899999999877655 5889999999999999999999997765433322211110000 000000
Q ss_pred -ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 253 -VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 253 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
..................++.++.+|+++||..||++|||++|+++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 00000000011111223567889999999999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=361.33 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=202.7
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeee-CccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-EEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 103 (313)
++|++++.||+|+||.||+|.. +|+.||||+++.+ ...+.+.+|++++++++||||++++++|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5799999999999999999998 5789999999764 345778999999999999999999999865 46689999999
Q ss_pred cCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|.+++.... ..+++..++.++.||+.||.||| +.+++||||||+|||++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999996542 35899999999999999999999 999999999999999999999999999999865422
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
.....++..|+|||++.+..++.++|||||||++|||+| |..||......+........
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------------- 216 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------------- 216 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 223457888999999999999999999999999999998 78887765443332222111
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
.....+..+++++.+|+++||..||++|||+.+++++|+.+..
T Consensus 217 -~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 -YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 0111234567889999999999999999999999999988764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=368.90 Aligned_cols=267 Identities=21% Similarity=0.219 Sum_probs=202.2
Q ss_pred cccccccceeeeEEEEEee-cceEEEEEEeecccc-----hhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 29 ILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG-----RAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 29 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
.++.||+|+||.||+|..+ +|+.||||+++.... .....+.+|++++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999965 699999999975421 1235688999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+.++++..+. .....+++..+..++.||+.||+||| ++|++||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 9886666554 44447899999999999999999999 99999999999999999999999999999987653321
Q ss_pred cccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccC-------Cccc-ccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGN-------NWLP-ISTMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~ 253 (313)
......+|..|+|||++.+ ..++.++|||||||++|+|++|..||......+........ .+.. .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 2234568999999998865 46799999999999999999999999776544332211110 0000 0000000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
........+ ........++++.+|+.+||..||++||||+|+++|+|-
T Consensus 236 ~~~~~~~~~-~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 236 TFKSFPGIP-LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp CCCCCCCCC-HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhccCCCCC-hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 000000000 111123567889999999999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-53 Score=366.81 Aligned_cols=272 Identities=17% Similarity=0.185 Sum_probs=208.1
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeeccc--chhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEe
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC--GRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEY 102 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (313)
++|++.+.||+|+||+||+|..++++.||||+++... ....+.+.+|+.++++++||||++++++|.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998889999999997642 23357888999999999999999999999999999999999
Q ss_pred ecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 103 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
+.++.+..+. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9775555554 44457999999999999999999999 99999999999999999999999999999987643221
Q ss_pred cccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc-------CCccc-ccccccc
Q 047140 183 TQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG-------NNWLP-ISTMEVV 253 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~-------~~~~~-~~~~~~~ 253 (313)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....... ..+.. .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23344688899999988654 568999999999999999999999976644333221111 00000 0000000
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.................+++++.+|+++||+.||++|||++|+++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0000000111112234567889999999999999999999999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=364.32 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=203.9
Q ss_pred ccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEEee
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
.++|++++.||+|+||.||+|..++++.||||+++... ...+.+.+|+.++++++||||++++++|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 36899999999999999999998888889999997653 345679999999999999999999999965 4579999999
Q ss_pred cCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcccccccc
Q 047140 104 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQSM 182 (313)
Q Consensus 104 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 182 (313)
++|+|..++... ...+++..++.++.||+.||+||| .++++||||||+|||+++++.+||+|||+++...... ..
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence 999999988654 346899999999999999999999 9999999999999999999999999999998664332 12
Q ss_pred cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChh-hhhhhhhhhhccCCcccccccccccccccChh
Q 047140 183 TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDE-IFNREMTLKHWGNNWLPISTMEVVDANLLSQE 261 (313)
Q Consensus 183 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (313)
......++..|+|||++....++.++|||||||++|||++|..|+.. ....+.........
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------------------ 231 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------------ 231 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------------
Confidence 23345688999999999999999999999999999999996655433 33222221111100
Q ss_pred hhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHH
Q 047140 262 DIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIR 304 (313)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~ 304 (313)
....+..+++++.+|+.+||+.||++|||+++|++.|+...
T Consensus 232 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 01123457788999999999999999999999998777644
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=366.91 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=203.4
Q ss_pred cccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC-cc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE-EF 95 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~ 95 (313)
++|++++.||+|+||.||+|... +++.||||+++.. .......+..|..++.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 68999999999999999999854 2468999999754 334456777888888777 789999999998654 56
Q ss_pred ceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC
Q 047140 96 KALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD 160 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~ 160 (313)
+++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 899999999999999996532 24889999999999999999999 999999999999999999
Q ss_pred CCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC-CCCChhhhhhhhhhhh
Q 047140 161 NMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKH 239 (313)
Q Consensus 161 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~p~~~~~~~~~~~~~ 239 (313)
++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++| ..||......+.....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999876544333334456789999999999999999999999999999999996 4677655432222111
Q ss_pred ccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 240 WGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.... .....+..+++++.+|+.+||..||++|||++++++||+.+.+.
T Consensus 250 ~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 250 LKEG-------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcC-------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1100 01112345778899999999999999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=369.10 Aligned_cols=275 Identities=20% Similarity=0.189 Sum_probs=208.7
Q ss_pred hcccccccccccccceeeeEEEEEee-c-ceEEEEEEeeccc--chhHHHHHHHHHHHhcC---CCCcceeeeeeeee--
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-S-AMEVAVKVFNLQC--GRAFKSFNIECEMMKSI---RHRNLIKVISTCSN-- 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-- 92 (313)
+..++|++++.||+|+||.||+|... + ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 45689999999999999999999963 4 6789999997542 22233456677777665 89999999999853
Q ss_pred ---CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCC
Q 047140 93 ---EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDF 169 (313)
Q Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~df 169 (313)
+...++++|++.++++..........+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 35789999999887776666666667999999999999999999999 999999999999999999999999999
Q ss_pred cchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCc-----
Q 047140 170 SIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNW----- 244 (313)
Q Consensus 170 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~----- 244 (313)
|.+...... .......||..|+|||++.+.+++.++||||+||++|||++|..||......+..........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 998765322 233456799999999999999999999999999999999999999987654333221111000
Q ss_pred -ccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 245 -LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.+........................+++.+.+|+++||+.||++|||++|+++|+|-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 0000000000000000011111234567889999999999999999999999999984
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=362.47 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=204.2
Q ss_pred ccccccccccccceeeeEEEEEeec----ceEEEEEEeecc---cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ---CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++.+.||+|+||.||+|.... ...||||+++.. .....+.+.+|++++++++||||++++++|.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 3689999999999999999998542 347999998754 334567899999999999999999999999765 67
Q ss_pred eEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhcc
Q 047140 97 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLT 176 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 176 (313)
++|+||++++++.+.+......+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999998877667999999999999999999999 9999999999999999999999999999998764
Q ss_pred cccccc-cccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhhhhccCCccccccccccc
Q 047140 177 GEYQSM-TQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTLKHWGNNWLPISTMEVVD 254 (313)
Q Consensus 177 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (313)
...... ......++..|+|||++.+..++.++||||||+++|||+| |..||.+....+..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~---------- 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------- 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----------
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC----------
Confidence 432222 2234457788999999999999999999999999999998 8999987655544332222111
Q ss_pred ccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 255 ANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
....+..++..+.+|+.+||+.||++|||+++|+..|.+.
T Consensus 233 ---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112345778899999999999999999999999877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=362.28 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=211.8
Q ss_pred ccccccccccccceeeeEEEEEeec--------ceEEEEEEeeccc-chhHHHHHHHHHHHhcC-CCCcceeeeeeeeeC
Q 047140 24 TSDFQILNFFICGVIIPVAQFLISS--------AMEVAVKVFNLQC-GRAFKSFNIECEMMKSI-RHRNLIKVISTCSNE 93 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (313)
.++|++++.||+|+||.||+|+... +..||||++..+. ......+.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4699999999999999999998532 2479999997653 34567888899999888 899999999999999
Q ss_pred ccceEEEEeecCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997543 35899999999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999987765444434455678889999999999999999999999999999998 788887655433322
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...... ....+..+++++.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 249 ~i~~~~--------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 LLKEGH--------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHTTC--------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCC--------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111100 111134567889999999999999999999999999988754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=365.40 Aligned_cols=244 Identities=20% Similarity=0.198 Sum_probs=202.6
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccc------hhHHHHHHHHHHHhcCC--CCcceeeeeeeeeCc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCG------RAFKSFNIECEMMKSIR--HRNLIKVISTCSNEE 94 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 94 (313)
.++|++++.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 478999999999999999999965 699999999975311 12234668999999986 899999999999999
Q ss_pred cceEEEEeecC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-CCceeEcCCcch
Q 047140 95 FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-NMVAHLSDFSIA 172 (313)
Q Consensus 95 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~ 172 (313)
..++|||++.+ +++.+++.... .+++..++.++.||+.||.||| +++|+||||||+|||++. ++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence 99999999975 57888887654 6899999999999999999999 999999999999999985 579999999999
Q ss_pred hhcccccccccccccccccccCCCcccccCCC-CCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRE-STNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
...... ......||..|+|||++.+..+ +.++|||||||++|+|++|..||........ ..
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~------~~-------- 220 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------GQ-------- 220 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH------CC--------
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhh------cc--------
Confidence 765322 2334568999999999887665 6779999999999999999999976432100 00
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
...+..+++++.+|+++||..||++|||++|+++|+|-
T Consensus 221 -------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 221 -------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp -------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred -------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 00123467889999999999999999999999999884
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=363.08 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=210.4
Q ss_pred cccccccccccceeeeEEEEEeec-ce--EEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCccceEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS-AM--EVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEFKALV 99 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 99 (313)
++|++++.||+|+||.||+|.+++ +. .||||.++.. .....+.+.+|+++++++ +||||++++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999999653 44 5788887643 344567899999999998 799999999999999999999
Q ss_pred EEeecCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCce
Q 047140 100 LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVA 164 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~ 164 (313)
|||+++|+|.+++... ...+++..+..++.||+.||.||| +++++||||||+|||+++++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999999643 246899999999999999999999 9999999999999999999999
Q ss_pred eEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCC-CCChhhhhhhhhhhhccCC
Q 047140 165 HLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRK-KPTDEIFNREMTLKHWGNN 243 (313)
Q Consensus 165 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~p~~~~~~~~~~~~~~~~~ 243 (313)
||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|. +||......+.........
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 999999997654222 223445889999999999999999999999999999999965 5676654444322211110
Q ss_pred cccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 244 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
....+..+++++.+|+.+||..||++|||+.+|+++|..+.++.+
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 244 --------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp --------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111234578889999999999999999999999999999886644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=359.28 Aligned_cols=281 Identities=19% Similarity=0.180 Sum_probs=206.2
Q ss_pred cccccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----cceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----FKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 98 (313)
|+++|.+.+.||+|+||.||+|+. +|+.||||+++... ........|+..+.+++||||+++++++.+.+ .+|+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 467899999999999999999986 68999999997542 22222333455556789999999999997654 5799
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
||||+++|+|.+++++. .+++..++.++.|++.||.|+|.. +.++|+||||||+|||++.++.+||+|||++.
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999875 488999999999999999999921 12699999999999999999999999999998
Q ss_pred hccccccc--ccccccccccccCCCcccccCC------CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCC-c
Q 047140 174 LLTGEYQS--MTQTQTLATIGCIAPEYRRKGR------ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNN-W 244 (313)
Q Consensus 174 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~-~ 244 (313)
........ .......||..|+|||++.+.. ++.++|||||||++|||+||..||................ .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76433221 1233466899999999877543 5678999999999999999998875543322211111110 0
Q ss_pred cccccccc-ccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 245 LPISTMEV-VDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 245 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
........ ......+ ..............+.+|+.+||+.||++|||+.||+++|.++.++-.
T Consensus 237 ~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTTSCCCC-CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccccCC-CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 00000111 1111111 111122233466779999999999999999999999999999987643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=359.73 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=216.3
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (313)
.++|++++.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||++++++|..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 379999999999999999999863 2578999999754 334456789999999999999999999999999999
Q ss_pred eEEEEeecCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEc
Q 047140 97 ALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLS 167 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~ 167 (313)
++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++++||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999986431 24688999999999999999999 9999999999999999999999999
Q ss_pred CCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhC-CCCChhhhhhhhhhhhccCCccc
Q 047140 168 DFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTR-KKPTDEIFNREMTLKHWGNNWLP 246 (313)
Q Consensus 168 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~p~~~~~~~~~~~~~~~~~~~~ 246 (313)
|||+++...............++..|+|||.+.+..++.++||||||+++|||+|| ..||......+..........
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~-- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC--
Confidence 99999877554443344455688999999999999999999999999999999998 577766655444332211110
Q ss_pred ccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHH
Q 047140 247 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRD 305 (313)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~ 305 (313)
...+..+++.+.+|+.+||+.||++|||+.+|+++|....+
T Consensus 254 ------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 254 ------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11134577889999999999999999999999999876543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=360.51 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=215.4
Q ss_pred ccccccccccccceeeeEEEEEee------cceEEEEEEeecc-cchhHHHHHHHHHHHhcC-CCCcceeeeeeeeeCcc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS------SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSI-RHRNLIKVISTCSNEEF 95 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (313)
.++|++++.||+|+||.||+|... +++.||||+++.. .......+.+|+.+++.+ +||||++++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 379999999999999999999852 3679999999764 344566789999999999 79999999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEe
Q 047140 96 KALVLEYMPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLL 158 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~ 158 (313)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +++++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 999999999999999997542 25889999999999999999999 9999999999999999
Q ss_pred cCCCceeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHh-CCCCChhhhhhhhhh
Q 047140 159 DDNMVAHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFT-RKKPTDEIFNREMTL 237 (313)
Q Consensus 159 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p~~~~~~~~~~~ 237 (313)
+.++.++++|||.++...............+|..|+|||++.+..++.++|||||||++|||+| |.+||..........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987754443444455678999999999999999999999999999999999 555554443322211
Q ss_pred hhccCCcccccccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 238 KHWGNNWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
... ... .....+..++..+.+|+.+||+.||++|||+++|++.|+++.++
T Consensus 259 ~~i-------------~~~------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMI-------------KEG------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHH-------------HHT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-------------hcC------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111 110 11112345678899999999999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=354.55 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=208.2
Q ss_pred ccccccceeeeEEEEEeec----ceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeee-CccceEEEEee
Q 047140 30 LNFFICGVIIPVAQFLISS----AMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN-EEFKALVLEYM 103 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 103 (313)
.+.||+|+||+||+|.+.+ ...||||+++.. .....+.+.+|++++++++||||+++++++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999999643 236899999753 45567889999999999999999999999876 45789999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc--
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS-- 181 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 181 (313)
++++|.+++.......+...+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999887767888999999999999999999 999999999999999999999999999999876433211
Q ss_pred ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhh-hhhhccCCcccccccccccccccCh
Q 047140 182 MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREM-TLKHWGNNWLPISTMEVVDANLLSQ 260 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (313)
.......++..|+|||.+.+..++.++||||||+++|||++|..||........ ........
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~----------------- 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------------- 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-----------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 123345688999999999999999999999999999999998777654332211 11111100
Q ss_pred hhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q 047140 261 EDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLL 308 (313)
Q Consensus 261 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~ 308 (313)
....+..+++.+.+|+.+||..||++|||+.||+++|+.+...+.
T Consensus 252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 011234567889999999999999999999999999999987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=360.50 Aligned_cols=275 Identities=19% Similarity=0.163 Sum_probs=204.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc-cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc----c
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ-CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----F 95 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 95 (313)
.++++|++++.||+|+||+||+|... +|+.||||++... .....+.+.+|+++|++++||||+++++++..+. .
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 45678999999999999999999954 6999999999754 3445677889999999999999999999997653 2
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.+++++++.+++|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||+++++.+||+|||++...
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 34455566688999999765 4899999999999999999999 999999999999999999999999999999765
Q ss_pred cccccc-ccccccccccccCCCcccc-cCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccc-----
Q 047140 176 TGEYQS-MTQTQTLATIGCIAPEYRR-KGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPIS----- 248 (313)
Q Consensus 176 ~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 248 (313)
...... .......++..|+|||++. +..++.++||||+||++|+|++|..||......+...........+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433221 1234456899999999874 556789999999999999999999999765432222111100000000
Q ss_pred -----ccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHH
Q 047140 249 -----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLF 301 (313)
Q Consensus 249 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~ 301 (313)
.......................+.++.+|+.+||..||++|||++|+++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 00000000000000001112345678999999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=360.46 Aligned_cols=269 Identities=22% Similarity=0.220 Sum_probs=202.6
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCc-----
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEE----- 94 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 94 (313)
+.++|++++.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+++|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 6789999999999999999999965 5999999999754 3345678889999999999999999999997654
Q ss_pred -cceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 95 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
.+|+||||+ +.+|..++... .+++..++.++.||+.||.||| ++||+||||||+|||++.++.+|++|||++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 579999999 55888877654 5999999999999999999999 9999999999999999999999999999998
Q ss_pred hcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcc-cccccc
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWL-PISTME 251 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 251 (313)
..... .....++..|+|||++.+ ..++.++||||+||++|+|++|..||.................. +.....
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 65432 234578999999998876 45689999999999999999999999765433222111110000 000000
Q ss_pred ccc--------ccccC-hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVD--------ANLLS-QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~--------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
... ..... ...........+++++.+|+.+||..||++|||+.|+++|+|-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 000 00000 0000011123567889999999999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=352.27 Aligned_cols=278 Identities=18% Similarity=0.205 Sum_probs=204.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN------ 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 92 (313)
.-.++|++.+.||+|+||+||+|... +|+.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 33589999999999999999999964 6999999998654 23345678899999999999999999999855
Q ss_pred --CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCc
Q 047140 93 --EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFS 170 (313)
Q Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 170 (313)
++..|+|||++.++ +..........+++..++.++.|++.||.||| ++||+||||||+|||++.++.+|++|||
T Consensus 87 ~~~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 87 RCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ----CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence 34689999999764 44455555557899999999999999999999 9999999999999999999999999999
Q ss_pred chhhccccccc--ccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc--CCcc
Q 047140 171 IAKLLTGEYQS--MTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG--NNWL 245 (313)
Q Consensus 171 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~--~~~~ 245 (313)
++......... .......+|..|+|||++.+. .++.++|||||||++|+|++|..||.+............ ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99765432211 122335689999999988755 689999999999999999999999976543322211110 0000
Q ss_pred cc--------ccccccccc-ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 246 PI--------STMEVVDAN-LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 246 ~~--------~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
+. ......... ...............++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 00 000000000 00111111111233466788999999999999999999999999843
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=351.02 Aligned_cols=272 Identities=19% Similarity=0.194 Sum_probs=210.0
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeCccceEEEE
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNEEFKALVLE 101 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (313)
++|++++.||+|+||+||+|... +++.||||+++.. .......+.+|+.+++.++||||++++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 6899999999654 23456788999999999999999999999999999999999
Q ss_pred eecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhccccccc
Q 047140 102 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLLTGEYQS 181 (313)
Q Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 181 (313)
++.+++|..++...+ .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999888887776554 7899999999999999999999 99999999999999999999999999999987643221
Q ss_pred ccccccccccccCCCcccccCC-CCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc----cC----Cccc-ccccc
Q 047140 182 MTQTQTLATIGCIAPEYRRKGR-ESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW----GN----NWLP-ISTME 251 (313)
Q Consensus 182 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~----~~----~~~~-~~~~~ 251 (313)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||............. .. .+.. .....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 223345677899999887665 6899999999999999999999974432222111110 00 0000 00000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
....................++.+.+|+.+||..||++||||+|+++|+|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 000011111111122234567889999999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=354.22 Aligned_cols=268 Identities=20% Similarity=0.175 Sum_probs=199.9
Q ss_pred ccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC------ccc
Q 047140 24 TSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE------EFK 96 (313)
Q Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~ 96 (313)
..+|+..+.||+|+||+||+|... +|+.||||++..... ...+|++++++++||||++++++|... .++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 447999999999999999999965 699999999976532 234699999999999999999998543 357
Q ss_pred eEEEEeecCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcch
Q 047140 97 ALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIA 172 (313)
Q Consensus 97 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~ 172 (313)
++||||++++ +.+.+. .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 8999999764 444332 23447999999999999999999999 99999999999999999775 8999999998
Q ss_pred hhcccccccccccccccccccCCCccccc-CCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc---CCccc--
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRK-GRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG---NNWLP-- 246 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~---~~~~~-- 246 (313)
....... ......++..|+|||.+.+ ..++.++||||+||++|||++|..||......+....... .....
T Consensus 171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 8664322 2334578999999997764 5789999999999999999999999976544332221110 00000
Q ss_pred -cccccccccc--ccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 247 -ISTMEVVDAN--LLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 247 -~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.......... ...............++++.+|+.+||..||++|||+.|+++|+|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0000000000 0000011111123467789999999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=353.57 Aligned_cols=272 Identities=20% Similarity=0.165 Sum_probs=199.5
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeee------
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSN------ 92 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 92 (313)
++.++|++++.||+|+||+||+|... +|+.||||+++.. .......+.+|+.+++.++||||++++++|..
T Consensus 14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 45578999999999999999999965 5999999999764 33455678899999999999999999999953
Q ss_pred CccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcch
Q 047140 93 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIA 172 (313)
Q Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 172 (313)
..+.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.++++|||++
T Consensus 94 ~~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp CCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhh
Confidence 3678999999976 5555553 25899999999999999999999 999999999999999999999999999998
Q ss_pred hhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhcc---CC----cc
Q 047140 173 KLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWG---NN----WL 245 (313)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~---~~----~~ 245 (313)
....... ......+|..|+|||++.+..++.++||||+||++++|++|..||.+............ .. +.
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 7654322 33455688999999999999999999999999999999999999965543222111100 00 00
Q ss_pred --ccccccccccc----------ccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 246 --PISTMEVVDAN----------LLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 246 --~~~~~~~~~~~----------~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
........... ... ............+.++.+|+++||..||++||||+|+++|+|-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 00000000000 000 00011112345688899999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-50 Score=349.33 Aligned_cols=267 Identities=20% Similarity=0.230 Sum_probs=203.3
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeC--ccceE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNE--EFKAL 98 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l 98 (313)
..++|++++.||+|+||+||+|+.. +++.||||+++.. ..+.+.+|+++|+.++ ||||++++++|... ...++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 3478999999999999999999964 6999999999754 3467889999999995 99999999999744 56899
Q ss_pred EEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCC-ceeEcCCcchhhccc
Q 047140 99 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNM-VAHLSDFSIAKLLTG 177 (313)
Q Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 177 (313)
||||+.+++|.... ..+++..++.++.||+.||.||| ++||+||||||+|||++.++ .++|+|||++.....
T Consensus 110 v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999999987653 25899999999999999999999 99999999999999998655 689999999986643
Q ss_pred ccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhc----c-----------
Q 047140 178 EYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHW----G----------- 241 (313)
Q Consensus 178 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~----~----------- 241 (313)
.. ......+|..|+|||.+.+. .++.++||||+||++++|++|..||............. .
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 22 23445688999999987765 47999999999999999999999996543211100000 0
Q ss_pred CCcccccccccccccccC--hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHH
Q 047140 242 NNWLPISTMEVVDANLLS--QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFK 302 (313)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~ 302 (313)
.................. ...........+++++.+|+++||..||++|||++|+++|+|-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000000001111110000 0111111234567889999999999999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=352.57 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=208.9
Q ss_pred cccccccccccceeeeEEEEEee----cceEEEEEEeecc----cchhHHHHHHHHHHHhcCCC-CcceeeeeeeeeCcc
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS----SAMEVAVKVFNLQ----CGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEF 95 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 95 (313)
++|++++.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 78999999999999999999852 3789999998653 22345678889999999966 899999999999999
Q ss_pred ceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchhhc
Q 047140 96 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAKLL 175 (313)
Q Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 175 (313)
.++++||+.+++|.+++...+ .+++..+..++.||+.||.|+| +++++||||||+|||++.++.++|+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999998766 5788999999999999999999 999999999999999999999999999999766
Q ss_pred ccccccccccccccccccCCCcccccC--CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccccc
Q 047140 176 TGEYQSMTQTQTLATIGCIAPEYRRKG--RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTMEVV 253 (313)
Q Consensus 176 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (313)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||................
T Consensus 180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---------- 248 (322)
T d1vzoa_ 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---------- 248 (322)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----------
T ss_pred cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----------
Confidence 433222 23345688999999988654 46889999999999999999999997664332222111100
Q ss_pred cccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCC-----CHHHHHHHHHH
Q 047140 254 DANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRI-----NAREIVAKLFK 302 (313)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~il~~l~~ 302 (313)
.......+..+++++.+|+.+||..||.+|| |++|+++|+|-
T Consensus 249 -------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 249 -------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp -------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred -------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 0001112446788999999999999999999 58999999884
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=354.81 Aligned_cols=272 Identities=18% Similarity=0.168 Sum_probs=204.3
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecc--cchhHHHHHHHHHHHhcCCCCcceeeeeeeeeC-----
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQ--CGRAFKSFNIECEMMKSIRHRNLIKVISTCSNE----- 93 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 93 (313)
.++++|++++.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 45789999999999999999999954 6999999999754 334556788999999999999999999998643
Q ss_pred ccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 94 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...+++++++.+|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++.++.++++|||.+.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred CceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 2346667777899999998654 5999999999999999999999 9999999999999999999999999999987
Q ss_pred hcccccccccccccccccccCCCcccccC-CCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccc-c----
Q 047140 174 LLTGEYQSMTQTQTLATIGCIAPEYRRKG-RESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLP-I---- 247 (313)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~---- 247 (313)
.... ......++..|+|||+..+. .++.++|||||||++|+|++|..||.+................. .
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6532 22345688899999987665 46899999999999999999999997654332222111110000 0
Q ss_pred -----cccccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHH
Q 047140 248 -----STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKI 303 (313)
Q Consensus 248 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~ 303 (313)
.......................+++++.+|+.+||..||++|||++|+++|+|-.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 00000000000000000111235678899999999999999999999999999853
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=342.70 Aligned_cols=266 Identities=16% Similarity=0.104 Sum_probs=205.9
Q ss_pred hcccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcce-eeeeeeeeCccceEE
Q 047140 22 SQTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNLI-KVISTCSNEEFKALV 99 (313)
Q Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 99 (313)
++.++|++++.||+|+||.||+|... +++.||||++.... ..+.+..|+++++.++|+|++ .+..++.+++..++|
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 45678999999999999999999964 68999999987652 234577899999999876654 555566777888999
Q ss_pred EEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC---CCceeEcCCcchhhcc
Q 047140 100 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD---NMVAHLSDFSIAKLLT 176 (313)
Q Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~~ 176 (313)
|||+ +++|.+.+......+++..+..++.|++.||+||| ++||+||||||+|||++. +..++++|||+++.+.
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9999 55888888776668999999999999999999999 999999999999999863 4579999999998765
Q ss_pred ccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCcccccccc
Q 047140 177 GEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTME 251 (313)
Q Consensus 177 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (313)
..... .......||..|+|||.+.+..++.++|||||||++|||++|..||...............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~--------- 228 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI--------- 228 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH---------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh---------
Confidence 33211 1223456999999999999999999999999999999999999999765432221111000
Q ss_pred cccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHH
Q 047140 252 VVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDS 306 (313)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~ 306 (313)
.. .............+++++.+++..||+.||++||+++++.+.|+.+..+
T Consensus 229 -~~---~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 229 -SE---KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -HH---HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hc---ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00 0000111112346788999999999999999999999888877766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-49 Score=337.64 Aligned_cols=268 Identities=12% Similarity=0.054 Sum_probs=214.7
Q ss_pred cccccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCCC-CcceeeeeeeeeCccceEEE
Q 047140 23 QTSDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRH-RNLIKVISTCSNEEFKALVL 100 (313)
Q Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 100 (313)
+.++|++++.||+|+||.||+|... +++.||||+++... ....+.+|++.++.++| +|++.+++++.++...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 4679999999999999999999965 69999999986542 23456789999999965 89999999999999999999
Q ss_pred EeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecC-----CCceeEcCCcchhhc
Q 047140 101 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDD-----NMVAHLSDFSIAKLL 175 (313)
Q Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~-----~~~~~l~dfg~~~~~ 175 (313)
||+ +++|.+++...+..++..++..++.|++.||.||| ++||+||||||+|||++. ++.++|+|||+++.+
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 67999999877778999999999999999999999 999999999999999974 578999999999876
Q ss_pred cccccc-----ccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhhhhhccCCccccccc
Q 047140 176 TGEYQS-----MTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMTLKHWGNNWLPISTM 250 (313)
Q Consensus 176 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 250 (313)
...... .......||+.|+|||++.+..++.++||||||+++|||++|..||.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~---------- 226 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE---------- 226 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH----------
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH----------
Confidence 432211 11234568999999999999999999999999999999999999997543321111000
Q ss_pred ccccccccChhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHHHHHHHHHHHHHHhhc
Q 047140 251 EVVDANLLSQEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAREIVAKLFKIRDSLLR 309 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~il~~l~~~~~~~~~ 309 (313)
.+.... ...........+|+++.+++..|+..+|++||+++.+.+.+.++.++...
T Consensus 227 ~i~~~~---~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 227 RIGEKK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHHHH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhcc---CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 000000 00001112345778899999999999999999999999988888776543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-44 Score=318.43 Aligned_cols=270 Identities=14% Similarity=0.150 Sum_probs=192.9
Q ss_pred cccccccccccceeeeEEEEEee-cceEEEEEEeecccchhHHHHHHHHHHHhcCC-----------CCcceeeeeeeee
Q 047140 25 SDFQILNFFICGVIIPVAQFLIS-SAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-----------HRNLIKVISTCSN 92 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 92 (313)
.+|++++.||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 36999999999999999999964 6999999999765 334567788999888875 4789999998865
Q ss_pred C--ccceEEEEeecCCC-HHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCceeCCCCCCceEecCCCc----
Q 047140 93 E--EFKALVLEYMPHGS-LEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPINVLLDDNMV---- 163 (313)
Q Consensus 93 ~--~~~~lv~e~~~~~~-L~~~l-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~~i~h~di~p~nil~~~~~~---- 163 (313)
. ...+++++++..+. ..... ......+++..+..++.||+.||.||| + .||+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence 4 45566666654333 22222 233457899999999999999999999 6 89999999999999986653
Q ss_pred --eeEcCCcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHHHHHhCCCCChhhhhhhhh-----
Q 047140 164 --AHLSDFSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLMETFTRKKPTDEIFNREMT----- 236 (313)
Q Consensus 164 --~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p~~~~~~~~~~----- 236 (313)
++++|||.+..... ......++..|+|||++.+..++.++|+||+||++++|++|..||.........
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999875432 234456899999999999999999999999999999999999999754321100
Q ss_pred -h---hhccCC---------c-----ccccccccccc-cccC---hhhhhhhhhhhhHHHHHHHHhHhhccCCCCCCCHH
Q 047140 237 -L---KHWGNN---------W-----LPISTMEVVDA-NLLS---QEDIHFVAKEQCVSFVFNLAIECTVESPEQRINAR 294 (313)
Q Consensus 237 -~---~~~~~~---------~-----~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 294 (313)
. ...... . ........+.. .... ............+.++.+|+.+||..||++||||+
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 0 000000 0 00000000000 0000 00111112345788899999999999999999999
Q ss_pred HHHHHHHHH
Q 047140 295 EIVAKLFKI 303 (313)
Q Consensus 295 ~il~~l~~~ 303 (313)
|+++|+|-.
T Consensus 324 e~L~Hp~f~ 332 (362)
T d1q8ya_ 324 GLVNHPWLK 332 (362)
T ss_dssp HHHTCGGGT
T ss_pred HHhcCcccC
Confidence 999999753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=9.6e-26 Score=180.44 Aligned_cols=171 Identities=15% Similarity=0.082 Sum_probs=121.5
Q ss_pred cccccccccceeeeEEEEEeecceEEEEEEeeccc------------------chhHHHHHHHHHHHhcCCCCcceeeee
Q 047140 27 FQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQC------------------GRAFKSFNIECEMMKSIRHRNLIKVIS 88 (313)
Q Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (313)
+.+++.||+|+||.||+|...+|+.||||++.... .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999998789999999875321 011234556888999999999998876
Q ss_pred eeeeCccceEEEEeecCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCceEecCCCceeEcC
Q 047140 89 TCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAQVIHCDLKPINVLLDDNMVAHLSD 168 (313)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i~h~di~p~nil~~~~~~~~l~d 168 (313)
+.. .+++|||+++..+.+ ++......++.|++.+|.||| ..|++||||||+|||+++++ ++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEE
Confidence 532 479999998754432 344556779999999999999 99999999999999999754 88999
Q ss_pred CcchhhcccccccccccccccccccCCCcccccCCCCCcchhHHHHHHHH
Q 047140 169 FSIAKLLTGEYQSMTQTQTLATIGCIAPEYRRKGRESTNGDVYSFGIMLM 218 (313)
Q Consensus 169 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 218 (313)
||.+.....+............ -.+ +....++.++|+||+.--+.
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHHh
Confidence 9998754322110000000000 001 11356788899999875443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=3.3e-09 Score=87.19 Aligned_cols=142 Identities=13% Similarity=0.066 Sum_probs=98.7
Q ss_pred cccccccccccceeeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCccceEEEEee
Q 047140 25 SDFQILNFFICGVIIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEFKALVLEYM 103 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 103 (313)
..|+..+..+-++.+.||+... ++..+++|+...........+.+|...++.+. +-.+++++.++.+++..++||+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 3566666554455578998764 46667889887654444456778888887773 445788888888888899999999
Q ss_pred cCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 047140 104 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY----------------------------------------- 142 (313)
Q Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------------- 142 (313)
+|.++.+...... . ...++.+++..+..||...
T Consensus 93 ~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred ccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 9988766543211 1 2234555666666666211
Q ss_pred ---------------CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 ---------------SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ---------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0117999999999999987777899998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.52 E-value=1.2e-07 Score=77.18 Aligned_cols=124 Identities=15% Similarity=0.053 Sum_probs=83.2
Q ss_pred eeeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCC--CCcceeeeeeeeeCccceEEEEeecCCCHHHHHhcC
Q 047140 38 IIPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIR--HRNLIKVISTCSNEEFKALVLEYMPHGSLEKYLYSS 115 (313)
Q Consensus 38 ~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 115 (313)
-+.||+.....+..+++|...... ...+..|...++.+. .-.+++++.+..+++..++||++++|.++...
T Consensus 24 ~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~---- 96 (255)
T d1nd4a_ 24 DAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS---- 96 (255)
T ss_dssp SCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS----
T ss_pred CCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc----
Confidence 367899887678889999865442 345667888887773 34467888888888888999999988654321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------------------
Q 047140 116 NCILDIFQRLNIMIDVASALEYLHFG------------------------------------------------------ 141 (313)
Q Consensus 116 ~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------------------------------------ 141 (313)
..... ..+.++...|.-||..
T Consensus 97 --~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 97 --HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp --CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred --cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 01111 1123333444444410
Q ss_pred -CCCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 142 -YSAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 142 -~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01127999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=1.1e-05 Score=69.58 Aligned_cols=76 Identities=14% Similarity=0.061 Sum_probs=49.1
Q ss_pred ccccccceeeeEEEEEeec-ceEEEEEEeecc-------cchhHHHHHHHHHHHhcC-CC--CcceeeeeeeeeCccceE
Q 047140 30 LNFFICGVIIPVAQFLISS-AMEVAVKVFNLQ-------CGRAFKSFNIECEMMKSI-RH--RNLIKVISTCSNEEFKAL 98 (313)
Q Consensus 30 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l-~h--~~i~~~~~~~~~~~~~~l 98 (313)
.+.+|.|....||++...+ ++.|++|.-... -+........|.+.|+.+ .+ ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578989999999998543 778999975431 112234556688888776 33 345666654 4455679
Q ss_pred EEEeecCCC
Q 047140 99 VLEYMPHGS 107 (313)
Q Consensus 99 v~e~~~~~~ 107 (313)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00019 Score=61.70 Aligned_cols=77 Identities=16% Similarity=0.143 Sum_probs=50.8
Q ss_pred cccccccccccceeeeEEEEEeec--------ceEEEEEEeecccchhHHHHHHHHHHHhcCC-CCcceeeeeeeeeCcc
Q 047140 25 SDFQILNFFICGVIIPVAQFLISS--------AMEVAVKVFNLQCGRAFKSFNIECEMMKSIR-HRNLIKVISTCSNEEF 95 (313)
Q Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (313)
+.+++ +.|+-|-.-.+|++..++ .+.|++++.... . ......+|..+++.+. +.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 34443 466668888999988653 356888877533 2 2345667999998884 4334577777753
Q ss_pred ceEEEEeecCCCH
Q 047140 96 KALVLEYMPHGSL 108 (313)
Q Consensus 96 ~~lv~e~~~~~~L 108 (313)
.+|+||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 589999876433
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00061 Score=56.75 Aligned_cols=132 Identities=14% Similarity=0.119 Sum_probs=75.9
Q ss_pred eeEEEEEeecceEEEEEEeecccchhHHHHHHHHHHHhcCCCCcc--eeee-----eeeeeCccceEEEEeecCCCH---
Q 047140 39 IPVAQFLISSAMEVAVKVFNLQCGRAFKSFNIECEMMKSIRHRNL--IKVI-----STCSNEEFKALVLEYMPHGSL--- 108 (313)
Q Consensus 39 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~~L--- 108 (313)
-.||++...+|+.+++|+.... ....+.+..|...+..|....+ +..+ ..+..++..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5799999888999999998654 2334667778888888742222 1111 122445567888998876321
Q ss_pred --HHH------Hh-------cC----CCCCC----------------------HHHHHHHHHHHHHHHHHHh-cCCCCCc
Q 047140 109 --EKY------LY-------SS----NCILD----------------------IFQRLNIMIDVASALEYLH-FGYSAQV 146 (313)
Q Consensus 109 --~~~------l~-------~~----~~~~~----------------------~~~~~~~~~~i~~~l~~lH-~~~~~~i 146 (313)
... +. .. ....+ .......+.++...+.-.- .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 10 00 00111 1122233344444333321 1113578
Q ss_pred eeCCCCCCceEecCCCceeEcCCcchh
Q 047140 147 IHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 147 ~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
+|+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999743 4589998665
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.0063 Score=49.90 Aligned_cols=31 Identities=39% Similarity=0.417 Sum_probs=27.7
Q ss_pred CCCceeCCCCCCceEecCCCceeEcCCcchh
Q 047140 143 SAQVIHCDLKPINVLLDDNMVAHLSDFSIAK 173 (313)
Q Consensus 143 ~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 173 (313)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999998888999999765
|